Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemical synaptic transmission (GO:0007268),0.5614465082174142,2.6357482864853448,0.0,0.0,0.0,107/284,15.97%,KCND2;NRXN1;GRID2;GRM5;GRIA3;KCNQ3;NLGN1;GRIK5;GRIK2;GRID1;SYT1;ASIC2;SYT5;DLG2;GLRA3;GABRG3;CHRM2;AMPH;HTR2C;RIT2;GABRB1;ERC2;GRIN2B;DLGAP1;CDH8;GRIA4;SNAP25;GABRB3;HCRTR1;SNPH;RIMS1;DLGAP2;PTPRN2;HTR3A;GAD2;CACNA1B;PCDHB5;CDK5;PNOC;GRIN2A;GLRA1;GABRB2;APBA2;PLP1;GABRA2;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;MTNR1B;CHRM3;CACNB3;SNCG;CNP;NPY;SLC1A2;RAPSN;NPTX2;HOMER1;GRIK1;GRM1;CACNB4;SLC12A5;STXBP2;CACNA1E;HTR4;GRIA2;GABRA3;TSPOAP1;SYN2;SLC6A2;SLC6A5;PDLIM4;GRM7;GABRA1;KIF5A;MINK1;HTR1D;PENK;RAB3A;SLC17A6;SLC1A3;LIN7C;CBLN1;MBP;PRKAR1B;NAAA;DLG4;SLC12A4;DTNA;GPR176;APOE;NLGN2;UTS2;PPFIA3;SCN2B;PTCHD1;KCNC4;UNC13A;NOVA1;GABRE;HRH1;GRM4;CACNB1;HTR1F;SNAPIN
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5742392233476974,2.5863759423016215,0.0,0.0,0.0,87/224,15.84%,KCND2;NRXN1;GRM5;GRIA3;KCNQ3;NLGN1;GRIK2;SYT1;ASIC2;SYT5;DLG2;GLRA3;GABRG3;CHRM2;AMPH;HTR2C;RIT2;GABRB1;GRIN2B;DLGAP1;GRIA4;SNAP25;GABRB3;HCRTR1;HTR3A;GAD2;CACNA1B;PCDHB5;CDK5;PNOC;GRIN2A;GLRA1;GABRB2;APBA2;PLP1;GABRA2;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;MTNR1B;CHRM3;CACNB3;SNCG;CNP;NPY;SLC1A2;RAPSN;NPTX2;HOMER1;GRIK1;GRM1;CACNB4;SLC12A5;CACNA1E;HTR4;GRIA2;GABRA3;SYN2;SLC6A2;SLC6A5;GRM7;GABRA1;KIF5A;MINK1;HTR1D;PENK;SLC1A3;CBLN1;MBP;PRKAR1B;DLG4;SLC12A4;DTNA;GPR176;NLGN2;UTS2;SCN2B;PTCHD1;KCNC4;NOVA1;GABRE;HRH1;GRM4;CACNB1;HTR1F
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5553362596161766,2.4446016168983125,0.0,0.0,0.0,59/159,11.81%,KIRREL3;PTPRD;GRID2;CDH18;LRRC4C;IL1RAPL1;TENM4;ROBO2;UNC5D;NLGN1;L1CAM;LRFN5;CNTN6;CNTN4;DSCAML1;CDH8;TENM1;PCDHGB4;CDH20;CDH9;CDH10;ADGRL3;DSCAM;ROBO1;TENM3;IGSF11;PCDHB5;CD177;MMP24;NTNG1;CLDN18;IGSF21;PTPRT;CEACAM5;DCHS1;CDH19;TENM2;CXADR;CLDN14;CDH12;NECTIN3;CLDN11;MYPN;SDK1;CDH7;VSTM2L;SLITRK1;CNTN2;EMB;PTPRS;CDH24;CDH17;CDHR3;LRFN4;MAG;LRRC4B;CBLN1;CELSR2;CDH2
prerank,neurotransmitter secretion (GO:0007269),0.6845370818115507,2.3654788528942166,0.0,0.0,0.0,22/44,18.47%,NRXN1;SYT1;PCLO;RIMS2;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;UNC13A;GRM4;SNAPIN;GAD1;SLC32A1
prerank,regulation of cell junction assembly (GO:1901888),-0.7475819510476692,-2.347499883595723,0.0,0.0,0.0,16/27,15.79%,TJP1;PRKCH;RAPGEF2;CLDN5;CBFB;F11R;PDLIM5;RAP1A;MEF2C;SETD5;ROCK1;RAP1B;OCLN;RAPGEF1;FLOT1;ROCK2
prerank,signal release from synapse (GO:0099643),0.67607165789572,2.321629918377806,0.0,0.0,0.0,21/43,18.47%,NRXN1;SYT1;PCLO;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;UNC13A;GRM4;SNAPIN;GAD1;SLC32A1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5587738551032976,2.3162702002755737,0.0,0.00011068601554119568,0.001,42/107,14.46%,GRID2;GRM5;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;SYT1;DGKI;DLGAP1;ATP1A2;RIMS2;CNTNAP4;RIMS1;DLGAP2;TMEM108;PSMC5;GRM8;CACNA1B;CDK5;CLN3;NPTXR;CACNA1A;SYN1;SLC8A2;NPTX2;HOMER1;GRIK1;GRM1;GRM7;MCTP2;CLSTN2;CDH2;DLG4;SLC8A3;CACNG5;NLGN2;DLGAP3;BDNF;BEGAIN;UNC13A
prerank,neurotransmitter transport (GO:0006836),0.5926573131697627,2.312407587573468,0.0,9.487372760673915e-05,0.001,33/73,15.97%,NRXN1;SYT1;ATP1A2;PPFIA2;SNAP25;SNPH;RIMS1;PTPRN2;SLC22A1;GAD2;SLC6A15;GABRA2;SYN1;SLC1A2;SLC28A2;STXBP2;SLC29A4;TSPOAP1;SYN2;SLC6A2;RAB3A;SLC17A6;SLC1A3;LIN7C;NAAA;GLS2;GLS;PPFIA3;UNC13A;GRM4;SLC6A4;PPFIA4;SNAPIN
prerank,glutamate receptor signaling pathway (GO:0007215),0.6714498998036174,2.3121721300093094,0.0,8.301451165589676e-05,0.001,15/37,9.69%,GRID2;GRM5;GRIA3;GRIK2;GRIN2B;GRIA4;GRM8;GRIN2A;CLN3;HOMER1;GRIK1;GRM1;TRPM1;GRIA2;GRM7
prerank,regulation of endothelial cell migration (GO:0010594),-0.5873859991239933,-2.2941245498497382,0.0,0.0006338952612924392,0.001,39/85,16.67%,FOXP1;TEK;DAB2IP;PTPRM;NRP2;SP100;ACVRL1;BMPER;ETS1;RAC1;RHOJ;BMPR2;THBS1;ANXA3;KDR;PRKD2;SLIT2;ABL1;BMP4;FGF1;PTK2;PRKD1;SCARB1;FLT4;RRAS;PIK3CD;ADAMTS9;BCAR1;AKT1;EDN1;BCAS3;CEACAM1;RIN2;FGF2;PRCP;PIK3CB;SMOC2;ROCK2;ANGPT1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6108747522857175,2.271628980169206,0.0,7.379067702746379e-05,0.001,29/57,14.40%,GRIA3;NLGN1;DLG2;LRRC7;GRIN2B;DLGAP1;GRIA4;DLGAP2;OPRM1;LYNX1;GRIN2A;SHANK1;NPTXR;GRIA1;CACNG8;CAMK2B;NPTX2;CACNG3;NETO1;GRIA2;MINK1;CACNG2;CACNG4;PRRT1;DLG4;CACNG5;NLGN2;DLGAP3;BEGAIN
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.6084668704479338,-2.2679693747442697,0.0,0.00042259684086162606,0.001,32/67,16.40%,FLT1;DAB2IP;WASF2;NRP2;DOCK1;ABI1;CLEC14A;RAC1;ELMO1;CRK;PAK2;KDR;PRKD2;PXN;NCK1;PIK3R1;PTK2;MAPKAPK2;ROCK1;PRKD1;FLT4;SHB;BCAR1;VEGFC;NCK2;RHOA;NCF2;PIK3CB;NCKAP1;ELMO2;ROCK2;FYN
prerank,establishment of endothelial barrier (GO:0061028),-0.7137812821735458,-2.264511202275978,0.0,0.0003169476306462196,0.001,15/29,11.22%,TJP1;RAPGEF2;PECAM1;F11R;RAB1A;ICAM1;MSN;AFDN;PDE2A;ROBO4;EZR;RAP1A;TJP2;RAP1B;RAPGEF1
prerank,presynapse assembly (GO:0099054),0.8220186730403956,2.2632407605577205,0.0,0.0001328232186494348,0.002,5/16,0.55%,PTPRD;IL1RAPL1;NLGN1;LRRTM3;PCLO
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.5649037777853683,-2.217393811768836,0.0,0.0005071162090339513,0.002,35/84,16.67%,FOXP1;TEK;NRP2;NOS3;ETS1;RAC1;BMPR2;TMSB4X;THBS1;ANXA3;KDR;PRKD2;PLCG1;SP1;ABL1;BMP4;FGF1;PRKD1;SCARB1;FLT4;RRAS;AKT3;PIK3CD;BCAR1;AKT1;EDN1;BCAS3;RIN2;FGF2;PIK3CB;CD40;LGMN;SMOC2;ROCK2;ANGPT1
prerank,neuron cell-cell adhesion (GO:0007158),0.8390671090662013,2.1955384259836546,0.0,0.0007244902835423716,0.012,7/14,5.17%,NRXN3;NRXN1;NLGN1;NCAM2;CNTN4;ASTN2;ASTN1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6140042456366387,2.1698174121701954,0.0,0.0013835751942649459,0.022,24/46,15.39%,NRXN1;GRM5;NLGN1;SYT1;DGKI;ATP1A2;GRM8;CDK5;CLN3;CACNG8;ATAD1;HOMER1;GRIK1;CACNG3;GRM1;GRM7;CACNG2;CACNG4;CDH2;CCL2;CACNG5;NLGN2;UNC13A;GRM4
prerank,regulation of synapse assembly (GO:0051963),0.6038897656087157,2.1577672143628055,0.0,0.001685833159781288,0.029,19/46,13.72%,PTPRD;NRXN1;GRID2;IL1RAPL1;ROBO2;NLGN1;LRFN5;IL1RAPL2;MUSK;EPHB1;SYNDIG1;MDGA1;SLITRK1;SLIT1;LRFN4;LRRC4B;CLSTN2;NLGN2;BDNF
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.7731818787287236,-2.152135269816074,0.0,0.002324282624738943,0.01,9/17,12.08%,PBX1;CREBBP;MAML2;KAT2B;NOTCH3;PLXND1;MAML1;NOTCH4;NOTCH1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6421399465209984,2.1494908680214198,0.0,0.0017551639607246744,0.033,13/37,6.71%,PTPRD;GRID2;IL1RAPL1;TENM4;NLGN1;TENM1;TENM3;IGSF21;CEACAM5;DCHS1;TENM2;CXADR;NECTIN3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6382825271776197,2.1466636390947973,0.0,0.0017267018424426525,0.035,15/35,10.44%,CDH18;NLGN1;CDH8;PCDHGB4;CDH20;CDH9;CDH10;PCDHB5;DCHS1;CDH19;CDH12;CDH7;CDH24;CDH17;CDHR3
prerank,regulation of cation channel activity (GO:2001257),0.5278480581928416,2.132741630041211,0.0,0.002282899070537161,0.047,40/89,18.03%,GRIA3;FGF14;NLGN1;DLG2;LRRC7;ANK3;GRIN2B;GRIA4;FGF12;OPRM1;GRIN2A;SHANK1;HPCA;GRIA1;CALM2;CACNB3;CACNG8;CAMK2B;HOMER1;CACNG3;NETO1;CACNB4;GRIA2;STAC;MINK1;CACNG2;CACNG4;PRRT1;DLG4;HRC;CACNG5;NLGN2;KCNS2;CACNB1;SELENON;NEFL;SHISA9;EPO;KCNAB1;CNIH2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.5351602865630883,-2.1190392706024626,0.0,0.0028978069087654363,0.014,42/92,17.53%,FOXP1;TEK;RREB1;NRP2;DOCK1;ETS1;RAC1;PRKCE;BMPR2;THBS1;ANXA3;KDR;MTOR;PRKD2;PLCG1;ADAM9;ABL1;BMP4;FGF1;TGFB2;PPM1F;PRKD1;SCARB1;FLT4;PLCG2;RRAS;PIK3CD;BCAR1;AKT1;EDN1;FGF7;BCAS3;RIN2;FGF2;PIK3CB;SMOC2;ROCK2;RAB11A;ANGPT1;HDAC6;MAP4K4;CTSH
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.5280752641153516,-2.102496059402732,0.0,0.0038033715677546344,0.022,32/87,16.15%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;GCNT2;F11R;ID1;SMURF1;TGFBR3;TGFBR2;ADAM9;PXN;CBL;ITGB5;TGFB2;PTPRK;PTK2;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;RHOA;SMAD6;SKI;ARHGEF18
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.6429383641178354,-2.097109236316537,0.0,0.0035216403405135504,0.023,16/33,13.72%,TJP1;SEMA6A;KLF4;BMPER;RHOJ;KLF2;THBS1;JAK1;FGF1;SMAD1;CEMIP2;ADAMTS9;CEACAM1;S100A1;FGF2;PIK3CB
prerank,Notch signaling pathway (GO:0007219),-0.5723915062705732,-2.0887497318727304,0.0,0.003803371567754635,0.028,27/59,17.56%,PBX1;ZNF423;CREBBP;MAML2;GMDS;KAT2B;DTX3L;NOTCH3;HES1;JAG2;SORBS2;PSEN2;PLXND1;MAML1;NOTCH2;ADAM10;NOTCH4;MIB1;PSEN1;NOTCH1;GALNT11;DTX3;NLE1;JAG1;APH1A;HEY2;HEY1
prerank,neuropeptide signaling pathway (GO:0007218),0.5612189586995762,2.081043618279855,0.0,0.005117600483257636,0.109,16/58,11.53%,GLRA3;HCRTR1;NXPH3;OPRM1;SORCS3;SORCS1;PNOC;GLRA1;GPR37;NXPH4;CPE;NPY;KISS1R;SORL1;PENK;NMUR2
prerank,positive regulation of nervous system development (GO:0051962),0.6057466585665588,2.0788847995007655,0.0,0.004943975360840075,0.111,14/42,13.72%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;OPRM1;MME;EPHB1;SYNDIG1;GPER1;LRRC4B;CLSTN2;NLGN2;BDNF
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.8025504236484,-2.071298328288666,0.0,0.005647430509696276,0.045,9/14,12.64%,GHR;LYN;PTPN1;PXN;PIK3R1;STAT6;PTK2;SOCS2;JAK2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.5027201216763656,-2.065706114592245,0.0,0.005705057351631951,0.05,35/112,12.70%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;LIMS1;GCNT2;F11R;ID1;NR3C1;SMURF1;TGFBR3;TGFBR2;ADAM9;PXN;PDE2A;CBL;PDE3A;ITGB5;TGFB2;PTPRK;MEF2C;PTK2;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;WWOX;RHOA
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.48988287535690056,-2.064318759882969,0.0,0.00546125148190409,0.052,40/128,12.70%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;BMPR2;SMURF2;GCNT2;F11R;BMP5;ID1;RNF111;SMURF1;TGFBR3;BMP6;TGFBR2;ADAM9;PXN;PDCD4;CBL;HIVEP1;ITGB5;BMP4;TGFB2;PTPRK;PTK2;CDH5;JUN;SMAD1;SMAD2;SMAD4;ACVR2A;RGMB;SMAD7;HFE;USP15;RHOA
prerank,regulation of cellular component biogenesis (GO:0044087),-0.6095781610352335,-2.0613284753257206,0.0,0.0052522750221373525,0.053,22/39,22.65%,TJP1;DAB2IP;RAPGEF2;SNCAIP;TIE1;MSN;IRGM;EZR;RAP1A;ROCK1;RAP1B;SPTY2D1;HJURP;RAPGEF1;NOTCH1;HCFC1;ROCK2;NCLN;CCL19;PTPN11;HSP90AA1;GFAP
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6315762708758238,2.06062105852508,0.0,0.006186765710776305,0.145,10/33,4.16%,GRID2;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;PSMC5;CACNA1B;CACNA1A
prerank,calcium ion transport into cytosol (GO:0060402),0.7020875794038867,2.0560347819397142,0.0,0.0066743667371341,0.163,10/21,12.07%,GRIN2B;MS4A1;CACNA2D1;ATP2B4;GRIN2A;CACNB3;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.6275609820037881,-2.0554891527297787,0.0,0.005747317035718113,0.06,17/32,21.18%,JCAD;KLF4;RHOJ;THBS1;KDR;MEOX2;PIK3C2A;AKT3;STARD13;MAP3K3;NOTCH1;RHOA;FGF2;GATA2;ANXA1;HDAC7;DLL4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6739616607290961,-2.052702586422671,0.0,0.005705057351631952,0.063,20/26,26.42%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;CDK10;AKT1;RGCC;RPTOR;LSM11;UBE2E2;LSM10;ANXA1;CCND1;MTBP;TFDP1;ADAM17;RDX;FGF10
prerank,positive regulation of synapse assembly (GO:0051965),0.6476158675575723,2.048421081106084,0.0,0.007178778722243264,0.184,7/27,3.93%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1
prerank,sprouting angiogenesis (GO:0002040),-0.5686211586603217,-2.0407830362458275,0.0,0.007159287656949901,0.08,28/51,23.92%,TEK;ENG;ACVRL1;RSPO3;ADGRA2;BMPER;THBS1;PARVA;KDR;RNF213;OTULIN;SLIT2;BMP4;FLT4;RAMP2;AKT1;VEGFC;NAXE;FGF2;PIK3R3;JMJD6;ANGPT1;SEMA3E;PTK2B;RECK;ESM1;SEMA5A;E2F7
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5710111079543704,-2.0320440805960964,0.0,0.00831107120361198,0.095,29/48,29.63%,JCAD;NOS3;ETS1;RHOJ;TMSB4X;THBS1;KDR;PRKD2;PLCG1;SP1;PIK3C2A;PRKD1;AKT3;AKT1;MAP3K3;FGF2;CD40;ANGPT1;GATA2;ANXA1;HDAC7;MAP2K3;HMGB1;ADAM17;HMOX1;ANGPT4;FOXC2;FGF18;MAPK14
prerank,regulation of cation transmembrane transport (GO:1904062),0.6316911835564959,2.0312131058643654,0.0,0.00896556725883685,0.23,12/29,8.46%,KCNIP4;KCNIP1;DPP10;FGF12;DPP6;ATP2B4;KCNN2;CD63;WNK3;CACNA1D;HOMER1;SCN5A
prerank,regulation of potassium ion transport (GO:0043266),0.6193570428207212,2.0289168603431262,0.0,0.008806756888712526,0.234,9/31,6.63%,KCNIP4;KCNIP1;DPP10;ANK3;DPP6;KCNA5;KCNN2;CD63;CACNA1D
prerank,protein localization to cell-cell junction (GO:0150105),-0.7769147707946195,-2.0264019619191527,0.0,0.008607630390181541,0.104,11/15,16.15%,TJP1;MPP7;F11R;LSR;PAK2;JAK1;CGNL1;TJP2;CDH5;ACTB;ARHGEF18
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.6709123378729143,-2.0162792918359154,0.0,0.009761987023903563,0.118,10/23,11.49%,ENG;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,potassium ion transport (GO:0006813),0.4748100078610835,2.01173506962194,0.0,0.011428331104628453,0.302,20/120,5.04%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;KCNMA1;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;SLC9A9
prerank,negative regulation of DNA binding (GO:0043392),-0.6433157165289138,-2.008905871510481,0.0,0.010685662976072544,0.134,13/28,17.56%,LEF1;SP100;SMO;NFKBIA;JUN;SIN3A;JAK2;ILRUN;MAD2L2;SUMO1;TFAP4;HEY2;HEY1
prerank,axon development (GO:0061564),0.5187549806150552,2.0082195391619657,0.0,0.011475926091311166,0.31,34/78,14.08%,CTNNA2;L1CAM;ANK3;DCC;CNTN4;DSCAML1;CDK5;SHTN1;NTNG2;NTNG1;PLPPR4;NRCAM;PLP1;ATL1;MAP1S;PAK3;PAX2;FGFR2;SLITRK1;NEFH;S100A6;MAPT;POU4F1;RTN4;SPTBN4;GRM7;SLITRK4;MAP1B;CCK;RAB3A;LLGL1;GAP43;AMIGO1;BRSK2
prerank,regulation of DNA binding (GO:0051101),-0.5808060046877357,-2.0063358883805313,0.0,0.010488085232293083,0.138,21/44,21.05%,LEF1;SP100;SMO;HES1;NFKBIA;ZBTB7A;JUN;NGF;DOT1L;HJURP;JAK2;MAPK8;FOXC1;SKI;ILRUN;SUMO1;TFAP4;IGF1;CEBPG;TXN;PPARG
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5036483786726137,-2.0059840867551633,0.0,0.010087202853610118,0.139,34/100,14.32%,FLT1;TEK;DAB2IP;IGF1R;GAB1;INSR;ROR1;LYN;PDGFD;KDR;EGFR;PIP4K2A;CBL;PIK3R1;NEDD4;TGFB2;STAMBP;PTK2;PIP4K2B;PIP5K1B;MAPK1;HAX1;IER3;PIK3CD;WNT16;MAZ;CEACAM1;JAK2;FGF2;MYOC;HGF;PIK3CB;PIK3IP1;PTPN13
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5341020972793613,-1.9992152105660186,0.0,0.01072339483686376,0.156,39/66,29.21%,RB1;DCUN1D3;KLF4;PKD2;ANKRD17;KMT2E;DDX3X;EGFR;DLG1;PLCB1;CCND3;PSME2;FAM107A;AKT1;RGCC;RPTOR;CDC73;LSM11;UBE2E2;CDK6;LSM10;CDK2AP2;PSME1;ANXA1;CCND1;FHL1;CDKN2C;PTEN;E2F7;APC;TFDP1;ADAM17;RDX;FGF10;KIF14;INO80;CDKN2B;CCND2;JADE1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7473138255474387,-1.9967375443484978,0.0018315018315018315,0.011257979840553718,0.17,7/14,13.13%,NOS3;ACE;ECE1;EDN1;ENPEP;AGTR1;EDN3
prerank,maintenance of blood-brain barrier (GO:0035633),-0.633546365352473,-1.9839820572884759,0.0,0.013360561661086793,0.206,14/30,11.80%,TJP1;PECAM1;CLDN5;ITGB1;JAM2;ESAM;F11R;LSR;SLC12A2;TJP2;CDH5;OCLN;MFSD2A;ACTB
prerank,endothelial cell proliferation (GO:0001935),-0.7205257832799823,-1.980130717408134,0.0,0.013710919725732755,0.213,8/17,6.97%,TEK;ACVRL1;BMPER;CD34;BMPR2;DLG1;BMP4;ERN1
prerank,synapse assembly (GO:0007416),0.512744454232721,1.9747910865745089,0.0,0.018263192564297287,0.455,19/67,9.77%,KIRREL3;NRXN1;GRID2;NLGN1;LRRTM3;GABRB3;ADGRL3;DSCAM;PCDHB5;CDK5;DNER;GABRB2;NRCAM;GABRA2;SDK1;GPM6A;SLITRK1;POU4F1;GABRA1
prerank,receptor clustering (GO:0043113),0.6408179396627071,1.9727688670779429,0.0,0.017955731410016187,0.461,6/27,3.22%,MAGI2;NRXN1;NLGN1;DLG2;LRRC7;MUSK
prerank,regulation of NMDA receptor activity (GO:2000310),0.5931130111735664,1.9655892977810725,0.0,0.019306803567971417,0.502,13/32,12.36%,GRIA3;NLGN1;DLG2;LRRC7;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA1;CAMK2B;GRIA2;DLG4;CCL2
prerank,secondary palate development (GO:0062009),-0.7482811455530101,-1.96558683998049,0.0,0.015983216231159357,0.254,7/14,12.95%,LEF1;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD4;WNT11
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.5904152963734742,-1.964271258265533,0.0,0.015738089245881246,0.258,22/33,26.42%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;STXBP4;PLCG2;AKT1;RGCC;RPTOR;CDC73;LSM11;UBE2E2;LSM10;ANXA1;CCND1;CRNN;TFDP1;ADAM17;RDX;FGF10
prerank,blood vessel morphogenesis (GO:0048514),-0.5400786536780855,-1.9541963000782279,0.0,0.01863652068199771,0.309,20/54,12.24%,FLT1;ENG;CAV1;LRP5;TBX1;ID1;KDR;SOX17;TGFBR3;TGFBR2;HES1;RASIP1;FLT4;COL4A1;RAMP2;CUL7;SMAD7;LAMA1;ADM;RASA1
prerank,positive regulation of synaptic transmission (GO:0050806),0.5106867950462288,1.950814681717044,0.0,0.02267154939016215,0.573,25/72,13.40%,NRXN1;NLGN1;GRIK2;SYT1;MPP2;SLC24A2;GRIN2B;RIMS2;RIMS1;ADCY8;GRIN2A;CACNG8;SLC8A2;CACNG3;GPER1;CACNG2;PRKCZ;CACNG4;CLSTN2;ADRA1A;DLG4;SLC8A3;CCL2;CACNG5;NLGN2
prerank,neuronal action potential (GO:0019228),0.645522812285931,1.9500611422401908,0.0,0.022137203108239134,0.575,8/22,10.44%,ANK3;SCN8A;SCN1A;SCN3A;KCNA2;SCN2A;SCN5A;GPER1
prerank,central nervous system neuron differentiation (GO:0021953),0.5959831521593972,1.9473103575548867,0.0,0.022280023773453582,0.586,16/33,13.59%,GRID2;MDGA2;SPOCK1;CHD5;LHX1;TOX;MDGA1;MAP2;NPY;PROX1;NTRK2;MAPT;FAIM2;CBLN1;KNDC1;WNT2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5684432822010355,-1.94550110005278,0.0,0.020448234235239972,0.346,16/42,14.54%,UTRN;TEK;FERMT2;RAC1;LIMS1;GSK3B;CCL25;KDR;PTPRJ;ABL1;ROCK1;PPM1F;RRAS;RIN2;MYOC;CDK6
prerank,synaptic vesicle exocytosis (GO:0016079),0.5652395453514616,1.9378599408129198,0.0022123893805309734,0.024510034566403518,0.626,10/40,6.32%,SYT1;PCLO;SYT5;RIMS2;SNAP25;SNPH;RIMS1;CDK5;STX2;PRRT2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6467287898501978,-1.9328521202816358,0.0,0.02400878302145113,0.393,12/24,16.96%,SEC31A;SEC24B;ACE;SEC24A;ABCB9;TAP2;SEC13;SEC24D;BCAP31;HFE;PDIA3;ERAP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5774747394976716,-1.9271398547459775,0.0,0.025816825187182976,0.425,21/39,23.25%,TEK;THBS1;KDR;PLCG1;ICAM1;GAS6;PDCD4;CDH5;RAMP2;RGCC;ANO6;ITGA4;ECSCR;CD40;ANGPT1;TNFAIP3;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6058670777349849,-1.9225947976472832,0.0,0.02669817688737567,0.446,11/30,11.49%,ENG;XIAP;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6778474198396793,-1.9222652106433027,0.0,0.02597159441981022,0.447,9/19,8.19%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;ABL1;ROCK1;PPM1F
prerank,tight junction assembly (GO:0120192),-0.5449733501884145,-1.9150925617298273,0.0,0.02789139149686732,0.484,14/49,9.31%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;LSR;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,protein localization to synapse (GO:0035418),0.74640617652387,1.9104754702721551,0.006787330316742082,0.03346742615363789,0.74,6/12,13.40%,NRXN1;NLGN1;PCLO;SHANK1;DLG4;NLGN2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6945936361872562,1.909981282731345,0.0021929824561403508,0.032639352700471407,0.741,6/15,9.69%,GRM5;GRM8;HOMER1;GRM1;TRPM1;GRM7
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.6242317863142004,-1.9053763070887155,0.0017921146953405018,0.031694763064621954,0.533,10/29,12.64%,GHR;PKD2;IL15;IFNAR1;NMI;STAMBP;STAT6;SOCS2;STAT2;JAK2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7777557136305842,-1.9052540731611642,0.001838235294117647,0.030860690352395057,0.533,3/11,1.73%,MECOM;ETV6;CD34
prerank,mesenchymal cell differentiation (GO:0048762),-0.5344179685452453,-1.895501783418776,0.0,0.03387276216752418,0.57,24/51,20.49%,LEF1;ENG;LIMS1;GSK3B;FBXL17;TGFBR3;LOXL3;LRP6;TGFB2;MEF2C;ROCK1;HNRNPAB;NOTCH4;CUL7;FOXF2;NOTCH1;HGF;FOXC1;ROCK2;BMP7;CTNNB1;HEY2;TRIM28;AKNA
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.487590106024264,-1.8946000908650236,0.0,0.03327950121785305,0.574,51/91,29.66%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPLP1;RPL3;SRPRA;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;RPS27;SIL1;SRP14;RPL27A;RPS3;RPL35A;RPL36A;RPL37A;RPL32;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;RPL30;RPL13A;RPL22;RPS17;RPL34;RPS2;RPS15A;RPS26;RPL15;RPL39;SEC61A1;RPL19;RPLP2;RPS13;RPL8;RPL18
prerank,epithelial to mesenchymal transition (GO:0001837),-0.5457738632309649,-1.8937132446020026,0.0,0.03299347530726988,0.578,22/47,20.49%,LEF1;ENG;LIMS1;GSK3B;TGFBR3;LOXL3;TGFB2;ROCK1;HNRNPAB;TASOR;NOTCH4;CUL7;FOXF2;NOTCH1;HGF;ROCK2;BMP7;CTNNB1;HEY2;HEY1;TRIM28;AKNA
prerank,regulation of gastrulation (GO:0010470),0.7120688302149465,1.8873336447356364,0.0021645021645021645,0.04199111183874275,0.837,5/14,6.13%,TENM4;LHX1;OSR1;PHLDB1;PHLDB2
prerank,sodium ion export across plasma membrane (GO:0036376),0.720874094265541,1.882776430225642,0.0022026431718061676,0.04318599373032318,0.854,5/13,8.80%,ATP1A2;SLC4A4;ATP12A;ATP1B1;ATP4A
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.5718174433292285,-1.8805286122864346,0.0,0.03899965131380149,0.646,9/33,5.99%,PTPRG;DAB2IP;PTPRM;SP100;ACVRL1;CORO1C;THBS1;MCC;SLIT2
prerank,synaptic membrane adhesion (GO:0099560),0.7141294552242062,1.8802906488970532,0.0,0.04316754606106631,0.86,8/14,10.93%,PTPRD;LRRC4C;LRFN5;NTNG1;SLITRK1;PTPRS;LRFN4;LRRC4B
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.7027062144248152,-1.8786599803752713,0.0018315018315018315,0.039006671194878925,0.658,9/15,15.43%,TMSB4X;THBS1;PRKD2;FGF1;PRKD1;NOTCH1;FGF2;LGMN;SMOC2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5785089432712521,-1.8780352013894448,0.0,0.03852354383399959,0.662,18/38,23.52%,SP100;NOS3;THBS1;GSK3B;BMP5;TNFSF10;DDX3X;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;FEM1B;GPX1;TNFAIP3;BRCA1;SERPINE1;RIPK1
prerank,bicellular tight junction assembly (GO:0070830),-0.5427915591284506,-1.877125928720341,0.0,0.03806188880027045,0.665,13/46,9.31%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.49990254012028473,-1.877030173714182,0.0,0.03726201709858164,0.666,23/72,13.72%,FLT1;TEK;IGF1R;GAB1;INSR;ROR1;LYN;PDGFD;KDR;CBL;PIK3R1;NEDD4;TGFB2;PTK2;HAX1;PIK3CD;WNT16;MAZ;JAK2;FGF2;MYOC;HGF;PIK3CB
prerank,regulation of angiogenesis (GO:0045765),-0.4269177477983846,-1.8755795954224213,0.0,0.037143564885093135,0.671,75/192,24.76%,FLT1;TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;SP100;ITGB1;GAB1;NOS3;TIE1;COL4A2;ADGRA2;KLF4;BMPER;ETS1;CD34;RHOJ;THBS1;ANXA3;KDR;PRKD2;PLCG1;SP1;FGF1;TGFB2;CDH5;ISM1;ROCK1;PLXND1;PRKD1;CEMIP2;RRAS;RAMP2;PIK3CD;HSPG2;VEGFC;PIK3R6;STAB1;RGCC;NAXE;MTDH;CEACAM1;FGF2;ECSCR;MECP2;AGO2;CD40;FOXC1;SMOC2;FOXO4;HIPK1;NPR1;ROCK2;GTF2I;TNFAIP3;CTNNB1;CTSH;GATA2;SASH1;EPHA2;SEMA3E;BRCA1;F3;PPARG;WARS1;NF1;RAPGEF3;SERPINE1;SEMA5A;THBS4;PTGIS;GLUL;ADGRB1;TSPAN12
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5180352421188266,-1.8755603693926062,0.0,0.036396152919207544,0.672,25/54,18.74%,TEK;ACVRL1;FERMT2;RAC1;CORO1C;THBS1;LIMS1;KDR;PTPRJ;ABL1;MACF1;PTK2;ROCK1;PPM1F;LDB1;FAM107A;LIMCH1;BCAS3;RHOA;DUSP3;MYOC;ROCK2;SLK;MAP4K4;DUSP22
prerank,apical junction assembly (GO:0043297),-0.5284633352799915,-1.8750424747776915,0.0,0.035912107047914504,0.675,17/53,13.60%,CTNNA1;PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2;RHOA;RHOC;PKN2
prerank,synapse organization (GO:0050808),0.44543645043095575,1.8723486411786137,0.0,0.04589391739123892,0.89,33/125,8.88%,KIRREL3;PTPRD;NRXN1;GRM5;LRRC4C;NLGN1;L1CAM;LRFN5;ANK3;ARHGAP39;CTNND2;PPFIA2;WNT7B;ADGRL3;DSCAM;PCDHB5;CDK5;DNER;MUSK;NTNG1;NRCAM;CACNB3;SNCG;PAK3;SLC8A2;SDK1;GPM6A;CACNB4;SLITRK1;MAPT;CNTN2;POU4F1;PTPRS
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.45237744674302094,-1.8616751442728683,0.0,0.04274989642156209,0.758,46/122,20.15%,SORBS1;INSR;KLF4;THBS1;STN1;EIF3E;METTL14;KDR;DDX3X;MTOR;PRKD2;NIBAN1;EGFR;EIF3C;PLD1;NFKB1;IRS1;UPF3B;TGFB2;ABCB10;SAMD4A;LDB1;NAMPT;RPL26;AKT1;ZCCHC4;EEF2;RGCC;JAK2;FGF2;DNA2;LARP4B;RPS4X;HGF;CTC1;RPL5;SMOC2;METTL5;IGF1;NLRC5;CCL19;NOD2;SOX4;FGFR4;PRKDC;IGF2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.658651752116369,-1.8599044233896762,0.0018148820326678765,0.042682280927024224,0.762,10/19,19.36%,TJP1;PRKCH;CLDN5;CBFB;F11R;ROCK1;OCLN;ROCK2;IKBKB;EPHA2
prerank,stress fiber assembly (GO:0043149),-0.6981689868477131,-1.8587093024728478,0.0,0.04164572263811836,0.764,9/15,12.70%,SORBS1;ITGB1;FAM171A1;CUL3;ITGB5;PDLIM1;PHACTR1;TNFAIP1;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6981689868477131,-1.8587093024728478,0.0,0.04164572263811836,0.764,9/15,12.70%,SORBS1;ITGB1;FAM171A1;CUL3;ITGB5;PDLIM1;PHACTR1;TNFAIP1;RHOA
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.780864610241159,-1.8578254043186202,0.0017152658662092624,0.04141449040443935,0.767,6/11,6.94%,TJP1;RAPGEF2;F11R;RAB1A;AFDN;TJP2
prerank,sodium ion transmembrane transport (GO:0035725),0.4627777987119968,1.8561002309219334,0.0,0.05392963249522564,0.937,22/84,9.60%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SCN1B;SCN1A;SLC4A4;ATP12A;SLC6A15;SLC9A7;SCN3A;SLC9A9;SLC6A11;ATP1B1;SCN2A;SLC8A2;SCN5A;ATP4A;SLC6A2;SLC6A5
prerank,positive regulation of glucose import (GO:0046326),-0.6397221213719176,-1.8549396640709248,0.0,0.042436406401432016,0.789,9/21,16.85%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;CREBL2;IGF1
prerank,positive regulation of lipid transport (GO:0032370),0.7238761656780232,1.8485979506844876,0.0022624434389140274,0.05825958428010835,0.948,5/12,13.32%,ABCA12;PRELID1;TRIAP1;SPP1;APOE
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5905683595875278,-1.8477991227790165,0.0,0.04588948909427765,0.813,17/30,27.83%,NOS3;GSK3B;BMP5;TNFSF10;DDX3X;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;GPX1;TNFAIP3;BRCA1;SERPINE1;RIPK1;RNF34;HMOX1
prerank,regulation of epithelial cell migration (GO:0010632),-0.5220826451460736,-1.8476162582739375,0.0,0.04519562003320127,0.813,16/51,8.83%,PTPRG;DAB2IP;RREB1;DOCK1;BMPER;RHOJ;PRKCE;BMPR2;CORO1C;MCC;PLCG1;MACF1;TGFB2;PTK2;PPM1F;PLCG2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6596543836958124,-1.84529643790721,0.001834862385321101,0.046033911044202645,0.827,12/19,25.41%,CBFB;ELF1;KLF4;IFIH1;LIFR;IRAK1;MAVS;IRAK2;MAPK7;TAF9;DHX9;PARP9
prerank,positive regulation of angiogenesis (GO:0045766),-0.4536819796916837,-1.842539314093509,0.0,0.046628905661172636,0.835,34/108,15.71%,FLT1;TJP1;TEK;ITGB1;GAB1;NOS3;TIE1;KLF4;BMPER;ETS1;CD34;THBS1;JAK1;ANXA3;KDR;PRKD2;PLCG1;SP1;FGF1;CDH5;SMAD1;PRKD1;RRAS;RAMP2;PIK3CD;VEGFC;PIK3R6;MTDH;S100A1;FGF2;AGO2;CD40;SMOC2;HIPK1
prerank,sensory perception of chemical stimulus (GO:0007606),0.6784472221430634,1.8399031665720094,0.002070393374741201,0.06297764318402471,0.964,6/15,16.71%,SLC24A4;GNAL;BBS4;UBR3;ADCY3;MKKS
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6346149440121285,-1.8364613968048848,0.001851851851851852,0.049190272276293266,0.859,8/21,17.42%,DAB2IP;CD2AP;CGNL1;SLIT2;TGFB2;STAMBP;SPRY4;ARHGAP12
prerank,vascular process in circulatory system (GO:0003018),-0.7114690872904796,-1.8358063288105024,0.0035026269702276708,0.048155591623990135,0.862,10/13,26.23%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;NPR1;ROCK2;GCLC;ACE2;ADCY6
prerank,regulation of tube diameter (GO:0035296),-0.7114690872904796,-1.8358063288105024,0.0035026269702276708,0.048155591623990135,0.862,10/13,26.23%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;NPR1;ROCK2;GCLC;ACE2;ADCY6
prerank,BMP signaling pathway (GO:0030509),-0.494935884624866,-1.8343838346176196,0.0,0.04831690547184592,0.868,20/62,11.76%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;BMP4;TGFB2;SMAD1;SMAD2;SMAD4;ACVR2A;RGMB;SMAD7;HFE;USP15
prerank,calcium ion import into cytosol (GO:1902656),0.6816430550266529,1.8323842649287434,0.009009009009009009,0.066743667371341,0.97,7/15,12.21%,SLC24A2;MS4A1;CACNA2D1;ATP2B4;SLC8A2;SLC8A1;SLC8A3
prerank,neuron projection morphogenesis (GO:0048812),0.42839352015864096,1.8319177902444623,0.0,0.06542315746500067,0.97,48/137,12.99%,CNTNAP2;NLGN1;CTNNA2;ANK3;DCC;CNTN4;DSCAML1;CTNND2;DOCK10;EPB41L3;CDK5;SHTN1;EPHB1;NTNG2;NTNG1;PLPPR4;NBL1;SHANK1;NRCAM;TNIK;ATL1;DCDC2;IMPACT;MAP1S;PAK3;PAX2;MAP2;PAK1;GPM6A;FGFR2;NYAP2;SLITRK1;NEFH;S100A6;POU4F1;SPTBN4;MINK1;CPNE1;SLITRK4;MAP1B;CCK;RAB3A;SRGAP2;CELSR2;LLGL1;DLG4;GAS7;SGK1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5691626068470601,-1.8316695954356346,0.0,0.0491863104309102,0.876,20/34,24.96%,FLT1;DAB2IP;SEMA6A;GAB1;KDR;PRKD2;ERN1;MAPKAPK2;PRKD1;FLT4;RAMP2;VEGFC;NOTCH1;FOXC1;ANXA1;DLL4;MAP2K3;RELA;PIK3CA;MT1G
prerank,sensory perception of smell (GO:0007608),0.7399327026835062,1.8312914996802647,0.00646551724137931,0.06437398040225449,0.97,5/11,16.71%,SLC24A4;BBS4;UBR3;ADCY3;MKKS
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.474574066591344,1.8305180316317293,0.0,0.06354853105605181,0.97,30/75,11.93%,CTNNA2;ANK3;DCC;CNTN4;DSCAML1;CDK5;SHTN1;NTNG2;NTNG1;PLPPR4;NRCAM;ATL1;DCDC2;MAP1S;PAK3;PAX2;MAP2;FGFR2;SLITRK1;NEFH;S100A6;POU4F1;SPTBN4;MINK1;SLITRK4;MAP1B;CCK;RAB3A;CELSR2;LLGL1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.479967373651274,1.8284973258338422,0.002257336343115124,0.06374070764535376,0.971,20/59,8.96%,KIRREL3;ROBO2;L1CAM;CNTN6;CNTN4;DSCAML1;DSCAM;ROBO1;TENM3;IGSF11;IGSF21;PTPRT;CEACAM5;NECTIN3;MYPN;SDK1;VSTM2L;CNTN2;EMB;CDH17
prerank,positive regulation of cell communication (GO:0010647),0.5940190164538053,1.8260839251505585,0.0,0.06389644624816429,0.971,9/28,11.94%,GRIK2;SYT1;ANK3;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;DLG4
prerank,blood vessel diameter maintenance (GO:0097746),-0.5554052690154684,-1.8245426325292158,0.0,0.05303265278320436,0.891,17/34,26.23%,NOS3;EDNRA;KLF2;ACE;ECE1;ROCK1;EDN1;SCPEP1;AGTR1;EDN3;NPR1;ROCK2;KCNMB2;GCLC;NOS1;ACE2;ADCY6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5908464562294828,-1.8222373172700395,0.005405405405405406,0.05355454510555516,0.895,10/25,12.08%,ENG;ZNF423;ACVRL1;BMPR2;BMP4;CDH5;SMAD2;SMAD4;ACVR2A;NOTCH1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6042046604283624,-1.820533212653474,0.0,0.054117625292429125,0.902,12/24,13.06%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;ABL1;PIK3R1;ROCK1;PPM1F;DUSP3;MYOC
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.7432356002585067,-1.8182380118560002,0.0,0.05496244794970913,0.909,4/12,7.04%,IGF1R;INSR;IRGM;BNIP3
prerank,regulation of sodium ion transport (GO:0002028),0.5445129765520084,1.8171709416876258,0.0,0.06886053741856636,0.979,13/34,9.51%,NKAIN2;ANK3;FGF12;SCN1B;ATP2B4;NKAIN3;PKP2;NKAIN4;GPD1L;WNK2;WNK3;SCN5A;SPTBN4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.57183500806498,-1.815899438753736,0.0,0.05592977319925173,0.915,17/33,23.74%,TEK;CAST;KDR;ICAM1;GAS6;PPARA;CDH5;RAMP2;YAP1;ANGPT1;TNFAIP3;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A;TCF7L2
prerank,synaptic vesicle cycle (GO:0099504),0.5679000501862164,1.815749753370626,0.0,0.06853949150104,0.981,8/30,10.83%,NLGN1;PCLO;SNAP25;RIMS1;CDK5;SYNDIG1;RAB3A;SLC17A6
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5294142715298336,-1.813575995840378,0.0,0.056923794464061025,0.921,16/43,16.85%,FOXP1;THBS1;LDLRAP1;MMP2;IL6R;BMP4;ERN1;JUN;AKT1;EDN1;FGF2;P2RY6;HTR1B;DNMT1;IGFBP5;IGF1
prerank,regulation of presynapse assembly (GO:1905606),0.640198764629398,1.8117635719493725,0.0069124423963133645,0.06857324209881605,0.982,8/18,10.93%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,regulation of presynapse organization (GO:0099174),0.640198764629398,1.8117635719493725,0.0069124423963133645,0.06857324209881605,0.982,8/18,10.93%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,dendrite self-avoidance (GO:0070593),0.6387042474460792,1.8049037453768377,0.013824884792626729,0.07227371099395688,0.991,8/16,8.58%,CNTN6;CNTN4;DSCAML1;DSCAM;MYPN;VSTM2L;CNTN2;EMB
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.764234042848404,-1.8042427817826234,0.001736111111111111,0.06240743487935421,0.935,5/10,12.64%,GHR;LYN;PTPN1;STAT6;JAK2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6995731590649912,-1.8039347647418038,0.00186219739292365,0.06175196337090511,0.935,10/14,22.69%,SEC31A;SEC24B;RAB1A;SEC24A;SEC13;SEC24D;SEC23B;TBC1D20;SEC24C;SAR1A
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7713183437623055,-1.8012689253618872,0.003663003663003663,0.06326795717502344,0.942,7/10,12.49%,RAPGEF2;CD34;KDR;RAP1A;RRAS;CEACAM1;RIN2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.502362379899473,-1.7999442654867146,0.0,0.06352658456411794,0.945,31/54,29.63%,ACVRL1;NOS3;ETS1;TMSB4X;THBS1;KDR;PRKD2;PLCG1;SP1;MEF2C;PRKD1;AKT3;AKT1;RGCC;FGF2;PRCP;MECP2;CD40;ANGPT1;GATA2;EPHA2;PPARG;MAP2K3;NF1;GADD45A;HMGB1;ADAM17;ANGPT4;JUP;FGF18;MAPK14
prerank,positive regulation of cell motility (GO:2000147),-0.407202831644194,-1.7992660929942978,0.0,0.06332191063470605,0.947,80/205,25.07%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;SEMA3C;ITGB1;PODXL;FERMT2;INSR;CAV1;DAB2;CBLL1;PDGFD;NTN1;SEMA7A;THBS1;GCNT2;SPOCK2;ATM;SYNE2;KDR;SMO;EGFR;ADAM9;FGF1;PTK2;CDH5;PPM1F;FAM107A;ADAM10;PIK3CD;BCAR1;MYLK;EDN1;MAZ;TWIST2;NOTCH1;NEDD9;SEMA3G;SEMA6B;SEMA4C;ACTN4;WNT11;MYOC;RHOC;HGF;NUMB;PIK3R3;VSIR;CAVIN1;SEMA5B;ROCK2;IGF1;MAP4K4;RIPOR1;CTSH;SEMA4A;CCL19;WASHC1;SEMA3E;F3;SEMA4G;SH3RF2;FERMT3;LAMC2;CCN1;SPAG9;PTK2B;MIEN1;HAS2;SEMA5A;CXCL12;PDGFRB;BMP2;LAMB1;WNT5B;APC
prerank,sodium ion transport (GO:0006814),0.45124084802084724,1.7990279469055126,0.0,0.07537091133739154,0.994,25/85,14.03%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SLC5A12;SCN1B;SCN1A;CATSPER4;SLC4A4;SLC6A15;SCN3A;SLC6A11;ATP1B1;SCN2A;SLC8A2;SCN5A;SLC6A2;SLC6A5;SLC8A1;SLC8A3;SGK1;SCN2B;ASIC1
prerank,potassium ion transmembrane transport (GO:0071805),0.4219266954079854,1.7985367523912712,0.0,0.0742703164281423,0.994,40/135,18.41%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;ATP12A;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;SLC9A9;ATP1B1;SLC12A5;KCNJ6;ATP4A;SLC1A3;KCNN3;SLC12A4;KCND1;KCNC4;KCNS2;KCNK12;KCNK9;KCNK10;KCNA4;KCNT2;KCNG2;KCNQ2;KCNAB1;NALCN;ABCC8
prerank,myeloid cell development (GO:0061515),-0.6344682862085641,-1.7979234795343402,0.0071301247771836,0.0636063850344229,0.949,6/18,7.89%,FOXP1;ALAS1;ANXA2;APP;MED1;ABCB10
prerank,Ras protein signal transduction (GO:0007265),-0.4287307281546608,-1.7960773410462565,0.0,0.06403165379652716,0.952,64/137,21.22%,RREB1;RAPGEF2;GNB1;RB1;EPS8;ARHGEF3;BRAP;RAC1;NTN1;ELMO1;PLEKHG5;EPS8L2;ARHGAP5;PLD1;GNA12;SHOC2;PHACTR4;PLCE1;RAP1A;JUN;ARHGDIA;PLK2;RASGRP2;ROCK1;PRKD1;RAP1B;RRAS;TP53;GRAP;RASSF1;RAPGEF1;ARHGAP1;ARHGEF11;AGTR1;GDI1;RHOA;FGF2;RHOG;CDC42EP3;RTKN;NCKAP1;KSR1;TAX1BP3;GRB2;ROCK2;DNMT1;ARHGAP29;RERG;IGF1;RIPOR1;ADGRG1;CFL1;DBNL;WASF1;NRAS;KRAS;RGL2;RAP2C;RRAS2;RAP2A;TRIM28;CDC42EP1;HACE1;ARHGEF1
prerank,protein targeting to ER (GO:0045047),-0.4571799239148862,-1.7951019224272031,0.0,0.06386088414405111,0.952,54/99,29.66%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPLP1;RPL3;SRPRA;RPL26;RPS11;SRP9;CHMP4B;CHMP4A;RPL13;RPL38;SGTA;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;RPS27;SRP14;RPL27A;RPS3;RPL35A;RPL36A;RPL37A;RPL32;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;RPL30;RPL13A;RPL22;RPS17;ZFAND2A;RPL34;RPS2;RPS15A;RPS26;RPL15;RPL39;SEC61A1;RPL19;RPLP2;RPS13;RPL8;RPL18
prerank,positive regulation of protein modification process (GO:0031401),-0.40508266517059827,-1.7949574680012148,0.0,0.06314880640976576,0.953,58/203,13.64%,TEK;PECAM1;ENG;TRABD2B;DYRK1A;PPP2R5A;INSR;DAB2;RAC1;LYN;FAM20A;RAB3GAP1;DVL3;APP;RALBP1;ATG7;RAMP1;LIMK2;TBX1;ATG10;KDR;ALG10B;DDX3X;SLCO3A1;LRRK2;ACE;NIBAN1;TFRC;EGFR;GAS6;FAS;ABL1;BMP4;FGF1;IRGM;PRKCD;CCND3;PTK2;CDH5;SPPL3;FLT4;IL34;ASPSCR1;ACVR2A;NOS1AP;AKT1;VEGFC;FGF7;AXIN2;ILK;LIMCH1;RAB3GAP2;KAT5;FGF2;CHP1;FLOT1;CSNK1D;HGF
prerank,negative regulation of angiogenesis (GO:0016525),-0.45763020685203337,-1.7943823568947046,0.0,0.06277147824948379,0.953,27/84,17.19%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;KLF2;THBS1;SLC12A2;TGFB2;ISM1;ROCK1;ADAMTS9;HSPG2;STAB1;RGCC;NAXE;ECSCR;PIK3CB;MECP2;FOXC1;FOXO4;NPR1;ROCK2;GTF2I;CTNNB1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6815181447718199,-1.793918919775355,0.0,0.06240346683390011,0.953,6/14,12.70%,KLF4;THBS1;MEOX2;STARD13;NOTCH1;RHOA
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5480044434831888,-1.7933313566854348,0.0037174721189591076,0.062260883346942734,0.954,12/34,13.06%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;LIMS1;CRK;ABL1;FLNA;ILK;NEDD9;MYOC
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.47833467369098037,-1.793277964920646,0.0018214936247723133,0.0615718505607186,0.954,21/67,14.54%,UTRN;RREB1;DOCK1;RSU1;FERMT2;RAC1;LIMS2;LIMS1;GSK3B;VIT;CRK;CCL25;ABL1;PPM1F;FLNA;FBLN2;ILK;NEDD9;JAK2;MYOC;CDK6
prerank,clathrin-dependent endocytosis (GO:0072583),-0.5820943346454256,-1.7924198907523252,0.0034782608695652175,0.061412376623784154,0.954,12/26,13.02%,FCHO2;FNBP1L;AP2B1;AP2A2;AP2S1;ITSN1;GPR107;PICALM;FCHSD2;ITSN2;GAK;LMBRD1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5746422723493319,1.7905260119285864,0.004464285714285714,0.07925923701953547,0.996,13/26,13.40%,NRXN1;NLGN1;RIMS2;RIMS1;TMEM108;SHANK1;SLC8A2;MTMR2;PRKCZ;CBLN1;DLG4;SLC8A3;NLGN2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.631503455392715,1.7889774046479352,0.004597701149425287,0.07902981509641371,0.997,8/18,10.83%,GRID2;GRIK5;GRIK2;GRID1;CDH8;GRIK1;GRIA2;SLC17A6
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6468151662102279,-1.7879727707140836,0.0,0.06379223605994734,0.96,8/18,12.08%,ENG;ACVRL1;NOS3;TGFBR2;BMP4;TGFB2;TBX2;NOTCH1
prerank,regulation of interleukin-8 production (GO:0032677),-0.47202793037463575,-1.7868997284036825,0.0,0.06403816314079896,0.962,37/69,35.77%,AFAP1L2;KLF4;NOD1;TMSB4X;RAB1A;PRKD2;LBP;ANXA4;MAVS;HYAL2;ANXA1;NOD2;PTPRC;F3;RELA;SERPINE1;RIPK1;HSPA1B;HMGB1;ARRB1;F2R;LGALS9;CACTIN;DDIT3;TLR6;TLR1;C5AR2;NOS2;TLR5;STAT3;CD14;PARK7;CD74;CD33;MAPKBP1;TLR8;SYK
prerank,neuromuscular process controlling balance (GO:0050885),0.6994027471030322,1.7866381622990504,0.0044742729306487695,0.0795191637967011,0.997,4/12,3.84%,NRXN1;PCDH15;CLN3;SHANK1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4845432056902424,-1.7864029755975717,0.0,0.06359353839724607,0.964,15/56,11.57%,RBPMS;ENG;ACVRL1;BMPER;DAB2;BMPR2;BMP5;BMP6;LDLRAD4;BMP4;TGFB2;SMAD4;ACVR2A;SMAD7;HFE
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.4746583096494454,-1.7856153191642647,0.0017241379310344827,0.06341833955021176,0.965,23/72,11.38%,BCR;AKAP13;HEG1;EPS8;ARHGEF3;RAC1;ARHGEF28;NET1;STARD8;ITGA3;RALBP1;F11R;SCAI;EPS8L2;RASIP1;ABL1;CUL3;ARHGDIA;PRAG1;RAF1;ARHGEF2;STARD13;TNFAIP1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.5777257788471736,-1.7851345695765377,0.0,0.06326132259325218,0.965,16/27,26.09%,ACVRL1;BMPR2;ATM;PRKD2;PARP4;DACH1;HMBOX1;RGCC;FGF2;HGF;SMOC2;TERF2;FGFR4;PDGFRB;SMG6;PINX1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3707624003238268,-1.7829933217319547,0.0,0.06433332574050155,0.969,140/476,18.78%,MECOM;LEF1;RREB1;SMARCA2;FLI1;ZBTB16;NFIB;SP100;ZNF423;ACVRL1;FOXO1;AFAP1L2;CREBBP;NSD1;ELF1;DYRK1A;KAT6B;KLF4;ETS1;ZMIZ1;LRP5;ESR1;MLLT3;ZFHX3;KLF2;DVL3;RXRA;NFATC1;PRDM16;TRIM56;BICRA;TBX1;MAP3K5;KMT2E;RNF111;DTX3L;TEAD1;ARID1B;KAT6A;MITF;SOX17;CD38;NAA16;SP1;FZD4;EGFR;CRLF3;TASP1;CTCF;HES1;SIX1;PPARA;NFKB1;HDAC1;RYBP;DNM2;PLCB1;SMARCC1;FOXO3;BMP4;LRP6;MED1;MEF2C;NSD3;JUN;ACTA2;CREB3L2;ZFP90;SETD3;CDH1;SMAD2;HNRNPAB;PPARD;PHF5A;PICALM;SMAD4;IRF1;TAL1;GLIS2;TP53;SP3;AKT1;NAA15;ELF2;NOTCH4;GLI3;MDFIC;ETS2;YAP1;FGF7;KDM3A;ILK;RGMB;SMARCC2;MAZ;MED13;ARHGEF11;PSEN1;MED17;FOXF2;HDAC4;NOTCH1;RPS6KA1;KAT5;YAF2;FGF2;WNT11;RHOG;XPC;ZIC3;FBXW11;ATF4;HCFC1;SMARCD3;MRPL12;FOXC1;TRIM16;JMJD6;CREBL2;TCF3;NR1D2;TADA3;MAD2L2;PCBD2;SIX4;BMP7;RARA;TFAP4;IGF1;CTNNB1;GPATCH3;HEY2;HEY1;NCOA6;CITED2;RNF10;WBP2;IKBKB;SOX4;EDRF1
prerank,cytoplasmic translation (GO:0002181),-0.46070311523449287,-1.7821932589881482,0.0,0.06432295431620201,0.97,51/91,29.75%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPLP1;RPL3;RPL26;RPS11;RPL13;RPL38;RPL27;RPS16;DRG1;RPS4X;RPL10;RPL7A;RWDD1;GSPT1;RPL5;RPS27;RPL27A;RPS3;RPL35A;RPL36A;RPL37A;RPL32;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;RPL30;RPL13A;RPL22;RPS17;EIF3I;RPL34;RPS2;RPS15A;RPS26;RPL15;RPL39;RPL22L1;RPL19;RPS13;RPL8;RPL18;EIF4A2
prerank,receptor internalization (GO:0031623),-0.5142439916611992,-1.7799920569800614,0.0,0.06538767423549181,0.973,18/44,15.42%,ITGB1;CAV1;CALCRL;DNM3;RAMP1;LDLRAP1;TFRC;DNM2;NEDD4;RAB5A;PICALM;RAMP2;ADM;CEACAM1;LMBRD1;ACKR3;SAG;GRB2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.6395910601097048,-1.778283597217639,0.005628517823639775,0.06602053226751145,0.974,10/17,22.14%,CLDN5;F11R;CDH5;ROCK1;PPP1R12A;ROCK2;TNFRSF1A;IKBKB;VCL;S1PR3
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.4571995034701174,-1.7771507055403057,0.0,0.06607346563982254,0.975,29/85,16.85%,DAB2IP;BCR;AKAP13;EPS8;LYN;ARHGEF28;STARD8;EPS8L2;SHOC2;PLCE1;TGFB2;STAMBP;ARHGDIA;NGF;DENND3;NOTCH2;RAF1;ARHGEF2;ARHGAP17;STARD13;GABARAP;RAPGEF1;NOTCH1;JAK2;SPRY4;GRB2;DENND4C;ARHGEF18;IGF1
prerank,mesoderm formation (GO:0001707),-0.6404205203978406,-1.7767970393003245,0.006872852233676976,0.06559147808952291,0.976,8/17,20.66%,ITGB1;BMPR2;ITGA3;ITGB4;SMAD2;KDM6B;ITGA2;ITGB3
prerank,endocardial cushion development (GO:0003197),-0.6110248986520816,-1.7763741498196568,0.0017857142857142857,0.06542327342589048,0.976,8/21,12.08%,ENG;ACVRL1;NOS3;BMPR2;BMP4;TGFB2;TBX2;NOTCH1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.6188378943571861,-1.775375514645523,0.005385996409335727,0.0655722170289519,0.977,15/20,30.44%,ENG;ACVRL1;TGFBR3;PDCD4;BMP4;TGFB2;NOTCH1;HEY2;HEY1;HAS2;TBX3;BMP2;SNAI2;TGFBR1;SPRY1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7334199684702895,-1.775016166169782,0.003663003663003663,0.0651359722572945,0.977,7/11,10.01%,IGF1R;GHR;GIGYF2;PLCB1;PIK3R1;IRS1;AKT1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.46897383862403064,-1.7743074363846247,0.0,0.06505430156294122,0.977,31/76,19.45%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;NOTCH3;IL6ST;EGFR;JAG2;ZBTB7A;TGFB2;PRAG1;AAK1;MAML1;ARRDC1;TSPAN14;AKT1;NOTCH4;YAP1;MFNG;TSPAN5;NOTCH1;GALNT11;TCIM;CCN3;JAG1;HEY1;GATA2;NOD2;WWP2;RITA1
prerank,hemopoiesis (GO:0030097),-0.4544919456118756,-1.7737251074213847,0.0,0.06492355266157161,0.977,30/87,16.27%,MECOM;FLT1;TEK;KITLG;ZBTB16;ETV6;SNRK;CD34;CDK13;KDR;KAT6A;TGFBR3;TGFBR2;TET2;BMP4;TGFB2;NOTCH2;FLT4;RRAS;TAL1;TP53;FUT10;NOTCH4;PRRC2C;ZFPM1;MKNK2;ASH2L;ATF4;HIPK1;JAG1
prerank,nervous system development (GO:0007399),0.35884877960858036,1.7732660402692695,0.0,0.08936941565162403,0.997,95/429,12.01%,LSAMP;RBFOX1;KIRREL3;NRXN1;ROBO2;NLGN1;NRG1;L1CAM;NAV3;ASIC2;ERBB4;MYT1L;CNTN6;CHRM2;IL1RAPL2;CNTN4;DSCAML1;ADAM23;ADAM22;TENM1;SCN8A;FGF12;ADGRL3;GPM6B;DSCAM;SH3GL2;APC2;MOBP;ROBO1;ZEB2;CYP46A1;NPAS1;SPOCK1;PCDHB5;CDK5;KALRN;DNER;VLDLR;LHX1;EPHB1;TYRO3;APBA2;NBL1;NRCAM;SRRM4;GFRA1;NELL1;DCHS1;ATXN10;PCDHA4;EFNB3;PTPRZ1;LIMK1;CHRM3;SCN2A;HPCAL4;DPYSL5;MAP1S;NFASC;CYP51A1;TMOD2;SDK1;PCDHA5;PROX1;GRIK1;GPM6A;GSN;MSI1;SCRG1;ACVR1B;AHI1;SLITRK1;LRCH4;NCAN;POU4F1;KLK6;FGF5;DCX;VEGFA;POU3F3;NRSN1;SDHA;DPF1;ALDH1A2;MOG;HAPLN2;RBFOX3;CBLN1;MBP;NMUR2;ARNT2;CDH2;DLG4;ESS2;FZD9
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4607799455271927,-1.7709072262090544,0.0,0.06671590720335274,0.978,49/87,29.66%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPLP1;RPL3;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;RPS27;SRP14;RPL27A;RPS3;RPL35A;RPL36A;RPL37A;RPL32;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;RPL30;RPL13A;RPL22;RPS17;RPL34;RPS2;RPS15A;RPS26;RPL15;RPL39;SEC61A1;RPL19;RPLP2;RPS13;RPL8;RPL18
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4641918434115999,-1.768329069701647,0.0,0.06824938979915261,0.983,27/70,16.40%,WASF2;DOCK1;MYO10;ABI1;RAC1;PRKCE;LYN;ELMO1;CRK;PLCG1;YES1;NCK1;ABL1;PIK3R1;PRKCD;PTK2;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;NCKAP1;ELMO2;GRB2;ARPC4;FYN
prerank,regulation of vasculogenesis (GO:2001212),-0.6835929556452618,-1.7659369609054152,0.0035149384885764497,0.0693099847832568,0.985,9/14,17.56%,RAPGEF2;CD34;KDR;RAP1A;RRAS;CEACAM1;RIN2;HEY2;HEY1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.5950626658533891,-1.7652781476626012,0.0,0.06905801260041668,0.987,9/23,11.02%,LYN;THBS1;BMP5;MSN;SLIT2;PTK2;MAPK1;IL34;STK10
prerank,membrane depolarization (GO:0051899),0.544139947354013,1.764869056731752,0.0091324200913242,0.09455212175044511,0.998,13/32,11.00%,SCN8A;SCN1B;SCN1A;CACNA1B;CACNA1A;SCN3A;SCN2A;CACNB3;CACNB4;CACNA1E;SCN5A;CACNG2;CACNG4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.46264771316570824,-1.7639327677221355,0.0,0.06953529161491727,0.988,30/74,24.04%,ITGA6;NOS3;EYA4;MCL1;THBS1;GSK3B;BMP5;TNFSF10;DDX3X;ICAM1;FAS;BMP4;BIRC6;ARHGEF2;SH3RF1;CASP8;AKT1;CFLAR;GPX1;TNFAIP3;IGF1;ZMYND11;BRCA1;MAPK7;TERT;RELA;SERPINE1;RIPK1;TCF7L2;HSPA1B
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5971346216171417,-1.7610948301794664,0.005434782608695652,0.07133115732732277,0.988,6/21,3.10%,FOXP1;PRKCH;CBFB;ELF1;LYN;SLC39A10
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.7341722502692601,1.7605684442665541,0.0,0.09716018444206158,0.998,7/10,19.51%,GABRG3;GABRB2;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,regulation of glucose import (GO:0046324),-0.5580295493354502,-1.7599571888348138,0.0017513134851138354,0.07151760368525537,0.988,11/30,16.85%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;GRB10;GSK3A;AKT1;CREBL2;IGF1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7051501199597183,-1.7595501537075984,0.0018181818181818182,0.07110191847496858,0.988,4/12,6.02%,FOXP1;DAB2;HDAC1;ZBTB7A
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6684183699915949,-1.7589729398511875,0.003552397868561279,0.07096137594761781,0.989,8/14,14.90%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.47705528237997785,1.7586264396648208,0.0,0.09755974281291684,0.998,20/57,15.84%,CHRM2;GNAI2;OPRM1;GRM8;GNAI1;ADCY8;GNAL;GPR37;CHRM3;GNAT3;MTNR1A;ADCY7;HTR4;GRM7;ADRA2A;HTR1D;GABBR1;ADCY3;GRM4;HTR1F
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6757557163093296,-1.7581127723383476,0.0017452006980802793,0.07092711705443036,0.989,6/15,6.15%,IGF1R;DYRK1A;KDR;EGFR;BMX;ABL1
prerank,actomyosin structure organization (GO:0031032),-0.46361199731479125,-1.7573032561408146,0.0,0.07099626926475318,0.99,27/75,16.92%,TJP1;FRMD6;PGM5;SORBS1;ITGB1;MYH9;FAM171A1;F11R;TMOD3;CUL3;ITGB5;MYO18A;CDC42BPA;ROCK1;PDLIM1;EPB41L2;EPB41L5;CSRP2;PHACTR1;FRMD5;TNFAIP1;LMOD1;RHOA;TPM1;ROCK2;SIX4;CDC42BPB
prerank,sulfur compound transport (GO:0072348),-0.5580989568334092,-1.7565419099981991,0.007207207207207207,0.07103022793946527,0.99,8/27,10.71%,ABCG2;SLC6A6;SLC26A7;SLC13A4;SLC5A6;SLC19A2;LRRC8D;SLC25A11
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.6602178508757481,-1.7553349065630819,0.005272407732864675,0.07142260590066667,0.991,9/15,23.74%,GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;RAPGEF3;TCF7L2
prerank,artery morphogenesis (GO:0048844),-0.5492682857199345,-1.7548339523778016,0.0017730496453900709,0.07120756768518399,0.991,20/30,30.22%,ENG;PKD2;BMPR2;TBX1;HES1;BMP4;TGFB2;TBX2;ADAMTS9;SMAD7;NOTCH1;JAG1;HEY2;NF1;PDGFRB;FOXF1;GJA5;STRA6;LRP2;TGFBR1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.53809073765734,-1.754066933778235,0.0018115942028985507,0.07120573030761503,0.991,11/35,11.91%,TJP1;TEK;ESAM;BAIAP2L1;F11R;ABL1;ARHGDIA;NOTCH2;HAX1;ABI3;BCAS3
prerank,endothelial cell development (GO:0001885),-0.5826057636242851,-1.7538701310539069,0.0018656716417910447,0.07076675546325074,0.992,10/25,11.22%,RAPGEF2;PECAM1;ICAM1;MSN;PDE2A;ROBO4;EZR;RAP1A;RAP1B;RAPGEF1
prerank,regulation of autophagosome assembly (GO:2000785),-0.5512527429940436,-1.7531333734111614,0.0,0.07077955293610619,0.993,16/33,23.27%,RAB3GAP1;MTMR3;LRRK2;PIP4K2A;PIP4K2B;RAB5A;TBC1D14;SCFD1;CHMP4B;CHMP4A;RAB3GAP2;PHF23;SEC22B;IFT20;TBC1D12;RALB
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.49246616002549926,-1.7526883827767457,0.0017241379310344827,0.0705127898281742,0.993,12/45,11.57%,RBPMS;ENG;ACVRL1;DAB2;BMPR2;BMP5;BMP6;BMP4;TGFB2;SMAD4;ACVR2A;HFE
prerank,receptor signaling pathway via STAT (GO:0097696),-0.5949898484746983,-1.7512453404278894,0.005434782608695652,0.07097496186101225,0.994,9/25,12.64%,GHR;PKD2;IFNAR1;NMI;STAMBP;STAT6;SOCS2;STAT2;JAK2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.45846488610496605,-1.7505264495296786,0.0,0.07107022371190395,0.994,27/71,16.40%,WASF2;DOCK1;MYO10;ABI1;RAC1;PRKCE;LYN;ELMO1;CRK;PLCG1;YES1;NCK1;ABL1;PIK3R1;PRKCD;PTK2;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;NCKAP1;ELMO2;GRB2;ARPC4;FYN
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.61615860230888,-1.7504729716060636,0.009124087591240875,0.07054573213689244,0.994,10/19,15.92%,TJP1;BMP6;AFDN;PPM1F;DENND6A;NOTCH4;RGCC;NOTCH1;FLOT1;MAD2L2
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.5064129114239041,-1.7452506999830553,0.003590664272890485,0.07415535384562041,0.996,22/44,26.65%,TNRC6B;ZC3HAV1;METTL14;GIGYF2;FTO;PUM1;ROCK1;POLR2G;CELF1;RC3H1;AGO2;BTG2;ROCK2;MOV10;TNRC6A;TOB1;RBM24;METTL16;CNOT8;NANOS1;CNOT1;PABPC1
prerank,cellular response to BMP stimulus (GO:0071773),-0.46329664978418983,-1.7419635392330215,0.0,0.07639726303576518,0.996,20/66,11.76%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;BMP4;TGFB2;SMAD1;SMAD2;SMAD4;ACVR2A;RGMB;SMAD7;HFE;USP15
prerank,cell differentiation in hindbrain (GO:0021533),0.6818017847833406,1.7416470251810094,0.009302325581395349,0.11284617810256417,0.999,6/11,12.92%,GRID2;LHX1;PROX1;FAIM2;CBLN1;KNDC1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5908438677897615,-1.7413142960155863,0.007042253521126761,0.0762719136974451,0.996,12/22,23.28%,MEF2A;IL6ST;ROCK1;SMAD4;LMCD1;EDN1;PDE9A;NOTCH1;ROCK2;IGF1;MTPN;GLRX3
prerank,neuron differentiation (GO:0030182),0.3943015548710174,1.7408225036201865,0.0,0.11185612484834545,0.999,38/165,14.89%,PTPRD;IL1RAPL1;TENM4;PHOX2A;MYT1L;ATP8A2;TENM1;SNPH;WNT7B;IRX4;NIF3L1;TENM3;SPOCK1;CDK5;ATP2B2;RUNX2;FUT9;LHX1;ITM2C;TENM2;EPHA5;NTRK2;IRX3;ADNP2;INSM1;ACSL3;LMX1B;VEGFA;FZD3;WNT6;RUNX3;NRBP2;UGDH;PBX4;WNT2;BRSK2;WNT4;RNF112
prerank,inorganic cation transmembrane transport (GO:0098662),0.3725644035628842,1.739977965158204,0.0,0.11091776438623506,0.999,66/268,16.37%,TRPM3;KCND2;KCNC2;KCNQ3;ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;SCN8A;KCNH7;SCN1B;RYR3;KCNA5;SCN1A;SLC4A4;ATP12A;KCNH4;SLC6A15;ATP2B4;SLC9A7;KCNH5;KCNN2;CACNA1A;SCN3A;KCNA2;SLC9A9;SLC6A11;ATP1B1;SLC46A1;SCN2A;SLC8A2;CACNA1D;UCP3;SLC36A2;TMCO1;TRPM1;ATP6V0C;SCN5A;ATP4A;SLC6A2;SLC6A5;SLC1A3;SLC39A2;KCNN3;P2RX3;SLC8A1;SLC8A3;KCND1;SCN2B;ASIC1;SLC39A7;KCNC4;KCNS2;CACNA2D4;KCNK12;KCNK9;KCNK10;SLC6A4;KCNA4;SLC4A11;ATP6V0D1;KCNG2
prerank,regulation of monooxygenase activity (GO:0032768),-0.5835046274182849,-1.7380077242017113,0.005454545454545455,0.07858272775190109,0.996,9/23,10.01%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;CYGB;WASL;NOS1AP;AKT1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7173162626723047,-1.7365942010515065,0.00718132854578097,0.07912622753656733,0.996,6/11,13.49%,RSPO3;DAB2;MLLT3;NKD1;PLEKHA4;CSNK1D
prerank,endothelial tube morphogenesis (GO:0061154),-0.74395608338539,-1.7355489694392139,0.0057361376673040155,0.0795513596415661,0.996,6/10,17.19%,ACVRL1;PRKD2;BMP4;STARD13;RHOA;CTNNB1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.506668009057372,-1.7353853437175693,0.001763668430335097,0.0790289107789433,0.996,21/46,25.03%,PIEZO2;F11R;NFKB1;PDE2A;FAS;BNIP3;IRF1;CRADD;CASP8;MAPK8;CD40;TNFRSF1A;MAP2K4;CASP8AP2;CHEK1;CASP2;LTBR;PIEZO1;GADD45A;MAP3K14;CASP1
prerank,I-kappaB phosphorylation (GO:0007252),-0.7266317588916001,-1.734448099792408,0.01098901098901099,0.07910423190919136,0.996,2/10,1.43%,DAB2IP;ERC1
prerank,lipid modification (GO:0030258),0.5124162088706293,1.7330678434910074,0.004694835680751174,0.11609771027027135,1.0,15/37,16.75%,DGKK;DGKI;DGKQ;PLPPR4;PLPPR1;PLPP2;PLA2G7;SGPP1;PLPP4;PLPPR5;ALOX12;MBOAT7;CYP1A1;ALOX5;MBOAT2
prerank,positive regulation of cell migration (GO:0030335),-0.3808329001609658,-1.728418050351644,0.0,0.08378144907328222,0.996,74/253,17.75%,FLT1;TJP1;LEF1;DAB2IP;IGF1R;RREB1;ITGA6;RAPGEF2;SEMA6A;PECAM1;SEMA3C;DOCK1;ITGB1;GAB1;PODXL;FERMT2;INSR;CAV1;DAB2;PRKCE;BMPR2;CBLL1;PDGFD;SEMA7A;SMURF2;THBS1;GCNT2;ATM;SYNE2;KDR;MTOR;PLCG1;SMO;EGFR;ADAM9;NIPBL;FGF1;TGFB2;PTK2;CDH5;PPM1F;ARHGEF2;PLCG2;FAM107A;ADAM10;PIK3CD;BCAR1;MYLK;EDN1;MAZ;TWIST2;NOTCH1;NEDD9;SEMA3G;SEMA6B;SEMA4C;ACTN4;WNT11;MYOC;RHOC;HGF;AGO2;NUMB;PIK3R3;VSIR;SEMA5B;ROCK2;RAB11A;HDAC6;IGF1;MAP4K4;RIPOR1;CTSH;SEMA4A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4507272137630114,-1.7283192722538907,0.0017605633802816902,0.08319028497816497,0.996,29/76,19.12%,NFAT5;NR3C2;NOD1;UACA;TMSB4X;LIMS1;APP;DDX3X;EGFR;NMI;NFKBIA;DLG1;PDCD4;EZR;RASSF2;PPM1B;ILK;IRAK1;RHOA;ACTN4;TCIM;CCN3;IFI35;C1QTNF3;BMP7;CCL19;NOD2;RPS3;SASH1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5927691614081428,1.7273456693739913,0.00663716814159292,0.1205068838292145,1.0,10/21,19.08%,GCK;PGLS;H6PD;TKT;RPIA;HK1;PGD;PGM2;HK3;PGM2L1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.6721650523640574,-1.7256186739625394,0.007207207207207207,0.08494196501318685,0.997,6/13,6.68%,ABHD2;NR3C2;ESR1;NR3C1;BMP4;MED1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5681399136316361,-1.7255051275733195,0.0074487895716946,0.08442722299649826,0.997,12/26,22.34%,DAB2IP;IQGAP1;PLCG1;EGFR;PTPN12;MED1;DUSP3;ZPR1;FOXC1;DUSP22;PTPN11;SYAP1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.501193604565831,-1.7231849405233544,0.003663003663003663,0.08589753846677692,0.997,22/47,26.13%,RREB1;ZBTB16;LRP5;SOX13;TRPM4;SIX1;NAPEPLD;PPARD;AKT1;TMEM64;LPL;CREBL2;BMP7;CARM1;CMKLR1;PPARG;AAMDC;CREB1;SYAP1;PIM1;BMP2;HNRNPU
prerank,axonogenesis (GO:0007409),0.37622658826366645,1.7222757910661468,0.0,0.12400137800779325,1.0,63/237,10.91%,NRXN3;NRXN1;ROBO2;UNC5D;CTNNA2;L1CAM;DAB1;CNTN6;ANK3;DCC;NCAM1;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;CDK5;SHTN1;VLDLR;EPHB1;NTNG2;NTNG1;PLPPR4;NRCAM;TNR;DOK5;ATL1;UNC5C;GFRA1;SEMA6D;EFNA3;EFNB3;EPHA5;SEMA3B;DOK6;MAP1S;PAK3;PAX2;GPC1;MYPN;SHC3;FGFR2;VSTM2L;SLITRK1;NEFH;S100A6;CNTN2;EMB;POU4F1;SHC1;SPTBN4;KIF5A;SPTBN2;SLITRK4;MAP1B;SLIT3;SLIT1;CCK;RAB3A;AUTS2;LAMA2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5088790216423801,1.7190115536318205,0.004338394793926247,0.12554724086312388,1.0,11/34,12.39%,PDE4B;STC1;ATP1B1;CALM2;CHGA;RNF207;RYR2;SCN5A;ADRA1A;SLC8A1;SRI
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.6112898683322199,-1.718559912862092,0.003683241252302026,0.0896093123444808,0.998,10/18,20.39%,JCAD;RHOJ;KDR;PIK3C2A;AKT3;MAP3K3;FGF2;GATA2;ANXA1;HDAC7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.6541971327781168,-1.7183118924502407,0.005272407732864675,0.08924872399432077,0.998,8/15,12.91%,TJP1;KLF4;BMPER;JAK1;FGF1;SMAD1;S100A1;FGF2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.7264676757900608,-1.7180831803866046,0.008896797153024912,0.0887916063080431,0.998,8/10,23.37%,RXRA;TBX1;RARG;ACTN4;RARA;PPARG;RARB;RXRG
prerank,pharyngeal system development (GO:0060037),-0.64222033896487,-1.7179925178347335,0.0076045627376425855,0.08822168397378685,0.998,8/15,16.64%,BMPR2;BMP5;TBX1;HES1;BMP4;TGFB2;SIX4;BMP7
prerank,regulation of actin filament-based movement (GO:1903115),0.7066436790404539,1.7170817046259357,0.011286681715575621,0.12584518723488117,1.0,5/10,12.39%,PDE4B;PDPN;STC1;SCN5A;SRI
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.3921517612874866,-1.7155663112129722,0.0,0.09007697266941192,0.998,58/186,16.25%,NXN;DAB2IP;TRABD2B;CAV1;CSNK1A1;DAB2;MLLT3;FZD6;GSK3B;DVL3;NFATC1;MCC;PSMA2;SOX13;ZNRF3;IGFBP4;SOX17;EMD;FZD4;VGLL4;RNF213;LIMD1;RBX1;FRMD8;KREMEN1;HDAC1;STK3;RNF43;CUL3;LRP6;NKD1;PSME2;CTNND1;KLHL12;GRB10;PSMB4;GSK3A;LATS2;UBAC2;GLI3;HMGXB4;AXIN2;WWOX;TMEM64;NOTUM;WNT11;DKK2;APCDD1;PSMC2;TAX1BP3;PSMB2;LMBR1L;TMEM170B;FUZ;RUVBL2;HIC1;MAD2L2;PSMB1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5863181120447607,1.715419313081139,0.008771929824561403,0.1258784617886215,1.0,8/21,13.19%,ATP1A2;AKAP6;CALM2;RYR2;SLC8A1;SRI;HRC;CASQ1
prerank,regulation of catecholamine secretion (GO:0050433),0.5418183523627301,1.7135732275876525,0.017278617710583154,0.12645331640293728,1.0,9/29,13.67%,SYT1;SYT5;SYT12;SYT11;KCNA2;CHGA;FGF20;SYT4;SYT3
prerank,calcium ion import across plasma membrane (GO:0098703),0.6443498026155254,1.712964673190381,0.011337868480725623,0.12535191260040413,1.0,6/14,12.21%,SLC24A2;CACNA2D1;ATP2B4;SLC8A2;SLC8A1;SLC8A3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.606160931928959,1.7127947976675713,0.01079913606911447,0.12380761524658616,1.0,8/18,13.40%,NRXN1;NLGN1;RIMS2;RIMS1;SHANK1;PRKCZ;DLG4;NLGN2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6919646196815605,1.712419835292946,0.01312910284463895,0.12254736828770489,1.0,7/10,14.40%,DLGAP1;DLGAP2;NPTXR;NPTX2;CACNG5;DLGAP3;BEGAIN
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6110254609791649,1.7116843957476793,0.006726457399103139,0.12173690733282863,1.0,7/15,15.32%,MELTF;PDPN;DDR2;FSCN1;DDR1;CST3;CLASP2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5257587804132158,-1.7106787300820687,0.005535055350553505,0.09434172617349472,0.999,15/34,18.87%,FLT1;TEK;DAB2IP;PIK3R1;IRS1;AMBRA1;PTK2;PRKD1;FGF2;PIK3IP1;PIK3R3;TNFAIP8L3;CCL19;NOD2;WASHC1
prerank,mesenchyme morphogenesis (GO:0072132),-0.6240118626116183,-1.7103553335907713,0.00718132854578097,0.09399632711420083,0.999,7/17,12.08%,ENG;ACVRL1;NOS3;TGFB2;TBX2;SMAD2;NOTCH1
prerank,regulation of protein import into nucleus (GO:0042306),-0.5156471132225923,-1.7094320669269862,0.005208333333333333,0.09436111290985617,0.999,17/36,20.49%,UBR5;PIK3R1;BMP4;PRKCD;CDH1;FLNA;MDFIC;PSEN1;CHP1;UFM1;ZPR1;RAB23;TPR;MAVS;HYAL2;ZIC1;TRIM28
prerank,regulation of dopamine secretion (GO:0014059),0.5562501140654759,1.7093489823018235,0.01282051282051282,0.12248572735586366,1.0,8/25,13.67%,SYT1;SYT5;SYT12;SYT11;KCNA2;FGF20;SYT4;SYT3
prerank,positive regulation of vascular permeability (GO:0043117),-0.6989965116917148,-1.7077225895197832,0.009009009009009009,0.09554530392935127,0.999,9/12,17.98%,TJP1;BMP6;PDE2A;PDE3A;TJP2;OCLN;FGFBP3;ANGPT1;TRPV4
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.45883639076360594,1.7068116483028823,0.0022026431718061676,0.12361184218725323,1.0,15/53,15.84%,CHRM2;HTR2C;OPRM1;CNR1;MTNR1B;CHRM3;MTNR1A;NPY;HTR4;ADRB3;HTR1D;TSHR;CCL2;HRH1;HTR1F
prerank,receptor metabolic process (GO:0043112),-0.47663123525178536,-1.7065611804754892,0.003676470588235294,0.09619360590112763,0.999,32/53,33.05%,ITGB1;CAV1;CALCRL;DNM3;RAMP1;LDLRAP1;SMURF1;TFRC;DNM2;NEDD4;PICALM;RAMP2;ADM;ACKR3;REP15;LGMN;GRB2;AP2M1;SNX25;KIF16B;BECN1;ARFGEF2;GRK3;FCER1G;PHETA2;GRK4;CD9;LILRB1;TGFB1;RAB31;LRP1;PLEKHJ1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5835562954117423,-1.7055698540416822,0.003590664272890485,0.0964482569285089,0.999,13/24,23.25%,TEK;KDR;ICAM1;GAS6;CDH5;RAMP2;ANGPT1;TNFAIP3;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,clathrin coat assembly (GO:0048268),-0.6396498240877547,-1.7036860479065243,0.014059753954305799,0.09815824703629769,1.0,7/15,14.60%,HIP1;FCHO2;EPS15;AP2S1;PIK3C2A;PICALM;HIP1R
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.607221179954474,-1.7032787669785194,0.012915129151291513,0.09795622282666018,1.0,5/19,5.58%,KLF4;SLCO1C1;KLF2;APP;NFKB1
prerank,regulation of GTPase activity (GO:0043087),-0.39088455046922743,-1.7029278960060212,0.0,0.09760273793467636,1.0,45/177,11.99%,DOCK9;DAB2IP;CHN2;PRKG1;ITGA6;RAPGEF2;ITGB1;RSU1;FGD5;FERMT2;FGD6;RAB3GAP1;SH3BP4;NET1;LIMS1;GSK3B;PKP4;DVL3;RALBP1;F11R;LRCH1;CRK;CCL25;LRRK2;RASIP1;AFDN;CHN1;RAP1A;PTK2;EPHA4;PLXNA4;TGM2;AGRN;SNX9;USP6NL;TBC1D30;RASGRP2;PLXND1;PICALM;RASA4;RAPGEF1;ARAP1;RAB3GAP2;BCAS3;ARFGEF1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4793563273051655,-1.7009842087993887,0.0054446460980036296,0.09913441193715715,1.0,15/45,11.50%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;SLC30A10;CBL;PIK3R1;PLCE1;PTK2;PIK3C2A;BCAR1;AKT1;BRAF;NCK2
prerank,protein-containing complex assembly (GO:0065003),-0.37098219151329453,-1.7006175671749955,0.0,0.09883694914071711,1.0,96/259,24.30%,LEF1;FBXL7;SLC2A1;PARD3;MNAT1;CREBBP;SEC31A;SEC24B;FERMT2;CSNK1A1;CD2AP;CTSC;TRAPPC3;GSK3B;TRAPPC9;RANBP9;TEAD1;LRRK2;RAB1A;MITF;SH3PXD2B;RBX1;HES1;AFDN;HDAC1;FAS;TRRAP;CUL3;SEC24A;KPNA3;WASL;SNX9;SEC16B;SEC13;KLHL12;OCLN;SEC24D;PICALM;DET1;AFG3L2;SCFD1;ADAM10;TP53;SAMM50;CASP8;YAP1;AXIN2;HFE;ANO6;PPP6R3;KAT5;CDC73;CDC123;ASH2L;CSNK1D;CD40;PEX14;TCF7L1;F5;CTSZ;TBC1D20;TUBGCP4;TNFRSF1A;TFG;TFAP4;CTNNB1;FANCC;IKBKG;DBNL;DNAJB12;WASF1;MAGI1;VAMP3;MDN1;AP2M1;FERMT3;BLM;PREB;VAMP2;CAND2;SEC24C;TERT;SEC22B;PTK2B;BET1;MDM2;AMER1;PPIH;TSPAN33;NDUFAF1;RIPK1;CD247;TCF7L2;CXCL12;DHX9;GPAA1
prerank,myelination in peripheral nervous system (GO:0022011),-0.6614371301888055,-1.6973808699730955,0.0018018018018018018,0.1016499328273849,1.0,9/13,21.92%,PARD3;ADGRG6;CNTNAP1;DICER1;MYOC;ARHGEF10;SKI;SOD1;NF1
prerank,cardiac muscle cell contraction (GO:0086003),0.5876927421664577,1.697264353786114,0.017937219730941704,0.13275510417833256,1.0,8/19,8.46%,FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;CACNA1D;GSN;SCN5A
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.4405862280728746,-1.6964434520320915,0.0,0.1018903225256373,1.0,23/75,17.19%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;THBS1;TGFB2;ISM1;ROCK1;HSPG2;STAB1;RGCC;NAXE;ECSCR;MECP2;FOXC1;FOXO4;NPR1;ROCK2;GTF2I;CTNNB1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.42466379387865466,-1.6959468647844271,0.0017543859649122807,0.10184583864765188,1.0,44/101,26.90%,KLF4;THBS1;ATG7;EIF3E;ATG10;METTL14;DDX3X;MTOR;NIBAN1;VGLL4;MSN;EIF3C;PLD1;NFKBIA;UPF3B;EZR;SAMD4A;ASPSCR1;ASPH;RPL26;CASP8;AKT1;ZCCHC4;PERP;EEF2;AGTR1;LARP4B;RPS4X;FBXW11;RPL5;METTL5;SOX4;FGFR4;PRKDC;RBM3;AMER1;HSP90AA1;OGT;POLDIP3;FXR1;RDX;HNRNPD;VPS35;LARP6
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.41159647920300585,-1.694229363901617,0.0,0.10306149059896162,1.0,58/132,27.76%,ZBTB20;FOXO1;INSR;DAPK1;SH3BP4;GSK3B;APP;PTPN1;ZC3HAV1;DTX3L;LRRK2;VGLL4;MSN;ADAM9;PPARA;TNFRSF1B;FOXO3;IRS1;IRGM;PRKCD;EZR;BNIP3;PIK3C2A;PLK2;SNX9;ROCK1;PRKD1;GSK3A;PRKAA1;TRIM14;PFKFB3;PSEN1;MTDH;KAT5;PIK3CB;RC3H1;IGF1;MOV10;RNF152;DAGLB;ARNT;ORMDL3;AMER1;HSP90AA1;ATF6;TRIM68;PNPLA2;HMGB1;PFKFB4;CNOT8;PLEKHF1;RDX;CNOT1;VPS35;TPCN1;DXO;PFKFB2;TRIM6
prerank,positive regulation of protein metabolic process (GO:0051247),-0.41885624997845794,-1.6932354869284534,0.0,0.10351714099247881,1.0,35/110,18.91%,DAB2IP;WWP1;FOXO1;KLF4;NEDD4L;KLF2;SMURF2;GSK3B;APP;ATG7;RANBP9;RAB7A;RAB1A;SMURF1;TIPARP;CDKN1B;NFKBIA;NEDD4;NKD1;PLK2;ABCB10;LDB1;GSK3A;AKT1;AREL1;AGTR1;PSEN1;MAPK8;ROCK2;TNFAIP3;OAZ2;PAEP;GPC3;HUWE1;WWP2
prerank,circulatory system development (GO:0072359),-0.40958240271551305,-1.6919921619914857,0.0,0.10439767341747017,1.0,45/118,18.76%,NXN;TEK;ACVRL1;MEF2A;AKAP13;HEG1;PKD2;KAT2B;MICAL2;TBX1;SH3PXD2B;SOX17;CDKN1B;PDLIM5;TGFBR2;RBP4;SMYD4;PLCE1;TGFB2;MEF2C;CDH5;MTHFD1;ECE1;WDR11;KDM6A;PDLIM1;FLT4;RAMP2;PCSK5;HSPG2;CASP8;NOTCH4;KDM6B;ZFPM1;NOTCH1;PDLIM3;RBM20;BCOR;FOXC1;TAB2;HEY2;HEY1;NCOA6;CITED2;SOX4
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.42556252755996604,-1.6915157787468502,0.0,0.1042576015101488,1.0,25/95,11.49%,ENG;CREBBP;CAV1;DAB2;IL17RD;SMURF2;THBS1;ITGA3;PRDM16;RNF111;SPRED2;SMURF1;TGFBR3;TGFBR2;PPARA;NREP;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4837981261488085,-1.691152812327954,0.00530035335689046,0.10391870289871365,1.0,24/46,27.04%,UBR5;GSK3B;YWHAE;EMD;GAS6;PIK3R1;NEDD4;PRKCD;CDH1;TP53;FLNA;PSEN1;ZPR1;TPR;MAVS;XPO4;HYAL2;ZIC1;TRIM28;RAPGEF3;TCF7L2;DHX9;RAN;KHDRBS1
prerank,regulation of developmental growth (GO:0048638),-0.5479684131658167,-1.6901009772435045,0.011538461538461539,0.1045967048759021,1.0,15/29,17.65%,GHR;INSR;GSK3B;APP;SIX1;NIPBL;DNM2;PLCB1;ABL1;MFSD2A;LATS2;SIN3A;SIX4;IGF1;SOD1
prerank,regulation of chromatin organization (GO:1902275),-0.6474591367197174,-1.689027333025079,0.012567324955116697,0.1051711475391818,1.0,9/14,26.13%,MLLT3;TLK2;TLK1;METTL4;SETD5;HPF1;IGF2;ALKBH4;HNRNPU
prerank,embryonic limb morphogenesis (GO:0030326),-0.5204701291662704,-1.6887886441093258,0.008319467554076539,0.1047698938074025,1.0,11/34,10.36%,MBNL1;MAP3K20;CREBBP;RARG;NIPBL;HDAC1;LRP6;TGFB2;ECE1;TBX2;GLI3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.420225075857067,-1.6878942530883008,0.0,0.105164006435158,1.0,58/110,29.66%,RPS21;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;UPF2;RPSA;RPLP1;RPL3;RPL26;RPS11;HELZ2;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;GSPT1;RPL5;RPS27;RPL27A;RPS3;RPL35A;PPP2CA;RPL36A;RPL37A;RNPS1;DCP1A;RPL32;CTIF;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;RPL30;RPL13A;RPL22;RPS17;SMG6;RPL34;RPS2;RPS15A;RPS26;RPL15;RPL39;PABPC1;SMG1;RPL19;RPLP2;RPS13;RPL8;RPL18
prerank,heart trabecula morphogenesis (GO:0061384),-0.5893351999061149,-1.6872080090319945,0.010810810810810811,0.10528883622227912,1.0,11/18,17.56%,TEK;ENG;ADGRG6;BMP5;TGFBR3;RBP4;TGFB2;S1PR1;NOTCH1;BMP7;HEY1
prerank,chloride transmembrane transport (GO:1902476),0.4774432006513235,1.6859897040267489,0.0045662100456621,0.14423088369419956,1.0,14/48,12.06%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;ANO4;SLC12A5;GABRA3;GABRA1;SLC1A3;SLC12A4
prerank,positive regulation of vasculature development (GO:1904018),-0.4263565630653824,-1.685117519730345,0.0017793594306049821,0.10666447335747652,1.0,33/94,20.16%,FLT1;TEK;ITGB1;GAB1;NOS3;TIE1;ETS1;CD34;THBS1;ANXA3;KDR;PRKD2;PLCG1;SP1;FGF1;CDH5;PRKD1;RRAS;RAMP2;PIK3CD;VEGFC;PIK3R6;MTDH;FGF2;AGO2;CD40;SMOC2;HIPK1;CTSH;GATA2;SASH1;BRCA1;F3
prerank,long-term memory (GO:0007616),0.5707588164920779,1.6828085614071766,0.018475750577367205,0.14637118695167717,1.0,8/19,13.89%,RASGRF1;SHANK1;CAMK4;SLC2A4;CPEB3;SGK1;APOE;LDLR
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.4785333036548993,-1.6824951310758458,0.0,0.10887631336380439,1.0,26/49,35.77%,AFAP1L2;NOD1;RAB1A;PRKD2;LBP;MAVS;HYAL2;NOD2;F3;RELA;SERPINE1;RIPK1;HSPA1B;HMGB1;F2R;LGALS9;DDIT3;TLR1;NOS2;TLR5;STAT3;CD14;PARK7;CD74;TLR8;SYK
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4675739171535343,-1.6824385117011997,0.0035650623885918,0.10828153029643615,1.0,26/59,23.74%,LEF1;CBFB;TNRC6B;MED15;MED26;MITF;NFKB1;MED1;JUN;TP53;MED13;MED17;MECP2;CCNC;CTNNB1;MOV10;TNRC6A;CCND1;PPM1D;MED10;TRIM28;MED27;PTEN;RELA;MED20;TCF7L2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6413660193549243,-1.6824103852435586,0.0074487895716946,0.10768627881955987,1.0,8/15,22.51%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;IGF1;MTPN
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.43559211357805966,-1.6821840955341254,0.0017241379310344827,0.10731695846237828,1.0,24/80,15.00%,XIAP;KLF4;DAPK1;NOD1;UACA;THBS1;MAP3K5;TNFSF10;DDX3X;YWHAE;GAS6;NGF;PPM1F;DNAJB6;ARL6IP5;RAF1;SH3RF1;AKT1;BCAP31;SOX7;RPS6KA1;HGF;GPX1;RPS6KA3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5388321141978748,1.6815274165512397,0.015021459227467811,0.14603174983735082,1.0,6/27,3.66%,SYT1;SYT5;RIMS2;RIMS1;SYT12;SYT11
prerank,cell-substrate junction assembly (GO:0007044),-0.5270668506518065,-1.6814011316813948,0.003703703703703704,0.107439620499767,1.0,9/33,8.74%,ITGA6;SORBS1;THSD1;BCR;FERMT2;ITGB4;LAMA3;PTPRK;DST
prerank,regulation of defense response (GO:0031347),-0.4428026492009337,-1.6811219470559748,0.005226480836236934,0.10700897769747304,1.0,29/76,23.85%,FOXP1;IL1R1;XIAP;CASP12;SEMA7A;TMSB4X;BIRC3;SAMHD1;IRF1;CELF1;CASP8;AREL1;MGLL;AGTR1;USP18;JAK2;N4BP1;NR1D2;ERAP1;ZMPSTE24;ANXA1;NOD2;DAGLB;TKFC;AKNA;RELA;BCL6;SHPK;ACE2
prerank,muscle tissue development (GO:0060537),-0.647545581938145,-1.6808861266279855,0.013539651837524178,0.10662044155142182,1.0,5/13,8.57%,PGM5;ENG;SMO;BMP4;CSRP2
prerank,regulation of ion transport (GO:0043269),0.4300357130157931,1.6806954575648556,0.0022522522522522522,0.1454657213513719,1.0,16/76,9.51%,NKAIN2;SYT1;SYT5;ANK3;CA2;KCNA5;STC1;KCNJ3;NKAIN3;SYT12;SYT11;NKAIN4;KCNA2;KCNJ6;FGF20;SPTBN4
prerank,heme catabolic process (GO:0042167),-0.6468955897331261,-1.6804521408442283,0.012844036697247707,0.10584218796354565,1.0,4/14,12.35%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6468955897331261,-1.6804521408442283,0.012844036697247707,0.10584218796354565,1.0,4/14,12.35%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,monocarboxylic acid transport (GO:0015718),-0.47639371395800595,-1.6791771954583354,0.0034965034965034965,0.10667655770784598,1.0,15/51,12.48%,ABCC4;ABCG2;ATP8B1;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SLC5A6;SLC16A12;SLC16A9;SLC16A1;SLCO2B1;SLC16A6;SLC27A4;CEACAM1
prerank,positive regulation of GTPase activity (GO:0043547),-0.38359922927314644,-1.6773189026457396,0.0,0.1081099312487665,1.0,77/188,25.64%,DOCK9;ITGA6;TBC1D4;RAPGEF2;ITGB1;RSU1;BCR;RALGAPA1;FERMT2;RAB3GAP1;NET1;CORO1C;LIMS1;GSK3B;PKP4;DVL3;RALBP1;F11R;CCL25;TBC1D1;AFDN;ARHGEF15;TBC1D2B;RAP1A;TBC1D8B;TGM2;AGRN;SNX9;USP6NL;TBC1D30;RASGRP2;TBC1D14;SIPA1L3;PICALM;MTSS2;TBC1D22B;RAPGEF1;ARAP1;TBC1D22A;SLC27A4;BCAS3;WNT11;RHOG;LARS1;ARHGEF10;TAX1BP3;CD40;ABR;ARHGAP22;TBC1D20;ARHGAP29;MAP4K4;TBC1D8;ALS2;CCL19;TBC1D17;NDEL1;TBC1D25;EPHA2;ARHGEF5;SNX13;EVI5;NF1;ARHGAP11A;ASAP3;TBC1D12;RAPGEF3;ARHGAP42;PIP5K1A;ADRB1;SYDE1;PLXNB1;FZD10;SIPA1L1;SIPA1;ARHGAP27;SNX18
prerank,negative regulation of binding (GO:0051100),-0.4413800434346467,-1.6770499547586588,0.0,0.10780541455116642,1.0,28/81,19.11%,LEF1;SP100;CAV1;DAB2;BTAF1;GSK3B;LRRK2;SMO;NFKBIA;PRKCD;JUN;ROCK1;NES;WAPL;AKT1;ZFPM1;ACTB;ARHGAP28;JAK2;MAPK8;PEX14;MITD1;CTSZ;ILRUN;SUMO1;TFAP4;PLN;TFIP11
prerank,heart morphogenesis (GO:0003007),-0.47934341976247646,-1.6762373353068825,0.010714285714285714,0.10805586341082186,1.0,17/50,17.89%,ENG;ACVRL1;NOS3;INSR;TBX1;SOX17;TGFBR3;HES1;NIPBL;TGFB2;PTK2;TBX2;ZFPM1;NOTCH1;HEY2;HEY1;FLRT2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3409714755436176,-1.6751285449427953,0.0,0.10864537433432433,1.0,187/572,24.69%,FOXP1;KLF12;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ZBTB16;ETV6;NFIB;SP100;MEF2A;RB1;CREBBP;NSD1;CBFB;CAV1;KLF4;ZEB1;USP9X;DAB2;ESR1;NEDD4L;CUX1;MIER1;ZFHX3;PRDM5;KLF2;NRIP1;SMURF2;IRF2;RXRA;PRDM16;WWC2;ID1;NFATC4;NR3C1;SOX13;THRB;MITF;NFIX;BMP6;ZNF148;ZHX2;CTCF;HES1;PPARA;RARG;NIPBL;NFKB1;HDAC1;RPS14;PDE2A;DLG1;ZBTB7A;FOXO3;HIVEP1;BMP4;NEDD4;MED1;EZR;MEF2C;ZBTB4;GTF2IRD1;JUN;SPEN;MAX;SKIL;DACH1;ZFP90;SUV39H1;TBX2;LDB1;PHF21A;SMAD2;PPARD;USP2;CTBP2;SMAD4;PRDM2;ZNF25;GLIS2;UBE2D3;TP53;HMBOX1;PRDM6;EDN1;KLF10;NOTCH4;GLI3;PER3;ETS2;YAP1;SIN3A;FRK;FNIP2;NFIC;ZFPM1;DICER1;SMAD7;MAZ;CHD3;SFPQ;PSEN1;HDAC4;NOTCH1;WWOX;MTDH;KAT5;RTF1;LRRFIP1;CDC73;ZHX1;RPL10;MECP2;ATF4;MZF1;BCOR;HCFC1;PHF6;FOXC1;DR1;TCF3;KMT5A;NR1D2;NR2C1;TPR;SKI;HIC1;MAD2L2;SUMO1;ORC2;TAF7;RARA;MIER2;HDAC10;IGBP1;TAF3;HEY2;HEY1;ZNF692;KDM1B;MIER3;VPS72;CITED2;RNF2;ARID5B;DUSP22;CCND1;WWP2;LIN37;NCOA5;ELK4;RITA1;ATRX;IGF2;TBL1X;PRDM1;PPARG;NKAP;DLL4;TRPS1;HSF4;MDM2;MCPH1;RARB;SUDS3;AASS;GADD45A;RELA;GLIS1;BCL6;SUPT4H1;BEND3;NR2F2;YY1;TCF7L2;TBX3;E2F7;ACVR2B;APBB1;GPS2;TLE6;HMGB1;CNOT2;TRIB3;BMP2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4905375374762113,-1.6745499105731545,0.007259528130671506,0.10862627511108534,1.0,13/43,9.82%,NFIB;KLF4;ETS1;NFATC4;NR3C1;TEAD1;PPARA;FOXO3;BMP4;TGFB2;JUN;PPARD;TP53
prerank,positive regulation of protein catabolic process (GO:0045732),-0.4319859593580499,-1.6731857676543778,0.003703703703703704,0.10973431301040222,1.0,38/84,26.63%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;VGLL4;MSN;ADAM9;TNFRSF1B;NEDD4;EZR;NKD1;PLK2;SNX9;GSK3A;AREL1;TNFAIP3;OAZ2;GPC3;HUWE1;WWP2;HACE1;SEC22B;AMER1;HSP90AA1;FZR1;PLK3;APC;TNFSF12;DTL;RDX;VPS35
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.34829056879161124,-1.6707994793790333,0.0,0.11183173195353682,1.0,148/417,24.80%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;FOXO1;ZHX3;RB1;KAT6B;KLF4;ZEB1;CBFA2T3;BTAF1;FOXN3;PRDM5;SMURF2;RBFOX2;LIMS1;RPS6KA5;PRDM16;SPINDOC;ID1;UIMC1;NR3C1;SOX13;KAT6A;PSPC1;CD38;LOXL3;CDKN1B;VGLL4;RCOR1;ELK3;ZNF148;ZHX2;LIMD1;CTCF;HES1;GAS6;NIPBL;HDAC1;PDCD4;PLCB1;ZBTB7A;BMP4;PTPRK;ZBTB4;JUN;SPEN;MIDEAS;DACH1;PBXIP1;SUV39H1;PPM1F;TBX2;LDB1;SMAD2;SMARCE1;NAB1;PPARD;CTBP2;SMAD4;IRF1;GLIS2;TP53;SP3;HMBOX1;KLF10;GLI3;MDFIC;SIN3A;SOX7;EHMT1;SMARCC2;SFPQ;TWIST2;HDAC4;NOTCH1;PA2G4;KAT5;SCMH1;YAF2;WNT11;ZHX1;CIC;MECP2;SAMD1;FBXW11;BCOR;PEX14;PHC1;KMT5A;NR1D2;SUMO1;SIX4;BMP7;TAF7;RARA;HDAC6;TFAP4;ZBTB14;HDAC10;CTNNB1;HEY2;HEY1;ZMYND11;DAP;PATZ1;CITED2;BAP1;ARID5B;WWP2;PIAS4;SCML4;BRCA1;TIMELESS;TRIM28;FOXL2;NONO;PPARG;GCLC;NKAP;NACC1;CBFA2T2;MDM2;SUDS3;PHC3;RELA;BCL6;RBM15;TSHZ3;CEBPA;NR2F2;TCF7L2;TBX3;MBTD1;GCFC2;ATF5;HIC2;TRIB3;BMP2;EID2B;RBAK
prerank,regulation of peptide hormone secretion (GO:0090276),0.4343983840539735,1.670671115706338,0.0,0.1562833196783591,1.0,15/67,11.56%,KCNC2;HTR2C;SNAP25;GIP;GCK;KCNA5;CACNA1A;MTNR1B;CACNA1D;ADRA2C;CACNA1E;GIPR;EIPR1;ADRA2A;CCL5
prerank,regulation of hydrolase activity (GO:0051336),-0.44016403688029976,-1.6704455439588566,0.0018148820326678765,0.1116003953974304,1.0,31/71,25.34%,DAB2IP;CHN2;PRKG1;FGD5;CAV1;FGD6;RAB3GAP1;RALBP1;CRK;RASIP1;CHN1;PTK2;EPHA4;PLXNA4;PLXND1;RAB3GAP2;PAFAH1B1;GPR137B;FBXW11;ARHGAP12;SOD1;WRN;CDK5RAP3;ARHGEF5;NOS1;NF1;EPHB3;VAV2;PLXNB1;SIPA1L1;ARHGAP27
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.5948574915357159,-1.6698270711806187,0.00927643784786642,0.11169026669460876,1.0,8/18,21.75%,ABL1;RFK;EDN1;AGTR1;EDN3;SIRT3;NOD2;POR
prerank,limb development (GO:0060173),-0.5396856022818968,-1.6688557043850492,0.007079646017699115,0.1122408022440634,1.0,8/28,12.11%,MAP3K20;KAT2B;SMOC1;ZNRF3;KREMEN1;PCSK5;GLI3;COMP
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.667441824477101,-1.6684134861259157,0.0055147058823529415,0.11205212343127213,1.0,6/13,12.64%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2
prerank,translation (GO:0006412),-0.374215962998133,-1.6665086393378774,0.0,0.11366491803562057,1.0,96/208,29.66%,WARS2;YARS1;RPS21;RRBP1;RPL37;RPL31;RPL9;RPS14;FARS2;RPSA;PTCD3;RPLP1;RPL3;MRPL32;MRPL47;RPL26;RPS11;EEF2;RPL13;RPL38;RPL27;RPS16;MRPS18A;DRG1;LARS1;RPS4X;RPL10;MRPL2;MRPS24;RPL7A;RWDD1;AGO2;AIMP2;GSPT1;DARS2;RPL5;N6AMT1;HARS2;RPS27;MRPL24;RPL27A;MRPL57;RPS3;RPL35A;RPL36A;FARSA;RPL37A;NDUFA7;MRPS14;MRPS21;RPL32;MRPL35;GFM2;IARS2;WARS1;ABCE1;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;MRPL34;RPL30;RPL13A;MRPL13;MRPL9;RPL22;RPS17;MRPS28;SRBD1;NOA1;MRPS2;MRPL43;RPL34;RPS2;EEF1B2;TUFM;RPS15A;RPS26;RPL15;MRPL11;TRMT112;RPL39;EEF1G;RPL22L1;GATB;RPL19;RPLP2;COPS5;RPS13;MRPS17;EEF1D;RPL8;TNIP1;RPL18
prerank,response to laminar fluid shear stress (GO:0034616),-0.7201099838986218,-1.6652163505297537,0.007326007326007326,0.11452826362580934,1.0,6/10,22.93%,KLF4;KLF2;SMAD7;SMAD6;MAPK7;NFE2L2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.6558952876901846,-1.6647353087596444,0.014625228519195612,0.11451250459581817,1.0,5/13,8.87%,NFIB;NFATC4;PPARA;BMP4;PPARD
prerank,positive regulation of neuron migration (GO:2001224),-0.6958357159033663,-1.6642517876698204,0.008710801393728223,0.11441641769169453,1.0,5/11,8.73%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2
prerank,regulation of T cell cytokine production (GO:0002724),-0.6319934147785459,-1.6630395995410223,0.021621621621621623,0.11528886657485013,1.0,7/15,23.84%,TRPM4;TNFRSF1B;CD55;SMAD7;HFE;FZD5;MAP3K7
prerank,cellular response to growth factor stimulus (GO:0071363),-0.389461033545738,-1.6625276052610514,0.0,0.11535566226179371,1.0,61/151,22.96%,FLT1;DAB2IP;RAPGEF2;SEMA6A;ACVRL1;KLF4;BMPR2;LIMS1;IQGAP1;TBX1;NR3C1;KDR;PRKD2;PLCG1;EMD;BMP6;EGFR;PTPN12;TGFBR2;PDE2A;DSTYK;PDE3A;BMP4;MED1;RAP1A;MEF2C;ERN1;MAPKAPK2;PRKD1;FLT4;SMAD4;RAMP2;ACVR2A;MTSS2;BCAR1;AKT1;RAPGEF1;SMAD7;EHD1;NOTCH1;WWOX;DUSP3;ZPR1;HGF;HAS1;FOXC1;LGMN;BMP7;CTNNB1;HYAL2;ANXA1;DUSP22;SMAD9;DLL4;PTPN11;MAPK7;MAP2K3;NOS1;SYAP1;RELA;HAS2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.681900300470929,-1.6590144604076225,0.012939001848428836,0.11880253688722463,1.0,3/11,2.66%,CD34;CD200;THBS1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5734377635713358,-1.655382739239535,0.009124087591240875,0.12245017166582754,1.0,9/22,21.45%,SORBS1;ZBTB20;MTOR;PPARA;PPARD;AKT1;CREBL2;PPARG;CREB1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.43502970595924895,-1.6551949659885787,0.0017543859649122807,0.121988895283979,1.0,32/75,27.83%,TEK;JCAD;NRP2;BMPR2;KDR;PRKD2;PLCG1;SP1;BMP4;PRKD1;FLT4;AKT3;PIK3CD;AKT1;VEGFC;AGTR1;ITGA4;FGF2;GATA2;NRAS;ARNT;IGF2;F3;ITGB3;SEMA5A;THBS4;HMGB1;BMP2;TNFSF12;ADAM17;EGR3;HMOX1
prerank,action potential (GO:0001508),0.4722564943710804,1.6530224355911736,0.002352941176470588,0.17694740813053578,1.0,12/44,12.39%,KCND2;ANK3;SCN8A;SCN1A;AKAP6;CLN3;SCN3A;KCNA2;SCN2A;SCN5A;GPER1;SRI
prerank,positive regulation of catabolic process (GO:0009896),-0.4433243310847899,-1.652770082352812,0.003676470588235294,0.12426947717275567,1.0,28/65,25.42%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;NEDD4;NKD1;PLK2;GSK3A;AREL1;VSIR;TNFAIP3;OAZ2;GPC3;HUWE1;WWP2;HACE1;SEC22B;FZR1;APC;TNFSF12;DTL
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5475508827030966,-1.6524519183214312,0.009074410163339383,0.12395886517763574,1.0,8/24,10.01%,SORBS1;INSR;GSK3B;PPP1R3B;IRS1;PPP1R3C;GSK3A;AKT1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.596843049384551,-1.6507374776402632,0.0018181818181818182,0.12528601976488535,1.0,11/18,26.08%,FLT1;PLCG1;SP1;MEF2C;AKT3;ITGA4;FGF2;IGF2;PPARG;HMGB1;ADAM17
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.38542421753856854,-1.6496502193592448,0.0,0.12602350033088672,1.0,50/153,16.37%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;RPS6KA5;ATM;PAK2;MARK1;LRRK2;MTOR;PRKD2;TLK1;CSNK1G3;NEK6;TGFBR2;GAS6;RICTOR;MAST2;PRKCD;MAST4;ERN1;MAPKAPK2;PLK2;ROCK1;PRKD1;MAPK1;AKT3;LATS2;CLSPN;AKT1;STK32C;STK38;IKBKE;CSNK1G1;RPS6KA1;ULK2;MKNK2;CSNK1D;MAPK8;PKN2;MARK2;PKN3;MAPK12;RPS6KA3;HIPK1;ROCK2;MARK3;SRPK2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.6249087470094713,-1.6483064287711224,0.014059753954305799,0.1271358174306725,1.0,7/15,12.16%,PRKCE;LDLRAP1;PPARA;IRS1;PPARD;AKT1;ADM
prerank,cilium movement (GO:0003341),0.4623016442932435,1.647618912138308,0.004608294930875576,0.18240534485821797,1.0,18/47,18.81%,TEKT1;TTC29;ADCY10;CFAP54;CCDC63;DNAAF5;ODAD2;DNAAF1;ROPN1L;DNAI4;CFAP70;GAS8;ODAD1;SPAG17;CABYR;DNAAF2;CAMSAP3;ODAD3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.32715146516152804,-1.647063068887419,0.0,0.12795809744449177,1.0,268/807,24.89%,FOXP1;MECOM;KLF12;LEF1;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ZBTB16;ETV6;ATP8B1;WWP1;SP100;ZNF423;FOXO1;MEF2A;ZHX3;RB1;CREBBP;NSD1;CBFB;KAT6B;CAV1;KLF4;ZEB1;CBFA2T3;USP9X;DAB2;ESR1;BTAF1;NEDD4L;CUX1;MIER1;FOXN3;ZFHX3;PRDM5;KLF2;NRIP1;SMURF2;IRF2;RBFOX2;LIMS1;RXRA;RPS6KA5;PRDM16;SPINDOC;WWC2;ID1;UIMC1;NR3C1;SOX13;THRB;KAT6A;KDM2A;MITF;PSPC1;CD38;NFIX;BMP6;LOXL3;CDKN1B;VGLL4;RCOR1;ELK3;ZNF148;ZHX2;LIMD1;CTCF;HES1;GAS6;PPARA;RARG;NIPBL;NFKB1;HDAC1;RPS14;PDE2A;DLG1;PDCD4;PLCB1;ZBTB7A;FOXO3;HIVEP1;BMP4;MED1;PTPRK;EZR;MEF2C;ZBTB4;GTF2IRD1;JUN;SPEN;MIDEAS;MAX;SKIL;DACH1;PBXIP1;ZFP90;SUV39H1;PPM1F;TBX2;LDB1;PHF21A;SMAD2;SMARCE1;NAB1;PPARD;USP2;CTBP2;SMAD4;PRDM2;IRF1;ZNF25;GLIS2;UBE2D3;TP53;SP3;HMBOX1;FLNA;PRDM6;EDN1;KLF10;NOTCH4;GLI3;PER3;MDFIC;ETS2;YAP1;SIN3A;FRK;FNIP2;NFIC;SOX7;EHMT1;ZFPM1;SMARCC2;DICER1;SMAD7;MAZ;CHD3;SFPQ;TWIST2;PSEN1;HDAC4;NOTCH1;WWOX;MTDH;PA2G4;KAT5;SCMH1;RTF1;LRRFIP1;CDC73;YAF2;WNT11;ZHX1;CIC;RPL10;MECP2;SAMD1;FBXW11;ATF4;MZF1;BCOR;HCFC1;PHF6;FOXC1;DR1;PEX14;TCF3;PHC1;KMT5A;NR1D2;NR2C1;TPR;SKI;NAB2;HIC1;MAD2L2;SUMO1;ORC2;SIX4;BMP7;TAF7;RARA;HDAC6;TFAP4;MIER2;ZBTB14;HDAC10;IGBP1;CTNNB1;TAF3;HEY2;HEY1;ZMYND11;ZNF692;DAP;KDM1B;MIER3;PATZ1;VPS72;CITED2;RNF2;BAP1;ARID5B;DUSP22;CCND1;WWP2;LIN37;PIAS4;NCOA5;ELK4;SCML4;RITA1;IGF2;BRCA1;TIMELESS;TRIM28;FOXL2;TBL1X;PRDM1;NONO;PPARG;GCLC;NKAP;DLL4;NACC1;CREB1;TRPS1;HSF4;CBFA2T2;MDM2;MCPH1;RARB;SUDS3;PHC3;AASS;GADD45A;RELA;GLIS1;BCL6;RBM15;SUPT4H1;TSHZ3;CEBPA;BEND3;NR2F2;YY1;TCF7L2;TBX3;E2F7;MBTD1;ACVR2B;GCFC2;ATF5;APBB1;GPS2;TLE6;HIC2;HMGB1;CNOT2;TRIB3;BMP2;EID2B;RBAK;PLK3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4304288998906786,-1.6468359273676432,0.001763668430335097,0.12762424594021107,1.0,20/73,12.08%,ENG;ZNF423;ACVRL1;XIAP;CRIM1;BMPER;BMPR2;SMURF2;ITGA3;SMURF1;BMP4;CDH5;SKIL;SMAD1;SMAD2;SMAD4;ACVR2A;UBE2D3;SMAD7;NOTCH1
prerank,regulation of cellular component size (GO:0032535),-0.5282264469309992,-1.646713189111194,0.012544802867383513,0.1271305189380163,1.0,19/30,28.23%,RIN3;EPS8;RAC1;MTOR;MSN;RARG;EZR;PICALM;RPTOR;LARS1;PEX11A;AP2M1;PTEN;MTPN;PPP1CA;VAV2;RDX;RAB22A;PEX11B
prerank,Rho protein signal transduction (GO:0007266),-0.46208112185880273,-1.646284648672174,0.003656307129798903,0.12702261792538838,1.0,24/53,18.03%,EPS8;ARHGEF3;RHOJ;NTN1;PLEKHG5;EPS8L2;ARHGAP5;GNA12;PHACTR4;ARHGDIA;ROCK1;ARHGAP1;ARHGEF11;AGTR1;RHOA;RHOG;CDC42EP3;RTKN;TAX1BP3;ROCK2;ARHGAP29;RIPOR1;ADGRG1;CFL1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.4580283382929084,-1.646266221229637,0.0035335689045936395,0.1264310313307194,1.0,35/54,36.81%,PELI1;UBR5;NEDD4L;ZNRF1;UBE2K;DTX3L;RBX1;CUL3;RNF115;UBE2D3;UBE2E2;TNFAIP3;KLHL3;RNF152;RNF4;HACE1;RNF216;UBE2R2;RNF146;RNF34;ARIH2;FBXO38;RNF187;UBE2H;TRIM32;CDC34;UBE2A;UBE2T;UBE2G2;TOPORS;IFI27;UBE3A;UBE2C;KBTBD7;RNF5
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4977357193191449,-1.643424740488379,0.011214953271028037,0.12950016362403585,1.0,18/33,29.14%,ACVRL1;KLF4;THBS1;MEOX2;MEF2C;STARD13;RGCC;NOTCH1;RHOA;FGF2;MECP2;PPARG;DLL4;GADD45A;HMGB1;HDAC5;ANGPT4;JUP
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.5007334645618449,-1.6424521523573357,0.019197207678883072,0.13010238663807927,1.0,19/33,31.99%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;FHL1;CDKN2C;PTEN;E2F7;PLK3;APC;CDKN2B;JADE1;CDK4;WEE1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.42816440466732586,-1.6417945929665827,0.005244755244755245,0.1303068171908979,1.0,30/75,23.41%,DAB2IP;RB1;HEG1;LRP5;LYN;PTPN1;PTPRJ;CDKN1B;RASIP1;ABL1;BMP4;LRP6;PRKCD;LATS2;AKT1;STK38;PIK3CB;SPRY4;PKIG;BMP7;TFAP4;CDK5RAP3;HYAL2;UCHL1;PTEN;NF1;MYOCD;GADD45A;CEBPA;NR2F2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.38330672012301137,-1.6414362478323803,0.0,0.13022281016839385,1.0,50/136,26.63%,DAB2IP;SP100;RB1;KLF4;PKD2;ESR1;CD200;FZD6;TMSB4X;ID1;SIK1;TAX1BP1;HES1;GAS6;NFKBIA;OTULIN;ANXA4;GLIS2;NFKBIL1;FLNA;SMAD7;IRAK1;HDAC4;CHP1;PEX14;MTURN;MAD2L2;SUMO1;BMP7;TNFAIP3;NLRC5;TAF3;IRAK2;CEBPG;DAP;CDK5RAP3;RNF2;WWP2;USP7;CMKLR1;CTNNBIP1;KEAP1;PIM1;TCF7L2;PTGIS;ARRB1;EIF2AK4;TBX6;ERBIN;SFRP4
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6329354350217004,1.6413920559068083,0.029227557411273485,0.18975186794499488,1.0,4/12,6.56%,ANK3;ATP1B1;WNK2;WNK3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5253280168254502,-1.6410026791263008,0.016216216216216217,0.13016993695765025,1.0,12/27,24.06%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;FGF2;TNFAIP8L3;CCL19;NOD2;PTK2B;PDGFRB
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.38367439977530604,-1.6396028149164217,0.0,0.13113783681708915,1.0,83/168,29.69%,PAN3;TUT7;TENT4B;RPS21;ATM;CNOT4;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;UPF2;XRN1;SAMD4A;RPSA;POLR2G;RPLP1;RPL3;RPL26;RPS11;HELZ2;TUT4;XRN2;RPL13;RPL38;RPL27;RPS16;RPS4X;TENT2;RPL10;RC3H1;RPL7A;PDE12;PARN;GSPT1;RPL5;EXOSC8;RPS27;RPL27A;RPS3;RPL35A;PPP2CA;RPL36A;PELO;RPL37A;EXOSC5;RNPS1;DCP1A;RPL32;CTIF;RPS7;RPL36;RPS8;DIS3L2;RPL28;RPS15;RPS23;RPL30;RPL13A;RPL22;RPS17;CNOT2;CNOT8;THRAP3;SMG6;EXOSC7;RPL34;RPS2;RPS15A;RPS26;RPL15;RPL39;CNOT1;PABPC1;DXO;SMG1;RPL19;RPLP2;RPS13;RPL8;RPL18;NBDY
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.6568580502057695,-1.6395292669616643,0.010101010101010102,0.13060044928390954,1.0,4/12,6.97%,DAB2IP;PTPN1;PIK3R1;ERN1
prerank,renal filtration (GO:0097205),-0.7049026204505999,-1.6383566540180183,0.019193857965451054,0.13144356455856426,1.0,5/10,10.78%,CD34;ITGA3;XPNPEP3;TBC1D8B;MCAM
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.47749458624936864,-1.6369225122306656,0.008726003490401396,0.1324811335760292,1.0,17/44,17.14%,CAST;XIAP;KLF4;THBS1;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;SH3RF1;AKT1;RPS6KA1;HGF;GPX1;RPS6KA3;IGBP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5259727543126793,-1.635531115377435,0.01092896174863388,0.13373412736836934,1.0,5/26,6.02%,FOXP1;DAB2;STRN3;HDAC1;ZBTB7A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3866469133632226,-1.634926633625427,0.0,0.13393764618601361,1.0,46/140,17.54%,CHN2;ARHGAP31;BCR;AKAP13;CD2AP;ARHGEF3;RAC1;RHOJ;NET1;STARD8;RALBP1;MCF2L;ARHGAP10;ARAP3;CGNL1;PLEKHG5;ARHGAP5;RASGRF2;SLIT2;CHN1;RHOQ;ARHGEF12;PLCE1;ARHGDIA;TGM2;ITSN1;ARHGEF2;SOS2;ARHGAP17;STARD13;ARAP1;ARHGAP1;ARHGEF11;ARHGAP28;RHOA;FAM13A;RHOG;RHOC;TRIO;ABR;DEPDC7;ARHGAP22;ARHGEF18;ARHGAP29;ARHGAP12;PREX1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.5271169267961688,-1.6334371130349616,0.017953321364452424,0.1352779442802605,1.0,12/27,25.74%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;PPP1CA;CRTC1;FBXL22;CRY2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4824850918428886,-1.632315370565305,0.008928571428571428,0.13605086589600948,1.0,14/39,16.27%,PODXL;KLF4;BMP6;PPARA;PTK2;FXYD5;PPM1F;CDH1;AKT1;NOTCH4;RGCC;NOTCH1;MAD2L2;JAG1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.5548781368542502,-1.6315065748480198,0.010869565217391304,0.13656081216210142,1.0,8/22,16.84%,DAB2IP;MFHAS1;LYN;WDFY1;LBP;FLOT1;IFI35;TNFAIP3
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4124889030645696,-1.6309732710014544,0.0,0.13668402752854591,1.0,18/88,11.13%,TEK;PTPRM;NRP2;ACVRL1;TIE1;CAV1;BMPR2;THBS1;KDR;PRKD2;BMP4;PRKD1;FLT4;AKT3;PIK3CD;AKT1;VEGFC;RGCC
prerank,regulation of nervous system process (GO:0031644),0.5667127004381373,1.6303766276920495,0.0332541567695962,0.20352486526616267,1.0,11/18,14.40%,HTR2C;DLGAP1;DLGAP2;TMEM108;NPTXR;SLC8A2;NPTX2;SLC8A3;CACNG5;DLGAP3;BEGAIN
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4986625004278259,-1.630330669934632,0.008680555555555556,0.13681188543948905,1.0,11/35,11.26%,UBR5;ZMIZ1;NR3C2;ESR1;RBFOX2;NR3C1;NEDD4;MED1;YAP1;KDM3A;NCOA4
prerank,positive regulation of sodium ion transport (GO:0010765),0.6439111950395706,1.630236098727077,0.023094688221709007,0.20145357946750073,1.0,6/12,8.46%,ANK3;SCN1B;PKP2;GPD1L;WNK3;SCN5A
prerank,cell junction assembly (GO:0034329),0.3985328131287308,1.6301088406038742,0.00211864406779661,0.19939152952424422,1.0,28/100,8.92%,KIRREL3;NRXN1;CDH18;NLGN1;CTNND2;CDH8;CDH20;CDH9;CDH10;ADGRL3;DSCAM;PCDHB5;CDK5;DNER;NRCAM;PKP2;DCHS1;CDH19;FLNC;FSCN1;FLCN;CDH12;SDK1;GPM6A;CDH7;SLITRK1;POU4F1;CDH24
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4605416485506974,-1.630072334474874,0.0034129692832764505,0.13651407722150383,1.0,18/50,17.14%,XIAP;KLF4;THBS1;PAK2;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;CAAP1;SH3RF1;AKT1;RPS6KA1;HGF;GPX1;RPS6KA3;IGBP1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4438698863521198,-1.6297415459980835,0.010752688172043012,0.1362989027141139,1.0,33/56,31.83%,RB1;ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CUL3;CCND3;AKT1;RGCC;CDC16;NSMCE2;RPTOR;LSM11;UBE2E2;MECP2;RAB11A;LSM10;ANXA1;CCND1;CDC25A;DTL;TFDP1;ANAPC7;ADAM17;RDX;BRD4;FGF10;CCND2;STOX1;ANAPC5;ANAPC11;CDK4
prerank,regulation of protein export from nucleus (GO:0046825),-0.5576477132562361,-1.6296648054575158,0.01549053356282272,0.13580140005822863,1.0,11/23,23.74%,SP100;PTPN14;GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;RAPGEF3;TCF7L2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.3353996021209527,-1.6275004713891907,0.0,0.13809861049585279,1.0,170/497,24.80%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;ACVRL1;FOXO1;ZHX3;RB1;KAT6B;KLF4;ZEB1;CBFA2T3;DAPK1;BTAF1;FOXN3;BMPR2;PRDM5;SMURF2;RBFOX2;LIMS1;GSK3B;RPS6KA5;PRDM16;RNF139;SPINDOC;ID1;UIMC1;NR3C1;SOX13;DDX3X;KAT6A;PSPC1;CD38;LOXL3;CDKN1B;VGLL4;GIGYF2;RCOR1;ELK3;ZNF148;ZHX2;LIMD1;LARP1;CTCF;HES1;GAS6;NIPBL;HDAC1;PDCD4;PLCB1;ZBTB7A;BMP4;PTPRK;ZBTB4;JUN;SPEN;MIDEAS;DACH1;PBXIP1;SAMD4A;SUV39H1;PPM1F;TBX2;LDB1;SMAD2;SMARCE1;NAB1;PPARD;GSK3A;CTBP2;SMAD4;IRF1;WAPL;GLIS2;TP53;SP3;HMBOX1;KLF10;GLI3;MDFIC;SIN3A;SOX7;EHMT1;SMARCC2;SFPQ;TWIST2;HDAC4;NOTCH1;PA2G4;KAT5;SCMH1;PDS5A;YAF2;WNT11;ZHX1;CIC;MECP2;SAMD1;FBXW11;BCOR;BTG2;PEX14;PHC1;KMT5A;NR1D2;SUMO1;IGFBP5;SIX4;BMP7;TAF7;RARA;HDAC6;TFAP4;ZBTB14;HDAC10;SYNCRIP;CTNNB1;HEY2;HEY1;ZMYND11;DAP;PATZ1;CITED2;RPS3;BAP1;ARID5B;WWP2;PIAS4;SCML4;BRCA1;TIMELESS;TOB1;TRIM28;FOXL2;CAPRIN1;NONO;PPARG;GCLC;NKAP;NACC1;CBFA2T2;MDM2;SUDS3;PHC3;RPL13A;RELA;MRPL13;BCL6;RBM15;TSHZ3;CEBPA;NR2F2;TCF7L2;TBX3;MBTD1;GCFC2;ATF5;HIC2;CNOT8;FXR1;TRIB3;BMP2;EID2B;RBAK
prerank,response to lipid (GO:0033993),-0.401456840826601,-1.6271172505904274,0.003616636528028933,0.1379525127308692,1.0,32/105,17.53%,FOXP1;FOXO1;PELI1;NOS3;SRR;ESR1;ACER2;ASXL1;RXRA;IFNAR1;HNRNPA0;PPARA;RARG;STRN3;GGT5;FOXO3;RBP4;ALPL;GCH1;MAPKAPK2;LBP;PPARD;SOCS2;IRAK1;JAK2;RPS6KA3;TRIM16;SMAD6;TAB2;RARA;CTNNB1;CTSH
prerank,regulation of exocytosis (GO:0017157),0.45501218196001086,1.6267720114461566,0.006696428571428571,0.20223072946146725,1.0,8/46,5.70%,IL1RAPL1;STXBP5L;SYT1;RIMS2;CADPS;RAB15;RAB27B;RAB3C
prerank,response to histamine (GO:0034776),0.6661878134289031,1.6264603954241832,0.026905829596412557,0.20056306016064657,1.0,3/10,3.68%,GABRB1;GABRB3;GABRB2
prerank,receptor catabolic process (GO:0032801),-0.5373296971982855,-1.6262375167281415,0.019784172661870502,0.13852013882384245,1.0,13/24,22.92%,ZNRF3;SMURF1;AP2B1;AP2A2;RNF43;NEDD4;AP2S1;LGMN;MYLIP;AP2M1;SNX25;KIF16B;BECN1
prerank,presynaptic endocytosis (GO:0140238),0.5331133708524592,1.6257939667900627,0.01511879049676026,0.1993286704655893,1.0,6/24,6.10%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5467644324616567,-1.6256820575976954,0.016100178890876567,0.13866389028518658,1.0,10/24,15.84%,PECAM1;ITGB1;F11R;NT5E;ICAM1;MSN;EZR;ROCK1;ITGA4;VCAM1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.529723540589993,-1.6255793086584853,0.005357142857142857,0.13819472744649988,1.0,10/26,16.85%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;BRAF;CREBL2;IGF1
prerank,response to ethanol (GO:0045471),0.6078509063438147,1.6252018462850528,0.021231422505307854,0.19818509608482607,1.0,4/14,7.20%,GRIN2B;GRIN2A;GLRA1;ADCY7
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4220823760304967,-1.6249230469302216,0.007029876977152899,0.13839954268165663,1.0,27/73,16.40%,WASF2;DOCK1;MYO10;ABI1;RAC1;PRKCE;LYN;ELMO1;CRK;PLCG1;YES1;NCK1;ABL1;PIK3R1;PRKCD;PTK2;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;NCKAP1;ELMO2;GRB2;ARPC4;FYN
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.31000449100696414,-1.6246648864818198,0.0,0.13812302136926904,1.0,508/1668,24.43%,FOXP1;MECOM;KLF12;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ITGA6;ZBTB16;ETV6;BAZ2B;NFIB;SP100;TEF;ERG;ENG;MNAT1;ACVRL1;ZBTB20;FOXO1;MEF2A;ZHX3;MLLT10;MRTFB;RB1;CREBBP;NSD1;SENP1;CBFB;NFAT5;ELF1;KAT6B;CAV1;KLF4;ZEB1;ETS1;CHD1;ZMIZ1;NR3C2;USP9X;DAB2;PKD2;LRP5;DACH2;ESR1;NEDD4L;CUX1;MIER1;BMPR2;TEAD4;VGLL3;PKNOX2;HIVEP2;TCF12;ZFHX3;TNRC6B;ASXL1;MED15;PRDM5;KLF2;NRIP1;SMURF2;ZNF260;MED26;IRF2;MAML2;CHD2;DVL3;RXRA;CDK13;NFATC1;APP;KAT2B;KLF3;RPS6KA5;PRDM16;TBX15;DEK;LMO2;FOSL2;BMP5;CRK;TRAK1;WWC2;ATM;PRRX1;TBX1;ID1;NFATC4;RNF111;NR3C1;ZSCAN21;TEAD1;SOX13;THRB;ARID1B;ZBTB37;DDX3X;KANSL3;KAT6A;KDM2A;MITF;PRKD2;PLAGL1;SOX17;MKX;PBX3;CDK12;NFIX;BMP6;SP1;EGFR;ZBTB46;CRLF3;RCOR1;ELK3;ZNF148;RTRAF;ZHX2;MGA;MEOX2;CTCF;HES1;SIX1;PPARA;LHX6;RARG;NIPBL;NFKB1;HDAC1;TET2;RPS14;NFKBIA;PDE2A;LMO7;DLG1;HOXB6;IKZF2;SMARCC1;ZBTB7A;UBP1;PHF20;NCK1;FOXO3;ABL1;PIK3R1;NFYC;HIVEP1;RHOQ;BMP4;PRPF6;LRP6;BBX;FGF1;ZIC4;MED1;E2F4;AATF;BRD2;FUS;EZR;MEF2C;STAT6;ZBTB4;GABPB2;GTF2IRD1;JUN;SPEN;MIDEAS;WASL;MAX;SKIL;BAZ1A;DACH1;TSHZ2;CREB3L2;AGRN;SMAD1;ZFP90;ZNF182;SUV39H1;SRCAP;PRKD1;TBX2;MAML1;SETD3;LDB1;PHF21A;SMAD2;ZBTB39;SMARCE1;ATAD2B;ARHGEF2;ANXA4;EBF1;PPARD;NOP2;AKIRIN2;NAMPT;BACH2;USP2;HAX1;PHF20L1;CTBP2;SMAD4;ZIC5;ACVR2A;PRDM2;IRF1;HOXC6;HSF5;ZNF25;RBBP8;TAL1;GLIS2;UBE2D3;TP53;SP3;HMBOX1;PRDM6;EDN1;ZBTB40;ELF2;KLF10;NOTCH4;KDM6B;GLI3;PER3;BCLAF3;ETS2;YAP1;POGZ;DOT1L;SIN3A;FRK;FNIP2;KDM3A;HELZ2;MAMLD1;STAT2;NFIC;ZBTB7C;PPP1R12A;GMEB1;RGCC;ZFPM1;SMARCC2;DICER1;JMJD1C;SMAD7;MAZ;MED13;NCK2;CHD3;SFPQ;HR;TWIST2;PSEN1;MED17;PRRX2;BCAS3;FOXF2;HDAC4;NOTCH1;CREBRF;ZSCAN25;WWOX;MTDH;RPS6KA1;ZNF394;KAT5;RTF1;LRRFIP1;CDC73;FGF2;TIAL1;TCEA1;EIF5A;PROX2;ZHX1;FOXJ3;ZBTB6;GABPB1;SP140;KLF9;CIC;HGF;RPL10;ARID3B;DBX2;GRHL1;PLSCR1;MECP2;PIAS2;ZIC3;TFCP2L1;HIF3A;AGO2;ZBTB25;ATF4;MZF1;ZBTB34;BCOR;HCFC1;MYBL2;PGBD1;SMARCD3;PHF6;MED29;CD40;RPS6KA3;FOXC1;DR1;KDM7A;ZNF462;JMJD6;TCF3;TCF7L1;KMT2C;KMT5A;NR1D2;NR2C1;SMAD6;BRWD3;FOXO4;ETV1;TPR;ZNF32;TADA3;RUVBL2;ZFP1;SKI;HIC1;MAD2L2;SUMO1;JAG1;TNFRSF1A;ZNF235;ZKSCAN1;ORC2;SIX4;FOXQ1;KDM5B;MAMSTR;ZNF691;TAF7;RARA;TFAP4;IGF1;MAVS;ZXDB;ZNF83;MIER2;CC2D1B;ZBTB14;CCNC;HDAC10;IGBP1;HOXA2;CTNNB1;HLF;EPAS1;NLRC5;TAF3;MOV10;THAP3;HEY2;ZNF250;ZFP28;ZBTB8A;HEY1;CEBPG;ZNF692;TSHZ1;KDM1B;IKBKG;MIER3;NCOA6;PATZ1;VPS72;CITED2;ZNF507;NRF1;GATA2;RNF10;HOXB9;HYAL2;WBP2;IKBKB;NOD2;TNRC6A;RNF2;ARID5B;DUSP22;SOX4;CCND1;WWP2;LIN37;PIAS4;PCGF3;NCOA5;ELK4;ELOC;ARNT;ZBTB12;ZSCAN12;ZFX;RNF4;PPM1D;ZIC1;RITA1;PCGF5;ATRX;MED10;SMAD9;SS18;ZSCAN26;PRKDC;CKAP2;IGF2;BRCA1;TRIM28;AKNA;LPIN2;FOXL2;PBX2;BAZ1B;TBL1X;TOX4;PRDM1;TET3;ZSCAN18;PPARG;NKAP;DLL4;MED27;NACC1;CREB1;TRPS1;CAPRIN2;MAPK7;CCN1;HSF4;PTEN;NOS1;MDM2;MYOCD;MCPH1;ATAD2;RARB;SUDS3;USP16;GLMP;AASS;OGT;GADD45A;RELA;ATF6;GLIS1;BCL6;MSX1;GABPA;NFE2L2;SERPINE1;SUPT4H1;RFXANK;ELF4;TSHZ3;PCBP1;RXRG;CEBPA;BEND3;MED20;NR2F2;ZNF697;FZD5;CCNK;RIPK1;KDM3B;YY1;GMEB2;ZFP3;TCF4;TCF7L2;KLF16;SSBP4;TBX3;E2F7;ACVR2B;ARID3A;TAF9;AEBP2;ZKSCAN8;ATF5;ZKSCAN4;APBB1;DHX9;CRTC1;GPS2;TLE6;HIC2;HMGB1;ARRB1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3248057992957796,-1.624150872051349,0.0,0.1381891669617517,1.0,270/834,24.43%,LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;ITGA6;NFIB;ERG;ENG;ACVRL1;FOXO1;MEF2A;MLLT10;MRTFB;CREBBP;SENP1;NFAT5;ELF1;KAT6B;KLF4;ETS1;ZMIZ1;DAB2;PKD2;LRP5;ESR1;BMPR2;TCF12;ZFHX3;ASXL1;KLF2;NRIP1;IRF2;MAML2;DVL3;RXRA;CDK13;NFATC1;APP;KAT2B;RPS6KA5;LMO2;FOSL2;BMP5;ATM;MICAL2;TBX1;RNF111;NR3C1;ZSCAN21;TEAD1;THRB;DDX3X;KANSL3;KAT6A;MITF;PRKD2;PLAGL1;SOX17;NOTCH3;CDK12;NFIX;BMP6;SP1;EGFR;CRLF3;ELK3;RTRAF;MEOX2;HES1;SIX1;PPARA;RARG;NFKB1;HDAC1;TET2;NFKBIA;LMO7;UBP1;NCK1;FOXO3;ABL1;PIK3R1;HIVEP1;RHOQ;BMP4;PRPF6;LRP6;FGF1;MED1;TGFB2;E2F4;AATF;MEF2C;STAT6;GABPB2;JUN;WASL;MAX;AGRN;SMAD1;PLXND1;PRKD1;MAML1;SETD3;LDB1;SMAD2;ATAD2B;ARHGEF2;PPARD;AKIRIN2;NAMPT;HAX1;CTBP2;SMAD4;ACVR2A;PRDM2;IRF1;TAL1;GLIS2;TP53;SP3;EDN1;KLF10;NOTCH4;KDM6B;GLI3;BCLAF3;YAP1;POGZ;DOT1L;SIN3A;HELZ2;NFIC;PPP1R12A;RGCC;ZFPM1;SMAD7;MED13;NCK2;SFPQ;MED17;BCAS3;FOXF2;HDAC4;NOTCH1;CREBRF;WWOX;RPS6KA1;KAT5;CDC73;FGF2;TCEA1;EIF5A;FOXJ3;GABPB1;HGF;GRHL1;PLSCR1;ZIC3;AGO2;ATF4;MZF1;HCFC1;MYBL2;SMARCD3;CD40;RPS6KA3;FOXC1;DR1;ZNF462;JMJD6;TCF3;KMT2C;NR1D2;FOXO4;ETV1;RUVBL2;SKI;JAG1;TNFRSF1A;GCN1;TAF7;RARA;IGF1;MAVS;CCNC;CTNNB1;HLF;EPAS1;NLRC5;THAP3;HEY2;HEY1;CEBPG;KDM1B;IKBKG;NCOA6;CITED2;ZNF507;NRF1;GATA2;RNF10;HYAL2;WBP2;IKBKB;NOD2;SOX4;ELK4;ARNT;RNF4;PCGF5;ATRX;MED10;SMAD9;SS18;PRKDC;CKAP2;IGF2;BRCA1;AKNA;LPIN2;PBX2;TBL1X;TET3;PPARG;CREB1;CAPRIN2;MAPK7;CCN1;TERT;NOS1;MYOCD;ATAD2;RARB;USP16;GLMP;OGT;RELA;ATF6;GLIS1;GABPA;NFE2L2;SERPINE1;SUPT4H1;RFXANK;ELF4;PCBP1;RXRG;CEBPA;NR2F2;FZD5;CCNK;RIPK1;YY1;TCF4;TCF7L2;SSBP4;TBX3;E2F7;TAF9;ATF5;APBB1;DHX9;CRTC1;GPS2;HMGB1;ARRB1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.42597222560563075,-1.6241114718764618,0.0,0.13761538245799562,1.0,22/73,12.48%,DOCK1;ITGB1;FERMT2;DAB2;MYH9;SEMA7A;ITGBL1;ITGB4;ADAM9;LAMA3;ABL1;CUL3;ITGB5;PTK2;PRKD1;DST;ADAM10;BCAR1;ILK;LAMA5;NEDD9;CEACAM1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.5573896653382175,-1.6240478372806626,0.016363636363636365,0.1370900524314421,1.0,11/21,27.70%,CAV1;CSNK1A1;GSK3B;DVL3;LRP6;CTNNB1;AMER1;PPP1CA;FZD5;APC;FZD1
prerank,Rap protein signal transduction (GO:0032486),-0.6943626634138858,-1.6222005394207537,0.017421602787456445,0.13883389803947652,1.0,9/10,27.58%,RAPGEF2;RAP1A;PLK2;RAP1B;RAPGEF1;RAP2C;RAP2A;RAPGEF3;RAP2B
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.5269301043097541,-1.621726506171178,0.0071174377224199285,0.13887431332927633,1.0,14/29,25.36%,LEF1;CREBBP;HDAC1;TRRAP;AXIN2;KAT5;CDC73;ASH2L;TCF7L1;CTNNB1;TERT;TCF7L2;LEO1;RBBP5
prerank,plasma membrane tubulation (GO:0097320),-0.6427482644883131,-1.621073213505868,0.018214936247723135,0.13913463785995062,1.0,6/13,10.96%,CAVIN2;FNBP1L;EHD2;SNX9;BIN3;CHMP4A
prerank,myeloid cell differentiation (GO:0030099),-0.4650274179596884,-1.6210155407537115,0.008896797153024912,0.13864920909230993,1.0,12/47,12.64%,ZBTB16;SNRK;MFHAS1;LYN;KMT2E;KAT6A;TET2;RPS14;ACIN1;TAL1;ZFPM1;JAK2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.49871644798558407,-1.6207507772156013,0.005484460694698354,0.1383596261916791,1.0,18/35,24.61%,SEMA6A;SEMA3C;NRP2;RAC1;SEMA7A;ARHGDIA;PLXNA4;PLXND1;FLNA;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G;SEMA5A;PLXNB1
prerank,photoperiodism (GO:0009648),-0.5190339462222804,-1.620476742119257,0.01444043321299639,0.13815203502175968,1.0,12/28,25.74%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;PPP1CA;CRTC1;FBXL22;CRY2
prerank,positive regulation of cartilage development (GO:0061036),-0.5884136566193368,-1.6178236079782957,0.022813688212927757,0.14098887103245997,1.0,5/17,12.10%,ZBTB16;ACVRL1;BMPR2;BMP4;PKDCC
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5849996735682267,-1.616884821220382,0.015463917525773196,0.14157169520250723,1.0,10/18,15.90%,CTNNA1;MFHAS1;GSK3B;LATS2;MDFIC;SIN3A;CHP1;UFM1;RAB23;ILRUN
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.4273966638944164,-1.6167418200466577,0.007259528130671506,0.14121195676146858,1.0,16/66,14.54%,DAB2IP;PTPRM;NFIB;CAV1;THBS1;MCC;TGFBR3;AQP11;MED1;TGFB2;PTPRK;RGCC;CEACAM1;CDC73;KLF9;CDK6
prerank,regulation of humoral immune response (GO:0002920),0.4645290247715041,1.6163277020975315,0.015486725663716814,0.2100373120866515,1.0,12/44,13.64%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;SERPING1;CPN1;C3;GATA6;CLU
prerank,membrane assembly (GO:0071709),0.48780599452418516,1.616127301385018,0.013636363636363636,0.20818291849369308,1.0,6/34,3.50%,PTPRD;NRXN1;IL1RAPL1;NLGN1;ANK3;STX2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5720225184221579,1.615615706443869,0.013574660633484163,0.2066784625192976,1.0,9/18,13.40%,NRXN1;NLGN1;CACNG8;CACNG3;CACNG2;CACNG4;CCL2;CACNG5;NLGN2
prerank,epithelial tube morphogenesis (GO:0060562),-0.5050604946047766,-1.6152581546001812,0.00946969696969697,0.14256121822893741,1.0,11/32,9.15%,ACVRL1;PODXL;PKD2;PRKD2;SOX17;HES1;RASIP1;SLIT2;BMP4;MEF2C;COL4A1
prerank,generation of neurons (GO:0048699),0.3647925622735106,1.614224077710319,0.0,0.20662911024948158,1.0,46/190,15.27%,PTPRD;IL1RAPL1;TAFA1;MYT1L;SNPH;WNT7B;IRX4;ADGRL3;NIF3L1;SPOCK1;ASTN2;CDK5;DNER;ATP2B2;RUNX2;FUT9;LHX1;CDKL5;NRCAM;MDGA1;ITM2C;ASTN1;DCDC2;GPM6A;NTRK2;IRX3;ADNP2;INSM1;MAPT;ACSL3;LMX1B;DCX;MAP1B;CCK;AUTS2;HMGB2;FZD3;WNT6;RUNX3;NRBP2;TUBGCP2;WNT2;BRSK2;WNT4;RNF112;RACGAP1
prerank,granulocyte differentiation (GO:0030851),-0.5760178854318528,-1.61405721689477,0.017793594306049824,0.1435409056431551,1.0,7/18,16.74%,LEF1;CBFA2T3;RXRA;DEK;TAL1;LBR;RARA
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5221019550096851,-1.6134022701993653,0.01845018450184502,0.14373639732995985,1.0,7/26,10.12%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.51749065588495,-1.613345873593296,0.0035398230088495575,0.14321910009200717,1.0,11/28,18.86%,FOXP1;XIAP;BIRC3;SAMHD1;CD55;IRF1;CASP8;N4BP1;ERAP1;ZMPSTE24;TKFC
prerank,embryonic organ development (GO:0048568),-0.43763802214640174,-1.613093393091292,0.0018181818181818182,0.1429523637429613,1.0,24/61,17.56%,PBX1;KITLG;TEAD4;TEAD1;KDR;SOX17;PBX3;TGFBR2;RBP4;TGFB2;TBX2;NES;MFSD2A;PCSK5;TAL1;GLI3;ZFPM1;PKDCC;RPL10;ERCC3;ATF4;TBC1D23;HEY2;HEY1
prerank,regulation of regulated secretory pathway (GO:1903305),0.49205728564748,1.612928153068344,0.011185682326621925,0.2065604350843583,1.0,14/34,17.49%,SYT1;SYT5;RIMS2;RIMS1;RAB15;SYT12;SYT11;SYN1;RAB3A;SYT4;SYT3;SNAPIN;SYT9;RIMS3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.48741706569886556,-1.6126580284686285,0.008264462809917356,0.14301495024126834,1.0,17/39,16.27%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;IL6ST;JAG2;TGFB2;AAK1;MAML1;TSPAN14;NOTCH4;YAP1;TSPAN5;NOTCH1;CCN3;JAG1
prerank,DNA double-strand break processing (GO:0000729),-0.5896555022111016,-1.6125856871080542,0.016333938294010888,0.1425118744062279,1.0,9/18,21.01%,ATM;MRE11;RBBP8;KAT5;DNA2;UBE2V2;SMARCAD1;BRCA1;BLM
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5398217403334403,-1.6121717453723723,0.019963702359346643,0.14245401427972726,1.0,11/24,9.26%,SEMA3C;NRP2;ENG;BMPR2;PARVA;TBX1;TGFBR2;BMP4;TGFB2;TBX2;SMAD4
prerank,vascular transport (GO:0010232),-0.41807115632623976,-1.612052152159741,0.0033783783783783786,0.14199253852950636,1.0,23/81,9.03%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC12A2;ABCC9;TFRC;SLC5A6;SLC16A12;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLC13A3;SLCO2B1;MFSD2A
prerank,negative regulation of MAPK cascade (GO:0043409),-0.4114795908733728,-1.6120513915656551,0.005253940455341506,0.1414290760750242,1.0,31/87,21.92%,DAB2IP;SEMA6A;FOXO1;CAV1;LYN;PTPN1;RANBP9;SPRED2;PTPRJ;PPEF2;DLG1;BMP4;PRKCD;EZR;SMAD4;PEBP1;TIMP3;STK38;DUSP3;CNKSR3;PIK3CB;SPRY4;ABCA7;BMP7;IGBP1;CDK5RAP3;HYAL2;PTPRC;UCHL1;PTEN;NF1
prerank,positive regulation of blood coagulation (GO:0030194),-0.5856624735322051,-1.6114903271528265,0.02527075812274368,0.141606689240024,1.0,9/17,26.29%,ST3GAL4;THBS1;ENPP4;ANO6;F3;SERPINE1;HPSE;DMTN;F2R
prerank,erythrocyte development (GO:0048821),-0.6705519222530139,-1.611059773823874,0.02664298401420959,0.14160820833171486,1.0,4/10,7.89%,ALAS1;ZBTB7A;MED1;ABCB10
prerank,peptide biosynthetic process (GO:0043043),-0.37980728896271326,-1.6100483271155364,0.0,0.1422908421818793,1.0,68/153,29.66%,RPS21;RRBP1;RPL37;RPL31;RPL9;RPS14;GGT5;RPSA;RPLP1;RPL3;MRPL32;PCSK5;RPL26;RPS11;RPL13;RPL38;RPL27;RPS16;MRPS18A;RPS4X;RPL10;RPL7A;AGO2;GSPT1;RPL5;HARS2;RPS27;MRPL24;RPL27A;RPS3;RPL35A;RPL36A;RPL37A;MRPS14;MRPS21;RPL32;MRPL35;WARS1;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;MRPL34;RPL30;RPL13A;MRPL13;MRPL9;RPL22;RPS17;SRBD1;MRPL43;RPL34;RPS2;RPS15A;RPS26;RPL15;MRPL11;RPL39;RPL19;RPLP2;COPS5;RPS13;MRPS17;RPL8;TNIP1;RPL18
prerank,RNA destabilization (GO:0050779),-0.587681221884848,-1.6093803203088224,0.02097902097902098,0.14274033684556228,1.0,10/18,26.97%,METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;ROCK2;RBM24;METTL16;DXO
prerank,regulation of inflammatory response (GO:0050727),-0.3683683066124447,-1.6090012854478615,0.0,0.14262396727227236,1.0,65/190,25.15%,FOXP1;TEK;IL1R1;XIAP;RB1;KLF4;ETS1;MFHAS1;CD200;CASP12;SEMA7A;TMSB4X;APP;IL15;BIRC3;PPARA;TNFRSF1B;NMI;NFKBIA;PDE2A;PDCD4;OTULIN;PRKCD;CDH5;NAPEPLD;PPARD;FEM1A;CELF1;AREL1;MGLL;AGTR1;USP18;JAK2;LPL;IL17RA;CCN3;IFI35;C1QTNF3;NR1D2;TNFRSF1A;TNFAIP3;IL16;HYAL2;ANXA1;NOD2;DAGLB;VAMP3;AKNA;PPARG;GPR4;LPCAT3;VAMP2;MAPK7;RELA;BCL6;SERPINE1;SHPK;CEBPA;RIPK1;ACE2;PTGIS;DHX9;GPS2;CASP1;DDT
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4475436463976483,1.6088409717219359,0.011210762331838564,0.21094071264805442,1.0,12/47,12.04%,VTN;SPOCK3;SPOCK1;SERPIND1;TIMP1;FETUB;SORL1;SERPING1;ANXA8;ANXA8L1;SERPINA2;PCID2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5180042296140563,-1.6084793685827727,0.025974025974025976,0.14274436779289973,1.0,12/27,24.66%,TNRC6B;EGFR;LIMD1;BMP4;PUM1;TP53;AGO2;WTIP;AJUBA;RIPK1;DHX9;FXR1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.4804546593640642,-1.6071485005854986,0.01079136690647482,0.1438232476238953,1.0,18/36,24.41%,DAB2IP;PTPRM;SP100;ACVRL1;THBS1;SLIT2;MEF2C;ADAMTS9;RGCC;NOTCH1;FGF2;MECP2;PPARG;DLL4;GADD45A;NR2F2;ADGRB1;HMGB1
prerank,neuron projection organization (GO:0106027),-0.6158808678151291,-1.6070129390806827,0.02018348623853211,0.14338710810434974,1.0,6/15,15.23%,INSR;GSK3B;APP;DCTN1;PSEN1;LGMN
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.5084849627532823,-1.6065692995334124,0.016483516483516484,0.14335262031618745,1.0,10/29,15.34%,SORBS1;ZBTB20;MTOR;ELOVL5;PPARA;SCARB1;MFSD2A;AKT1;CHP1;CREBL2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.45946739764122785,-1.6058718223075046,0.012987012987012988,0.14369099071816013,1.0,16/47,14.33%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;CORO1C;LIMS1;CRK;ABL1;PTK2;FLNA;ILK;NEDD9;ACTN4;MYOC;SPRY4
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.43875493383499814,-1.6057962987055066,0.0,0.14325550855580765,1.0,25/64,21.92%,UTRN;ACER2;CORO1C;THBS1;GSK3B;CCL25;MACF1;PTK2;ROCK1;LDB1;LIMCH1;RASA1;RHOA;DUSP3;MYOC;PIK3CB;CDK6;ROCK2;JAG1;SLK;MAP4K4;SEMA3E;VCL;PTK2B;NF1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5292293271052763,-1.6049508673403041,0.009174311926605505,0.1439806645762872,1.0,11/26,18.60%,TAB3;NOD1;IFIH1;CASP8;ALPK1;IRAK1;TAB2;TNFAIP3;IRAK2;IKBKG;NOD2
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.3429913573857955,-1.6048701549720314,0.0,0.14355216007804472,1.0,116/348,21.83%,TEK;RBPMS;RAPGEF2;PECAM1;GHR;ENG;ACVRL1;INSR;CAV1;DAB2;RAC1;LYN;FAM20A;BMPR2;PDGFD;IQGAP1;DVL3;UBE2K;APP;RALBP1;RPS6KA5;BMP5;LIMK2;PAK2;TBX1;IL15;KDR;DDX3X;SLCO3A1;LRRK2;PRKD2;NIBAN1;TFRC;PTPRJ;BMP6;EGFR;IL6R;GAS6;MRNIP;FAS;ABL1;BMP4;FGF1;TGFB2;IRGM;CCND3;RAP1A;PTK2;RASSF2;NGF;MRE11;SNX9;PRKD1;MAPK1;MMD;FLT4;IL34;RAF1;ARHGEF2;PLCG2;CSPG4;HAX1;SMAD4;ACVR2A;TP53;AKT1;VEGFC;FGF7;FNIP2;AXIN2;ILK;LIMCH1;BRAF;HFE;MTCP1;RPTOR;JAK2;FGF2;FLOT1;CSNK1D;HGF;CD40;MIF;PIK3R3;CREBL2;ROCK2;MAD2L2;TAB2;BMP7;ANGPT1;HDAC6;IGF1;PELI2;MAVS;ALS2;AKTIP;CENPE;CCL19;CCND1;KRAS;BRAT1;RAP2C;TXN;CACUL1;PTPRC;RAP2A;IGF2;ITGB3;P2RY1;PTPN11;CAPRIN2;MAP2K3;CCN1;NOS1;TTK;PTK2B
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5895891158102207,-1.604263659952916,0.016304347826086956,0.14386562753467877,1.0,5/17,8.87%,CAV1;ADIPOR2;PANK2;PPARA;PPARD
prerank,transport across blood-brain barrier (GO:0150104),-0.41426596575214975,-1.6042449630172853,0.0051813471502590676,0.1433363015178641,1.0,23/83,9.03%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC12A2;ABCC9;TFRC;SLC5A6;SLC16A12;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLC13A3;SLCO2B1;MFSD2A
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5603756032735782,-1.604192931067405,0.010657193605683837,0.1428629618733706,1.0,10/21,16.85%,LDLRAP1;MMP2;ERN1;JUN;FGF2;P2RY6;HTR1B;DNMT1;IGFBP5;IGF1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3470497013026142,-1.6036515638633442,0.0,0.1429634115691067,1.0,132/306,29.66%,MEF2A;ST3GAL4;ALAS1;EXT1;RPS21;ATM;THRB;RRBP1;RBMS1;RPL37;RPL31;TOP3A;RPL9;RPS14;MRE11;RPSA;POLR2G;MCM9;RPLP1;RPL3;MRPL32;ST3GAL2;RBBP8;CLSPN;RPL26;MCM4;PWP1;RPS11;ORC5;TAF1B;EEF2;RPL13;POLD3;RPL38;KAT5;RPA3;DNA2;RPL27;RPS16;MRPS18A;RPA1;DRG1;REV1;RPS4X;RPL10;TBRG1;RPL7A;AGO2;GAL3ST2;GSPT1;RPL5;HARS2;CREBL2;TOP1MT;RPS27;PTMS;B4GALT5;ORC2;POLE2;MRPL24;GOLPH3;RPL27A;WRN;ORC4;RPA2;RPS3;LARGE1;RPL35A;RPL36A;RPL37A;MRPS14;RNPS1;BRCA1;TIMELESS;MRPS21;RPL32;MRPL35;BLM;PTMA;RFC4;WARS1;CHEK1;TERT;RPS7;RPL36;RPS8;RPL28;MCM3;RPS15;RPS23;MRPL34;RPL30;RPL13A;MRPL13;TOP1;MRPL9;MED20;RPL22;POLR2C;RPS17;SRBD1;POLR2H;MRPL43;MLF1;RPL34;RPS2;POLR2L;EEF1B2;TUFM;RPS15A;RPS26;RPL15;MRPL11;POLA2;RPL39;EEF1G;MCM7;MCM5;MCM10;POLL;EXO1;MMS19;SET;RPL19;RPLP2;COPS5;RPS13;MRPS17;EEF1D;RPL8;TNIP1;RPL18
prerank,regulation of complement activation (GO:0030449),0.47000866133550534,1.6034971020405946,0.019955654101995565,0.2172323741011506,1.0,11/40,13.64%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;SERPING1;CPN1;C3;CLU
prerank,presynapse organization (GO:0099172),0.6793641533162483,1.6024218707114046,0.02197802197802198,0.21687664458981723,1.0,2/10,0.53%,NLGN1;LRRTM3
prerank,collagen fibril organization (GO:0030199),-0.4061790892306758,-1.6014753707345535,0.003663003663003663,0.14515262379506053,1.0,23/88,9.15%,TLL1;COL8A1;ITGA6;COL12A1;COL25A1;COL4A2;PLOD1;PLOD2;ADAMTS2;COL4A6;P3H2;ITGB4;LOXL3;COL5A1;LAMA3;COL4A5;COL8A2;TGFB2;COLGALT2;COL5A2;DST;LOXL1;COL4A1
prerank,regulation of secretion (GO:0051046),0.610175810109591,1.6011785086555361,0.020134228187919462,0.2166971746612985,1.0,7/13,15.42%,NRG1;POFUT2;ACSL3;OAS2;GPLD1;SGK1;MYO6
prerank,embryonic hemopoiesis (GO:0035162),-0.6307951720032351,-1.6002254678175285,0.021505376344086023,0.14654909930071547,1.0,6/12,14.31%,KITLG;KDR;TGFBR2;TAL1;ZFPM1;ATF4
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5231083165676229,-1.5992626396051126,0.019927536231884056,0.14716158150578074,1.0,7/25,10.12%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.3286366022187607,-1.5989611951813052,0.0,0.14693367082265768,1.0,146/509,20.16%,FLT1;HIP1;TEK;VWF;DAB2IP;IGF1R;KITLG;JCAD;RAPGEF2;ENG;ITGB1;GAB1;PELI1;AKAP13;FERMT2;NFAT5;INSR;CAV1;NR3C2;TAB3;ESR1;RAC1;ROR1;MFHAS1;LYN;MIER1;ANKRD17;NOD1;PDGFD;THBS1;TRAF5;LIMS1;IQGAP1;ADRA1B;TRIM25;GCNT2;APP;TBX1;PLEKHG5;KDR;TNFSF10;DDX3X;RPL37;PRKD2;TFRC;PTPRJ;NEK6;EGFR;BIRC3;GAS6;RICTOR;NMI;PDCD4;CBL;PIK3R1;IRS1;FGF1;NEDD4;TGFB2;PTK2;TGM2;PUM1;PLK2;SEC13;ROCK1;PRKD1;FLT4;PLCG2;HAX1;MIOS;PIK3CD;WNT16;TP53;NOS1AP;CASP8;ALPK1;FLNA;MAP3K3;BCAP31;FGF7;CFLAR;THEM4;TRIM14;DDX60;ILK;MAZ;USP15;IKBKE;IRAK1;ADGRV1;MTDH;RPTOR;JAK2;RHOA;FGF2;ACTN4;WNT11;RHOG;MYOC;TCIM;LARS1;RHOC;HGF;PIK3CB;KSR1;CD40;MIF;IFI35;CGAS;TNFRSF19;TNFAIP8L3;GRB2;BBC3;ROCK2;MIB2;TAB2;GSDME;BCL2L11;TNFRSF1A;FYN;TFG;ANGPT1;IGF1;PELI2;MAVS;TRIM13;GOLPH3;GAB2;IAPP;IKBKG;CDK5RAP3;VAPA;CCL19;IKBKB;NOD2;RPS3;SIAH1;LURAP1;EDAR;SASH1;TXN;PTPRC;FGFR4;TMEM9B;IGF2;F3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.382224608406606,-1.5981432495910315,0.0,0.14741997751852848,1.0,53/138,25.85%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;NR3C1;TEAD1;THRB;NOTCH3;PPARA;RARG;HDAC1;MED1;POLR2G;MAML1;NOTCH2;GTF2E2;GTF2E1;PPARD;ERCC2;TAF11;NOTCH4;YAP1;MAZ;MED17;NOTCH1;ERCC3;TAF8;DR1;NR1D2;NR2C1;TAF7;RARA;HDAC10;TAF3;HDAC7;TBL1X;PPARG;MED27;TAF4B;RARB;TAF13;RXRG;POLR2C;TAF9;TAF15;POLR2H;POLR2L;E2F3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.46835936049110605,-1.597283471695136,0.014492753623188406,0.14799034023817156,1.0,11/38,12.64%,INSR;CAV1;KLF4;CD34;PKD2;RAC1;KLF2;NOS1AP;AKT1;EDN1;JAK2
prerank,regulation of cell migration (GO:0030334),-0.33643399379334826,-1.5972631514905922,0.0,0.1474771105728627,1.0,133/382,22.09%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;CLDN5;SEMA3C;ENG;ITGB1;ACVRL1;PODXL;FERMT2;INSR;CAV1;DAB2;RAC1;CBLL1;PDGFD;SEMA7A;TMSB4X;CORO1C;THBS1;GCNT2;ATM;SYNE2;ARID2;KDR;MITF;SCAI;ACE;PTPRJ;SMO;EGFR;ADAM9;AFDN;GNA12;LDLRAD4;LMO4;TCAF1;STK24;SLIT2;FOXO3;ROBO4;MACF1;FGF1;PTPRK;PTK2;CDH5;NKD1;EPHA4;DACH1;PLXNA4;ROCK1;PPM1F;PLXND1;CDH1;LDB1;FAM107A;ADAM10;PIK3CD;BCAR1;MYLK;AKT1;FLNA;EDN1;PHACTR1;FGF7;ZMYND8;LMNA;FRMD5;LIMCH1;SMAD7;MAZ;ABI3;TWIST2;NOTCH1;NEDD9;SEMA3G;SEMA6B;CEACAM1;RHOA;SEMA4C;DUSP3;FGF2;ACTN4;WNT11;MYOC;RHOC;TPM1;HGF;NUMB;MIF;PIK3R3;TBCCD1;VSIR;FUZ;SEMA5B;ROCK2;JAG1;TMSB10;IGFBP5;SLK;IGF1;ADARB1;MAP4K4;RIPOR1;CTSH;SEMA4A;CITED2;ANXA1;DUSP22;WASHC1;SASH1;RAP2C;SEMA3E;RAP2A;SPATA13;F3;VCL;AMOTL2;SEMA4G;SH3RF2;FERMT3;HACE1;LAMC2;CCN1;PTEN;SPAG9;PTK2B;NF1;RECK
prerank,positive regulation of cell differentiation (GO:0045597),-0.3555508143238096,-1.5963670978814821,0.0,0.1480934943656278,1.0,66/237,15.36%,LEF1;PRKCH;KITLG;CTNNA1;SLC6A6;ZBTB16;RAPGEF2;ACVRL1;MEF2A;ZHX3;FERMT2;ZEB1;BOC;CD34;DAB2;LRP5;BMPR2;GCNT2;KDR;MTOR;IL6ST;BMP6;TGFBR2;TRPM4;IL6R;NFKB1;PLCB1;ABL1;BMP4;TGFB2;BLOC1S5;RAP1A;MEF2C;CDON;NGF;PRKD1;BNIP2;SMAD2;MMD;ARHGEF2;PPARD;RRAS;SMAD4;ACVR2A;AKT1;YAP1;SIN3A;AXIN2;RGCC;AGTR1;PKDCC;RPS6KA1;PA2G4;CEACAM1;RIN2;RHOA;TMEM64;EDN3;LPL;HGF;SMYD1;MAPK12;RPS6KA3;FOXC1;CREBL2;TCF3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.6072361873341955,-1.5961953354690983,0.025134649910233394,0.1477796830372769,1.0,5/15,9.44%,LEF1;CHD1;SP1;JUN;TAF11
prerank,purine-containing compound salvage (GO:0043101),-0.6500503347491193,-1.5959996987448557,0.01936619718309859,0.1474317688360802,1.0,9/12,31.80%,ADK;AMPD2;HPRT1;AMPD3;ADA;PNP;APRT;GMPR2;DCK
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.6294101500197162,1.595763858763057,0.04212860310421286,0.22307853004044395,1.0,4/12,1.31%,SYT1;SYT5;RIMS2;RIMS1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.47258365748156494,-1.5957019733471085,0.019572953736654804,0.1473127309010679,1.0,18/39,21.18%,ENG;TIE1;PKD2;LRP5;KDR;TGFBR2;RASIP1;SIX1;SLIT2;BMP4;LRP6;COL4A1;NOTCH4;FGF2;CTNNB1;EPHA2;SEMA3E;DLL4
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.371095050025453,-1.5953140472785838,0.0,0.14729830954217474,1.0,46/161,16.25%,DAB2IP;CAV1;CSNK1A1;DAB2;MLLT3;FZD6;GSK3B;DVL3;MCC;PSMA2;SOX13;ZNRF3;IGFBP4;SOX17;EMD;FZD4;LIMD1;RBX1;FRMD8;KREMEN1;HDAC1;STK3;CUL3;LRP6;NKD1;PSME2;CTNND1;KLHL12;PSMB4;GSK3A;LATS2;UBAC2;GLI3;AXIN2;TMEM64;NOTUM;WNT11;DKK2;PSMC2;PSMB2;LMBR1L;TMEM170B;FUZ;RUVBL2;MAD2L2;PSMB1
prerank,regulation of cell cycle (GO:0051726),-0.3491865390306139,-1.5950593026651925,0.0,0.14700076066482395,1.0,99/271,26.62%,MECOM;GRK5;APBB2;DAB2IP;TTC28;MAP3K20;PPP1R13B;AFAP1L2;XIAP;RB1;DCUN1D3;NEK7;PKD2;ANKRD17;THBS1;IQGAP1;FBXL12;LIN52;KAT2B;ATM;FBXL17;SIK1;PLAGL1;FBXL3;NEK6;CDKN1B;CRLF3;BIRC3;PDCD4;ABL1;PHACTR4;BMP4;LRP6;TGFB2;PTPRK;ERN1;RNF40;CDC14A;JUN;CDK10;PUM1;UHRF2;NOTCH2;ADAM10;IRF1;TP53;RASSF1;RGCC;NOTCH1;SON;CDC123;TBRG1;NUDT6;CDK6;HCFC1;MYBL2;RNF167;MAPK12;MIF;FOXO4;SRPK2;BMP7;RARA;TFAP4;ADARB1;CITED2;CDK5RAP3;BAP1;CCND1;LIN37;RAD23A;BOP1;PTPRC;BRCA1;CDK11B;PES1;CDKN2C;CHEK1;MDM2;CDC25A;GADD45A;TCF7L2;TBX3;APBB1;BMP2;APC;SIPA1;MLF1;DTL;FBXL22;MAEA;RPS15A;NUPR2;CDKN3;HNRNPU;FGF10;GAS2L1;PIM3;WDR12
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.42581455862779827,-1.5924450617181005,0.0034482758620689655,0.14974263607039626,1.0,19/67,12.64%,FLT1;TEK;IGF1R;GHR;DYRK1A;INSR;ABI1;LYN;IL15;KDR;EGFR;BMX;ABL1;PTK2;EPHA4;FLT4;ABI3;PKDCC;JAK2
prerank,sodium-independent organic anion transport (GO:0043252),-0.6711380341001194,-1.5904073649938553,0.02127659574468085,0.15190719610225642,1.0,7/10,28.99%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1;SLCO4A1;SLCO1B1;SLC16A2
prerank,negative regulation of vascular permeability (GO:0043116),-0.6234813535222798,-1.5890859555514116,0.029250457038391225,0.15309571447467077,1.0,9/12,16.67%,CLDN5;FERMT2;PTPRJ;PDE2A;SLIT2;PDE3A;RAMP2;CEACAM1;ANGPT1
prerank,atrial septum morphogenesis (GO:0060413),-0.6773879469280916,-1.5888432104594432,0.015734265734265736,0.1528441161493937,1.0,6/10,18.76%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;SOX4
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5696821787887231,-1.5882206890278723,0.029411764705882353,0.15319503596948983,1.0,8/18,17.31%,ANKRD17;RNF125;BIRC3;PUM1;SEC14L1;DDX60;USP15;GPATCH3
prerank,phosphorylation (GO:0016310),-0.3358931267027454,-1.5873509248799873,0.0,0.1537944357206524,1.0,113/384,17.63%,GRK5;PRKCH;PRKG1;SNRK;ERG;MAP3K20;ACVRL1;BCR;DYRK1A;INSR;NEK7;CSNK1A1;DAPK1;PRKCE;LYN;FAM20A;BMPR2;TLK2;GSK3B;PRKACB;CDK13;APP;RPS6KA5;ATM;LIMK2;PAK2;MARK1;MAP3K5;SIK1;JAK1;PANK2;MAP4K3;LRRK2;MTOR;PRKD2;CDK17;TLK1;MERTK;CDK12;NEK6;TGFBR2;LIMD1;GAS6;BMX;STK3;STK24;ABL1;MAST2;TGFB2;PRKCD;BRD2;ERN1;MAPKAPK2;PRAG1;AAK1;CDK10;CDC42BPA;PLK2;ROCK1;BIRC6;PRKD1;MAPK1;MAML1;YWHAZ;GSK3A;AKT3;ADAM10;PIK3CD;ACVR2A;LATS2;PXK;DGKA;DGKZ;AKT1;WNK4;SIK3;PRKAA1;FRK;FNIP2;TAOK3;STK10;ILK;BRAF;STK38;IKBKE;IRAK1;JAK2;CLK3;WNT11;CSK;MKNK2;CSNK1D;AGK;MAPK8;PKN2;PIK3CB;PNKP;LIPE;GK5;CDK6;MARK2;PKN3;GMFB;HIPK1;ROCK2;MARK3;SRPK2;FYN;RARA;CDC42BPB;NUAK1;MAP4K4;PLK4
prerank,positive regulation of phosphorylation (GO:0042327),-0.3504643632070133,-1.5872792516815584,0.0,0.15334123777492878,1.0,87/240,24.69%,FLT1;TEK;IGF1R;ITGA6;PECAM1;ENG;ZBTB20;TIE1;INSR;DAB2;RAC1;ROR1;LYN;FAM20A;THBS1;DVL3;APP;RALBP1;LIMK2;TBX1;KDR;SLCO3A1;LRRK2;NIBAN1;TFRC;MERTK;EGFR;GAS6;LMO4;FAS;DSTYK;ABL1;BMP4;FGF1;IRGM;CCND3;PTK2;EPHA4;MRE11;FLT4;IL34;ACVR2A;AKT1;VEGFC;PRKAA1;FGF7;AXIN2;PFKFB3;ILK;LIMCH1;PSEN1;FGF2;FLOT1;CSNK1D;HGF;PTGES3;CD40;MIF;PIK3R3;ROCK2;ANGPT1;IGF1;PELI2;MAVS;AKTIP;CCND1;KRAS;BRAT1;ARNT;EPHA2;RAP2A;FGFR4;IGF2;ITGB3;P2RY1;EPHB6;CCN1;HSP90AA1;FZD7;RALB;RIPK1;EPHB3;PDGFRB;ARRB1;PFKFB4;FXR1;BMP2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4892054126231541,-1.5872027576923995,0.0176678445229682,0.15296111239559412,1.0,18/31,31.99%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;FHL1;CDKN2C;PTEN;E2F7;APC;CDKN2B;JADE1;CDK4;WEE1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.48937464362806826,-1.587096816243242,0.014545454545454545,0.15258795623028443,1.0,13/35,18.26%,DAB2IP;HEG1;ITGA3;SCAI;RASIP1;CUL3;TGFB2;STAMBP;TNFAIP1;MYOC;SPRY4;KCTD10;ARHGAP35
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.48533178728199194,-1.5869420993373453,0.01054481546572935,0.15219998893566064,1.0,17/37,21.65%,PRKG1;LDLRAP1;CDKN1B;MMP2;PDCD4;MEF2C;ERN1;JUN;FGF2;TPM1;P2RY6;HTR1B;DNMT1;IGFBP5;IGF1;PPARG;PTEN
prerank,endothelial cell differentiation (GO:0045446),-0.625069052937977,-1.586918320754795,0.013651877133105802,0.15171082355928667,1.0,6/12,16.27%,ACVRL1;TIE1;BMPR2;KDR;KDM6B;JAG1
prerank,protein phosphorylation (GO:0006468),-0.331064118752363,-1.5851888742859637,0.0,0.1533983410201084,1.0,133/478,17.00%,FLT1;GRK5;TEK;PRKCH;DAB2IP;IGF1R;PRKG1;SNRK;ERG;MAP3K20;ACVRL1;BCR;ERC1;DYRK1A;INSR;NEK7;ABI1;CSNK1A1;DAPK1;PRKCE;LYN;FAM20A;BMPR2;TLK2;GSK3B;PRKACB;CDK13;APP;RPS6KA5;ATM;LIMK2;PAK2;MARK1;MAP3K5;SIK1;JAK1;MAP4K3;KDR;LRRK2;MTOR;PRKD2;CDK17;TLK1;MERTK;TGFBR3;CSNK1G3;CDK12;NEK6;EGFR;TGFBR2;GAS6;RICTOR;BMX;STK3;STK24;ABL1;MAST2;BMP4;TGFB2;PRKCD;BRD2;MAST4;ERN1;PTK2;EPHA4;MAPKAPK2;PRAG1;AAK1;CDK10;CDC42BPA;PLK2;ROCK1;BIRC6;PRKD1;MAPK1;MAML1;SMAD2;FLT4;YWHAZ;GSK3A;AKT3;ADAM10;PIK3CD;ACVR2A;LATS2;PXK;CLSPN;AKT1;MAP3K3;WNK4;SIK3;PRKAA1;FRK;FNIP2;TAOK3;STK10;STK32C;ILK;BRAF;SMAD7;ABI3;USP15;STK38;IKBKE;IRAK1;PKDCC;CSNK1G1;RPS6KA1;JAK2;ULK2;CLK3;WNT11;CSK;MKNK2;CSNK1D;MAPK8;PKN2;LIPE;CDK6;MARK2;PKN3;MAPK12;RPS6KA3;GMFB;HIPK1;ROCK2;MARK3;SRPK2;FYN;SLK;RARA;CDC42BPB;STK16
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.31084845755422,-1.5850305440589085,0.0,0.1530502504434416,1.0,343/1082,24.43%,MECOM;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;FLI1;ITGA6;ZBTB16;NFIB;SP100;ERG;ENG;ZNF423;ACVRL1;FOXO1;MEF2A;AFAP1L2;MLLT10;MRTFB;CREBBP;NSD1;SENP1;NFAT5;ELF1;DYRK1A;KAT6B;KLF4;ETS1;ZMIZ1;DAB2;PKD2;LRP5;ESR1;MLLT3;BMPR2;TCF12;ZFHX3;ASXL1;KLF2;NRIP1;IRF2;MAML2;DVL3;RXRA;NFATC1;APP;KAT2B;RPS6KA5;PRDM16;TRIM56;LMO2;FOSL2;BMP5;ATM;BICRA;TBX1;MAP3K5;KMT2E;RNF111;NR3C1;ZSCAN21;DTX3L;TEAD1;THRB;ARID1B;DDX3X;KANSL3;KAT6A;MTOR;MITF;PRKD2;PLAGL1;SOX17;CD38;NFIX;BMP6;NAA16;SP1;FZD4;EGFR;CRLF3;ELK3;RTRAF;TASP1;MEOX2;CTCF;HES1;SIX1;PPARA;RARG;NFKB1;HDAC1;TET2;RYBP;NFKBIA;DNM2;LMO7;WDR75;PLCB1;SMARCC1;UBP1;NCK1;FOXO3;ABL1;PIK3R1;HIVEP1;RHOQ;BMP4;PRPF6;LRP6;FGF1;MED1;E2F4;AATF;MEF2C;STAT6;NSD3;GABPB2;JUN;WASL;MAX;ACTA2;CREB3L2;AGRN;SMAD1;ZFP90;PRKD1;MAML1;SETD3;CDH1;LDB1;SMAD2;HNRNPAB;ATAD2B;ARHGEF2;PPARD;AKIRIN2;DDX39B;PHF5A;NAMPT;HAX1;PICALM;CTBP2;SMAD4;ACVR2A;PRDM2;IRF1;TAL1;GLIS2;TP53;SP3;AKT1;EDN1;NAA15;ELF2;KLF10;NOTCH4;KDM6B;GLI3;MDFIC;BCLAF3;ETS2;YAP1;POGZ;DOT1L;FGF7;SIN3A;KDM3A;HELZ2;NFIC;PPP1R12A;RGCC;ILK;RGMB;ZFPM1;SMARCC2;SMAD7;MAZ;MED13;ARHGEF11;NCK2;SFPQ;PSEN1;MED17;BCAS3;ICE1;FOXF2;HDAC4;NOTCH1;CREBRF;WWOX;RPS6KA1;RPTOR;KAT5;YAF2;FGF2;WNT11;RHOG;TCEA1;EIF5A;FOXJ3;ZPR1;GABPB1;XPC;HGF;GRHL1;PLSCR1;ZIC3;FBXW11;AGO2;ATF4;MZF1;HCFC1;MYBL2;SMARCD3;CD40;MRPL12;RPS6KA3;FOXC1;DR1;TRIM16;ZNF462;JMJD6;CREBL2;TCF3;KMT2C;NR1D2;FOXO4;ETV1;TADA3;RUVBL2;SKI;MAD2L2;THOC1;JAG1;TNFRSF1A;PCBD2;SIX4;BMP7;TAF7;RARA;TFAP4;IGF1;MAVS;CCNC;CTNNB1;HLF;EPAS1;NLRC5;GPATCH3;THAP3;HEY2;HEY1;CEBPG;KDM1B;IKBKG;NCOA6;CITED2;ZNF507;NRF1;GATA2;RNF10;HYAL2;WBP2;IKBKB;NOD2;SOX4;EDRF1;ELK4;ARNT;RNF4;ELOF1;ZIC1;PCGF5;ATRX;MED10;SS18;PRKDC;CKAP2;IGF2;BRCA1;TRIM28;AKNA;LPIN2;FOXL2;PBX2;TBL1X;TET3;BLM;PPARG;CREB1;CAPRIN2;CHEK1;MAPK7;CAND2;MAP2K3;CCN1;NOS1;UBTF;MYOCD;ATAD2;RARB;KCNH2;USP16;GLMP;OGT;RELA;ATF6;GLIS1;GABPA;NFE2L2;SERPINE1;SUPT4H1;RFXANK;ELF4;FZD7;PCBP1;RXRG;CEBPA;NR2F2;FZD5;CCNK;RIPK1;YY1;TCF4;TCF7L2;SSBP4;TBX3;E2F7;TAF9;ATF5;TAF15;APBB1;DHX9;CRTC1;GPS2;ERCC6;HMGB1;FANK1;ARRB1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.381691571329147,-1.5844363677036974,0.003703703703703704,0.15333412401533325,1.0,56/137,25.64%,DOCK9;ITGA6;RAPGEF2;ITGB1;RSU1;FERMT2;RAB3GAP1;CD200;NET1;LIMS1;GSK3B;PKP4;DVL3;RALBP1;F11R;CCL25;AFDN;RAP1A;TGM2;AGRN;SNX9;USP6NL;TBC1D30;RASGRP2;PICALM;RAPGEF1;ARAP1;BCAS3;MTCL1;RHOA;WNT11;LARS1;RHOC;MAPK8;CD40;MAPK12;TBC1D20;MAP4K4;CTSH;WRN;ALS2;CCL19;RPS3;NDEL1;SNX13;EVI5;NF1;ARHGAP11A;ASAP3;RAPGEF3;ADRB1;PLXNB1;BMP2;FZD10;ARHGAP27;SNX18
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3353021035447601,-1.5839388353619865,0.0,0.15343253381747765,1.0,109/390,16.85%,PTPRG;FLT1;TEK;IGF1R;RAPGEF2;SORBS1;GHR;WASF2;NRP2;DOCK1;FOXO1;GAB1;TIE1;COL4A2;INSR;ANKS1A;ABI1;RAC1;ROR1;LYN;ARHGEF28;PDGFD;RBFOX2;COL4A6;GSK3B;ELMO1;CRK;PAK2;NFATC4;KDR;SPRED2;PRKD2;MERTK;PTPRJ;GIGYF2;EGFR;YES1;AP2B1;CEP57;MMP2;AP2A2;PXN;PLCB1;CBL;PSEN2;NCK1;CHN1;SHOC2;PIK3R1;DDIT4;IRS1;RHOQ;FGF1;AP2S1;PTK2;PIK3C2A;WASL;NGF;EPHA4;MAPKAPK2;HNRNPM;ROCK1;PRKD1;MAPK1;POLR2G;ITSN1;FLT4;GRB10;GRB14;NAMPT;SHB;GSK3A;ZNF106;MPZL1;BCAR1;SOCS2;AKT1;VEGFC;FGF7;FRK;RAPGEF1;HNRNPF;NCK2;PSEN1;ACTB;NEDD9;RASA1;JAK2;RHOA;ATP6V1E1;FGF2;TIAL1;NCF2;HGF;PIK3CB;NCKAP1;ELMO2;HNRNPA1;FOXC1;PIK3R3;GRB2;FOXO4;ROCK2;ARPC4;APH1A;ANGPTL1;FYN;ANGPT1;IGF1
prerank,positive regulation of neuron differentiation (GO:0045666),0.46844251792893377,1.5828021018751406,0.016055045871559634,0.24293238976348308,1.0,13/40,10.02%,BRINP3;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;PROX1;BRINP2;ADRA2C;FGF20;CPNE1
prerank,membrane depolarization during action potential (GO:0086010),0.5165486137842282,1.5824797402108066,0.023809523809523808,0.24113106608528823,1.0,12/26,18.40%,ATP1A2;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;CACNA1D;SCN5A;SLC8A1;SCN2B;CACNA1G;CACNA1I
prerank,Notch signaling involved in heart development (GO:0061314),-0.6434867396378237,-1.582042986303789,0.01971326164874552,0.15535539098399997,1.0,7/11,21.18%,NOTCH2;NOTCH1;GALNT11;JAG1;HEY2;HEY1;DLL4
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.5545497822753893,-1.5813754808709317,0.024013722126929673,0.15570078856133548,1.0,11/21,17.56%,NOS3;SRGN;TRPM4;GAS6;ASPN;ROCK1;NOTCH1;BCOR;ROCK2;HEY2;HEY1
prerank,histone lysine demethylation (GO:0070076),-0.5176382442437129,-1.580951154349005,0.009107468123861567,0.15576496957318675,1.0,14/25,30.97%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;KDM5B;KDM1B;KDM3B;RIOX1;KDM4D;KDM4A
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.4286794507928497,-1.5808520653983775,0.005226480836236934,0.15536541198202128,1.0,31/66,29.14%,FERMT2;UBR5;LIMK2;DTX3L;TFRC;PIK3R1;PRKCD;TCP1;CDH1;AKT1;FLNA;YAP1;PSEN1;ZPR1;TPR;MAVS;CDK5RAP3;HYAL2;ZIC1;TRIM28;ORMDL3;TERT;CCT5;EIF2AK3;PARP9;RAN;CCT2;PINX1;LARP7;NMD3;JUP
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.6355951127684661,-1.5804766553823262,0.020146520146520148,0.15538829865390483,1.0,5/12,8.94%,GMDS;CSGALNACT1;GFPT2;FUT8;SLC35A3
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5703868201735176,-1.5800552175402554,0.023679417122040074,0.15547379616570595,1.0,10/19,19.81%,CYTH3;PARD3;MSN;CYTH1;EZR;MYO18A;SIPA1L3;RHOA;GOLPH3;RAP2A
prerank,aorta morphogenesis (GO:0035909),-0.5803844468247914,-1.5789586030129836,0.019538188277087035,0.1564053149967871,1.0,11/17,24.06%,ENG;ACVRL1;TBX1;TBX2;ADAMTS9;MYLK;JAG1;HEY2;HEY1;DLL4;PDGFRB
prerank,small GTPase mediated signal transduction (GO:0007264),-0.39785725136424005,-1.578780096088576,0.0017123287671232876,0.1560878751265074,1.0,39/103,19.35%,RAPGEF5;ARHGAP31;RREB1;RAPGEF2;GNB1;BCR;RB1;BRAP;RAC1;NTN1;RALBP1;PLD1;SHOC2;PLCE1;JUN;PLK2;RASGRP2;PRKD1;PLD2;RRAS;TP53;GRAP;RASSF1;ARHGAP1;RIN2;FGF2;CHP1;KSR1;GRB2;ABR;ARHGEF18;DNMT1;RERG;IGF1;NRAS;KRAS;RGL2;RGL1;RRAS2
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6565032826060424,-1.576800572253838,0.028419182948490232,0.1583163772843574,1.0,7/10,21.18%,BMP5;PHACTR4;LRP6;NOTCH1;BMP7;ARHGAP12;DLL4
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4735171372646245,-1.5741569244658824,0.01415929203539823,0.161467783169605,1.0,17/36,22.22%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;GCH1;CYGB;WASL;SCARB1;NOS1AP;AKT1;S100A1;PIK3CB;TERF2;TERT;GLA;HSP90AA1
prerank,Wnt signaling pathway (GO:0016055),-0.39751466678538544,-1.573233038029519,0.005199306759098787,0.16221956004892873,1.0,36/92,26.63%,LEF1;NXN;FERMT2;CSNK1A1;LRP5;FZD6;GSK3B;DVL3;DDX3X;LRRK2;CSNK1G3;FZD4;RBX1;RARG;LRP6;KLHL12;PLCG2;WNT16;VPS26A;CSNK1G1;WNT11;TCF7L1;USP34;CTNNB1;PTEN;AMER1;FZD7;FZD5;TCF7L2;PLPP3;FZD10;WNT5B;APC;WNT2B;VPS35;SFRP4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6573773966555942,-1.5728460719209814,0.02717391304347826,0.16228949553671473,1.0,5/11,13.72%,SEMA6A;KLF2;THBS1;ADAMTS9;PIK3CB
prerank,neuron development (GO:0048666),0.3649033865152891,1.5721386770209094,0.0024154589371980675,0.2574640258103714,1.0,32/141,10.42%,CNTNAP2;TENM4;NLGN1;L1CAM;RASGRF1;MYT1L;BLK;PPP1R9A;CNTN4;ATP8A2;TENM1;GPM6B;SH3GL2;TMEM108;TENM3;CDK5;PLP1;SRRM4;ATXN10;TENM2;EPHA5;MAP2;NPY;GPM6A;NTRK2;INSM1;MAPT;POU4F1;ARL3;DCX;STMN2;ZFYVE27
prerank,aortic valve development (GO:0003176),-0.4835650981967664,-1.5719704234900047,0.014209591474245116,0.16294788897378026,1.0,17/34,17.56%,ELN;RB1;NOS3;TIE1;BMPR2;NFATC1;TNFRSF1B;SLIT2;BMP4;ROCK1;NOTCH1;SMAD6;ROCK2;JAG1;TNFRSF1A;HEY2;HEY1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.5939328818502843,-1.5719284053506788,0.01877133105802048,0.1624891647274381,1.0,5/16,10.14%,CREBBP;KAT2B;NAA16;NAA80;NAA15
prerank,cellular component maintenance (GO:0043954),-0.6381585059576498,-1.57183544879279,0.026041666666666668,0.1620821421950821,1.0,3/12,2.99%,IGF1R;INSR;ITGA3
prerank,regulation of transferase activity (GO:0051338),-0.5818810031105516,-1.5717857579183854,0.031746031746031744,0.16162101416032526,1.0,11/17,30.37%,ATM;PARP4;LDB1;FEM1A;HMBOX1;FEM1B;NLRC5;SMG6;PINX1;BAG5;EMP2
prerank,negative regulation of apoptotic process (GO:0043066),-0.3287415899206583,-1.571622126359908,0.0,0.16130817502646833,1.0,123/444,18.55%,TJP1;LEF1;GRK5;TEK;PRKCH;IGF1R;ITGB1;FOXO1;XIAP;RB1;ERC1;CAV1;KLF4;MCL1;DAB2;TNFAIP8;THBS1;GSK3B;ARHGAP10;PAK2;TBX1;NFATC4;KDR;DDX3X;YWHAE;TFRC;CD38;MERTK;IL6ST;TAX1BP1;NAA16;EGFR;SLC30A10;RNF213;BIRC3;GAS6;SIX1;NFKB1;HDAC1;NFKBIA;FAS;DSTYK;CBL;PSEN2;PIK3R1;BMP4;MED1;PRKCD;AATF;MEF2C;PTK2;BNIP3;ARHGDIA;MYO18A;RNF144B;NGF;MRE11;PLK2;BIRC6;MAPK1;NOTCH2;BNIP2;DNAJB6;FLT4;RAF1;ANXA4;YWHAZ;HAX1;ADAM10;SH3RF1;TP53;SOCS2;AKT1;FLNA;NAA15;YAP1;PRKAA1;CFLAR;AREL1;BRAF;MAZ;SFPQ;PSEN1;IRAK1;NOTCH1;COMP;RASA1;CAT;MTDH;RPS6KA1;PA2G4;SON;WNT11;UFM1;TCIM;MAPK8;HGF;RPL10;ZFAND6;GPX1;BABAM2;MIF;RPS6KA3;LGMN;PRDM9;SMAD6;SIX4;FOXQ1;ANGPT1;IGF1;IGBP1;CTNNB1;API5;MAP4K4;GOLPH3;CTSH;PPIF;SOD1;CFL1;CITED2;CLCF1;ANXA1;IKBKB
prerank,copper ion homeostasis (GO:0055070),-0.5666449479483833,-1.5698612687630662,0.034482758620689655,0.163251171990755,1.0,4/17,4.68%,XIAP;APP;ATOX1;SLC31A1
prerank,positive regulation of coagulation (GO:0050820),-0.6707307380507472,-1.568310828568708,0.0325497287522604,0.16417287366595978,1.0,7/10,26.29%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,positive regulation of hemostasis (GO:1900048),-0.6707307380507472,-1.568310828568708,0.0325497287522604,0.16417287366595978,1.0,7/10,26.29%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,lipid phosphorylation (GO:0046834),0.6470437008454666,1.5664289083726344,0.037122969837587005,0.26534230936831715,1.0,3/10,1.90%,DGKK;DGKI;DGKQ
prerank,response to gamma radiation (GO:0010332),-0.5264428982211812,-1.565912779729132,0.03571428571428571,0.16687791098854662,1.0,13/24,21.88%,MAP3K20;DCUN1D3;TLK2;ATM;RPL26;TP53;YAP1;PRKAA1;FANCD2;TRIM13;WRN;LIG4;MDM2
prerank,positive regulation of wound healing (GO:0090303),-0.47266978401991167,-1.565406796967442,0.020072992700729927,0.16714566146818877,1.0,12/36,11.99%,RREB1;ITGB1;ST3GAL4;FERMT2;PRKCE;THBS1;MTOR;ENPP4;PTK2;OCLN;MYLK;ARFGEF1
prerank,cellular response to cadmium ion (GO:0071276),-0.5307619720768579,-1.5645673645061609,0.023381294964028777,0.16773264798336246,1.0,14/24,24.98%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5847747011619957,-1.563977721129946,0.031598513011152414,0.16806320905780162,1.0,10/15,29.29%,TMSB4X;KDR;PRKD2;PRKD1;FGF2;LGMN;SMOC2;SEMA5A;MET;FGF18
prerank,amino acid import (GO:0043090),-0.5402578479976444,-1.5632012244382802,0.020676691729323307,0.16867913530615325,1.0,5/21,2.45%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SH3BP4
prerank,insulin receptor signaling pathway (GO:0008286),-0.419828971992063,-1.562239964310897,0.01282051282051282,0.169456099788102,1.0,21/69,15.58%,IGF1R;SORBS1;FOXO1;GAB1;INSR;GSK3B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GRB14;NAMPT;GSK3A;ZNF106;BCAR1;AKT1;ATP6V1E1;PIK3R3;GRB2;FOXO4
prerank,positive regulation of gene expression (GO:0010628),-0.32673310121111604,-1.5619195416423237,0.0,0.16939872624612515,1.0,131/442,20.16%,LEF1;CLDN5;NOS3;UBR5;DYRK1A;KLF4;ETS1;CD34;TNRC6B;MED26;THBS1;LIMS1;GSK3B;TENT4B;APP;KAT2B;DEK;ATM;IL15;EIF3E;METTL14;DDX3X;MTOR;MITF;NIBAN1;TFRC;SMO;BMP6;SP1;EGFR;MSN;EIF3C;CTCF;GAS6;PLD1;AFDN;PDE2A;PIK3R1;UPF3B;BMP4;FGF1;MED1;EZR;MEF2C;ERN1;CDH5;NGF;ACTA2;RAB27A;SMAD1;SEC16B;SAMD4A;ROCK1;PPM1F;MAPK1;OCLN;PLCG2;GSK3A;RAMP2;SF3B1;PIK3CD;WNT16;RPL26;MYOM1;TP53;CELF1;NOS1AP;TENT4A;AKT1;ZCCHC4;YAP1;PRKAA1;FGF7;TAF1B;EEF2;RGCC;BRAF;MAZ;HFE;PSEN1;ACTB;NOTCH1;FGF2;WNT11;ZPR1;FLOT1;LARP4B;TAF1C;RPS4X;MAPK8;PIK3CB;PLSCR1;RBM20;AGO2;ATF4;HCFC1;FAM98A;MIF;RPL5;PIK3R3;C1QTNF3;AGPAT1;VSIR;TADA3;ROCK2;TERF2;DNMT1;SRPK2;METTL5;BMP7;ANGPT1;IGF1;MOV10;HEY2;CTSH;HEY1;SOD1;CITED2;GATA2;WBP2;RPS3;TNRC6A;LURAP1;SOX4;KRAS;FUBP1;PRKAB1;FGFR4;PRKDC;BRCA1;F3
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6184337015510175,-1.561312209301674,0.023679417122040074,0.1697083898001696,1.0,8/13,26.26%,CAV1;NEDD4L;CASQ2;NOS1;PTK2B;KCNH2;CAB39;ACTN2
prerank,erythrocyte differentiation (GO:0030218),-0.45181325227721514,-1.5603808448602399,0.021164021164021163,0.17055282563951663,1.0,15/44,18.12%,ALAS1;MFHAS1;LYN;KMT2E;TGFBR3;RPS14;MED1;ACIN1;ABCB10;TAL1;ZFPM1;JAK2;FLVCR1;CEBPG;CDK5RAP3
prerank,macrophage activation (GO:0042116),-0.4849865644861732,-1.5603149318377731,0.019748653500897665,0.17012042917584672,1.0,9/34,15.04%,FOXP1;APP;DYSF;NMI;CD93;LBP;PLCG2;JAK2;IFI35
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.643763979840053,-1.5599203036942244,0.027932960893854747,0.1701197081418544,1.0,6/10,15.92%,BMP6;PPM1F;NOTCH4;RGCC;NOTCH1;MAD2L2
prerank,homologous chromosome segregation (GO:0045143),0.5375496381433952,1.5588563104338722,0.02207505518763797,0.27735455805389386,1.0,4/20,3.73%,SYCP1;MAJIN;ZCWPW1;FMN2
prerank,regulation of immune effector process (GO:0002697),0.45512369124278257,1.5586201520102656,0.02237136465324385,0.2752791670550511,1.0,11/41,13.64%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;SERPING1;CPN1;C3;CLU
prerank,regulation of leukocyte activation (GO:0002694),-0.6096764598343984,-1.5584287592235886,0.02608695652173913,0.17173359401069205,1.0,7/14,14.99%,MFHAS1;LYN;CD200;MYO18A;PLSCR1;GPR137B;MIF
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.49194958865945015,-1.5560222399377137,0.019332161687170474,0.1747783698014438,1.0,11/29,18.60%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;DGKZ;FGF2;TNFAIP8L3;CCL19;NOD2
prerank,inhibitory synapse assembly (GO:1904862),0.6270474292927772,1.5553783621715247,0.0477326968973747,0.2791038443156692,1.0,4/11,9.77%,GABRB3;GABRB2;GABRA2;GABRA1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5574999974619352,1.5540571293145917,0.045662100456621,0.27933560505877536,1.0,6/16,8.74%,GPR137C;RRAGA;PIP4P1;FLCN;KLHL22;SEH1L
prerank,regulation of intracellular signal transduction (GO:1902531),-0.32733877342868867,-1.5540236035661341,0.0,0.17722256036254475,1.0,137/420,22.31%,SGMS1;TEK;VWF;DAB2IP;CHN2;ARHGAP31;MOB3B;PPP1R13B;XIAP;BCR;AKAP13;ARHGEF3;RAC1;RHOJ;LYN;NET1;TMSB4X;STARD8;TRAF5;RALBP1;MCF2L;CRK;WWC2;ARHGAP10;ATM;PAK2;ARAP3;PLEKHG5;KAT6A;LRRK2;MTOR;PRKD2;EGFR;ARHGAP5;BIRC3;TOP3A;RASGRF2;PIP4K2A;RICTOR;GNA12;HDAC1;NFKBIA;STK3;PDE2A;DLG1;PHF20;CHN1;DDIT4;RHOQ;ARHGEF12;PAK1IP1;FGF1;EZR;PIP4K2B;RASSF2;ARHGDIA;MRE11;PIP5K1B;MAPK1;ITSN1;ARHGEF2;PLCG2;NOP2;USP2;IER3;RRAS;SOS2;ARHGAP17;TAF11;RBBP8;TP53;AKT1;STARD13;PRKAA1;TAOK3;EHMT1;ARAP1;ARHGAP1;ARHGEF11;CHD3;ARHGAP28;TTI1;CEACAM1;KAT5;RPA3;RHOA;FAM13A;RHOG;DNA2;MYOC;RPA1;RHOC;ZFAND6;PTPN13;RPL5;TRIO;KMT5A;CASTOR1;HIPK1;ABR;DEPDC7;ARHGAP22;ARHGEF18;ARHGAP29;TAF7;TAF3;NUAK1;ARHGAP12;MAP4K4;PREX1;WRN;IKBKG;ARHGAP35;RPA2;ITFG2;ARHGAP26;PRKAB1;BOP1;USP7;CMKLR1;VRK2;TMEM127;BRCA1;ARHGEF5;PRDM1;FAM13B;RRS1;BLM;ARHGEF1;RFC4;CHEK1;TAF4B;PTEN;MDM2;NRK;ARHGAP11A;TAF13
prerank,positive regulation of cell division (GO:0051781),-0.4632339242741509,-1.5539623453218414,0.018018018018018018,0.17679186091600033,1.0,10/38,13.60%,PRKCE;PKP4;SVIL;CUL3;FGF1;CDC14A;TAL1;KIF23;RHOA;PKN2
prerank,"phagocytosis, engulfment (GO:0006911)",-0.46532909834841873,-1.55286107448438,0.026501766784452298,0.17781809053408204,1.0,7/36,3.29%,GULP1;DOCK1;MYH9;RAC1;RHOBTB1;THBS1;ELMO1
prerank,negative regulation of programmed cell death (GO:0043069),-0.3311840806758224,-1.5513991842876387,0.0,0.17930505600558228,1.0,100/355,18.55%,MECOM;TJP1;LEF1;GRK5;TEK;IGF1R;FOXO1;XIAP;ERC1;MCL1;DAB2;TNFAIP8;THBS1;GSK3B;ARHGAP10;PAK2;RAB7A;KDR;DDX3X;TFRC;CD38;IL6ST;TAX1BP1;NAA16;EGFR;BIRC3;GAS6;NFKB1;HDAC1;NFKBIA;FAS;DSTYK;CBL;PSEN2;PIK3R1;BMP4;MED1;AATF;PTK2;BNIP3;ARHGDIA;MYO18A;RNF144B;NGF;MRE11;PLK2;BIRC6;NOTCH2;BNIP2;FLT4;RAF1;ANXA4;YWHAZ;HAX1;ADAM10;SH3RF1;TP53;SOCS2;AKT1;FLNA;NAA15;PRKAA1;CFLAR;AREL1;BRAF;PSEN1;IRAK1;COMP;RASA1;CAT;MTDH;TM7SF3;RPS6KA1;PA2G4;SON;WNT11;UFM1;TCIM;MAPK8;HGF;RPL10;ZFAND6;BABAM2;MIF;RPS6KA3;PRDM9;SMAD6;SIX4;ANGPT1;IGF1;CTNNB1;API5;MAP4K4;GOLPH3;CTSH;PPIF;CFL1;CITED2;ANXA1;IKBKB
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.43845435096931024,-1.5506243252341407,0.01818181818181818,0.17988244513284907,1.0,19/50,19.12%,NFAT5;NR3C2;NOD1;LIMS1;APP;DDX3X;EGFR;NMI;PDCD4;ILK;IRAK1;RHOA;ACTN4;TCIM;IFI35;CCL19;NOD2;RPS3;SASH1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.57019866130816,1.550487821188287,0.02358490566037736,0.2837317416239043,1.0,5/15,13.40%,NLGN1;CNTNAP4;CLN3;ADRA1A;NLGN2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.36034965903576965,-1.5504640915327967,0.0,0.17956592550539982,1.0,52/166,20.15%,SORBS1;INSR;KLF4;PKD2;KLF2;THBS1;STN1;EIF3E;METTL14;DDX3X;MTOR;PRKD2;NIBAN1;SP1;EGFR;EIF3C;ELOVL5;PLD1;IRS1;UPF3B;ABCB10;SAMD4A;LDB1;SCARB1;MFSD2A;RPL26;NOS1AP;AKT1;ZCCHC4;EDN1;EEF2;RGCC;STARD4;FGF2;DNA2;CHP1;LARP4B;RPS4X;HGF;CTC1;RPL5;SMOC2;METTL5;IGF1;GIPC1;STAR;CCL19;SOX4;ARNT;FGFR4;PRKDC;IGF2
prerank,neurotransmitter uptake (GO:0001504),0.6000660760878089,1.5495659379372686,0.046189376443418015,0.2830427526618044,1.0,4/12,11.03%,ATP1A2;SNAP25;SLC29A4;SLC1A3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.4324412981391229,-1.5495061092166158,0.007207207207207207,0.18049650291721028,1.0,25/60,23.74%,LEF1;CBFB;TNRC6B;MED15;MED26;NFKB1;MED1;TP53;MED13;MED17;MECP2;CCNC;CTNNB1;MOV10;HEY2;TNRC6A;CCND1;PPM1D;MED10;TRIM28;MED27;PTEN;RELA;MED20;TCF7L2
prerank,actin filament organization (GO:0007015),-0.3617151075462537,-1.5488277491333715,0.0017452006980802793,0.18105023885990973,1.0,45/151,17.98%,HIP1;SHROOM4;MYO1D;EPS8;BAIAP2L1;ABI1;CD2AP;SHROOM3;RAC1;TPM3;RHOBTB1;PLS3;CORO1C;SVIL;ELMO1;CGNL1;RND3;TMOD3;DLG1;WASL;MYO1F;BIN3;NEBL;ARHGEF2;SHROOM1;ARHGAP17;BCAR1;FLNA;SHROOM2;NEDD9;FAT1;LMOD1;ACTN1;RHOA;RHOG;LCP1;RHOC;TPM1;ELMO2;HIP1R;MAD2L2;ARPC4;CORO7;ARHGAP12;TRPV4
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5875699316123988,1.5481712477698022,0.04194260485651214,0.2835134904391247,1.0,4/12,7.88%,DGKQ;H6PD;CLCN2;ABCA2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5023383276840955,-1.5457157387017662,0.027726432532347505,0.1851273346578072,1.0,7/26,15.04%,CAV1;MFHAS1;DDX3X;WDFY1;LBP;FLOT1;IFI35
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.4465241375943974,-1.545546066113653,0.028119507908611598,0.18483640060156592,1.0,15/44,21.92%,DAB2IP;LYN;PTPN1;PTPRJ;PDCD4;BMP4;PRKCD;STK38;PIK3CB;SPRY4;BMP7;CDK5RAP3;HYAL2;UCHL1;NF1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6186634820333572,-1.545522317080284,0.029616724738675958,0.18434269056107336,1.0,7/13,15.61%,SP100;MDFIC;NUP153;CHP1;UFM1;RAB23;TPR
prerank,positive regulation of cellular component organization (GO:0051130),-0.38879473084092986,-1.5450211497913866,0.008960573476702509,0.18453395384291005,1.0,33/107,18.77%,ATP10A;DAB2IP;IGF1R;SHANK3;RB1;TRABD2B;INSR;ASAP1;MPP7;DAB2;NEDD4L;CBLL1;GSK3B;TFRC;TGFB2;SPIDR;BNIP3;CDH5;TAL1;FNIP2;DCTN1;ICE1;FLOT1;RHOC;ABCB7;GPX1;SLF2;SUMO1;BCL2L11;BMP7;CCL19;RPS3;GPC3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5112835290079777,-1.5447993085613412,0.023722627737226276,0.18427686383087957,1.0,11/27,13.06%,TJP1;WASF2;SHANK3;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC
prerank,dopamine metabolic process (GO:0042417),-0.5434960759377792,-1.5437476248157926,0.036585365853658534,0.1854106784904728,1.0,4/18,9.55%,SNCAIP;GCH1;TGFB2;MAOA
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6351649999716711,-1.5424589583400097,0.033210332103321034,0.1868429249879076,1.0,5/11,11.76%,TGFBR3;TGFBR2;TGFB2;SMAD7;USP15
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2955563356456209,-1.5420251316666405,0.0,0.18703940756031126,1.0,494/1646,24.43%,FOXP1;MECOM;KLF12;LEF1;APBB2;PBX1;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ZBTB16;ETV6;BAZ2B;NFIB;ATP8B1;WWP1;SP100;TEF;ERG;ENG;ZNF423;MNAT1;ACVRL1;ZBTB20;FOXO1;MEF2A;ZHX3;AFAP1L2;RB1;CREBBP;NSD1;BNC2;CBFB;NFAT5;ERC1;ELF1;DYRK1A;KAT6B;INSR;KLF4;ZEB1;ETS1;CHD1;ZMIZ1;NR3C2;CBFA2T3;LRP5;DACH2;ESR1;BTAF1;MLLT3;CUX1;FOXN3;TEAD4;VGLL3;PKNOX2;HIVEP2;TCF12;ZFHX3;PRDM5;KLF2;SMURF2;ZNF260;MED26;IRF2;RBFOX2;LIMS1;ZNF326;CHD2;DVL3;RXRA;NFATC1;KLF3;RPS6KA5;PRDM16;TBX15;TRIM56;DEK;FOSL2;CRK;SPINDOC;TRAK1;WWC2;PRRX1;BICRA;TBX1;ID1;MAP3K5;UIMC1;NFATC4;KMT2E;RNF111;NR3C1;ZSCAN21;DTX3L;TEAD1;SOX13;ARID1B;ZBTB37;KAT6A;KDM2A;MITF;PLAGL1;CDK17;SOX17;MKX;PSPC1;CD38;PBX3;NFIX;LOXL3;CDKN1B;NAA16;SP1;FZD4;VGLL4;EGFR;ZBTB46;CRLF3;VSX1;METTL4;RCOR1;ELK3;ZNF148;ZHX2;LIMD1;MGA;TASP1;MEOX2;CTCF;HES1;GAS6;SIX1;PPARA;LHX6;NIPBL;NFKB1;HDAC1;RYBP;DNM2;PDCD4;HOXB6;IKZF2;TRRAP;PLCB1;SMARCC1;ZBTB7A;UBP1;PHF20;FOXO3;ABL1;NFYC;HIVEP1;BMP4;LRP6;BBX;ZIC4;MED1;E2F4;AATF;BRD2;FUS;PTPRK;MEF2C;STAT6;ZBTB4;SLC39A8;NSD3;GTF2IRD1;JUN;SPEN;MIDEAS;MAX;SETD5;BAZ1A;DACH1;ASCC1;TSHZ2;ACTA2;CREB3L2;PBXIP1;SMAD1;ZFP90;ZNF182;SUV39H1;SRCAP;PPM1F;TBX2;SETD3;CDH1;LDB1;SMAD2;HNRNPAB;ZBTB39;SMARCE1;NAB1;ANXA4;EBF1;PPARD;NOP2;PHF5A;BACH2;PICALM;PHF20L1;CTBP2;SMAD4;GPBP1;ZIC5;USP13;PRDM2;IRF1;HOXC6;HSF5;ZNF25;RBBP8;TAL1;GLIS2;SPTY2D1;TP53;SP3;AKT1;HMBOX1;NAA15;ZBTB40;ELF2;KLF10;NOTCH4;HMG20A;GLI3;MDFIC;ETS2;YAP1;FGF7;SIN3A;KDM3A;MAMLD1;STAT2;NFIC;ZBTB7C;GMEB1;SOX7;ILK;EHMT1;RGMB;SMARCC2;JMJD1C;SMAD7;MAZ;MED13;ARHGEF11;CHD3;SFPQ;HR;TWIST2;PSEN1;MED17;PRRX2;FOXF2;HDAC4;NOTCH1;CREBRF;ZSCAN25;MTDH;OGG1;RPS6KA1;PA2G4;ZNF394;KAT5;SCMH1;LRRFIP1;YAF2;FGF2;TIAL1;WNT11;RHOG;PROX2;ZHX1;FOXJ3;ZBTB6;TCIM;SP140;KLF9;TAF5L;XPC;CIC;ARID3B;DBX2;GPBP1L1;GRHL1;MECP2;PIAS2;ZIC3;SAMD1;FBXW11;TFCP2L1;HIF3A;ZBTB25;ATF4;MZF1;ZBTB34;BCOR;HCFC1;MYBL2;PGBD1;SMARCD3;POLR3F;PHF6;MED29;MRPL12;RPS6KA3;FOXC1;KDM7A;TRIM16;JMJD6;PEX14;CREBL2;TCF3;TCF7L1;PHC1;KMT5A;NR1D2;NR2C1;SMAD6;BRWD3;FOXO4;ETV1;ZNF32;TADA3;RUVBL2;ZFP1;NAB2;HIC1;MAD2L2;THOC1;SUMO1;ZNF235;ZKSCAN1;PCBD2;SIX4;FOXQ1;KDM5B;MAMSTR;BMP7;ZNF691;TAF7;RARA;HDAC6;UBE2L3;TFAP4;IGF1;ZXDB;ZNF83;CC2D1B;ZBTB14;CCNC;HDAC10;HOXA2;CTNNB1;HLF;EPAS1;GPATCH3;HEY2;ZNF250;ZFP28;ZBTB8A;HEY1;ZMYND11;CEBPG;ZNF692;HINT1;TSHZ1;DAP;NCOA6;PATZ1;CITED2;NRF1;GATA2;RNF10;HOXB9;WBP2;IKBKB;BAP1;ARID5B;SOX4;EDRF1;WWP2;WTIP;PIAS4;PCGF3;ELK4;ELOC;ARNT;PPP2CA;CARM1;ZBTB12;ZSCAN12;SCML4;ZFX;RNF4;ZIC1;PCGF5;ATRX;SMAD9;UTP4;ZSCAN26;IGF2;BRCA1;TIMELESS;TRIM28;FOXL2;CDK11B;SRSF10;PBX2;BAZ1B;TBL1X;TOX4;PRDM1;NONO;BLM;ZSCAN18;PPARG;GCLC;NKAP;MED27;NACC1;CREB1;TRPS1;CAND2;MAP2K3;HSF4;CBFA2T2;NOS1;MDM2;MYOCD;ATAD2;SUDS3;KCNH2;PHC3;USP16;OGT;RELA;ZNHIT3;ATF6;GLIS1;BCL6;RBM15;MSX1;GABPA;NFE2L2;CDK14;SUPT4H1;TCEA2;RFXANK;ELF4;TSHZ3;FZD7;AJUBA;RXRG;CEBPA;MED20;MYCBP;NR2F2;ZNF697;CCNK;KDM3B;YY1;GMEB2;TULP3;ZFP3;TCF4;TCF7L2;KLF16;TBX3;E2F7;MBTD1;ACVR2B;ARID3A;GCFC2;AEBP2;ZKSCAN8;ATF5;TAF15;ZKSCAN4;APBB1;DHX9;CDK18;ERCC6;HIC2;HMGB1;FANK1;ARRB1
prerank,regulation of lymphocyte migration (GO:2000401),-0.6501507506115519,-1.5414329374158604,0.030797101449275364,0.18742474356795868,1.0,5/10,11.02%,JAM2;MSN;WASL;AKT1;STK10
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5262895045273369,1.5408832535952899,0.04338394793926247,0.2955201116498925,1.0,6/20,12.40%,ATP1A2;ATP1B1;CALM2;RYR2;SLC8A1;HRC
prerank,positive regulation of axon extension (GO:0045773),0.517123322384873,1.5408459501504896,0.028037383177570093,0.2930297758678458,1.0,9/22,10.42%,L1CAM;DSCAM;SHTN1;CDKL5;LIMK1;MEGF8;MAPT;VEGFA;ZFYVE27
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6186157995267743,-1.538224227835779,0.029143897996357013,0.19161487964481846,1.0,8/12,29.80%,LMO2;THRB;MED1;KLF9;CTSH;RDX;GAS2L1;BRD8
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4152955321699366,-1.5367040094690785,0.005504587155963303,0.1933289731001926,1.0,22/63,23.74%,ITGA6;SP100;CAV1;THBS1;PAK2;TNFSF10;FAS;BMP4;BIRC6;SH3RF1;CASP8;CFLAR;WWOX;FEM1B;IGF1;ZMYND11;HYAL2;G0S2;LTBR;RELA;RIPK1;TCF7L2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6033628555681751,-1.5366798495373064,0.044964028776978415,0.1928019604160723,1.0,8/13,21.18%,ENG;KDR;TGFBR2;COL4A1;NOTCH4;CTNNB1;SEMA3E;DLL4
prerank,ncRNA processing (GO:0034470),-0.34949168647857326,-1.5366606537579601,0.0017035775127768314,0.1922923984084722,1.0,87/200,29.99%,INTS8;TUT7;UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;FARS2;DDX10;SMAD1;SMAD2;EXOSC1;EXOSC2;RPLP1;RPL3;NOL9;RPL26;ESF1;EXOSC3;DICER1;TUT4;XRN2;RPL13;INTS3;RPL38;RPL27;RPS16;UTP3;RPL10;RRP1;RPL7A;AGO2;RPL5;PUS10;DCAF13;UTP14A;INTS9;EXOSC8;RPS27;RPL27A;RPL35A;WDR74;MDN1;RPL36A;BOP1;RPL37A;EXOSC5;UTP4;DROSHA;RPL32;PES1;TRPT1;RPS7;RPL36;EBNA1BP2;RPL28;RPS15;INTS7;RPL30;RPL13A;RCL1;RPL22;RPS17;NOL8;WDR46;EXOSC7;RPL34;RPS2;RPL15;RPP30;RPL39;EMG1;WDR12;WDR55;BYSL;INTS5;UTP20;POP4;RPL19;RPLP2;INTS12;RPL8;RPL18;SSB;FCF1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5826198393647876,-1.5365132723518682,0.020833333333333332,0.19192619706676986,1.0,5/16,12.70%,ST3GAL4;NFAT5;ETS1;IRAK1;RHOA
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5720156908300431,-1.536147046324468,0.04291044776119403,0.19193199240073222,1.0,10/15,26.65%,TNRC6B;TENT4B;POLR2G;TENT4A;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,long-term synaptic potentiation (GO:0060291),0.5158650414969009,1.5360227401183661,0.023965141612200435,0.3000612738232937,1.0,7/21,12.21%,MPP2;SLC24A2;GRIN2B;GRIN2A;SLC8A2;PRKCZ;SLC8A3
prerank,extracellular matrix organization (GO:0030198),-0.3344747167410047,-1.5357884875464134,0.0,0.1919234296760554,1.0,81/276,15.84%,VWF;TLL1;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;COL12A1;ITGB1;JAM2;BSG;COL25A1;COL4A2;PLOD1;PLOD2;THBS1;ADAMTS2;COL4A6;ITGA3;APP;VIT;F11R;SPOCK2;SMOC1;ITGA1;KDR;P3H2;SH3PXD2B;ITGB4;HTRA1;ICAM1;LOXL3;COL5A1;MMP2;LAMA4;LAMA3;GAS6;COL4A5;ITGB5;COL8A2;TGFB2;SLC39A8;AGRN;COLGALT2;CDH1;COL5A2;DST;LOXL1;COL4A1;ADAM10;ADAMTS9;HSPG2;ADAMTS4;FBLN5;CAPN2;THSD4;ADAMTS10;ADAMTS17;ADAMTS20;P4HA1;LAMA1;ADAMTS5;LAMA5;BGN;COMP;ITGA4;FGF2;LCP1;FLOT1;LAMC3;ICAM2;COL6A3;COL26A1;HAS1;EXOC8;NID1;SMOC2;COL6A2;ITGA2;VCAM1
prerank,amide transport (GO:0042886),-0.49702214560835534,-1.5337787574861659,0.03364485981308411,0.19439692762362046,1.0,9/26,7.78%,ABCG2;CERT1;PLTP;SLC25A32;SLC5A6;SLC38A5;AQP11;ABCB9;TAP2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5040432616546267,1.5336873785271428,0.03956043956043956,0.30235854980947396,1.0,8/22,15.79%,PDE4B;STAC2;HPCA;CACNB3;CACNB4;STAC;SRI;CACNB1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.4022900936893475,-1.5333879041881626,0.010362694300518135,0.1945203761927843,1.0,24/78,15.26%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP2R5A;DAB2;PRKCE;ITGA3;LDLRAP1;PTPN9;EGFR;DLG1;STX3;PIK3R1;RHOQ;PPFIA1;STX8;PICALM;AKT1;ABI3;ACTB;RHOG;NUMB;STAC3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.553701531251929,-1.5331850842176795,0.045372050816696916,0.1942915610116002,1.0,12/17,34.45%,BMP4;NOTCH2;NOTCH1;GALNT11;JAG1;HEY2;HEY1;DLL4;BMP2;SNAI2;TGFB1;BMPR1A
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6309110186976848,1.5323748870417544,0.04025423728813559,0.3025746405679163,1.0,7/10,19.55%,GALNT13;GALNT16;MGAT5B;GALNT3;GALNT2;POGLUT1;POGLUT2
prerank,regulation of vasculature development (GO:1901342),-0.5030757792394298,-1.5317695348681422,0.040280210157618214,0.19588425968229037,1.0,18/26,39.83%,SP100;ADGRA2;BMPER;ETS1;PLXND1;FGF2;CTNNB1;EPHA2;WARS1;NF1;TSPAN12;HMOX1;EMP2;VASH2;PROK2;HTATIP2;EGLN1;GPNMB
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4090760283560243,-1.5310898831025552,0.008605851979345954,0.19636980445363436,1.0,32/65,32.41%,CAV1;IL17RD;SMURF2;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD7;SMAD6;SKI;NRROS;DAND5;STRAP;SNX25;HTRA3;PMEPA1;MTMR4;ADAM17;FBN1;EMILIN1;BAMBI;TGFBR1;SPRY1;TGFB1;ADAMTSL2;LTBP1
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.36278078837332445,-1.530200643486783,0.0017825311942959,0.19734920304203885,1.0,53/150,24.98%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;ESR1;RAC1;MFHAS1;THBS1;GCNT2;PTPRJ;EGFR;GAS6;RICTOR;PIK3R1;IRS1;FGF1;PTK2;HAX1;PIK3CD;FGF7;THEM4;MAZ;MTDH;FGF2;RHOG;MYOC;HGF;PIK3CB;TNFAIP8L3;GRB2;FYN;ANGPT1;GAB2;IAPP;CCL19;TXN;FGFR4;IGF2;F3;PTPN11;HSP90AA1;SEMA5A;TCF7L2;HPSE;PDGFRB;PIK3CA;TRIB3;FRS2
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.4146431474853638,-1.5300061678708903,0.010327022375215147,0.19713615843429239,1.0,25/62,26.38%,NUP42;RAE1;LIMD1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;IPO8;NUP214;TNRC6A;WTIP;PPARG;AJUBA;NUP188;POLR2C;DHX9;FXR1;POLR2H;POLR2L;NUP88
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6181027031001934,1.5295739573253537,0.05321507760532151,0.3056760348193431,1.0,4/10,12.72%,QDPR;ASRGL1;PCBD1;THAP4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.6024194027295373,-1.5288568314478035,0.03237410071942446,0.1983917058657132,1.0,5/13,15.58%,ALG14;ALG12;ALG8;ALG11;ALG13
prerank,regulation of stress fiber assembly (GO:0051492),-0.4002464107822964,-1.5272517493721596,0.01079136690647482,0.2003213801760354,1.0,25/74,13.54%,TJP1;WASF2;FERMT2;RAC1;F11R;PAK2;CGNL1;PXN;ABL1;PIK3R1;ARHGEF15;PPFIA1;ROCK1;PPM1F;RGCC;LIMCH1;ARAP1;ARHGAP28;RHOA;WNT11;MYOC;ARHGEF10;SORBS3;RHOC;TPM1
prerank,negative regulation of cell differentiation (GO:0045596),-0.34981347506247074,-1.5266911156112624,0.0016556291390728477,0.20064178196304142,1.0,66/181,25.56%,DAB2IP;ZBTB16;FOXO1;RB1;FERMT2;CRIM1;CAV1;LRP5;ASXL1;IL17RD;BMP5;TBX1;METTL14;SPRED2;EGFR;COL5A1;TRPM4;LIMD1;HES1;PPARA;LDLRAD4;NFKBIA;PDCD4;BMP4;MED1;SUZ12;COL5A2;NOTCH4;YAP1;ANKRD26;ZFPM1;SMAD7;TWIST2;ADGRV1;NOTCH1;TMEM64;CDC73;CDK6;TRIO;SMAD6;SKI;MAD2L2;JAG1;BMP7;NELFB;HEY1;GATA2;PPP2CA;IGF2;HDAC7;ITGB3;PPARG;PTPN11;PTEN;USH2A;PTK2B;MYOCD;TBX3;GPS2;TRIB3;EID2B;GDF10;NEPRO;LEO1;EIF2AK4;ADAMTS7
prerank,regulation of cellular component organization (GO:0051128),-0.36731335701643975,-1.526589840299986,0.0017574692442882249,0.20029353557495067,1.0,38/135,12.53%,HIP1;TJP1;DAB2IP;RAPGEF2;SNCAIP;RUFY1;MLLT3;NET1;STON1;PTPN1;MTOR;TFRC;METTL4;RAB5B;ABL1;NEDD4;PLCE1;IRGM;AP2S1;RAP1A;SETD5;RASGRP2;ROCK1;RAP1B;RAB5A;FAM107A;PICALM;RAB4B;BCAR1;SOCS2;HJURP;SNX12;RAPGEF1;ARHGEF11;LTBP4;AGTR1;CEACAM1;RPTOR
prerank,response to interferon-beta (GO:0035456),-0.5294923586425677,-1.526581575881703,0.027472527472527472,0.19975321329481466,1.0,13/22,34.47%,UBE2K;IRGM;IRF1;IFITM3;IKBKE;PLSCR1;IFNAR2;IFITM2;BST2;TRIM6;CDC34;SHFL;UBE2G2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.40190604634611776,-1.5263784306357193,0.010582010582010581,0.19951637444798972,1.0,34/72,28.79%,CBFB;ELF1;PTPN1;JAK1;TAX1BP1;BIRC3;GAS6;OTULIN;LIFR;CASP8;CFLAR;IRAK1;USP18;JAK2;AGPAT1;HIPK1;SUMO1;TNFRSF1A;TNFAIP3;IRAK2;IKBKG;IKBKB;PTPRC;VRK2;IFNGR2;PTPN11;ABCE1;IFNAR2;RIPK1;IL7;TRIM44;PTPN2;RNF31;AXL
prerank,cardiac atrium morphogenesis (GO:0003209),-0.558030935844235,-1.5259862741936854,0.034482758620689655,0.1995633195700387,1.0,9/16,24.69%,ENG;BMPR2;TGFB2;NOTCH2;ZFPM1;NOTCH1;HEY2;DLL4;BMP2
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5188639831369783,-1.524514669030431,0.03214285714285714,0.20133131933049125,1.0,11/24,16.15%,TJP1;WASF2;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC;ARHGEF18
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6458124234926719,-1.5244640047638927,0.04639175257731959,0.20087969507313802,1.0,2/10,0.61%,DAB2IP;SEMA6A
prerank,response to molecule of bacterial origin (GO:0002237),-0.4040974843073555,-1.5239799537807512,0.01618705035971223,0.20113787104944994,1.0,16/69,16.84%,FOXP1;PELI1;NOS3;SRR;IFNAR1;HNRNPA0;GGT5;GCH1;MAPKAPK2;LBP;IRAK1;JAK2;RPS6KA3;SMAD6;TAB2;TNFAIP3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.4423612970746442,-1.5237532601176995,0.01079136690647482,0.20092775763450713,1.0,17/47,19.81%,DAB2IP;IGF1R;FOXO1;TGFBR3;EGFR;MID1;FAS;TGFB2;MAPK1;ARL6IP5;TAOK3;SEMA4C;IGBP1;MAP4K4;NOD2;KLHDC10;RAP2A
prerank,regulation of neuron projection development (GO:0010975),0.3473194755684562,1.5237186738257422,0.0,0.314867868077718,1.0,42/163,14.08%,MAGI2;LRRC4C;CSMD3;IL1RAPL1;CTNNA2;LRRC7;DCC;RIT2;PPFIA2;SCN1B;CCDC88A;TENM3;SPOCK1;CDK5;FUT9;CDKL5;TOX;NTNG2;NTNG1;ITM2C;KIDINS220;NDRG4;NCS1;PAK3;CAMK2B;PAK1;NTRK2;TANC2;PLA2G3;PLPPR5;TSKU;PTPRS;ABI2;STMN2;MAG;CDH2;KNDC1;DENND5A;APOE;PAQR3;BDNF;BRSK2
prerank,regulation of cell killing (GO:0031341),-0.5668704125791096,-1.5235246126655382,0.03664921465968586,0.20065759059335353,1.0,6/16,13.58%,RAC1;CR1L;ICAM1;CD55;TGFB2;MAPK8
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.489366984347855,-1.5231333515781242,0.025225225225225224,0.20073462934734954,1.0,10/29,14.60%,TJP1;SHANK3;LIMA1;KANK3;SLIT2;PRKCD;KANK4;SMAD4;ARFGEF1;HIP1R
prerank,sensory perception (GO:0007600),0.43076739512592693,1.5231257819184594,0.011210762331838564,0.31344646528906167,1.0,15/45,18.79%,PCDH15;OPRM1;MME;PNOC;GNAL;KCNA2;TTC8;BBS4;PENK;CCL2;WHRN;NTSR2;CLRN1;RETREG1;TRPV2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4815732027782504,-1.5230849308055188,0.023636363636363636,0.2002770948211418,1.0,10/29,15.81%,TUT7;SMAD1;PUM1;ZC3H7B;SMAD2;SNIP1;DICER1;TUT4;AGO2;PUS10
prerank,pulmonary valve development (GO:0003177),-0.5482252716070838,-1.5228053982006902,0.03776978417266187,0.20015242875308764,1.0,14/18,17.56%,NOS3;BMPR2;NFATC1;TNFRSF1B;SLIT2;BMP4;TGFB2;NOTCH2;NOTCH1;SMAD6;JAG1;TNFRSF1A;HEY2;HEY1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5376345904129118,-1.5218950590134745,0.037366548042704624,0.20087922245784534,1.0,6/18,10.91%,DNAJC13;DAB2;MSN;EZR;MAPK1;SNX12
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.45956155784153374,1.5209339020074124,0.019230769230769232,0.31556313064903324,1.0,7/34,4.01%,GRID2;MPP2;GABRG3;GRIN2B;GRIN2A;GLRA1;GABRA2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5992193237180248,-1.5209050426126418,0.027124773960216998,0.20189060980686968,1.0,8/13,26.08%,PLCG1;SP1;AKT3;ITGA4;FGF2;IGF2;HMGB1;ADAM17
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.469882641580989,-1.519149641514467,0.020446096654275093,0.2040841682926212,1.0,20/34,34.31%,RB1;INSR;LRP5;CUL3;EDN1;RGCC;CDC16;NSMCE2;EDN3;IGF1;IGF2;PDGFRB;ANAPC7;BTC;ANAPC5;ANAPC11;PHIP;AURKA;IL1A;ESPL1
prerank,protein autoprocessing (GO:0016540),0.5366183007056338,1.518700994570985,0.04487179487179487,0.3177849063937183,1.0,5/17,12.85%,OMA1;MYRF;KLK6;CASP4;HTRA2
prerank,response to ionizing radiation (GO:0010212),-0.4055508815449795,-1.5186011069903722,0.0156794425087108,0.20448460242039412,1.0,28/70,22.70%,DCUN1D3;NET1;ATM;UIMC1;MRNIP;XRCC4;SPIDR;NABP1;INIP;TP53;PRKAA1;INTS3;KAT5;NHEJ1;RNF168;BABAM2;GRB2;RFWD3;FANCD2;TRIM13;BRCC3;ANXA1;BRAT1;LIG4;BRCA1;BLM;INTS7;GADD45A
prerank,regulation of hemopoiesis (GO:1903706),-0.6545899127156906,-1.5180285652369576,0.04830053667262969,0.20493284754444852,1.0,2/10,1.27%,CREBBP;CBFB
prerank,Golgi to endosome transport (GO:0006895),-0.5543678181582593,-1.5170024038119994,0.043706293706293704,0.20597281521639452,1.0,7/16,22.45%,VPS13A;EPS15;VPS13C;WIPI1;CORO7;AP4M1;KIF16B
prerank,regulation of glycolytic process (GO:0006110),-0.40386606981739226,-1.5167186268546176,0.010273972602739725,0.2059282407324487,1.0,20/68,19.18%,ZBTB20;INSR;CBFA2T3;APP;NUP42;RAE1;RANBP2;PPARA;ZBTB7A;NUP98;SEC13;PRKAA1;PFKFB3;PSEN1;HDAC4;NUP153;TPR;IGF1;NUP214;ARNT
prerank,regulation of insulin secretion (GO:0050796),0.3687772184296447,1.5166929405435012,0.01179245283018868,0.3194079632794149,1.0,29/101,16.66%,KCNC2;ABCA12;BLK;SNAP25;GIP;GCK;NR1D1;KCNA5;CACNA1A;MTNR1B;EPHA5;CHGA;TRH;CACNA1D;ADRA2C;CACNA1E;GIPR;EIPR1;ADRA2A;GPER1;CCL5;NLGN2;BRSK2;GLUD1;MCU;BMP8A;ALOX5;KCNG2;SLC8B1
prerank,microtubule-based transport (GO:0099111),0.5991807729442777,1.5165195441407961,0.0625,0.3171839544399082,1.0,9/12,24.19%,ADCY10;ROPN1L;DYNC1I1;HTT;SPAG17;CABYR;DNAAF2;DYNC1I2;SPEF2
prerank,positive regulation of protein import (GO:1904591),-0.4735815665874634,-1.515723777441792,0.03633217993079585,0.2068677566774044,1.0,13/30,20.49%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;HYAL2;ZIC1;ARHGEF5;TRIM28
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.48019020818473623,-1.5157003308009536,0.041379310344827586,0.20637983226483655,1.0,12/28,20.49%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;HYAL2;ZIC1;TRIM28
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.4102994737271383,-1.5147618319688694,0.005535055350553505,0.20734615463933512,1.0,29/64,29.19%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;RTF1;CDC73;TCEA1;ERCC3;MLLT1;NELFB;ELOC;ELOF1;ADRM1;SUPT4H1;TCEA2;CCNK;POLR2C;POLR2H;LEO1;POLR2L;POLR1E;GTF2H3;ELP2;CCNH
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6176178879245203,-1.5144615416741196,0.05063291139240506,0.20729194030388456,1.0,6/11,26.26%,CAV1;NEDD4L;CASQ2;KCNH2;CAB39;ACTN2
prerank,T-helper cell differentiation (GO:0042093),-0.5882841005898358,-1.5144426909508502,0.036297640653357534,0.2068001602432911,1.0,2/14,0.16%,FOXP1;LEF1
prerank,cytoskeleton organization (GO:0007010),-0.37279550382266474,-1.5143907416661881,0.0016863406408094434,0.20636305424049334,1.0,38/114,18.93%,SEMA6A;FGD5;FGD6;RAC1;PDZD8;RHOBTB1;ARHGAP10;RANBP9;MICAL2;MARK1;ARAP3;RND3;DIAPH1;LIMD1;ZMYM6;CNTNAP1;MAST2;PLCE1;MAST4;PPP2R3C;PLD2;DST;SIPA1L3;LRCH3;CECR2;NEDD9;RHOA;ZMYM4;RHOG;RHOC;TPM1;BRWD3;TNFAIP3;CDC42BPB;CAPZB;CFL1;FMNL2;WTIP
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.4494341710029104,-1.5143346363889842,0.017825311942959002,0.20592493906201095,1.0,13/39,15.42%,DAB2IP;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;PTPN3;DUSP3;LGMN;GRB2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5576481617196364,1.5143313670301188,0.04157549234135667,0.3189848951817135,1.0,5/14,10.13%,ANK3;ATP1B1;WNK2;WNK3;TESC
prerank,positive regulation of biosynthetic process (GO:0009891),-0.44402367192386527,-1.5127980213578325,0.02882882882882883,0.20771985741267276,1.0,16/40,26.90%,SORBS1;ZBTB20;MTOR;PPARA;BMP4;RAB27A;PLCG2;AKT1;RGCC;CREBL2;CREB1;MTPN;ADGRB1;SLC5A3;F2R;LARP6
prerank,phospholipid translocation (GO:0045332),-0.4891472187187446,-1.5119819674817367,0.04204753199268738,0.20855477512470882,1.0,10/28,16.94%,ATP10A;ATP8B1;PLSCR4;PLSCR2;MFSD2A;ATP10B;ANO6;PLSCR1;ABCA7;ATP9B
prerank,regulation of multicellular organism growth (GO:0040014),-0.5753772795853795,-1.5118436083543125,0.033391915641476276,0.20829507952362084,1.0,5/15,17.65%,GHR;APP;MFSD2A;IGF1;SOD1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5438669423411537,-1.511525294681491,0.04664179104477612,0.20824263769067403,1.0,10/18,32.65%,NR3C1;FAM107A;KLF9;BCL2L11;UBE2L3;ANXA1;HNRNPU;ZFP36L1;SSTR2;AQP1
prerank,negative regulation of blood pressure (GO:0045776),-0.5902418681872601,-1.5114955762905393,0.04797047970479705,0.2077667946797137,1.0,4/13,13.17%,NOS3;BMPR2;SCPEP1;PRCP
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.630048468580417,-1.5109726986886365,0.03300970873786408,0.2080232949141354,1.0,8/11,33.55%,LIMD1;PUM1;WTIP;AJUBA;DHX9;FXR1;PUM2;STAT3
prerank,gene silencing by miRNA (GO:0035195),-0.47193322502835905,-1.5108697214986808,0.030534351145038167,0.2076909123862789,1.0,15/32,26.43%,TNRC6B;LIMD1;PUM1;ZC3H7B;NOTCH4;SNIP1;DICER1;AGO2;MOV10;TNRC6A;WTIP;AJUBA;CNOT8;RAN;CNOT1
prerank,positive regulation of cytokinesis (GO:0032467),-0.4739364254503551,-1.5106067924913564,0.0297951582867784,0.20756725133838147,1.0,8/32,13.60%,PRKCE;PKP4;SVIL;CUL3;CDC14A;KIF23;RHOA;PKN2
prerank,neuron migration (GO:0001764),0.42751900246791985,1.5104847142256153,0.029345372460496615,0.32439995792333054,1.0,18/48,10.69%,ADGRL3;SPOCK1;ASTN2;CDK5;DNER;CDKL5;NRCAM;MDGA1;ASTN1;DCDC2;GPM6A;NTRK2;SOX1;DCX;VEGFA;MAP1B;CCK;AUTS2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.3214318520053017,-1.510093822648318,0.0,0.20787951666564675,1.0,104/348,20.16%,LEF1;CLDN5;RESF1;NOS3;UBR5;INSR;KLF4;ETS1;CD34;TNRC6B;KLF2;MED26;LIMS1;GSK3B;ANXA2;APP;PTPN1;ATM;DTX3L;DDX3X;MTOR;MITF;TFRC;SMO;BMP6;SP1;MSN;CTCF;GAS6;AFDN;PDE2A;BMP4;FGF1;MED1;EZR;MEF2C;CDH5;ECE1;NGF;ACTA2;RAB27A;SMAD1;SEC16B;ROCK1;PPM1F;MAPK1;OCLN;PLCG2;GSK3A;RAMP2;PIK3CD;WNT16;MYOM1;TP53;CELF1;NOS1AP;AKT1;TASOR;YAP1;PRKAA1;FGF7;RGCC;BRAF;MAZ;HFE;PSEN1;NOTCH1;FGF2;WNT11;ZPR1;MAPK8;PIK3CB;PLSCR1;AGO2;ATF4;HCFC1;FAM98A;RPL5;PIK3R3;VSIR;TADA3;ROCK2;TERF2;DNMT1;SRPK2;BMP7;ANGPT1;IGF1;MOV10;HEY2;CTSH;HEY1;PPHLN1;CITED2;GATA2;RPS3;TNRC6A;VAMP3;KRAS;FUBP1;PRKAB1;FGFR4;BRCA1;F3
prerank,positive regulation of binding (GO:0051099),-0.3886322279715975,-1.5096742063078143,0.0053475935828877,0.20799688261158158,1.0,44/84,29.42%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;HES1;STK3;BMP4;SPPL3;NGF;DPH3;HMBOX1;HFE;PSEN1;FLOT1;HIP1R;FOXC1;MARK3;SKI;RARA;IGF1;CEBPG;AKTIP;TXN;CLN5;PPARG;CAPRIN2;TERT;RALB;TCF7L2;DHX9;HMGB1;TRIB3;BMP2;PARP9;RAN;MET;MED25;STMN1;NMD3;PLAUR;BAMBI
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4760497800693577,-1.5096105051590423,0.02631578947368421,0.20756987274261246,1.0,9/28,21.65%,DAB2IP;CTSC;RNF139;SMURF1;PTK2;ECSCR;PSMC2;CDK5RAP3;PTEN
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5052115799289586,-1.5093331123055158,0.037037037037037035,0.2074887414475231,1.0,9/23,19.18%,ZBTB20;INSR;APP;NFKB1;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6142829359597031,1.507721733843099,0.06956521739130435,0.32756367957393756,1.0,4/10,12.39%,PDE4B;CACNA2D1;CACNB3;SRI
prerank,vasculogenesis (GO:0001570),-0.4694009536441492,-1.506751721817282,0.034420289855072464,0.21107611142271707,1.0,12/32,12.24%,ENG;CAV1;KDR;SOX17;TGFBR3;TGFBR2;RASIP1;RAMP2;CUL7;NOTCH1;ADM;RASA1
prerank,hippo signaling (GO:0035329),-0.487919595230443,-1.5066353705023756,0.04900181488203267,0.21075134580761842,1.0,10/26,15.53%,TJP1;TEAD4;TEAD1;YWHAE;STK3;TJP2;LATS2;YAP1;SAV1;FAT4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.44834157941718444,-1.506143408603016,0.03146853146853147,0.21100103746872523,1.0,15/40,17.19%,LEF1;FERMT2;DAB2;GCNT2;MTOR;TGFBR2;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;NOTCH1;FOXC1;JAG1;CTNNB1
prerank,alpha-amino acid metabolic process (GO:1901605),0.4231733899505061,1.5047513689419265,0.0136986301369863,0.33109252399571226,1.0,15/45,14.70%,ASNS;SLC25A13;DDAH2;OAT;GADL1;GNMT;PYCR2;RIMKLA;DPEP1;ASPA;THAP4;GLS2;GLS;GLUD1;GPT2
prerank,heart development (GO:0007507),-0.35505903234884056,-1.5047107797212183,0.005025125628140704,0.21286702496080925,1.0,55/150,22.03%,TEK;ACVRL1;MEF2A;AKAP13;HEG1;INSR;PKD2;BMPR2;KAT2B;BMP5;MICAL2;TBX1;SH3PXD2B;SOX17;TGFBR3;CDKN1B;PDLIM5;TGFBR2;NIPBL;RBP4;SMYD4;BMP4;PLCE1;TGFB2;MEF2C;PTK2;MTHFD1;ECE1;WDR11;KDM6A;PDLIM1;TBX2;RAMP2;PCSK5;CASP8;KDM6B;ZFPM1;NOTCH1;PDLIM3;RBM20;BCOR;FOXC1;TAB2;BMP7;FLRT2;NCOA6;CITED2;SOX4;GPC3;DAND5;PTPN11;PTEN;NF1;MYOCD;NDUFV2
prerank,positive regulation of chemotaxis (GO:0050921),-0.4357863963149682,-1.5040031761888195,0.030685920577617327,0.21347785720960555,1.0,19/43,27.01%,TMSB4X;THBS1;KDR;PRKD2;IL6R;STX3;PPM1F;PRKD1;FGF2;EDN3;LGMN;SMOC2;CCL19;F3;SEMA5A;PDGFRB;PTN;ADAM17;MET
prerank,receptor-mediated endocytosis (GO:0006898),-0.3580101320590322,-1.5033894380257833,0.003590664272890485,0.21400490461015473,1.0,38/132,15.42%,FCHO2;ITGB1;INSR;CAV1;CALCRL;DNAJC13;DNM3;DAB2;EPS15;FNBP1L;RAMP1;LDLRAP1;TFRC;AP2B1;SCARF1;AP2A2;DNM2;LRP6;NEDD4;AP2S1;PI4KB;SNX9;SCARB1;GPR107;PICALM;RAMP2;IGF2R;HSPG2;FCHSD2;STAB1;GAK;ADM;AP1G1;LMBRD1;ACKR3;HIP1R;LMBR1L;GRB2
prerank,purine nucleotide catabolic process (GO:0006195),-0.5914804591709315,-1.503241889577617,0.05474452554744526,0.21373274355323357,1.0,8/13,27.11%,NT5C2;NT5E;NT5C1A;GPX1;HINT1;GDA;NT5C;PNP
prerank,regulation of endocytosis (GO:0030100),-0.4074737441521016,-1.502978108083034,0.016363636363636365,0.2136443482595961,1.0,23/61,19.72%,HIP1;RUFY1;DAB2;NEDD4L;CBLL1;STON1;PTPN1;RAB5B;ABL1;AP2S1;ROCK1;PRKD1;RAB5A;PICALM;RAB4B;SNX12;FLOT1;HIP1R;ABCA7;ZFYVE16;CCL19;GPC3;RUFY2
prerank,organelle fission (GO:0048285),-0.49198022023044496,-1.5028099232389383,0.04752851711026616,0.21340831998664772,1.0,6/24,7.97%,DNM3;CORO1C;TMCC1;MIEF1;DNM2;SEC16B
prerank,nuclear export (GO:0051168),-0.3923535860641858,-1.5019419795567572,0.02214022140221402,0.21436122180657227,1.0,33/80,25.96%,SRSF11;NUP42;SMURF1;CSE1L;SARNP;RAE1;THOC2;XPO7;UPF3B;THOC7;DDX39B;DHX38;SLU7;NUP153;CHP1;HNRNPA1;TPR;THOC1;THOC3;LSG1;XPO4;PHAX;NUP214;WASHC4;RITA1;SRRM1;RNPS1;SRSF3;NUP188;POLDIP3;NXF1;NEMF;RAN
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4284847257079972,1.501684994279088,0.039301310043668124,0.334881807417012,1.0,11/39,7.33%,FGF14;ANK3;HECW1;FGF12;SCN1B;OSR1;GPD1L;WNK2;HECW2;WNK3;NETO1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.5390759889681273,-1.5008200325881602,0.05565529622980251,0.21577303540681275,1.0,8/18,26.08%,LYN;MTUS1;IL6R;SLIT2;EDN3;PTK2B;PTN;ADAM17
prerank,cellular response to dsRNA (GO:0071359),-0.5607041676049902,-1.5005658622231146,0.05,0.21568056593279117,1.0,9/15,27.05%,CAV1;IFIH1;FLOT1;PDE12;CGAS;MAVS;RALB;DHX9;RIOK3
prerank,somite development (GO:0061053),-0.6176154494080077,-1.5004829159257422,0.04678362573099415,0.2153105446548969,1.0,4/11,7.15%,SMO;LOXL3;MEOX2;MTHFD1
prerank,response to reactive oxygen species (GO:0000302),-0.4190119992612868,-1.5003196005059074,0.019538188277087035,0.2151160140076351,1.0,21/54,20.42%,PKD2;EGFR;ADAM9;PXN;STK24;PTPRK;JUN;MAPK1;AKT1;CAT;TPM1;MAPK8;TXNRD2;GPX1;AGAP3;FYN;SOD1;HYAL2;RPS3;ERCC6L2;COA8
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5355902851073701,-1.4999162036847085,0.05128205128205128,0.21528420790109784,1.0,7/18,17.48%,ITGB1;JAM2;SLC39A8;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,cellular response to reactive oxygen species (GO:0034614),-0.41487235255024285,-1.4998907534586814,0.01584507042253521,0.2148116357944354,1.0,25/59,23.52%,PKD2;NET1;MAP3K5;EGFR;PXN;ABL1;PRKCD;PTPRK;JUN;ANKZF1;MAPK1;AKT1;TPM1;MAPK8;AGAP3;HDAC6;TNFAIP3;PPIF;ANXA1;RPS3;ERCC6L2;MAPK7;RELA;NFE2L2;RIPK1
prerank,vasoconstriction (GO:0042310),-0.6317333414242065,-1.499667263944988,0.04059040590405904,0.2147074355193865,1.0,5/11,13.13%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,organic anion transport (GO:0015711),-0.3896215838867482,-1.49565029614056,0.012237762237762238,0.22064988480930814,1.0,15/76,9.53%,ABCC4;ABCG2;SLC26A7;LRRC8C;SLCO2A1;SLCO1C1;SLC4A10;SLCO3A1;CA4;ABCC6;LRRC8D;SLC39A8;SLC35A3;SLCO2B1;SLC52A1
prerank,defense response to tumor cell (GO:0002357),-0.6214376635633856,-1.4955267299860373,0.0449438202247191,0.22033958372212104,1.0,3/10,11.58%,KLF4;DAPK1;ABI3
prerank,regulation of cellular response to heat (GO:1900034),-0.3917027179216996,-1.4949745661869185,0.008680555555555556,0.2208238733935519,1.0,21/77,13.97%,CREBBP;CD34;GSK3B;NUP42;ATM;MTOR;YWHAE;CAMK2G;RAE1;RANBP2;NUP98;DNAJC7;MAPKAPK2;SEC13;MAPK1;DNAJB6;RPTOR;RPA3;NUP153;RPA1;PTGES3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6011650731159977,-1.494939091329963,0.04283054003724395,0.220361773953973,1.0,5/12,16.35%,PRKG1;DOCK4;MEF2C;TPM1;IGFBP5
prerank,hemidesmosome assembly (GO:0031581),-0.6290255852294984,-1.4938901214380371,0.05892857142857143,0.2215194831738224,1.0,4/11,8.74%,ITGA6;ITGB4;LAMA3;DST
prerank,response to thyroid hormone (GO:0097066),-0.5935658348577812,-1.4936504996875841,0.04868913857677903,0.2213920216816045,1.0,9/13,32.72%,LMO2;THRB;MED1;KLF9;CTSH;RDX;GAS2L1;BRD8;HPN
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6244913236468703,-1.4933440912142997,0.04963235294117647,0.22137824789558996,1.0,8/11,23.91%,CD34;ADIPOR2;KDR;MCAM;PRCP;GATA2;ITGB3;HPSE
prerank,glycerolipid catabolic process (GO:0046503),-0.5332897081815628,-1.4932829194008497,0.04690431519699812,0.22092808614880743,1.0,6/19,14.15%,GPCPD1;ABHD2;PLA2G4A;GDPD1;MGLL;GDPD3
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5852797755622077,-1.4932160782090231,0.044642857142857144,0.22049483859853541,1.0,3/12,10.01%,PPP1R3B;PPP1R3C;AKT1
prerank,body fluid secretion (GO:0007589),0.5450369791573104,1.4930432034897403,0.07709750566893424,0.35167965846952626,1.0,3/15,9.26%,ERBB4;SLC22A4;VEGFA
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.37344482834753273,-1.4921905185030766,0.0035087719298245615,0.22171558031918526,1.0,43/108,23.25%,NXN;RSPO3;TRABD2B;CBFB;ESR1;NFATC1;ITGA3;APP;LRRK2;EMD;VGLL4;KREMEN1;RNF43;OTULIN;MACF1;NKD1;GRB10;MDFIC;HMGXB4;CCNY;SOX7;PSEN1;WWOX;CDC73;NOTUM;APCDD1;TAX1BP3;TCF7L1;DAAM2;SKI;HIC1;SENP2;TNFAIP3;CTNNB1;GPC3;PPP2CA;CTNNBIP1;TERT;AMER1;RSPO2;CDK14;FZD7;PPP1CA
prerank,cellular potassium ion homeostasis (GO:0030007),0.575002392054463,1.4907095867811972,0.051224944320712694,0.3542485121753948,1.0,5/13,8.80%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A
prerank,positive regulation of protein binding (GO:0032092),-0.4148283448831245,-1.4905540122304615,0.025454545454545455,0.22403627544106314,1.0,26/56,25.96%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;STK3;ABL1;BMP4;SPPL3;HFE;PSEN1;FLOT1;HIP1R;MARK3;PPP2CB;AKTIP;PPP2CA;CAPRIN2;TERT;RALB;TCF7L2;TRIB3;BMP2;RAN
prerank,peptidyl-lysine modification (GO:0018205),-0.3761651673026239,-1.4905021685772726,0.0125,0.2235988319589084,1.0,30/99,21.28%,SENP1;PLOD1;PLOD2;IFIH1;KAT2B;NUP42;RAE1;LOXL3;TRPM4;RANBP2;UBA2;SIRT5;NUP98;LOXL1;HDAC4;NSMCE2;KAT5;NUP153;SIRT3;PIAS2;TPR;SENP2;SUMO1;HDAC6;HDAC10;NUP214;PIAS4;CTH;TRIM28;LOX
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.4001606775266492,-1.4890422784833108,0.017271157167530225,0.22567845182124333,1.0,19/65,15.42%,HIP1;DAB2IP;AFAP1L2;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;RHBDF2;AKT1;ARAP1;PTPN3;CEACAM1;DUSP3;HIP1R;GRB2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5480582229007784,-1.488438934166244,0.04283054003724395,0.22616738779923537,1.0,8/15,26.63%,RSPO3;ZNRF3;RNF213;CSNK1D;DAAM2;GPC3;WNT5B;SFRP4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.31812236371651065,-1.4880770425868466,0.0,0.22617499769966998,1.0,105/327,24.80%,APBB2;NFIA;RREB1;SMARCA2;ENG;ZNF423;ACVRL1;RB1;CREBBP;NSD1;BNC2;ERC1;KAT6B;INSR;ZMIZ1;ESR1;FOXN3;ZFHX3;IRF2;RPS6KA5;WWC2;NR3C1;ZSCAN21;SOX13;MITF;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;DNM2;TRRAP;ABL1;NFYC;FUS;MEF2C;ZBTB4;SLC39A8;NSD3;GTF2IRD1;ASCC1;LDB1;NAB1;GPBP1;USP13;PRDM2;SPTY2D1;TP53;SP3;HMG20A;SOX7;JMJD1C;CHD3;SFPQ;PRRX2;NOTCH1;OGG1;YAF2;ACTN4;TAF5L;GPBP1L1;ATF4;MZF1;HCFC1;MYBL2;FOXC1;CREBL2;TCF3;TCF7L1;NR1D2;FOXO4;NAB2;HIC1;UBE2L3;HDAC10;HINT1;PATZ1;SOX4;WTIP;PPP2CA;CARM1;ATRX;UTP4;ZSCAN26;IGF2;CDK11B;SRSF10;NONO;RELA;ZNHIT3;SUPT4H1;FZD7;AJUBA;CEBPA;MYCBP;TULP3;ACVR2B;GCFC2;ATF5;APBB1;BMP2;SERTAD3;RBAK
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.6409598823531468,-1.487836418386971,0.053475935828877004,0.2260543363293124,1.0,6/10,18.57%,DDX39B;WDR76;FEM1B;THOC1;RFWD3;RPA2
prerank,cardiac muscle cell action potential (GO:0086001),0.4703510581745293,1.4877034934997457,0.04428904428904429,0.3585533050900004,1.0,11/30,13.94%,ATP1A2;FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;ATP1B1;CACNA1D;SCN5A;SLC8A1;SCN2B
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5493886241082773,-1.4875084149013884,0.05291970802919708,0.22610578726072833,1.0,8/16,16.85%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;TRPC3;IGF1
prerank,regulation of response to stress (GO:0080134),0.6139537751172586,1.4865816024304395,0.06928406466512702,0.3583472051592381,1.0,4/10,16.92%,OPRM1;ADCY8;CORO2B;MLC1
prerank,amino sugar metabolic process (GO:0006040),-0.6239142682523839,-1.4852375104677527,0.05309734513274336,0.22944107336308983,1.0,5/10,8.94%,ST3GAL1;ST6GAL1;CSGALNACT1;GFPT2;SLC35A3
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49139364640195066,-1.4849693271771638,0.03577817531305903,0.2293890386183826,1.0,14/26,24.98%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6148194746190879,-1.4847647756455007,0.052346570397111915,0.2291812940360213,1.0,4/11,5.92%,FOXO1;CAV1;ATG7;FAS
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4880845905091737,-1.4846538192737384,0.03925233644859813,0.22886212140544157,1.0,10/27,15.81%,CREBBP;KAT6B;KAT2B;KAT6A;TRRAP;PHF20;SGF29;PHF20L1;KAT5;RUVBL2
prerank,postsynaptic membrane organization (GO:0001941),0.5326144330080553,1.4840258171486767,0.06479481641468683,0.36164051201249425,1.0,6/17,13.40%,NRXN1;NLGN1;MUSK;DLG4;APOE;NLGN2
prerank,atrial septum development (GO:0003283),-0.5736227226201782,-1.4839446003056123,0.04900181488203267,0.22949020824695157,1.0,7/13,25.55%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;DAND5;GJA5
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.45767350960457787,1.4834397470532186,0.0467706013363029,0.36035811780882065,1.0,11/31,19.48%,SYT1;SYT5;SYT12;SYT11;ADRA2A;SYT4;SYT3;SYT9;CACNA1G;CACNA1I;SYT17
prerank,transcription by RNA polymerase II (GO:0006366),-0.32065172686687604,-1.4832456434420451,0.0,0.23013553119700253,1.0,101/305,25.51%,RREB1;MNAT1;INTS8;CREBBP;CBFB;NR3C2;ESR1;MLLT3;TEAD4;MED26;MAML2;RXRA;CDK13;KAT2B;SETD2;DEK;PRRX1;NR3C1;TEAD1;THRB;NOTCH3;CDK12;NFIX;SP1;PPARA;RARG;NFKB1;HDAC1;RPRD2;IWS1;MED1;EAF1;POLR2G;MAML1;NABP1;NOTCH2;GTF2E2;GTF2E1;PPARD;ERCC2;TAF11;NOTCH4;CPSF7;YAP1;NFIC;MAZ;MED17;SNAPC1;ICE1;NOTCH1;INTS3;RTF1;CDC73;LSM11;TCEA1;TAF5L;TAF1C;ERCC3;SNRPE;TAF8;MLLT1;PIR;ATF4;NR1D2;NR2C1;INTS9;GTF2I;TAF7;RARA;HDAC10;TAF3;NELFB;LSM10;PHAX;HSF2BP;ELOC;ELOF1;ADRM1;FIP1L1;HDAC7;TBL1X;PPARG;MED27;TAF4B;RARB;TAF13;INTS7;SUPT4H1;RXRG;MED20;CCNK;GMEB2;POLR2C;TAF9;TAF15;ERCC6;SNAPC3;POLR2H;LEO1;POLR2L;TFDP1
prerank,axonemal dynein complex assembly (GO:0070286),0.4696934581290587,1.4831572559553503,0.04597701149425287,0.3584301929351415,1.0,11/27,18.81%,DNAAF3;CCDC63;SPAG1;DNAAF5;ODAD2;DNAAF1;DNAI4;ODAD1;DNAAF2;LRRC49;ODAD3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5161534259850031,1.482944237159087,0.06493506493506493,0.356348451070124,1.0,8/18,17.14%,ADCY10;AQP4;DNAAF1;NEK10;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,regulation of microglial cell activation (GO:1903978),0.5474647830172594,1.482769005317698,0.0659090909090909,0.35422529307890166,1.0,6/15,18.47%,NR1D1;SYT11;SPHK1;GRN;LDLR;CX3CL1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.4332839621970304,-1.4827297851422534,0.03754266211604096,0.2305089287406808,1.0,12/43,10.73%,CTNNA1;FERMT2;MFHAS1;GSK3B;LIMK2;DTX3L;TFRC;BMP4;LATS2;AKT1;YAP1;SIN3A
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.37656750285918045,-1.4817409263688917,0.020689655172413793,0.23163732108930868,1.0,20/86,12.64%,RBPMS;ENG;ZNF423;ACVRL1;CREBBP;DAB2;BMPR2;THBS1;BMP5;RNF111;BMP6;BMP4;TGFB2;CDH5;SMAD2;SMAD4;ACVR2A;HFE;NOTCH1;JAK2
prerank,negative regulation of hippo signaling (GO:0035331),-0.5994446596418715,-1.4817399157740405,0.05818181818181818,0.23111963675095654,1.0,7/12,23.29%,WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,cholesterol biosynthetic process (GO:0006695),0.4582862070314944,1.4816574751369596,0.036281179138321996,0.35419524973182615,1.0,12/31,14.32%,IDI2;INSIG1;LSS;SC5D;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4855632272697565,-1.481427576632663,0.03525046382189239,0.23117847495574076,1.0,10/27,11.89%,PTPN1;PIP4K2A;NCK1;IRS1;PRKCD;PIP4K2B;GRB10;GRB14;GSK3A;SLC27A4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5251175771172496,-1.4813424391905383,0.03873239436619718,0.23081728928188489,1.0,9/20,14.77%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;PKDCC;CSK;NUMB
prerank,regulation of protein binding (GO:0043393),-0.36395334989008044,-1.4812105095505037,0.008561643835616438,0.23049167471878515,1.0,42/114,24.69%,RAPGEF2;CLDN5;CAV1;DAB2;GSK3B;APP;CRK;DTX3L;LDLRAP1;LRRK2;STK3;BMP4;PRKCD;SPPL3;ROCK1;NES;AKT1;ZFPM1;HFE;PSEN1;ACTB;HDAC4;FLOT1;MAPK8;BTBD1;HIP1R;MARK2;PEX14;MITD1;CTSZ;MARK3;AKTIP;TFIP11;PPP2CA;CTNNBIP1;CAPRIN2;TERT;PPP1CA;RALB;TCF7L2;TRIB3;BMP2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5410751121369426,1.4812009195537539,0.07081545064377683,0.35265032238814553,1.0,5/16,12.40%,ATP1A2;CALM2;RYR2;SLC8A1;HRC
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.6273484298360167,-1.4806611635145452,0.058823529411764705,0.23077740532718766,1.0,7/11,25.22%,RESF1;TASOR;TPR;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,regulation of store-operated calcium entry (GO:2001256),0.618894938761973,1.4803308442606047,0.0659090909090909,0.3521254986440139,1.0,6/10,19.40%,EFHB;HOMER1;CASQ1;SLC8B1;GRAMD2A;CD84
prerank,protein hydroxylation (GO:0018126),-0.5614296091170824,-1.4800291166368407,0.04659498207885305,0.23130978950174721,1.0,5/15,9.03%,PLOD1;PLOD2;P3H2;OGFOD1;ASPH
prerank,regulation of protein phosphorylation (GO:0001932),-0.3255276995236748,-1.4790564726330677,0.0,0.23234018242280566,1.0,80/256,21.65%,TEK;DAB2IP;PECAM1;ENG;NSD1;PPP2R5A;INSR;BMPER;DAB2;RAC1;LYN;FAM20A;CORO1C;DVL3;APP;RALBP1;LIMK2;TBX1;KDR;SLCO3A1;LRRK2;NIBAN1;TFRC;EGFR;GAS6;FAS;SLIT2;ABL1;BMP4;LRP6;FGF1;PLCE1;IRGM;CCND3;PTK2;CDH5;OCLN;FLT4;IL34;ACVR2A;AKT1;VEGFC;FGF7;FNIP2;STAT2;AXIN2;ILK;LIMCH1;FGF2;CHP1;FLOT1;CSNK1D;HGF;TRAF3IP1;ATF4;PTPN13;DNAJC10;CD40;PIK3R3;ROCK2;FYN;BMP7;ANGPT1;PELI2;MAVS;SOD1;CDK5RAP3;AKTIP;CCND1;KRAS;BRAT1;PPP2CA;RAP2A;PRKDC;IGF2;ITGB3;P2RY1;WARS1;CCN1;PTEN
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.6200735943234491,-1.478733725887121,0.06309751434034416,0.23242358773007948,1.0,3/10,12.10%,ZBTB16;ACVRL1;PKDCC
prerank,response to leucine (GO:0043201),-0.6200973722659535,-1.4778131510099408,0.061371841155234655,0.232888092516594,1.0,6/10,18.56%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,cellular response to leucine (GO:0071233),-0.6200973722659535,-1.4778131510099408,0.061371841155234655,0.232888092516594,1.0,6/10,18.56%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.5140559864977687,-1.4777033378973643,0.044036697247706424,0.23257408160359824,1.0,11/21,20.45%,CORO1C;MACF1;PTK2;ROCK1;LDB1;LIMCH1;RHOA;DUSP3;ROCK2;SLK;VCL
prerank,regulation of fat cell differentiation (GO:0045598),-0.3915742706835245,-1.477610022870707,0.021352313167259787,0.23223642575008213,1.0,28/74,24.74%,ZBTB16;FOXO1;FERMT2;LRP5;ASXL1;TRPM4;FTO;PPARD;AKT1;YAP1;ANKRD26;ZFPM1;TMEM64;LPL;TAF8;CREBL2;TRIO;GATA2;CARM1;CMKLR1;PPARG;AAMDC;CREB1;SYAP1;GPS2;TRIB3;BMP2;PTPRQ
prerank,regulation of RNA metabolic process (GO:0051252),-0.4113677496689364,-1.4775342470618855,0.020442930153321975,0.23184199027016072,1.0,18/59,14.06%,MBNL1;MBNL2;ZNF326;AHNAK;MITF;METTL4;NOVA2;TNFRSF1B;AHNAK2;MED1;FUS;CELF1;HNRNPF;RASA1;SON;CLK3;RC3H1;RBM20
prerank,canonical Wnt signaling pathway (GO:0060070),-0.398136520235579,-1.4768999516423624,0.020146520146520148,0.23236275073655552,1.0,30/68,28.68%,LEF1;CAV1;CSNK1A1;LRP5;FZD6;GSK3B;DVL3;LRRK2;FZD4;RARG;LRP6;RAB5A;WNT16;WNT11;TCF7L1;CTNNB1;PTEN;AMER1;FZD7;PPP1CA;FZD5;TCF7L2;PLPP3;FZD10;WNT5B;APC;WNT2B;SFRP4;FZD1;FRZB
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5037943975514755,-1.4764015209065358,0.053475935828877004,0.23269618334685888,1.0,4/21,4.11%,FOXP1;PRKCH;SLC39A10;PRKD2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.42800593403923565,-1.4762564251866648,0.02058319039451115,0.2324549044486443,1.0,12/46,13.51%,DAB2IP;SEMA6A;LYN;PTPN1;RANBP9;SPRED2;DLG1;EZR;SMAD4;TIMP3;DUSP3;CNKSR3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.47622323789393467,-1.4754399137534957,0.05670103092783505,0.2333037071225339,1.0,7/28,10.65%,DAB2IP;DDX3X;ZDHHC3;NGF;CRADD;CASP8;GABARAP
prerank,negative regulation of TOR signaling (GO:0032007),-0.44681835594878827,-1.4749823610076205,0.027972027972027972,0.23362744961322243,1.0,14/36,19.88%,SH3BP4;SESN1;ATM;DDIT4;GSK3A;UBR2;PRKAA1;KPTN;CASTOR1;RNF152;UBR1;ITFG2;TMEM127;AKT1S1
prerank,spinal cord development (GO:0021510),-0.5998608039543354,-1.4744996350131911,0.0696798493408663,0.23399360498378136,1.0,6/12,21.92%,PKD2;VIT;LOXL3;ZPR1;SOX4;NF1
prerank,positive regulation of signaling (GO:0023056),0.44553749563952605,1.4740483527001291,0.032119914346895075,0.36327150300620425,1.0,9/37,13.18%,GRIK2;SYT1;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;DLG4;INPP5F
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4524493660105098,-1.4736447925596179,0.05136986301369863,0.23488278507329538,1.0,18/32,36.59%,ZBTB20;INSR;TMSB4X;APP;PPARA;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT;BEND3;PFKFB4;PFKFB2;TREM2;PID1;VCP;ENTPD5;HIF1A
prerank,adipose tissue development (GO:0060612),-0.6070956206481813,-1.4733951623768484,0.06440071556350627,0.2347811726265626,1.0,5/11,18.70%,LRP5;SH3PXD2B;NAMPT;DGAT2;ARID5B
prerank,regulation of dendrite extension (GO:1903859),0.5176848544877215,1.4732032817790333,0.05543710021321962,0.3625982266909812,1.0,8/18,14.46%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4008255079453552,-1.4724823376871048,0.010968921389396709,0.2358280812644313,1.0,27/62,29.19%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;RTF1;CDC73;TCEA1;ERCC3;MLLT1;NELFB;ELOC;ELOF1;ADRM1;SUPT4H1;CCNK;POLR2C;POLR2H;LEO1;POLR2L;GTF2H3;ELP2;CCNH
prerank,zinc ion homeostasis (GO:0055069),-0.47205316239818207,-1.4720769197801653,0.0338680926916221,0.23606965366795682,1.0,14/28,24.98%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,iron ion transmembrane transport (GO:0034755),-0.6306513007010004,-1.4715228292130869,0.0625,0.23644564141618785,1.0,5/10,16.75%,SLC40A1;SCARA5;SLC39A8;ABCB7;SLC25A28
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.42229515915858656,-1.4713585839448933,0.01903114186851211,0.23618207577672917,1.0,13/52,10.01%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;DLG1;STX3;PIK3R1;EPB41L2;AKT1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5611582619207374,1.4703456718048948,0.06578947368421052,0.3664237800789459,1.0,3/12,6.32%,SNAP25;STX2;PRRT2
prerank,striated muscle tissue development (GO:0014706),-0.46589851169015367,-1.4700409571294246,0.05313092979127135,0.23784559431685454,1.0,13/29,16.78%,PGM5;CAV1;BMPR2;SVIL;BMP5;SIX1;RBP4;MEF2C;TBX2;CFLAR;SIX4;BMP7;MYL6
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.3720521890750223,-1.4696729499349481,0.0137221269296741,0.23799469729492517,1.0,32/94,20.15%,DAB2IP;ITPR1;PPP1R13B;MCL1;ATM;MAP3K5;FHIT;DDX3X;TNFRSF1B;STK24;ABL1;CUL3;PRKCD;ERN1;BNIP3;CUL2;PPM1F;ATP2A3;ARL6IP5;TP53;FNIP2;ERO1A;IKBKE;ATF4;DNAJC10;BBC3;HIC1;BCL2L11;HINT1;EPHA2;PRKDC;BRCA1
prerank,regulation of vasoconstriction (GO:0019229),-0.4662466585965095,-1.4695566761007528,0.05545286506469501,0.23768386301596583,1.0,8/27,12.16%,CAV1;BMPR2;ADRA1B;ACE;TRPM4;ECE1;AGTR1;ADM
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.572595889989561,-1.469497273911532,0.05693950177935943,0.23726444999944185,1.0,6/13,17.56%,TMSB4X;SIN3A;PSEN1;MAD2L2;HEY2;HEY1
prerank,positive regulation of programmed cell death (GO:0043068),-0.32328421237796223,-1.4693094509741058,0.0032520325203252032,0.23710357435886978,1.0,88/272,24.69%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;MCF2L;ATM;MAP3K5;PLEKHG5;UTP11;TNFSF10;DDX3X;LRRK2;RBM5;RASGRF2;RARG;RYBP;STK3;DNM2;FAS;SLIT2;PSEN2;FOXO3;ABL1;ARHGEF12;BMP4;BNIP3;JUN;RASSF2;NGF;TGM2;ITSN1;ARL6IP5;ARHGEF2;SOS2;LATS2;CRADD;TP53;CASP8;ARHGEF11;PSEN1;SLC27A4;ANO6;CTNNBL1;STPG1;MAPK8;ERCC3;ATF4;HIP1R;TRIO;ABR;ARHGEF18;BCL2L11;APH1A;HDAC6;TFAP4;CTNNB1;PREX1;SOD1;IAPP;SIAH1;SOX4;RNPS1;ARHGEF5;FOXL2;PNMA2;ARHGEF1;PHLDA3;NF1;CASP2;SUDS3;GADD45A;ATF6;BCL6;RIPK1;APBB1;HMGB1;FANK1;VAV2;BMP2
prerank,positive regulation of kinase activity (GO:0033674),-0.3638520188544733,-1.4667655689733552,0.013888888888888888,0.2408962134872016,1.0,23/107,8.63%,FLT1;TEK;IGF1R;RAPGEF2;TIE1;INSR;ROR1;IQGAP1;KDR;MERTK;EGFR;GAS6;MRNIP;LMO4;DSTYK;RAP1A;PTK2;RASSF2;EPHA4;MRE11;SNX9;MMD;FLT4
prerank,plasma membrane organization (GO:0007009),-0.39444823886387276,-1.4663696084303157,0.021015761821366025,0.2410479950955866,1.0,14/61,8.04%,SPTBN1;PLSCR4;MYOF;MYH9;CAVIN2;FNBP1L;A4GALT;PLSCR2;COL5A1;EHD2;DYSF;AHNAK2;SNX9;BIN3
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6217758076237223,-1.4663411525160421,0.064030131826742,0.24057720532975435,1.0,4/10,10.01%,CD200;LRCH1;WASL;AKT1
prerank,regulation of hippo signaling (GO:0035330),-0.5325250016901345,-1.465840720318137,0.06371681415929203,0.2409199835125469,1.0,8/17,23.29%,MOB3B;WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.40462609160132296,-1.4658347869844364,0.022847100175746926,0.2404170190375729,1.0,20/59,24.46%,DAB2IP;ERC1;TAB3;BIRC3;NFKBIA;ROCK1;NFKBIL1;AKT1;ROCK2;TAB2;TNFRSF1A;IRAK2;IKBKG;IKBKB;TBKBP1;NKIRAS2;RELA;RIPK1;MAP3K7;MAP3K14
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5740455805866017,-1.4652054899865166,0.059233449477351915,0.24097528358032072,1.0,3/13,6.64%,DAB2IP;PTPN1;NEDD4
prerank,cell-cell junction organization (GO:0045216),0.3716918331002395,1.4648957460429806,0.011061946902654867,0.3761743299607207,1.0,24/79,11.81%,CDH18;CADM2;CTNND2;CDH8;CDH20;CDH9;CDH10;CD177;PKP2;DCHS1;CDH19;CXADR;FSCN1;FLCN;CDH12;ANG;NECTIN3;SDK1;CDH7;CDH24;CDH17;CDHR3;CSF1R;CDH2
prerank,positive regulation of response to external stimulus (GO:0032103),-0.35030733232432115,-1.464664817989735,0.0018248175182481751,0.241359903813186,1.0,44/128,29.58%,ETS1;ANKRD17;THBS1;APP;IL15;BMP6;SCARF1;NMI;NFKBIA;PDE2A;PDCD4;STX3;NAPEPLD;PUM1;PPM1F;AKIRIN2;FEM1A;DDX60;AGTR1;USP15;LPL;IL17RA;PLSCR1;POLR3F;IFI35;TNFRSF1A;GBP5;IL16;HYAL2;CCL19;SASH1;GPR4;SERPINE1;CEBPA;RIPK1;PDGFRB;DHX9;DDT;PTN;RIOK3;GPSM3;OASL;TNIP1;TREM2
prerank,regulation of response to external stimulus (GO:0032101),-0.35805795055617423,-1.4645982895351315,0.0071174377224199285,0.24099593120605162,1.0,30/121,18.86%,FOXP1;IL1R1;XIAP;ADGRA2;CAV1;CASP12;SEMA7A;TMSB4X;BIRC3;SAMHD1;STK24;CD55;NMT1;IRF1;CELF1;CASP8;AREL1;MGLL;AGTR1;USP18;JAK2;SAG;N4BP1;NR1D2;ERAP1;ZMPSTE24;ANXA1;NOD2;DAGLB;TKFC
prerank,histone mRNA catabolic process (GO:0071044),-0.547306165665314,-1.4643251066035714,0.05525846702317291,0.24098256746996907,1.0,6/15,13.65%,TUT7;TENT4B;ATM;XRN1;TUT4;TENT2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4757735843767176,-1.4642084989072364,0.033210332103321034,0.24066016953100883,1.0,10/28,11.89%,PTPN1;PIP4K2A;NCK1;IRS1;PRKCD;PIP4K2B;GRB10;GRB14;GSK3A;SLC27A4
prerank,focal adhesion assembly (GO:0048041),-0.500395666108951,-1.4637199838120158,0.06386861313868614,0.24097691733099416,1.0,5/21,6.87%,SORBS1;THSD1;BCR;FERMT2;PTPRK
prerank,positive regulation of signal transduction (GO:0009967),-0.3253633780717687,-1.4630365610416949,0.0,0.24171234986047782,1.0,79/238,22.43%,TEK;VWF;DAB2IP;JCAD;SORBS1;SHANK3;RSPO3;CREBBP;NOS3;ZMIZ1;PKD2;LIMS2;ASXL1;KLF2;LIMS1;MAML2;KAT2B;TTC23;LRRK2;PRKD2;SMO;IL6ST;BMP6;LOXL3;JAG2;GAS6;FAS;DSTYK;PIK3R1;MACF1;IRS1;FGF1;TGFB2;ERN1;AAK1;MAML1;TSPAN14;GRB10;CTBP2;CRADD;TPD52L1;FLNA;NOTCH4;YAP1;TSPAN5;ILK;NOTCH1;JAK2;CDC73;P2RY6;CCN3;FGFBP3;TRIM16;AGPAT1;SMOC2;SKI;JAG1;TNFAIP3;IGF1;CITED2;NOD2;RPS3;GKAP1;SASH1;ARNT;PTPRC;KIF7;IGF2;F3;ITGB3;DLL4;PTPN11;PTEN;TERT;PTK2B;TUBD1;ESM1;TRIM39;RSPO2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5234430505583163,-1.4620743513009598,0.06417112299465241,0.24285347488890785,1.0,10/19,18.76%,BMPR2;TGFBR2;TGFB2;SMAD4;ZFPM1;NOTCH1;SMAD6;HEY2;HEY1;SOX4
prerank,hepaticobiliary system development (GO:0061008),-0.5110135881630256,-1.4615295484957322,0.045207956600361664,0.2432391210011823,1.0,11/20,23.38%,PKD2;LSR;TGFBR3;NIPBL;PRKCSH;CEBPG;CITED2;CDK5RAP3;ARID5B;NF1;CEBPA
prerank,regulation of JUN kinase activity (GO:0043506),-0.45151905377216,-1.4611393237445611,0.0433996383363472,0.2433509648699068,1.0,13/33,26.85%,DAB2IP;DVL3;MAP3K5;PPEF2;PDCD4;EDN1;TAOK3;RPS3;SASH1;ARHGEF5;MAP3K7;FZD10;AIDA
prerank,endothelial cell migration (GO:0043542),-0.44861234372609843,-1.4609699528558684,0.03888888888888889,0.24314928559379406,1.0,14/37,18.08%,NOS3;ADGRA2;MYH9;ID1;PLEKHG5;PXN;ABL1;CDH5;PLXND1;STARD13;RHOA;CCN3;LGALS8;GIPC1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.37888133157350556,-1.4597221019440612,0.025735294117647058,0.2447093914397895,1.0,31/78,24.89%,CAV1;CSNK1A1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;BCAP31;GABARAP;SMAD7;SGTA;CSNK1D;ZER1;SUMO1;ZYG11B;RAD23A;HERPUD1;SH3RF2;MDM2;KEAP1;NFE2L2;RCHY1;CEBPA;HSPA1B;FZR1;TRIB3;PLK3
prerank,embryonic digit morphogenesis (GO:0042733),-0.529696185767081,-1.459675183149014,0.05391304347826087,0.24430993340811968,1.0,6/18,10.36%,MAP3K20;CREBBP;HDAC1;ECE1;TBX2;GLI3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.32031909012160203,-1.459201041269531,0.0,0.2446347107778894,1.0,75/248,18.77%,DAB2IP;XIAP;UBR5;ADGRA2;CAV1;CSNK1A1;DAB2;MLLT3;FZD6;SMURF2;GSK3B;DVL3;MCC;PSMA2;SOX13;ZNRF3;DDX3X;LRRK2;IGFBP4;SOX17;CSNK1G3;EMD;FZD4;EGFR;TRPM4;LIMD1;RBX1;FRMD8;KREMEN1;NFKB1;HDAC1;STK3;OTULIN;CUL3;LRRK1;LRP6;NKD1;PSME2;CTNND1;KLHL12;PSMB4;GSK3A;LATS2;PPM1B;UBAC2;GLI3;CCNY;AXIN2;SOX7;ILK;PSEN1;CSNK1G1;TMEM64;NOTUM;WNT11;DKK2;PLEKHA4;CSNK1D;PSMC2;PSMB2;LMBR1L;TMEM170B;DAAM2;FUZ;USP34;RUVBL2;MAD2L2;PSMB1;CTNNB1;LYPD6;PSMA8;TMEM88;PSME1;SOX4;GPC3
prerank,regulation of AMPA receptor activity (GO:2000311),0.4737633146236698,1.459163442851899,0.04524886877828054,0.3870809624032954,1.0,13/25,19.11%,NLGN1;SHANK1;CACNG8;CACNG3;MINK1;CACNG2;CACNG4;PRRT1;CACNG5;NLGN2;SHISA9;CNIH2;NLGN3
prerank,protein localization to chromatin (GO:0071168),-0.526192059992092,-1.4589977289161569,0.04991394148020654,0.2444448977443058,1.0,9/18,17.90%,ESR1;NIPBL;MRNIP;SGF29;MCM9;WAPL;TASOR;RUVBL2;PPHLN1
prerank,manganese ion transport (GO:0006828),-0.5623122911478718,-1.4587814059697968,0.059033989266547404,0.24433524861429248,1.0,5/14,16.36%,SLC30A10;TRPC4;SLC39A8;TRPC6;TRPC3
prerank,positive regulation of innate immune response (GO:0045089),-0.45272958115635226,-1.4580798158575066,0.05319148936170213,0.2449902943724101,1.0,16/30,32.51%,UBE2K;NMI;LBP;AKIRIN2;PLSCR1;POLR3F;IFI35;GBP5;MAVS;NLRC5;DHX9;RIOK3;TRIM6;SPI1;PLA2G5;TRIM62
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5066528071351667,-1.4577701475704024,0.05419580419580419,0.24501773697248033,1.0,9/20,18.97%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40;PIAS4
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5066215001027754,-1.4573060177483947,0.05415860735009671,0.24527418813044716,1.0,12/21,25.61%,CAV1;NCK1;DDIT4;RASSF2;PPM1F;SMAD7;NCK2;CNKSR3;PTEN;GADD45A;INPP5J;DMTN
prerank,organic hydroxy compound transport (GO:0015850),-0.4441719187956048,-1.4572483325591865,0.0351493848857645,0.24487412053662472,1.0,8/36,8.98%,ABCC4;ATP8B1;SLCO1C1;RXRA;RALBP1;RBP4;SLC16A1;SLCO2B1
prerank,calcium ion transmembrane transport (GO:0070588),0.36268868526989134,1.457167999401818,0.018140589569160998,0.3895464316618558,1.0,16/86,8.20%,TRPM3;SLC24A4;SLC24A2;GRIN2B;SLC25A23;RYR3;PHB2;CACNA2D1;ATP2B4;GRIN2A;CACNA1A;CACNB3;SLC8A2;CACNA1D;TMCO1;TRPM1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.605933110491141,-1.457152893733089,0.08152173913043478,0.2445466494824423,1.0,3/10,15.04%,WDFY1;LBP;IFI35
prerank,negative regulation of protein kinase activity (GO:0006469),-0.37087238782039533,-1.4566745011461055,0.01615798922800718,0.24490625661933554,1.0,30/88,22.70%,PTPRB;DAB2IP;RB1;CAV1;LRP5;CORO1C;PTPN1;CEP85;PAK2;CDKN1B;RTRAF;ABL1;LRP6;PPM1F;SH3BP5L;PRKRIP1;AKT1;CEACAM1;DUSP3;CHP1;TAF7;UBASH3B;ADARB1;CDK5RAP3;HYAL2;PTPRC;AKT1S1;WARS1;NF1;GADD45A
prerank,negative regulation of peptidase activity (GO:0010466),0.40259428456043345,1.4558575843978814,0.036637931034482756,0.38993797787038903,1.0,9/47,10.71%,VTN;SPOCK3;SPOCK1;ECM1;SERPIND1;TIMP1;FETUB;SERPING1;SERPINA2
prerank,negative regulation of growth (GO:0045926),-0.3572182161770757,-1.4557741951974492,0.008865248226950355,0.24590590275715057,1.0,46/121,25.19%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;SOX17;PTPRJ;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;NOTCH2;SMAD4;TP53;DCBLD2;NOTCH1;WNT11;ST7L;CCN3;NPR1;OSGIN2;RERG;HYAL2;PPP2CA;FHL1;CDKN2C;CAPRIN2;BCL6;MSX1;HSPA1B;APBB1;GNG4;SERTAD3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SIPA1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6261031945402449,-1.4552054102826821,0.05514705882352941,0.24639748249975169,1.0,3/10,8.24%,LYN;FAS;MAPK1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5266073883692084,-1.4550027646413355,0.0544464609800363,0.24620542257746056,1.0,9/18,18.26%,HEG1;ITGA3;SCAI;RASIP1;CUL3;TNFAIP1;MYOC;KCTD10;ARHGAP35
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.4115892508122705,-1.4549752039677115,0.032758620689655175,0.24576056518400807,1.0,13/52,10.01%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;DLG1;STX3;PIK3R1;CNST;AKT1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.33182340926606163,-1.4549592211044333,0.005226480836236934,0.24529742200123977,1.0,91/193,35.54%,FBXL7;NEDD4L;SMURF2;TRIM25;UBE2K;CNOT4;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;RNF43;CBL;UBE4B;CUL3;NEDD4;RNF40;RNF144B;BIRC6;ARRDC1;TRIP12;FEM1A;SPSB1;MIB1;AREL1;NTAN1;CDC16;ATXN3;ANAPC16;UBE4A;FEM1C;RC3H1;KLHL25;PSMC2;UBR4;RNF168;RNF167;MYLIP;UBE2L3;KLHL3;KCTD10;SIAH1;ELOC;ADRM1;BUB1B;HERPUD1;BUB3;HACE1;NDFIP2;UBE2R2;MDM2;KEAP1;RCHY1;RNF146;ARRB1;FZR1;DTL;TRPC4AP;ANAPC7;RNF34;ARIH2;RNF114;UBE2I;UBA1;UBE2H;RNF14;TRIM32;CDC34;ANAPC10;ANAPC5;PSMD13;ANAPC11;RNF19A;UBE2A;AURKA;RNF20;RBBP6;FBXL14;PLK1;RNF185;RNF11;TOLLIP;WDR81;UBE2G2;KLHL15;TOPORS;CDC20;OS9;NEDD8
prerank,regulation of protein neddylation (GO:2000434),-0.6180454437046077,-1.4545443067336121,0.05860805860805861,0.2454762525071249,1.0,6/10,21.23%,DCUN1D3;COPS9;RPL5;DCUN1D2;EPAS1;DCUN1D5
prerank,regulation of osteoblast differentiation (GO:0045667),-0.37862792510922066,-1.4543484783145084,0.02197802197802198,0.24535490087969908,1.0,27/82,16.85%,ZHX3;FERMT2;CRIM1;LRP5;BMPR2;SMOC1;IL6ST;BMP6;TRPM4;LIMD1;IL6R;BMP4;MEF2C;PTK2;PRKD1;ACVR2A;YAP1;TWIST2;NOTCH1;TMEM64;HGF;ATF4;CDK6;SMAD6;SKI;BMP7;IGF1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3794991342463473,-1.454316360208108,0.015655577299412915,0.24493264561773903,1.0,23/67,21.90%,ATP8B1;MYO10;PODXL;CAV1;RAC1;PLD1;TBC1D1;TBC1D2B;IFT140;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;TBC1D20;TBC1D8;CAPZB;TBC1D17;EPHA2;EVI5;IFT20
prerank,metal ion export (GO:0070839),0.44652398298223533,1.453501684389375,0.029055690072639227,0.39305117232657916,1.0,7/31,8.80%,ATP1A2;KCNA5;SLC4A4;ATP12A;ATP2B4;ATP1B1;ATP4A
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5635185005906996,-1.4530867705923058,0.0584070796460177,0.24655045454998198,1.0,8/13,31.40%,NAMPT;NAXE;NAPRT;NUDT12;PARP16;PTGIS;PARP9;NAXD
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5312959035250339,-1.4528238558265565,0.0705244122965642,0.246484776180597,1.0,6/16,9.74%,PDGFD;PTPN1;PTPRJ;ABL1;PIK3C2A;BCAR1
prerank,negative regulation of glycolytic process (GO:0045820),-0.6189719230905261,-1.4527778821742525,0.09477756286266925,0.24558313372480917,1.0,3/10,12.03%,CBFA2T3;PPARA;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6189719230905261,-1.4527778821742525,0.09477756286266925,0.24558313372480917,1.0,3/10,12.03%,CBFA2T3;PPARA;HDAC4
prerank,central nervous system myelination (GO:0022010),0.5858378580058415,1.452588131744909,0.09230769230769231,0.39253193377249584,1.0,6/11,17.21%,TENM4;MYRF;PLP1;ABCA2;CLU;B4GALT6
prerank,positive regulation of glycolytic process (GO:0045821),-0.5049903096610703,-1.4522196735868171,0.06293706293706294,0.2455451760684052,1.0,8/20,19.18%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5049903096610703,-1.4522196735868171,0.06293706293706294,0.2455451760684052,1.0,8/20,19.18%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,steroid catabolic process (GO:0006706),0.5950958672480695,1.452099616408021,0.06744186046511629,0.391129653898102,1.0,3/10,9.39%,CYP24A1;HSD17B14;SPP1
prerank,negative regulation of cellular process (GO:0048523),-0.29950121782185596,-1.4507631674577477,0.0,0.2477695105805222,1.0,183/521,26.83%,APBB2;DAB2IP;SMARCA2;RAPGEF2;IGFBP7;SP100;ACVRL1;JAM2;PPP1R13B;RB1;PODXL;NOS3;FERMT2;DCUN1D3;PTPN14;KLF4;ETS1;ABI1;CBFA2T3;CD34;PKD2;MYH9;LYN;BMPR2;CBLL1;PDS5B;CD200;SH3BP4;BTG3;APP;KAT2B;RNF139;BMP5;TBX1;ITGA1;ARID2;DDX3X;P3H2;THAP12;SOX17;TGFBR3;PTPRJ;CDKN1B;VGLL4;CRLF3;RBM5;DYSF;CTCF;RARG;TNFRSF1B;NMI;PDCD4;SLIT2;NCK1;BMP4;AQP11;TGFB2;PTPRK;SUZ12;BNIP3;ARHGDIA;NGF;PLXNA4;CDK10;PLXND1;PRKD1;RAF1;CTBP2;SMAD4;ADAM10;IRF1;WNT16;TP53;CELF1;KLF10;NOTCH4;UBR2;VPS13C;LMNA;FRK;ZBTB7C;CHMP4B;AXIN2;TXNIP;SOX7;RGCC;NCK2;DCBLD2;NOTCH1;RASA1;RAD18;ACTN1;JAK2;CDC73;FGF2;WNT11;CTTNBP2NL;ST7L;CCN5;TBRG1;PLSCR1;PDE12;NUDT6;CDK6;CCN3;RNF167;ATG5;BTG2;MIF;IFI35;FUZ;SMAD6;FOXO4;NPR1;SKI;OSGIN2;GSDME;RERG;BMP7;ANGPT1;PIP4P2;TFAP4;NOX4;CTNNB1;ADARB1;ADGRG1;TNS2;TES;HYAL2;BAP1;SOX4;VAMP3;PPP2CA;PPM1D;TMEM127;TGFBI;TOB1;FHL1;BLM;CDKN2C;DLL4;LPCAT3;CAPRIN2;WARS1;CCN1;PTEN;NOS1;PTK2B;MYOCD;DIS3L2;PARP16;BCL6;TXNDC12;MSX1;BECN1;SEMA5A;COPS8;CEBPA;E2F7;HSPA1B;ATF5;APBB1;ADGRB1;GNG4;PLXNB1;BMP2;SERTAD3;EIF2AK3;APC;PLPP1;SIPA1;TPTE;NUPR2;CDKN3;SERTAD2;PINX1;RND1;F2R;FABP3;VPS35;SFRP4;CGREF1;PTPN2
prerank,positive regulation of cell projection organization (GO:0031346),0.3475653651421024,1.4504794312635325,0.007159904534606206,0.3924106747079649,1.0,28/115,13.76%,PTPRD;MAGI2;IL1RAPL1;ROBO2;LRRC7;GRIP1;RIT2;SCN1B;ROBO1;TENM3;FUT9;CDKL5;TOX;KIDINS220;NDRG4;CAMK2B;NTRK2;CARMIL1;PLA2G3;SLITRK1;PLPPR5;STMN2;DLG4;PLXNA2;APOE;PLXNA1;BDNF;AMIGO1
prerank,regulation of cell population proliferation (GO:0042127),-0.29088037359859564,-1.4502008856607622,0.0,0.248222104174336,1.0,174/691,20.22%,FLT1;TJP1;LEF1;GRK5;DAB2IP;IGF1R;SMARCA2;KITLG;ELN;RAPGEF2;IGFBP7;OSMR;CLDN5;ENG;ACVRL1;XIAP;NOS3;PTPN14;INSR;KLF4;ETS1;ABI1;CBFA2T3;PKD2;LRP5;ACER2;LYN;BMPR2;PDS5B;CD200;PDGFD;SH3BP4;BTG3;THBS1;RBFOX2;LIMS1;CDK13;GCNT2;APP;KAT2B;RNF139;BMP5;TBX1;IL15;ITGA1;ARID2;KDR;P3H2;THAP12;TFRC;PTPRJ;IL6ST;BMP6;CDKN1B;EGFR;TGFBR2;TRPM4;RBM5;CTCF;IL6R;HES1;JAG2;SIX1;RARG;HDAC1;NMI;STX3;DNAJA2;CUL3;IRS1;BMP4;FGF1;AQP11;TGFB2;PTPRK;STAMBP;STAT6;PTK2;JUN;NGF;CDK10;BIRC6;TBX2;FLT4;IL34;RAF1;ARHGEF2;NOP2;NAMPT;CTBP2;LIFR;ADAM10;IRF1;TP53;CELF1;AKT1;EDN1;KLF10;VEGFC;YAP1;DOT1L;FGF7;LMNA;FRK;PTGFR;STAT2;ZBTB7C;AXIN2;SOX7;RGCC;MAZ;NCK2;ACER3;AGTR1;HDAC4;NOTCH1;JAK2;RHOA;CDC73;FGF2;RHOG;CDC123;EDN3;ASH2L;RPS4X;TBRG1;MECP2;NUDT6;KSR1;COPS9;CDK6;BTG2;FAM98A;IFI35;LGMN;FUZ;SMAD6;FOXO4;SKI;GSDME;JAG1;SRPK2;RERG;SIX4;COX17;RARA;TFAP4;IGF1;NOX4;CTNNB1;NUAK1;ADARB1;GAB2;CTSH;ADGRG1;TNS2;TBC1D8;TES;CLCF1;TNFSF13;BAP1;DUSP22;SOX4;KRAS;PPM1D;CACUL1;ECRG4;TMEM127;FGFR4;PRKDC;IGF2;PRC1;TIMELESS;TOB1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.44858825996552193,1.450095780132991,0.06444444444444444,0.3907701938865937,1.0,10/30,8.46%,FGF12;SCN1B;KCNA5;SCN1A;CACNA2D1;PKP2;GPD1L;CACNA1D;RYR2;SCN5A
prerank,protein deacetylation (GO:0006476),-0.4247986275143581,-1.450021013347285,0.03616636528028933,0.24805863481765475,1.0,18/41,23.83%,MIER1;PRDM5;RCOR1;HDAC1;SIRT5;MIDEAS;FLNA;SIN3A;HDAC4;SIRT3;HDAC6;MIER2;HDAC10;MIER3;HDAC7;TBL1X;SUDS3;MORF4L1
prerank,cellular response to hexose stimulus (GO:0071331),-0.4852685265251869,-1.4498136831232695,0.06739526411657559,0.24792755123266322,1.0,6/23,10.57%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,chloride transport (GO:0006821),0.3770758611807001,1.4495182580147388,0.03139013452914798,0.38961477470500877,1.0,16/74,12.06%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;SLC12A5;GABRA3;GABRA1;SLC1A3;SLC12A4
prerank,supramolecular fiber organization (GO:0097435),-0.3094597955441063,-1.4492275119284963,0.0,0.24845524766357152,1.0,79/333,16.52%,HIP1;TLL1;COL8A1;ITGA6;PGM5;SHROOM4;COL12A1;SNCAIP;COL25A1;MYO1D;COL4A2;CLIP1;CD2AP;USP9X;SHROOM3;RAC1;PLOD1;TPM3;RHOBTB1;PLOD2;CORO1C;ADAMTS2;COL4A6;APP;ELMO1;CGNL1;RND3;P3H2;ITGB4;LOXL3;COL5A1;LAMA3;TMOD3;DLG1;COL4A5;COL8A2;TGFB2;MYH11;MYO1F;COLGALT2;BIN3;TSPAN14;DNAJB6;COL5A2;ARHGEF2;DST;LOXL1;SHROOM1;COL4A1;ADAM10;ARHGAP17;HSPG2;BCAR1;SHROOM2;FBLN5;TSPAN5;P4HA1;DCTN1;FAT1;LMOD1;ACTN1;SLAIN2;RHOA;RHOG;CHP1;RHOC;TPM1;COL6A3;COL26A1;ELMO2;H3-3A;HIP1R;COL6A2;MAD2L2;TUBGCP5;TUBGCP4;APH1A;SLK;COLGALT1
prerank,inorganic anion transmembrane transport (GO:0098661),0.38594880928665426,1.4488627353424528,0.032036613272311214,0.38887169788729914,1.0,15/63,12.06%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;SLC25A3;ANO4;SLC12A5;GABRA3;GABRA1;SLC1A3;SLC12A4
prerank,vacuolar acidification (GO:0007035),0.5034772360571371,1.4484764071321943,0.052873563218390804,0.38729737382266527,1.0,7/21,11.87%,TMEM9;CLN3;GRN;CCDC115;ATP6V0A2;ATP6V0D2;DMXL2
prerank,regulation of interleukin-1 production (GO:0032652),-0.5452595030136681,-1.4480683355918815,0.06329113924050633,0.2500418716856222,1.0,6/15,26.29%,FOXP1;GAS6;CEACAM1;ANXA1;HMGB1;F2R
prerank,Golgi organization (GO:0007030),-0.35372337178989843,-1.4478633547827675,0.005376344086021506,0.24992717189003236,1.0,36/112,22.28%,ATP8B1;VTI1A;CSNK1A1;COG1;DYM;SYNE1;LRRK2;RAB1A;GOLPH3L;RAB2A;ATL2;MYO18A;SEC16B;USP6NL;PRKD1;YWHAZ;CUL7;FBXW8;GAK;BCAS3;FAM174B;ARFGEF1;CSNK1D;TRAPPC12;VCPIP1;PI4K2B;TBC1D20;LMAN2;GOLPH3;TMED5;HUWE1;TJAP1;HACE1;SEC22B;BET1;GORASP2
prerank,pore complex assembly (GO:0046931),-0.5075958384766036,-1.4477621616869603,0.06060606060606061,0.24961171260346093,1.0,7/19,15.61%,AFDN;AHCTF1;NUP98;ADAM10;ANO6;NUP153;TPR
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5195220523305557,1.4477171228460632,0.06430155210643015,0.38668263950086085,1.0,6/17,18.40%,NLGN1;RAB15;RAB3A;SYT4;CACNA1G;CACNA1I
prerank,protein acetylation (GO:0006473),-0.46216536937180497,-1.44734973136835,0.04684684684684685,0.24980796079558906,1.0,8/30,12.59%,FOXO1;CREBBP;KAT2B;KAT6A;NAA16;NAA80;NAA15;KAT5
prerank,mitochondrion transport along microtubule (GO:0047497),0.5408515983302644,1.4467740099098505,0.0876068376068376,0.3865072648186897,1.0,7/13,25.19%,SYBU;MAP1S;MAPT;NEFL;RHOT1;UBB;SPAST
prerank,regulation of urine volume (GO:0035809),-0.604719153348283,-1.44657642937888,0.07933579335793357,0.25070859439002297,1.0,7/10,38.63%,ADM;NPR1;HYAL2;HAS2;ADCY6;TFAP2B;NPR3
prerank,gene expression (GO:0010467),-0.30920571580375694,-1.4465317350711984,0.0,0.2503404232476775,1.0,130/348,26.48%,RBPMS;MEF2A;SRSF11;NUP42;RPS21;THRB;RRBP1;RBMS1;RPL37;SARNP;RPL31;RAE1;RANBP2;RBM5;TASP1;THOC2;RPL9;RPS14;UPF3B;NUP98;THOC7;UPF2;RBMS2;SEC13;RPSA;POLR2G;AGFG1;TSPAN14;DDX39B;RPLP1;RPL3;MRPL32;NOL9;RPL26;PWP1;RPS11;TAF1B;TSPAN5;HNRNPUL1;DHX38;HNRNPF;XRN2;RBM39;RPL13;TSPAN17;RPL38;SLU7;NUP153;RPL27;RPS16;MRPS18A;DRG1;MCM3AP;RPS4X;RPL10;RPL7A;AGO2;GSPT1;RPL5;HARS2;CREBL2;TPR;APOBEC1;THOC1;THOC3;RPS27;NOX4;MRPL24;SYNCRIP;ADARB1;GOLPH3;RPL27A;NXT1;NUP214;RPS3;RPL35A;TFIP11;RPL36A;RPL37A;SRRM1;MRPS14;FIP1L1;DROSHA;RNPS1;SRSF3;GLE1;MRPS21;RPL32;MRPL35;PTMA;RBM3;WARS1;RBM6;RPS7;RPL36;RPS8;RPL28;RPS15;RPS23;TSPAN33;MRPL34;RPL30;RPL13A;MRPL13;MRPL9;MED20;NUP188;POLDIP3;RPL22;POLR2C;RPS17;ALKBH5;SRBD1;NXF1;POLR2H;MRPL43;SMG6;MLF1;RPL34;RPS2;POLR2L;RPS15A;RPS26;RPL15;MRPL11;HNRNPU;HNRNPL;RPL39;NUP88;HNRNPD
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3807466777483446,-1.446511622210821,0.03759398496240601,0.24989907342617562,1.0,29/76,24.66%,CSNK1A1;CBFA2T3;DAB2;GSK3B;RNF139;LRRK2;SMURF1;RBX1;PTK2;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;CSNK1D;ZER1;SUMO1;ZYG11B;CDK5RAP3;RAD23A;SH3RF2;PTEN;MDM2;KEAP1;RCHY1;CEBPA;HSPA1B;TRIB3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.45814456097769984,-1.4460998966525755,0.05765765765765766,0.25017732979008267,1.0,10/30,16.11%,ACVRL1;BMPR2;STN1;TENT4B;XRN1;DACH1;TP53;CTC1;HNRNPA1;TERF2
prerank,regulation of actin filament polymerization (GO:0030833),-0.3843868772145599,-1.4459896057581132,0.0150093808630394,0.24993447640705438,1.0,25/69,22.51%,KANK3;ESAM;BAIAP2L1;PRKCE;SLIT2;NCK1;PRKCD;SNX9;KANK4;HAX1;FCHSD2;NCK2;ARHGAP28;ARFGEF1;RASA1;LMOD1;CDC42EP3;NCKAP1;HIP1R;GBA2;DBNL;FCHSD1;CDC42EP1;PTK2B;MTPN
prerank,peptidyl-serine modification (GO:0018209),-0.3351192270847872,-1.4451506280919288,0.008756567425569177,0.25088617618918824,1.0,49/166,16.37%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;RPS6KA5;ATM;PAK2;MARK1;LRRK2;MTOR;PRKD2;TLK1;CSNK1G3;NEK6;TGFBR2;GAS6;RICTOR;MAST2;PRKCD;MAST4;MAPKAPK2;PLK2;ROCK1;PRKD1;MAPK1;AKT3;LATS2;CLSPN;AKT1;STK32C;STK38;IKBKE;CSNK1G1;RPS6KA1;ULK2;MKNK2;CSNK1D;MAPK8;PKN2;MARK2;PKN3;MAPK12;RPS6KA3;HIPK1;ROCK2;MARK3;SRPK2
prerank,response to cytokine (GO:0034097),-0.34179379099380797,-1.4434344998576034,0.007142857142857143,0.2532954737119204,1.0,35/141,14.90%,LEF1;IL1R1;OSMR;SP100;NFAT5;PTPN14;MCL1;APP;SETD2;TRIM56;MAP4K3;LDLRAP1;PTPN9;IL6ST;PTPN12;ADAM9;IL6R;GGT5;GCH1;MAPKAPK2;HAX1;LIFR;ADAM10;CASP8;TIMP3;IFITM3;IKBKE;IRAK1;HDAC4;JAK2;RHOA;MAPK8;PLSCR1;PTPN13;CD40
prerank,positive regulation of dendrite extension (GO:1903861),0.5233667721180005,1.4430476142505788,0.056768558951965066,0.39260398461540075,1.0,8/17,14.46%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A
prerank,positive regulation of catalytic activity (GO:0043085),-0.44010666537477544,-1.4427395901468443,0.04788213627992634,0.25402995136560685,1.0,15/37,20.15%,CAV1;XRCC4;PSEN2;ABL1;PHACTR4;PSEN1;BCAS3;NHEJ1;MAPK8;APH1A;SOD1;WRN;NOD2;FGFR4;IGF2
prerank,cellular response to cytokine stimulus (GO:0071345),-0.3021234729043425,-1.4422651459919196,0.0,0.25445007721110197,1.0,154/416,29.23%,LEF1;DAB2IP;IL1R1;ST3GAL6;OSMR;GHR;ITGB1;FOXO1;NFAT5;PTPN14;ZEB1;MCL1;DAPK1;GSK3B;UBE2K;LRCH1;CRK;CCL25;JAK1;LDLRAP1;IFNAR1;PTPN9;SLC12A2;PTPRJ;ICAM1;IL6ST;CDKN1B;PTPN12;MMP2;IL6R;GAS6;NFKB1;TNFRSF1B;PDE2A;STX3;CBL;FOXO3;PIK3R1;IRGM;STAT6;GBP6;LBP;IL34;S1PR1;GRB10;ARHGEF2;YWHAZ;GSK3A;HAX1;LIFR;GREM2;PIK3CD;IRF1;MAOA;TP53;SOCS2;AKT1;IL4R;STAT2;RAPGEF1;LAMA5;IRAK1;JAK2;RHOA;FGF2;GBP4;CSK;MAPK8;HGF;PIK3CB;RC3H1;PDE12;ZFAND6;PTPN13;CD40;FOXC1;ASAH1;GRB2;TPR;USP10;VCAM1;GSDME;BCL2L11;TNFRSF1A;FYN;GBP5;SYNCRIP;GAB2;IRAK2;IL16;CLCF1;IL10RB;HYAL2;ANXA1;IL20RB;CCL19;IKBKB;RPS3;CCND1;IFNGR2;INPP5D;BRCA1;F3;IL13RA1;PTPN11;ITGAM;HSP90AA1;RPL13A;IL3RA;RELA;BCL6;NFE2L2;HAS2;IFNAR2;SHPK;CEBPA;PIM1;RIPK1;CXCL12;PTGIS;DHX9;MAPK11;PIK3CA;GBP3;MT1X;CASP1;IL7;CRNN;IFITM2;ADAMTS7;LCN2;HNRNPU;ERBIN;PTPN2;IL12RB2;CXCL10;TRIM6;HMOX1;BAG4;DUSP1;LGALS9;RORC;IL2RA;CACTIN;PTPN18;AXL;IL22;HYAL3;PLP2;IL2RG;BIRC5;IFNLR1;WNK1;SHMT1
prerank,ribosome biogenesis (GO:0042254),-0.3290171098161685,-1.4417128689981349,0.0034542314335060447,0.2549992072271049,1.0,79/187,29.99%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;PAK1IP1;RPF1;DDX10;EXOSC1;EXOSC2;RPLP1;RPL3;NOL9;RPL26;ESF1;EXOSC3;XRN2;RPL13;RPL38;RPL27;RPS16;UTP3;RPL10;NIP7;RRP1;RPL7A;RPL5;DCAF13;UTP14A;EXOSC8;RPS27;LSG1;RPL27A;RPL35A;WDR74;MDN1;RPL36A;BOP1;RPL37A;EXOSC5;UTP4;DDX31;RPL32;RRS1;PES1;ABCE1;RPS7;RPL36;EBNA1BP2;RPL28;RPS15;RPL30;RPL13A;RCL1;RPL22;RPS17;NOP16;GLUL;NOL8;WDR46;EXOSC7;RPL34;RPS2;NAF1;RPL15;RAN;RPL39;EMG1;WDR12;WDR55;BYSL;UTP20;POP4;RPL19;RPLP2;RPL8;RPL18;FCF1
prerank,regulation of fibroblast migration (GO:0010762),-0.4978830052285279,-1.44167089915801,0.05945945945945946,0.2546102521656255,1.0,9/20,14.76%,ITGB1;RAC1;PRKCE;CORO1C;THBS1;GNA12;PTK2;FGF2;HAS1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.48593368547486876,-1.4415888171690197,0.060109289617486336,0.2542842457304711,1.0,10/23,24.70%,DAB2IP;DVL3;MAP3K5;EDN1;TAOK3;RPS3;SASH1;ARHGEF5;MAP3K7;FZD10
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.43964623630456884,-1.4413707349366796,0.0427807486631016,0.2541199930539872,1.0,16/36,23.84%,LEF1;GNB1;TNRC6B;FZD6;NFATC1;FZD4;PLCB3;PLCB1;WNT11;AGO2;CTNNB1;MOV10;TNRC6A;FZD5;TCF7L2;MAP3K7
prerank,response to estrogen (GO:0043627),-0.45000313212049936,-1.4411114163929035,0.052336448598130844,0.2541048097237409,1.0,10/31,20.15%,CAV1;ESR1;TRIM25;NCOA4;BCAS3;ASH2L;RARA;CITED2;WBP2;BRCA1
prerank,cellular response to oxidative stress (GO:0034599),-0.35486987403707826,-1.440123002216992,0.012567324955116697,0.25541157192290675,1.0,40/118,23.13%,FOXO1;PKD2;DAPK1;LRRK2;EGFR;PXN;FOXO3;ABL1;PYROXD1;PRKCD;PTPRK;JUN;PRKD1;MAPK1;WNT16;TP53;AKT1;PRKAA1;ERO1A;CAT;NCF2;TPM1;MAPK8;MSRA;TXNRD2;ATF4;GPX1;AGAP3;NOX4;SOD1;FANCC;CCS;RPS3;ARNT;ERCC6L2;VRK2;KEAP1;SLC25A24;NFE2L2;TXNRD1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5213820332528302,-1.4401045321995412,0.05545286506469501,0.2549808472145431,1.0,10/20,23.52%,PELI1;BIRC3;CASP8;CFLAR;FLOT1;ASAH1;PDCD6IP;HSP90AA1;OGT;RIPK1
prerank,regulation of apoptotic process (GO:0042981),-0.2919106763523407,-1.4397141205091795,0.0,0.2552523975813543,1.0,172/676,18.76%,HIP1;TJP1;LEF1;UNC13B;GRK5;TEK;DAB2IP;IGF1R;ITGA6;MAP3K20;ITGB1;FOXO1;PPP1R13B;XIAP;AKAP13;CREBBP;DCUN1D3;ERC1;MCL1;DAB2;ARHGEF3;DAPK1;ACER2;TNFAIP8;NET1;THBS1;GSK3B;ATG7;MCF2L;ARHGAP10;ATM;PAK2;MAP3K5;PLEKHG5;KDR;UTP11;TNFSF10;DDX3X;TFRC;CD38;IL6ST;TAX1BP1;NAA16;EGFR;IER3IP1;BIRC3;RBM5;RASGRF2;GAS6;RARG;NFKB1;HDAC1;RYBP;NFKBIA;STK3;DNM2;FAS;DSTYK;SLIT2;CBL;ZBTB7A;PSEN2;FOXO3;ABL1;PIK3R1;ARHGEF12;BMP4;MED1;AATF;MEF2C;PTK2;BNIP3;JUN;RASSF2;ARHGDIA;STEAP3;MYO18A;RNF144B;NGF;MRE11;TGM2;PLK2;BIRC6;NOTCH2;BNIP2;ITSN1;ARL6IP5;FLT4;RAF1;ARHGEF2;ANXA4;YWHAZ;HAX1;SOS2;ADAM10;SH3RF1;LATS2;BCAR1;CRADD;TP53;SOCS2;CASP8;AKT1;FLNA;NAA15;PERP;PRKAA1;CFLAR;AREL1;BRAF;ARHGEF11;PSEN1;SLC27A4;IRAK1;ANO6;COMP;RASA1;CAT;MTDH;RPS6KA1;PA2G4;ACTN1;CTNNBL1;JAK2;SON;ACTN4;WNT11;STPG1;UFM1;TCIM;NDRG1;MAPK8;HGF;RPL10;SPTLC1;RTKN;ERCC3;ZFAND6;ATF4;HIP1R;BABAM2;MIF;RPS6KA3;PRDM9;TRIO;SMAD6;ABR;ARHGEF18;BCL2L11;APH1A;SLK;SIX4;ANGPT1;TFAP4;IGF1;CTNNB1;API5;MAP4K4;GOLPH3;CTSH;PPIF;PREX1;SOD1;WRN;IAPP;CFL1;CITED2;ANXA1;IKBKB;RPS3;SIAH1;SOX4
prerank,positive regulation of cell junction assembly (GO:1901890),0.38914353576273797,1.4381516967306436,0.03619909502262444,0.4018476291633395,1.0,13/56,11.18%,CNTNAP2;PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1;NPHP4;IRX3;VEGFA;LRRC4B;CLSTN2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5258845307945722,-1.4380081125231274,0.0945179584120983,0.2578222781750425,1.0,5/17,11.91%,TEK;BAIAP2L1;ABL1;HAX1;BCAS3
prerank,regulation of dendritic spine development (GO:0060998),0.5002093683461447,1.4379511003909349,0.06196581196581197,0.3998182597941008,1.0,9/19,14.35%,NLGN1;PPFIA2;SHANK1;CAMK2B;TANC2;PTPRS;CPEB3;APOE;GRIN3A
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.39389707786072,1.437934044084492,0.033734939759036145,0.39742488794795217,1.0,11/54,6.63%,KCNIP4;KCNIP1;DPP10;KCNMA1;DPP6;KCNJ3;AKAP6;KCNN2;CD63;GABBR2;CACNA1D
prerank,cellular protein modification process (GO:0006464),-0.28205166530792863,-1.4378319628351666,0.0,0.25764398557503004,1.0,224/982,16.95%,PTPRG;PTPRB;GRK5;PRKCH;PTPRM;PRKG1;FBXL7;ZBTB16;ST3GAL6;IGFBP7;KLHL5;SNRK;ERG;MAP3K20;ACVRL1;BCR;ST3GAL4;DCAF10;ST3GAL1;DCUN1D3;PTPN14;DYRK1A;PPP2R5A;INSR;NEK7;PTP4A2;PPM1H;CSNK1A1;DAPK1;PRKCE;LYN;FAM20A;BMPR2;ST8SIA4;PLOD2;TLK2;THBS1;GSK3B;PRKACB;FBXL12;MTMR3;CDK13;GCNT2;APP;PTPN1;ATG7;RPS6KA5;ZDHHC6;PSMA2;ZC3HAV1;ATM;LIMK2;PAK2;MARK1;MAP3K5;SIK1;ATG10;JAK1;MAP4K3;ALG10B;PTPN9;MAN2A1;LRRK2;RAB1A;MTOR;PRKD2;IGFBP4;TIPARP;CDK17;CUL9;TLK1;FBXL3;PARP4;MERTK;CSNK1G3;PTPRJ;CDK12;DAD1;NEK6;YES1;PTPN12;TGFBR2;B3GNT2;RBX1;RAB2A;GAS6;BMX;PIGT;STK3;STK24;PPEF2;LMO7;ABL1;PPM1L;CUL3;MAST2;DCAF5;SIRT5;BMP4;TGFB2;PRKCD;BRD2;PTPRK;ERN1;OGFOD1;PARP14;ILKAP;PSME2;MAPKAPK2;PRAG1;AAK1;TGM2;CDK10;CDC42BPA;CUL2;PLK2;NAA80;PDIA6;ROCK1;PPM1F;MTMR6;BIRC6;PRKD1;MAPK1;MAML1;RAB5A;SETD3;PHKA2;LOXL1;PSMB4;YWHAZ;GSK3A;WSB2;ST3GAL2;AKT3;ADAM10;PIK3CD;ACVR2A;LATS2;PXK;PPM1B;UBA7;FEM1A;UBE2D3;SOCS2;SPSB1;FUT10;AKT1;WNK4;SIK3;PRKAA1;CUL7;FBXW8;FRK;FNIP2;TAOK3;UBLCP1;PPP1R12A;STK10;ILK;ITIH2;ERO1A;BRAF;STK38;IKBKE;IRAK1;KLHL13;WIPI1;PTPN3;LRRC41;JAK2;MSLN;ANO8;PRKCSH;NOTUM;CLK3;CCDC8;WNT11;ASB1;CTTNBP2NL;CSK;MKNK2;FEM1C;CSNK1D;UBE2E2;MAPK8;PKN2;SIRT3;KLHL25;FBXW11;MSRA;PSMC2;LIPE;HIF3A;PTPN13;PSMB2;BTBD1;FEM1B;CDK6;MARK2;SERPINC1;PKN3;ATG5;UBE2M;ERCC8;ABCA7;GMFB;F5;PTAR1;HIPK1;ROCK2;MARK3;DCAF13;PSMB1;IGFBP5;SRPK2;B4GALT5;FYN;PPP2CB;RAB11A;RARA;UBE2L3;CDC42BPB;KLHL3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5656163020090896,-1.4377924987495982,0.07446808510638298,0.25722630724224876,1.0,11/13,35.45%,IFIH1;GAS6;AGPAT1;MAVS;TAF9;DHX9;IL7;TRIM44;AXL;CD74;TSLP
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4661953180157327,-1.4375866695696315,0.04291044776119403,0.2570916344322168,1.0,13/28,23.84%,TAB3;NOD1;OTULIN;IRGM;CASP8;IRAK1;TAB2;TNFAIP3;IRAK2;IKBKG;NOD2;RELA;MAP3K7
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5262135495896596,-1.4371462286703893,0.07207207207207207,0.25733825647808956,1.0,6/16,13.17%,BMPR2;ACE;PLCB3;GSK3A;ADM;PRCP
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.5677350488531443,-1.4366631075889782,0.10611510791366907,0.25776939405909033,1.0,7/12,24.26%,CAV1;IFIH1;FLOT1;CGAS;MAVS;RALB;DHX9
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5734658570885593,-1.4366002218232616,0.0661764705882353,0.2574308806753827,1.0,2/12,1.51%,FOXP1;KLF4
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3955757770025845,-1.4364316290340629,0.04553415061295972,0.2572691051905529,1.0,16/56,12.64%,FLT1;TEK;DYRK1A;INSR;ABI1;LYN;KDR;EGFR;ABL1;PTK2;EPHA4;TPST2;FLT4;ABI3;PKDCC;JAK2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.39530086049573765,-1.4363897229715874,0.03754266211604096,0.25686819031776087,1.0,26/62,25.76%,ZBTB16;CREBBP;CBFB;LYN;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;CDC73;ASH2L;H3-3A;CDK6;KMT2C;MOV10;TNRC6A;PTK2B;WDR5;RBM15;LEO1;RBBP5;MYL9
prerank,telomere organization (GO:0032200),-0.42196125492655695,-1.4363431817091907,0.04838709677419355,0.2565032440249768,1.0,19/43,21.68%,SP100;STN1;ATM;MRE11;DOT1L;POLD3;RPA3;DNA2;RPA1;CTC1;PTGES3;H3-3A;TERF2;WRN;RPA2;PRKDC;DCLRE1B;BLM;TERT
prerank,telomere maintenance (GO:0000723),-0.4047468171594745,-1.435996725375603,0.028368794326241134,0.2567046136038258,1.0,20/50,21.68%,SP100;STN1;ATM;SMC5;MRE11;POLD3;NSMCE2;RPA3;DNA2;RPA1;CTC1;PTGES3;TEP1;TERF2;WRN;RPA2;PRKDC;DCLRE1B;BLM;TERT
prerank,rRNA metabolic process (GO:0016072),-0.3383464012851933,-1.435866914075756,0.008865248226950355,0.25647883711331043,1.0,70/160,29.99%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;DDX10;XRN1;EXOSC1;EXOSC2;RPLP1;RPL3;NOL9;RPL26;ESF1;EXOSC3;XRN2;RPL13;RPL38;RPL27;RPS16;UTP3;RPL10;RRP1;RPL7A;RPL5;DCAF13;UTP14A;EXOSC8;RPS27;RPL27A;RPL35A;WDR74;MDN1;RPL36A;BOP1;RPL37A;EXOSC5;UTP4;RPL32;PES1;RPS7;RPL36;EBNA1BP2;RPL28;RPS15;RPL30;RPL13A;RCL1;RPL22;RPS17;NOL8;WDR46;EXOSC7;RPL34;RPS2;RPL15;RPL39;EMG1;WDR12;WDR55;BYSL;UTP20;POP4;RPL19;RPLP2;RPL8;RPL18;FCF1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4531749442036498,-1.4357603397681364,0.05381944444444445,0.2561714922007156,1.0,11/32,21.45%,SORBS1;ZBTB20;ADIPOR2;MTOR;PPARA;AKT1;CEACAM1;ASAH1;CREBL2;STAR;CREB1
prerank,response to ketone (GO:1901654),-0.4771504431990147,-1.435369011003555,0.045112781954887216,0.2563700867391414,1.0,7/24,10.44%,ABHD2;CAV1;THBS1;TGFBR3;SLIT2;TGFB2;YAP1
prerank,regulation of signal transduction (GO:0009966),-0.32712886943588393,-1.4352436967344038,0.006802721088435374,0.2561096469536168,1.0,51/190,17.57%,GRK5;IGFBP7;SP100;RSPO3;CREBBP;RGS3;CBFB;ELF1;BRAP;ESR1;RGS5;GIT2;ITGA3;APP;PTPN1;CRK;FBXL17;LRRK2;IGFBP4;ZDHHC3;PXN;PLCB1;RGS12;NCK1;CD55;PLCE1;WDR11;PRAG1;TMEM204;PRKD1;LIFR;SOCS2;MDFIC;MFNG;ILK;NCK2;MGLL;IRAK1;GALNT11;CSK;PLSCR1;TCF7L1;FUZ;CASTOR1;SENP2;KIF26A;IGFBP5;FYN;NCLN;UBASH3B;IRAK2
prerank,synaptic vesicle recycling (GO:0036465),0.45157856180546246,1.4350580298181987,0.049107142857142856,0.40197940887746525,1.0,6/31,6.10%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,regulation of MAP kinase activity (GO:0043405),-0.3655906438124041,-1.4335071775233301,0.023636363636363636,0.2587453479657565,1.0,29/92,18.60%,FLT1;DAB2IP;LYN;PDGFD;PTPN1;LRRK2;PTPRJ;CDK12;EGFR;PPEF2;BMP4;FGF1;PRKCD;IL34;TPD52L1;EDN1;PIK3R6;STK38;IRAK1;FGF2;EDN3;PIK3CB;KSR1;SPRY4;CD40;BMP7;CDK5RAP3;HYAL2;NOD2
prerank,negative regulation of GTPase activity (GO:0034260),-0.4930103954502096,-1.4333737601443362,0.0684931506849315,0.25850657720190373,1.0,8/22,11.99%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;RASA4;BCAS3;ARFGEF1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5293985417883145,-1.4333668069012417,0.08070175438596491,0.2580532043662837,1.0,9/15,29.63%,EHD2;ADAM9;EHD1;FLOT1;CD53;RAPGEF3;ADGRB1;TREM2;MAPK14
prerank,protein modification by small protein conjugation (GO:0032446),-0.30328492866304574,-1.431969367122188,0.0,0.259983085772504,1.0,112/361,23.20%,FBXL7;WWP1;DCUN1D3;USP9X;BRAP;NEDD4L;CBLL1;SMURF2;IFIH1;UBE2K;ATG7;RNF139;NUP42;FBXL17;CNOT4;ATG10;RNF111;DTX3L;ZNRF3;SMURF1;CUL9;FBXL3;RAE1;TRPM4;RNF213;RANBP2;UBA2;RBX1;LMO7;RNF43;OTULIN;CBL;CUL3;NEDD4;NUP98;RNF40;CUL2;UHRF2;BIRC6;ARRDC1;UBE2J2;DET1;UBA7;UBE2D3;SPSB1;PDZRN3;UBR2;MIB1;RNF25;CUL7;FBXW8;TRIM14;AREL1;TNFAIP1;TSPAN17;KLHL13;CDC16;NSMCE2;RAD18;ANAPC16;RTF1;CDC73;NUP153;ASB1;UFM1;PIAS2;KLHL25;FBXW11;HIF3A;RNF168;UBE2V2;DTX3;UBE2M;PEX14;TPR;VCPIP1;DCUN1D2;MIB2;SUMO1;RFWD3;HERC2;MYLIP;UBE2L3;KLHL3;EPAS1;TRIM13;RNF152;KCTD10;CDK5RAP3;NUP214;UBR1;SDE2;HUWE1;WWP2;PIAS4;ELOC;TRIM47;USP7;PRKDC;BRCA1;TRIM28;HACE1;DCUN1D5;CAND2;MOCS3;UBE2R2;MDM2;KEAP1;TRIM39;NFE2L2;RCHY1;TRIM68
prerank,regulation of cellular pH (GO:0030641),0.44806164577029867,1.4307324482434203,0.05,0.4100236756910625,1.0,7/29,5.62%,CA2;SLC4A4;SLC4A5;SLC9A7;CLN3;SLC9A9;SLC4A2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5766872277983958,-1.4295221884673934,0.07777777777777778,0.26389929779923665,1.0,6/12,14.59%,BMP5;PLCB1;SLIT2;WASL;AKT1;CCN3
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.464116920640083,-1.4289533407378097,0.06486486486486487,0.2644719311153131,1.0,11/27,24.56%,MAP3K20;MAP3K5;NFKB1;MAPK1;MAP3K8;MAPK8;FBXW11;IKBKG;IKBKB;MAP3K7;MAPK11
prerank,heterochromatin organization (GO:0070828),-0.5652416940037948,-1.4283360915422452,0.06398537477148081,0.26507405608446954,1.0,2/14,3.12%,MECOM;PRDM16
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5440836791225079,-1.4270905683970088,0.08166969147005444,0.26680246933802193,1.0,5/15,6.61%,EDA;TBX1;ANKRD11;HDAC1;LRP6
prerank,sterol biosynthetic process (GO:0016126),0.43240707989410126,1.426305375926157,0.0518018018018018,0.4182062318212728,1.0,12/33,14.32%,IDI2;INSIG1;LSS;SC5D;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4343622134644822,1.4260541275938088,0.06651376146788991,0.4163217290263059,1.0,12/33,14.08%,OMA1;MPV17L;PSMD10;PRELID1;FLCN;TRIAP1;MAPT;TMEM14A;FZD9;GHITM;CLU;ADCK1
prerank,negative regulation of response to stimulus (GO:0048585),-0.38931716166819885,-1.4255258417270706,0.03339517625231911,0.2694380222662379,1.0,19/60,21.68%,KLF7;KLF4;CD34;BRAP;LYN;PTPN1;SLC30A10;SLIT2;AQP11;AKT3;MAP3K3;VPS13C;CDK6;TERF2;KIF26A;UBASH3B;LPCAT3;MAPK7;TERT
prerank,synaptic vesicle membrane organization (GO:0048499),0.5117669693508292,1.4253471144376968,0.059734513274336286,0.4155087528732733,1.0,5/17,12.95%,SNAP25;STX2;PRRT2;SYP;SYNGR1
prerank,pentose-phosphate shunt (GO:0006098),0.5877481797082288,1.4251110491597117,0.08501118568232663,0.41366619478790156,1.0,6/11,17.99%,PGLS;H6PD;TKT;RPIA;PGD;PGM2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.46464122997899415,-1.4250084218124135,0.0542907180385289,0.2699609843701365,1.0,12/25,27.59%,ZNF326;SETD5;EAF1;LDB1;DDX39B;THOC1;ZMYND11;SUPT4H1;TCEA2;CCNK;ERCC6;HTATSF1
prerank,regulation of gene expression (GO:0010468),-0.2815702509467259,-1.4249519782626785,0.0,0.26962349235608035,1.0,231/903,20.22%,FOXP1;LEF1;MBNL1;APBB2;NFIA;RREB1;SMARCA2;CLDN5;MBNL2;ENG;ZNF423;ACVRL1;RB1;AFF1;CREBBP;NSD1;BNC2;NOS3;UBR5;ERC1;KAT6B;INSR;KLF4;ETS1;CD34;ESR1;LYN;FOXN3;ZFHX3;TNRC6B;SLC7A5;PRDM5;MED26;IRF2;LIMS1;GSK3B;ZNF326;GCNT2;APP;RPS6KA5;WWC2;ATM;NR3C1;ZSCAN21;SOX13;KDR;AHNAK;DDX3X;MTOR;MITF;TIPARP;SOX17;TFRC;PSPC1;SMO;BMP6;HMG20B;SP1;VSX1;METTL4;MSN;ZNF148;LIMD1;LARP1;CTCF;GAS6;SIX1;AFDN;NOVA2;NFKB1;HDAC1;RYBP;PDE2A;DNM2;TRRAP;ABL1;NFYC;AHNAK2;BMP4;FGF1;MED1;TGFB2;FUS;EZR;MEF2C;ZBTB4;CDH5;SLC39A8;NSD3;GTF2IRD1;PARP14;NGF;ASCC1;ACTA2;RAB27A;SMAD1;KDM6A;PUM1;SEC16B;ZC3H7B;ROCK1;PPM1F;MAPK1;NOTCH2;CDH1;LDB1;HNRNPAB;OCLN;NAB1;PLCG2;GSK3A;PICALM;RAMP2;GPBP1;ADAM10;PIK3CD;USP13;PRDM2;WNT16;SPTY2D1;MYOM1;TP53;CELF1;NOS1AP;SP3;CASP8;AKT1;PRDM6;KDM6B;HMG20A;YAP1;POGZ;PRKAA1;FGF7;SNX12;TRIM14;SOX7;RGCC;BRAF;DICER1;JMJD1C;MAZ;HNRNPF;CHD3;HFE;SFPQ;PSEN1;PRRX2;HDAC4;NOTCH1;OGG1;SON;YAF2;CLK3;FGF2;WNT11;EDN3;ZPR1;TAF5L;MAPK8;PIK3CB;GPBP1L1;PLSCR1;RC3H1;MECP2;RBM20;ICOSLG;MARF1;AGO2;ATF4;MZF1;CDK6;HCFC1;GPX1;MYBL2;FAM98A;MIF;RPL5;FOXC1;PIK3R3;ZNF462;LGMN;PRDM9;VSIR;CREBL2;TCF3;TCF7L1;NR1D2;FOXO4;TADA3;ROCK2;NAB2;HIC1;TERF2;DNMT1;SRPK2;BMP7;ANGPT1;HDAC6;UBE2L3;IGF1;HDAC10;MOV10;HEY2;CTSH;HEY1;HINT1;PATZ1;CITED2;ZNF507;GATA2;RPS3;TNRC6A;SOX4;WWP2;WTIP;KRAS;PPP2CA;CARM1;FUBP1;ATRX;CAVIN4;PRKAB1;PTPRC;UTP4;FGFR4;ZSCAN26;IGF2;BRCA1;F3;TOB1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4451138908324118,-1.4249246852340145,0.05172413793103448,0.26922245995271626,1.0,16/32,25.42%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TAOK3;BABAM2;BRCC3;CDK5RAP3;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.35629028117899664,-1.4247382091478045,0.01950354609929078,0.26911917483285047,1.0,38/100,24.66%,EIF3H;CSNK1A1;CBFA2T3;DAB2;TLK2;GSK3B;FHIT;LRRK2;RBX1;GNA12;RYBP;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;HFE;FOXF2;CSNK1D;ZER1;N4BP1;SUMO1;ZYG11B;GIPC1;RAD23A;USP7;HERPUD1;SH3RF2;MDM2;KEAP1;TRIM39;OGT;RCHY1;CEBPA;HSPA1B;TAF9;TRIB3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.4754754615827074,-1.4238809738943885,0.0686456400742115,0.27021286843472225,1.0,11/24,26.32%,TAB3;NOD1;CASP8;IRAK1;TAB2;TNFAIP3;IRAK2;IKBKG;NOD2;MAP3K7;RNF34
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5676688151122466,-1.4237214649844359,0.0990990990990991,0.2700860075819876,1.0,6/12,25.13%,HES1;EPHA4;NOTCH1;CLCF1;BMP2;SERPINE2
prerank,positive regulation of receptor internalization (GO:0002092),0.46365104047069783,1.42366584834325,0.07042253521126761,0.4148006978904352,1.0,5/22,9.26%,MAGI2;CD63;ATAD1;AHI1;VEGFA
prerank,adherens junction organization (GO:0034332),0.3985339157244897,1.4236293089286034,0.032119914346895075,0.4124624275874193,1.0,18/48,12.79%,CDH18;CADM2;CDH8;CDH20;CDH9;CDH10;INAVA;DCHS1;CDH19;CDH12;ANG;NECTIN3;CDH7;CDH24;CDH17;CDHR3;CDH2;JAM3
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.3342223721231622,-1.423140892852395,0.008319467554076539,0.27072868699680963,1.0,60/166,25.90%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;NR3C1;TEAD1;THRB;NOTCH3;PPARA;RARG;HDAC1;MED1;POLR2G;MAML1;NOTCH2;GTF2E2;GTF2E1;PPARD;ERCC2;TAF11;NOTCH4;YAP1;TAF1B;BRF1;MAZ;MED17;NOTCH1;TAF1C;ERCC3;TAF8;NR1D2;CAVIN1;NR2C1;TAF7;RARA;HDAC10;TAF3;NCOA6;HDAC7;TBL1X;PPARG;MED27;TAF4B;UBTF;RARB;TAF13;RXRG;POLR2C;TAF9;TAF15;POLR2H;POLR2L;TAF1D;E2F3;POLR1E
prerank,regulation of protein kinase activity (GO:0045859),-0.3516001649708116,-1.4231114643808223,0.007142857142857143,0.27031373737480335,1.0,36/106,21.92%,RAPGEF2;RB1;IQGAP1;CEP85;PAK2;RTRAF;GAS6;MRNIP;LRP6;PLCE1;RAP1A;PTK2;RASSF2;SNX9;PPM1F;MMD;PRKRIP1;AKT1;CEACAM1;CHP1;TAB2;TAF7;UBASH3B;SOD1;ALS2;CENPE;CCL19;RAP2C;CACUL1;PTPRC;AKT1S1;WARS1;MAP2K3;CCN1;PTK2B;NF1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.37579013449185344,-1.4229847298036724,0.028021015761821366,0.270059259559191,1.0,30/72,26.43%,SP100;ACER2;ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;CRADD;TP53;RGCC;KAT5;NDRG1;BTG2;USP10;TFAP4;SOX4;CARM1;ATRX;MDM2;CASP2;GADD45A;E2F7;ARID3A;CNOT2;CNOT8;PLK3;TFDP1;CNOT1
prerank,COPII-coated vesicle budding (GO:0090114),-0.37598729958838273,-1.422660647595284,0.036036036036036036,0.2702179744102823,1.0,26/68,22.69%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;CUL3;SEC24A;SEC16B;SEC13;KLHL12;SEC24D;SCFD1;PPP6R3;CSNK1D;SEC23B;F5;CTSZ;TBC1D20;TFG;VAPA;PREB;SEC24C;SEC22B;BET1;SAR1A
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.40564274304482717,-1.4226052697953304,0.039783001808318265,0.2698544951927021,1.0,26/51,29.42%,CRIM1;BMPER;BMPR2;SMURF2;SMURF1;SKIL;SMAD1;SMAD4;GREM2;ACVR2A;UBE2D3;SMAD7;NOTCH1;SMAD6;SKI;DAND5;SMAD9;HTRA3;PPARG;CHRDL1;ACVR2B;BMP2;RBPMS2;FBN1;LRP2;BAMBI
prerank,axoneme assembly (GO:0035082),0.4437185865695703,1.4225914325947446,0.07158836689038031,0.41266945611547956,1.0,10/30,17.14%,DNAAF3;CFAP74;SPAG1;DNAAF1;DCX;DNAI4;FOXJ1;GAS8;SPAG17;DNAAF2
prerank,apoptotic process (GO:0006915),-0.3234870577324984,-1.4215761338944255,0.003430531732418525,0.27127421367399795,1.0,73/203,25.67%,HIP1;ZBTB16;SEMA6A;FOXO1;DAPK1;PRKCE;YARS1;CASP12;APP;ELMO1;TBX1;MAGI3;MTOR;PLAGL1;TGFBR2;KREMEN1;NFKBIA;STK3;PDCD4;FAS;DDIT4;PRKCD;BNIP3;RFK;NOTCH2;BNIP2;RAF1;PPARD;IER3;ERCC2;IRF1;CASP8;AKT1;CFLAR;TNFAIP1;JAK2;ERCC3;PLSCR1;NCKAP1;FEM1B;TNFRSF19;BBC3;THOC1;BCL2L11;RNF152;DAP;IAPP;IKBKG;PAEP;SIAH1;BRAT1;PPP2CA;TNFRSF25;LIG4;CDK11B;CHEK1;PTK2B;MDM2;CASP2;BIK;OGT;GADD45A;RIPK1;AKAP1;MAP3K7;AHCYL1;PIK3CA;FXR1;PLK3;CASP1;MAGEH1;TNFSF12;DMPK
prerank,regulation of secretion by cell (GO:1903530),0.3839846654082135,1.4212738519108812,0.038636363636363635,0.4133015820308246,1.0,10/54,11.93%,STXBP5L;SYT1;RIMS2;RIMS1;RAB15;SYN1;RAB3C;MCTP2;RAB3A;LLGL1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5925805426040586,-1.4207952962628374,0.0913884007029877,0.2720638980101393,1.0,6/11,32.55%,MFHAS1;LYN;TNFAIP3;TREM2;TLR6;TLR1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.4948264149936025,-1.420598452449548,0.07253886010362694,0.27191588645367964,1.0,11/20,31.24%,ADAM9;NFKB1;PSEN2;ADAM10;PSEN1;APH1A;RELA;ADAM17;RHBDD1;MBTPS1;TGFB1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3618553558751166,1.4203835163271883,0.040268456375838924,0.4130612352542209,1.0,16/76,11.53%,GRM5;CHRM2;HTR2C;OPRM1;CALCA;PTGER3;HOMER1;TRHR;GRM1;C3AR1;GPR65;ADRA2A;ADRA1D;ADRA1A;TACR1;NMUR2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4136054875112899,-1.4203748604350013,0.04712041884816754,0.27183396065375526,1.0,12/43,15.42%,DAB2IP;EPS15;ITGA1;RAB7A;PTPRJ;EGFR;CBL;EPS15L1;RNF115;PTPN3;DUSP3;GRB2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4044522024778374,-1.4201982152280168,0.04475043029259897,0.2716955826989472,1.0,17/50,17.49%,IGF1R;PLCB4;PLCB3;PLCB1;PIK3R1;IRS1;PLCE1;EZR;PI4KB;PIK3C2A;NGF;PIK3CD;RHOA;PIK3CB;TNFAIP8L3;IGF1;GAB2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5498264157368126,1.4198151326088393,0.08215962441314555,0.41217082375842085,1.0,4/12,8.22%,TMEM9;CLN3;GRN;CCDC115
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3754621811673729,-1.4195050455147245,0.030874785591766724,0.27249218565496147,1.0,17/74,11.42%,LEF1;DAB2IP;FERMT2;DAB2;IL17RD;GCNT2;BMP5;SPRED2;MTOR;TGFBR2;LDLRAD4;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;SMAD7
prerank,positive regulation of cell death (GO:0010942),-0.3924607321505028,-1.4191203282367288,0.04981549815498155,0.2727032636264735,1.0,13/59,10.97%,SLC6A6;ACER2;GSK3B;MAP3K5;LRRK2;CDKN1B;RARG;DDIT4;BMP4;BNIP3;PICALM;CELF1;AXIN2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.475287828007388,-1.4187219523524395,0.056338028169014086,0.272891909986395,1.0,11/23,22.72%,UACA;TMSB4X;DDX3X;NMI;PPM1B;CCN3;IFI35;C1QTNF3;BMP7;HDAC7;RELA
prerank,RNA 3'-end processing (GO:0031123),-0.3727858628194853,-1.4186596629912964,0.039792387543252594,0.2725402877431653,1.0,21/69,20.29%,SRSF11;TUT7;TENT4B;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;TENT4A;CPSF7;DHX38;TUT4;SLU7;TENT2;THOC1;THOC3;SRRM1;FIP1L1;RNPS1;SRSF3
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4280782159717945,1.4179028679878856,0.06073752711496746,0.4144947397576755,1.0,7/32,6.07%,PTPRD;IL1RAPL1;ADGRB3;HECW1;CDKL5;TNIK;HECW2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.40329134074422784,1.4177939090753766,0.043478260869565216,0.41249071369225315,1.0,9/41,7.56%,SLC24A2;HTR2C;GRIN2B;RYR3;CACNA2D1;ATP2B4;GRIN2A;SLC8A2;RYR2
prerank,smooth muscle cell differentiation (GO:0051145),-0.5704576488349904,-1.41775160398146,0.07441016333938294,0.2736631852787184,1.0,7/12,21.97%,MRTFB;BMP4;MEF2C;TMEM204;HEY2;HEY1;MYOCD
prerank,rRNA processing (GO:0006364),-0.32738162080135236,-1.4164479418428877,0.01680672268907563,0.27551442215342853,1.0,73/172,29.99%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;RRP15;DDX10;NOP2;EXOSC1;EXOSC2;RPLP1;RPL3;NOL9;RPL26;ESF1;EXOSC3;XRN2;RPL13;RPL38;RPL27;RPS16;UTP3;RPL10;RRP1;RPL7A;RPL5;DCAF13;UTP14A;EXOSC8;RPS27;RPL27A;RPL35A;WDR74;MDN1;RPL36A;BOP1;RPL37A;EXOSC5;UTP4;PRKDC;RPL32;PES1;RPS7;RPL36;EBNA1BP2;RPL28;RPS15;RPL30;RPL13A;RCL1;RPL22;RPS17;NOL8;WDR46;EXOSC7;RPL34;RPS2;RPL15;RPL39;EMG1;WDR12;WDR55;RIOK3;BYSL;UTP20;POP4;RPL19;RPLP2;RPL8;RPL18;FCF1
prerank,positive regulation of MAPK cascade (GO:0043410),-0.31353282879761524,-1.4156472281930295,0.005050505050505051,0.2765443541109848,1.0,62/245,16.90%,FLT1;TEK;DAB2IP;IGF1R;JCAD;RAPGEF2;FERMT2;INSR;BMPER;ROR1;MFHAS1;PDGFD;SEMA7A;IQGAP1;ADRA1B;GCNT2;APP;TBX1;CCL25;KDR;LRRK2;PRKD2;PTPRJ;ICAM1;EGFR;SLC30A10;MID1;GAS6;DSTYK;FGF1;TGFB2;RAP1A;ROCK1;NOTCH2;ARL6IP5;FLT4;IL34;PLCG2;TPD52L1;EDN1;HTR2A;PIK3R6;TAOK3;BRAF;IRAK1;NOTCH1;SEMA4C;FGF2;EDN3;ACKR3;KSR1;P2RY6;CD40;MIF;ABCA7;TNFAIP8L3;ROCK2;MTURN;GSDME;ANGPT1;IGF1;PELI2
prerank,Golgi localization (GO:0051645),-0.5828240956420284,-1.4154375875635543,0.09769094138543517,0.27646443175186236,1.0,5/11,17.45%,ARCN1;COPG1;YWHAZ;TBCCD1;RIPOR1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4454397732155843,1.415416033713728,0.03712871287128713,0.4160260657429728,1.0,13/28,20.30%,MAP1S;MAP2;MAPT;STMN2;MAP1B;MAPRE3;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP1A;STMN3
prerank,copper ion transport (GO:0006825),-0.5773309538968278,-1.41539532784218,0.09289617486338798,0.2760646094891011,1.0,8/11,34.37%,ATOX1;SLC31A1;STEAP3;COX17;ATP7B;STEAP2;STEAP4;CUTC
prerank,neuron projection development (GO:0031175),0.32038190683099316,1.4149715600886945,0.009852216748768473,0.4147921537067794,1.0,43/168,13.72%,CNTNAP2;NLGN1;L1CAM;RASGRF1;BLK;PPP1R9A;CNTN4;CTNND2;GPM6B;SH3GL2;TMEM108;DOCK10;EPB41L3;CDK5;SHTN1;EPHB1;NBL1;SHANK1;PLP1;TNIK;ATXN10;MAP1S;PAK3;MAP2;NPY;PAK1;GPM6A;NYAP2;NEFH;MAPT;POU4F1;TSKU;GRM7;MINK1;STMN2;ZFYVE27;SRGAP2;DLG4;OMG;GAS7;SGK1;APOE;BDNF
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2913510385485442,-1.4147511856135646,0.0,0.27673014043061667,1.0,185/532,29.16%,IL1R1;OSMR;GHR;SP100;ITGB1;FOXO1;PELI1;EDA;ZEB1;MCL1;TAB3;NOD1;TMSB4X;IRF2;TRAF5;LIMS1;ANXA2;TRIM25;ADIPOR2;RPS6KA5;PSMA2;CRK;PAK2;IL15;CCL25;JAK1;IFNAR1;CAMK2G;PTPRJ;ICAM1;IL6ST;CDKN1B;MSN;BIRC3;MID1;MMP2;RBX1;IL6R;SAMHD1;NFKB1;TNFRSF1B;NFKBIA;PDCD4;STX3;PLCB1;CBL;FOXO3;PIK3R1;IRS1;PRKCD;STAT6;TCP1;PSME2;LBP;RAP1B;TXNDC17;IL34;S1PR1;GRB10;PSMB4;YWHAZ;SMAD4;LIFR;GREM2;PIK3CD;IRF1;MAOA;TP53;SOCS2;AKT1;MAP3K3;YAP1;IL4R;STAT2;ILK;RAPGEF1;HNRNPF;IFITM3;LAMA5;IRAK1;CEACAM1;JAK2;FGF2;ACTN4;EIF5A;CSK;LCP1;ACKR3;IL17RA;MAP3K8;HGF;PIK3CB;FBXW11;PSMC2;PSMB2;IL17RE;CD40;MIF;IFI35;FOXC1;TALDO1;GRB2;TNFRSF11B;VCAM1;TAB2;PSMB1;BCL2L11;TNFRSF1A;FYN;PELI2;GAB2;IRAK2;SOD1;PSMA8;IL16;IKBKG;CFL1;CLCF1;TNFSF13;IL10RB;PSME1;ANXA1;IL20RB;CCL19;IKBKB;NOD2;CCND1;EDAR;IFNGR2;TNFRSF25;INPP5D;F3;IL13RA1;PTPN11;PSMD4;TNFSF8;ITGAM;PITPNA;PTK2B;LTBR;HSP90AA1;IL3RA;RELA;BCL6;FCGR1A;IFNAR2;TRIM68;CEBPA;PIM1;RIPK1;PSMD5;MAP3K7;CXCL12;MAP3K14;PIK3CA;CASP1;IL7;TNFSF12;IFITM2;PSMA3;LCN2;ADAM17;FCER1G;IL15RA;PSMB10;IL12RB2;CD300LF;IRF7;CXCL10;BST2;MTAP;TNFRSF9;HMOX1;TNFRSF12A;CNN2;BAG4;RSAD2;RORC;IL2RA;IL22;OASL;PLP2;IL2RG;BIRC5;IFNLR1
prerank,negative regulation of developmental process (GO:0051093),-0.3785881950846162,-1.4144034399895569,0.025830258302583026,0.27689658613037094,1.0,24/69,18.90%,KLF7;NFIB;NOS3;TBX1;TFRC;GAS6;ARHGEF15;BMP4;SUZ12;BNIP3;ROCK1;TBX2;NOTCH4;NOTCH1;WNT11;RC3H1;CDK6;MIF;FOXC1;FUZ;ROCK2;HEY2;HEY1;HUWE1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.41739792170909495,-1.4144025933070599,0.03467153284671533,0.27643178209056013,1.0,16/43,22.69%,SORBS1;PTPN1;PIP4K2A;NCK1;IRS1;PRKCD;PIP4K2B;GRB10;GRB14;GSK3A;SLC27A4;TNS2;GKAP1;IGF2;PTPN11;OGT
prerank,external encapsulating structure organization (GO:0045229),-0.3162439562414152,-1.4143032431816693,0.008576329331046312,0.27613075193592795,1.0,62/205,16.20%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;THBS1;ADAMTS2;COL4A6;ITGA3;APP;VIT;F11R;SPOCK2;SMOC1;ITGA1;KDR;ITGB4;ICAM1;COL5A1;MMP2;LAMA4;LAMA3;COL4A5;ITGB5;COL8A2;SLC39A8;AGRN;HRNR;CDH1;COL5A2;LOXL1;COL4A1;ADAMTS9;HSPG2;ADAMTS4;FBLN5;THSD4;ADAMTS10;ADAMTS17;ADAMTS20;LAMA1;ADAMTS5;LAMA5;BGN;COMP;ITGA4;FGF2;LAMC3;ICAM2;COL6A3;NID1;SMOC2;COL6A2;ITGA2;VCAM1;GFOD2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.43772840129166174,-1.4139769397891926,0.056466302367941715,0.27624409727993565,1.0,16/31,36.99%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;TOMM70;PEX26;AIFM1;PAM16;DNLZ;TIMM23
prerank,cholesterol metabolic process (GO:0008203),0.3682861150917575,1.4137684314110832,0.022675736961451247,0.4153807668531455,1.0,29/68,21.52%,IDI2;AKR1D1;CYP46A1;INSIG1;PIP4P1;SULT2B1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;CYP27A1;TSKU;OSBPL5;CYP11B1;FDFT1;DHCR24;ABCA5;APOE;IDI1;CLN8;SOAT2;ACAT2;HMGCS1;MVK;SOAT1;ABCG1;ANGPTL3
prerank,aortic valve morphogenesis (GO:0003180),-0.4524157723487607,-1.4135200919936983,0.06469500924214418,0.2766016862806702,1.0,14/30,17.56%,ELN;RB1;NOS3;TIE1;NFATC1;SLIT2;BMP4;ROCK1;NOTCH1;SMAD6;ROCK2;JAG1;HEY2;HEY1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.36170753922724386,-1.4132543832683044,0.015517241379310345,0.27661830097384194,1.0,26/87,15.79%,ESAM;EPS8;RAC1;RHOBTB1;IQGAP1;F11R;CRK;RND3;MTOR;RICTOR;ABL1;RHOQ;PRKCD;EZR;ARHGDIA;CDK10;ROCK1;NOTCH2;FAM107A;ARHGAP17;ABI3;RHOA;RHOG;RHOC;HIP1R;ROCK2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.43904528226064277,1.4130572628815063,0.06666666666666667,0.4149265986985503,1.0,14/30,20.21%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1;ACAT2;HMGCS1;MVK
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4674537357569899,-1.411330564319376,0.054003724394785846,0.2796050516080757,1.0,12/26,23.39%,SETD2;KMT5B;TET2;SETD5;SUV39H1;SETD3;PRDM9;ANTKMT;WDR82;TET3;OGT;BEND3
prerank,negative regulation of macrophage activation (GO:0043031),0.5167748818994604,1.4106105494649628,0.08647450110864745,0.41851652643517545,1.0,7/16,18.47%,LRFN5;NR1D1;SYT11;GRN;LDLR;FCGR2B;CX3CL1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5439400914729672,-1.4106031759840814,0.08363636363636363,0.2805139978319022,1.0,4/13,14.39%,KPNA4;RANBP2;KPNA3;KPNA1
prerank,cell differentiation in spinal cord (GO:0021515),0.5860548162264104,1.4103790616456306,0.09655172413793103,0.41671841120622677,1.0,3/10,4.22%,MDGA2;LHX1;MDGA1
prerank,regulation of cholesterol storage (GO:0010885),-0.5344477202741639,-1.408576831518387,0.07238095238095238,0.283623756760076,1.0,6/15,21.05%,PPARA;SCARB1;PPARD;EHD1;LPL;PPARG
prerank,motile cilium assembly (GO:0044458),0.5436261954867531,1.4080518278212468,0.09234234234234234,0.4199116312183875,1.0,4/12,11.62%,DNAAF3;BBOF1;DNAAF1;BBS5
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5400634158565424,-1.4078947777495614,0.08880994671403197,0.2843837665910735,1.0,6/14,15.04%,GAB1;KDR;FLT4;PIK3CD;VEGFC;FOXC1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.45308912340623997,1.406622102134237,0.07234042553191489,0.42089607090360287,1.0,5/25,3.53%,GRID2;MPP2;GRIN2B;GRIN2A;GLRA1
prerank,positive regulation of autophagy (GO:0010508),-0.36747169311829986,-1.4065287747022168,0.02697841726618705,0.2864174658523442,1.0,33/81,25.77%,FOXO1;DAPK1;GNAI3;SH3BP4;SESN1;GSK3B;KDR;LRRK2;LARP1;FOXO3;IRGM;BNIP3;PIK3C2A;PLK2;ROCK1;PRKD1;GSK3A;PRKAA1;TRIM14;MTDH;KAT5;PIK3CB;TRIM13;RNF152;IKBKG;ORMDL3;ATF6;TRIM68;MAP3K7;HMGB1;PLK3;EIF2AK4;PLEKHF1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5440607753424458,1.406118240857297,0.09544468546637744,0.4197781936995506,1.0,6/13,12.40%,ANK3;CALM2;IRX3;SLC8A1;SRI;HRC
prerank,regulation of striated muscle contraction (GO:0006942),0.44113633861907586,1.4060383115700077,0.058315334773218146,0.41770429492559624,1.0,7/27,12.88%,ATP1A2;CALM2;RNF207;RYR2;SLC8A3;SRI;MYL2
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5434198739282459,-1.4054010375541086,0.0913978494623656,0.28804495019186743,1.0,6/13,22.54%,AKAP13;RAC1;ROCK1;ROCK2;ALMS1;ASAP3
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.4304244186783817,-1.4047590156894572,0.05862068965517241,0.2887434895005689,1.0,19/35,33.55%,ETS1;LYN;FOXO3;MED1;ABCB10;LDB1;ACVR2A;TAL1;ZFPM1;CDK6;ARNT;PRKDC;HSPA1B;MAPK11;MAPK14;SPI1;ZFP36L1;HOXA5;STAT3
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5587239191576525,-1.4046772705473476,0.0843806104129264,0.28840034091204797,1.0,7/12,31.16%,HES1;NOTCH1;JAG1;NELFB;HNRNPU;N4BP2L2;TCF15
prerank,protein autophosphorylation (GO:0046777),-0.32683108447687054,-1.4045878117962565,0.015873015873015872,0.28806669308139404,1.0,37/157,13.32%,FLT1;GRK5;TEK;IGF1R;DYRK1A;INSR;DAPK1;LYN;GSK3B;ATM;PAK2;SIK1;KDR;LRRK2;MTOR;PRKD2;CDK12;NEK6;EGFR;BMX;STK24;ABL1;ERN1;PTK2;EPHA4;MAPKAPK2;AAK1;PRKD1;FLT4;AKT1;MAP3K3;TAOK3;STK10;IRAK1;JAK2;ULK2;MKNK2
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3838975519330583,-1.404270199197044,0.047619047619047616,0.28815395660280085,1.0,31/61,26.87%,EYA4;USP9X;UIMC1;PRKD2;EGFR;MRE11;PPP1R10;RGCC;OTUD4;FGF2;HGF;MECP2;RNF168;BABAM2;ERCC8;SMOC2;CEBPG;WRN;BRCC3;RPS3;ATRX;USP7;FGFR4;BRCA1;TRIM28;PDGFRB;DHX9;ERCC6;HMGB1;FGF10;STPG4
prerank,organelle organization (GO:0006996),-0.29622750289217376,-1.4037343237874724,0.0,0.2886788212470695,1.0,99/388,18.93%,SEMA6A;ATP8B1;FGD5;SEC31A;NOS3;CAV1;FGD6;CSNK1A1;ALAS1;PEX1;PKD2;PDZD8;RAB3GAP1;COG1;DYM;EPS15;TMCC1;FNBP1L;ARHGAP10;RANBP9;MICAL2;MARK1;ARAP3;RAB7A;SYNE1;DIAPH1;LRRK2;RAB1A;GOLPH3L;LIMD1;ZMYM6;RAB2A;CNTNAP1;MAST2;TOR1B;SIRT5;ATL2;PLCE1;MAST4;ABCD3;WASL;MYO18A;SEC16B;CEP78;USP6NL;PEX7;PRKD1;PYROXD2;PLD2;DST;SIPA1L3;HAX1;TMEM135;CECR2;VPS13C;CUL7;FBXW8;CHMP4B;CHMP4A;GAK;AGTPBP1;BCAS3;FAM174B;ARFGEF1;NEDD9;MTX1;ZMYM4;MIEF2;GABPB1;MCOLN1;CHMP2B;CSNK1D;TPM1;SIRT3;AFG1L;TRAPPC12;HCFC1;PEX14;RAB32;VPS13D;BRWD3;PI4K2B;TBC1D20;CHMP5;LMAN2;TNFAIP3;CDC42BPB;GOLPH3;FANCG;CAPZB;TMED5;CFL1;ZFYVE16;VAPA;NRF1;PEX11A;FMNL2;HUWE1;WTIP
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.35559718736799034,-1.4036535655485356,0.022298456260720412,0.28835885027403874,1.0,28/98,16.40%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP1R13B;PRKCE;ITGA3;PTPN9;YWHAE;EGFR;MIEF1;TCAF1;DLG1;STX3;PIK3R1;YWHAZ;NMT1;TP53;CASP8;AKT1;MTCL1;RHOG;CHP1;MIEF2;MAPK8;STAC3;BBC3;FYN
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.43962816762930823,1.403491463701369,0.07441860465116279,0.42150640254792593,1.0,13/29,16.52%,GRIK2;CLN3;CAMK2B;SLC8A2;SYP;NETO1;RAB3A;DLG4;SYNGR1;APOE;PPFIA3;NCDN;SHISA9
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4341024749126114,1.4028337693802324,0.06808510638297872,0.4207664799421135,1.0,11/29,17.43%,HSD17B12;ACSBG1;HACD1;ACLY;ACACA;ACSL3;ACSL6;TECR;SCD5;HACD2;SCD
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.40946904117106353,1.4024238203530384,0.07918552036199095,0.41949536283765343,1.0,17/37,20.30%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT;STMN2;TPPP;MAPRE3;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP6;MAP6D1;STMN3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4812268376124444,1.4021165361961643,0.06487695749440715,0.41799536087736855,1.0,4/19,6.47%,PTPRD;IL1RAPL1;CDKL5;CAMK2B
prerank,blood circulation (GO:0008015),-0.39593229797866625,-1.4021146268466085,0.0625,0.2907396986957354,1.0,22/49,23.94%,ELN;ACVRL1;MYOF;NOS3;ACE;MEOX2;ROCK1;SCPEP1;AGTR1;EDN3;GPX1;F5;NPR1;ROCK2;GUCY1A1;SOD1;TBC1D8;PLN;GCLC;DLL4;ACE2;CXCL12
prerank,regulation of microtubule depolymerization (GO:0031114),0.4478686403224282,1.4017403828235329,0.04751131221719457,0.41670015886034345,1.0,9/25,18.44%,NAV3;APC2;MAP1S;STMN2;MAP1B;HDGFL3;CLASP2;CAMSAP3;MAP1A
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5547802604008466,-1.4010069288450044,0.07678571428571429,0.2922910761783372,1.0,3/13,5.49%,NOS3;TMSB4X;PPARA
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3189129091407368,-1.4007062657283635,0.01020408163265306,0.2923437939848787,1.0,49/182,18.91%,FOXP1;CLDN5;ENG;ACVRL1;RB1;RIN3;KLF4;CD34;ESR1;TNRC6B;SLC7A5;APP;KDR;TIPARP;SMO;ZNF148;NFKB1;HDAC1;BMP4;TGFB2;MEF2C;PARP14;NOTCH2;OCLN;PICALM;ADAM10;CELF1;YAP1;PRKAA1;SNX12;DICER1;PSEN1;NOTCH1;FGF2;MECP2;AGO2;MIF;LGMN;APOBEC1;ROCK2;TERF2;DNMT1;IGF1;MOV10;HEY2;CITED2;GATA2;TNRC6A;WWP2
prerank,positive regulation of apoptotic process (GO:0043065),-0.30750890003580117,-1.4006576016352041,0.00825082508250825,0.29196202329981186,1.0,93/293,24.69%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;MCF2L;ATM;MAP3K5;SIK1;PLEKHG5;UTP11;TNFSF10;DDX3X;RBM5;RASGRF2;RARG;RYBP;STK3;DNM2;FAS;SLIT2;PSEN2;FOXO3;ABL1;ARHGEF12;BMP4;TGFB2;BNIP3;JUN;RASSF2;NGF;TGM2;ITSN1;ARL6IP5;ARHGEF2;SOS2;LATS2;CRADD;TP53;CASP8;TPD52L1;ARHGEF11;PSEN1;SLC27A4;ANO6;CTNNBL1;STPG1;MAPK8;ERCC3;ATF4;HIP1R;TRIO;ABR;ARHGEF18;BCL2L11;APH1A;SRPK2;TFAP4;CTNNB1;PREX1;SOD1;IAPP;RPS3;SIAH1;SOX4;RNPS1;ARHGEF5;FOXL2;PNMA2;ARHGEF1;PHLDA3;NF1;CASP2;SUDS3;TRIM39;GADD45A;ATF6;BCL6;RIPK1;PTGIS;APBB1;HMGB1;FANK1;VAV2;BMP2
prerank,endochondral bone morphogenesis (GO:0060350),-0.5683897527743225,-1.4004707405600287,0.10207939508506617,0.29180862476271646,1.0,6/11,22.55%,BMPR2;BMP4;MEF2C;FOXC1;TRPV4;COL13A1
prerank,vasculature development (GO:0001944),-0.5072678066572452,-1.3993765222191714,0.08272058823529412,0.29344093905429214,1.0,11/16,29.32%,ACVRL1;BMPR2;CDH5;FLT4;NOTCH4;ACVR2B;PDGFRB;PIK3CA;FOXF1;STRA6;APLNR
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.4685752949814157,-1.3992448443569494,0.08376963350785341,0.29321566227620943,1.0,8/24,14.77%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;GDI1;NUMB
prerank,muscle cell migration (GO:0014812),-0.5876590434818579,-1.3989732151417822,0.09090909090909091,0.2932582352898483,1.0,6/10,23.42%,SIX1;ROCK1;CCN3;PLAT;ITGB3;THBS4
prerank,muscle organ development (GO:0007517),-0.3828767675361567,-1.3987234139646845,0.05975395430579965,0.2932473330613925,1.0,21/54,27.44%,UTRN;MEF2A;TEAD4;TCF12;CHD2;TBX1;MKX;EMD;MEF2C;COL6A3;MAPK12;IGF1;LARGE1;SMTN;FHL1;ITGA7;FXR1;POU6F1;ITGA11;CXCL10;EGR3
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.48744903601807754,-1.3976530275428412,0.08211678832116788,0.29482376437002916,1.0,7/21,14.59%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2;CCN3
prerank,regulation of ossification (GO:0030278),-0.4212524373759634,-1.397605506627014,0.061946902654867256,0.29444434887033794,1.0,12/36,18.20%,ZBTB16;BMPR2;SGMS2;BMP4;LRP6;TGFB2;MEF2C;S1PR1;NOTCH1;NOTUM;SMAD6;ANKH
prerank,protein kinase A signaling (GO:0010737),-0.5609198074481603,-1.3970048633661944,0.08156028368794327,0.29500321788089773,1.0,6/12,28.17%,PRKACB;EZR;MYOM1;LCP1;RDX;TTN
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.30099830278566303,-1.3962541870681278,0.0016611295681063123,0.2958232239322811,1.0,137/336,30.04%,FOXP1;SUSD6;MNAT1;FOXO1;XIAP;UBR5;MCL1;ACER2;LYN;PDS5B;TLK2;ATM;DTX3L;RNF169;PARP4;SMC5;KMT5B;NIPBL;SAMHD1;TNFRSF1B;MRNIP;TRRAP;ABL1;SPIDR;AATF;ZBTB4;MAPKAPK2;MRE11;STXBP4;SUV39H1;NABP1;INIP;MCM9;TRIP12;RBBP8;UBA7;TP53;ZBTB40;WDR76;YAP1;DOT1L;FNIP2;TAOK3;NSMCE3;ENDOV;PSEN1;IKBKE;INTS3;RAD18;OGG1;PDS5A;RPA1;XPC;ASH2L;UBE2E2;ERCC3;PNKP;RNF168;BABAM2;MAPK12;BTG2;SLF2;CGAS;ERCC8;GRB2;USP10;VCPIP1;HIC1;SUMO1;BCL2L11;RFWD3;HERC2;POLE2;HPF1;FANCG;WRN;FANCC;IKBKG;NCOA6;AKTIP;RPS3;CCND1;BRAT1;EPHA2;RAD54L;NSMCE4A;PRKDC;FANCL;BRCA1;CBX1;TIMELESS;TRIM28;BAZ1B;CHRNA4;BLM;DCUN1D5;RFC4;CHEK1;CASP2;USP16;GADD45A;BCL6;RBM24;CCNK;MSH3;YY1;PWWP3A;TAF9;APBB1;SETD7;PLK3;APC;RBBP5;DTL;NUPR2;MCM7;LIG1;MCM10;INO80;EXO1;IRF7;GTF2H3;ALKBH7;MMS19;APLF;CHD1L;BOD1L1;RAD51AP1;XRCC2;DDIT3;GNL1;HINFP;UBA1;RAD51D;MAPK14;TDP1;ZBTB38
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5734869425585246,1.3960552477501196,0.1,0.4279303935693621,1.0,5/10,19.00%,LAPTM4B;TSKU;GATA6;HSP90AB1;CD24
prerank,cardiac ventricle development (GO:0003231),-0.4785109446637147,-1.395829795814317,0.07735849056603773,0.29612981837327684,1.0,11/20,27.89%,ENG;HES1;PDE2A;HECTD1;NOTCH1;HEY2;HEY1;DAND5;DLL4;GJA5;STRA6
prerank,DNA conformation change (GO:0071103),-0.5010440222526235,-1.3952570688200474,0.09906542056074766,0.29676050463275266,1.0,8/17,24.41%,KAT6A;TOP3A;ABL1;TOP3B;ERCC3;TOP1MT;TOP1;HMGB1
prerank,filopodium assembly (GO:0046847),-0.512238582370469,-1.395023643926846,0.07522935779816514,0.2967644055266683,1.0,4/16,6.91%,FGD5;FGD6;DNM3;EZR
prerank,eosinophil chemotaxis (GO:0048245),0.5299900933551531,1.39499529848666,0.08530805687203792,0.4261117941560108,1.0,5/14,18.47%,CCL7;CCL13;CCL5;CCL2;CX3CL1
prerank,eosinophil migration (GO:0072677),0.5299900933551531,1.39499529848666,0.08530805687203792,0.4261117941560108,1.0,5/14,18.47%,CCL7;CCL13;CCL5;CCL2;CX3CL1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.5732937535766937,-1.3948280309231165,0.0979381443298969,0.29662855346875294,1.0,10/11,42.20%,TENT4B;EXOSC2;EXOSC3;PARN;EXOSC5;LARP7;EXOSC4;FBL;DKC1;FBLL1
prerank,COPII vesicle coating (GO:0048208),-0.37506380216648,-1.3944224419001587,0.04056437389770723,0.2960280792409597,1.0,23/61,21.87%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;CUL3;SEC24A;SEC16B;SEC13;KLHL12;SEC24D;SCFD1;PPP6R3;CSNK1D;F5;CTSZ;TBC1D20;TFG;PREB;SEC24C;SEC22B;BET1
prerank,vesicle coating (GO:0006901),-0.37506380216648,-1.3944224419001587,0.04056437389770723,0.2960280792409597,1.0,23/61,21.87%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;CUL3;SEC24A;SEC16B;SEC13;KLHL12;SEC24D;SCFD1;PPP6R3;CSNK1D;F5;CTSZ;TBC1D20;TFG;PREB;SEC24C;SEC22B;BET1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.37506380216648,-1.3944224419001587,0.04056437389770723,0.2960280792409597,1.0,23/61,21.87%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;CUL3;SEC24A;SEC16B;SEC13;KLHL12;SEC24D;SCFD1;PPP6R3;CSNK1D;F5;CTSZ;TBC1D20;TFG;PREB;SEC24C;SEC22B;BET1
prerank,T cell homeostasis (GO:0043029),-0.5826322999198699,-1.394382890245308,0.0766488413547237,0.2956286262077049,1.0,3/10,10.01%,FAS;PPP2R3C;AKT1
prerank,response to interferon-alpha (GO:0035455),-0.5256465280367161,-1.3942329488128178,0.10420475319926874,0.2954213110598893,1.0,10/16,33.15%,IFNAR1;GAS6;IFITM3;PDE12;TPR;IFNAR2;IFITM2;BST2;AXL;RO60
prerank,anion transport (GO:0006820),-0.439935762623367,-1.393886913292278,0.06204379562043796,0.29554764758461277,1.0,8/33,9.24%,ABCG2;SLC26A7;LRRC8C;SLC13A4;LRRC8D;SLC13A3;SLCO2B1;SLC17A5
prerank,T cell differentiation (GO:0030217),-0.4131051920176504,-1.3936440193010278,0.06557377049180328,0.2955193671373165,1.0,24/40,40.52%,SOX13;JAG2;PIK3CD;GLI3;NHEJ1;LMBR1L;ANXA1;SOX4;PTPRC;LIG4;DLL4;ADAM17;FCER1G;PTPN2;SPI1;LFNG;ZFP36L1;SHH;ZAP70;GPR89B;GPR89A;GATA3;LCK;CD28
prerank,cellular response to fluid shear stress (GO:0071498),-0.5662516909182481,-1.393433475532808,0.0855614973262032,0.2954451835021262,1.0,7/12,22.96%,KLF4;PKD2;KLF2;MEF2C;MAPK7;NFE2L2;HAS2
prerank,extracellular structure organization (GO:0043062),-0.3120440022356369,-1.3930400838779393,0.010221465076660987,0.2957246176460979,1.0,61/204,16.20%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;THBS1;ADAMTS2;COL4A6;ITGA3;APP;VIT;F11R;SPOCK2;SMOC1;ITGA1;KDR;ITGB4;ICAM1;COL5A1;MMP2;LAMA4;LAMA3;COL4A5;ITGB5;COL8A2;SLC39A8;AGRN;CDH1;COL5A2;LOXL1;COL4A1;ADAMTS9;HSPG2;ADAMTS4;FBLN5;THSD4;ADAMTS10;ADAMTS17;ADAMTS20;LAMA1;ADAMTS5;LAMA5;BGN;COMP;ITGA4;FGF2;LAMC3;ICAM2;COL6A3;NID1;SMOC2;COL6A2;ITGA2;VCAM1;GFOD2
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4407163554612545,-1.392298150953995,0.06826568265682657,0.29667693595413525,1.0,16/31,30.53%,CRIM1;LRP5;TRPM4;LIMD1;TWIST2;NOTCH1;TMEM64;CDK6;SMAD6;SKI;HDAC7;PPARG;GDF10;BAMBI;SUFU;RIOX1
prerank,ameboidal-type cell migration (GO:0001667),-0.38852307696333477,-1.3921450598064846,0.04152249134948097,0.2964838596050614,1.0,22/51,20.69%,SEMA6A;SEMA3C;SEMA7A;CORO1C;TBX1;PHACTR4;PDLIM1;AKT1;SEMA3G;SEMA6B;SEMA4C;ITGA4;PDXDC1;PKN2;CCN3;PKN3;SEMA5B;SEMA4A;GPC3;SEMA3E;AMOTL2;SEMA4G
prerank,detection of calcium ion (GO:0005513),0.5354895382851119,1.3913991969884405,0.09836065573770492,0.43231260752245865,1.0,3/13,7.56%,SYT1;CALM2;RYR2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5069228148711913,-1.3910144818770256,0.08487084870848709,0.2981791643675139,1.0,5/17,12.78%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.38077821707951554,-1.3907598336014824,0.06394316163410302,0.2981569513983301,1.0,27/55,31.65%,DAB2IP;CAV1;PAK2;TNFSF10;FAS;CRADD;TP53;TPD52L1;BCAP31;WWOX;BBC3;GSDME;BCL2L11;HYAL2;RPS3;SIAH1;G0S2;LTBR;TRIM39;BECN1;RIPK1;TNFSF12;TNFRSF12A;DDIT3;TGFBR1;PMAIP1;ING5
prerank,protein import into mitochondrial matrix (GO:0030150),-0.4948285990636363,-1.3903895940703586,0.08043875685557587,0.2984141179441818,1.0,10/18,36.99%,TOMM40;TIMM17B;DNAJC19;TOMM40L;TIMM50;TOMM20;TOMM70;PAM16;DNLZ;TIMM23
prerank,nucleotide catabolic process (GO:0009166),-0.5096840797535709,-1.3903811808944895,0.08928571428571429,0.2979663737893598,1.0,13/16,43.55%,NT5C2;NT5E;SAMHD1;NT5C1A;GPX1;GDA;NT5C;PNP;DERA;VCP;NUDT15;NUDT3;XDH
prerank,endodermal cell differentiation (GO:0035987),-0.4395326964400747,-1.3903312382547848,0.06805293005671077,0.29759703978826124,1.0,10/31,12.82%,COL8A1;COL12A1;COL4A2;SETD2;MMP2;LAMA3;ITGB5;RTF1;ITGA4;CDC73
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.4679831967635847,-1.3901586326164908,0.09172661870503597,0.2974733429454873,1.0,9/25,17.56%,RB1;NSD1;ZBTB7A;DOT1L;SIN3A;MAD2L2;IGF1;HEY2;HEY1
prerank,protein sumoylation (GO:0016925),-0.39756473674068,-1.3901235196950423,0.04753521126760563,0.29708229809434994,1.0,19/49,28.10%,IFIH1;NUP42;RAE1;TRPM4;RANBP2;UBA2;NUP98;NSMCE2;NUP153;PIAS2;TPR;SUMO1;NUP214;PIAS4;TRIM28;NUP188;SAE1;NUP88;UBE2I
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.44630870934990396,-1.389911026447755,0.08453237410071943,0.2970226809912693,1.0,6/25,8.07%,CAV1;FAM20A;CNNM2;TMTC2;TRPM7;CNNM4
prerank,regulation of receptor internalization (GO:0002090),0.41567555778823473,1.3898353713487535,0.06132075471698113,0.4338086820010934,1.0,10/35,13.42%,MAGI2;ANKRD13B;WDR54;CD63;MTMR2;ATAD1;AHI1;VEGFA;DLG4;RSPO1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.398083688254623,-1.3892586376472305,0.04895104895104895,0.29736447997742005,1.0,19/50,26.38%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;IPO8;NUP214;TNRC6A;NUP188;POLR2C;POLR2H;POLR2L;NUP88
prerank,regulation of gene silencing by RNA (GO:0060966),-0.398083688254623,-1.3892586376472305,0.04895104895104895,0.29736447997742005,1.0,19/50,26.38%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;IPO8;NUP214;TNRC6A;NUP188;POLR2C;POLR2H;POLR2L;NUP88
prerank,regulation of kinase activity (GO:0043549),-0.3578737869697198,-1.3891602976908999,0.027210884353741496,0.2970836226588673,1.0,18/89,8.63%,FLT1;TEK;IGF1R;RB1;TIE1;INSR;ROR1;KDR;MERTK;CDKN1B;EGFR;LMO4;DSTYK;PLCE1;EPHA4;MRE11;LDB1;FLT4
prerank,myelin assembly (GO:0032288),0.5774785509364259,1.3887138190400363,0.10386965376782077,0.434291877782049,1.0,6/10,16.97%,TENM4;EPB41L3;GPC1;ABCA2;TPPP;NCMAP
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5307271024170498,-1.3885887962113646,0.09420289855072464,0.29762798770575044,1.0,5/15,14.60%,DAB2;WASL;AAK1;PIK3CB;HIP1R
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5114096697746671,-1.3885252847680436,0.10091743119266056,0.2973027288870274,1.0,8/16,20.35%,IGF1R;INSR;BNIP3;OGFOD1;GSPT1;HDAC6;TBC1D25;GLE1
prerank,histone mRNA metabolic process (GO:0008334),-0.44768564378346176,-1.3883396246517656,0.08422939068100359,0.2972374802943278,1.0,9/27,17.76%,TUT7;TENT4B;ATM;XRN1;TUT4;LSM11;TENT2;SNRPE;LSM10
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.37383557632220793,-1.3878505656152995,0.040280210157618214,0.29781799389592806,1.0,28/63,26.43%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;CRADD;TP53;RGCC;BTG2;RFWD3;RPA2;SDE2;SOX4;CCND1;CARM1;PRKDC;MDM2;CASP2;GADD45A;E2F7;ARID3A;CNOT2;CNOT8;PLK3;TFDP1;CNOT1
prerank,entry into host (GO:0044409),-0.5488579062969902,-1.387626146949824,0.10275229357798166,0.2977657464760226,1.0,6/13,17.19%,CBLL1;CBL;CTNND1;CDH1;GRB2;CTNNB1
prerank,cellular senescence (GO:0090398),-0.452589342338104,-1.387100347125593,0.05794392523364486,0.29831653781355405,1.0,18/27,42.46%,KAT6A;SMC5;PRKCD;TBX2;NSMCE2;TERF2;ECRG4;TBX3;CDKN2B;MAPK14;SPI1;MAPKAPK5;HMGA1;SMC6;SIRT1;CDKN1A;PML;MAP2K1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.4072659859572431,-1.3866661882992581,0.0625,0.2987069315853953,1.0,14/42,18.51%,SMARCA2;ARID1B;HDAC1;SMARCC1;SRCAP;SMARCE1;SPTY2D1;CECR2;SMARCC2;CHD3;ACTB;INO80B;VPS72;SMARCAD1
prerank,outer dynein arm assembly (GO:0036158),0.5168728309046156,1.3866238061391736,0.0957683741648107,0.4371975859260133,1.0,7/14,18.81%,CCDC63;DNAAF5;ODAD2;DNAAF1;ODAD1;LRRC49;ODAD3
prerank,negative regulation of cell aging (GO:0090344),-0.4952210527380628,-1.3858344637633042,0.08492201039861352,0.29978221079622125,1.0,7/16,21.68%,SLC30A10;AKT3;MAP3K3;CDK6;MIF;TERF2;TERT
prerank,histone H3-K9 demethylation (GO:0033169),-0.5762191337206263,-1.3854572385714583,0.09090909090909091,0.30000902302483434,1.0,7/11,30.97%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5704894089896781,-1.3851317084937678,0.10112359550561797,0.30011761512223945,1.0,8/11,30.52%,MERTK;GAS6;CCL19;NOD2;CXCL12;IRF7;AXL;LILRB1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.508499318082532,-1.3849723872507116,0.0905861456483126,0.29998540145406344,1.0,8/16,21.68%,GCH1;SCARB1;NOS1AP;AKT1;S100A1;PIK3CB;TERF2;TERT
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4526504183812987,1.3846933206447585,0.08459869848156182,0.4398232729785613,1.0,10/22,15.76%,MAGI2;SH3GL2;TMEM108;KIDINS220;NTRK2;MAPT;ACAP2;STMN2;BDNF;RAB35
prerank,myeloid leukocyte differentiation (GO:0002573),-0.37219271178362107,-1.3844408411753297,0.04886561954624782,0.30055279411551966,1.0,11/65,9.94%,FOXP1;LEF1;CBFA2T3;MYH9;RXRA;DEK;IL15;TGFBR2;BMP4;PIK3CD;CASP8
prerank,excitatory postsynaptic potential (GO:0060079),0.47337127698886217,1.3841720380691285,0.09090909090909091,0.4388558049059692,1.0,4/19,3.26%,GRID2;MPP2;GRIN2B;GRIN2A
prerank,sensory perception of taste (GO:0050909),0.5699077754619368,1.3841621072761547,0.11255411255411256,0.4367201257130629,1.0,3/10,14.03%,ASIC2;GNAT3;ASIC1
prerank,peroxisome organization (GO:0007031),-0.4615037152402453,-1.3833049615437907,0.09854014598540146,0.3021695278073141,1.0,12/25,30.87%,PEX1;ABCD3;SEC16B;PEX7;TMEM135;PEX14;PEX11A;PEX3;PEX6;PEX11B;LONP2;PEX19
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3485478249831188,-1.3824329934869606,0.027923211169284468,0.30320493458871334,1.0,37/93,24.23%,NSD1;CAV1;APP;PRKD2;TFRC;EGFR;GAS6;NCK1;DDIT4;IRGM;RASSF2;NGF;PPM1F;PRKD1;RAF1;HAX1;AKT1;FNIP2;BRAF;SMAD7;NCK2;MTCP1;RPTOR;CNKSR3;MIF;CREBL2;MAD2L2;HDAC6;TXN;CAPRIN2;PTEN;NOS1;HSP90AA1;RAPGEF3;SH2D3C;AKAP9;INPP5J
prerank,positive regulation of cell adhesion (GO:0045785),-0.35964187563606925,-1.3820573886242489,0.04936014625228519,0.3034666002024437,1.0,20/74,13.54%,RSU1;RAC1;ZFHX3;LIMS1;VIT;ATM;PRKD2;PTPRJ;ADAM9;AFDN;STX3;TGFB2;EPHA4;TGM2;PPM1F;FBLN2;FRMD5;SMAD7;JAK2;TPM1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.32597881285089564,-1.3812356038281217,0.0108499095840868,0.3046019476356264,1.0,61/158,28.85%,PELI1;AKAP13;TAB3;ROR1;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;TNFSF10;TFRC;NEK6;BIRC3;PLK2;PRKD1;CASP8;ALPK1;FLNA;MAP3K3;CFLAR;TRIM14;IKBKE;IRAK1;MTDH;RHOA;RHOC;CD40;TNFRSF19;MIB2;TAB2;TNFRSF1A;TFG;PELI2;MAVS;TRIM13;IKBKG;VAPA;CCL19;IKBKB;NOD2;LURAP1;EDAR;TMEM9B;NDFIP2;LTBR;RELA;TRIM68;RIPK1;MAP3K7;MAP3K14;CASP1;F2R;BRD4;BST2;TRIM6;HMOX1;SLC20A1;RNF31;LGALS9;TIFA
prerank,regulation of cell development (GO:0060284),-0.4117253323781144,-1.3812010350999777,0.07922535211267606,0.30419156089191063,1.0,9/36,17.56%,FOXO1;ADGRA2;HES1;NOTCH2;AKT1;YAP1;CTNNB1;HEY2;HEY1
prerank,heart contraction (GO:0060047),0.39676139977651814,1.3811672127278796,0.06621004566210045,0.44177718726431986,1.0,11/41,13.94%,SGCZ;ATP1A2;SCN1B;ATP1B1;RYR2;SCN5A;TNNC1;SLC8A1;MYL2;TNNI2;SCN2B
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.49058700438425806,-1.3810660566431592,0.09642857142857143,0.3040241623912214,1.0,11/20,23.25%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G;SEMA5A
prerank,actin filament bundle assembly (GO:0051017),-0.42626999586362213,-1.3810086768942087,0.07142857142857142,0.30369190185385536,1.0,10/33,13.18%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;FAM107A;SHROOM1;SHROOM2;NEDD9;LCP1
prerank,muscle tissue morphogenesis (GO:0060415),-0.518281314115743,-1.3793735052160374,0.10536044362292052,0.30650354195492524,1.0,7/16,17.44%,TBX1;TGFBR3;BMP4;MYLK;ZFPM1;NOTCH1;HEY2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4229215326118041,-1.379331831888325,0.08139534883720931,0.30611171703166,1.0,6/35,11.13%,FLT1;PTPRM;CAV1;THBS1;MEF2C;RGCC
prerank,leukocyte tethering or rolling (GO:0050901),-0.506669325114858,-1.3776963183290365,0.09345794392523364,0.30873159117000526,1.0,6/17,17.48%,ITGB1;JAM2;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5275443143947381,1.3760454121731513,0.10307017543859649,0.4522727782734219,1.0,4/13,18.40%,SYT1;SYT4;CACNA1G;CACNA1I
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.519897344637166,1.3760293971204758,0.09409190371991247,0.4501159657241283,1.0,8/13,16.52%,GRIK2;CLN3;SLC8A2;SYP;RAB3A;SYNGR1;PPFIA3;SHISA9
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.3990705491912137,-1.3760103731273843,0.07992895204262877,0.3115382651228805,1.0,15/42,13.72%,RSU1;RAC1;CORO1C;LIMS1;GCNT2;VIT;FZD4;PTK2;PPM1F;FBLN2;NOTCH1;ATXN3;JAK2;RHOA;PIK3CB
prerank,positive regulation of vacuole organization (GO:0044090),-0.5842379731895927,-1.375633338208898,0.1009009009009009,0.3117915718690997,1.0,5/10,11.56%,RAB3GAP1;ANXA2;PIP4K2A;PIP4K2B;RAB3GAP2
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.32456306479940794,-1.3755423973361298,0.03197158081705151,0.3115241998668408,1.0,57/144,25.96%,PPP1R13B;UBR5;GSK3B;YWHAE;EMD;MIEF1;GAS6;TCAF1;PIK3R1;HPS4;PRKCD;SEC16B;CDH1;UBE2J2;YWHAZ;NMT1;GSK3A;UBE2D3;TP53;CASP8;FLNA;PSEN1;BCAS3;ICE1;MTCL1;CHP1;MIEF2;ZPR1;MAPK8;TPR;BBC3;FYN;UBE2L3;MAVS;XPO4;RIPOR1;OAZ2;HYAL2;BAP1;HUWE1;PCM1;ZIC1;NPEPPS;PPP3CC;TRIM28;VAMP2;ITGAM;SAR1A;RAPGEF3;CEP131;PCNT;FZD5;TCF7L2;PLK3;TFDP1;SAE1;RAN
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4903003395858837,-1.3755223752249042,0.08944543828264759,0.3110920937073372,1.0,3/19,0.61%,DAB2IP;JCAD;SEMA6A
prerank,regulation of osteoclast differentiation (GO:0045670),0.4149879441202632,1.375308001623786,0.06108597285067873,0.4497253018696419,1.0,8/33,15.26%,BGLAP;CARTPT;CAMK4;POU4F1;TMEM178A;TCTA;LRRC17;IL23A
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.3436402814643751,-1.3750996399420705,0.02577319587628866,0.31142569859229424,1.0,26/101,13.23%,FLT1;DAB2IP;RAPGEF2;FERMT2;PKD2;PDGFD;DDX3X;LRRK2;EGFR;FGF1;IRGM;CCND3;IL34;AKT1;TPD52L1;EDN1;PIK3R6;CCNY;RGCC;IRAK1;MTCP1;RPTOR;RHOA;FGF2;EDN3;TCIM
prerank,positive regulation of translation (GO:0045727),-0.3526171441785165,-1.3749892807171784,0.032667876588021776,0.3111600543848335,1.0,37/94,27.04%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;EIF3C;LARP1;PLD1;UPF3B;SAMD4A;POLR2G;RPL26;ZCCHC4;EEF2;EIF5A;EIF5AL1;CDC123;LARP4B;RPS4X;RPUSD4;AGO2;RPL5;MRPS27;MPV17L2;METTL5;UQCC2;SOX4;PRKDC;RBM3;USP16;POLDIP3;DHX9;FXR1;HNRNPD;LARP6;KHDRBS1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.445673513758699,-1.374116340998568,0.1037037037037037,0.31233901546736964,1.0,6/26,9.19%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,protein ADP-ribosylation (GO:0006471),-0.4520687079543126,-1.3733411302155203,0.08743169398907104,0.31336490698652536,1.0,12/28,25.41%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;HPF1;PARP11;ART3;PARP16;PARP6;PARP9
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.36275968990588386,-1.3729524349878752,0.043478260869565216,0.3136353178523085,1.0,25/73,26.96%,HIP1;SENP1;ACER2;NOD1;CASP12;TNFSF10;FAS;NGF;ATP2A3;CRADD;CASP8;CFLAR;JAK2;HIP1R;BBC3;DAP;CASP8AP2;F3;PPARG;CASP2;RIPK1;EIF2AK3;CASP1;F2R;BEX3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5558954861879881,-1.3720272482875275,0.09982174688057041,0.3148930642405011,1.0,7/12,25.22%,RESF1;TASOR;APOBEC1;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,regulation of lipid catabolic process (GO:0050994),0.47013788813592994,1.3718262601781896,0.11479028697571744,0.4563211919749657,1.0,5/19,15.14%,PDE3B;BSCL2;TYSND1;ADRA2A;APOC1
prerank,cation transport (GO:0006812),0.3099591525798524,1.3717379186537915,0.013729977116704805,0.4543348475051397,1.0,29/167,9.84%,TRPM3;KCNMA1;ATP1A2;KCNA6;SLC22A4;SCN8A;SLC22A1;SLC5A12;KCNA5;SCN1A;CATSPER4;SLC4A4;KCNJ3;KCNH4;CLN3;KCNN2;SLC7A8;SCN3A;KCNA2;ATP1B1;SCN2A;SLC8A2;SLC36A2;TRPM1;SCN5A;SLC29A4;KCNJ6;PANX2;SLC7A6
prerank,chromatin organization (GO:0006325),-0.3295153783768359,-1.3712838260218023,0.03741496598639456,0.3158790377534681,1.0,48/132,28.52%,MECOM;SMARCA2;BAZ2B;RB1;CHD1;ESR1;KAT2B;PRDM16;SETD2;HDAC1;SMARCC1;ZBTB7A;SETD5;BAZ1A;KDM6A;SUV39H1;SMARCE1;KDM6B;HMG20A;EHMT1;SMARCC2;HDAC4;HMGN3;MCM3AP;HCFC1;SMARCD3;DR1;TCF7L1;RUVBL2;KDM5B;HDAC10;HMGN2;SMARCAD1;ATRX;BAZ1B;TOP1;NPM3;SUPT4H1;PWWP3A;SETD7;SMARCB1;SETDB2;INO80;RSF1;HDAC5;PHF19;CDAN1;CHD1L
prerank,neuromuscular process (GO:0050905),0.4852655802889342,1.3712520181935457,0.11663066954643629,0.45340786914778014,1.0,4/16,6.32%,NRXN1;CLN3;SHANK1;PRRT2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5365191845309811,-1.3710516243549293,0.11913357400722022,0.3159047707002223,1.0,5/13,13.77%,GFPT2;GNPDA2;SLC35A3;GNPNAT1;UAP1
prerank,nucleosome disassembly (GO:0006337),-0.5229003594121134,-1.3708034785261738,0.08957952468007313,0.3154388857845469,1.0,10/14,38.74%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3;SMARCB1;SET;GRWD1;NFE2;HMGA1
prerank,chromatin disassembly (GO:0031498),-0.5229003594121134,-1.3708034785261738,0.08957952468007313,0.3154388857845469,1.0,10/14,38.74%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3;SMARCB1;SET;GRWD1;NFE2;HMGA1
prerank,cellular response to interleukin-7 (GO:0098761),-0.48860473548095823,-1.370782304475233,0.09800362976406533,0.3145654411657357,1.0,9/17,35.45%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;IL7R;TSLP
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.48860473548095823,-1.370782304475233,0.09800362976406533,0.3145654411657357,1.0,9/17,35.45%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;IL7R;TSLP
prerank,superoxide metabolic process (GO:0006801),-0.44654357338870054,-1.3706799561040415,0.09430604982206406,0.31428102612637215,1.0,9/29,17.81%,SH3PXD2A;NOS3;SH3PXD2B;NCF2;NOX4;NRROS;PREX1;SOD1;CCS
prerank,cellular metal ion homeostasis (GO:0006875),0.33844415525214533,1.3702066337101508,0.016706443914081145,0.4539060386514442,1.0,20/102,12.21%,SLC24A4;SLC24A2;KCNMA1;HTR2C;ATP1A2;STC1;ATP12A;ATP2B4;ATP2B2;ATP1B1;SLC8A2;CCL7;RYR2;TMCO1;ATP4A;CCL13;ATP13A2;CCL5;SLC8A1;SLC8A3
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5010602418246882,-1.37004556789675,0.0931098696461825,0.31501830408059983,1.0,11/18,37.67%,CD34;CD200;TGFB2;SMAD4;LGALS9;LRRC32;LILRB1;LTBP1;ITGB6;HIF1A;SMAD3
prerank,peptidyl-lysine acetylation (GO:0018394),-0.586718177696248,-1.3699466361411603,0.10442477876106195,0.31472669717632124,1.0,3/10,12.59%,CREBBP;KAT2B;KAT5
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5363759265091489,-1.3699210616217097,0.1252302025782689,0.31430731907961884,1.0,3/13,5.06%,CAV1;ADRA1B;TRPM4
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5519970753512253,-1.36987620510693,0.11359724612736662,0.31392951862067375,1.0,6/12,26.13%,CDYL;PCGF3;PCGF5;BRCA1;RBM15;HNRNPU
prerank,regulation of JNK cascade (GO:0046328),-0.338705439908096,-1.369658758406125,0.0392156862745098,0.313871589768445,1.0,34/101,24.41%,MECOM;DAB2IP;IGF1R;MFHAS1;TRAF5;APP;MAP3K5;TGFBR3;EGFR;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TPD52L1;TAOK3;DUSP3;TNFRSF19;MTURN;MAP4K4;ZMYND11;CCL19;NOD2;DUSP22;EDAR;RAP2A;SH3RF2;PTK2B;LTBR;GADD45A;FZD7;RIPK1;GPS2;HMGB1
prerank,regulation of biomineral tissue development (GO:0070167),-0.4473646622392891,-1.3695631579073404,0.09314586994727592,0.31358880900196867,1.0,11/26,18.20%,NOS3;SGMS2;GAS6;ROCK1;S1PR1;NOTCH1;NOTUM;ROCK2;HEY2;HEY1;ANKH
prerank,positive regulation of transport (GO:0051050),-0.35233957683778044,-1.3693101666323833,0.051418439716312055,0.3136301845525392,1.0,22/85,18.77%,DAB2;NEDD4L;CBLL1;GSK3B;ANXA2;RXRA;IL15;MERTK;GAS6;RAB27A;GSK3A;ACTB;CHP1;FLOT1;HIP1R;ABCA7;LMAN2;TULP1;GATA2;ANXA1;CCL19;GPC3
prerank,steroid metabolic process (GO:0008202),0.35124828372105305,1.36895608678607,0.04186046511627907,0.4550416961744871,1.0,15/72,12.82%,AKR1D1;CYP46A1;AKR1C1;CYP24A1;SULT2B1;LSS;CYP26B1;HSD17B7;CYP51A1;HSD17B14;CYP27A1;GC;CYP11B1;FDFT1;DHCR24
prerank,axon guidance (GO:0007411),0.3041371285087149,1.368855347798673,0.01647058823529412,0.45313919387786283,1.0,42/201,10.41%,NRXN3;NRXN1;ROBO2;UNC5D;L1CAM;DAB1;CNTN6;DCC;NCAM1;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;VLDLR;LHX1;EPHB1;TNR;DOK5;UNC5C;GFRA1;SEMA6D;EFNA3;EFNB3;EPHA5;SEMA3B;DOK6;GPC1;MYPN;SHC3;VSTM2L;CNTN2;EMB;SHC1;VEGFA;SPTBN4;KIF5A;SPTBN2;SLIT3;SLIT1
prerank,positive regulation of axonogenesis (GO:0050772),0.38428569195192414,1.368638458656904,0.06407322654462243,0.4515461865221662,1.0,14/43,13.76%,ROBO2;L1CAM;ROBO1;SHTN1;CDKL5;LIMK1;NTRK2;SLITRK1;MAPT;ZFYVE27;PLXNA2;PLXNA1;BDNF;AMIGO1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.32418424678256275,-1.3679306166782457,0.01967799642218247,0.31580205877832995,1.0,47/151,21.70%,SGMS1;CERT1;ST3GAL4;ALAS1;ACER2;DEGS2;SGMS2;PLA2G4A;PRKD3;PRKD2;SPNS2;GSTT1;LPCAT1;ELOVL5;CERS4;PPM1L;GCH1;SLC44A1;PRKD1;PAM;STARD7;MFSD2A;ST3GAL2;PCSK5;GSTM2;ACER3;TYW1;SPTLC1;MOCS2;GAL3ST2;CERS5;B4GALT5;ESD;PCTP;CEPT1;GOLPH3;HPGDS;VAPA;LARGE1;ELOVL7;DEGS1;CDO1;GSTO2;LPIN2;LCAT;LPCAT3;MOCS3
prerank,substrate-dependent cell migration (GO:0006929),-0.5195929374172339,-1.3678955818085408,0.12389380530973451,0.31542664632673906,1.0,6/14,19.63%,ANKS1A;CD2AP;NTN1;VEGFC;ITGA2;PTPRC
prerank,response to prostaglandin E (GO:0034695),-0.5687951031385771,-1.3674133459931805,0.13035714285714287,0.31591084356175275,1.0,5/10,26.23%,GNB1;TGFBR3;CCL19;GNG2;ADCY6
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.583528760893303,-1.3674118842177132,0.11029411764705882,0.31546369818640313,1.0,5/10,30.75%,ACADL;ACAD11;ACADVL;IVD;ACADS
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4231859436553096,1.366665084520268,0.09071274298056156,0.4542708523413751,1.0,12/31,17.39%,DSCAML1;COL2A1;OSR1;HOXD3;MEGF8;FGFR2;HOXA4;EIF4A3;PDGFRA;HOXA9;TWIST1;HOXD4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5592414630652736,-1.366497377076966,0.12609457092819615,0.31672272932318585,1.0,4/11,9.94%,PELI1;BIRC3;ARHGEF2;CASP8
prerank,positive regulation of inflammatory response (GO:0050729),-0.35165565393217735,-1.365860055607426,0.03676470588235294,0.3174782915363872,1.0,25/86,25.15%,OSMR;ETS1;APP;IL15;IL6ST;NMI;NFKBIA;PDE2A;PDCD4;NAPEPLD;LBP;FEM1A;AGTR1;LPL;IL17RA;IFI35;TNFRSF1A;IL16;HYAL2;GPR4;SERPINE1;CEBPA;RIPK1;DHX9;DDT
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.32026420833525027,-1.3658026527261034,0.026929982046678635,0.31713752794275507,1.0,33/149,18.62%,PRKCH;EDA;ERC1;CAV1;TAB3;ROR1;NOD1;TRAF5;TRIM25;APP;RPS6KA5;SLCO3A1;PRKD2;TFRC;NFKB1;NFKBIA;ZBTB7A;PRKD1;ARHGEF2;RNF25;CFLAR;TRIM14;IRAK1;MTDH;FLOT1;CD40;TAB2;TRIM13;IRAK2;IKBKG;IKBKB;NOD2;RPS3
prerank,regulation of acrosome reaction (GO:0060046),0.5618180886880881,1.3654662324781575,0.10683760683760683,0.455134746682311,1.0,2/10,3.98%,GLRA1;SPINK13
prerank,water transport (GO:0006833),0.5358383573524753,1.3645869857109878,0.13626373626373625,0.45516435930039617,1.0,2/12,4.55%,PDPN;AQP4
prerank,GPI anchor metabolic process (GO:0006505),0.43418896432084503,1.3645676432777991,0.09523809523809523,0.45310386703222566,1.0,7/26,11.98%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3;GPLD1
prerank,response to nutrient levels (GO:0031667),-0.5006340638365085,-1.3642923874106523,0.10771992818671454,0.319629495213226,1.0,5/17,14.31%,MTOR;FAM107A;PRKAA1;RPTOR;ATF4
prerank,cellular response to starvation (GO:0009267),-0.32321948766039493,-1.36393585961504,0.021702838063439065,0.31984569518362194,1.0,43/147,18.76%,FOXO1;BMPR2;SESN1;MTMR3;ATG7;MAP3K5;SIK1;LRRK2;MTOR;MAP1LC3B;PPARA;STK24;FAS;FOXO3;SEC13;PRKD1;MAPK1;DAPL1;MFSD2A;MIOS;TP53;KLF10;PRKAA1;GABARAP;WIPI1;RPTOR;ATP6V1E1;LARS1;MAPK8;ATF4;HNRNPA1;ZFYVE1;KPTN;ATG5;CASTOR1;GCN1;NUAK1;RIPOR1;WRN;RNF152;DAP;LAMP2;ITFG2
prerank,mRNA destabilization (GO:0061157),-0.4138552648589833,-1.3638727791167116,0.07815275310834814,0.31951022427354664,1.0,15/38,23.19%,TUT7;METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;TUT4;RC3H1;PDE12;ROCK2;MOV10;DIS3L2;RBM24;METTL16
prerank,regulation of dendrite development (GO:0050773),0.40317821897957146,1.3634398449855687,0.09010989010989011,0.45369742896299636,1.0,8/37,6.07%,CSMD3;ADGRB3;DCC;HECW1;VLDLR;CDKL5;TNIK;HECW2
prerank,smooth muscle contraction (GO:0006939),-0.5169087462320131,-1.3626974722058185,0.10990990990990991,0.3212545218541497,1.0,9/14,24.21%,EDNRA;MYH11;PIK3C2A;ACTA2;ROCK1;MYLK;ROCK2;SMTN;TPCN2
prerank,regulation of autophagy (GO:0010506),-0.3049194942830081,-1.362456455436444,0.01485148514851485,0.32128792766192443,1.0,76/216,27.01%,ITPR1;FOXO1;MCL1;TAB3;DAPK1;ACER2;SH3BP4;TLK2;GSK3B;MTMR3;ATM;EXOC4;LRRK2;MTOR;PIP4K2A;RASIP1;FOXO3;ABL1;NEDD4;IRGM;ERN1;BNIP3;PIP4K2B;PIK3C2A;PLK2;ROCK1;PRKD1;TBC1D14;DAPL1;GSK3A;HAX1;USP13;AKT1;PRKAA1;TRIM14;VPS26A;MTDH;RPTOR;KAT5;ATP6V1E1;MAPK8;HGF;PIK3CB;GPR137B;EXOC8;USP10;TAB2;RAB39B;HDAC6;ATP6V0A1;RNF152;DAP;DRAM2;WASHC1;WDR41;PRKAB1;UCHL1;ORMDL3;CTSA;KEAP1;MTMR4;GFAP;ATF6;ATP6V1H;TRIM68;FZD5;RHEB;TPCN2;HMGB1;TRIB3;PLEKHF1;VPS35;ATP6V0E2;WDR24;TPCN1;MET
prerank,cell projection assembly (GO:0030031),-0.45948767933170204,-1.3624270852835096,0.09074074074074075,0.3208926648041923,1.0,7/22,13.98%,PARVB;RAC1;RHOJ;PARVA;RHOQ;RHOG;NCKAP1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5342985807514947,-1.362337614473962,0.11977186311787072,0.32061312104132017,1.0,6/13,20.15%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,chromatin remodeling (GO:0006338),-0.3426894289066413,-1.3617724400001368,0.036395147313691506,0.32123916415003295,1.0,27/100,19.50%,SMARCA2;BAZ2B;RB1;ESR1;KAT2B;ARID1B;HDAC1;SMARCC1;ZBTB7A;BAZ1A;KDM6A;SRCAP;SMARCE1;CECR2;KDM6B;SMARCC2;CHD3;ACTB;HDAC4;HCFC1;SMARCD3;DR1;RUVBL2;KDM5B;INO80B;SMARCAD1;ATRX
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5832648996088277,-1.3614066098381006,0.10720887245841035,0.3215134621479795,1.0,4/10,16.66%,ST3GAL1;ST6GAL1;GNPDA2;GNE
prerank,positive regulation of nervous system process (GO:0031646),0.478403875818295,1.3606475638344875,0.11670480549199085,0.4582551978881239,1.0,5/18,2.77%,TENM4;MYRF;RIMS2;RIMS1;CARTPT
prerank,cellular protein catabolic process (GO:0044257),-0.3765807303652427,-1.3598531389805235,0.0575139146567718,0.32406223568857345,1.0,21/59,23.52%,DAB2IP;CTSC;RAB7A;AP2B1;AP2A2;AP2S1;BNIP3;DENND3;CASP8;CAPN2;AFG1L;MAGEC2;LGMN;CTSZ;MYLIP;CTSH;AP2M1;CTSF;MDM2;CTSO;RIPK1
prerank,protein monoubiquitination (GO:0006513),-0.41419238815009846,-1.3597596050843437,0.07265774378585087,0.32380651982177705,1.0,15/36,25.42%,TRIM25;DTX3L;RBX1;CUL3;RNF40;KLHL12;UBE2D3;RAD18;OBI1;CDC73;HUWE1;FANCL;UBE2R2;LEO1;DTL
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.5482916310223666,1.3595050207251815,0.14606741573033707,0.45899136688947223,1.0,3/11,8.05%,PLA2G7;LIPC;PLA2G3
prerank,alcohol catabolic process (GO:0046164),0.5564046142874589,1.3594549181825861,0.12389380530973451,0.45702854119746406,1.0,4/10,13.32%,AKR1D1;CYP46A1;CYP27A1;APOE
prerank,protein localization to membrane (GO:0072657),0.30021110975729665,1.3593139072888643,0.011737089201877934,0.45525604906954714,1.0,38/187,11.94%,KCNIP4;MAGI2;NRXN1;NLGN1;ABCA12;DLG2;LRRC7;DPP10;MAP7;ANK3;DPP6;CYP46A1;EPB41L3;RAB15;ANK1;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;CPE;MYO5A;WNK3;CD81;HGS;ARL3;NKD2;SPTBN4;TESC;ZFYVE27;RAB3A;C2CD5;LIN7C;TSPAN32;PPIL2;DLG4
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.454470736263727,-1.3590494123806316,0.08207705192629816,0.3247126253336364,1.0,8/25,14.99%,ITGA6;THBS1;APP;EGFR;ILK;PSEN1;PTGES3;MIF
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3764749871247232,-1.3589105720781678,0.05615942028985507,0.32453484199496624,1.0,25/54,29.38%,NXN;DCUN1D3;CAV1;IVNS1ABP;AKT1;SMAD7;SPOPL;CHP1;COPS9;N4BP1;RPL5;SENP2;TNFAIP3;CTNNB1;RPS3;SOX4;SH3RF2;OGT;HSPA1B;ADGRB1;ARRB1;PINX1;BAG5;PRMT3;PRKCG
prerank,protein-containing complex subunit organization (GO:0043933),-0.33815224174716507,-1.3588149143293078,0.02882882882882883,0.32430790821160393,1.0,41/109,25.61%,SLC2A1;PARD3;MNAT1;CREBBP;CD2AP;RANBP9;TEAD1;MITF;HES1;FAS;NUP98;KPNA3;WASL;SNX9;OCLN;PICALM;DET1;AFG3L2;TP53;YAP1;HFE;CD40;PEX14;TPR;TUBGCP4;TFAP4;FANCC;IKBKG;WASF1;MAGI1;VAMP3;MDN1;VAMP2;PTK2B;MDM2;PPIH;NDUFAF1;CD247;GPAA1;APC;DMTN
prerank,response to exogenous dsRNA (GO:0043330),-0.47707523804093166,-1.358287875237058,0.1213235294117647,0.32495454229863413,1.0,8/18,24.26%,CAV1;IFIH1;FLOT1;CGAS;MAVS;SLC3A2;RALB;DHX9
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3223756086872768,1.3580826343361536,0.043689320388349516,0.45615584713718954,1.0,26/124,10.42%,CNTNAP2;NLGN1;L1CAM;RASGRF1;BLK;PPP1R9A;CNTN4;GPM6B;SH3GL2;TMEM108;CDK5;TTC29;PLP1;PLEK;ATXN10;TSGA10IP;MAP2;NPY;GPM6A;CARMIL1;MAPT;POU4F1;KIFAP3;CATIP;STMN2;ZFYVE27
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5441729673850599,-1.3576499933688593,0.12406015037593984,0.325740827673855,1.0,6/12,20.15%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.38251987428496065,-1.357341657930929,0.0650994575045208,0.3258398215539319,1.0,25/58,24.76%,ATM;UIMC1;KDM2A;SMC5;XRCC4;ZBTB7A;MRE11;NSMCE2;KAT5;NHEJ1;RNF168;BABAM2;UBE2V2;ERCC8;SUMO1;HERC2;BRCC3;PIAS4;PRKDC;LIG4;BRCA1;DCLRE1B;ERCC6;HMGB1;DCLRE1A
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4437918788544073,1.3562752323143075,0.08078602620087336,0.4584703312528758,1.0,14/23,23.86%,CCDC88A;TUBA1C;KIF5A;DYNC1I1;KIF1C;HOOK1;TUBB;MAP6;MAP6D1;HOOK3;DYNC1I2;KIF5C;CCDC88C;F8A1
prerank,negative regulation of organelle assembly (GO:1902116),-0.41912333020494963,-1.3560589161080496,0.07317073170731707,0.3279662995970303,1.0,10/35,10.96%,KAT2B;LIMK2;LRRK2;CDK10;TBC1D30;SCFD1;SMAD4;YAP1;CHMP4B;CHMP4A
prerank,response to lipopolysaccharide (GO:0032496),-0.32297992465334463,-1.3551661434010935,0.04085257548845471,0.329218786412739,1.0,46/138,28.79%,FOXP1;DAB2IP;PELI1;NOS3;SRR;IFNAR1;ADAM9;HNRNPA0;NFKB1;TNFRSF1B;GGT5;PDCD4;GCH1;IRGM;MEF2C;MAPKAPK2;LBP;SCARB1;NFKBIL1;IRAK1;JAK2;RHOA;CDC73;MAPK8;RPS6KA3;SMAD6;TAB2;CHMP5;TNFAIP3;DEFA6;NOD2;NOS1;RELA;SERPINE1;SHPK;HMGB1;CASP1;ADAM17;F2R;ERBIN;CXCL10;TRIM6;SELP;LGALS9;CACTIN;AXL
prerank,modulation by host of symbiont process (GO:0051851),-0.42965041306544904,-1.3538220559163043,0.07918968692449356,0.3313575381810088,1.0,7/31,9.44%,LEF1;CHD1;SP1;HDAC1;JUN;NAPEPLD;TAF11
prerank,negative regulation of histone methylation (GO:0031061),-0.5676698762075223,-1.3536037171659285,0.13142857142857142,0.33129719318162626,1.0,6/10,31.42%,BCOR;DNMT1;BRCA1;WDR5;AASS;DNMT3B
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.46763340868596026,-1.3528111097168272,0.09642857142857143,0.33243291156592497,1.0,8/21,16.96%,MYH9;ADAM9;PSEN2;SPPL3;ADAM10;PSEN1;APH1A;ERAP1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5451091302196356,-1.3526624517782668,0.1243432574430823,0.3322749378895696,1.0,9/12,31.88%,TP53;RFWD3;RPA2;SDE2;CCND1;PRKDC;PLK3;FBXO31;RPS27L
prerank,protein-DNA complex disassembly (GO:0032986),-0.5035360440303387,-1.3526522582641047,0.10841121495327102,0.3318446064557376,1.0,10/16,38.74%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3;SMARCB1;SET;GRWD1;NFE2;HMGA1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3780820781038582,-1.3526068268099913,0.07678571428571429,0.3314486395987606,1.0,15/48,13.06%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;CUX1;LIMS1;CRK;ABL1;FLNA;CUL7;FBXW8;ILK;NEDD9;MYOC
prerank,regulation of organelle assembly (GO:1902115),-0.3525624878344885,-1.352602582225368,0.03903345724907063,0.3309997022156679,1.0,28/72,26.33%,MTMR3;STX18;MSN;TBC1D1;TBC1D2B;IFT140;EZR;PLK2;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;TRAPPC12;ATG5;TBC1D20;TBC1D8;ALMS1;TBC1D17;RNF4;PDCD6IP;EVI5;IFT20;TBC1D12;SENP6;CEP295;RDX
prerank,activation of GTPase activity (GO:0090630),-0.34099110654122866,-1.3522372503535987,0.043243243243243246,0.33125729372874696,1.0,35/89,25.19%,TBC1D4;BCR;RALGAPA1;CORO1C;TBC1D1;ARHGEF15;TBC1D2B;TBC1D8B;USP6NL;TBC1D30;TBC1D14;SIPA1L3;MTSS2;TBC1D22B;TBC1D22A;SLC27A4;BCAS3;RHOG;ARHGEF10;TAX1BP3;ABR;ARHGAP22;ARHGAP29;TBC1D8;TBC1D17;TBC1D25;EPHA2;ARHGEF5;EVI5;TBC1D12;ARHGAP42;PIP5K1A;SYDE1;SIPA1L1;SIPA1
prerank,negative regulation of calcium ion transport (GO:0051926),0.5003583033052778,1.3520119753737938,0.09954751131221719,0.46717334736475985,1.0,4/15,9.76%,ATP1A2;STC1;TRIM27;ADRA2A
prerank,phospholipid dephosphorylation (GO:0046839),0.40276177593345974,1.3516336324868237,0.0851528384279476,0.46611295194816305,1.0,13/37,13.18%,PIP4P1;PLPPR4;PLPPR1;PLPP2;MTMR2;SGPP1;PLPP4;PLPPR5;MTMR11;MTMR10;MTMR7;OCRL;INPP5F
prerank,cellular response to ionizing radiation (GO:0071479),-0.3888493662112943,-1.3514424814547117,0.08145580589254767,0.33238024120509224,1.0,23/47,30.69%,MAP3K20;NET1;TLK2;ATM;NIPBL;SPIDR;RPL26;TP53;YAP1;GRB2;WRN;LIG4;BLM;MDM2;INTS7;GADD45A;INO80;TMEM109;RAD51AP1;EEF1D;MAPK14;SWI5;KDM4D
prerank,muscle contraction (GO:0006936),-0.32695263144381914,-1.351172987574832,0.04006968641114982,0.3324285686165231,1.0,34/126,20.45%,UTRN;SORBS1;MYOF;GJC1;EDNRA;TPM3;ITGA1;EMD;DYSF;PXN;TMOD3;ITGB5;SNTB1;MYH11;ACTA2;ROCK1;ASPH;CHRNB1;MYOM1;MYLK;ARHGEF11;LMOD1;SORBS3;TPM1;ROCK2;MYL6;CASQ2;SSPN;CALD1;MYL12B;GAMT;SNTA1;SMTN;VCL
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5060374843014479,-1.3505615365586086,0.10237659963436929,0.333108057581166,1.0,4/14,11.76%,ANKRD17;PUM1;DDX60;USP15
prerank,organic acid transport (GO:0015849),-0.33888459129509896,-1.3498718656407553,0.036521739130434785,0.3338601640520137,1.0,25/94,16.43%,ABCC4;ABCG2;SLC6A6;SLC26A7;ATP8B1;SLCO1C1;SLC7A1;RXRA;SLC25A32;SLC5A6;SLC38A5;SLC16A1;LRRC8D;SLC1A5;SLC13A3;PPARD;SLCO2B1;MFSD2A;SLC25A11;SLC27A4;CEACAM1;SFXN5;SLC7A7;SLC43A1;ACSL1
prerank,embryonic skeletal system development (GO:0048706),0.4016561189407496,1.3494024747398126,0.06666666666666667,0.46957668256387464,1.0,11/35,14.31%,DSCAML1;COL1A1;OSR1;HOXD3;UCMA;DEAF1;MEGF8;SLC2A10;HOXA4;PDGFRA;HOXA9
prerank,ERBB signaling pathway (GO:0038127),-0.35775914227393124,-1.3493386711499094,0.05772811918063315,0.33449952453870435,1.0,17/64,11.50%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;PTPN12;SLC30A10;CBL;PIK3R1;PLCE1;PTK2;PIK3C2A;MAPK1;BCAR1;AKT1;BRAF;NCK2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.44255932886879573,-1.349318192342267,0.10460992907801418,0.33407834781651496,1.0,15/25,33.44%,CDK13;CDK12;EAF1;LDB1;CDC73;RNF168;NELFB;ZMYND11;SUPT4H1;LEO1;HNRNPU;BRD4;LARP7;NELFA;NELFCD
prerank,sulfation (GO:0051923),0.5455047191980917,1.348926278457816,0.12967032967032968,0.46878475986477164,1.0,2/11,4.35%,HS3ST5;SULT2B1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5240831724665982,-1.3484081881802632,0.11666666666666667,0.3354401234253113,1.0,8/13,26.65%,TNRC6B;POLR2G;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3505808120960557,-1.3483605655225246,0.04280821917808219,0.3350791021689484,1.0,21/79,15.88%,DAB2IP;CRIM1;BMPER;BMPR2;SMURF2;THBS1;PTPN1;SMURF1;SLIT2;NEDD4;SKIL;SMAD1;SMAD4;ACVR2A;UBE2D3;SMAD7;NOTCH1;FGF2;SPRY4;SMAD6;SKI
prerank,dorsal/ventral pattern formation (GO:0009953),0.46355165388157615,1.3483051952145184,0.12366737739872068,0.46828846957750736,1.0,5/20,8.99%,DSCAML1;LHX1;NBL1;FBXL15;LMX1B
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4695088150664783,1.3477649556098752,0.10672853828306264,0.4675751041447647,1.0,4/21,5.98%,NUDT19;LPIN1;HAO1;CYP26B1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3945382801000838,-1.3476890457462418,0.07394366197183098,0.3359593278722821,1.0,16/46,18.03%,ANXA2;PAK2;JAK1;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;HNRNPF;JAK2;LCP1;MIF;TALDO1;SOD1;CFL1
prerank,negative regulation of synaptic transmission (GO:0050805),0.44965080753222625,1.3473404900451513,0.1352549889135255,0.46655300578360953,1.0,6/23,11.60%,SLC24A2;SYT11;MTMR2;ATAD1;CBLN1;PRRT1
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.30630192540369244,-1.3466431564171564,0.016778523489932886,0.33753634258819754,1.0,48/199,19.19%,PTPRG;DAB2IP;KLF7;NFIB;ZNF423;RB1;NOS3;BMPR2;IL17RD;CORO1C;GSK3B;MCC;RPS6KA5;BMP5;WWC2;IL15;ID1;SPRED2;SRGN;EGFR;LAMA4;GAS6;NOVA2;LDLRAD4;BMP4;MEF2C;RAB11FIP3;ROCK1;GSK3A;RGCC;SMAD7;ADAMTS5;NOTCH1;ADM;WNT11;ASB1;ATF4;N4BP1;SMAD6;ROCK2;MAD2L2;PCTP;HEY2;HEY1;PAEP;PROCR;RAB11FIP1;PPP2CA
prerank,response to progesterone (GO:0032570),-0.4811339561061223,-1.3464115166114,0.11152416356877323,0.3375290689404696,1.0,5/18,10.44%,ABHD2;CAV1;THBS1;TGFB2;YAP1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.45406481407862714,1.3463460214749265,0.11853448275862069,0.46707883397642774,1.0,5/20,10.02%,AKR1D1;CYP46A1;AKR1C1;TSPOAP1;CYP11B1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5149282360422973,-1.3460466581734496,0.1310344827586207,0.3377719465948942,1.0,4/14,10.17%,CAV1;ZEB1;SPRED2;NOTCH4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4195965933641132,1.3458355748812014,0.08695652173913043,0.466428031387636,1.0,7/29,13.70%,SYCP1;MAJIN;ZCWPW1;REC8;SYCP2;SIRT7;RAD21
prerank,mitochondrion distribution (GO:0048311),-0.5407696233427196,-1.345809107881224,0.1092896174863388,0.337803725747852,1.0,3/12,4.05%,MEF2A;TRAK1;LRRK2
prerank,cellular response to chemical stress (GO:0062197),-0.34166664588914103,-1.3456816672067073,0.049910873440285206,0.3376320943475842,1.0,33/96,24.59%,FOXO1;CAV1;PKD2;ATG7;ATM;DDX3X;LRRK2;FAS;FOXO3;ABL1;PYROXD1;LRRC8D;PRKD1;PRKAA1;ERO1A;CAT;NCF2;MSRA;TXNRD2;ATF4;GPX1;NOX4;SOD1;FANCC;CCS;TRPV4;VRK2;KEAP1;SLC25A24;NFE2L2;TXNRD1;HSPA1B;PIK3CA
prerank,lipid transport (GO:0006869),-0.33657210821670247,-1.3450480511441794,0.04488330341113106,0.33847276852294667,1.0,38/97,27.14%,ABCC4;PITPNC1;ATP8B1;CERT1;PLTP;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SPNS2;ABCD3;LBP;SCARB1;PPARD;SLCO2B1;MFSD2A;ABCA9;SLC27A4;CEACAM1;ABCA7;TNFAIP8L3;MFSD2B;ACSL1;PCTP;PRELID2;GLTP;OSBPL2;PITPNA;ABCA6;PEX3;SLC10A3;SLC27A3;ATP8A1;FABP3;STARD5;ABCG4;PRELID3A;SLCO1B1
prerank,endomembrane system organization (GO:0010256),-0.3070811725682445,-1.345005916520187,0.025408348457350273,0.3381064410211341,1.0,49/178,19.93%,SPTBN1;ATP8B1;MYOF;SEC31A;DNAJC13;CSNK1A1;COG1;DYM;TMCC1;A4GALT;SYNE1;SRGN;LRRK2;RAB1A;GOLPH3L;DYSF;RAB2A;TOR1B;ATL2;ALS2CL;MYO18A;SEC16B;USP6NL;PRKD1;REEP3;CUL7;FBXW8;GAK;BCAS3;FAM174B;ARFGEF1;CHMP2B;CSNK1D;TRAPPC12;EXOC8;PI4K2B;TBC1D20;SUN1;LMAN2;TLCD1;GOLPH3;TMED5;ALS2;VAPA;AKTIP;HUWE1;WASHC4;TJAP1;OSBPL2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.32917453140120156,-1.3448968422333731,0.044563279857397504,0.3378449026158065,1.0,22/113,10.63%,TEK;RREB1;NRP2;BMPR2;BMP5;TBX1;KDR;PRKD2;BMP6;EGFR;BMP4;FGF1;STXBP4;PRKD1;NOTCH2;FLT4;AKT3;PIK3CD;AKT1;VEGFC;YAP1;FGF7
prerank,regulation of cellular catabolic process (GO:0031329),-0.3628814894102866,-1.344791299985604,0.05363321799307959,0.3376197538589843,1.0,22/62,24.66%,ITPR1;DAPK1;ACER2;MTMR3;ATM;LRRK2;PIP4K2A;ABL1;PIP4K2B;ROCK1;USP13;RPTOR;GPR137B;USP10;RAB39B;HDAC6;DRAM2;WDR41;KEAP1;MTMR4;TPCN2;TRIB3
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5579227970074087,1.3446298487860404,0.15137614678899083,0.46756316387936897,1.0,4/10,10.56%,ENPP2;PLA2G7;LIPC;PLA2G6
prerank,positive regulation of defense response (GO:0031349),-0.33993062570775356,-1.3437110562464591,0.05964912280701754,0.3393096225144636,1.0,29/89,27.42%,ETS1;APP;IL15;NMI;NFKBIA;PDE2A;PDCD4;MEF2C;NAPEPLD;AKIRIN2;FEM1A;AGTR1;LPL;IL17RA;PLSCR1;POLR3F;IFI35;TNFRSF1A;GBP5;IL16;HYAL2;GPR4;SERPINE1;CEBPA;RIPK1;DHX9;DDT;RIOK3;GPSM3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.28328704927323944,-1.3431047813418098,0.010452961672473868,0.3400237910272264,1.0,79/366,15.91%,APBB2;NFIA;RREB1;SMARCA2;ENG;ZNF423;ACVRL1;RB1;CREBBP;NSD1;BNC2;ERC1;KAT6B;INSR;ESR1;FOXN3;ANKRD17;ZFHX3;IRF2;APP;RPS6KA5;WWC2;NR3C1;ZSCAN21;SOX13;MITF;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;DNM2;TRRAP;FOXO3;ABL1;NFYC;FUS;MEF2C;ZBTB4;SLC39A8;NSD3;GTF2IRD1;ASCC1;LDB1;NAB1;GPBP1;USP13;PRDM2;SPTY2D1;TP53;SP3;HMG20A;ORC5;SOX7;JMJD1C;CHD3;SFPQ;PRRX2;NOTCH1;OGG1;OBI1;YAF2;TAF5L;RPL10;GPBP1L1;ATF4;MZF1;HCFC1;MYBL2;FOXC1;CREBL2;TCF3;TCF7L1;NR1D2;FOXO4;NAB2;HIC1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5401173287159353,-1.3415483267787605,0.13111888111888112,0.3427469138841885,1.0,4/12,8.63%,LYN;PTK2;MAPK1;IL34
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4976583036493327,-1.3413697192515335,0.1048951048951049,0.34265504166951394,1.0,5/16,12.63%,RB1;PDS5B;NIPBL;POGZ;PDS5A
prerank,plasma membrane repair (GO:0001778),-0.5259941865966165,-1.341060244329603,0.12695652173913044,0.3428149464618894,1.0,4/13,6.49%,MYOF;MYH9;DYSF;AHNAK2
prerank,histone deacetylation (GO:0016575),-0.3869988283651424,-1.3409633547457291,0.09107142857142857,0.3425445236042065,1.0,17/43,23.83%,MIER1;PRDM5;RCOR1;HDAC1;MIDEAS;SIN3A;SFPQ;HDAC4;HDAC6;MIER2;HDAC10;MIER3;SMARCAD1;ELK4;TBL1X;SUDS3;MORF4L1
prerank,proton transmembrane transport (GO:1902600),0.3950445517799338,1.340018325131874,0.10392609699769054,0.4775050991472033,1.0,7/36,8.80%,ATP1A2;ATP12A;SLC46A1;UCP3;SLC36A2;ATP6V0C;ATP4A
prerank,negative regulation of cellular senescence (GO:2000773),-0.5113957315419184,-1.3395305688393029,0.1252236135957066,0.34494509226649034,1.0,6/13,21.68%,SLC30A10;AKT3;MAP3K3;CDK6;TERF2;TERT
prerank,regulation of muscle cell differentiation (GO:0051147),-0.41922316799495263,-1.3381300255657451,0.09800362976406533,0.34723336392579357,1.0,13/31,21.97%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;MAPK12;TCF3;CTNNB1;IGF2;SPAG9;MYOCD
prerank,actin filament bundle organization (GO:0061572),-0.4136955146590488,-1.3379233277152762,0.09057971014492754,0.34720836310648723,1.0,10/33,13.18%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;FAM107A;SHROOM1;SHROOM2;NEDD9;LCP1
prerank,positive regulation of chromatin organization (GO:1905269),-0.5207178021945537,-1.3377888991437763,0.1275797373358349,0.3470090233814795,1.0,6/12,19.50%,MIER1;TAL1;SIN3A;H3-3A;TERF2;ATRX
prerank,apical protein localization (GO:0045176),-0.5573212972685557,-1.3377382774871889,0.13333333333333333,0.3466561327335817,1.0,4/10,11.80%,ATP8B1;SHROOM3;SHROOM2;ACTB
prerank,regulation of myoblast fusion (GO:1901739),-0.5437580847721566,-1.3376048289557827,0.16007194244604317,0.34642292402288616,1.0,7/11,29.63%,EHD2;CFLAR;EHD1;FLOT1;CD53;ADGRB1;MAPK14
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.43371745584234433,-1.3371061336544683,0.09417808219178082,0.34693530291494984,1.0,9/28,15.69%,DAB2IP;ITPR1;MAP3K5;ERN1;ATP2A3;ERO1A;ATF4;DNAJC10;BBC3
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.3076085373435604,-1.3362964537896649,0.02226027397260274,0.3480502020851604,1.0,65/190,23.52%,DAB2IP;ITPR1;CAV1;CD2AP;MCL1;ESR1;LYN;UACA;SH3BP4;TMSB4X;THBS1;WWC2;CGNL1;DDX3X;PTPRJ;VGLL4;LIMD1;PPARA;NMI;PDE2A;PPEF2;SLIT2;DDIT4;PDE3A;STAMBP;GSK3A;PPM1B;CASP8;AKT1;UBR2;PRKAA1;THEM4;PEBP1;DUSP3;PIK3CB;PIK3IP1;TRIM59;CCN3;IFI35;C1QTNF3;ABCA7;USP10;MARK3;BMP7;TNFAIP3;ARHGAP12;PPIF;ZMYND11;HYAL2;UBR1;WTIP;EPHA2;TMEM127;HERPUD1;AKT1S1;HDAC7;MAP2K3;PTEN;PHLDA3;MDM2;NF1;TRIM39;RELA;AJUBA;RIPK1
prerank,intracellular pH reduction (GO:0051452),0.40414179520759586,1.336090540976826,0.09554140127388536,0.48512139414021316,1.0,11/33,17.01%,TMEM9;ATP6V1B2;ATP6V0C;ATP6V0A2;ATP6V0D2;ATP6V1G2;DMXL2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1
prerank,cellular glucan metabolic process (GO:0006073),-0.5545781837980172,-1.3349681915771672,0.15970961887477314,0.35025003872305494,1.0,4/11,13.59%,GBE1;GSK3B;PPP1R3C;PHKB
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5389553735964887,-1.3348066317680989,0.13620689655172413,0.3501397840918472,1.0,2/12,0.61%,DAB2IP;SEMA6A
prerank,synaptic vesicle endocytosis (GO:0048488),0.40596885275362865,1.3345229100029177,0.07865168539325842,0.48688917967403217,1.0,7/33,6.10%,NLGN1;SYT1;SYT5;AMPH;CDK5;DNM1;SNCG
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4236956888739617,1.3338067705475523,0.107981220657277,0.4867748665227895,1.0,7/27,7.13%,IL1RAPL1;CTNNA2;CCDC88A;NTNG2;NTNG1;NCS1;HOMER1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3298299533322629,-1.333555918368371,0.028268551236749116,0.3522148047508906,1.0,34/108,25.03%,HIP1;SENP1;DAPK1;ACER2;NOD1;UACA;CASP12;MAP3K5;TNFSF10;DDX3X;FAS;NGF;PPM1F;ATP2A3;ARL6IP5;CRADD;CASP8;BCAP31;CFLAR;SOX7;JAK2;HIP1R;BBC3;DAP;RPS3;CASP8AP2;F3;FOXL2;PPARG;CASP2;RIPK1;HMGB1;EIF2AK3;CASP1
prerank,negative regulation of cell death (GO:0060548),-0.34177600191292906,-1.3333959583551347,0.05945945945945946,0.35210226706108955,1.0,28/88,18.76%,MECOM;FERMT2;CD34;CD200;GSK3B;LRRK2;INPP5A;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;WNT16;AKT1;CHMP4B;CHMP4A;TM7SF3;RAD18;FGF2;WNT11;CCN5;PDE12;CCN3;ATG5;FYN;BMP7;IKBKG;SOX4
prerank,negative regulation of signal transduction (GO:0009968),-0.29451412121823434,-1.3333632956667067,0.015,0.3517082923602297,1.0,69/249,20.01%,NXN;DAB2IP;SEMA6A;RB1;TRABD2B;BRAP;LYN;ASXL1;NTN1;THBS1;NFATC1;PTPN1;BMP5;LRRK2;NOTCH3;PTPRJ;VGLL4;EGFR;PTPN12;PIP4K2A;PALM;RNF43;ZBTB7A;NCK1;PHACTR4;DDIT4;IRS1;HERC4;NEDD4;PRKCD;PIP4K2B;NKD1;ARRDC1;GRB10;GRB14;GSK3A;GLIS2;NFKBIL1;AKT1;GLI3;HMGXB4;MOSMO;OTUD4;MAZ;SLC27A4;WWOX;NOTUM;FGF2;TCIM;APCDD1;PIK3CB;TAX1BP3;SPRY4;LGMN;HIC1;KIF26A;IGFBP5;GPR108;TNFAIP3;UBASH3B;HEY1;TNS2;GATA2;SIAH1;GPC3;WWP2;RITA1;PTPRC;KIF7
prerank,nucleotide-excision repair (GO:0006289),-0.33039029990210567,-1.3329287968002743,0.05663716814159292,0.3521064740812986,1.0,39/101,29.26%,MNAT1;RNF111;RBX1;POLR2G;ERCC2;TP53;POLD3;OGG1;ATXN3;RPA3;TCEA1;RPA1;XPC;ERCC3;PNKP;ERCC8;FANCC;CETN2;RPA2;RAD23A;USP7;LIG4;RFC4;COPS7A;COPS8;RFC1;COPS4;POLR2C;ERCC6;POLR2H;POLR2L;LIG1;POLL;GTF2H3;MMS19;CHD1L;PPIE;CCNH;COPS5
prerank,regulation of mRNA stability (GO:0043488),-0.31695889288065876,-1.3325757204248097,0.04036697247706422,0.35229700237503336,1.0,52/145,27.30%,PSMA2;METTL14;GIGYF2;LARP1;PRKCD;FUS;FTO;XRN1;PSME2;MAPKAPK2;PUM1;SAMD4A;ROCK1;PSMB4;EXOSC1;EXOSC2;YWHAZ;CELF1;AKT1;SERBP1;EXOSC3;AXIN2;RC3H1;PDE12;PSMC2;PARN;PSMB2;ZC3H14;ROCK2;EXOSC8;PSMB1;PSMA8;TNFSF13;NUP214;PSME1;EXOSC5;DCP1A;PSMD4;RBM24;METTL16;PSMD5;TAF15;FXR1;THRAP3;EXOSC7;PSMA3;CARHSP1;HNRNPU;HNRNPD;PABPC1;PSMB10;TENT5C
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.329247357100737,-1.3324072498891408,0.038391224862888484,0.3521766899463288,1.0,31/113,16.89%,UNC13B;DAB2IP;TRABD2B;FERMT2;ASAP1;MPP7;ESR1;GSK3B;ATM;DDX3X;TFRC;RBX1;RASIP1;SPIDR;CDH5;RAP1B;ERCC2;TAL1;TP53;FNIP2;ICE1;RPA3;LCP1;RPA1;RHOC;ERCC3;PSMC2;SLF2;SUMO1;BCL2L11;GBP5
prerank,positive regulation of protein acetylation (GO:1901985),-0.5382487585099568,-1.332272404961009,0.13854351687388988,0.3520055831335634,1.0,7/12,25.35%,DDX3X;DIP2B;PRKAA1;KAT5;RAPGEF3;DIP2A;CEP295
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.5781201385214072,-1.3321248973678128,0.1337099811676083,0.3518299813104835,1.0,2/10,13.74%,GNB1;SAG
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3530122128961234,-1.3312819419822997,0.043478260869565216,0.3530327966878864,1.0,27/80,16.91%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;SP1;EIF3C;PLD1;UPF3B;PRKCD;EPHA4;SAMD4A;GSK3A;PICALM;RPL26;ZCCHC4;EEF2;SLC2A13;LARP4B;RPS4X;SIRT3;RPL5;ROCK2;TNFRSF1A;METTL5;SMPD2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.42074583723487113,-1.3296001845975223,0.09872029250457039,0.35600444670662906,1.0,11/31,15.69%,PPP1R13B;GSK3B;YWHAE;YWHAZ;NMT1;GSK3A;TP53;CASP8;MAPK8;HIP1R;BBC3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.36777019346436235,-1.3295797725710075,0.06989247311827956,0.3555799796235634,1.0,23/54,26.43%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;CRADD;TP53;RGCC;BTG2;SOX4;CARM1;MDM2;CASP2;GADD45A;E2F7;ARID3A;CNOT2;CNOT8;PLK3;TFDP1;CNOT1
prerank,stress-activated MAPK cascade (GO:0051403),-0.358946573134238,-1.3293541785191052,0.08648648648648649,0.3555431708059967,1.0,23/61,24.56%,MAP3K20;TAB3;NOD1;MAP3K5;MAP4K3;NFKB1;MAPK1;IRAK1;MAP3K8;MAPK8;FBXW11;TNFRSF19;TAB2;IRAK2;MAP2K4;IKBKG;IKBKB;NOD2;MAP2K3;SH2D3C;MAP3K7;GPS2;MAPK11
prerank,RNA stabilization (GO:0043489),-0.41522492740992173,-1.3289816128555099,0.09734513274336283,0.35591051408741514,1.0,14/33,27.30%,LARP1;FUS;AXIN2;TENT2;PARN;TRDMT1;PHAX;RBM24;TAF15;THRAP3;NAF1;HNRNPU;PABPC1;TENT5C
prerank,negative regulation of gene expression (GO:0010629),-0.2857642533901626,-1.3287984119746123,0.008375209380234505,0.35582272792058445,1.0,99/302,27.84%,FOXP1;CLDN5;ENG;ACVRL1;RB1;KLF4;CD34;ESR1;DAPK1;TNRC6B;SLC7A5;APP;KAT2B;RPS6KA5;RNF139;KDR;DDX3X;SRGN;TIPARP;SMO;GIGYF2;ZNF148;LARP1;NFKB1;HDAC1;BMP4;TGFB2;MEF2C;SUZ12;ERN1;PARP14;SAMD4A;NOTCH2;OCLN;PICALM;ADAM10;CELF1;TASOR;YAP1;PRKAA1;SNX12;RGCC;DICER1;PSEN1;NOTCH1;FGF2;ASB1;MECP2;AGO2;H3-3A;N4BP1;BTG2;MIF;LGMN;ROCK2;TERF2;DNMT1;IGFBP5;IGF1;SYNCRIP;MOV10;HEY2;PPHLN1;CITED2;GATA2;RPS3;TNRC6A;NUDT12;WWP2;PPM1D;TOB1;CAPRIN1;DLL4;PTBP3;TERT;NDFIP2;DIS3L2;RPL13A;MRPL13;METTL16;YY1;HSPA1B;AEBP2;DIP2A;CNOT8;FXR1;BMP2;EIF2AK3;SETDB2;PARP9;RPS26;NANOS1;CNOT1;SLC24A3;DXO;EMILIN1;TRIM6;LSM2;PHF19
prerank,regulation of intracellular pH (GO:0051453),0.39766757853690915,1.3287768593201974,0.09330143540669857,0.49779928629497344,1.0,7/34,5.62%,CA2;SLC4A4;SLC4A5;SLC9A7;CLN3;SLC9A9;SLC4A2
prerank,positive regulation of secretion by cell (GO:1903532),-0.35227951657649426,-1.3277682576218255,0.07116788321167883,0.35746634627987495,1.0,16/70,11.13%,UNC13B;CD2AP;SLC12A2;GOLPH3L;BMP6;IER3IP1;ADAM9;TGFB2;RAB2B;EZR;MYO18A;RAB27A;RAB5A;MYOM1;EDN1;RGCC
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3646180824901761,-1.3276131345684632,0.06702898550724638,0.35731812217130665,1.0,23/57,27.31%,PAK1IP1;RPL26;RPL38;RPS16;NIP7;RPL5;TGS1;RPL35A;WDR74;BOP1;DDX31;RRS1;PES1;RPS7;EBNA1BP2;RPS15;RPS17;NOP16;GLUL;NAF1;EMG1;WDR12;BYSL
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2765686252602789,-1.3270873588342773,0.0033222591362126247,0.3579319294013607,1.0,128/423,26.42%,FOXP1;FLT1;TJP1;LEF1;GRK5;PRKCH;IGF1R;KITLG;OSMR;CLDN5;INSR;LRP5;ACER2;LYN;PDGFD;THBS1;CDK13;GCNT2;BMP5;TBX1;IL15;KDR;TGFBR3;IL6ST;BMP6;EGFR;TGFBR2;TRPM4;IL6R;HES1;GAS6;HDAC1;STX3;DNAJA2;CUL3;IRS1;BMP4;FGF1;AQP11;TGFB2;MEF2C;STAMBP;PTK2;TBX2;FLT4;IL34;NES;NOP2;NAMPT;LIFR;ADAM10;AKT1;EDN1;MAP3K3;VEGFC;YAP1;DOT1L;FGF7;PTGFR;MAZ;ACER3;HDAC4;NOTCH1;SAAL1;FGF2;RHOG;CDC123;EDN3;ASH2L;RPS4X;MECP2;COPS9;CDK6;FAM98A;MIF;LGMN;SRPK2;COX17;RARA;IGF1;GAB2;CTSH;TBC1D8;CLCF1;TNFSF13;NOD2;SOX4;KRAS;CACUL1;PTPRC;FGFR4;LIG4;IGF2;PRC1;IL13RA1;DLL4;NACC1;LAMC2;CCN1;PTEN;TERT;TTK;PTK2B;MDM2;S1PR3;ESM1;RELA;HAS2;CEP131;PIM1;TCF7L2;TBX3;HPSE;PDGFRB;DHX9;MVD;CNOT8;BMP2;LAMB1;IL7;RPS15A;PTN;TBX6;ADAM17;HNRNPU;F2R;RBPMS2;FGF10
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.4171486313852995,-1.3270796185182232,0.1070811744386874,0.3574811691747089,1.0,9/30,14.78%,FLT1;MLLT3;KDR;ACE;BMP4;FLT4;TP53;PRRC2C;LMBR1L
prerank,mitochondrion localization (GO:0051646),-0.47232068286430456,-1.326894981060741,0.12154696132596685,0.3573919339371315,1.0,4/19,4.05%,MEF2A;TRAK1;MARK1;LRRK2
prerank,sulfate transport (GO:0008272),-0.5084087259773616,-1.3262220303304364,0.13214285714285715,0.35834212605946725,1.0,5/14,16.50%,SLC26A7;SLC26A2;SLC13A4;SLC25A11;SLC26A11
prerank,cytosolic transport (GO:0016482),-0.3271765139263207,-1.3253776493047442,0.03907637655417407,0.3596396264431486,1.0,32/108,22.92%,VPS13A;VTI1A;MYO1D;ERC1;EPS15;RAB7A;TMEM87B;HEATR5A;VPS54;RAB5A;STX8;BET1L;VPS13C;GAK;DCTN1;VPS26A;AP1G1;ANKFY1;VPS52;TBC1D23;CORO7;ANKRD27;AKTIP;TBC1D17;VAMP3;WASHC1;AP4M1;CLN5;EVI5;SPAG9;KIF16B;BECN1
prerank,urogenital system development (GO:0001655),0.5245928265705191,1.3246872910680623,0.14099783080260303,0.5064119442826822,1.0,3/11,6.22%,LHX1;OSR1;PAX2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.5333251098378391,-1.324641084963083,0.12784588441331,0.3606896378348942,1.0,6/12,20.43%,SRR;MTHFD1;SERINC3;SERINC5;SEPHS2;CTH
prerank,protein deacylation (GO:0035601),-0.4512102371918661,-1.3239838698255098,0.10469314079422383,0.3615415566457274,1.0,15/23,29.87%,HDAC1;SIRT5;SIN3A;HDAC4;ABHD17A;NOTUM;SIRT3;ABHD17C;HDAC6;HDAC10;HDAC7;LYPLA1;HDAC5;PPT1;ABHD10
prerank,positive regulation of cellular process (GO:0048522),-0.26896947424930756,-1.3238699598794408,0.0,0.3613106211464415,1.0,133/565,19.14%,FLT1;TJP1;LEF1;GRK5;IGF1R;KITLG;SLC6A6;OSMR;CLDN5;PARD3;INSR;CAV1;ETS1;LRP5;RAC1;ACER2;LYN;ANKRD17;ZFHX3;PDGFD;THBS1;CDK13;GCNT2;BMP5;ATM;TBX1;IL15;KDR;DDX3X;PRKD2;MERTK;PTPRJ;IL6ST;BMP6;CDKN1B;EGFR;SMC5;TGFBR2;TRPM4;IL6R;HES1;GAS6;TNFRSF1B;HDAC1;STX3;DNAJA2;CUL3;IRS1;BMP4;LRP6;FGF1;AQP11;TGFB2;PRKCD;STAMBP;PTK2;EPHA4;TGM2;RAB27A;LBP;TBX2;FLT4;IL34;NOP2;EXOSC2;NAMPT;MFSD2A;LIFR;ADAM10;TAL1;ACACB;CELF1;AKT1;EDN1;VEGFC;DOT1L;PRKAA1;FGF7;LMNA;PTGFR;FRMD5;AXIN2;DICER1;MAZ;ACER3;HDAC4;NOTCH1;RAD18;RPS6KA1;PA2G4;RPTOR;FGF2;ACTN4;RHOG;CDC123;EDN3;FLOT1;ASH2L;RPS4X;TPM1;MAPK8;MECP2;H3-3A;COPS9;HCFC1;FAM98A;RPS6KA3;AGPAT1;LGMN;N6AMT1;ABCA7;TRPC3;SRPK2;LMAN2;COX17;RARA;IGF1;TULP1;TRIM13;GAB2;CTSH;ADGRG1;TBC1D8;CITED2;CLCF1;TNFSF13;GATA2;RNF10;SOX4;CCND1;RAD23A;KRAS;BRAT1
prerank,glial cell differentiation (GO:0010001),0.41686324316137086,1.3231236935343305,0.12702078521939955,0.5083040295021543,1.0,9/28,12.46%,MYRF;CDK5;MMP24;PTPRZ1;PAX2;GPC1;CDH2;SLC8A3;TPPP
prerank,calcium ion import (GO:0070509),0.4058979559095957,1.3213126420059276,0.1292517006802721,0.5110359672596814,1.0,10/28,18.40%,MS4A1;SLC25A23;CACNA1B;CACNA1A;CACNA1D;CACNA1E;SLC8A1;MCU;CACNA1G;CACNA1I
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5076492672474504,-1.3208355181267357,0.13924050632911392,0.36718242055255607,1.0,3/14,5.75%,PKD2;TMSB4X;NFKBIA
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5208375706572037,-1.3207401323885137,0.13537906137184116,0.36693365062869365,1.0,4/13,7.45%,RREB1;SOX13;SIX1;NAPEPLD
prerank,cellular response to UV-A (GO:0071492),0.5315713030042538,1.3204376087955487,0.15384615384615385,0.5112169717133492,1.0,4/11,12.29%,MME;CERS1;TIMP1;PPID
prerank,cellular glucose homeostasis (GO:0001678),-0.3861177556018817,-1.3202004229988646,0.0913884007029877,0.36754998696718655,1.0,8/41,7.06%,UNC13B;IGF1R;ZBTB20;FOXO1;GAS6;PIK3R1;ERN1;LRRC8D
prerank,cellular protein metabolic process (GO:0044267),-0.27641171594908964,-1.3197759433582283,0.004815409309791332,0.36801712153257216,1.0,151/396,30.13%,DAB2IP;ST3GAL6;IGFBP7;ST3GAL1;ST8SIA4;MSRB3;PLOD2;APP;RPS21;RRBP1;RPL37;IGFBP4;PARP4;CSNK1G3;RPL31;YES1;MMP2;GAS6;RPL9;RPS14;PSEN2;ABL1;BMP4;SPPL3;DENND3;PDIA6;RPSA;PHKA2;RPLP1;RPL3;AFG3L2;MRPL32;ADAM10;PCSK5;LMCD1;UBA7;RPL26;UBE2D3;FDX1;RPS11;ITIH2;ERO1A;PSEN1;STK38;RPL13;RPL38;GALNT11;MSLN;ANO8;PRKCSH;NOTUM;RPL27;RPS16;MRPS18A;RPS4X;FDXR;RPL10;RPL7A;MSRA;AGO2;MAGEC2;SERPINC1;GSPT1;RPL5;UBE2M;LGMN;HARS2;F5;RPS27;APH1A;IGFBP5;UBE2L3;IGF1;MRPL24;CTSH;RPL27A;PLAT;RPS3;BAP1;RPL35A;GPC3;WWP2;RPL36A;RPL37A;CLN5;MRPS14;PRKDC;IGF2;MRPS21;RPL32;MRPL35;MFGE8;UBL4A;LOX;WARS1;CCN1;CHRDL1;RPS7;RPL36;RPS8;RPL28;KTN1;RPS15;RPS23;MRPL34;RPL30;RPL13A;MRPL13;MRPL9;RIPK1;MSRB2;RPL22;RPS17;PNPLA2;SRBD1;LAMB1;MRPL43;RPL34;RPS2;RPS15A;RPS26;RPL15;MRPL11;SEC11A;ADAM17;PAPPA;STOML2;RPL39;RABGGTB;TMEM132A;SCG3;FBN1;MANBA;IGFALS;DNAJC3;UBE2I;LIPT1;DUSP12;RPL19;ATG3;YME1L1;RPLP2;COPS5;RPS13;MRPS17;RPL8;TNIP1;RPL18;AHSG;MBTPS1;CDC34
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4547800057813126,-1.319747810348719,0.13454545454545455,0.3676079629317604,1.0,11/22,28.48%,ERI3;RPS21;EXOSC2;NOL9;EXOSC3;EXOSC8;RRS1;PES1;EXOSC7;WDR12;UTP20
prerank,myoblast fusion (GO:0007520),0.5273971164658946,1.319687346221537,0.13752913752913754,0.5110495318043927,1.0,4/12,6.97%,ADAM12;ADGRB3;ADAMTS15;CD81
prerank,protein acylation (GO:0043543),-0.3996942679035386,-1.318930524060184,0.09357798165137615,0.3689462510195114,1.0,7/38,8.05%,FOXO1;CREBBP;KAT2B;ZDHHC6;KAT6A;ZDHHC3;NAA80
prerank,positive regulation of nuclear division (GO:0051785),-0.4359850891073106,-1.3186397230714841,0.11281070745697896,0.36910769822485034,1.0,15/25,40.53%,INSR;LRP5;EDN1;RGCC;EDN3;IGF1;IGF2;PDGFRB;BTC;PHIP;AURKA;IL1A;DRD3;CD28;NPM2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4649412797941607,-1.3186197045706494,0.1282051282051282,0.3686971153275494,1.0,5/20,12.33%,PRKCE;LYN;LBP;IRAK1;MTDH
prerank,positive regulation of JNK cascade (GO:0046330),-0.348984352701212,-1.3178706599105194,0.0661764705882353,0.3698439974816163,1.0,25/70,24.41%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TPD52L1;TAOK3;TNFRSF19;MTURN;CCL19;NOD2;DUSP22;EDAR;SH3RF2;PTK2B;LTBR;GADD45A;FZD7;RIPK1;HMGB1
prerank,thymus development (GO:0048538),-0.5232371752030855,-1.3173341229082136,0.13620071684587814,0.3705165583304153,1.0,8/13,33.04%,TBX1;HES1;SIX1;SOD1;EPHB3;FGF10;TGFBR1;SHH
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.45228082301276196,1.3171156993763626,0.11159737417943107,0.5159642112747415,1.0,6/20,12.07%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.32562590187845425,-1.3170582517366338,0.04912280701754386,0.37059409912071767,1.0,31/108,14.68%,TJP1;RAC1;RHOBTB1;GSK3B;IQGAP1;F11R;CRK;PAK2;RND3;DIAPH1;MTOR;RICTOR;ABL1;RHOQ;PRKCD;EZR;PTK2;CDK10;ROCK1;MAPK1;FAM107A;ARHGAP17;PRKAA1;CAPN2;RHOA;RHOG;SORBS3;RHOC;TRAF3IP1;HIP1R;MARK2
prerank,cellular response to hydroxyurea (GO:0072711),-0.5563456621172304,-1.3170370996419778,0.14031971580817051,0.3701662358160795,1.0,7/10,21.01%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.3503981149355162,-1.3160284637565773,0.06417112299465241,0.3716895242997593,1.0,16/70,16.31%,DAB2IP;MCL1;GSK3B;DDX3X;IL6R;TNFRSF1B;FAS;TGFB2;NGF;GSK3A;CRADD;CASP8;GABARAP;JAK2;HIPK1;TNFRSF1A
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2811853567025246,-1.31568781993768,0.00338409475465313,0.37190634980027404,1.0,119/351,26.83%,DAB2IP;SMARCA2;RAPGEF2;IGFBP7;ACVRL1;NOS3;PTPN14;KLF4;ETS1;ABI1;CBFA2T3;PKD2;LYN;BMPR2;PDS5B;CD200;SH3BP4;BTG3;APP;KAT2B;MCC;RNF139;BMP5;ITGA1;ARID2;P3H2;THAP12;TGFBR3;PTPRJ;EMD;CDKN1B;VGLL4;RBM5;CTCF;HES1;RARG;NMI;RBP4;BMP4;AQP11;TGFB2;PTPRK;NGF;CDK10;RAF1;CTBP2;IRF1;TP53;CELF1;KLF10;LMNA;FRK;ZBTB7C;AXIN2;SOX7;RGCC;NCK2;NOTCH1;JAK2;CDC73;TBRG1;NUDT6;CDK6;CCN3;BTG2;IFI35;FUZ;SMAD6;FOXO4;SKI;GSDME;IGFBP5;RERG;TFAP4;TNFAIP3;NOX4;CTNNB1;ADARB1;ADGRG1;TNS2;TES;GATA2;BAP1;SOX4;PPM1D;TMEM127;TOB1;CTNNBIP1;PPARG;CDKN2C;DLL4;WARS1;PTEN;PTK2B;NF1;MYOCD;DIS3L2;COPS8;CEBPA;TBX3;E2F7;HSPA1B;ATF5;ADGRB1;PLXNB1;BMP2;APC;PLPP1;TFDP1;E2F3;TPTE;NUPR2;CDKN3;PINX1;F2R;FABP3;SFRP4;CGREF1;PTPN2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.44951505065125463,-1.3151230536540948,0.1303538175046555,0.37259904458455523,1.0,9/21,25.15%,THBS1;MTUS1;PTK2;MAPK1;IL34;MIF;CMKLR1;PTK2B;DDT
prerank,cellular response to gamma radiation (GO:0071480),-0.47391365825281817,-1.314884637270814,0.14990859232175502,0.37265769747531713,1.0,6/17,10.44%,MAP3K20;TLK2;ATM;RPL26;TP53;YAP1
prerank,double-strand break repair (GO:0006302),-0.3069299500059553,-1.3148768601094425,0.03951890034364261,0.37221414028891403,1.0,67/158,30.97%,ATM;UIMC1;DTX3L;KDM2A;SMC5;SAMHD1;XRCC4;ZFYVE26;SPIDR;MRE11;MMS22L;NABP1;MCM9;RBBP8;TENT4A;RAD54B;SFPQ;NSMCE2;KAT5;RPA3;DNA2;RPA1;NHEJ1;MAPK8;RNF168;BABAM2;UBE2V2;PALB2;MAD2L2;SUMO1;RFWD3;HERC2;HPF1;WRN;BRCC3;SMARCAD1;RPA2;BAP1;PIAS4;PRKDC;LIG4;BRCA1;RAD51AP2;DCLRE1B;BAZ1B;BLM;YY1;MORF4L1;APBB1;HMGB1;DCLRE1A;PARP9;TRIP13;POLL;INO80;APLF;RAD51AP1;XRCC2;AP5Z1;RAD51D;TDP1;SWI5;KDM4D;CYREN;MDC1;HUS1B;KDM4A
prerank,cellular calcium ion homeostasis (GO:0006874),0.3064471336890971,1.3148685258970616,0.043859649122807015,0.5198684645564143,1.0,26/133,12.40%,SLC24A4;SLC24A2;HTR2C;HCRTR1;STC1;ATP2B4;ATP2B2;BCL2;ADCY8;CALCA;CLN3;ATP1B1;SLC8A2;CCL7;SELENOK;RYR2;TMCO1;GPER1;CCL13;TMEM178A;ATP13A2;CCL5;FZD9;SLC8A1;SLC8A3;HRC
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.46822846717748157,1.314704921135117,0.13286713286713286,0.5182167500681991,1.0,9/17,21.39%,GGA3;NTRK2;SORL1;RTN4;APOE;CLU;RTN3;HAP1;RTN1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.43500874681314217,-1.3143466405875261,0.11484098939929328,0.37288809902833536,1.0,10/25,24.56%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;ARNT;PRKDC;HSPA1B;MAPK11
prerank,cellular response to glucose stimulus (GO:0071333),-0.41424440164692317,-1.3140624407510682,0.1105072463768116,0.3730217692258898,1.0,6/30,10.57%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,regulation of calcium ion transport (GO:0051924),0.3603061385587458,1.3134426786398248,0.08771929824561403,0.51937345764705,1.0,15/54,13.19%,CACNA2D1;STC1;BCL2;EFHB;CAMK2B;WNK3;CACNA1D;HOMER1;PLPP4;ADRA2A;LILRA5;CCL5;SRI;HRC;CASQ1
prerank,homeostasis of number of cells (GO:0048872),-0.5263916116698106,-1.3132863599859412,0.1625,0.3742876253240225,1.0,7/12,26.29%,NOS3;NAPEPLD;NOTCH1;CCN3;LPCAT3;OCIAD2;F2R
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.45777009887267683,-1.3132458544951386,0.14642857142857144,0.37390394464413124,1.0,7/20,19.31%,ENTPD1;APP;NT5E;TXNIP;ANO6;PSTPIP1;TXN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4883176892280684,-1.3130776566110711,0.1336996336996337,0.37380678034601017,1.0,4/15,13.17%,PRKCH;NFKB1;AGTR1;LPL
prerank,lysine catabolic process (GO:0006554),-0.5172119435467745,-1.3128919147072897,0.14587332053742802,0.37328291988004364,1.0,5/12,22.67%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,lysine metabolic process (GO:0006553),-0.5172119435467745,-1.3128919147072897,0.14587332053742802,0.37328291988004364,1.0,5/12,22.67%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.42537698491596165,-1.3125344866009891,0.11317254174397032,0.37355736948020996,1.0,18/29,35.76%,DCUN1D3;DTX3L;ABL1;FEM1A;SMAD7;FEM1B;MAGEC2;DCUN1D2;UBE2L3;DCUN1D5;TRIB3;RPS2;BAG5;PLK1;BMI1;TOPORS;PARK7;FBXO5
prerank,positive regulation of macroautophagy (GO:0016239),-0.37335847664643873,-1.3120516302113094,0.09411764705882353,0.3740606568976418,1.0,14/48,17.91%,RAB3GAP1;GNAI3;SESN1;KDR;LARP1;PIP4K2A;IRGM;BNIP3;PIP4K2B;RAB3GAP2;SPTLC1;VPS13D;TRIM13;IKBKG
prerank,positive regulation of protein processing (GO:0010954),0.45289265111694404,1.3117715612388932,0.14350797266514806,0.5215702149926006,1.0,7/19,16.97%,MELTF;CLEC3B;GSN;PLGRKT;NKD2;ADAM8;KLKB1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5623250209342419,-1.3117523061656642,0.14473684210526316,0.3742134010778117,1.0,3/10,10.36%,BMP4;IRF1;GLI3
prerank,mesonephric tubule development (GO:0072164),0.4863947149704299,1.3115688645420729,0.14046121593291405,0.5200505268678299,1.0,6/15,7.48%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,endoderm formation (GO:0001706),-0.3991150189870887,-1.3115532020621523,0.1233140655105973,0.37417887209941847,1.0,8/35,6.40%,COL8A1;COL12A1;COL4A2;SETD2;SOX17;MMP2;LAMA3;ITGB5
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3960481024897623,-1.3109168445821398,0.09734513274336283,0.37517577155590937,1.0,15/37,22.92%,CAV1;NCK1;TP53;BCAP31;SFPQ;EIF5A;BBC3;GSDME;BCL2L11;SOD1;RPS3;SIAH1;RPS7;MSX1;BECN1
prerank,mitochondrial genome maintenance (GO:0000002),-0.5453875587218099,-1.3106724312936084,0.1559633027522936,0.375210062750304,1.0,3/11,9.27%,MEF2A;TOP3A;AKT3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3977471963332344,-1.3103692066640469,0.12769784172661872,0.3753466863707719,1.0,18/36,28.79%,UBE2K;GAS6;IRGM;PARP14;EDN1;AGPAT1;MAVS;NLRC5;RIPK1;HSPA1B;CASP1;IL7;PARP9;ADAM17;TRIM44;CD300LF;TRIM6;AXL
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2967083236716015,-1.3099717776368096,0.025423728813559324,0.3757418035976344,1.0,60/214,21.83%,TEK;DAB2IP;RAPGEF2;SEMA6A;FERMT2;BMPER;ROR1;MFHAS1;LYN;PDGFD;SEMA7A;GCNT2;APP;PTPN1;RANBP9;CCL25;KDR;SPRED2;PRKD2;TGFBR3;ICAM1;EGFR;SLC30A10;GAS6;DLG1;DSTYK;EZR;RAP1A;NOTCH2;FLT4;YWHAZ;RRAS;SMAD4;HTR2A;BRAF;TIMP3;NOTCH1;CEACAM1;DUSP3;FGF2;ACKR3;CNKSR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN;ANGPT1;CCL19;NOD2;EPHA2;PTPRC;FGFR4;ARHGEF5;P2RY1;PTPN11;CCN1;APIP;PTEN;PTK2B
prerank,negative regulation of secretion (GO:0051048),0.5321998267754907,1.309758911335859,0.1550561797752809,0.5226804484361053,1.0,2/10,5.51%,NRG1;PTGER3
prerank,macrophage activation involved in immune response (GO:0002281),-0.49793171189091,-1.3094695771531653,0.14853195164075994,0.376292301298645,1.0,5/13,15.04%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,regulation of smooth muscle cell migration (GO:0014910),0.45407271433240737,1.3089821282182428,0.14316702819956617,0.522612116019208,1.0,6/20,11.56%,VTN;IGFBP3;NDRG4;SORL1;PDGFA;CCL5
prerank,positive regulation of ion transport (GO:0043270),0.36419028313409957,1.3087320401831717,0.10835214446952596,0.5212265479874967,1.0,11/48,11.56%,ANK3;SCN1B;PKP2;GPD1L;WNK3;CACNA1D;PLA2G3;SCN5A;ADRA2A;LILRA5;CCL5
prerank,skeletal muscle organ development (GO:0060538),-0.41554764317233095,-1.3087258490387625,0.11560693641618497,0.37738877076745203,1.0,13/26,28.26%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SIX4;MYL6;LARGE1;FOXL2;DISP1;FXR1;STRA6;MSC
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5263926679657098,-1.3083099614106553,0.14954954954954955,0.37785253442364974,1.0,5/12,16.73%,TAF11;TAF1B;BDP1;DR1;TAF7
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.45497365622062835,-1.30770617423444,0.1275797373358349,0.3786837851936982,1.0,8/21,20.42%,SLC30A10;PPARA;SIRT5;AATF;ABCB7;HDAC6;BRCA1;COA8
prerank,cardiac muscle contraction (GO:0060048),0.39549150204697897,1.3076124775394065,0.11347517730496454,0.5219822274080975,1.0,10/34,13.94%,ATP1A2;SCN1B;ATP1B1;GSN;RYR2;SCN5A;TNNC1;SLC8A1;TNNI2;SCN2B
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.40367847658446165,-1.3074864001746118,0.12456140350877193,0.37865498514646867,1.0,13/33,22.72%,KLF4;ETS1;NR3C1;TEAD1;FOXO3;TGFB2;JUN;TP53;FGF2;GATA2;PPARG;TERT;RELA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.29852037548453997,-1.30745659807082,0.03281519861830743,0.37824930272309976,1.0,43/173,18.13%,SPTBN1;SPTAN1;SEC31A;SEC24B;VTI1A;COG5;CTSC;COG1;TRAPPC3;ARCN1;RAB1A;PROS1;IER3IP1;RAB2A;GAS6;CUL3;SEC24A;CD55;ATL2;SEC16B;SEC13;KLHL12;COPG1;SEC24D;SCFD1;BET1L;BCAP31;DCTN1;KDELR3;COPA;DCTN3;COPE;TRAPPC12;USE1;F5;CTSZ;ERGIC2;TBC1D20;LMAN2;TFG;CAPZB;TMED5;VAPA
prerank,regulation of protein kinase B signaling (GO:0051896),-0.2980795230326653,-1.307292058198427,0.01694915254237288,0.3781135290346388,1.0,60/193,24.98%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;ESR1;RAC1;MFHAS1;THBS1;GCNT2;PTPRJ;EGFR;GAS6;RICTOR;PPARA;PIK3R1;IRS1;FGF1;PTK2;HAX1;RRAS;PIK3CD;AKT1;FGF7;THEM4;MAZ;MTDH;FGF2;RHOG;MYOC;HGF;PIK3CB;TNFAIP8L3;GRB2;FYN;ANGPT1;GAB2;IAPP;HYAL2;CCL19;TXN;EPHA2;FGFR4;IGF2;F3;PTPN11;PTEN;PHLDA3;HSP90AA1;SEMA5A;TCF7L2;HPSE;PDGFRB;PIK3CA;TRIB3;FRS2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5408901722452881,-1.3070827047119107,0.16399286987522282,0.37807324512799045,1.0,7/11,25.41%,TIPARP;PARP4;PARP14;PARP11;PARP16;PARP6;PARP9
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.547735547989608,-1.306976890983158,0.15699658703071673,0.3778399007158616,1.0,4/10,15.10%,PRKCH;MED1;FOXC1;TRIM16
prerank,protein K63-linked ubiquitination (GO:0070534),-0.38092715962173285,-1.3062503286779987,0.08981001727115717,0.37891778260343906,1.0,12/41,19.29%,PELI1;TRAF5;TRIM56;NEDD4;RNF115;HECTD1;UBE2E2;RNF168;UBE2V2;RNF152;WWP2;RNF4
prerank,mammary gland development (GO:0030879),0.4385008765733035,1.3061251977504658,0.11563169164882227,0.5237722786824128,1.0,3/21,1.33%,NRG1;ERBB4;WNT7B
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5140915438352847,-1.3061220012614518,0.15236427320490367,0.37870386331572803,1.0,6/13,21.78%,LRRK2;SCFD1;CHMP4B;CHMP4A;PHF23;SEC22B
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.42873829511949035,-1.305410300106538,0.1195079086115993,0.37977352460337455,1.0,9/26,21.75%,GCH1;SCARB1;NOS1AP;AKT1;S100A1;PIK3CB;TERF2;TERT;POR
prerank,axonal fasciculation (GO:0007413),0.5075279736105245,1.3051081030153517,0.1475054229934924,0.5246413772280185,1.0,5/12,13.76%,CNTN4;NRCAM;MEGF8;RTN4;AMIGO1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3609125627277468,-1.3048779941454116,0.10131332082551595,0.38042716837694657,1.0,14/58,9.19%,SGMS1;CERT1;ST3GAL4;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ST3GAL2
prerank,B cell receptor signaling pathway (GO:0050853),0.39657323563746893,1.3040378572877223,0.11061946902654868,0.5255603686300592,1.0,5/32,3.61%,BLK;MS4A1;BLNK;BCL2;NFATC2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4611455331214135,-1.3040248412373243,0.1400709219858156,0.3818411342343472,1.0,8/20,19.26%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;NUMB;AP2M1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.39709743411382853,-1.3037535437144494,0.12884615384615383,0.38191238269488165,1.0,12/38,19.12%,ANKRD17;BMP6;NMI;PUM1;AKIRIN2;DDX60;USP15;PLSCR1;POLR3F;IFI35;GBP5;SASH1
prerank,limb morphogenesis (GO:0035108),-0.4623190417559294,-1.3029696317831525,0.1392857142857143,0.38314332140938634,1.0,6/20,10.36%,MBNL1;NIPBL;LRP6;TGFB2;PCSK5;GLI3
prerank,regulation of DNA repair (GO:0006282),-0.383286201414905,-1.302513088840764,0.09498207885304659,0.3836561868142306,1.0,17/44,20.49%,UBR5;EYA4;DEK;UIMC1;EGFR;TRIP12;AXIN2;RNF168;BABAM2;UBE2V2;ERCC8;CEBPG;BRCC3;RPS3;BRCA1;USP1;TRIM28
prerank,regulation of innate immune response (GO:0045088),-0.35989398537804895,-1.3023315929819983,0.09107806691449814,0.38359307334482917,1.0,25/57,29.58%,XIAP;PTPN1;BIRC3;SAMHD1;NMI;AKIRIN2;IRF1;CASP8;USP18;PLSCR1;N4BP1;POLR3F;IFI35;TNFAIP3;GBP5;ERAP1;TKFC;PTPN11;ABCE1;IFNAR2;DHX9;PARP9;RIOK3;CACTIN;TREM2
prerank,regulation of axon extension (GO:0030516),0.3795245994758039,1.3014809246485277,0.09545454545454546,0.5301313124732567,1.0,14/37,13.32%,L1CAM;SHTN1;CDKL5;NRCAM;LIMK1;MAP2;MAPT;RTN4;PTPRS;ZFYVE27;MAG;OLFM1;TRIM46;APOE
prerank,Rac protein signal transduction (GO:0016601),-0.46181917006996337,-1.300670713062354,0.13859649122807016,0.38661249265965597,1.0,8/18,21.18%,EPS8;RAC1;ELMO1;RHOG;NCKAP1;DBNL;WASF1;HACE1
prerank,ventricular septum morphogenesis (GO:0060412),-0.42115735237761365,-1.3004853674625345,0.1417910447761194,0.3865535663903814,1.0,15/27,18.76%,BMPR2;TGFBR3;TGFBR2;HES1;SLIT2;BMP4;TGFB2;SMAD4;ZFPM1;SMAD7;NOTCH1;HEY2;HEY1;CITED2;SOX4
prerank,cell-cell junction assembly (GO:0007043),0.34792809342323416,1.29981991343108,0.08385744234800839,0.5324576320535881,1.0,22/63,12.79%,CDH18;CTNND2;CDH8;CDH20;CDH9;CDH10;EPB41L3;PKP2;DCHS1;CDH19;FSCN1;FLCN;CDH12;CLDN11;CDH7;GJB2;CDH24;CDHR3;GJB6;PATJ;CDH2;JAM3
prerank,miRNA metabolic process (GO:0010586),-0.4530229009212294,-1.2997106271643772,0.13953488372093023,0.38778825935814054,1.0,9/20,25.96%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2;DROSHA;DIS3L2;RAN
prerank,regulation of neuron death (GO:1901214),0.323502968146017,1.2990970030055593,0.06621004566210045,0.5323717451860029,1.0,22/82,15.39%,GRID2;DCC;GRIN2B;CDK5;EPHB1;EGR1;CHGA;NAE1;SNCG;SORL1;MAPT;FAIM2;KIR3DL2;TRIM2;ATP13A2;CCL5;DHCR24;HTRA2;SIGMAR1;CLU;LANCL1;GRM4
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.27929717026810297,-1.2989260311238802,0.02159468438538206,0.3889098355472278,1.0,66/308,18.74%,LEF1;PRKCH;IGF1R;RREB1;ZBTB16;GHR;FERMT2;CAV1;DAB2;BMPR2;SMURF2;ADRA1B;ADIPOR2;GCNT2;PRDM16;IL15;SHLD1;MTOR;TFRC;SMO;TGFBR2;TRPM4;GAS6;KMT5B;SIX1;PLCB1;BMP4;MED1;TGFB2;STAT6;RBM19;UCP2;LBP;ROCK1;SMAD2;GRB10;ACADL;SMAD4;PIK3CD;KDM6B;IL4R;KDM3A;AXIN2;RGCC;EHMT1;JAK2;FGF2;FLOT1;AGO2;MIF;FOXC1;C1QTNF3;TRIM16;AGPAT1;ABCA7;NPR1;MAD2L2;B4GALT5;ACSL1;SIX4;CTNNB1;EPAS1;SOD1;CFL1;ALMS1;LURAP1
prerank,response to glucocorticoid (GO:0051384),-0.42609822954237864,-1.2979650518196553,0.12244897959183673,0.3904161668040039,1.0,11/26,31.98%,NR3C1;ADAM9;SLIT2;FAM107A;BCL2L11;UBE2L3;ANXA1;PDCD7;HNRNPU;ZFP36L1;SSTR2
prerank,dendritic spine morphogenesis (GO:0060997),0.47993422699111266,1.2977075261762756,0.14775160599571735,0.5342002836013824,1.0,5/15,6.15%,CTNND2;DOCK10;EPHB1;SHANK1;PAK3
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.380267988170791,-1.2974298199462724,0.1099290780141844,0.39112241035417544,1.0,10/45,14.06%,DYRK1A;EGFR;NFKB1;WDR75;PIK3R1;BMP4;ERN1;TP53;ZPR1;RBM20
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.47805961817507764,-1.2973949815944776,0.16820702402957485,0.39073664842869527,1.0,9/17,35.62%,KLF4;TMSB4X;ANXA4;ANXA1;ARRB1;CACTIN;TLR6;CD33;MAPKBP1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3865598546547927,-1.2972982472399663,0.1059245960502693,0.3904990085352818,1.0,15/39,20.05%,EFR3B;PIP4K2A;PIK3R1;PI4KB;PIP4K2B;PIK3C2A;ITPKB;PIK3CD;SOCS2;TTC7A;PIK3CB;PIK3R3;PI4K2B;TMEM150A;TTC7B
prerank,regulation of monocyte differentiation (GO:0045655),-0.49719026734625443,-1.2963217711816302,0.159369527145359,0.39223938424962423,1.0,4/14,14.54%,FOXP1;ACIN1;IL34;CDK6
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.4876428346279109,1.2955015012456375,0.14814814814814814,0.5382269536549893,1.0,7/14,17.51%,AK7;AK3;AK5;ENPP3;NME2;ENPP1;AK1
prerank,regulation of lipid kinase activity (GO:0043550),-0.5439985281702446,-1.2951009650510998,0.16081330868761554,0.39427685824246644,1.0,4/11,15.06%,RB1;PPP2R5A;PIK3R1;PIK3R3
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.39077621754189595,-1.294740771435113,0.12105263157894737,0.39456125752649546,1.0,7/36,11.42%,SGMS1;DAB2IP;RB1;FAS;CRADD;TPD52L1;MAZ
prerank,sensory perception of light stimulus (GO:0050953),0.32380935819710016,1.294494404614793,0.07142857142857142,0.5389805214953278,1.0,11/87,6.22%,COL2A1;PCDH15;COL1A1;EML2;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3925575632780692,-1.2944909972955003,0.10777385159010601,0.394640166126371,1.0,14/36,22.31%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;CHEK1;PHC3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.471780359284845,-1.293956750966809,0.15145985401459855,0.39534158453863516,1.0,4/17,3.18%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.4076452690515818,1.2939425040512202,0.12558139534883722,0.5383926515493213,1.0,6/27,9.62%,AK9;AK7;TYMS;AK5;AK6;NME2
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3350560126800856,-1.2934014174996409,0.07954545454545454,0.396023454335493,1.0,28/80,25.35%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;RBX1;CUL3;FAM107A;GSK3A;NSMCE3;SMAD7;MAGEC2;FANCM;DCUN1D2;SENP2;ANGPT1;UBE2L3;CDK5RAP3;HUWE1;BRCA1;PHF23;DCUN1D5;NDFIP2;AMER1;RCHY1;FANCI;TRIB3;RPS2
prerank,reverse cholesterol transport (GO:0043691),0.4868732432070161,1.293150873461592,0.15575620767494355,0.538438364292752,1.0,5/13,13.64%,APOM;LIPC;ABCA5;APOE;CLU
prerank,aspartate family amino acid metabolic process (GO:0009066),0.44533798771702215,1.2929869985183933,0.15098468271334792,0.5368545359629102,1.0,9/18,23.87%,ASNS;SLC25A13;GADL1;ASPA;NIT2;SMS;NAT8L;SLC25A12;MTHFR
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3307689972022865,-1.2928205445880556,0.08064516129032258,0.39687504466173223,1.0,24/85,16.85%,DAB2IP;ACVRL1;TIE1;LIMS1;MCC;BMP5;TBX1;TGFBR3;BMP6;EGFR;BMP4;FGF1;AQP11;TGFB2;PRKD1;YAP1;FGF7;CDC73;FGF2;CDK6;GPX1;SIX4;ANGPT1;IGF1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4714967471293902,-1.2924221942666656,0.14388489208633093,0.39726335066560775,1.0,4/17,7.71%,XIAP;ITGA3;SLIT2;TMEM204
prerank,purine nucleotide metabolic process (GO:0006163),-0.43695514386989354,-1.2921574019669106,0.1270718232044199,0.3973624093384292,1.0,11/24,27.11%,NT5C2;FHIT;NT5E;MTHFD1;NT5C1A;GPX1;HPRT1;GDA;PRPS2;NT5C;PNP
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.29905231089321316,-1.2920177487064677,0.05253940455341506,0.39722371086727026,1.0,45/150,22.35%,DAB2IP;PARD3;ENG;RB1;CAV1;LYN;CORO1C;CEP85;PAK2;SPRED2;LRRK2;NIBAN1;RTRAF;LDLRAD4;PPEF2;SLIT2;NCK1;DDIT4;LRP6;PRKCD;RASSF2;PPM1F;OCLN;PRKRIP1;AKT1;SMAD7;NCK2;CEACAM1;CHP1;CNKSR3;TRAF3IP1;PTPN13;DNAJC10;SMAD6;TAF7;UBASH3B;CDK5RAP3;PTPRC;AKT1S1;PRKDC;SNX25;WARS1;PTEN;NF1;PMEPA1
prerank,ion homeostasis (GO:0050801),0.39928903223476786,1.2919943327770542,0.13176470588235295,0.5375573726713544,1.0,7/30,8.00%,UNC80;SLC4A4;SLC4A5;WNK2;SLC4A2;WNK3;SLC12A5
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5474025954296065,-1.2917384860966827,0.15140186915887852,0.39730182504317524,1.0,3/10,5.05%,LRP5;TBX1;TGFBR2
prerank,regulation of neuron differentiation (GO:0045664),0.331958385293733,1.2916828105723552,0.06206896551724138,0.5364033590327639,1.0,13/76,7.58%,BRINP3;NLGN1;CNTN4;YWHAG;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;BRINP2;ADRA2C
prerank,histone acetylation (GO:0016573),-0.3502102562637065,-1.291621928593285,0.09124087591240876,0.39708058184301254,1.0,24/69,24.24%,LEF1;CREBBP;KAT6B;KAT2B;KAT6A;EP400;TRRAP;PHF20;SGF29;PHF20L1;KAT5;TAF5L;ZZZ3;DR1;TRIM16;TADA3;RUVBL2;JADE2;WDR5;BEND3;MORF4L1;MAP3K7;TAF9;APBB1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.468012346832196,-1.2913311848839975,0.15818181818181817,0.3972148954827807,1.0,11/17,17.56%,NOS3;NFATC1;SLIT2;BMP4;TGFB2;NOTCH2;NOTCH1;SMAD6;JAG1;HEY2;HEY1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4706445696103514,-1.291184662601438,0.15555555555555556,0.39709622449942344,1.0,7/18,15.79%,TEK;CDH5;ROCK1;RAP1B;BCAS3;ARFGEF1;ROCK2
prerank,neural crest cell migration (GO:0001755),-0.39094854851867034,-1.2906947531725814,0.10553633217993079,0.3976552638674436,1.0,13/36,20.69%,SEMA6A;SEMA3C;SEMA7A;CORO1C;TBX1;PHACTR4;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.33714697549188327,-1.290536638714952,0.07262569832402235,0.3975481502070663,1.0,20/76,19.63%,DAB2IP;KLF4;CD200;TMSB4X;TAX1BP1;NFKBIA;OTULIN;ANXA4;NFKBIL1;IRAK1;CHP1;MTURN;BMP7;TNFAIP3;NLRC5;IRAK2;DAP;CDK5RAP3;USP7;CMKLR1
prerank,negative regulation of cytokine production (GO:0001818),-0.3003644516973367,-1.2904579760622,0.03583617747440273,0.39723661302134805,1.0,35/163,17.31%,LEF1;KLF4;CD34;RAC1;CD200;TMSB4X;THBS1;IFIH1;TRIM25;RPS6KA5;SRGN;RNF125;TAX1BP1;GAS6;PPARA;PDCD4;EZR;ANXA4;UBA7;RGCC;ZFPM1;IKBKE;CEACAM1;KAT5;ASB1;TRAF3IP1;N4BP1;C1QTNF3;VSIR;ILRUN;RARA;TNFAIP3;MAVS;NLRC5;GPATCH3
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4254811097779715,1.2904023906827558,0.14732142857142858,0.5378676239208863,1.0,6/22,12.01%,TAFA1;TOX;PTPRZ1;PROX1;INSM1;FZD9
prerank,regulation of protein ubiquitination (GO:0031396),-0.31821669472074277,-1.2897741271588468,0.056363636363636366,0.3983141910649704,1.0,38/108,24.43%,NXN;XIAP;CAV1;LRRK2;IVNS1ABP;BIRC3;CUL3;FAM107A;GSK3A;AKT1;NSMCE3;SMAD7;SPOPL;FOXF2;CHP1;N4BP1;SENP2;ANGPT1;UBE2L3;TNFAIP3;CDK5RAP3;RPS3;SOX4;WASHC1;HUWE1;SASH1;BRCA1;SH3RF2;PHF23;NDFIP2;AMER1;HSP90AA1;OGT;RCHY1;FANCI;HSPA1B;ADGRB1;ARRB1
prerank,regulation of exosomal secretion (GO:1903541),0.44648239033764575,1.289646951590238,0.139186295503212,0.5379095294013089,1.0,8/19,18.65%,ATP9A;SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,pigment granule transport (GO:0051904),0.46556324704541807,1.2891195400036095,0.14573991031390135,0.5353992041413335,1.0,9/18,16.89%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,melanosome transport (GO:0032402),0.46556324704541807,1.2891195400036095,0.14573991031390135,0.5353992041413335,1.0,9/18,16.89%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.47187250906855743,-1.2889676393059155,0.1552901023890785,0.3995787793302917,1.0,8/17,19.61%,LYN;MID1;TGFB2;ARL6IP5;TAOK3;SEMA4C;NOD2;KLHDC10
prerank,regulation of cytokinesis (GO:0032465),-0.3362256280470442,-1.2889401502656033,0.09208103130755065,0.3991735305467853,1.0,21/78,20.20%,PRKCE;PKP4;SETD2;SVIL;AHCTF1;ZFYVE26;CUL3;CDC14A;RAB11FIP3;PLK2;BIRC6;KIF23;KLHL13;RHOA;PKN2;RAB11A;PLK4;CETN2;GIPC1;KIF13A;PRC1
prerank,cellular copper ion homeostasis (GO:0006878),-0.5011030328103095,-1.2887530880639595,0.14638447971781304,0.39907847170296956,1.0,3/14,4.68%,APP;ATOX1;SLC31A1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.45751496670619995,1.2881125594270315,0.14725274725274726,0.5362761690784552,1.0,9/17,25.93%,BCL2;GGCT;FZD9;CLU;MFF;FIS1;DNM1L;SFN;BOK
prerank,positive regulation of exocytosis (GO:0045921),0.3770248020147883,1.288015163626954,0.12608695652173912,0.5345724006145743,1.0,13/35,20.24%,CADPS;RAB15;SMPD3;RAB27B;HGS;TSG101;RAB3A;ATP13A2;SDC4;CLASP2;CHMP2A;VPS4B;EXPH5
prerank,smooth muscle tissue development (GO:0048745),-0.5395104270341045,-1.2879306209305699,0.18,0.4003934271673952,1.0,9/10,33.96%,ENG;SMO;BMP4;MYLK;NF1;STRA6;EFEMP2;SHH;PTCH1
prerank,cellular response to interleukin-6 (GO:0071354),-0.4154595792417323,-1.2878438443931828,0.13527397260273974,0.40013486829250683,1.0,9/26,12.64%,ST3GAL6;JAK1;IL6ST;IL6R;NFKB1;CBL;SMAD4;YAP1;JAK2
prerank,response to organophosphorus (GO:0046683),0.45523834598539925,1.2878014465274552,0.14864864864864866,0.5332034114746895,1.0,3/16,5.25%,DGKQ;AKR1C1;TYMS
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.46032193922097253,-1.2877732370241182,0.14285714285714285,0.3998447722358824,1.0,5/18,15.04%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.28484978814395195,-1.2874641877239397,0.03502626970227671,0.400057207976591,1.0,69/234,25.51%,PRKCH;EDA;ERC1;CAV1;TAB3;ESR1;ROR1;NOD1;CD200;TRAF5;TRIM25;APP;RPS6KA5;ANXA3;SLCO3A1;PRKD2;TFRC;SMO;FZD4;NFKB1;NFKBIA;STK3;ZBTB7A;LRP6;PRKD1;ARHGEF2;PLCG2;AKT1;EDN1;RNF25;CFLAR;TRIM14;RGCC;IKBKE;IRAK1;HDAC4;MTDH;FLOT1;CD40;ADCY1;TCF3;TAB2;MAVS;CTNNB1;TRIM13;IRAK2;CEBPG;IKBKG;IKBKB;NOD2;RPS3;ARID5B;ARHGEF5;PPARG;PTEN;MYOCD;MTPN;RELA;TRIM68;RIPK1;MAP3K7;HSPA1B;DHX9;CRTC1;FANK1;PLPP3;SMARCB1;CRNN;TFDP1
prerank,response to peptide hormone (GO:0043434),-0.3757379004435196,-1.2874133403821686,0.10948905109489052,0.39967751978206856,1.0,14/43,22.69%,CAV1;TGFBR3;IRS1;STAT6;ROCK1;EIF2B2;AKT1;STAT2;TRIM16;ROCK2;IGFBP5;ANXA1;CREB1;OGT
prerank,keratan sulfate metabolic process (GO:0042339),-0.40225296569991636,-1.2873660803715452,0.14774774774774774,0.39934382571221816,1.0,6/31,9.19%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4414941662695811,-1.2873331577353,0.13059701492537312,0.3989643725728918,1.0,10/22,26.41%,CDK13;CDK12;DDX39B;CDC73;THOC1;SUPT4H1;CCNK;ERCC6;LEO1;BRD4
prerank,regulation of defense response to virus by host (GO:0050691),-0.41144922582635934,-1.287229764579672,0.13430127041742287,0.39870632323614624,1.0,16/30,30.52%,DTX3L;SIN3A;CGAS;TNFAIP3;MAVS;ZDHHC1;RNF216;HSP90AA1;DHX9;EIF2AK4;PARP9;TRIM44;TRIM6;TOMM70;IFNLR1;LILRB1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4421450887758509,-1.2871220021083318,0.1426086956521739,0.3984720733811341,1.0,4/20,3.18%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.39477976180207597,-1.2870282016147987,0.12614259597806216,0.3982151764990919,1.0,14/32,23.00%,ACVRL1;ACER2;CORO1C;THBS1;FAM107A;BCAS3;RASA1;MYOC;JAG1;MAP4K4;DUSP22;SEMA3E;PTEN;SERPINE1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3291588788906588,-1.286572727225255,0.05807622504537205,0.39874327534422427,1.0,27/94,18.60%,IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;RBX1;NFKB1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;MAP3K8;FBXW11;PSMC2;PSMB2;TAB2;PSMB1;PELI2;IRAK2;PSMA8;IKBKG;PSME1;IKBKB;NOD2
prerank,recombinational repair (GO:0000725),-0.3359839631166194,-1.2864271800440346,0.06976744186046512,0.39855748943984176,1.0,36/77,33.15%,SMC5;SAMHD1;ZFYVE26;SPIDR;MRE11;MMS22L;NABP1;MCM9;RBBP8;RAD54B;SFPQ;NSMCE2;RPA3;RPA1;PALB2;RFWD3;WRN;RPA2;BRCA1;RAD51AP2;BLM;YY1;MORF4L1;POLL;INO80;RAD51AP1;XRCC2;AP5Z1;RAD51D;SWI5;KDM4D;HUS1B;MEIOB;RAD50;FAN1;RMI1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.45298708221010164,-1.286316839958194,0.15916955017301038,0.3983793465017711,1.0,11/20,31.09%,RPS6KA5;DIP2B;PRKAA1;RUVBL2;SOX4;BRCA1;NOS1;ARRB1;DIP2A;GLYR1;RPS6KA4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3346345292720486,-1.2862354061201815,0.09306260575296109,0.39810930105224485,1.0,20/73,18.46%,KITLG;CBFB;TCF12;LMO2;PSMA2;METTL14;ABL1;PSME2;LDB1;PSMB4;TAL1;YAP1;PSMC2;PSMB2;FOXC1;TCF3;PSMB1;PSMA8;GATA2;PSME1
prerank,stem cell differentiation (GO:0048863),-0.385028813870601,-1.2861564074638425,0.11376146788990826,0.39779808988197335,1.0,14/39,19.63%,MLLT3;SETD2;FBXL17;ACE;LRP6;TGFB2;MEF2C;PUM1;TP53;LMBR1L;FOXO4;METTL5;NELFB;PTPRC
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.31756733992731795,-1.2860128878870412,0.0774526678141136,0.3976559523932944,1.0,33/104,22.49%,CRIM1;CAV1;BMPER;BMPR2;IL17RD;SMURF2;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD1;SMAD2;SMAD4;ACVR2A;UBE2D3;SMAD7;NOTCH1;CCN3;SMAD6;SKI;DAND5;SMAD9;STRAP;SNX25;HTRA3;PPARG;PMEPA1;MTMR4
prerank,purine-containing compound catabolic process (GO:0072523),-0.5010511579660553,-1.2859103599745234,0.16225749559082892,0.397393395257314,1.0,7/13,27.11%,NT5C2;NT5E;NT5C1A;GPX1;GDA;NT5C;PNP
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.37739181043130676,-1.2858257527477017,0.1111111111111111,0.39715727678914614,1.0,18/43,25.42%,FOXN3;ATM;UIMC1;MRNIP;MRE11;NABP1;CLSPN;TAOK3;INTS3;BABAM2;BRCC3;CDK5RAP3;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL
prerank,cellular sodium ion homeostasis (GO:0006883),0.47339575107790066,1.284600197732543,0.15800865800865802,0.5400678381402831,1.0,5/15,12.07%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,fatty acid biosynthetic process (GO:0006633),0.33740954072579643,1.284262445010932,0.12307692307692308,0.5390185992220606,1.0,19/63,17.43%,FADS1;ACSBG1;HACD1;ELOVL4;ACLY;ACACA;LIPC;OXSM;ALOX12;TECR;OLAH;ACOT7;SCD5;NDUFAB1;CYP1A1;HACD2;ALOX5;ASAH2;SCD
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4860019590858635,-1.2842455546637463,0.1410488245931284,0.4001600081365135,1.0,5/16,7.52%,RREB1;SOX13;SIX1;NAPEPLD;FTO
prerank,cellular response to ATP (GO:0071318),0.492012446199693,1.2842416404765156,0.16780045351473924,0.5371199577384885,1.0,4/14,14.20%,RYR3;CIB2;P2RX3;TAF1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.50697257408231,-1.2841722545904528,0.17168141592920355,0.39984107537997543,1.0,4/13,12.70%,NFAT5;ETS1;IRAK1;RHOA
prerank,regulation of actin filament-based process (GO:0032970),-0.34279582121110186,-1.2835670520752436,0.0797872340425532,0.4007133836847283,1.0,21/70,15.79%,RAC1;RHOBTB1;IQGAP1;F11R;CRK;RND3;MTOR;RICTOR;ABL1;RHOQ;PRKCD;EZR;CDK10;ROCK1;FAM107A;ARHGAP17;RHOA;RHOG;RHOC;HIP1R;ROCK2
prerank,central nervous system development (GO:0007417),0.27712960521134505,1.2835175791093025,0.01707317073170732,0.537132352531934,1.0,51/250,13.84%,CNTNAP2;ROBO2;ASIC2;CNTN6;IL1RAPL2;CNTN4;GRIN2B;MYRF;DSCAML1;ADAM23;ADAM22;ADGRL3;SH3GL2;NPAS1;SPOCK1;CDK5;DNER;GRIN2A;NRCAM;MDGA1;MEIS1;POMK;NDRG4;MEIS3;PTPRZ1;PITPNM1;HPCAL4;SMG9;MAP1S;PROX1;GRIK1;GSN;AHI1;NCAN;KLK6;DCX;POU3F3;MOG;HAPLN2;MBP;NMUR2;ARNT2;CDH2;C3;SLC8A3;TPPP;TUBGCP2;PBX4;CAPG;AMIGO1;RPS6KA6
prerank,artery development (GO:0060840),-0.4356055047716169,-1.2832151267967074,0.16023166023166024,0.4010620300307969,1.0,9/23,11.42%,ENG;ACVRL1;PKD2;BMPR2;TBX1;HES1;PDE2A;HECTD1;SMAD7
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.532414987850965,-1.2831858977067137,0.19680851063829788,0.4006817682020789,1.0,6/11,31.24%,MEF2C;MYOCD;FZD7;BMP2;FRS2;TGFB1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5029201392576483,-1.2831777549598498,0.17509025270758122,0.4002495966706858,1.0,3/13,10.06%,PKD2;NFKBIA;FLNA
prerank,lipid droplet formation (GO:0140042),0.5464038706277285,1.283049345216522,0.17987152034261242,0.5365041770376325,1.0,4/10,17.81%,BSCL2;SQLE;AUP1;CDS1
prerank,negative regulation of neuron projection development (GO:0010977),0.3499540052177193,1.2824212188770217,0.10273972602739725,0.5362855204051293,1.0,15/56,14.31%,NLGN1;DCC;SPOCK1;ITM2C;EFNB3;RTN4;TSKU;PTPRS;STMN2;MAG;OMG;DENND5A;APOE;PAQR3;NGEF
prerank,blood vessel endothelial cell migration (GO:0043534),-0.44387333057815215,-1.281904658710143,0.14571948998178508,0.40249927469723373,1.0,8/22,15.06%,MYH9;ID1;KDR;SLIT2;CDH5;AKT1;FGF2;PIK3R3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.30685648325544856,-1.2818633363342915,0.03333333333333333,0.40213433187700975,1.0,56/148,26.32%,PPP1R13B;ATM;RPL37;KAT6A;MTOR;TOP3A;PIP4K2A;RICTOR;HDAC1;PHF20;PAK1IP1;PIP4K2B;MRE11;NOP2;USP2;TAF11;RBBP8;TP53;AKT1;PRKAA1;EHMT1;CHD3;KAT5;RPA3;DNA2;RPA1;RPL5;KMT5A;HIPK1;TAF7;TAF3;NUAK1;WRN;CDK5RAP3;RPA2;PRKAB1;BOP1;USP7;BRCA1;PRDM1;RRS1;BLM;RFC4;CHEK1;TAF4B;MDM2;TAF13;RPS15;CCNG1;TAF9;TAF15;MAPK11;PLK3;PPP1R13L;PRR5;RNF34
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5406030378662072,-1.2816160964496994,0.1780821917808219,0.40215964072587623,1.0,3/10,5.99%,CD200;BMP5;SLIT2
prerank,establishment of protein localization to membrane (GO:0090150),-0.3480466850054558,-1.2815033684040047,0.09689213893967093,0.401944963890516,1.0,33/66,36.70%,PARD3;RAB3GAP1;ZDHHC6;ZDHHC3;EGFR;AFDN;COX18;AQP11;BRAF;RAB3GAP2;RAB11A;ZDHHC1;REEP1;ZDHHC4;GORASP2;ZDHHC12;RAB3IP;VPS37B;ATG3;GOLGA7B;RTP4;ZDHHC9;NPC1;ZDHHC22;SEC63;SYNE3;NCF1;ICMT;YIF1B;RAB10;VPS37C;RABGEF1;TAOK2
prerank,regulation of neuron apoptotic process (GO:0043523),0.3136843404089943,1.28136648351895,0.08501118568232663,0.5371783981378944,1.0,28/96,17.97%,GRID2;CDK5;BCL2;TYRO3;CLN3;PTPRZ1;NAE1;NTRK2;VSTM2L;PLA2G3;GRN;FAIM2;POU4F1;BACE1;FGF20;TRIM2;MAG;FZD9;CCL2;NRBP2;APOE;SIGMAR1;BDNF;LANCL1;GRM4;ADAM8;RETREG1;MSH2
prerank,regulation of MAPK cascade (GO:0043408),-0.30164577428161293,-1.281337556700551,0.06394316163410302,0.4018654877859344,1.0,49/157,22.19%,FLT1;TEK;DAB2IP;IGF1R;JCAD;INSR;CAV1;ROR1;LYN;IQGAP1;ADRA1B;PAK2;TBX1;KDR;TGFBR3;PTPRJ;EGFR;STK3;PPEF2;FAS;ROCK1;MAPK1;FLT4;PLCG2;YWHAZ;RRAS;TAOK3;PEBP1;CEACAM1;DUSP3;FGF2;MYOC;KSR1;ABCA7;ROCK2;GSDME;IGF1;PELI2;MAP4K4;IAPP;EPHA2;PTPRC;VRK2;IGF2;ARHGEF5;CCN1;APIP;NF1;NRK
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5029081168755338,-1.280976972550727,0.1546572934973638,0.4021459868153705,1.0,6/13,18.76%,SESN1;ATM;KPTN;CASTOR1;RNF152;ITFG2
prerank,nucleic acid metabolic process (GO:0090304),-0.34011495843072187,-1.2808028952486439,0.10683012259194395,0.4020480694747295,1.0,26/69,28.26%,RBFOX2;METTL14;NT5E;HNRNPA0;HNRNPR;HNRNPM;POLR2G;WTAP;HNRNPA3;HNRNPF;XRN2;DNA2;PDE12;HNRNPA1;WRN;WDR74;PCBP1;POLR2C;POLR2H;POLR2L;RAN;HNRNPU;HNRNPL;HNRNPD;DXO;MMS19
prerank,negative regulation of cellular protein localization (GO:1903828),-0.39518349669607106,-1.280800499821615,0.11049723756906077,0.40161116228934035,1.0,10/34,15.90%,CTNNA1;MFHAS1;NEDD4L;GSK3B;PICALM;LATS2;SIN3A;TAX1BP3;ROCK2;ILRUN
prerank,regulation of acute inflammatory response (GO:0002673),-0.46147800101126035,-1.280617980166504,0.14814814814814814,0.40155782419748276,1.0,2/18,4.61%,OSMR;IL6ST
prerank,inositol phosphate metabolic process (GO:0043647),-0.3688086565879561,-1.2802436119953233,0.11270125223613596,0.401886775213305,1.0,12/46,12.91%,PLCB4;PLCG1;INPP1;INPP5A;PLCB3;PLCB1;PLCE1;MINPP1;PLCG2;ITPKB;INPP4A;FGF2
prerank,mitotic recombination (GO:0006312),-0.48134426528310986,-1.2801964918046769,0.17272727272727273,0.4015247537201292,1.0,11/15,40.90%,SMC5;DMC1;RAD54B;NSMCE2;TEP1;MSH3;RAD51D;RAD50;RAD52;SMC6;ERCC1
prerank,regulation of translational initiation (GO:0006446),-0.3491199533801917,-1.2796164952622182,0.08348794063079777,0.40235112206496443,1.0,37/63,38.88%,EIF3H;EIF4H;EIF3E;DDX3X;LARP1;NCK1;EIF3B;POLR2G;EIF2B2;NCK2;CDC123;KLHL25;AGO2;ATF4;TPR;GLE1;CTIF;EIF2AK3;EIF2AK4;KHDRBS1;DNAJC3;EIF5B;MTIF2;EIF4A2;BOLL;CEBPB;ATF3;EIF4G3;EIF2B5;PAIP2B;MIF4GD;EIF4EBP3;ALKBH1;EIF4EBP1;DAZL;RPS6KB2;PAIP2
prerank,diacylglycerol metabolic process (GO:0046339),0.4217088548074857,1.2790307645808265,0.141280353200883,0.5414416909522911,1.0,5/23,9.06%,DGKK;DGKI;DGKQ;ANG;PGS1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5001063370827818,1.2789834562038365,0.1829787234042553,0.539667728068372,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,actin filament-based transport (GO:0099515),-0.4325924234286086,-1.2780524901839267,0.1596330275229358,0.40505204430221786,1.0,6/21,12.92%,MYO1D;FNBP1L;SYNE2;WASL;MYO1F;ACTN4
prerank,response to estradiol (GO:0032355),-0.40464927152664565,-1.2779304498796418,0.1387900355871886,0.4049081445227037,1.0,10/31,18.48%,ESR1;NRIP1;EGFR;STRN3;GGT5;SOCS2;KAT5;RUVBL2;CTNNB1;ANXA1
prerank,positive regulation of neurogenesis (GO:0050769),0.3320085708985178,1.277785423029867,0.0835214446952596,0.5409875763086027,1.0,15/68,13.76%,PTPRD;IL1RAPL1;ROBO2;OPRM1;MME;ROBO1;CDKL5;NTRK2;SLITRK1;VEGFA;GPER1;FZD3;PLXNA2;PLXNA1;AMIGO1
prerank,cellular response to interleukin-12 (GO:0071349),-0.3721951293981022,-1.2772844161996275,0.11711711711711711,0.4059243670459956,1.0,16/48,18.03%,ANXA2;PAK2;JAK1;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;HNRNPF;JAK2;LCP1;MIF;TALDO1;SOD1;CFL1
prerank,steroid biosynthetic process (GO:0006694),0.3450512500981395,1.2772751115236438,0.10480349344978165,0.5404586022818927,1.0,12/56,14.25%,AKR1D1;CYP46A1;INSIG1;LSS;SC5D;CYP51A1;OSBPL6;SQLE;CYP27A1;CYP11B1;FDFT1;OSBPL9
prerank,regulation of hormone secretion (GO:0046883),-0.4873146087531234,-1.2767566614715309,0.14411247803163443,0.40658952627075695,1.0,9/15,39.98%,EDN1;EDN3;ANXA1;VAMP3;VAMP2;NMB;IL11;LIF;SNX6
prerank,regulation of TORC1 signaling (GO:1903432),0.37775616417633856,1.2766288881904044,0.1360544217687075,0.5402446061046334,1.0,8/33,8.74%,DGKQ;GPR137C;RRAGA;PIP4P1;STK11;FLCN;KLHL22;SEH1L
prerank,cGMP-mediated signaling (GO:0019934),0.49357437563776296,1.2765211566805108,0.15777777777777777,0.5386739849489847,1.0,2/13,0.81%,KCNC2;HTR2C
prerank,membrane organization (GO:0061024),-0.28329103065325995,-1.2763803607866724,0.03508771929824561,0.40694956313144487,1.0,68/227,21.61%,SPTBN1;HIP1;FCHO2;CERT1;MYOF;DNM3;DAB2;CORO1C;EPS15;TMCC1;FNBP1L;STX18;A4GALT;LDLRAP1;TFRC;EMD;FZD4;EGFR;AP2B1;DYSF;AP2A2;DNM2;CBL;COX18;TOR1B;AP2S1;RABEP1;PIK3C2A;WASL;EPS15L1;AAK1;SNX9;RAB5A;AGFG1;ITSN1;PICALM;REEP3;IGF2R;CHRNB1;ATP10B;CHMP4B;CHMP4A;GAK;ACTB;CHP1;CHMP2B;HIP1R;GRB2;MITD1;CHMP5;ARPC4;SUN1;REPS1;TLCD1;MOSPD3;VAPA;GLTP;VAMP3;HUWE1;AP2M1;M6PR;REEP1;OSBPL2;PDCD6IP;HACE1;LPCAT3;VAMP2;STON2
prerank,positive regulation of locomotion (GO:0040017),-0.41299049789353887,-1.2762902626987125,0.1431095406360424,0.4066672230091254,1.0,13/27,35.69%,NTN1;THBS1;SPOCK2;STX3;PPM1F;CAVIN1;CCL19;PDGFRB;TREM2;TRIM32;TGFB1;PHPT1;AKT2
prerank,atrioventricular valve development (GO:0003171),-0.49259120537220996,-1.2760581912717424,0.1488970588235294,0.4067555097246138,1.0,5/14,12.08%,BMPR2;TGFBR2;TGFB2;ZFPM1;NOTCH1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.451181191684247,-1.2758907737634932,0.15454545454545454,0.4066846053586878,1.0,13/19,46.98%,PRKCE;NMI;LBP;IRAK1;ITGAM;LGALS9;PIK3AP1;CD14;TLR4;TNIP3;TICAM2;SCIMP;RAB11FIP2
prerank,purine ribonucleotide transport (GO:0015868),-0.4734224248016893,-1.2755741327626928,0.18342151675485008,0.4068743808130423,1.0,4/16,7.06%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,rRNA 3'-end processing (GO:0031125),-0.5450346537623143,-1.2754159476804219,0.2025089605734767,0.40679932668430147,1.0,5/10,16.13%,ERI3;RPS21;EXOSC2;EXOSC3;EXOSC8
prerank,regulation of cellular response to stress (GO:0080135),-0.31433056914990504,-1.2753997753987625,0.07530647985989491,0.40638663769949634,1.0,31/115,18.57%,CREBBP;MCL1;GSK3B;NUP42;ATM;MTOR;YWHAE;CAMK2G;RAE1;NEK6;RANBP2;ABL1;NUP98;DNAJC7;MAPKAPK2;SEC13;MAPK1;DNAJB6;IER3;RPTOR;RPA3;NUP153;RPA1;PTGES3;ATF4;TPR;ROCK2;ARMT1;NUAK1;NUP214;RPA2
prerank,histone modification (GO:0016570),-0.3180647690918597,-1.2751379238639415,0.08362989323843416,0.40648169123244926,1.0,32/109,20.68%,CREBBP;NSD1;KAT6B;EYA4;MIER1;PRDM5;RPS6KA5;KAT6A;RCOR1;HDAC1;TRRAP;PHF20;PRKCD;NSD3;MIDEAS;SGF29;PHF20L1;SIN3A;EHMT1;HDAC4;KAT5;PHC1;RUVBL2;HDAC6;MIER2;HDAC10;MIER3;HUWE1;CARM1;ATXN7;BAZ1B;TBL1X
prerank,regulation of cellular component movement (GO:0051270),-0.36560086749031473,-1.2751219295456149,0.1103448275862069,0.4060660915713354,1.0,19/49,17.14%,SP100;ETS1;LYN;DIAPH1;TGFBR3;EGFR;ABL1;PRAG1;ROCK1;RAF1;ARAP1;ACTN1;RHOA;ACTN4;PKN2;CDK6;ROCK2;HDAC6;IGBP1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.37370405769991055,-1.2746885409561426,0.12724014336917563,0.4065520165430109,1.0,14/42,21.48%,WARS2;YARS1;NARS2;CARS2;FARS2;TARS3;LARS1;AIMP2;DARS2;HARS2;VARS2;FARSA;IARS2;WARS1
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.4549085980992602,-1.2744229692331315,0.1663778162911612,0.4066618027793547,1.0,13/19,35.55%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;PDCD6IP;HSPA1B;HNRNPU;CCSAP;CHMP3;CHMP1A;PLK1;CHMP1B
prerank,regulation of phospholipase C activity (GO:1900274),-0.48217561962369926,-1.2742433448935684,0.1657848324514991,0.4065473778519783,1.0,4/15,6.15%,FLT1;ESR1;PLCG1;ABL1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5085336645085676,1.2742070531571517,0.19037199124726478,0.5429080360630829,1.0,4/12,10.88%,ATIC;PAICS;ADSS2;ADSS1
prerank,positive regulation of phospholipid transport (GO:2001140),0.5272243748120546,1.274071044082776,0.16417910447761194,0.5414029580791309,1.0,3/10,13.32%,PRELID1;TRIAP1;APOE
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.49807119898203034,-1.273570848523605,0.16117216117216118,0.40756565126705757,1.0,6/12,19.63%,CBFB;ELF1;LYN;ELF2;RC3H1;PTPRC
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.3275861946726081,-1.2735189648841603,0.09734513274336283,0.4072380438161654,1.0,26/76,23.72%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;UBA2;CUL3;FAM107A;GSK3A;NSMCE3;SMAD7;HDAC4;DCUN1D2;SENP2;ANGPT1;UBE2L3;CDK5RAP3;HUWE1;PIAS4;BRCA1;PHF23;DCUN1D5;NDFIP2;AMER1;RCHY1;FANCI
prerank,positive regulation of cell growth (GO:0030307),0.3141859756269787,1.2730762760080971,0.06756756756756757,0.5422371439152235,1.0,20/96,11.33%,L1CAM;SYT1;RIMS2;RIMS1;CXCL16;SHTN1;BCL2;CDKL5;AKAP6;PSMD10;EXOSC9;LIMK1;SPHK1;KLHL22;ADNP2;CPNE9;MAPT;RNF157;ZFYVE27;SYT4
prerank,NAD biosynthetic process (GO:0009435),-0.44003065118394075,-1.2729286496910936,0.16140350877192983,0.40805905019159394,1.0,12/20,36.97%,NAMPT;NADSYN1;NAXE;NAPRT;NUDT12;KYNU;PARP16;PTGIS;PARP9;NAXD;NMNAT3;NNMT
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4325896475282873,1.272512964338158,0.1542056074766355,0.5418824663644656,1.0,10/22,19.50%,STAC2;AKAP6;ATP1B1;CALM2;RYR2;STAC;CASQ1;HTT;VMP1;HAP1
prerank,positive regulation of cell cycle (GO:0045787),-0.3462019377834542,-1.2714418102945897,0.12567324955116696,0.41084121538619184,1.0,26/62,22.37%,PKD2;ANKRD17;APP;CDKN1B;EGFR;LRP6;TGFB2;CCND3;USP2;TAL1;AKT1;CCNY;RGCC;DUSP3;PKN2;HCFC1;LGMN;SMOC2;SRPK2;RARA;CITED2;CCND1;RAD23A;CHEK1;MDM2;CCNYL1
prerank,membrane protein proteolysis (GO:0033619),-0.38013237877931694,-1.2713424280873735,0.12390924956369982,0.4106114994389681,1.0,11/37,17.53%,MYH9;ADAM9;NFKB1;PSEN2;SPPL3;AFG3L2;ADAM10;PSEN1;APH1A;ERAP1;CTSH
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.33655340267318795,-1.2711114361944111,0.09294320137693632,0.4106514978734572,1.0,24/70,21.67%,TEK;RB1;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;MEF2C;SIPA1L3;ILK;LAMA5;ACTN1;RHOA;ITGA4;LAMC3;ATF4;ATRNL1;VAMP3;EPHA2;ITGB3;FERMT3;USH2A
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44756583174818376,1.2707818419301622,0.16916488222698073,0.5445571252764719,1.0,7/18,15.64%,HSD17B12;ACSBG1;HACD1;ACSL3;ACSL6;TECR;HACD2
prerank,striated muscle contraction (GO:0006941),0.3513356083328543,1.270574778955625,0.12472647702407003,0.5433280089519744,1.0,13/53,13.94%,SMPX;ATP1A2;SCN1B;STAC2;ATP1B1;RYR2;SCN5A;STAC;TNNC1;DTNA;SLC8A1;TNNI2;SCN2B
prerank,positive regulation of isotype switching (GO:0045830),-0.4714724440083813,-1.270119778058438,0.17345132743362832,0.4122788920198097,1.0,7/15,18.23%,SHLD1;TFRC;KMT5B;CD40;MAD2L2;CLCF1;TNFSF13
prerank,cellular response to interferon-beta (GO:0035458),-0.4855501799088765,-1.270023687272971,0.16637478108581435,0.4120456256835728,1.0,7/14,34.47%,UBE2K;IRGM;IRF1;IFITM2;TRIM6;CDC34;UBE2G2
prerank,positive regulation of heart rate (GO:0010460),-0.4602529599774648,-1.269790690956484,0.18382352941176472,0.4121058514688323,1.0,8/17,16.77%,ADRA1B;TRPM4;KCNQ1;EDN1;ADM;EDN3;TPM1;SCN3B
prerank,cellular response to nutrient levels (GO:0031669),-0.34355327021938387,-1.2695401262227666,0.09965635738831616,0.41218919698150636,1.0,19/62,18.22%,FOXO1;BMPR2;ATG7;LRRK2;MTOR;MAP1LC3B;PPARA;STK24;FAM107A;MFSD2A;KLF10;PRKAA1;WIPI1;RPTOR;LPL;ZFYVE1;RIPOR1;WRN;LAMP2
prerank,protein localization to mitochondrion (GO:0070585),-0.508414465921641,-1.2695153093148839,0.17625231910946196,0.4117887445027792,1.0,3/11,10.01%,LRRK2;COX18;AKT1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3255422597252228,-1.269233310709874,0.09926470588235294,0.4119432154439949,1.0,29/85,24.66%,DAB2IP;CSNK1A1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;USP13;GABARAP;SMAD7;ATXN3;ECSCR;CSNK1D;PSMC2;ZER1;SUMO1;ZYG11B;RAD23A;SH3RF2;MDM2;KEAP1;RCHY1;CEBPA;HSPA1B;TRIB3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3623829775583933,-1.2684776017891637,0.11310592459605028,0.4131783841728745,1.0,16/48,22.02%,MCL1;ATM;TNFRSF1B;ABL1;DDIT4;TP53;FNIP2;IKBKE;HIPK1;HIC1;BCL2L11;EPHA2;PRKDC;BRCA1;PHLDA3;CASP2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.3259622061763478,-1.2676256747971613,0.08288288288288288,0.41457975664755725,1.0,38/87,32.83%,FBXL7;RB1;DCUN1D3;KLF4;PKD2;PSMA2;RBX1;DLG1;PSME2;PSMB4;FAM107A;RGCC;CDC73;PSMC2;PSMB2;CDK6;PSMB1;PSMA8;CDK2AP2;PSME1;FHL1;CDKN2C;PSMD4;PTEN;PSMD5;E2F7;APC;PSMA3;PINX1;PSMB10;CDKN2B;JADE1;PSMD13;ZFP36L1;CDK4;WEE1;PSMB6;AURKA
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3534828470240894,-1.267599205631562,0.09880749574105621,0.41419750193445787,1.0,19/52,23.36%,SEC31A;PDIA5;ERN1;KLHDC3;PDIA6;GSK3A;SRPRA;CUL7;LMNA;DCTN1;KDELR3;WIPI1;EXTL3;ACADVL;DNAJB9;PREB;PARP16;FKBP14;TLN1
prerank,ncRNA export from nucleus (GO:0097064),-0.3822012001140226,-1.2675885276610461,0.13471502590673576,0.4137780193272468,1.0,13/36,26.38%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;PHAX;NUP214;NUP188;RAN;NUP88
prerank,regulation of cellular senescence (GO:2000772),-0.40646504776430076,-1.267567667745445,0.15682656826568267,0.41338386776352715,1.0,10/28,17.39%,NEK6;SLC30A10;YPEL3;AKT3;MAP3K3;ABI3;CDK6;CGAS;TERF2;NUAK1
prerank,plasma membrane invagination (GO:0099024),-0.40605942282317936,-1.2675233818766696,0.125,0.41302581337276423,1.0,12/29,27.80%,GULP1;DOCK1;MYH9;ELMO1;SNX9;RHOA;ARHGAP12;ITGAM;ALKBH4;FCGR1A;SNX18;BIN2
prerank,ventricular septum development (GO:0003281),-0.38122029381998596,-1.2665514868569803,0.12639405204460966,0.4146717956184165,1.0,17/37,19.55%,BMPR2;TGFBR3;TGFBR2;HES1;PDE2A;SLIT2;TGFB2;HECTD1;SMAD4;ZFPM1;SMAD7;NOTCH1;HEY2;HEY1;CITED2;SOX4;DAND5
prerank,adenine nucleotide transport (GO:0051503),-0.45817897894180026,-1.2660245410760578,0.20588235294117646,0.4153684955377314,1.0,4/17,7.06%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3611881256920706,-1.2655330951771606,0.11754385964912281,0.41604613929858975,1.0,16/49,18.63%,CBFB;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;ASH2L;H3-3A;KMT2C;MTURN;MOV10;TNRC6A
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.39633868159776336,1.2654592900385881,0.16666666666666666,0.5550933594530298,1.0,7/27,12.84%,LPIN1;ETNK1;PLA2G3;PLA2G4E;PLA2G6;NAAA;CHKA
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4129925176104139,-1.2645917550354469,0.16425992779783394,0.4175040763768655,1.0,8/28,12.64%,RAC1;ADIPOR2;MITF;TNFRSF1B;SIRT5;MED1;NOS1AP;JAK2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.3535019140337591,-1.2643658660054014,0.11945392491467577,0.4175373676200763,1.0,30/57,33.95%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TP53;TAOK3;BABAM2;RFWD3;FANCD2;BRCC3;CDK5RAP3;RPA2;SDE2;CCND1;PRKDC;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL;RINT1;FBXO31;MDC1;HUS1B;RPS27L;PLK1;TICRR
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4071427212550734,-1.264361261389891,0.1512455516014235,0.41710308193042495,1.0,8/27,21.05%,PRKCH;PPARA;NFKB1;NFKBIA;AGTR1;LPL;ITGB3;PPARG
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.39212584718324534,-1.2640090275317326,0.15544041450777202,0.4169888060084528,1.0,12/32,26.38%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;RAN;NUP88
prerank,tRNA export from nucleus (GO:0006409),-0.39212584718324534,-1.2640090275317326,0.15544041450777202,0.4169888060084528,1.0,12/32,26.38%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;RAN;NUP88
prerank,motor neuron axon guidance (GO:0008045),-0.47566795785009225,-1.2626784918125433,0.20689655172413793,0.4194210972291342,1.0,6/15,12.96%,RAC1;NTN1;SLIT2;CHN1;EPHA4;RHOG
prerank,gas transport (GO:0015669),0.51428297027247,1.2622925700062868,0.21244635193133046,0.561826562319255,1.0,2/10,4.08%,CA2;NGB
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4170794316855181,1.2621583862923684,0.14870689655172414,0.560288896373709,1.0,9/21,24.97%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3;CIB1;TAOK1;CLASP1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5217094051361876,1.2621160678174335,0.2072072072072072,0.5585394034133349,1.0,6/10,21.45%,CPEB1;HSF1;CPEB3;DHX36;NCBP2;PAF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.33483932735488836,-1.2619862775208177,0.10934744268077601,0.420486539811863,1.0,29/73,27.84%,KAT2B;DEK;CTCF;SUZ12;SF3B1;TASOR;TAF1B;ACTB;HDAC4;TAF1C;MECP2;H3-3A;GPX1;DNMT1;HDAC6;KDM1B;PPHLN1;WBP2;PPM1D;IGF2;BAZ1B;AEBP2;ERCC6;POLR2H;POLR2L;TAF1D;POLR1E;HDAC5;PHF19
prerank,cell chemotaxis (GO:0060326),-0.3425272940349286,-1.2618815293023642,0.10727272727272727,0.4202725582368871,1.0,20/60,24.06%,LEF1;PARVA;DOCK4;CCL25;PLEKHG5;PRKCD;CCR9;BCAR1;AGTR1;RHOG;ACKR3;HGF;ELMO2;CCN3;HOXB9;EPHA2;SEMA5A;PIP5K1A;CXCL12;PDGFRB
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4254656115365183,1.2618167387164025,0.1545253863134658,0.557470117273232,1.0,6/20,14.78%,BICD1;PLEK;RPGRIP1L;RNF157;CCL5;MRAP2
prerank,odontogenesis (GO:0042476),-0.3855116118437041,-1.2613707689735418,0.1273996509598604,0.42094527707278884,1.0,14/35,24.71%,EDA;TBX1;ANKRD11;HDAC1;BMP4;LRP6;TGFB2;AXIN2;BCOR;FOXC1;TUFT1;MSX1;BMP2;LAMB1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.522965422034467,1.2607131490631691,0.18571428571428572,0.5584598561796411,1.0,2/10,2.53%,UBE2J1;INSIG1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5096767080023266,-1.2606160407471971,0.20075757575757575,0.42222238796466005,1.0,4/12,15.10%,ASXL1;KLF2;CTBP2;TRIM16
prerank,polyol metabolic process (GO:0019751),-0.36378007458088496,-1.2597024451193701,0.11806797853309481,0.42371055498069343,1.0,11/46,11.14%,PLCB4;PLCG1;INPP1;INPP5A;PLCB3;PLCB1;PLCE1;MINPP1;PLCG2;ITPKB;INPP4A
prerank,positive regulation of developmental growth (GO:0048639),0.34565457296490965,1.2591205484003378,0.13303769401330376,0.5607866661296304,1.0,15/49,14.46%,L1CAM;SYT1;RIMS2;RIMS1;SHTN1;CDKL5;LIMK1;CPNE9;MAPT;RNF157;ZFYVE27;SYT4;SYT3;BDNF;UNC13A
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5141813156991939,1.2591093883925004,0.19305856832971802,0.5589775292967658,1.0,4/10,6.07%,ATP1A2;HECW1;OSR1;HECW2
prerank,autophagy of peroxisome (GO:0030242),-0.4994354712986286,-1.2588853112856428,0.1757469244288225,0.4249807318828655,1.0,2/12,4.80%,ATM;MAP1LC3B
prerank,cytosolic calcium ion transport (GO:0060401),0.3927685570337316,1.2586349545998337,0.15654205607476634,0.5583730821368575,1.0,8/28,12.07%,SLC25A23;CACNA2D1;CACNB3;SLC8A2;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,mammary gland epithelium development (GO:0061180),0.47940740137420823,1.2585674179321045,0.15315315315315314,0.5567317871138269,1.0,5/14,14.58%,ERBB4;WNT7B;CSF1R;WNT2;WNT4
prerank,embryonic digestive tract development (GO:0048566),-0.4570339695123964,-1.2585395020436365,0.18265682656826568,0.42527506500449985,1.0,9/18,27.89%,NIPBL;TGFB2;PCSK5;GLI3;PKDCC;RARB;FOXF1;RBPMS2;STRA6
prerank,bile acid and bile salt transport (GO:0015721),-0.4146111626538282,-1.2579989077266471,0.155668358714044,0.42602023039600095,1.0,4/24,2.89%,ABCC4;ATP8B1;SLCO1C1;RXRA
prerank,error-prone translesion synthesis (GO:0042276),-0.4520766670137994,-1.2579733161257916,0.16939890710382513,0.4256264123377715,1.0,8/21,23.59%,RPA3;RPA1;REV1;MAD2L2;POLE2;RPA2;RFC4;RFC1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4392731190627336,-1.2575447100171149,0.15696649029982362,0.4261291125692053,1.0,7/19,13.13%,NFAT5;NFATC1;NFATC4;INPP5A;PLCE1;EDN1;EDN3
prerank,regulation of blood coagulation (GO:0030193),-0.4101356154177538,-1.257446513336165,0.15601503759398497,0.42590194641596685,1.0,12/27,26.29%,ST3GAL4;CAV1;CD34;THBS1;ENPP4;EDN1;TFPI;SERPINE1;HPSE;SERPINE2;DMTN;F2R
prerank,positive regulation of embryonic development (GO:0040019),0.4330624251028341,1.2571917228076643,0.18403547671840353,0.5585780625856591,1.0,3/19,4.38%,TENM4;LHX1;OSR1
prerank,cellular response to virus (GO:0098586),-0.396652732804227,-1.2563159352183142,0.16984402079722705,0.42792571629738646,1.0,15/30,29.63%,IFIH1;DDX3X;IRGM;EIF5A;LGALS8;GSDME;CCL19;HSP90AA1;MAPK11;VWCE;RIOK3;CXCL10;TOMM70;LGALS9;MAPK14
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.47247050738041046,1.2562062577096633,0.2073732718894009,0.5593631365716003,1.0,6/13,20.90%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,mitochondrion disassembly (GO:0061726),-0.387917776329751,-1.255628254617122,0.15114235500878734,0.42890134984488776,1.0,20/34,35.32%,ATG7;MAP1LC3B;AMBRA1;BNIP3;GABARAP;FUNDC1;WIPI1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B;ATG3;ATG9A;WIPI2;GABARAPL2;USP30
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3764606943603092,-1.255532317513892,0.17137809187279152,0.4286402403603779,1.0,10/37,12.53%,PARD3;UBE2K;APP;SPRED2;PPEF2;DDIT4;IRGM;MAPK1;SMAD7;RPTOR
prerank,calcium ion transport (GO:0006816),0.30353741279280794,1.2554457791130904,0.09468822170900693,0.5596514942678263,1.0,20/113,8.23%,TRPM3;SLC24A4;SLC24A2;MS4A1;RYR3;CACNA1B;CACNA2D1;ATP2B4;ATP2B2;CACNA1A;CACNB3;CACNG8;SLC8A2;CACNA1D;SELENOK;CACNG3;RYR2;TMCO1;TRPM1;CACNA1E
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3156352930750095,-1.255413283844185,0.10412926391382406,0.428456350968964,1.0,32/96,25.21%,SRSF11;NUP42;SARNP;RAE1;RANBP2;THOC2;UPF3B;NUP98;THOC7;UPF2;SEC13;AGFG1;DDX39B;DHX38;SLU7;NUP153;MCM3AP;TPR;THOC1;THOC3;NXT1;NUP214;SRRM1;FIP1L1;RNPS1;SRSF3;GLE1;NUP188;POLDIP3;ALKBH5;NXF1;SMG6
prerank,tRNA transport (GO:0051031),-0.38079534981506613,-1.2551885873551962,0.15724381625441697,0.42850923478830577,1.0,13/35,26.88%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;RAN;NUP88;TOMM20
prerank,positive regulation of secretion (GO:0051047),0.5015157085431463,1.2551695691407394,0.20190023752969122,0.5586054548986618,1.0,3/11,11.98%,TRH;ACSL3;GPLD1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.33083174898852974,-1.2544223806386436,0.1012216404886562,0.4297005134602511,1.0,27/73,23.79%,CAV1;APP;PRKD2;TFRC;EGFR;GAS6;IRGM;NGF;PRKD1;RAF1;HAX1;AKT1;FNIP2;BRAF;MTCP1;RPTOR;MIF;CREBL2;MAD2L2;HDAC6;TXN;CAPRIN2;NOS1;HSP90AA1;RAPGEF3;SH2D3C;AKAP9
prerank,protein insertion into membrane (GO:0051205),-0.3923133409293781,-1.2540632893677601,0.14629629629629629,0.4300089785912084,1.0,11/32,21.36%,APP;EMD;EGFR;COX18;UBE2J2;SGTA;TRAM2;VAPA;REEP1;WDR83OS;VAMP2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3660309762284718,1.2540430905755628,0.13990825688073394,0.5596570587093282,1.0,11/41,13.76%,KCNMA1;ANK3;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;STAC;GABBR1;KCNN3;AMIGO1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4038833111563862,-1.2536861197942566,0.16457960644007155,0.430322069092704,1.0,10/29,21.65%,DAB2IP;IL17RD;BMP5;SPRED2;LDLRAD4;SMAD7;FUZ;MAD2L2;PPP2CA;PTEN
prerank,carboxylic acid metabolic process (GO:0019752),-0.3927913197684189,-1.2533680393503412,0.16666666666666666,0.4306279343518594,1.0,5/33,3.66%,SLC2A1;ST3GAL1;ST6GAL1;CSGALNACT1;PLA2G4A
prerank,regulation of spindle assembly (GO:0090169),-0.4158153054994373,-1.2524923389326288,0.15641476274165203,0.43216417058422085,1.0,15/25,35.55%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;RNF4;PDCD6IP;HSPA1B;SENP6;HNRNPU;CCSAP;CHMP3;CHMP1A;PLK1;CHMP1B
prerank,icosanoid secretion (GO:0032309),-0.49563771638830323,-1.2524853887451102,0.19858156028368795,0.4317312322044736,1.0,2/12,4.31%,ABCC4;ACE
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5184390757988622,-1.252421300398923,0.1840607210626186,0.43142767267475,1.0,3/11,5.05%,LRP5;TBX1;TGFBR2
prerank,RNA processing (GO:0006396),-0.288690328991534,-1.2522117507019168,0.059931506849315065,0.4314600237781268,1.0,53/176,21.37%,MBNL1;RBPMS;SRSF11;TUT7;TENT4B;PRPF3;RBMS1;SMU1;IVNS1ABP;CDK12;RSRC1;HNRNPA0;PPIG;RBM5;HNRNPR;PRPF6;FUS;RBMS2;DDX39B;SF3B1;NOL9;CELF1;TENT4A;HNRNPUL1;DICER1;HNRNPF;SFPQ;TUT4;XRN2;RBM39;SLU7;SON;TENT2;YJU2;SCNM1;SF3A1;APOBEC1;THOC1;SRPK2;SYNCRIP;ADARB1;USB1;ZMAT5;TFIP11;PPP2CA;SRRM1;DROSHA;RNPS1;TSEN34;FASTKD5;NONO;LSM3;RBM3
prerank,negative regulation of DNA replication (GO:0008156),0.48597706799663615,1.2513334378242467,0.19172113289760348,0.565058159698782,1.0,4/13,10.71%,GMNN;GTPBP4;TERF1;ATR
prerank,positive regulation of ATPase activity (GO:0032781),0.3535128813262068,1.2513115608417695,0.1554054054054054,0.5633258332108056,1.0,14/41,21.43%,PFN2;DNAJB11;UHRF1;ATP1B1;PFN1;DNAJC24;RYR2;MYL4;MSH2;VMP1;DNAJB1;DNAJB2;ATP1B2;CHTOP
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3329037244878883,-1.2512494638006348,0.11599297012302284,0.4330688690791383,1.0,17/69,13.72%,IGF1R;PLCB4;PLCB3;PLCB1;PIK3R1;IRS1;PLCE1;EZR;PI4KB;PIK3C2A;NGF;PIK3CD;AKT1;EDN1;HTR2A;RHOA;PIK3CB
prerank,bile acid metabolic process (GO:0008206),0.4017848730086849,1.2512177646546694,0.1793103448275862,0.5617658309275025,1.0,5/27,8.66%,AKR1D1;CYP46A1;AKR1C1;OSBPL6;CYP27A1
prerank,neutral amino acid transport (GO:0015804),-0.40455191581340805,-1.250881772760707,0.14982578397212543,0.4334366676631499,1.0,11/28,23.69%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.45386355511469056,-1.2508252234235582,0.16363636363636364,0.43311432310288467,1.0,4/18,9.82%,ESR1;EGFR;BMP4;TP53
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5165715186468858,-1.2506589865694184,0.1916376306620209,0.43304959111676516,1.0,5/11,12.08%,FOXO1;GSK3A;SMAD4;LMNA;NOTCH1
prerank,response to hydroxyurea (GO:0072710),-0.5112247844440073,-1.2503501017931267,0.20877192982456141,0.4332338595970239,1.0,7/11,21.01%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3465402888046893,-1.250070899453384,0.12544802867383512,0.4334268611334403,1.0,13/57,11.08%,DAPK1;NOD1;UACA;MAP3K5;TNFSF10;DDX3X;PPM1F;ARL6IP5;ASPH;CASP8;BCAP31;PERP;SOX7
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.34398572748381184,-1.2497345293939488,0.1243432574430823,0.43369878494555386,1.0,18/59,16.92%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;ROCK1;PRKD1;MAPK1;GSK3A;AKT1;MAPK8;MARK2;HIPK1;ROCK2;CDC42BPB
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3709947550036313,-1.2493030025503336,0.14925373134328357,0.43415200673465293,1.0,15/43,16.85%,ZHX3;FERMT2;LRP5;BMPR2;IL6ST;BMP6;IL6R;BMP4;MEF2C;PRKD1;ACVR2A;YAP1;HGF;BMP7;IGF1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2882163130608635,1.2486486870061793,0.07529411764705882,0.5668886511880258,1.0,30/152,11.79%,ADGRB3;GNAO1;CHRM2;GNAI2;ADGRL3;GRM8;GNAI1;ADCY8;CALCA;GNAL;ADGRG4;CNR1;GPR37;PTGER3;GNAT3;MTNR1A;CACNA1D;ADCY7;PF4;GIPR;ADRB3;GPR65;ADRA2A;VIPR2;HTR1D;TSHR;GPER1;LGR5;ADRA1D;GABBR1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.44759902604269225,1.248456823030615,0.20238095238095238,0.5656118643306837,1.0,7/17,13.94%,ATP1A2;SCN1B;CACNA2D1;CACNA1D;SCN5A;SLC8A1;SCN2B
prerank,negative regulation of cell migration (GO:0030336),-0.29586186643693446,-1.2483498950221923,0.08348794063079777,0.4357708756437372,1.0,45/137,22.09%,PTPRG;DAB2IP;CLDN5;ENG;ACVRL1;RAC1;CORO1C;MCC;ARID2;MITF;SCAI;PTPRJ;AFDN;LDLRAD4;TCAF1;STK24;SLIT2;FOXO3;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;LIMCH1;SMAD7;DUSP3;FGF2;WNT11;TPM1;HAS1;MIF;FUZ;JAG1;IGFBP5;ADARB1;ADGRG1;CITED2;HYAL2;DUSP22;RAP2C;RAP2A;VCL;PTEN;NF1;RECK
prerank,amino sugar biosynthetic process (GO:0046349),-0.49669748000137903,-1.2471434848351257,0.20818505338078291,0.43809551518475975,1.0,4/12,13.77%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.48664718296513176,1.2471186452770286,0.2080536912751678,0.5674745918804713,1.0,4/12,19.58%,IL12RB1;IL23A;PRKCQ;ZBTB1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5332092724595573,-1.2467154820975135,0.2075812274368231,0.43854544707134463,1.0,4/10,18.60%,KDR;NAMPT;JAK2;NOD2
prerank,autophagosome assembly (GO:0000045),-0.35154364473934213,-1.246554574807974,0.12926391382405744,0.43846923322737574,1.0,19/52,23.92%,ATG7;RAB7A;RAB1A;SMURF1;MAP1LC3B;IRGM;AMBRA1;GABARAP;WIPI1;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;RAB19;ATG2A
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4893228527733273,1.2463882584422454,0.21304347826086956,0.5677061295401024,1.0,7/12,19.05%,BICD1;NINL;BBS4;KIF3A;CEP19;CCDC120;HOOK3
prerank,retrograde axonal transport (GO:0008090),0.44370630971734887,1.246367766482102,0.1875,0.5659731005237221,1.0,7/16,19.50%,DLG2;TMEM108;KIF5A;KIF1C;NEFL;MAP1A;HAP1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.30879832488564635,-1.2463028143774273,0.10590277777777778,0.43857151838422714,1.0,28/107,18.66%,DAB2IP;ITPR1;THBS1;GSK3B;RNF139;MAP3K5;ATG10;NIBAN1;RASGRF2;NCK1;PIK3R1;ERN1;JUN;CREB3L2;ATP2A3;TP53;BCAP31;ERO1A;UFM1;FLOT1;ATF4;DNAJC10;PDIA3;BBC3;BCL2L11;CDK5RAP3;DNAJB12;DNAJB9
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3386051177268342,-1.2461116808682149,0.12612612612612611,0.4385457833455087,1.0,21/66,20.21%,FLT1;DAB2IP;PDGFD;DVL3;MAP3K5;LRRK2;EGFR;FGF1;IL34;TPD52L1;EDN1;PIK3R6;TAOK3;IRAK1;FGF2;EDN3;CD40;NOD2;RPS3;SASH1;ARHGEF5
prerank,sphingoid metabolic process (GO:0046519),0.4839088820862535,1.246105028638034,0.17543859649122806,0.5649546084902582,1.0,6/12,17.11%,PLPP2;SPHK1;SGPP1;SPHK2;NAAA;ASAH2
prerank,negative regulation of blood coagulation (GO:0030195),0.3644476389665884,1.2457700729079377,0.17943107221006566,0.5640794559762357,1.0,8/38,13.32%,VTN;CPB2;C1QTNF1;F8;SERPING1;PDGFA;PDGFRA;APOE
prerank,positive regulation of phospholipase activity (GO:0010518),-0.43051747245167116,-1.2452272412965997,0.16574585635359115,0.4399916662684858,1.0,5/22,12.91%,FLT1;ESR1;PLCG1;AGTR1;FGF2
prerank,negative regulation of cellular component movement (GO:0051271),-0.46725478066551307,-1.2450212020905866,0.19230769230769232,0.4400276721421654,1.0,5/15,12.44%,SP100;CRK;TGFBR3;FRMD5;ACTN1
prerank,regulation of type I interferon production (GO:0032479),-0.3171457961838834,-1.244707627841653,0.12389380530973451,0.44028241139360363,1.0,23/84,17.31%,CREBBP;IFIH1;TRIM25;TRIM56;RNF125;TAX1BP1;NFKB1;STAT6;MRE11;IRF1;UBA7;IKBKE;IRAK1;LRRFIP1;TRAF3IP1;POLR3F;CGAS;ILRUN;TNFAIP3;MAVS;CTNNB1;NLRC5;GPATCH3
prerank,peripheral nervous system development (GO:0007422),0.4117350520608121,1.2435622124652947,0.17607223476297967,0.5681523522217008,1.0,4/23,6.27%,ASIC2;SCN8A;NFASC;GPC1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.35769650638633,-1.2432753338903821,0.14154411764705882,0.4430580712700784,1.0,16/44,15.79%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;LIMCH1;RHOA;WNT11;MYOC;ARHGEF10;SORBS3;RHOC;TPM1;ROCK2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.33701082516711134,-1.2427052346543443,0.12736660929432014,0.44382944201494723,1.0,19/61,18.10%,AKAP13;ARHGEF3;RAC1;LYN;NET1;F11R;SHOC2;NGF;PRAG1;NOTCH2;RAPGEF1;NOTCH1;JAK2;PIK3CB;GRB2;IGF1;MAP4K4;ADGRG1;ALS2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.4754057406918826,-1.2425709182738467,0.21033210332103322,0.44370101912894655,1.0,6/14,26.62%,NOL9;RPL7L1;BOP1;PES1;ZNHIT3;WDR12
prerank,protein localization to organelle (GO:0033365),-0.30067537981904985,-1.2425245911653804,0.08648648648648649,0.44334852496318816,1.0,41/133,21.90%,ZNF423;APP;DDX3X;LRRK2;YWHAE;EMD;SIX1;ZBTB7A;CEP250;TOR1B;BMP4;IFT140;CNTLN;UBE2J2;UBAC2;CROCC;LMNA;GAK;EHD1;TSPAN17;WDR35;SGTA;LMBRD1;RPA1;CSNK1D;ABCA7;SIX4;BMP7;RAB11A;TRAM2;GBP5;TULP1;RIPOR1;VAPA;LAMP2;RPA2;DCP1A;WDR83OS;VAMP2;MDM2;IFT20
prerank,mitotic cell cycle phase transition (GO:0044772),-0.2806575750154269,-1.2424876469932178,0.07308970099667775,0.4429839369419808,1.0,66/203,25.93%,FBXL7;MNAT1;RB1;EPS8;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CDKN1B;CRLF3;CEP57;DNM2;PLCB1;CUL3;CEP250;CCND3;MAX;CUL2;PLK2;CEP78;NES;PPP2R2D;LATS2;HAUS8;TPD52L1;CCNY;CHMP4B;PPP1R12A;DCTN1;CDC16;DCTN3;HAUS6;PAFAH1B1;CSNK1D;FBXW11;CDK6;GSPT1;CEP41;PLK4;CETN2;CEP152;ALMS1;CCND1;PCM1;CACUL1;CNTRL;TACC3;CDKN2C;ODF2;HSP90AA1;CDC25A;CDK14;CEP131;PCNT;AJUBA;CCNG1;AKAP9;PLK3;CCNE2;FBXL22;CCNJ;ANAPC7;E2F3;CDKN3;DYNLL1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.4260700584553873,-1.2423809790646434,0.17025089605734767,0.44277999775161675,1.0,6/21,14.23%,PAN3;TUT7;CNOT4;SAMD4A;TUT4;PARN
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.2969797322732001,-1.242373973799054,0.09532062391681109,0.4423489831231081,1.0,37/118,19.81%,SHANK3;SP100;FERMT2;ADGRA2;BMPER;ETS1;NEDD4L;PDZD8;GSK3B;KIF13B;PAK2;TBX1;LRRK2;PDLIM5;ZMYM6;CHN1;NEDD4;MEF2C;EPHA4;PLXND1;FLT4;STAT2;ABI3;CEACAM1;FGF2;ZMYM4;RC3H1;MARK2;TNFAIP3;CTNNB1;CAPZB;CFL1;ARHGAP35;FMNL2;WTIP;EPHA2;RAP2A
prerank,regulation of protein catabolic process (GO:0042176),-0.3101840061488224,-1.2421967456362988,0.0940959409594096,0.442280150515897,1.0,36/99,25.42%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;EGFR;NEDD4;NKD1;PLK2;GSK3A;FLNA;SNX12;AREL1;AZIN1;MAD2L2;TNFAIP3;OAZ2;GPC3;HUWE1;WWP2;HACE1;SEC22B;MDM2;CTSA;GFAP;ADGRB1;FZR1;APC;TNFSF12;DTL
prerank,respiratory chain complex IV assembly (GO:0008535),-0.42360121560557773,-1.241976043654281,0.18339100346020762,0.4423020128707764,1.0,7/21,20.42%,COX16;COX18;SCO1;COX17;COA6;COX10;COA8
prerank,mitotic sister chromatid segregation (GO:0000070),-0.3145124131474885,-1.241872717671235,0.10243055555555555,0.44206007988607315,1.0,42/98,30.64%,RB1;PDS5B;NIPBL;CUL3;WRAP73;SMC4;TENT4A;POGZ;CHMP4B;CHMP4A;KIF23;PDS5A;CHMP2B;KMT5A;CHMP5;RAB11A;DSN1;CENPE;PRC1;PDCD6IP;RRS1;NCAPD2;MCPH1;DIS3L2;NCAPH;BECN1;KIF18B;NCAPH2;RAN;PINX1;EML4;KIF14;SPDL1;INO80;CDCA8;CHMP3;TUBG2;TTN;SET;CHMP6;NUDC;CHMP1A
prerank,negative regulation of anoikis (GO:2000811),-0.4651507443862462,-1.2414385785891868,0.20774647887323944,0.4426129111102679,1.0,5/14,12.08%,ITGB1;CAV1;MCL1;PTK2;NOTCH1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.440919399440034,-1.2413581099920412,0.17582417582417584,0.4423304602429238,1.0,9/18,26.63%,DAB2IP;VGLL4;MSN;EZR;CDK5RAP3;AMER1;HSP90AA1;RDX;VPS35
prerank,microvillus assembly (GO:0030033),-0.4784171696482605,-1.2413550050953737,0.20512820512820512,0.4418897840112627,1.0,11/14,28.57%,RAPGEF2;EZR;RAP1A;FXYD5;RAP1B;MAP4K4;RAP2C;RAP2A;ESPN;RAP2B;RAPGEF6
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.45956142417513773,-1.2408530610214594,0.20577617328519857,0.4425743768040997,1.0,7/17,24.91%,ALG14;ALG12;ALG8;DOLPP1;ALG13;MVD;DOLK
prerank,positive regulation of exosomal secretion (GO:1903543),0.4572973222114206,1.2402516787283777,0.17970401691331925,0.5751987857562667,1.0,7/15,18.65%,SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,protein ubiquitination (GO:0016567),-0.2565877742334732,-1.2399858633740832,0.02861952861952862,0.4440753252984182,1.0,121/471,20.15%,FBXL7;WWP1;PELI1;CBFB;UBR5;USP9X;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;FBXL12;TRIM25;UBE2K;RNF139;PSMA2;FBXL17;CNOT4;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;CUL9;FBXL3;RNF213;RBX1;LMO7;RNF43;OTULIN;CBL;UBE4B;CUL3;NEDD4;RNF40;RNF115;RNF144B;PSME2;CUL2;UHRF2;KLHL12;BIRC6;ARRDC1;PSMB4;UBE2J2;DET1;TRIP12;SH3RF1;ZNRF2;UBE2D3;SPSB1;PDZRN3;UBR2;MIB1;RNF25;TPP2;CUL7;FBXW8;TRIM14;AREL1;TNFAIP1;RMND5A;HERC6;TSPAN17;KLHL13;CDC16;RAD18;OBI1;ANAPC16;RTF1;UBE4A;CDC73;ASB1;UBE2E2;RC3H1;KLHL25;FBXW11;PSMC2;HIF3A;PSMB2;RNF168;RNF167;UBE2V2;DTX3;ERCC8;PEX14;PHC1;VCPIP1;MIB2;PSMB1;RFWD3;HERC2;MYLIP;UBE2L3;PELI2;KLHL3;CTNNB1;EPAS1;TRIM13;PSMA8;RNF152;KCTD10;RNF10;AKTIP;PSME1;UBR1;SPOP;TRIM3;SIAH1;SDE2;HUWE1;WWP2;SASH1;ELOC;TRIM47;RNF4;USP7;NPEPPS;PRKDC;FANCL;BRCA1
prerank,"phototransduction, visible light (GO:0007603)",-0.4814672878305336,-1.239870233047741,0.22326454033771106,0.44389386407252074,1.0,6/14,37.35%,GNB1;SAG;GNA11;PDE6G;PDE6B;RP1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.351496312037716,-1.2397737119650978,0.1402936378466558,0.44367607250460417,1.0,20/48,25.98%,ZMIZ1;KAT2B;DEK;ARID1B;ATAD2B;SF3B1;TAF1B;ACTB;TAF1C;WBP2;ELOF1;BAZ1B;CHEK1;ATAD2;ERCC6;POLR2H;POLR2L;TAF1D;POLR1E;SERTAD2
prerank,cellular lipid catabolic process (GO:0044242),0.3970653976281827,1.2393553813316092,0.18433179723502305,0.575755755453684,1.0,4/27,6.50%,ENPP2;NUDT19;LPIN1;SMPDL3B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4472836748580188,1.2392389788967104,0.16898148148148148,0.5743271874919504,1.0,6/16,14.78%,CHGA;KLK6;PRMT5;GPER1;C3;MRAP2
prerank,protein heterooligomerization (GO:0051291),0.4484466863602541,1.2387721897359405,0.18243243243243243,0.5738514772871512,1.0,2/17,0.92%,KCNC2;GRIN2B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.392239439603631,1.2377488072160994,0.15348837209302327,0.5749615634776363,1.0,6/27,8.46%,PDE4B;CTNNA3;STC1;PKP2;RYR2;SCN5A
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.360159381954349,-1.2373383591635945,0.14647377938517178,0.4486196212027393,1.0,16/46,25.22%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;DGKZ;AGPAT4;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,RNA export from nucleus (GO:0006405),-0.3075281857176255,-1.2373077897145426,0.11879432624113476,0.44825360424282173,1.0,35/100,26.38%,SRSF11;NUP42;SARNP;RAE1;RANBP2;THOC2;UPF3B;NUP98;THOC7;UPF2;SEC13;AGFG1;DDX39B;DHX38;SLU7;NUP153;MCM3AP;HNRNPA1;TPR;THOC1;THOC3;NXT1;NUP214;SRRM1;FIP1L1;RNPS1;SRSF3;GLE1;NUP188;POLDIP3;ALKBH5;NXF1;SMG6;RAN;NUP88
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.375747884736797,-1.2370008907547325,0.1564625850340136,0.448545548373637,1.0,14/37,24.07%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;RPL5;GIPC1;USP7;RPS7;TRIM39;OGT;TAF9
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2805652818169869,-1.2369487574301572,0.06292517006802721,0.448240823711764,1.0,52/208,18.96%,DAB2IP;PELI1;AKAP13;TAB3;ESR1;ROR1;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;TNFSF10;TFRC;NEK6;BIRC3;PLK2;PRKD1;PLCG2;PPM1B;CASP8;ALPK1;FLNA;MAP3K3;CFLAR;TRIM14;IKBKE;IRAK1;MTDH;RHOA;RHOC;ZFAND6;TRIM59;CD40;TNFRSF19;USP10;MIB2;TAB2;TNFRSF1A;TFG;TNFAIP3;PELI2;MAVS;TRIM13;ZMYND11;IKBKG;VAPA;CCL19;IKBKB;NOD2;LURAP1;EDAR
prerank,acyl-CoA biosynthetic process (GO:0071616),0.44352355289568146,1.2368546208271207,0.21158129175946547,0.575611961407647,1.0,7/16,21.46%,ACLY;ACACA;ACSS1;SCD5;SCD;ACAT1;HSD17B8
prerank,histone H3 acetylation (GO:0043966),-0.36740266384714515,-1.236257919659961,0.16885553470919323,0.4493404643746239,1.0,14/40,24.07%,LEF1;KAT6B;KAT2B;KAT6A;SGF29;LDB1;TAF5L;DR1;TRIM16;TADA3;JADE2;WDR5;MAP3K7;TAF9
prerank,protein glycosylation (GO:0006486),-0.29905030255477005,-1.2360056668907577,0.10309278350515463,0.44948456486144706,1.0,33/125,18.89%,ST3GAL6;EOGT;ST3GAL4;ST3GAL1;PLOD1;ST8SIA4;PLOD2;GCNT2;TRAK1;GALNT10;ALG10B;DAD1;MAN1C1;B3GNT2;MGAT4B;GFPT2;TET2;FUT8;AQP11;SLC39A8;ST3GAL2;FUT10;ALG12;ALG8;ALG11;DOLPP1;GALNT18;MGAT2;B4GALT5;ST6GALNAC2;GALNT1;LARGE1;B4GALT1
prerank,negative regulation of phosphorylation (GO:0042326),-0.31525542078540936,-1.2352976088553964,0.11971830985915492,0.4506662340010763,1.0,25/85,21.65%,DAB2IP;CBFA2T3;LYN;CORO1C;LRRK2;NIBAN1;CDKN1B;PPARA;SLIT2;BMP4;LRP6;ROCK1;OCLN;PRKRIP1;HDAC4;CHP1;TRAF3IP1;PTPN13;DNAJC10;BMP7;CDK5RAP3;PRKDC;CDKN2C;WARS1;PTEN
prerank,regulation of synapse organization (GO:0050807),0.3986143926328806,1.2344619740783918,0.1615720524017467,0.5802167683816767,1.0,6/26,6.47%,IL1RAPL1;CTNNA2;CDKL5;CLN3;MDGA1;CAMK2B
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4485512238215834,-1.2343788539906126,0.1903114186851211,0.45229242798007296,1.0,7/17,21.65%,PRKG1;CDKN1B;PDCD4;MEF2C;TPM1;PPARG;PTEN
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4238858001232665,1.2339085564382668,0.17857142857142858,0.5799853013494364,1.0,10/19,21.39%,GGA3;NTRK2;SORL1;RTN4;APOE;CLU;FLOT2;RTN3;HAP1;RTN1
prerank,secretion (GO:0046903),0.4619270712693259,1.233231967622947,0.20909090909090908,0.5801798689527705,1.0,2/14,1.31%,SLC22A4;RIMS1
prerank,positive regulation of behavior (GO:0048520),0.5082524825733329,1.2327367989153142,0.22004357298474944,0.5797251959720399,1.0,3/10,11.07%,NLGN1;NR4A3;SGIP1
prerank,protein-containing complex disassembly (GO:0032984),-0.34482437712865843,-1.2318633456158263,0.1358695652173913,0.4574780091862759,1.0,8/54,6.99%,CAV1;CSNK1A1;LIX1L;GSK3B;DVL3;MAP1LC3B;LRP6;TECPR1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3619750019130261,-1.2317441993529137,0.15313653136531366,0.457271496274458,1.0,14/40,22.43%,RNF139;SMURF1;GNA12;PTK2;HFE;FOXF2;SGTA;RPL5;CDK5RAP3;RAD23A;PTEN;PTK2B;RPS7;TRIM39
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5141827154896219,-1.231511547624605,0.21206581352833637,0.45733071348762705,1.0,3/11,9.82%,EGFR;BMP4;TP53
prerank,cellular response to retinoic acid (GO:0071300),0.3484621131049268,1.2313745696123644,0.16631130063965885,0.5817656976845246,1.0,10/42,13.59%,BRINP3;WNT7B;BRINP1;PAX2;BRINP2;ADNP2;TESC;WNT6;HTRA2;WNT2
prerank,endoplasmic reticulum organization (GO:0007029),-0.32393401864238625,-1.2308541288531594,0.11602209944751381,0.45836128652093616,1.0,28/72,27.99%,SEC31A;APP;TMCC1;STX18;LRRK2;EMD;TOR1B;ATL2;SEC16B;UBE2J2;REEP3;GAK;SGTA;VCPIP1;LMAN2;TRAM2;MOSPD3;VAPA;REEP1;WDR83OS;LPCAT3;VAMP2;TLE6;EIF2AK3;SEC61A1;CAV2;HMOX1;RAB18
prerank,eye development (GO:0001654),-0.3447371945336362,-1.230791240160636,0.1410488245931284,0.4580383516808429,1.0,17/54,16.18%,PBX1;RAB3GAP1;SMOC1;SH3PXD2B;PBX3;COL5A1;NIPBL;RBP4;TGFB2;COL5A2;SIPA1L3;SHROOM2;LAMA1;FOXC1;HIPK1;SKI;FREM2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.44112070572632167,-1.2302077007550793,0.19337016574585636,0.45875798667937023,1.0,3/17,6.73%,PODXL;ADAM9;TGFB2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.4347143264034486,-1.2301831753373689,0.20527306967984935,0.45836174754103626,1.0,10/20,26.43%,TNRC6B;LIMD1;CELF1;AGO2;MOV10;TNRC6A;WTIP;AJUBA;CNOT8;CNOT1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.35151227082207637,-1.2298040825830343,0.15789473684210525,0.4587172472665484,1.0,9/45,9.47%,SP100;IRF2;TRIM25;JAK1;CAMK2G;ICAM1;MID1;PRKCD;IRF1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4127534482830545,1.2297127330816005,0.1939252336448598,0.5845438169574774,1.0,7/23,17.11%,FADS1;ACSBG1;ALOX12;ACOT7;CYP1A1;ALOX5;ASAH2
prerank,cell projection organization (GO:0030030),-0.38160323626549314,-1.2292765321852865,0.17636363636363636,0.45943907398392664,1.0,6/30,6.44%,ITGB1;PARVB;RAC1;RHOJ;PARVA;RHOQ
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5094400884980171,-1.22916144686663,0.20466786355475763,0.4592484162831779,1.0,4/11,8.59%,MAP3K5;STK24;PRKCD;ARL6IP5
prerank,oligodendrocyte differentiation (GO:0048709),0.4219027510613732,1.2290069810373796,0.18736383442265794,0.5846886038434267,1.0,7/19,17.70%,MYRF;CDK5;PTPRZ1;SLC8A3;TPPP;EIF2B1;SOX9
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.30238634509594053,-1.2287619489471182,0.09498207885304659,0.4597149990347787,1.0,44/114,28.25%,EDA;TMSB4X;TRAF5;LIMS1;PSMA2;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;PSMB4;TP53;ILK;JAK2;ACTN4;EIF5A;PSMC2;PSMB2;CD40;TNFRSF11B;PSMB1;TNFRSF1A;PSMA8;TNFSF13;PSME1;IKBKB;EDAR;TNFRSF25;PSMD4;TNFSF8;PTK2B;LTBR;RELA;RIPK1;PSMD5;MAP3K14;TNFSF12;PSMA3;ADAM17;PSMB10;TNFRSF9;TNFRSF12A;BAG4
prerank,negative regulation of protein binding (GO:0032091),-0.3274478035678727,-1.2285497542976866,0.12521440823327615,0.45972664587956036,1.0,17/71,15.70%,CAV1;DAB2;GSK3B;LRRK2;PRKCD;ROCK1;ATP2A3;NES;AKT1;ZFPM1;HFE;ACTB;ITGA4;MAPK8;PEX14;MITD1;CTSZ
prerank,negative regulation of cell cycle process (GO:0010948),-0.33218975611297635,-1.2284307476924312,0.13357400722021662,0.45954865905508974,1.0,20/61,22.31%,DAB2IP;MGA;RYBP;BMP4;SUZ12;MAX;WAPL;RBBP8;PPP1R10;EHMT1;YAF2;PHC1;FOXO4;TERF2;BMP7;RNF2;BRCA1;TOM1L2;CHEK1;PHC3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5180770284103933,-1.228369738064285,0.21847246891651864,0.4592335933494101,1.0,6/10,31.04%,PARD3;PRKD3;DGKH;PLPP1;F2R;DGKD
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2671373741655427,-1.2280875840094065,0.04835924006908463,0.45946954902320525,1.0,66/259,20.45%,ABCC4;ABLIM1;RAPGEF2;ITGB1;EXOC6;FGD5;PARVB;ASAP1;FGD6;DNM3;CD2AP;RAC1;NTN1;PARVA;FNBP1L;EXOC4;RAB1A;PTPDC1;EHD2;SSX2IP;CEP250;IFT140;EZR;RAP1A;CDC14A;RAB11FIP3;WDR11;FXYD5;RAP1B;EXOC2;S1PR1;MYLK;FLNA;PDE6D;EHD1;EMP1;ANO6;NOTCH1;WDR35;GALNT11;CFAP44;RAB8B;IFT52;TRAF3IP1;RAB23;EXOC8;CEP41;EHD4;FUZ;VSTM5;DZIP1L;NUDCD3;RAB11A;HDAC6;CFAP298;MAP4K4;GOLPH3;PLK4;TMEM17;PCM1;IFT43;KIF3B;RAP2C;RAP2A;SPATA13;VCL
prerank,peptide catabolic process (GO:0043171),-0.4214712996611165,-1.22780595044644,0.20036429872495445,0.459665503519544,1.0,9/23,19.79%,CPQ;ACE;GGT5;ECE1;ENPEP;XPNPEP1;ERAP1;CTSH;NPEPPS
prerank,microvillus organization (GO:0032528),-0.4833764618568729,-1.2269590259292422,0.21626617375231053,0.46113010139292704,1.0,8/13,19.81%,RAPGEF2;EZR;RAP1A;FXYD5;RAP1B;MAP4K4;RAP2C;RAP2A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.48156307758511346,-1.2267912095064009,0.21808510638297873,0.46109343984929907,1.0,5/13,18.60%,KDR;NAMPT;EDN1;JAK2;NOD2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3935116938987727,-1.2267524722836274,0.18783542039355994,0.46074513818990165,1.0,6/30,7.64%,AKAP13;ARHGEF3;RAC1;NET1;F11R;PRAG1
prerank,neutrophil activation (GO:0042119),-0.4903322118127152,-1.2267050006647322,0.2126537785588752,0.46040612889650123,1.0,3/12,6.78%,IL15;KMT2E;PRKCD
prerank,protein localization to cell junction (GO:1902414),-0.42298427752724355,-1.2266147633265723,0.1891891891891892,0.4601513948447328,1.0,7/22,6.94%,TJP1;FERMT2;HEG1;PAK2;JAK1;CGNL1;TJP2
prerank,methylguanosine-cap decapping (GO:0110156),0.5009080594216034,1.2261692520702894,0.21076233183856502,0.5907719048833958,1.0,2/10,4.19%,PATL2;DCPS
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.389756425715394,-1.2261583250021377,0.18959731543624161,0.46076323229153593,1.0,12/30,24.07%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;GIPC1;USP7;TRIM39;OGT;TAF9
prerank,response to glucose (GO:0009749),-0.35662216655011353,-1.2259761514905334,0.151183970856102,0.4607688312073343,1.0,9/46,13.17%,UNC13B;IGF1R;ZBTB20;THBS1;GAS6;ERN1;EIF2B2;PRKAA1;LPL
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3129990137285397,-1.2256249623214812,0.11663807890222985,0.4611532851266598,1.0,30/91,25.97%,ABCG2;APP;ATOX1;SLC39A10;SLC40A1;TFRC;BMP6;SLC31A1;SLC30A10;SCARA5;SLC39A8;SMAD4;HFE;HMOX2;ABCB7;SLC30A5;FLVCR1;SOD1;SLC39A6;SLC30A1;GLRX3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;LCN2
prerank,mRNA transport (GO:0051028),-0.3036846402672495,-1.225529258001235,0.13194444444444445,0.4609294366237238,1.0,31/101,24.19%,SRSF11;NUP42;SARNP;RAE1;RANBP2;THOC2;UPF3B;NUP98;THOC7;UPF2;SEC13;AGFG1;DDX39B;DHX38;SLU7;NUP153;MCM3AP;TPR;THOC1;THOC3;NXT1;NUP214;SRRM1;FIP1L1;RNPS1;SRSF3;GLE1;NUP188;POLDIP3;ALKBH5;NXF1
prerank,quinone biosynthetic process (GO:1901663),-0.4704321739048096,-1.225068641157549,0.20765027322404372,0.461550398118461,1.0,6/14,20.88%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,sulfur compound biosynthetic process (GO:0044272),-0.30700256686638316,-1.2242315480635997,0.11228070175438597,0.4629856068220454,1.0,35/104,25.89%,ST3GAL6;ST3GAL4;ST3GAL1;SLC26A2;CSGALNACT1;GSTT1;B3GNT2;GGT5;CHST15;B4GALT4;DSE;SLC10A7;CSPG4;ST3GAL2;CHST11;GSTM2;BGN;MAT2B;B4GALT5;ESD;ANGPT1;HPGDS;MAT2A;B4GALT1;CDO1;CHST7;GSTO2;CTH;GCLC;CHPF2;METTL16;GSTK1;OMD;MPST;CSGALNACT2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.4613531032766912,-1.2237008355711707,0.20987654320987653,0.46375484185398175,1.0,12/15,47.22%,IL17RA;GBP5;NOD2;TLR6;TICAM1;STAT3;HIF1A;TLR4;CARD9;IL6;TNF;MYD88
prerank,transition metal ion transport (GO:0000041),-0.37312248407521287,-1.2235838925169256,0.17204301075268819,0.46356229670176197,1.0,10/35,16.60%,ATOX1;TFRC;SLC31A1;SLC30A10;TRPC4;SLC39A8;TRPC6;SLC30A5;TRPC3;COX17
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5252339545629072,-1.2231545236599681,0.2087912087912088,0.46409910137916743,1.0,3/10,13.15%,THBS1;AKT1;CTTNBP2NL
prerank,aminoglycan biosynthetic process (GO:0006023),0.3436157825892534,1.2228262949534277,0.1572052401746725,0.5981748994885068,1.0,10/49,8.24%,GPC5;B3GALT1;HS3ST6;HS3ST5;B3GALT5;GPC1;HS6ST2;GALNT5;B4GALT7;HS3ST2
prerank,negative regulation of cell motility (GO:2000146),-0.29912901950299703,-1.2227458257986072,0.12476722532588454,0.46457154609833157,1.0,38/108,22.09%,CLDN5;ENG;ACVRL1;CRK;ARID2;MITF;SCAI;PTPRJ;AFDN;LDLRAD4;TCAF1;STK24;SLIT2;FOXO3;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;FRMD5;LIMCH1;SMAD7;DUSP3;WNT11;TPM1;MIF;FUZ;JAG1;IGFBP5;ADARB1;CITED2;DUSP22;RAP2C;RAP2A;VCL;PTEN;NF1;RECK
prerank,carboxylic acid transport (GO:0046942),-0.3450465494441292,-1.2221799621115685,0.1519434628975265,0.46540687419255755,1.0,19/55,23.69%,SLC6A6;SLC7A1;SLC7A5;SLC16A12;SLC38A5;SLC16A9;SLC16A1;SLC1A5;SLC13A3;SLC17A5;SLC16A6;SLC36A4;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC16A13;SLC38A6
prerank,regulation of endopeptidase activity (GO:0052548),0.32351712674797667,1.222048976109254,0.13333333333333333,0.5985380777130903,1.0,11/59,10.80%,VTN;SPOCK3;SPOCK1;PRELID1;SERPIND1;TIMP1;FETUB;A2ML1;SERPING1;SERPINA2;ATP13A2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.31783842222099784,-1.2217838235378393,0.13610586011342155,0.4654029863799373,1.0,24/78,21.60%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;DNM2;SEC24A;AP2S1;SEC13;SEC24D;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF26A;KIF15;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.31783842222099784,-1.2217838235378393,0.13610586011342155,0.4654029863799373,1.0,24/78,21.60%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;DNM2;SEC24A;AP2S1;SEC13;SEC24D;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF26A;KIF15;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.31627697530064114,-1.2217434006728372,0.1350844277673546,0.46502799007747797,1.0,24/79,21.60%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;DNM2;SEC24A;AP2S1;SEC13;SEC24D;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF26A;KIF15;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3352906675178384,-1.2216516132814954,0.1575091575091575,0.4647918829836033,1.0,14/55,20.15%,SLC7A1;IL15;TFRC;IL6ST;NCK1;NCK2;ICOSLG;VCAM1;IGF1;ANXA1;CCL19;RPS3;PTPRC;IGF2
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3769172671735115,-1.2215435349961419,0.19366852886405958,0.46459739679895085,1.0,7/32,8.59%,RREB1;WASF2;RAC1;CORO1C;PIK3R1;PLCE1;OCLN
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4749872074267815,-1.2212147150265424,0.23688969258589512,0.46490410741651156,1.0,4/14,18.66%,DAB2IP;PTPN1;BCL2L11;DNAJB9
prerank,negative regulation of lipid catabolic process (GO:0050995),0.43232521049669514,1.2212051549840521,0.19813519813519814,0.599123098772529,1.0,6/17,15.14%,PDE3B;BSCL2;SORL1;ADRA2A;GPLD1;APOC1
prerank,glycine transport (GO:0015816),0.5012442058380334,1.2206363216026905,0.25481798715203424,0.5989876580849254,1.0,3/10,9.60%,SLC7A8;SLC36A2;SLC6A5
prerank,negative regulation of cell growth (GO:0030308),-0.2975701632333598,-1.2205979621838414,0.12412587412587413,0.4658628613714992,1.0,40/121,25.19%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;SOX17;PTPRJ;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;DIP2B;GSK3A;SMAD4;TP53;DCBLD2;SEMA3G;ULK2;WNT11;ST7L;CCN3;NPR1;OSGIN2;RERG;HYAL2;PPP2CA;FHL1;CDKN2C;CAPRIN2;BCL6;MSX1;HSPA1B;APBB1;GNG4;SERTAD3;SIPA1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4407710043508504,-1.2205299383353148,0.2140221402214022,0.4655701098990722,1.0,7/17,18.54%,ABHD2;NR3C1;BMP4;MED1;BMP7;UBE2L3;TFPI
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4708536519545885,-1.2200791225489898,0.2114695340501792,0.4661717621185388,1.0,8/13,27.84%,PRPF3;PRPF6;PRPF31;SRSF12;CD2BP2;SRSF10;AAR2;LSM2
prerank,nucleosome organization (GO:0034728),-0.34049727442416994,-1.2199384590048565,0.1449016100178891,0.46602750383667807,1.0,16/55,19.50%,KAT6B;SETD2;ARID2;CTCF;SMARCC1;BRD2;SRCAP;SMARCE1;SPTY2D1;SMARCC2;MCM3AP;H3-3A;SMARCD3;PRDM9;VPS72;ATRX
prerank,DNA biosynthetic process (GO:0071897),0.4394218203556605,1.2199094573896252,0.19908466819221968,0.599171399175482,1.0,5/16,14.38%,WRNIP1;TYMS;POLD4;POLA1;PPIA
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.49853868297440623,-1.2198804426886318,0.22580645161290322,0.4648537209877071,1.0,4/12,12.18%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.49853868297440623,-1.2198804426886318,0.22580645161290322,0.4648537209877071,1.0,4/12,12.18%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.49853868297440623,-1.2198804426886318,0.22580645161290322,0.4648537209877071,1.0,4/12,12.18%,RB1;CUL3;CDC16;NSMCE2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5110926524381983,-1.2195940629462922,0.22719141323792486,0.4650594194537706,1.0,5/11,16.81%,SP100;TP53;KAT5;MAD2L2;TFAP4
prerank,bone development (GO:0060348),-0.3650862386896753,-1.2195915272316222,0.1732142857142857,0.4646242366180435,1.0,12/39,13.06%,AKAP13;LRP5;PLS3;DYM;SH3PXD2B;LRP6;TGM2;SLC10A7;TP53;RPL13;NOTUM;MYOC
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.49928510942254345,-1.2187884567054146,0.22939068100358423,0.466061604975085,1.0,4/11,13.77%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,mRNA processing (GO:0006397),-0.2643557342518222,-1.2186366353667981,0.05381944444444445,0.4659722763803185,1.0,96/287,27.84%,MNAT1;SRSF11;PRPF3;METTL14;SMU1;PSPC1;SARNP;CWF19L2;RSRC1;HNRNPA0;RBM5;THOC2;NOVA2;RPRD2;HNRNPR;UPF3B;PRPF6;THOC7;SF3B6;FUS;ERN1;SPEN;RBM19;HNRNPM;POLR2G;DDX39B;PHF5A;ERCC2;SF3B1;CELF1;HNRNPA3;PRPF31;PUF60;CPSF7;SNIP1;EFTUD2;HNRNPUL1;DHX38;DBR1;HNRNPF;SFPQ;CTNNBL1;SLU7;SON;ERCC3;SNRPE;HNRNPA1;SF3A1;THOC1;THOC3;SRSF12;CWC25;SYNCRIP;ZMAT5;CD2BP2;TFIP11;BUD13;RBM4B;SRRM1;FIP1L1;RNPS1;SRSF3;SRSF10;CWC22;NONO;TRA2B;LSM3;RBM6;PPIH;CMTR2;RBM15;SUPT4H1;PCBP1;PDCD7;USP39;POLDIP3;GEMIN7;POLR2C;SF3B5;ALKBH5;GCFC2;DHX9;RNPC3;POLR2H;PRPF40B;POLR2L;HNRNPU;HNRNPL;HNRNPD;PABPC1;TXNL4A;PRPF18;GTF2H3;CWC27;SCAF11;LSM2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.29875111883163236,-1.2178374453661045,0.10877192982456141,0.46727290178973424,1.0,34/112,25.15%,FOXP1;CD34;THBS1;IFIH1;APP;PTPRJ;FRMD8;GAS6;MAPKAPK2;LBP;ARHGEF2;PLCG2;NFKBIL1;DICER1;PSEN1;JAK2;LPL;MIF;VSIR;ILRUN;RARA;TNFAIP3;IGF1;MAVS;CCL19;NOD2;PTPRC;PTPN11;FZD5;RIPK1;DHX9;ARFGEF2;HMGB1;DDT
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.5078593031095974,-1.2174907035030555,0.22142857142857142,0.4676247134906617,1.0,4/10,15.48%,SETD2;SETD3;EHMT1;KMT5A
prerank,nuclear pore complex assembly (GO:0051292),-0.5245190272604691,-1.217342656225893,0.20938628158844766,0.46754849069960497,1.0,4/10,15.61%,AHCTF1;NUP98;NUP153;TPR
prerank,gland development (GO:0048732),-0.33122697611875807,-1.2170077645592718,0.14338235294117646,0.46787314284850173,1.0,23/59,23.94%,CAV1;PKD2;LSR;TBX1;TGFBR3;MSN;HES1;SIX1;EZR;NOTCH4;PRKCSH;WNT11;CEBPG;SOD1;CITED2;CDK5RAP3;ARHGAP35;ANXA1;ARID5B;NF1;CEBPA;TBX3;EPHB3
prerank,protein localization to plasma membrane (GO:0072659),0.2861971200399401,1.216882946083195,0.11650485436893204,0.6058549996123084,1.0,29/129,11.73%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;CCDC88A;EPB41L3;RAB15;ANK1;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;MYO5A;WNK3;NECTIN3;CD81;NKD2;SPTBN4;TESC;ZFYVE27;RAB3A;C2CD5;TSPAN32;PPIL2
prerank,mRNA 3'-end processing (GO:0031124),-0.3156911663342054,-1.216761105787819,0.15602836879432624,0.4679922411682798,1.0,21/78,20.29%,SRSF11;TENT4B;APP;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;CPSF7;DHX38;SLU7;CDC73;LSM11;TENT2;THOC1;THOC3;SRRM1;FIP1L1;RNPS1;SRSF3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.44328608243323653,-1.2162144996772974,0.23345588235294118,0.4687622720882591,1.0,5/17,11.42%,PARD3;SPRED2;PPEF2;DDIT4;SMAD7
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.25905484892534136,-1.2159271771427174,0.052980132450331126,0.46900637835317277,1.0,125/341,30.13%,FBXL7;WWP1;PELI1;USP9X;NEDD4L;ZNRF1;SMURF2;TRIM25;UBE2K;PSMA2;FBXL17;CNOT4;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;RNF43;CBL;UBE4B;CUL3;NEDD4;RNF40;RNF115;RNF144B;PSME2;BIRC6;ARRDC1;PSMB4;GSK3A;TRIP12;FEM1A;UBE2D3;SPSB1;MIB1;AREL1;TNFAIP1;RMND5A;ARMC8;SPOPL;NTAN1;CDC16;ATXN3;ANAPC16;KAT5;UBE4A;FEM1C;RC3H1;KLHL25;FBXW11;PSMC2;PSMB2;UBR4;FEM1B;RNF168;RNF167;APPBP2;ERCC8;AGAP3;PSMB1;MYLIP;UBE2L3;TNFAIP3;KLHL3;UBXN11;CTNNB1;TRIM13;PSMA8;KCTD10;PSME1;SPOP;TRIM3;SIAH1;HUWE1;WWP2;RAD23A;ELOC;RNF4;ADRM1;BUB1B;HERPUD1;UCHL1;TBL1X;BUB3;HACE1;PSMD4;RNF216;NDFIP2;UBE2R2;MDM2;KEAP1;NFE2L2;RCHY1;PSMD5;RNF146;ARRB1;FZR1;ZFAND2A;DTL;FBXL22;MAEA;TRPC4AP;ANAPC7;PSMA3;RNF34;RNF122;KIF14;PSMB10;ARIH2;RNF114;VPS37B;PPP2R5C;UBE2I;UBXN2A;ATE1;RNF187;DDIT3;KCTD17;UBA1;UBE2H;RNF14;TRIM32;CDC34
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4617926954550311,-1.2158359152846032,0.23134328358208955,0.4687902005086487,1.0,7/14,28.84%,ARID2;MRNIP;FUS;TIMELESS;ERCC6;MMS19;RAD51AP1
prerank,protein modification by small protein removal (GO:0070646),-0.26800007294348444,-1.2157389372104168,0.06007067137809187,0.4685839240497704,1.0,82/252,24.09%,SENP1;USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;TRRAP;STAMBP;PSME2;SMAD1;JOSD1;SMAD2;PSMB4;USP2;SMAD4;USP13;CLSPN;TP53;OTUD1;OTUD4;INO80E;SMAD7;USP15;ACTB;USP40;INO80D;ATXN3;USP18;RHOA;PSMC2;PSMB2;HCFC1;BABAM2;FOXO4;USP34;USP10;VCPIP1;TADA3;SENP2;PSMB1;TNFAIP3;INO80B;BRCC3;PSMA8;KDM1B;IKBKG;PSME1;BAP1;RAD23A;ADRM1;USP7;JOSD2;BRCA1;ATXN7;UCHL1;USP1;EIF3F;PSMD4;PTEN;COPS7A;MDM2;KEAP1;SUDS3;MBD6;USP16;CDC25A;OGT;BECN1;STAM2;COPS8;RIPK1;YY1;COPS4;PSMD5;MAP3K7;SENP6
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.34062319237652433,-1.2147900784045356,0.17463235294117646,0.4703490979196609,1.0,23/50,29.38%,NXN;CAV1;DTX3L;IVNS1ABP;ABL1;AKT1;SMAD7;SPOPL;CHP1;N4BP1;SENP2;TNFAIP3;RPS3;SOX4;SH3RF2;OGT;HSPA1B;ADGRB1;ARRB1;PINX1;BAG5;PRMT3;PRKCG
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3082401416054722,-1.2142236228810792,0.12754158964879853,0.4711808643989262,1.0,32/93,24.69%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;MID1;PLCB1;TGFB2;RASSF2;ARL6IP5;FLT4;SH3RF1;WNT16;TPD52L1;TAOK3;SEMA4C;TNFRSF19;MTURN;CCL19;NOD2;DUSP22;EDAR;SASH1;KLHDC10;SH3RF2;PTK2B;LTBR;GADD45A;FZD7;RIPK1;HMGB1;BMP2
prerank,response to hydrogen peroxide (GO:0042542),-0.35250561239398737,-1.2139959681796042,0.17723880597014927,0.47125821602728357,1.0,20/45,23.52%,NET1;MAP3K5;ADAM9;STK24;ABL1;PRKCD;ANKZF1;CAT;GPX1;FYN;HDAC6;TNFAIP3;PPIF;SOD1;ANXA1;RPS3;MAPK7;RELA;NFE2L2;RIPK1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.46203074555095197,-1.2135544882705478,0.23809523809523808,0.47185341984373363,1.0,8/15,31.98%,NR3C1;FAM107A;BCL2L11;UBE2L3;ANXA1;HNRNPU;ZFP36L1;SSTR2
prerank,regulation of anoikis (GO:2000209),-0.4278903812806822,-1.2135530546904219,0.20292504570383912,0.4714160313639586,1.0,6/19,12.08%,ITGB1;CAV1;MCL1;SIK1;PTK2;NOTCH1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3702815695601528,1.2133094578036467,0.1744186046511628,0.61384133987241,1.0,10/32,18.55%,NAV3;EML2;APC2;MAP2;STMN2;HDGFL3;MAPRE1;CLASP2;CAMSAP3;TUBB4A
prerank,organelle transport along microtubule (GO:0072384),0.36636010751775544,1.2132686411641236,0.1834862385321101,0.6121465887024294,1.0,14/31,19.50%,BICD1;CLN3;MAP1S;MAPT;DYNC1I1;TMEM201;RAB6A;HTT;COPG2;BORCS5;TRAK2;BICDL1;RHOT1;HAP1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.3825840912865716,-1.2130422964187615,0.18904593639575973,0.4720642800044957,1.0,15/30,32.67%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;POLR2H;POLR2L;TAF1D;POLR1E;GTF2H3;CCNH;POLR1H;POLR2E
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4736601705627701,-1.2121041845866434,0.2290909090909091,0.4737019682186979,1.0,7/13,22.93%,CAV1;USP13;BCAP31;ATXN3;SGTA;HERPUD1;NFE2L2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.47208822722418764,-1.2120731126130386,0.22977941176470587,0.4733371323685369,1.0,2/14,4.61%,OSMR;IL6ST
prerank,positive regulation of DNA recombination (GO:0045911),-0.38239107487659807,-1.2118386568019148,0.18470149253731344,0.4734626684116866,1.0,9/27,15.92%,SHLD1;ARID2;TFRC;KMT5B;MRNIP;FUS;ERCC2;PRDM9;MAD2L2
prerank,regulation of translation (GO:0006417),-0.27823104345001354,-1.211499311025432,0.0821917808219178,0.47380554227913296,1.0,61/173,26.90%,EIF3H;DAPK1;THBS1;EIF4H;APP;RNF139;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;GIGYF2;EIF3C;LARP1;PLD1;FOXO3;UPF3B;EIF3B;LTN1;OGFOD1;SAMD4A;EIF2B2;RPL26;ZCCHC4;EEF2;RPS6KA1;LARP4B;RPS4X;RPL10;KLHL25;GSPT1;BTG2;RPS6KA3;RPL5;IGFBP5;METTL5;SYNCRIP;RPS3;SOX4;RBM4B;PRKDC;TOB1;GLE1;CAPRIN1;CTIF;RBM3;MTPN;RPL13A;MRPL13;MTG2;POLDIP3;DHX9;CNOT8;FXR1;EIF2AK3;EIF2AK4;NEMF;NANOS1;CNOT1;HNRNPD;LARP6
prerank,myelin maintenance (GO:0043217),0.4978581614163984,1.2113170849200372,0.2184873949579832,0.6157263552319403,1.0,4/10,17.31%,MYRF;EPB41L3;CLU;CXCR4
prerank,histone lysine methylation (GO:0034968),-0.38047620313849373,-1.2112241386558138,0.2006980802792321,0.4739539108787746,1.0,15/33,25.98%,PRDM5;KDM6A;SUV39H1;SETD3;DOT1L;ASH2L;SMYD1;PRDM9;N6AMT1;WDR82;WDR5B;WDR5;SETDB2;RBBP5;TRMT112
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4610992320343204,-1.2108627453627976,0.22735674676524953,0.4743097815018406,1.0,4/14,8.63%,THBS1;PTK2;MAPK1;IL34
prerank,regulation of necroptotic process (GO:0060544),-0.4206833066724686,-1.2108475706406248,0.22021660649819494,0.4739026774894519,1.0,10/23,23.52%,PELI1;BIRC3;ARHGEF2;CASP8;CFLAR;FLOT1;PDCD6IP;HSP90AA1;OGT;RIPK1
prerank,telomere capping (GO:0016233),-0.4379864193035019,-1.2107382963309714,0.22122302158273383,0.473692001596561,1.0,8/16,24.76%,STN1;MRE11;CTC1;TERF2;TFIP11;PRKDC;DCLRE1B;DCLRE1A
prerank,heart looping (GO:0001947),-0.35650141165216936,-1.2102266352177815,0.17870036101083034,0.47445801882243427,1.0,10/39,14.00%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2;NOTCH1;ZIC3
prerank,regulation of cell death (GO:0010941),-0.30604734773455167,-1.2102235032578648,0.1451048951048951,0.47402500511696183,1.0,35/94,25.07%,FERMT2;ACER2;LRRK2;CDKN1B;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;WNT16;CELF1;CHMP4B;AXIN2;ACER3;RAD18;FGF2;WNT11;CHP1;CCN5;PDE12;CCN3;ATG5;CTSZ;BMP7;TRIM13;SOX4;RRAS2;CCN1;PARP16;SLC25A24;TXNDC12;BECN1;HSPA1B;NOA1;APC
prerank,response to copper ion (GO:0046688),-0.4180079933291405,-1.2102103537909061,0.21288014311270126,0.47361732747451724,1.0,13/20,35.60%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ATP7B;ATP5F1D;AQP1;IL1A;MT3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.35680604740632477,-1.2100381066817658,0.1854419410745234,0.4735606189960326,1.0,14/39,19.46%,ACER2;CORO1C;THBS1;GCNT2;FZD4;NOTCH1;RASA1;RHOA;ACTN4;MYOC;SPRY4;JAG1;MAP4K4;SEMA3E
prerank,regulation of B cell apoptotic process (GO:0002902),-0.4949227041618537,-1.2099277840114897,0.23304347826086957,0.4733722206260159,1.0,2/12,2.06%,FOXP1;LYN
prerank,ureteric bud development (GO:0001657),0.43888877530584064,1.2096288375436013,0.20342612419700215,0.6187078772367173,1.0,6/17,7.48%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.46029784482792,1.2096076841859444,0.23890063424947147,0.6169907223760625,1.0,2/13,3.86%,B3GALT1;B3GALT5
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.277333902171216,-1.2095373170287826,0.08361204013377926,0.47376329715164706,1.0,63/175,28.90%,DAB2IP;EDA;TMSB4X;TRAF5;LIMS1;PSMA2;CCL25;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;ARHGEF2;PSMB4;TP53;AKT1;ILK;JAK2;ACTN4;EIF5A;PSMC2;ZFAND6;PSMB2;CD40;ASAH1;TNFRSF11B;GSDME;PSMB1;TNFRSF1A;PSMA8;TNFSF13;HYAL2;PSME1;CCL19;IKBKB;RPS3;EDAR;TNFRSF25;BRCA1;PSMD4;TNFSF8;PTK2B;LTBR;RELA;NFE2L2;HAS2;RIPK1;PSMD5;DHX9;MAP3K14;GBP3;TNFSF12;ADAMTS7;PSMA3;ADAM17;ERBIN;PSMB10;TNFRSF9;TNFRSF12A;BAG4;CACTIN;HYAL3
prerank,protein deubiquitination (GO:0016579),-0.26744919402136336,-1.2088118804883379,0.060034305317324184,0.4749499536262192,1.0,78/242,23.84%,USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;OTULIN;TRRAP;MINDY1;STAMBP;PSME2;SMAD1;JOSD1;SMAD2;PSMB4;USP2;SMAD4;USP13;CLSPN;TP53;OTUD1;OTUD4;INO80E;SMAD7;USP15;ACTB;USP40;INO80D;ATXN3;USP18;RHOA;PSMC2;PSMB2;HCFC1;BABAM2;FOXO4;USP34;USP10;VCPIP1;TADA3;PSMB1;TNFAIP3;INO80B;BRCC3;PSMA8;KDM1B;IKBKG;PSME1;BAP1;RAD23A;ADRM1;USP7;JOSD2;BRCA1;ATXN7;UCHL1;USP1;EIF3F;PSMD4;PTEN;MDM2;KEAP1;SUDS3;MBD6;USP16;CDC25A;OGT;BECN1;STAM2;RIPK1;YY1;PSMD5;MAP3K7
prerank,anterograde axonal transport (GO:0008089),0.3543977000991049,1.2087515400709021,0.19402985074626866,0.6176317944783344,1.0,13/37,19.50%,DLG2;RAB27B;AP3S2;KIF5A;KIF3A;AP3M2;KIF1C;SNAPIN;NEFL;TRAK2;MAP1A;MAPK8IP3;HAP1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4460935714878662,-1.2083171768975536,0.23076923076923078,0.4756063805501467,1.0,8/16,29.32%,JCAD;THBS1;AGTR1;FGF2;GATA2;DLL4;HMOX1;APLNR
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3119151687081388,-1.2078291224439377,0.13978494623655913,0.4762906552368761,1.0,18/76,13.98%,TEK;BAIAP2L1;PRKCE;NCK1;ABL1;SNX9;NES;HAX1;EDN1;FCHSD2;CFL2;NCK2;BCAS3;LMOD1;SYNPO2;CDC42EP3;SORBS3;NCKAP1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4759994909281204,-1.20753455726812,0.2427536231884058,0.4765197333634368,1.0,3/13,8.20%,NRP2;PLXNA4;PLXND1
prerank,import into cell (GO:0098657),-0.35501967540225576,-1.2074999702802625,0.1978798586572438,0.47616843324887614,1.0,8/41,7.06%,SLC47A1;SLC6A6;SLC12A7;LRRC8C;SLC7A1;SLC7A5;SLC5A6;LRRC8D
prerank,mesenchyme development (GO:0060485),-0.4512906123187047,-1.2071306594422408,0.22666666666666666,0.476572191845862,1.0,7/15,25.08%,PKD2;BMPR2;BMP4;WNT11;BMP7;BMP2;FOXF1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.29849387623677726,-1.2069813868894297,0.11347517730496454,0.4764692545747534,1.0,35/110,23.29%,DAB2IP;RB1;TRABD2B;MPP7;GSK3B;DDX3X;TFRC;IRGM;SPIDR;CDH5;RAF1;TAL1;HJURP;FNIP2;ICE1;RHOC;TRAF3IP1;HCFC1;SLF2;SUMO1;BCL2L11;NCLN;HDAC6;IAPP;RPS3;TFIP11;PREB;PTPN11;WARS1;HSP90AA1;BIK;GFAP;SAR1A;RALB;AJUBA
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4036571155220475,1.2069547315820885,0.18736383442265794,0.620866486864241,1.0,9/23,15.64%,HSD17B12;FAR1;ACSBG1;HACD1;ACSL3;ACSL6;TECR;ACOT7;HACD2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3720922491488044,-1.2065152059021096,0.2088724584103512,0.47713805284480004,1.0,14/33,25.89%,IGF1R;PIK3R1;IRS1;PIK3C2A;PIK3CD;AKT1;EDN1;HTR2A;PIK3CB;IGF1;PTEN;NF1;PIK3CA;TPTE
prerank,regulation of mitochondrial fission (GO:0090140),-0.4073551627453352,-1.206450817189517,0.2017857142857143,0.47685334428973286,1.0,7/24,13.14%,RALBP1;KDR;LRRK2;MIEF1;BNIP3;STAT2;MIEF2
prerank,positive regulation of transferase activity (GO:0051347),-0.2865147424198027,-1.2061107384660594,0.10571923743500866,0.4771984310460672,1.0,23/142,10.06%,FLT1;TEK;IGF1R;TIE1;DCUN1D3;INSR;KLF4;NEK7;ROR1;CD200;DTX3L;KDR;MERTK;EGFR;LMO4;DSTYK;TCP1;EPHA4;MRE11;MAPK1;FLT4;GSK3A;HMBOX1
prerank,regulation of axon guidance (GO:1902667),0.498392888767536,1.206084968174027,0.23146067415730337,0.6214204692237161,1.0,5/10,24.04%,VEGFA;ZSWIM5;YTHDF1;ZSWIM8;MYCBP2
prerank,regulation of blood circulation (GO:1903522),-0.3719025467020989,-1.2056610903858458,0.1922365988909427,0.4777563031283027,1.0,9/34,17.94%,ACE;KCNQ1;ECE1;TBX2;AGTR1;S100A1;TPM1;KCNMB2;PLN
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.34171919296816883,1.2050237315980104,0.1824175824175824,0.6226847364013111,1.0,12/44,13.76%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;ATP1B1;WNK2;WNK3;KCNJ6;GABBR1;KCNN3;AMIGO1
prerank,negative regulation of type I interferon production (GO:0032480),-0.36075022193365935,-1.2049333585787694,0.19349005424954793,0.47896664928521215,1.0,13/40,17.31%,IFIH1;TRIM25;RNF125;TAX1BP1;PPM1B;UBA7;IKBKE;TRAF3IP1;ILRUN;TNFAIP3;MAVS;NLRC5;GPATCH3
prerank,UV protection (GO:0009650),-0.5167330853685882,-1.2049304551480935,0.2438095238095238,0.4785396809694745,1.0,6/10,33.34%,ERCC2;CAT;GPX1;SDF4;SCARA3;MFAP4
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3936134491647946,-1.20457784407802,0.18439716312056736,0.4789187991350807,1.0,10/26,18.67%,ST3GAL4;ST3GAL2;ALG8;ALG11;GK5;GAL3ST2;B4GALT5;GOLPH3;GBGT1;LARGE1
prerank,cellular protein localization (GO:0034613),-0.26303340255433827,-1.2041937757950751,0.07375643224699828,0.47939377964662155,1.0,93/285,24.63%,TBC1D4;SEC31A;FERMT2;ESAM;ARF3;ID1;ARCN1;LRRK2;RAB1A;SMURF1;SH3PXD2B;TLK1;RIC3;SYNRG;EGFR;TBC1D1;NIPBL;RAB5B;CNTNAP1;STX3;COX18;CEP250;TBC1D2B;PTPRK;WDR11;CNTLN;TBC1D8B;SNX9;USP6NL;TBC1D30;SEC13;RAB5A;ITSN1;OCLN;TBC1D14;ARHGEF2;STX8;SCFD1;FLNA;CROCC;FBLN5;TBC1D22B;FGF7;AXIN2;TBC1D22A;EHD1;RAB3GAP2;VPS26A;COPA;WIPI1;ARL4A;ABHD17A;SLU7;VPS45;WNT11;RAB23;RAB24;RAB32;SIL1;HERC2;SNX8;ANGPT1;HDAC6;CTNNB1;FAM91A1;HEY2;TBC1D8;TMED5;STX12;VPS26C;TBC1D17;AP4M1;TBC1D25;KIF13A;RAP2A;WDR45B;REEP1;VCL;ARL5C;AP3B1;SNX13;EVI5;CTSA;SAR1A;TBC1D12;ARL4C;NPHP1;RAB19;STX19;ARF5;COPZ1;PACSIN1;MYO7A
prerank,regulation of cell adhesion (GO:0030155),-0.28874561453197184,-1.2036849081924315,0.12387791741472172,0.4801033136872447,1.0,41/129,25.19%,ACVRL1;RSU1;PODXL;LYN;CBLL1;ZFHX3;PKP4;ATM;PRKD2;PTPRJ;STX3;ABL1;CYTH1;PTK2;ARHGDIA;EPHA4;PLXNA4;TGM2;ROCK1;PLXND1;ADAM10;FRMD5;PPP1R12A;RASA1;ATXN3;TPM1;ROCK2;ANGPT1;NUAK1;ADGRG1;PPP2CA;EPHA2;TGFBI;PTPN11;GPR4;PTK2B;SEMA5A;CXCL12;EPHB3;PLXNB1;SIPA1
prerank,protein export from nucleus (GO:0006611),-0.3988559442870517,-1.203403617548524,0.18933823529411764,0.48026314371168966,1.0,9/27,18.73%,NUP42;SMURF1;CSE1L;XPO7;CHP1;TPR;XPO4;NUP214;DUSP16
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.34027177120900537,-1.2028487656028977,0.17825311942959002,0.48104511713009007,1.0,20/53,24.66%,EYA4;ATM;UIMC1;SPRED2;EGFR;PRKCD;RNF168;BABAM2;ERCC8;HIC1;CEBPG;BRCC3;RPS3;NSMCE4A;BRCA1;TRIM28;MSX1;DHX9;ERCC6;FXR1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.38931695156924373,-1.2028104486258397,0.20454545454545456,0.4806976076111979,1.0,10/26,15.43%,APP;HES1;CUL3;USP2;TAL1;PPP1R10;DUSP3;PKN2;LGMN;SMOC2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.41706062292566903,-1.2026826085229299,0.22857142857142856,0.48052006922622303,1.0,8/20,24.04%,DCUN1D3;ZMIZ1;DCUN1D2;EPAS1;WASHC1;DCUN1D5;HSP90AA1;HSPA1B
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4653810177524373,-1.2025581080378565,0.23725834797891038,0.48037486015721054,1.0,7/14,22.06%,KMT2E;SMAD4;PRDM9;DNMT1;CTNNB1;BRCA1;WDR5
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.30002741066106486,-1.2024602800723632,0.13932980599647266,0.48019107950294593,1.0,36/104,25.93%,DAB2IP;MNAT1;RB1;LRP5;DDX3X;CDK12;CDKN1B;PPEF2;ABL1;LRP6;IRGM;CCND3;AKT1;ACTB;MTCP1;RPTOR;RHOA;KSR1;CDK5RAP3;CCND1;CNPPD1;PPP2CA;BLM;CDKN2C;SYAP1;PARP16;CDC25A;GADD45A;RALB;CCNG1;CCNK;TRIB3;CAB39;CCNE2;CCNJ;CDKN3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.45708359328915255,1.202332480944312,0.2111801242236025,0.628594396567338,1.0,5/13,16.15%,INSIG1;CD81;SORL1;BRSK2;SAR1B
prerank,N-glycan processing (GO:0006491),-0.4290246003956607,-1.201311428194883,0.24953445065176907,0.48241540466682953,1.0,8/18,13.22%,ST8SIA4;MAN2A1;MAN1C1;MGAT4B;FUT8;MAN1A2;PRKCSH;MAN1B1
prerank,mRNA export from nucleus (GO:0006406),-0.29984540934574033,-1.2010949433345386,0.14727272727272728,0.48249804288811016,1.0,32/102,24.19%,SRSF11;NUP42;SARNP;RAE1;RANBP2;THOC2;UPF3B;IWS1;NUP98;THOC7;UPF2;SEC13;AGFG1;DDX39B;DHX38;SLU7;NUP153;MCM3AP;TPR;THOC1;THOC3;NXT1;NUP214;SRRM1;FIP1L1;RNPS1;SRSF3;GLE1;NUP188;POLDIP3;ALKBH5;NXF1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4199068140241896,-1.2010555704123596,0.2265193370165746,0.48214654502174725,1.0,3/21,4.26%,MFHAS1;GSK3B;YWHAE
prerank,neuron fate commitment (GO:0048663),0.45024732342902507,1.200604774663653,0.24475524475524477,0.6317970345047761,1.0,2/14,8.71%,MYT1L;POU4F1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.4990588983871511,-1.2003478334246427,0.25084745762711863,0.48330815002813826,1.0,6/11,23.39%,TET2;PRDM9;WDR82;TET3;OGT;BEND3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.49374029799329666,-1.1998368269130846,0.2328519855595668,0.483982158834389,1.0,6/11,18.48%,RAPGEF2;LYN;MEF2C;PIK3CD;PIK3CB;ANXA1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.49189884748091384,-1.1998251010111636,0.2504472271914132,0.48357233933809857,1.0,4/11,19.86%,ATG7;ATG10;WIPI1;WDR45B
prerank,positive regulation of neuron projection development (GO:0010976),0.30152724193743075,1.1997634282010836,0.14087759815242495,0.6325075536362796,1.0,14/85,8.76%,MAGI2;LRRC7;RIT2;SCN1B;TENM3;FUT9;VLDLR;TOX;KIDINS220;NDRG4;CAMK2B;NTRK2;PLA2G3;PLPPR5
prerank,synaptonemal complex organization (GO:0070193),0.4431218167950095,1.1996396018267788,0.22787610619469026,0.629303314714113,1.0,4/15,13.70%,SYCP1;REC8;SYCP2;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.4431218167950095,1.1996396018267788,0.22787610619469026,0.629303314714113,1.0,4/15,13.70%,SYCP1;REC8;SYCP2;RAD21
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.32868200460124547,-1.199525307551127,0.17491166077738515,0.4838283612788962,1.0,23/60,26.01%,KLF4;NEK7;ATM;PRKD2;TCP1;MAPK1;HMBOX1;RGCC;FGF2;HGF;PNKP;PTGES3;PARN;HNRNPA1;SMOC2;CTNNB1;FGFR4;RFC4;HSP90AA1;CCT5;PDGFRB;NAF1;CCT2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.480572587920144,-1.1992261001480198,0.23943661971830985,0.48405330773848504,1.0,1/12,0.42%,IL1R1
prerank,negative regulation of chemotaxis (GO:0050922),-0.37921766170614535,-1.1991988787903534,0.22614840989399293,0.4836921080022781,1.0,14/31,20.69%,SEMA6A;SEMA3C;SEMA7A;THBS1;SLIT2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;DUSP3;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,protein neddylation (GO:0045116),-0.46815090384619423,-1.1990791422374314,0.2513863216266174,0.48354096509299116,1.0,5/13,21.23%,DCUN1D3;RBX1;UBE2M;DCUN1D2;DCUN1D5
prerank,regulation of phosphorylation (GO:0042325),-0.296183498839725,-1.1989460129219083,0.1310116086235489,0.48345568671191896,1.0,32/120,19.19%,ITGA6;LYN;CORO1C;THBS1;APP;NUP42;RAE1;CDKN1B;EGFR;RANBP2;ZBTB7A;BMP4;NUP98;PTK2;CDH5;SEC13;ROCK1;LDB1;PRKRIP1;FNIP2;STAT2;ILK;PSEN1;NUP153;PTGES3;MIF;TPR;BMP7;NLRC5;NUP214;IKBKB;PPP2CA
prerank,cortical cytoskeleton organization (GO:0030865),-0.35830270381076673,-1.1988961590931044,0.189873417721519,0.4831445727267871,1.0,17/41,18.62%,RAC1;RHOBTB1;RND3;DLG1;RHOQ;EZR;PPP2R3C;ROCK1;RHOA;RHOG;LCP1;RHOC;NCKAP1;ROCK2;TRPV4;IKBKB;FMNL2
prerank,regulation of cell size (GO:0008361),-0.41145647303329014,-1.1988946711899076,0.231203007518797,0.4827188617645106,1.0,14/23,26.33%,RAC1;MTOR;MSN;RARG;EZR;EDN1;RPTOR;RHOA;LARS1;AKT1S1;PTEN;MTPN;VAV2;RDX
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.44259871145275,-1.1988071149456185,0.2413793103448276,0.4824800163343971,1.0,7/16,14.07%,CDK13;RSRC1;HNRNPM;PUF60;SFPQ;SLU7;SCNM1
prerank,pre-miRNA processing (GO:0031054),-0.4577051426541918,-1.1984758393645034,0.2375886524822695,0.48280843874759055,1.0,5/14,20.09%,TUT7;DICER1;TUT4;AGO2;DROSHA
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3990263901533297,-1.1983697296456477,0.22021660649819494,0.4826397452946327,1.0,12/24,21.97%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;MAPK12;TCF3;CTNNB1;SPAG9;MYOCD
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.391841908733896,-1.1978702083787516,0.2058287795992714,0.4833442930417031,1.0,12/26,26.26%,ITGB1;NEDD4L;YWHAE;DLG1;NEDD4;CASQ2;WWP2;FHL1;VAMP2;AKAP9;CAB39;ACTN2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3362782127780921,1.1974550959870938,0.21149425287356322,0.6337141270346762,1.0,14/51,13.72%,CNTNAP2;EPB41L3;SHTN1;NBL1;TNIK;MAP1S;PAK1;GPM6A;NYAP2;MINK1;SRGAP2;GAS7;SGK1;BDNF
prerank,regulation of endocytic recycling (GO:2001135),0.481218431551938,1.1974320588613143,0.24489795918367346,0.6320152884710585,1.0,6/11,13.18%,ATP9A;PLA2G3;SORL1;PLA2G4E;EIPR1;INPP5F
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5164582660007786,-1.196679374800421,0.2364620938628159,0.48554691123348465,1.0,2/10,5.59%,TRPM4;TNFRSF1B
prerank,mitotic spindle assembly (GO:0090307),-0.34611270904277797,-1.1963248418371173,0.18561872909698995,0.48593995245741833,1.0,14/42,21.94%,CCDC61;STAG1;TOGARAM1;WRAP73;FLNA;KIF23;RHOA;ARHGEF10;KIF11;STAG2;RAB11A;KIF3B;PRC1;MISP
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.43183268317377843,-1.19608492667158,0.22467771639042358,0.4860428378961532,1.0,5/18,15.88%,DAB2IP;EMD;TP53;CDC73;SKI
prerank,negative regulation of cell activation (GO:0050866),0.4565591723203355,1.1947198970538475,0.2255125284738041,0.6380486090507794,1.0,7/14,13.89%,C1QTNF1;NR1D1;PDGFA;GPER1;PDGFRA;APOE;LDLR
prerank,sensory perception of sound (GO:0007605),0.2974838304640636,1.1946451293629852,0.13063063063063063,0.6365044029747302,1.0,15/88,11.81%,COL2A1;PCDH15;COL1A1;SLC26A5;LHFPL3;EML2;COL11A2;ATP2B2;DCDC2;TMC1;CACNA1D;SPTBN4;GRM7;MYO1A;TMC2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.48491560503669184,-1.1938515207518003,0.24866785079928952,0.4905598288230064,1.0,3/12,6.73%,MBNL1;LRP6;TGFB2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.4132247284198185,-1.1937518957186664,0.23454545454545456,0.4903661427302592,1.0,7/19,12.91%,TGFBR3;VGLL4;RBP4;MEF2C;TBX2;NOTCH1;FGF2
prerank,epidermal cell differentiation (GO:0009913),-0.35290761654298386,-1.1933244959767304,0.2074074074074074,0.49087774825394087,1.0,15/41,23.72%,BCR;ADAM9;HDAC1;MED1;ERCC2;WNT16;TXNIP;ERCC3;ASAH1;JAG1;CTNNB1;ANXA1;EPHA2;USH2A;PIP5K1A
prerank,regulation of RNA splicing (GO:0043484),-0.31922472904743227,-1.1932146427790664,0.17766497461928935,0.4906919492744324,1.0,24/69,21.58%,MBNL1;MBNL2;DYRK1A;ZNF326;AHNAK;METTL4;PIK3R1;AHNAK2;FUS;ERN1;CELF1;HNRNPF;RBM39;SON;CLK3;ZPR1;RBM20;JMJD6;SRPK2;SRSF3;SRSF10;CWC22;TRA2B;PTBP3
prerank,regulation of membrane repolarization (GO:0060306),-0.47233087781273253,-1.1929373955038363,0.24734982332155478,0.49088513935669936,1.0,5/13,6.50%,CAV1;NEDD4L;KCNJ2;YWHAE;KCNQ1
prerank,protein tetramerization (GO:0051262),0.3102424129498697,1.1926677178993783,0.14220183486238533,0.6402429644618638,1.0,14/67,15.58%,HCN1;GRIN2B;MS4A1;SYCP1;RYR3;AQP4;GNMT;HOMER1;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.3333633792592171,-1.1924098096574332,0.18047882136279927,0.4916002832984781,1.0,19/51,28.58%,THBS1;IL6R;GAS6;MOSPD2;PTK2;MAPK1;IL34;VEGFC;ANO6;EDN3;LGMN;CMKLR1;SERPINE1;CXCL12;HMGB1;PTN;ADAM17;CXCL10;LGALS9
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.33268652924007547,-1.1923740192656085,0.1956521739130435,0.4912515445173834,1.0,17/52,19.88%,PPP1R13B;YWHAE;HPS4;UBE2J2;YWHAZ;NMT1;GSK3A;UBE2D3;TP53;CASP8;MAPK8;BBC3;UBE2L3;BAP1;HUWE1;NPEPPS;PPP3CC
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.35163163974209505,-1.1923398220042623,0.22882882882882882,0.4909000764796934,1.0,11/41,18.65%,TJP1;PODXL;GCNT2;JAK1;AFDN;DENND6A;SMAD7;FLOT1;BMP7;CITED2;MAGI1
prerank,ion transport (GO:0006811),0.2869309590513348,1.19211241795348,0.11845102505694761,0.6400092309593319,1.0,22/111,12.21%,TRPM3;SLC24A4;SLC24A2;GABRB1;SLC5A12;GLRA1;SLC9A7;KCNN2;SLC9A9;SLC4A2;SLC8A2;SLC1A2;SLC36A2;SLC12A5;PANX2;VDAC2;SLC17A6;SLC1A3;KCNN3;SLC12A4;SLC8A1;SLC8A3
prerank,calcium ion homeostasis (GO:0055074),0.29555202796703367,1.1913438895006925,0.14,0.6403216575305558,1.0,17/95,12.21%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;CCL7;RYR2;TMCO1;CCL13;ATP13A2;CIB2;CCL5;SLC8A1;SLC8A3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5036433892832761,-1.1912021809541091,0.22695035460992907,0.4931348949389657,1.0,3/10,10.01%,PRKCE;IRS1;AKT1
prerank,V(D)J recombination (GO:0033151),-0.4878152912370748,-1.1911386579501482,0.2600732600732601,0.4928502293640225,1.0,6/11,26.70%,XRCC4;TCF3;PRKDC;LIG4;HMGB1;LIG1
prerank,lamellipodium organization (GO:0097581),-0.37512048863475306,-1.1909559588489729,0.20833333333333334,0.4928605101691274,1.0,4/29,1.94%,ABLIM1;ITGB1;PARVB;RAC1
prerank,ubiquinone metabolic process (GO:0006743),-0.44508441559893014,-1.1908493402887506,0.24041811846689895,0.4926665054945775,1.0,6/15,20.88%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,cardiac muscle tissue development (GO:0048738),-0.3393194200488199,-1.1903265739145676,0.18803418803418803,0.4934222967051386,1.0,18/50,17.56%,AKAP13;BMPR2;BMP5;SIK1;RBP4;BMP4;SMAD1;TBX2;MAML1;NOTCH2;SMAD4;ADAMTS9;KDM6B;ZFPM1;NOTCH1;BMP7;HEY2;HEY1
prerank,regulation of axonogenesis (GO:0050770),0.3311963208978851,1.1896576319645167,0.1872146118721461,0.6435431305238559,1.0,16/51,14.08%,LRRC4C;ROBO2;ROBO1;EFNB3;PAK3;PAK1;NTRK2;SLITRK1;RTN4;MAG;CDH2;OMG;PLXNA2;PLXNA1;AMIGO1;BRSK2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.31715398822256186,-1.189362847569768,0.14834205933682373,0.49514312441331576,1.0,23/69,25.15%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;FZD5;RIPK1;DHX9;ARFGEF2;HMGB1;DDT
prerank,androgen metabolic process (GO:0008209),0.4172689118566423,1.189211442756511,0.2330316742081448,0.6429264110851612,1.0,3/18,9.39%,AKR1D1;HSD17B7;SPP1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.40149327402028206,-1.1891627882524622,0.23835125448028674,0.49516465366209,1.0,5/22,12.78%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,positive regulation of filopodium assembly (GO:0051491),0.3866521833750744,1.188991122348342,0.23541666666666666,0.6418218069716737,1.0,6/24,8.76%,NLGN1;TENM1;TENM2;FSCN1;GPM6A;PLPPR5
prerank,inorganic cation import across plasma membrane (GO:0098659),0.305314522098986,1.1889225416609375,0.15777262180974477,0.640262349635624,1.0,16/75,12.21%,SLC24A2;ATP1A2;CACNA2D1;KCNJ3;ATP12A;ATP2B4;SLC9A7;SLC9A9;ATP1B1;SLC8A2;SLC12A5;KCNJ6;ATP4A;SLC12A4;SLC8A1;SLC8A3
prerank,regulation of macrophage migration (GO:1905521),-0.498075924514361,-1.1889050833273405,0.26145038167938933,0.49529013513654085,1.0,2/10,3.04%,CD200;MTUS1
prerank,negative regulation of translation (GO:0017148),-0.30379434019426066,-1.1886764848072866,0.1514629948364888,0.49538997568251014,1.0,31/87,26.43%,DAPK1;RNF139;EIF3E;METTL14;DDX3X;GIGYF2;LARP1;FTO;PUM1;SAMD4A;ROCK1;CELF1;AGO2;BTG2;TPR;ROCK2;IGFBP5;SYNCRIP;RPS3;TOB1;CAPRIN1;RPL13A;MRPL13;RBM24;METTL16;CNOT8;FXR1;EIF2AK3;EIF2AK4;NANOS1;CNOT1
prerank,dendrite morphogenesis (GO:0048813),0.3584755370925508,1.1880794042977834,0.21593291404612158,0.6408340287901765,1.0,11/35,11.94%,CTNNA2;CTNND2;DOCK10;EPHB1;SHANK1;DCDC2;PAK3;MAP2;MINK1;CELSR2;DLG4
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.41102518439102376,-1.188058322323034,0.23752151462994836,0.49639741564352546,1.0,8/21,21.43%,NT5C2;NT5E;PDE2A;PDE9A;NT5C1A;HPRT1;HINT1;AMPD3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3770920588457591,-1.1879605590132953,0.2257495590828924,0.4961882740159525,1.0,7/30,16.80%,FOXP1;DAB2;HDAC1;ZBTB7A;PIAS2;H3-3A;HDAC6
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4400383547100585,-1.1873913517514738,0.24485981308411214,0.4971094833178617,1.0,6/16,20.91%,LRRK2;SEC16B;UBAC2;BCAP31;VAPA;BCAP29
prerank,protein transport (GO:0015031),-0.2558425183469164,-1.187208633772126,0.08602150537634409,0.4971027566961414,1.0,95/332,23.31%,SPTBN1;TBC1D4;SEC31A;RUFY1;CALCRL;MYH9;RAMP1;ARF3;RAB7A;ARCN1;RAB1A;GOLPH3L;TLK1;TFRC;SCAMP2;SYNRG;TBC1D1;RAB5B;DNM2;STX3;MACF1;TANGO6;TBC1D2B;MON1A;WDR11;STEAP3;TBC1D8B;SLC10A7;SNX9;USP6NL;TBC1D30;SEC13;RAB5A;ARRDC1;COPG1;ARL6IP5;TBC1D14;ARHGEF2;STX8;SCFD1;RAMP2;TVP23A;TBC1D22B;TXNIP;ARHGAP1;TBC1D22A;EHD1;RAB3GAP2;HFE;VPS26A;COPA;ARL4A;GOLGA4;SLU7;ATP6V1E1;VPS45;RAB8B;MCOLN1;CHMP2B;RAB23;REP15;RAB24;RAB32;TOM1;SIL1;HERC2;SNX8;HDAC6;FAM91A1;GOLPH3;ATP6V0A1;TBC1D8;TMED5;STX12;VPS26C;LAMP2;TBC1D17;AP4M1;KIF3B;SCAMP1;TBC1D25;KIF13A;ARL5C;PPARG;AP3B1;PREB;VAMP2;SNX13;EVI5;CTSA;SAR1A;TBC1D12;ARL4C;ATP6V1H;RAB19
prerank,positive regulation of organelle organization (GO:0010638),-0.3716515404332094,-1.1869657382596874,0.22994652406417113,0.4972082940384377,1.0,13/32,29.58%,RAB3GAP1;GSK3B;ANXA2;STX18;IRGM;RAB3GAP2;SORBS3;ANXA1;LIG4;KATNBL1;SYNJ1;DOC2B;TREM2
prerank,regulation of cartilage development (GO:0061035),-0.4276471687314164,-1.186722131743975,0.2424812030075188,0.49732684301263885,1.0,4/18,12.95%,ZBTB16;BMPR2;BMP4;WNT11
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.34311344349953,-1.1867200041746624,0.20454545454545456,0.49689808108719047,1.0,18/46,21.67%,TEK;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;ILK;LAMA5;RHOA;ITGA4;LAMC3;ATRNL1;VAMP3;ITGB3;FERMT3;USH2A
prerank,response to cadmium ion (GO:0046686),-0.3949828422818333,-1.1864848475612881,0.2182468694096601,0.49704852533425564,1.0,14/26,24.98%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.40967443302749745,-1.1863137166199211,0.2302025782688766,0.49702433326507056,1.0,12/20,35.23%,PUM1;ZC3H7B;SNIP1;DICER1;AGO2;DROSHA;TERT;ZC3H7A;TSN;PUM2;MRPL44;TARBP2
prerank,metal ion homeostasis (GO:0055065),-0.3485463174205902,-1.186249109169486,0.21401515151515152,0.49674706321267154,1.0,8/40,10.72%,SLC12A7;CAV1;FAM20A;CNNM2;TMTC2;SLC12A2;CNNM4;COX11
prerank,cation transmembrane transport (GO:0098655),0.3357370163837812,1.186157832920562,0.20179372197309417,0.6445463244559448,1.0,11/44,11.96%,TRPM3;ASIC2;ATP1A2;SLC7A8;ATP1B1;MFSD12;TRPM1;SLC29A4;SLC6A5;ATP13A2;P2RX3
prerank,DNA repair (GO:0006281),-0.25885486965692084,-1.1859043063324617,0.08652246256239601,0.49711292578277855,1.0,94/284,27.32%,MNAT1;PDS5B;SETD2;ATM;UIMC1;DTX3L;PARP4;KMT5B;XRCC4;TRRAP;ABL1;FTO;MRE11;ASCC1;NABP1;INIP;ERCC2;RBBP8;TP53;TENT4A;DOT1L;NSMCE3;ENDOV;POLD3;INTS3;RAD18;OGG1;ATXN3;KAT5;PDS5A;RPA3;DNA2;RPA1;XPC;MAPK8;ERCC3;PNKP;RNF168;BABAM2;BTG2;FANCM;UBE2V2;ERCC8;VCPIP1;MAD2L2;SUMO1;RFWD3;HERC2;POLE2;HPF1;FANCD2;FANCG;WRN;FANCC;BRCC3;CETN2;RPA2;BAP1;HUWE1;PIAS4;RAD23A;RAD54L;ERCC6L2;NSMCE4A;PRKDC;LIG4;FANCL;BRCA1;TIMELESS;USP1;RAD51AP2;TRIM28;DCLRE1B;BAZ1B;CHRNA4;BLM;RFC4;CHEK1;GADD45A;MSH3;FANCI;ALKBH5;PWWP3A;APBB1;ERCC6;DCLRE1A;PARP9;LIG1;TRIP13;POLL;INO80;EXO1;ASCC2;GTF2H3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.37837554378616267,-1.185902620884895,0.22181818181818183,0.4966861981341697,1.0,9/29,18.57%,MNAT1;RBX1;ERCC2;RPA3;RPA1;XPC;ERCC3;CETN2;RPA2
prerank,membrane repolarization during action potential (GO:0086011),-0.4748756705316779,-1.1858490055821256,0.25919117647058826,0.4963716843550444,1.0,7/13,27.41%,KCNJ2;YWHAE;KCNQ1;KCNE4;KCNH2;KCND3;ATP1A1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3761732683177408,-1.1851969988304398,0.21129326047358835,0.49740194160163853,1.0,12/28,25.81%,SHANK3;GSK3B;APP;ABL1;EPHA4;FAM107A;LGMN;ADCY1;CALB1;CALB2;EIF2AK4;PTN
prerank,liver development (GO:0001889),-0.37200650366581445,-1.184666912605583,0.2,0.498308228923084,1.0,13/32,23.92%,PKD2;LSR;TGFBR3;PRKCSH;ZIC3;CEBPG;CITED2;CDK5RAP3;ANXA1;ARID5B;NF1;CEBPA;E2F7
prerank,keratan sulfate catabolic process (GO:0042340),0.4698265609339636,1.1846258365982496,0.24129930394431554,0.6470254525385692,1.0,5/11,22.00%,PRELP;FMOD;HEXB;OGN;ACAN
prerank,positive regulation of protein transport (GO:0051222),-0.3191691969320986,-1.184359942596645,0.16759776536312848,0.4985719767759803,1.0,27/67,24.89%,UNC13B;CD2AP;GOLPH3L;BMP6;IER3IP1;ADAM9;TGFB2;EZR;MYO18A;CNST;MYOM1;BCAS3;ICE1;CHP1;TPR;IGF1;RIPOR1;GOLPH3;OAZ2;PCM1;ARHGEF5;VAMP2;CEP131;PCNT;SYTL4;APBB1;PLK3
prerank,cell-matrix adhesion (GO:0007160),-0.29892605045876897,-1.1842662168650682,0.1556350626118068,0.498369107928385,1.0,22/95,12.78%,SORBS1;ITGB1;THSD1;BCR;FERMT2;CD34;RAC1;ITGBL1;ITGA3;ITGA1;ITGB4;ADAM9;ITGB5;PPFIA1;PTPRK;BCAM;ADAMTS9;FBLN5;ILK;ACTN1;MSLN;ITGA4
prerank,establishment of melanosome localization (GO:0032401),0.423377076744413,1.1841333945114512,0.23620309050772628,0.6466444552696929,1.0,9/19,16.89%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,regulation of centriole replication (GO:0046599),-0.43445941919693243,-1.1838940662708874,0.23357664233576642,0.49878687971217905,1.0,6/17,25.35%,KAT2B;PLK2;PLK4;ALMS1;BRCA1;CEP295
prerank,regulation of lamellipodium assembly (GO:0010591),-0.364440424528143,-1.183842944605863,0.2205029013539652,0.4984754446403132,1.0,10/34,19.36%,WASF2;RAC1;SLIT2;PIK3R1;PLCE1;OCLN;ABI3;NCKAP1;CAPZB;EPHA2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5194959315926313,-1.183261246984661,0.2676864244741874,0.4994366792960314,1.0,3/10,7.55%,DAB2IP;ANXA2;EPHA4
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4304081140876328,-1.1828592128339865,0.24817518248175183,0.49954200115565117,1.0,8/16,25.61%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN;DMTN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4304081140876328,-1.1828592128339865,0.24817518248175183,0.49954200115565117,1.0,8/16,25.61%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN;DMTN
prerank,primary miRNA processing (GO:0031053),-0.5012779555350728,-1.1827761273139545,0.2673992673992674,0.4992938331514383,1.0,7/10,37.67%,SMAD1;SMAD2;PUS10;DROSHA;MRPL44;DGCR8;SMAD3
prerank,negative regulation of cilium assembly (GO:1902018),-0.4786157411178556,-1.1827417482516838,0.26691042047531993,0.4989497325934237,1.0,5/12,10.44%,LIMK2;MAP4;CDK10;TBC1D30;YAP1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.46742236061496506,-1.1822328422023574,0.2571428571428571,0.4996933604281685,1.0,4/13,9.65%,ATG7;ATG10;UBA2;UBA7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.4864413888120085,-1.1818194193346538,0.2595281306715064,0.49981939424595634,1.0,8/11,46.37%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.4864413888120085,-1.1818194193346538,0.2595281306715064,0.49981939424595634,1.0,8/11,46.37%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,skeletal muscle tissue development (GO:0007519),-0.3637439210836282,-1.1815456855532418,0.22800718132854578,0.5000489512272015,1.0,12/32,28.26%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SKI;SIX4;MYL6;FOXL2;CAV2;KLHL41;MSC
prerank,sodium ion homeostasis (GO:0055078),0.3974795709804279,1.1815013517117352,0.22975929978118162,0.6522962588436402,1.0,5/21,12.07%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4617196221113542,-1.1814535597506255,0.2635514018691589,0.49981886715692997,1.0,3/13,10.36%,CBFB;TGFBR2;GLI3
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.29675158415194514,-1.181111896820575,0.1622103386809269,0.500193448041043,1.0,45/95,33.15%,SMC5;NIPBL;SAMHD1;ZFYVE26;SPIDR;MRE11;MMS22L;NABP1;MCM9;RBBP8;MCM4;RAD54B;SFPQ;NSMCE2;RPA3;RPA1;FANCM;PALB2;RFWD3;WRN;RPA2;RAD54L;BRCA1;RAD51AP2;BLM;MCM3;YY1;MORF4L1;MCM7;MCM5;POLL;INO80;RAD51AP1;XRCC2;AP5Z1;RAD51D;SWI5;KDM4D;HUS1B;MEIOB;RAD50;FAN1;MCM2;GINS2;RMI1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.35956032240303604,-1.1810955203311548,0.2028985507246377,0.49981403696626164,1.0,13/36,29.58%,MECOM;FOXO1;DLG1;EZR;TAOK3;DUSP3;IGBP1;ZMYND11;SH3RF2;GPS2;AIDA;DUSP1;TREM2
prerank,positive regulation of cytokine production (GO:0001819),-0.2555574406923525,-1.1808838526757974,0.0847457627118644,0.49990625529864036,1.0,117/292,35.77%,FOXP1;SPTBN1;IL1R1;AFAP1L2;CREBBP;CD34;NOD1;CD200;SLC7A5;IFIH1;APP;IL15;RAB1A;PRKD2;IL6ST;IL6R;NFKB1;PLCB1;STAT6;MRE11;LBP;FLT4;ARHGEF2;PLCG2;PIK3CD;IRF1;RGCC;ZFPM1;IRAK1;LRRFIP1;LPL;FLOT1;IL17RA;ATF4;POLR3F;CD40;MIF;C1QTNF3;AGPAT1;CGAS;ROCK2;RARA;GBP5;MAVS;CTNNB1;CEBPG;SOD1;IL16;PAEP;HYAL2;ANXA1;CCL19;NOD2;RPS3;LURAP1;ARNT;PTPRC;PRKDC;BRCA1;F3;PTPN11;RELA;SERPINE1;FZD5;RIPK1;MAP3K7;HPSE;HSPA1B;DHX9;HMGB1;MAPK11;POLR2H;EIF2AK3;IL7;POLR2L;CD276;ADAM17;STOML2;F2R;FCER1G;IL12RB2;POLR3GL;PNP;IRF7;HILPDA;TRIM6;HMOX1;LGALS9;DDIT3;MAPK14;TNFRSF14;POLR3K;LILRB1;TLR6;TGFB1;TICAM1;IRF5;RAB7B;CEBPB;CYP1B1;TLR1;NOS2;POLR2E;TLR5;FGR;STAT3;NLRP3;TBK1;IL1A;CD14;POLR3A;PARK7;CD274;CD74;TSLP;TLR8;SYK
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.5126087168700996,-1.1807300154607263,0.2608695652173913,0.49984360390905547,1.0,3/10,21.50%,KLF4;PTPRC;MAPK7
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.478736137190742,1.1806639876391316,0.2586605080831409,0.6529510877440348,1.0,4/10,14.03%,DGKQ;GNMT;SIRT7;SELENOS
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4122465775956534,1.1803465354793583,0.24411134903640258,0.6521263941267278,1.0,4/18,5.16%,NLGN1;RIMS2;RIMS1;SYN1
prerank,lamellipodium assembly (GO:0030032),-0.3857969202732977,-1.179997571420537,0.20802919708029197,0.5010670984541327,1.0,4/26,1.94%,ABLIM1;ITGB1;PARVB;RAC1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2849283290816985,-1.1797992640099682,0.1436077057793345,0.5010915225996372,1.0,29/119,15.87%,RUFY1;MTMR3;ARF3;EFR3B;PIP4K2A;BMX;PIK3R1;PI4KB;PIP4K2B;PIK3C2A;PIP5K1B;MTMR6;RAB5A;PLCG2;ITPKB;PIK3CD;SOCS2;TTC7A;PIK3R6;MTMR12;INPP4A;PIGV;FGF2;PLEKHA4;PIK3CB;PTPN13;PIGG;PIK3R3;PI4K2B
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4582704703362883,-1.1795393085714172,0.2768959435626102,0.5012562947672614,1.0,3/13,8.83%,SEMA7A;TGFB2;PLCG2
prerank,serine family amino acid metabolic process (GO:0009069),-0.4477859002508804,-1.179435696771869,0.26102292768959434,0.5010620809809995,1.0,6/16,21.06%,SRR;MTHFD1;CDO1;SEPHS2;CTH;GCLC
prerank,negative regulation of cell adhesion (GO:0007162),-0.31125219317157415,-1.1792364351407156,0.1982142857142857,0.5010864475273789,1.0,16/72,12.70%,SEMA6A;ACVRL1;PODXL;ACER2;CBLL1;GCNT2;FZD4;PTK2;ARHGDIA;PLXNA4;PLXND1;CDH1;ADAM10;NOTCH1;RASA1;RHOA
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4521380606986455,-1.1792010549993337,0.27586206896551724,0.5007451875207929,1.0,6/14,10.06%,LIMS2;LIMS1;LOXL3;PHACTR4;PRKD1;FLNA
prerank,positive regulation of developmental process (GO:0051094),-0.27305074693939924,-1.1792002895235976,0.12589928057553956,0.5003265339268981,1.0,24/164,7.56%,DAB2IP;RREB1;SLC6A6;ZBTB16;SHANK3;INSR;BMPR2;SMURF2;CORO1C;DVL3;RALBP1;ZDHHC6;BMP5;SHLD1;KDR;TFRC;FZD4;TRPM4;MIEF1;KMT5B;PLCB1;BMP4;BNIP3;RBM19
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.42785240959411974,-1.1790065041855122,0.25806451612903225,0.5003397192878116,1.0,6/18,15.24%,ASH1L;SETD2;SUV39H1;SETD3;EHMT1;PRDM9
prerank,telomere maintenance via recombination (GO:0000722),-0.488891631689259,-1.1789380839881474,0.26887661141804786,0.5000671231257859,1.0,8/11,40.90%,SMC5;NSMCE2;TEP1;RAD51D;RAD50;ERCC4;SMC6;ERCC1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3796489494754668,1.1789154513179687,0.2323943661971831,0.6544952884524863,1.0,5/27,9.75%,HTR2C;CALCA;GRM1;C3AR1;GPR65
prerank,myelination (GO:0042552),0.3372757958010714,1.1788192342884072,0.19501133786848074,0.6530209270493247,1.0,18/46,17.54%,MYRF;SCN8A;EPB41L3;PLP1;BCAS1;ACSBG1;SCN2A;NFASC;GPC1;KLK6;MBP;SLC8A3;TPPP;AMIGO1;GAL3ST1;B4GALT6;CXCR4;LGI4
prerank,myoblast differentiation (GO:0045445),-0.45005442319004924,-1.1786029210396283,0.261986301369863,0.5004235535189276,1.0,7/14,17.21%,MBNL1;RB1;PLEKHM3;MAPK12;JAG1;IGF1;EPAS1
prerank,T cell mediated immunity (GO:0002456),-0.4573602244190237,-1.1784508128302194,0.26136363636363635,0.5003344345424414,1.0,6/13,32.35%,CD55;JAG1;CTSH;GNL1;EMP2;MYO1G
prerank,response to UV (GO:0009411),-0.3003556025552304,-1.1783792259603174,0.17006802721088435,0.5000954999403415,1.0,35/95,27.07%,CREBBP;DCUN1D3;MAP4K3;EGFR;UBE4B;NEDD4;PRKCD;PTPRK;ERCC2;RPL26;TP53;AKT1;NSMCE3;CAT;REV1;MAPK8;ERCC3;ATF4;COPS9;GPX1;N4BP1;ERCC8;RUVBL2;WRN;SDE2;CCND1;USP1;CDC25A;RELA;YY1;ERCC6;EIF2AK4;DTL;INO80;RHBDD1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.33859852686152203,-1.178192398372705,0.19272727272727272,0.5001120117712883,1.0,9/43,8.29%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;HES1;MEF2C;TBX2
prerank,potassium ion homeostasis (GO:0055075),0.38802107566338634,1.1780991622923775,0.22666666666666666,0.6533524669911945,1.0,7/23,12.06%,KCNMA1;ATP1A2;ATP12A;ATP1B1;SLC12A5;ATP4A;SLC12A4
prerank,response to ATP (GO:0033198),0.41477208757997486,1.1777218948213304,0.2565789473684211,0.6526851931700364,1.0,5/18,14.20%,DGKQ;RYR3;CIB2;P2RX3;TAF1
prerank,phospholipid metabolic process (GO:0006644),0.3049681535645412,1.1774435996117576,0.19325842696629214,0.651733314873613,1.0,12/71,8.76%,ENPP2;IDI2;FADS1;PIP4P1;PLPPR4;PLPPR1;SMPD3;PLPP2;ABCA2;PLA2G3;PLA2G4E;PLPPR5
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.28776969564027066,-1.1773317639117102,0.15263157894736842,0.5016553659370886,1.0,41/109,25.91%,RUFY1;MTMR3;ARF3;PLA2G4A;PLCG1;PIP4K2A;BMX;PLCB3;PLCB1;PIK3R1;PI4KB;PIP4K2B;PIK3C2A;PIP5K1B;MTMR6;RAB5A;PLCG2;PIK3CD;PIK3R6;MTMR12;INPP4A;FGF2;PLEKHA4;PIK3CB;PTPN13;PIK3R3;PI4K2B;PIP4P2;PLA2G12A;INPP5D;LCLAT1;PIGW;PTEN;MTMR4;PIP5K1A;PDGFRB;INPP5J;PIK3CA;PLA2G4F;TPTE;INPP5E
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.49525894074067267,-1.177260963415594,0.2719298245614035,0.5013989511877505,1.0,5/10,29.03%,SLC44A1;SMOX;ALDH7A1;CHDH;DMGDH
prerank,relaxation of cardiac muscle (GO:0055119),0.45236195829486525,1.1771293241595469,0.25733634311512416,0.6509529267762697,1.0,5/13,12.07%,ATP1A2;ATP1B1;CHGA;GSN;SLC8A1
prerank,transition metal ion homeostasis (GO:0055076),-0.3790575515678063,-1.1770453554517366,0.24956672443674177,0.5014874735197993,1.0,7/28,14.48%,XIAP;SLC40A1;BDH2;PICALM;HFE;HMOX2;ABCB7
prerank,response to interleukin-1 (GO:0070555),-0.3096167711597495,-1.1768260555597287,0.1663619744058501,0.501553606005868,1.0,25/73,28.90%,DAB2IP;IL1R1;APP;CCL25;NFKB1;IRAK1;HDAC4;RC3H1;CD40;USP10;IGBP1;IRAK2;HYAL2;ANXA1;CCL19;RELA;HAS2;TAF9;PTGIS;MAPK11;GBP3;ADAMTS7;LGALS9;CACTIN;HYAL3
prerank,regulation of transmembrane transport (GO:0034762),-0.3679673705879285,-1.1759160944316327,0.23117338003502627,0.5031890215303515,1.0,13/31,25.68%,SLC2A1;NEDD4L;KCNJ2;NEDD4;OCLN;ACTB;CTTNBP2NL;KCNJ8;WWP2;PIM1;ACE2;TRIB3;KCNJ13
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3911287339631625,-1.1758642208206316,0.25,0.502901519273298,1.0,6/24,8.71%,DAB2IP;PTPN1;PRKD2;NEDD4;TMEM204;GRB10
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3981174236441997,1.1758275896993047,0.2329059829059829,0.6530795323817637,1.0,5/21,8.46%,SCN1B;KCNA5;CACNA2D1;CACNA1D;SCN5A
prerank,response to amyloid-beta (GO:1904645),0.3385641738931158,1.1752719864941,0.18888888888888888,0.6530039145215816,1.0,7/44,4.16%,GRM5;MMP12;CACNA1B;CACNA2D1;CDK5;GRIN2A;CACNA1A
prerank,MAPK cascade (GO:0000165),-0.25472628778244605,-1.175255206277787,0.09507042253521127,0.5039065860276073,1.0,74/295,19.32%,SPTBN1;TEK;DAB2IP;KITLG;RAPGEF2;SPTAN1;SHANK3;MAP3K20;MEF2A;RASAL2;BRAP;IL17RD;PSMA2;RANBP9;MAP3K5;JAK1;KDR;LRRK2;YWHAE;EGFR;RASGRF2;RBX1;NFKB1;DLG1;SHOC2;PIK3R1;CUL3;IRS1;FGF1;MEF2C;PTK2;PSME2;MAPKAPK2;MAPK1;RAF1;PSMB4;MAP3K3;PDE6D;RASA4;FGF7;TAOK3;PEBP1;BRAF;RASA1;PTPN3;ABHD17A;JAK2;FGF2;MAP3K8;MAPK8;HGF;PIK3CB;KSR1;FBXW11;PSMC2;PSMB2;MAPK12;ABHD17C;GRB2;MARK3;PSMB1;FYN;ANGPT1;IGF1;MAP4K4;CTSH;PSMA8;IKBKG;PSME1;IKBKB;NRAS;KRAS;RGL2;RGL1
prerank,positive regulation of protein kinase activity (GO:0045860),-0.27868662445355386,-1.1751829804066147,0.15502555366269166,0.5036516890546644,1.0,50/148,23.27%,DAB2IP;RAPGEF2;INSR;IQGAP1;PTPN1;PAK2;DDX3X;ACE;TGFBR2;IL6R;GAS6;MRNIP;STK3;TGFB2;IRGM;PRKCD;RAP1A;PTK2;RASSF2;EPHA4;SNX9;MMD;IL34;CLSPN;TAOK3;NEDD9;MTCP1;RPTOR;RHOA;MARK2;NAB2;TAB2;NOX4;MAP4K4;ALS2;CENPE;CCL19;PPP2CA;CACUL1;PTPRC;ITGB3;MAP2K3;CCN1;PTK2B;NRK;HSP90AA1;SYAP1;PARP16;FCGR1A;RALB
prerank,cellular component assembly (GO:0022607),-0.25798829789730837,-1.1750872623808262,0.10207612456747404,0.5034341319005537,1.0,62/253,19.20%,SPTBN1;SLC2A1;PARD3;MNAT1;LIMA1;CREBBP;FERMT2;PARVB;EPS8;BAIAP2L1;CD2AP;RAC1;LIMS2;RHOJ;PLS3;PARVA;LIMS1;RANBP9;TEAD1;MITF;HES1;GAS6;FAS;TOGARAM1;RHOQ;EZR;KPNA3;WASL;SNX9;OCLN;YWHAZ;FAM107A;SHROOM1;PICALM;DET1;AFG3L2;TP53;FLNA;SHROOM2;YAP1;ILK;HFE;ACTB;NEDD9;RHOA;RHOG;LCP1;NCKAP1;HAS1;CD40;PEX14;VCPIP1;TUBGCP4;TFAP4;TLCD1;FANCC;IKBKG;WASF1;MAGI1;VAMP3;CALD1;MDN1
prerank,DNA metabolic process (GO:0006259),-0.25711495077282404,-1.1740083177814131,0.10851419031719532,0.5054806222583472,1.0,89/270,27.32%,SP100;MNAT1;PDS5B;STN1;ATM;NT5E;PARP4;DMC1;TOP3A;KMT5B;SAMHD1;TRRAP;MRE11;TOP3B;UHRF2;NABP1;INIP;RBBP8;MCM4;DOT1L;ORC5;NSMCE3;AXIN2;ENDOV;POLD3;INTS3;RAD18;OGG1;KAT5;PDS5A;RPA3;DNA2;RPA1;XPC;CTC1;ERCC3;PNKP;PTGES3;BTG2;UBE2V2;TOP1MT;SUMO1;TERF2;DNMT1;SRPK2;ORC2;POLE2;FANCG;WRN;FANCC;PRIM2;ORC4;SMARCAD1;RPA2;RAD54L;USP7;NSMCE4A;PRKDC;LIG4;FANCL;BRCA1;TIMELESS;TRIM28;DCLRE1B;CHRNA4;BLM;RFC4;CHEK1;TERT;MCM3;GADD45A;TOP1;NTHL1;MSH3;RFC1;TCF7L2;PWWP3A;HMGB1;SMARCB1;RAN;POLA2;MCM7;LIG1;MCM5;MCM10;POLL;INO80;EXO1;GTF2H3
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4029925220884709,-1.1735751546105524,0.24861878453038674,0.506022160568033,1.0,7/22,13.27%,MED1;PTPRK;STXBP4;PRKD1;NOTCH2;FGF7;KLF9
prerank,positive regulation of type I interferon production (GO:0032481),-0.3090082710051433,-1.1733349105725737,0.20320855614973263,0.5062187606391256,1.0,27/73,28.28%,CREBBP;IFIH1;SETD2;TRIM56;DDX3X;NFKB1;STAT6;MRE11;IRF1;IRAK1;LRRFIP1;FLOT1;POLR3F;CGAS;MAVS;CTNNB1;PRKDC;PTPN11;HSP90AA1;RELA;DHX9;POLR2H;POLR2L;RIOK3;POLR3GL;IRF7;TOMM70
prerank,lymphocyte differentiation (GO:0030098),-0.31303607251764076,-1.1731570623574994,0.2040072859744991,0.5061963776017276,1.0,20/68,21.18%,PBX1;ITGB1;PTPRJ;JAG2;ZBTB7A;TPD52;PLCG2;PIK3CD;HDAC4;ITGA4;NHEJ1;LMBR1L;TCF3;VCAM1;CEBPG;CLCF1;DNAJB9;SOX4;PTPRC;DLL4
prerank,negative regulation of hydrolase activity (GO:0051346),-0.33192504425021846,-1.1725466396940922,0.1931166347992352,0.5071813316622862,1.0,20/49,29.17%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;ZCCHC9;RASA4;GPATCH2;BCAS3;ARFGEF1;CHP1;TERF2;SH3RF2;MAPK7;NOS1;ARL2;FZD10;RDX;FICD;WNK1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.32352773107942195,-1.1724900834043366,0.21061946902654868,0.5068884685178909,1.0,19/54,24.09%,PAK1IP1;RPF1;RRP15;NOP2;RPL3;RPL26;RPL10;NIP7;RPL7A;RPL5;NLE1;RPL35A;WDR74;MDN1;BOP1;RRS1;PES1;EBNA1BP2;NOP16
prerank,nitrogen compound transport (GO:0071705),-0.2751243044840215,-1.172318579948886,0.12393887945670629,0.506842517283418,1.0,26/141,11.07%,ABCG2;SLC6A6;CERT1;RUFY1;CALCRL;SLC7A1;MYH9;SLC7A5;RALBP1;RAMP1;RAB7A;SLC12A2;SCAMP2;SLC38A5;SLC19A2;SLC22A5;LRRC8D;SLC44A1;SLC1A5;ARRDC1;ARL6IP5;RAMP2;SLC52A1;EDN1;SEC14L1;TXNIP
prerank,sphingosine metabolic process (GO:0006670),0.4177629496093853,1.171906592022216,0.2595078299776286,0.6610754151134324,1.0,7/17,11.74%,PLPP2;SPHK1;SGPP1;ABCA2;ACER1;SPHK2;NAAA
prerank,bile acid biosynthetic process (GO:0006699),0.38645323625976236,1.1717208694416477,0.24249422632794457,0.6598921068159727,1.0,6/24,17.28%,AKR1D1;CYP46A1;OSBPL6;CYP27A1;OSBPL9;ACOX2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.32293586162297094,-1.1716985440984309,0.19796954314720813,0.5078444027638657,1.0,14/57,17.53%,GSK3B;RALBP1;ZDHHC6;KDR;TNFSF10;MIEF1;BNIP3;GSK3A;TP53;MIEF2;HIP1R;BBC3;BCL2L11;PPIF
prerank,RNA splicing (GO:0008380),-0.29383899469538066,-1.1716734052344444,0.16606498194945848,0.5074972790176184,1.0,27/95,21.30%,MBNL1;SRSF11;PRPF3;SMU1;IVNS1ABP;CDK12;RSRC1;PPIG;PRPF6;FUS;DDX39B;SF3B1;DBR1;SFPQ;SLU7;YJU2;SCNM1;SRPK2;SYNCRIP;USB1;ZMAT5;PPP2CA;SRRM1;RNPS1;SRSF10;NONO;TRA2B
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.37729073821552217,-1.1714573840310678,0.23388581952117865,0.507552404288009,1.0,7/29,12.53%,VTI1A;COG5;COG1;TRAPPC3;COPG1;COPA;COPE
prerank,regulation of cell motility (GO:2000145),-0.2835119914719227,-1.1710936960166813,0.1607773851590106,0.5079816093247181,1.0,34/121,16.41%,RAC1;NTN1;TMSB4X;SPOCK2;CRK;DIAPH1;EGFR;LMO4;ABL1;ROBO4;MACF1;FGF1;PRAG1;PLXNA4;ROCK1;PLXND1;LDB1;RAF1;AKT1;FLNA;FGF7;LMNA;FRMD5;ABI3;CEACAM1;RHOA;FGF2;PKN2;CDK6;TBCCD1;CAVIN1;ROCK2;TMSB10;SLK
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.40642830209829695,-1.1709965961485465,0.25354609929078015,0.5077501042952437,1.0,8/21,30.74%,LRRK2;NCK1;BCL2L11;HERPUD1;TXNDC12;EIF2AK3;DDIT3;PMAIP1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.3164233722015513,-1.1708752649921157,0.19478260869565217,0.5076118473040977,1.0,19/63,18.87%,DAB2IP;MCL1;TAB3;TLK2;MTOR;RASIP1;ROCK1;TBC1D14;DAPL1;MFSD2A;GSK3A;AKT1;TIMP3;PTPN3;HGF;TAB2;DAP;CDK5RAP3;WASHC1
prerank,response to X-ray (GO:0010165),-0.4491148968925568,-1.1705864188018942,0.258364312267658,0.507828298612015,1.0,7/14,21.01%,ATM;NIPBL;XRCC4;BRCC3;ANXA1;LIG4;BLM
prerank,protein localization to cell periphery (GO:1990778),0.27155118710810844,1.1701999838180468,0.13539192399049882,0.6624644503590202,1.0,29/133,11.73%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;EPB41L3;RAB15;ANK1;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;MYO5A;WNK3;CD81;ARL3;NKD2;SPTBN4;TESC;ZFYVE27;RAB3A;C2CD5;LIN7C;TSPAN32;PPIL2
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2767851251708715,-1.1701107411740495,0.1391941391941392,0.5084829643056287,1.0,44/141,21.01%,CTNNA1;RAPGEF2;GNB1;PKD2;ESR1;NRIP1;NR3C1;DIAPH1;LRRK2;TIPARP;EGFR;MSN;LARP1;PDE2A;PDE3A;KCNQ1;MED1;SPIDR;EZR;RAP1A;MEF2C;TGM2;RAP1B;CDH1;ARL6IP5;RAPGEF1;NCOA4;ACTB;KAT5;PDE12;P2RY6;ADCY1;ROCK2;RUVBL2;IGFBP5;UBE2L3;CTNNB1;GOLPH3;TFPI;SLC1A1;SLC5A5;BRCA1;P2RY1;BLM
prerank,positive regulation of viral life cycle (GO:1903902),0.3903120862327443,1.1694357751777011,0.2267818574514039,0.662925859209926,1.0,6/22,18.63%,LGALS1;TYRO3;DDB1;TSG101;P4HB;CHMP2A
prerank,negative regulation of nervous system development (GO:0051961),0.4201977377258589,1.1690598793389702,0.2777777777777778,0.6623043983088599,1.0,3/17,10.41%,ROBO2;SORL1;SLIT1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2717182629396849,-1.1686397616700022,0.1440536013400335,0.5114441835765686,1.0,57/172,25.22%,RUFY1;MTMR3;ARF3;PLA2G4A;LPCAT1;PIP4K2A;PLD1;BMX;PIK3R1;PI4KB;PIP4K2B;SLC44A1;PIK3C2A;PIP5K1B;MTMR6;RAB5A;PLD2;PLCG2;STARD7;MFSD2A;PIK3CD;DGKA;DGKZ;AGPAT4;PIK3R6;MTMR12;INPP4A;ACP6;AGPAT3;FGF2;PLEKHA4;AGK;PIK3CB;PLSCR1;PTPN13;PIK3R3;AGPAT1;PI4K2B;PCTP;PTDSS1;CEPT1;PLA2G12A;INPP5D;LCLAT1;LPIN2;LCAT;DDHD2;LPCAT3;PTEN;MTMR4;GPD1;PIP5K1A;CHAT;INPP5J;PIK3CA;DGKH;DGKE
prerank,regulation of protein localization (GO:0032880),-0.31847039415034406,-1.1681968737178765,0.20802919708029197,0.5120355274685915,1.0,14/58,16.25%,DVL3;TRIM25;AFDN;DLG1;AAK1;PPM1F;MMD;DNAJB6;PICALM;TRIM14;MAPK8;TPR;SUMO1;DZIP1L
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4240547972752428,1.1679965900166098,0.2494802494802495,0.6637574362355754,1.0,2/16,2.75%,KCNC2;DDAH2
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3301412923477158,-1.1678902995627634,0.21166666666666667,0.5122860925174428,1.0,17/49,24.34%,MAP3K20;ACER2;ATM;ABL1;CLSPN;TP53;DOT1L;NDRG1;GRB2;USP10;MAD2L2;ATRX;CHEK1;INTS7;GADD45A;E2F7;ERCC6
prerank,ubiquinone biosynthetic process (GO:0006744),-0.44104403796647285,-1.1675343968328704,0.24635036496350365,0.5127189917201659,1.0,6/15,20.88%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,regulation of cell morphogenesis (GO:0022604),-0.3695760737446911,-1.1669247835965788,0.24156305506216696,0.513719716952325,1.0,11/30,18.93%,FERMT2;PDZD8;ZMYM6;MACF1;MFSD2A;ZMYM4;MOV10;CAPZB;CFL1;FMNL2;WTIP
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.36708553171106545,-1.1667362262877645,0.23376623376623376,0.5137889544091588,1.0,15/31,35.96%,DCUN1D3;RAB1A;MAGEC2;DCUN1D2;UBE2L3;DCUN1D5;PTEN;FZR1;TRIB3;RPS2;PLK1;BMI1;TOPORS;CDC20;UBE2C
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3492179775033644,-1.1667229949745792,0.22495606326889278,0.5134002654886265,1.0,14/38,19.63%,CAV1;APP;PTPN1;ACE;GAS6;EPHA4;SH3BP5L;IL34;NCK2;NEDD9;NOX4;HYAL2;RAP2C;PTPRC
prerank,protein dephosphorylation (GO:0006470),-0.2761740566299979,-1.1665775452728726,0.15424610051993068,0.5133268301980589,1.0,37/135,19.88%,PTPRG;PTPRB;PTPRM;PTPN14;PPP2R5A;PPM1H;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PPEF2;NCK1;PPM1L;PTPRK;ILKAP;PPM1F;MTMR6;PPP2R2D;PPM1B;UBLCP1;PPP1R12A;PTPN3;DUSP3;CTTNBP2NL;FBXW11;PTPN13;PPP2CB;UBASH3B;TNS2;DUSP16;DUSP22;PPP2CA;PPM1D;PTPRC;PPP3CC
prerank,intracellular protein transport (GO:0006886),-0.25092746064460386,-1.1664251259719023,0.10961214165261383,0.5132369693138696,1.0,90/304,24.40%,TBC1D4;SEC31A;RASSF9;KIF13B;NUP42;TRAK1;ARF3;RAB7A;ARCN1;RAB1A;SMURF1;TLK1;CSE1L;SYNRG;TBC1D1;RAB5B;STX3;COX18;XPO7;HPS4;TBC1D2B;WDR11;TBC1D8B;SNX9;USP6NL;TBC1D30;SEC13;RAB5A;TBC1D14;ARHGEF2;STX8;SCFD1;SRPRA;PPP1R10;FUT10;AKT1;TBC1D22B;GABARAP;TBC1D22A;EHD1;RAB3GAP2;VPS26A;COPA;ARL4A;SLU7;VPS45;NUP153;CHP1;VPS36;RAB23;RAB24;RAB32;TPR;SIL1;HERC2;SNX8;HDAC6;XPO4;FAM91A1;IPO8;TBC1D8;TMED5;STX12;GIPC1;VPS26C;LAMP2;NXT1;NUP214;TBC1D17;AP4M1;AP4B1;TBC1D25;KIF13A;ARL5C;AP3B1;PREB;SNX13;EVI5;TECPR2;CTSA;HOMER3;SAR1A;TBC1D12;ARL4C;RAB19;NUP188;STX19;ARF5;COPZ1;RANBP6
prerank,RNA transport (GO:0050658),-0.308241543792596,-1.1663415762699492,0.2113970588235294,0.5130232656090269,1.0,24/71,24.19%,SRSF11;SARNP;RAE1;TGFBR2;RTRAF;THOC2;UPF3B;THOC7;DDX39B;DHX38;SLU7;NUP153;FLOT1;HNRNPA1;TPR;THOC1;THOC3;NUP214;SRRM1;RNPS1;SRSF3;NUP188;POLDIP3;NXF1
prerank,pyroptosis (GO:0070269),-0.4406313703772369,-1.1658513370260455,0.2646048109965636,0.5137803684991673,1.0,7/15,29.58%,CASP8;GSDME;APIP;DHX9;CASP1;NLRC4;TREM2
prerank,RNA metabolic process (GO:0016070),-0.27824641286470475,-1.1658279873501198,0.166383701188455,0.5134077097640125,1.0,45/127,26.48%,RBPMS;RBFOX2;METTL14;RBMS1;DDX3X;HNRNPA0;RBM5;HNRNPR;FTO;RBMS2;HNRNPM;POLR2G;RNASE3;DDX39B;NOL9;WTAP;HNRNPA3;HNRNPUL1;DICER1;HNRNPF;XRN2;RBM39;TENT2;PARN;AGO2;HNRNPA1;APOBEC1;THOC1;SYNCRIP;ADARB1;WDR74;TFIP11;DROSHA;RNASEH2C;RBM3;RBM6;PCBP1;POLR2C;DHX9;POLR2H;EXOSC7;POLR2L;HNRNPU;HNRNPL;HNRNPD
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.42131415277668105,-1.1655458253013642,0.24100719424460432,0.5136272925552267,1.0,7/18,12.64%,JAK1;IL6ST;IL6R;CBL;SMAD4;YAP1;JAK2
prerank,cellular response to superoxide (GO:0071451),-0.4949481658455088,-1.1652888278111286,0.28091872791519434,0.5138207714239005,1.0,3/10,17.81%,NOS3;SOD1;CCS
prerank,sphingolipid biosynthetic process (GO:0030148),-0.308368671215026,-1.165090757284962,0.2003780718336484,0.513847229982188,1.0,23/71,19.95%,SGMS1;CERT1;ACER2;DEGS2;SGMS2;A4GALT;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;AGK;SPTLC1;ASAH1;CERS5;SMPD2;VAPA;LARGE1;ELOVL7;DEGS1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4384339251631628,-1.1650518821091125,0.28063943161634103,0.5135281649940805,1.0,5/15,15.10%,PRKCH;BMP4;MED1;FOXC1;TRIM16
prerank,xenobiotic transport (GO:0042908),-0.4323739296340787,-1.164993180649469,0.260707635009311,0.5132692053384575,1.0,3/17,2.36%,ABCG2;SLC47A1;SLC7A5
prerank,regulation of microtubule nucleation (GO:0010968),0.478580950208903,1.1646461795497853,0.26419213973799127,0.67182189389614,1.0,3/10,7.16%,EML2;ARHGEF7;PAK1
prerank,cellular response to insulin stimulus (GO:0032869),-0.28123120934322726,-1.1643905723332098,0.18345323741007194,0.5141881190826049,1.0,28/124,15.96%,IGF1R;TBC1D4;SORBS1;FOXO1;GAB1;INSR;GSK3B;KAT2B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GRB14;NAMPT;GSK3A;ZNF106;BCAR1;AKT1;SLC27A4;CEACAM1;ATP6V1E1;RAB8B;INSIG2;PIK3R3;GRB2;FOXO4;DENND4C
prerank,visual perception (GO:0007601),0.29688457627552234,1.1639714092994957,0.19015659955257272,0.672129874588311,1.0,11/84,8.20%,COL2A1;COL1A1;EML2;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2;TRPM1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.42920700751077956,-1.1636817264205055,0.25842696629213485,0.5154040305731793,1.0,5/17,17.53%,CBFA2T3;PPARA;HDAC4;PDE12;PPIF
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.48882607875517536,-1.163665308979252,0.28900709219858156,0.5150283697731228,1.0,5/11,18.76%,BMP4;TGFB2;JAG1;HEY2;SOX4
prerank,energy reserve metabolic process (GO:0006112),-0.4149530060918698,-1.163109455498794,0.2676056338028169,0.5158852641590679,1.0,5/19,13.59%,GBE1;GSK3B;GFPT2;PPP1R3C;PHKB
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2890295382801774,-1.162632889618575,0.16753926701570682,0.5161553509776391,1.0,26/104,19.14%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PLCG2;PSMB4;ICAM2;FBXW11;PSMC2;PSMB2;TAB2;PSMB1;FYN;PSMA8;IKBKG;PSME1;IKBKB;NRAS;KRAS
prerank,cellular response to lectin (GO:1990858),-0.2890295382801774,-1.162632889618575,0.16753926701570682,0.5161553509776391,1.0,26/104,19.14%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PLCG2;PSMB4;ICAM2;FBXW11;PSMC2;PSMB2;TAB2;PSMB1;FYN;PSMA8;IKBKG;PSME1;IKBKB;NRAS;KRAS
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.31479659287132267,1.1621513525921348,0.21379310344827587,0.6757449363261099,1.0,14/59,17.28%,AKR1D1;CYP46A1;ELOVL4;ACLY;OSBPL6;ACACA;LIPC;CYP27A1;OXSM;ALDH1A2;OSBPL9;NDUFAB1;ALOX5;ACOX2
prerank,autophagy of nucleus (GO:0044804),-0.4303436440935688,-1.161849986949629,0.24508050089445438,0.517554793691302,1.0,9/16,30.45%,ATG7;WIPI1;ULK2;ATG5;WDR45B;ATG2A;ATG2B;ATG3;ATG9A
prerank,lipid translocation (GO:0034204),-0.4043155849467078,-1.1614361204536923,0.2467289719626168,0.5180822908247157,1.0,6/21,16.94%,ATP10A;ATP8B1;RFT1;ATP10B;ABCA7;ATP9B
prerank,synaptic vesicle localization (GO:0097479),0.4457807662538944,1.1613376806814906,0.2725274725274725,0.676324958920475,1.0,4/13,9.85%,NLGN1;CDK5;SYNDIG1;KIF5A
prerank,regulated exocytosis (GO:0045055),0.2594922250797988,1.161315692049854,0.13170731707317074,0.6746555478800584,1.0,32/173,13.67%,SYT1;ABCA12;PCLO;SYT5;BLK;RIMS2;SNAP25;RIMS1;CDK5;F8;SYT12;SYT11;CLEC3B;CD63;PLEK;RAB27B;ECM1;LY6G6F;TIMP1;PF4;STXBP2;VEGFA;SERPING1;PDGFA;RAB3A;VTI1B;CHID1;SYT4;SYNGR1;CDC37L1;CLU;SYT3
prerank,autophagosome organization (GO:1905037),-0.330392799171701,-1.1610726580151876,0.23007246376811594,0.5184906256935382,1.0,22/50,30.45%,ATG7;RAB7A;RAB1A;MAP1LC3B;IRGM;AMBRA1;GABARAP;WIPI1;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;RAB19;ATG2A;ATG2B;UBXN2A;ATG3;ATG9A
prerank,protein stabilization (GO:0050821),-0.27089078676866574,-1.1606284562752642,0.16319444444444445,0.5191255687752215,1.0,53/168,24.54%,HIP1;USP9X;PARVA;DVL3;SOX17;NAA16;STK3;PIK3R1;HPS4;IRGM;PRKCD;TCP1;RASSF2;EPHA4;AAK1;STXBP4;CTNND1;USP2;USP13;FLNA;NAA15;PER3;SMAD7;CHP1;FLOT1;TBRG1;PTGES3;HCFC1;HIP1R;RPL5;CREBL2;SUMO1;NCLN;IGF1;TMEM88;STX12;LAMP2;SOX4;USP7;COA8;TBL1X;CREB1;PTEN;RPS7;HSP90AA1;TRIM39;GLMP;MSX1;CCT5;HSPA1B;TAF9;CRTAP;PLPP3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3685411320257865,-1.1604512203008202,0.24857685009487665,0.5190700989493118,1.0,11/29,27.85%,CAV1;THBS1;PAK2;TNFSF10;WWOX;HYAL2;G0S2;LTBR;RIPK1;TNFSF12;TNFRSF12A
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3401258256655872,-1.1601078104738203,0.22654867256637168,0.5194949726758193,1.0,14/41,18.76%,ENG;TGFBR3;TGFBR2;BMP4;TGFB2;MEF2C;GSK3A;SMAD7;NOTCH1;TPM1;JAG1;HEY2;HEY1;SOX4
prerank,nuclear migration (GO:0007097),-0.4574786816739715,-1.159860095118895,0.2907801418439716,0.5196487301020377,1.0,5/13,18.92%,SYNE2;DCTN1;PAFAH1B1;FBXW11;PCM1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.34501428784866184,-1.1598394052590455,0.21612349914236706,0.5192699316398851,1.0,9/40,15.01%,FLT1;EDNRA;ESR1;PLCG1;EGFR;HTR2A;FGF2;P2RY6;LPAR2
prerank,negative regulation of leukocyte activation (GO:0002695),0.43793838736694046,1.1597726788897895,0.255863539445629,0.677504876470577,1.0,6/15,19.40%,LRFN5;GRN;GPER1;HAVCR2;FCGR2B;CD84
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.28756087192916313,-1.1590152733428492,0.1681109185441941,0.5206924286012633,1.0,26/105,19.14%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PLCG2;PSMB4;ICAM2;FBXW11;PSMC2;PSMB2;TAB2;PSMB1;FYN;PSMA8;IKBKG;PSME1;IKBKB;NRAS;KRAS
prerank,endodermal cell fate commitment (GO:0001711),-0.4963699453961684,-1.158885263610052,0.27706422018348625,0.5205669593623679,1.0,3/10,12.82%,SOX17;RTF1;CDC73
prerank,fluid transport (GO:0042044),0.46371641133095054,1.1588750707656394,0.27705627705627706,0.6784771823701841,1.0,2/12,4.55%,PDPN;AQP4
prerank,negative regulation of heart contraction (GO:0045822),0.45912748306850015,1.1582502696858445,0.30201342281879195,0.6785904614668321,1.0,3/11,12.39%,ATP1A2;SPTBN4;SRI
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3918861305865238,1.1582304027639718,0.2644444444444444,0.6769539939891112,1.0,6/21,8.15%,ABCA12;CTSK;SULT2B1;MAFG;SGPP1;MAFF
prerank,"transcription, DNA-templated (GO:0006351)",-0.2628171804738598,-1.1578770822305453,0.151618398637138,0.5224908293522048,1.0,71/207,29.19%,RREB1;MNAT1;MEF2A;CBFB;MLLT3;DEK;THRB;IVNS1ABP;NFIX;NFKB1;FOXO3;IWS1;EAF1;POLR2G;GTF2E2;GTF2E1;ERCC2;TAF11;TP53;PWP1;TAF1B;NFIC;BRF1;RTF1;CDC73;TCEA1;DRG1;TAF5L;TAF1C;ERCC3;MLLT1;PIR;ATF4;MRPL12;CREBL2;TAF7;TAF3;NELFB;NCOA6;HSF2BP;ELOC;RNPS1;PTMA;TAF4B;UBTF;TAF13;SUPT4H1;TCEA2;MED20;CCNK;GMEB2;POLR2C;TAF9;GTF3C4;TAF15;ERCC6;SNAPC3;POLR2H;LEO1;MLF1;POLR2L;TFDP1;TRIP13;POLR3GL;GTF2H3;RSF1;SLC25A33;MMS19;TRIP11;KLF13;CCNH
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.393870423575359,-1.1577573341626681,0.2797074954296161,0.5223084304479616,1.0,12/24,30.52%,DTX3L;SIN3A;CGAS;MAVS;ZDHHC1;HSP90AA1;EIF2AK4;PARP9;TRIM44;TRIM6;TOMM70;LILRB1
prerank,response to amino acid starvation (GO:1990928),-0.3108375919296356,-1.1577042991648332,0.20172413793103447,0.5220271658825812,1.0,21/72,18.76%,SESN1;MAP3K5;MTOR;LARP1;FAS;SEC13;PRKD1;MAPK1;DAPL1;MIOS;RPTOR;ATP6V1E1;LARS1;MAPK8;ATF4;KPTN;CASTOR1;GCN1;RNF152;DAP;ITFG2
prerank,regulation of mitotic nuclear division (GO:0007088),-0.32172700321699305,-1.1575269117612164,0.21206581352833637,0.5220415610952914,1.0,31/55,41.01%,INSR;LRP5;CDK13;CUL9;BMP4;EDN1;CUL7;RGCC;CCDC8;EDN3;BMP7;IGF1;IGF2;TOM1L2;CHEK1;PDGFRB;CAV2;DUSP1;BORA;BTC;OBSL1;PHIP;AURKA;IL1A;FBXO5;DRD3;CCNB1;TOM1L1;AURKAIP1;CD28;CDC25C
prerank,positive regulation of phagocytosis (GO:0050766),-0.3318317593221153,-1.1574883620494727,0.23048327137546468,0.521711458014275,1.0,20/47,32.27%,IL15;MERTK;PTPRJ;GAS6;MYO18A;RAB27A;ANO6;ABCA7;LMAN2;TULP1;GATA2;PTPRC;FCER1G;IL15RA;CD300LF;IL2RG;TREM2;AHSG;RAB31;PLA2G5
prerank,myotube differentiation (GO:0014902),0.41585832543827894,1.1573037090877174,0.25267665952890794,0.6779889263990603,1.0,4/17,10.56%,ADAM12;ADGRB3;ADAMTS15;PLD3
prerank,proteasomal protein catabolic process (GO:0010498),-0.2606623542319101,-1.1572725199387057,0.14991482112436116,0.5218058232657806,1.0,74/201,29.47%,WWP1;PELI1;NEDD4L;ZNRF1;SMURF2;UBE2K;RNF139;PSMA2;FBXL17;DDI2;SMURF1;RBX1;UBE4B;CUL3;NEDD4;PSME2;PSMB4;GSK3A;UBE2D3;SPSB1;AREL1;TNFAIP1;RMND5A;ARMC8;SPOPL;ATXN3;KAT5;FEM1C;FBXW11;PSMC2;PSMB2;FEM1B;APPBP2;ERCC8;AGAP3;PSMB1;UBXN11;CTNNB1;TRIM13;PSMA8;KCTD10;DNAJB12;PSME1;SPOP;TRIM3;SIAH1;HUWE1;WWP2;RAD23A;RNF4;UCHL1;TBL1X;HACE1;PSMD4;RNF216;MDM2;NFE2L2;PSMD5;ARRB1;ZFAND2A;FBXL22;MAEA;PSMA3;RNF34;RNF122;KIF14;PSMB10;RHBDD1;PPP2R5C;UBXN2A;ATE1;RNF187;DDIT3;KCTD17
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3875230572644429,-1.1572690252238138,0.24571428571428572,0.5214028062912422,1.0,6/23,15.07%,CBFA2T3;SIK1;PPARA;GSK3A;HDAC4;C1QTNF3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2918661097973125,-1.1562574898296452,0.199288256227758,0.523289104349088,1.0,32/86,23.79%,RB1;BAIAP2L1;CLIP1;RAC1;PRKCE;APP;NCK1;TOGARAM1;SNX9;OCLN;EDN1;FCHSD2;CFL2;NCK2;DCTN1;PSEN1;LMOD1;SYNPO2;SLAIN2;CDC42EP3;DRG1;NCKAP1;GPX1;COLGALT1;TRPV4;RPS3;FCHSD1;CDC42EP1;PTK2B;ARL2;SEMA5A;AKAP9
prerank,mitochondrial fission (GO:0000266),-0.4177720669020022,-1.1553547309293435,0.26032315978456017,0.5249619466362143,1.0,3/16,5.83%,DNM3;MIEF1;DNM2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.2966585286390336,-1.1551407720277842,0.19148936170212766,0.5250363274523931,1.0,29/86,21.83%,PECAM1;GHR;APP;PAK2;IL15;PTPRJ;BMP6;EGFR;IL6R;ABL1;PRKCD;ARHGEF2;PLCG2;CSPG4;HAX1;TP53;FGF7;JAK2;HGF;MIF;FYN;ANGPT1;IGF1;RAP2C;PTPRC;IGF2;ITGB3;PTPN11;PTK2B
prerank,cellular response to interleukin-1 (GO:0071347),-0.27527473326103213,-1.1550222364699723,0.1555944055944056,0.5249145402166,1.0,34/143,18.60%,DAB2IP;IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;CCL25;RBX1;NFKB1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;MAP3K8;RC3H1;FBXW11;PSMC2;PSMB2;CD40;USP10;TAB2;PSMB1;PELI2;IRAK2;PSMA8;IKBKG;HYAL2;PSME1;CCL19;IKBKB;NOD2
prerank,endocytic recycling (GO:0032456),-0.32894845664312355,-1.1549921371301959,0.22580645161290322,0.5245649044275937,1.0,14/50,18.87%,EPS15;RAB7A;EHD2;RAB11FIP3;ANKRD50;SNX12;EHD1;VPS26A;VPS52;EHD4;VPS35L;ANKRD27;VPS26C;WASHC1
prerank,mRNA stabilization (GO:0048255),-0.34172647477683765,-1.1548352366916548,0.24731182795698925,0.5245340246696543,1.0,22/40,40.02%,HNRNPA0;LARP1;FUS;MAPKAPK2;AXIN2;SYNCRIP;ANGEL2;RBM24;TAF15;DHX9;THRAP3;HNRNPU;PABPC1;TENT5C;MAPK14;BOLL;DAZL;TENT5B;TENT5D;NOCT;DND1;VIP
prerank,melanosome localization (GO:0032400),0.39642437631283733,1.1547531795979722,0.25386313465783666,0.6837041807311655,1.0,9/21,16.89%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,DNA catabolic process (GO:0006308),0.46271390447832383,1.1545848079654168,0.2774327122153209,0.6825049518892662,1.0,6/11,23.29%,MUS81;REXO4;DNASE1L1;FBH1;DNASE1L2;ISG20
prerank,negative regulation of ion transport (GO:0043271),0.3731089655017878,1.154353151083733,0.2721238938053097,0.6814976716976857,1.0,6/24,9.76%,GPM6B;STC1;SYT11;WNK2;WNK3;ADRA2A
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.34120114568485815,1.1541652697971814,0.25,0.680303301963877,1.0,8/38,8.46%,CTNNA3;SCN1B;KCNA5;CACNA2D1;KCNJ3;PKP2;CACNA1D;SCN5A
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3445195124369363,-1.1541531970560077,0.2381786339754816,0.5257338733379232,1.0,14/38,22.31%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;CHEK1;PHC3
prerank,glutathione derivative metabolic process (GO:1901685),-0.40724314470595147,-1.1537775203847316,0.2918149466192171,0.5257445181185673,1.0,10/20,40.25%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.40724314470595147,-1.1537775203847316,0.2918149466192171,0.5257445181185673,1.0,10/20,40.25%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4
prerank,regulation of T cell migration (GO:2000404),-0.4087205342756532,-1.1536305078549967,0.28651685393258425,0.5256627736244096,1.0,3/18,3.17%,CD200;APP;LRCH1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.397136827107446,-1.1535291374836278,0.2949907235621521,0.5254731759067102,1.0,10/23,26.83%,JAK1;IRGM;PARP14;JAK2;SUMO1;NLRC5;IFNGR2;PPARG;PARP9;PTPN2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.45476182749853256,-1.1534401495472097,0.27624309392265195,0.5252419170333661,1.0,6/13,18.50%,RAMP1;ALG10B;PLCB1;CHP1;IGF1;CCL19
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2830401609440209,-1.1533895799570533,0.16873889875666073,0.5249491302114759,1.0,44/124,27.70%,LEF1;GNB1;RAC1;TNRC6B;FZD6;SMURF2;DVL3;NFATC1;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;PLCB3;PLCB1;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;AGO2;PSMB2;PSMB1;CTNNB1;MOV10;PSMA8;PSME1;TNRC6A;AP2M1;PSMD4;FZD7;FZD5;PSMD5;TCF7L2;MAP3K7;FZD10;PSMA3;GNG2;SFRP4;PSMB10;CELSR1;FZD1
prerank,glycoprotein metabolic process (GO:0009100),-0.32540035993203054,-1.1533342073398438,0.22784810126582278,0.5246568041084242,1.0,16/53,18.67%,ST3GAL4;ST8SIA4;MAN2A1;ST6GALNAC3;MAN1C1;MGAT4B;FUT8;MAN1A2;ST3GAL2;ADAMTS9;PRKCSH;MAN1B1;GAL3ST2;B4GALT5;GOLPH3;LARGE1
prerank,negative regulation of axonogenesis (GO:0050771),0.3650282636883013,1.1525769473694456,0.23736263736263735,0.6832565137853874,1.0,12/27,21.82%,DCC;EFNB3;MAP2;RTN4;PTPRS;MAG;OMG;TRIM46;LINGO1;RUFY3;RTN4R;NGFR
prerank,macrophage differentiation (GO:0030225),-0.4542168629534454,-1.1525122651402755,0.2943201376936317,0.5261749278805457,1.0,3/13,9.94%,IL15;BMP4;CASP8
prerank,cellular response to calcium ion (GO:0071277),0.30265028862194865,1.1524491199049753,0.22657952069716775,0.6818906743433627,1.0,15/67,11.98%,NLGN1;SYT1;SYT5;RYR3;ADCY8;SYT12;SYT11;HPCA;CPNE9;DPEP1;ACER1;SCN5A;CPNE1;SYT4;GPLD1
prerank,carbohydrate derivative transport (GO:1901264),-0.4211026451233944,-1.1523643791894607,0.26929982046678635,0.5261081691798222,1.0,5/18,9.03%,PLTP;SLC10A7;LBP;SCARB1;MFSD2A
prerank,toxin transport (GO:1901998),0.47048894873223557,1.152266154507718,0.3002159827213823,0.680735434095513,1.0,4/10,13.07%,SLC22A1;SLC29A4;ANTXR1;ANTXRL
prerank,osteoclast differentiation (GO:0030316),-0.39781852942416396,-1.1519835433914092,0.259581881533101,0.5265908248322135,1.0,2/22,2.82%,FOXP1;ANXA2
prerank,amino acid import across plasma membrane (GO:0089718),-0.38558495582905894,-1.1514037688502106,0.2608695652173913,0.5275311166568455,1.0,4/24,2.36%,SLC47A1;SLC6A6;SLC7A1;SLC7A5
prerank,alanine transport (GO:0032328),-0.4822393623896699,-1.1512375529334553,0.2916666666666667,0.5274714005983685,1.0,3/10,20.25%,SLC6A6;SLC36A4;SLC1A4
prerank,AMP metabolic process (GO:0046033),0.44571579845300285,1.1512056500064887,0.2789115646258503,0.6820619859002534,1.0,4/13,10.88%,AK9;AK3;ADSS2;ADSS1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.37753516871626425,1.151189653749391,0.2595936794582393,0.6787755993447971,1.0,6/24,19.06%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,canonical glycolysis (GO:0061621),0.37753516871626425,1.151189653749391,0.2595936794582393,0.6787755993447971,1.0,6/24,19.06%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.39566879933921706,-1.150454033505624,0.27056672760511885,0.5289168449661685,1.0,7/22,14.03%,SP100;LRRK2;MDFIC;GDI1;CHP1;UFM1;RAB23
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.36977923828596326,-1.1502588205575937,0.2542056074766355,0.5289622832814976,1.0,14/29,34.89%,BIRC3;UBE2D3;CASP8;IKBKE;CD40;IKBKG;IKBKB;RIPK1;CD300LF;IRF7;TLR6;TICAM1;TBK1;CD14
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.332157634647482,-1.1502315042799292,0.2630597014925373,0.5286071913014748,1.0,13/41,21.33%,PLA2G4A;ELOVL5;PTGS1;EPHX1;GSTM2;MGLL;GPX1;ACOX1;ACSL1;DAGLB;DEGS1;PTGR1;PNPLA8
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.4445692390971724,-1.150184159400714,0.30052724077328646,0.5283180246014919,1.0,4/13,18.66%,PTPN1;NCK1;ABCA7;DNAJB9
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.30440730810227645,-1.14990230619156,0.22491349480968859,0.5285736378553118,1.0,22/69,25.42%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E2;GTF2E1;TAF11;SNAPC1;ICE1;INTS3;TAF8;INTS9;PHAX;TAF13;INTS7;CCNK;POLR2C;TAF9;SNAPC3;POLR2H;POLR2L
prerank,cellular response to glucose starvation (GO:0042149),-0.3395494982517237,-1.1498888997171088,0.24489795918367346,0.5281890235782267,1.0,20/41,34.81%,SESN1;MTMR3;SIK1;FOXO3;TP53;PRKAA1;ATF4;HNRNPA1;KPTN;NUAK1;ITFG2;BECN1;EIF2AK3;PMAIP1;NIM1K;PRKAG2;CPEB4;SZT2;NUAK2;TBL2
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.460233203088244,-1.1498292996672759,0.2854609929078014,0.5279206218652077,1.0,4/11,19.63%,SMAD7;HFE;CEACAM1;PTPRC
prerank,negative regulation of protein modification process (GO:0031400),-0.2987263746097922,-1.1496461461212686,0.21946902654867256,0.5279221918158116,1.0,17/79,14.61%,DAB2IP;MFHAS1;LYN;CORO1C;GSK3B;LRRK2;NIBAN1;CDYL;SLIT2;LRP6;OCLN;PRKAA1;CHP1;TRAF3IP1;PNKP;PTPN13;DNAJC10
prerank,regulation of myotube differentiation (GO:0010830),-0.37913270108029706,-1.1495612378311955,0.27255985267034993,0.5276859869369646,1.0,12/24,29.63%,SIK1;HDAC1;MAML1;HDAC4;NOTCH1;CCN3;SMYD1;PIEZO1;RBM24;DMPK;HDAC5;MAPK14
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4116385195950743,-1.149464414397115,0.25,0.5274659228498121,1.0,12/17,48.27%,CD55;BACH2;JAG1;GNL1;MYO1G;STAT3;IL18;TLR4;EBI3;BTN3A3;SLA2;IL12B
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.33046195653615085,-1.1494013157389544,0.2392857142857143,0.5271939918088736,1.0,12/49,19.75%,SGMS1;CAV1;MCL1;DDX3X;TP53;BCAP31;BBC3;GSDME;BCL2L11;PPIF;SIAH1;HERPUD1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.27121383255403403,-1.1491088821829585,0.1788756388415673,0.527457947341202,1.0,31/151,15.83%,TEK;RAPGEF2;FERMT2;BMPER;ROR1;MFHAS1;PDGFD;SEMA7A;GCNT2;APP;CCL25;KDR;PRKD2;ICAM1;EGFR;SLC30A10;GAS6;DSTYK;RAP1A;NOTCH2;FLT4;HTR2A;BRAF;NOTCH1;FGF2;ACKR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN
prerank,ncRNA catabolic process (GO:0034661),-0.36341385036109497,-1.148907727745479,0.29557522123893804,0.5274677385089911,1.0,10/28,25.31%,TENT4B;XRN1;EXOSC2;EXOSC3;TUT4;PARN;EXOSC8;EXOSC5;DIS3L2;EXOSC7
prerank,organic substance transport (GO:0071702),-0.27992712201457276,-1.1488356675547173,0.20353982300884957,0.527229853092263,1.0,23/121,11.07%,ABCG2;SLC47A1;RUFY1;PLTP;SLCO2A1;CALCRL;MYH9;RAMP1;RAB7A;SPNS2;SCAMP2;SLC19A2;SLC22A5;ABCD3;ABCB9;TAP2;ARRDC1;ARL6IP5;SLCO2B1;MFSD2A;RAMP2;ABCA9;TXNIP
prerank,regulation of cardiac conduction (GO:1903779),0.3119650961665285,1.1488193483839593,0.21052631578947367,0.6840639920774292,1.0,12/54,13.30%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;NPPC;SLC8A2;RYR2;SLC8A1;SLC8A3;CASQ1;FXYD4
prerank,cellular response to interleukin-4 (GO:0071353),-0.4898196561587713,-1.1484735957218901,0.299645390070922,0.5277200145756658,1.0,2/10,7.02%,LEF1;STAT6
prerank,regulation of phospholipase activity (GO:0010517),0.46116090466210186,1.1482657872532758,0.2906178489702517,0.6839242893878152,1.0,6/10,25.02%,FGFR2;RASGRP1;FGFR3;ANGPTL3;PDPK1;SNCA
prerank,cell junction maintenance (GO:0034331),0.438126438151115,1.1479110751164032,0.2863247863247863,0.6832782722303792,1.0,8/14,26.25%,CD177;CBLN1;CSF1R;NLGN2;PARD6A;CBLN2;CLDN1;PRTN3
prerank,macromolecule catabolic process (GO:0009057),-0.37188005571749033,-1.1473550416420093,0.2713310580204778,0.5299658763009106,1.0,10/26,22.92%,MTOR;SMURF1;NEDD4;USE1;LGMN;SIAH1;CLN5;SNX25;KIF16B;BECN1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3937937176867361,-1.1472067672037465,0.28256880733944956,0.5299040818378146,1.0,8/22,16.34%,KANK3;TMSB4X;SLIT2;PRKCD;KANK4;ARFGEF1;HIP1R;TMSB10
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.27618039285879237,-1.146962999274881,0.1955403087478559,0.530060866103824,1.0,44/128,27.65%,FBXL7;MNAT1;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;HAUS6;PAFAH1B1;CSNK1D;FBXW11;CEP41;PLK4;CETN2;CEP152;ALMS1;PCM1;CNTRL;ODF2;HSP90AA1;CDC25A;CDK14;CEP131;PCNT;AJUBA;AKAP9;PLK3;FBXL22;DYNLL1;ARPP19;KHDRBS1;HAUS1
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.4266024115839744,-1.146862810017429,0.2809611829944547,0.5298718251783241,1.0,10/16,41.19%,MCM4;RPA1;WRN;BLM;MCM7;MCM2;MCMDC2;HMGA1;TWNK;RECQL4
prerank,histone H3-K4 methylation (GO:0051568),-0.3851711455933536,-1.146465109836648,0.2697841726618705,0.5303404488462102,1.0,12/26,25.36%,TET2;KDM6A;ASH2L;PRDM9;KMT2C;WDR82;WDR5B;TET3;WDR5;OGT;BEND3;RBBP5
prerank,response to calcium ion (GO:0051592),0.28116135516400154,1.1461373593875233,0.17312072892938496,0.686767138004203,1.0,18/102,8.46%,NLGN1;SYT1;SYT5;KCNMA1;RYR3;SLC25A13;ADCY8;SYT12;SYT11;HPCA;CALM2;HOMER1;RYR2;CPNE9;DPEP1;ACER1;PPP3CA;SCN5A
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3691760352864398,-1.1456457079804416,0.2620817843866171,0.5318317706095554,1.0,10/27,21.90%,VPS13A;VPS13C;GAK;CSNK1D;VPS13D;GBP5;RIPOR1;GOLPH3;ARL5C;IFT20
prerank,vesicle transport along actin filament (GO:0030050),-0.40136486390290704,-1.1449769946946349,0.28893058161350843,0.532976986897187,1.0,5/19,12.92%,MYO1D;FNBP1L;WASL;MYO1F;ACTN4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.46803347814959784,-1.1448234037980691,0.2926391382405745,0.5329287754245017,1.0,5/12,15.79%,RANBP9;ROCK1;PICALM;ABCA7;ROCK2
prerank,regulation of receptor binding (GO:1900120),-0.4794487465701752,-1.1445829817545814,0.31046312178387653,0.5330386243268963,1.0,3/10,11.57%,ATP2A3;GREM2;HFE
prerank,protein polyubiquitination (GO:0000209),-0.24877774935727764,-1.144429633320796,0.12607944732297063,0.5330313674948446,1.0,71/297,19.29%,FBXL7;WWP1;PELI1;CBFB;UBR5;NEDD4L;ZNRF1;SMURF2;TRAF5;FBXL12;UBE2K;TRIM56;PSMA2;FBXL17;DTX3L;SMURF1;RNF125;FBXL3;RNF213;RBX1;LMO7;UBE4B;CUL3;NEDD4;RNF115;RNF144B;PSME2;HECTD1;PSMB4;UBE2J2;TRIP12;ZNRF2;UBE2D3;SPSB1;UBR2;TPP2;FBXW8;TRIM14;AREL1;RMND5A;HERC6;CDC16;UBE4A;UBE2E2;RC3H1;FBXW11;PSMC2;PSMB2;RNF168;RNF167;UBE2V2;ERCC8;MIB2;PSMB1;MYLIP;UBE2L3;TNFAIP3;PELI2;KLHL3;CTNNB1;PSMA8;RNF152;AKTIP;PSME1;SPOP;TRIM3;SIAH1;HUWE1;WWP2;SASH1;RNF4
prerank,regulation of cell growth (GO:0001558),-0.2595616776296873,-1.1442358903514835,0.16869565217391305,0.5330562547495129,1.0,48/204,16.43%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;NET1;DDX3X;MTOR;SOX17;TFRC;PTPRJ;CDKN1B;VGLL4;EGFR;CRLF3;SLIT2;PLCE1;TGFB2;RASGRP2;EXOSC2;FAM107A;MFSD2A;SMAD4;ADAM10;BCAR1;TP53;SOCS2;AKT1;ARHGEF11;LTBP4;AGTR1;DCBLD2;RPS6KA1;CEACAM1;RPTOR;WNT11;ST7L;H3-3A;CCN3;RPS6KA3;N6AMT1;NPR1;MAD2L2;OSGIN2;KIF26A;RERG
prerank,protein homooligomerization (GO:0051260),0.27458160725444203,1.1442160387339306,0.17906976744186046,0.6905485585313177,1.0,23/114,15.58%,KCNC2;MPP2;GLRA3;HCN1;SYCP1;RYR3;C9;ADCY8;ATL1;AQP4;GNMT;SLC1A2;ACACA;ALDH1A2;CARD11;P2RX3;GLS;SIGMAR1;ASIC1;GOLGA2;RNF112;CBY1;TDO2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.43293321659866446,-1.1441755090173418,0.2897196261682243,0.5327775346230944,1.0,2/13,6.05%,ENTPD1;ENTPD6
prerank,vesicle organization (GO:0016050),-0.3296406263372191,-1.1441084289195589,0.23977695167286245,0.5325225755494329,1.0,21/46,27.73%,CAV1;DNAJC13;CD34;EPS15;FNBP1L;SRGN;ALS2CL;WASL;CHMP2B;EXOC8;PI4K2B;ALS2;ZFYVE16;AKTIP;WASHC4;SAR1A;ARFGEF2;PLEKHF1;RAB22A;PHETA2;CAV2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2741396949840828,-1.1435831527208273,0.18739352640545145,0.5333415003421342,1.0,27/138,12.64%,PTPRG;FLT1;TEK;IGF1R;TIE1;INSR;ABI1;ROR1;LYN;BMPR2;KDR;MERTK;IL6ST;EGFR;YES1;PTK2;NGF;EPHA4;FLT4;LIFR;ACVR2A;MPZL1;BCAR1;FRK;RAPGEF1;NEDD9;JAK2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.47122905592182673,-1.1432057759651613,0.30124777183600715,0.533838825807088,1.0,5/12,18.38%,PTPN14;BMP4;NEDD4;TPR;NUP214
prerank,innate immune response in mucosa (GO:0002227),-0.484182776801406,-1.1430865327285054,0.2945590994371482,0.5337272000030359,1.0,9/10,51.61%,RNASE3;DEFA6;RPL39;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,acute inflammatory response (GO:0002526),-0.3776178834363191,-1.142798272652184,0.27121771217712176,0.5339811554517533,1.0,14/23,39.67%,IL6R;LBP;ANO6;PLSCR1;F3;CTNNBIP1;IL22;AHSG;VNN1;CEBPB;HPR;HP;CRP;SIGIRR
prerank,mitotic metaphase plate congression (GO:0007080),-0.3261322830931286,-1.1427036855100239,0.22702702702702704,0.5337872674074747,1.0,28/51,39.10%,MAD1L1;CUL3;CHMP4B;CHMP4A;CHMP2B;CHMP5;RAB11A;CENPE;PDCD6IP;RRS1;BECN1;PINX1;EML4;KIF14;SPDL1;CDCA8;CHMP3;CHMP6;NUDC;CHMP1A;BOD1;NUF2;MIS12;PSRC1;CHMP1B;RMDN1;KIF2C;CCNB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.453632315061381,-1.142355119679839,0.3001841620626151,0.533763986028878,1.0,4/13,15.42%,IL15;JAK1;PLCB1;GRB2
prerank,cellular response to interleukin-15 (GO:0071350),-0.453632315061381,-1.142355119679839,0.3001841620626151,0.533763986028878,1.0,4/13,15.42%,IL15;JAK1;PLCB1;GRB2
prerank,regulation of intracellular protein transport (GO:0033157),-0.35996849444925016,-1.142197149784983,0.26306306306306304,0.5337417426157376,1.0,15/32,24.89%,PTPN14;PTPN1;BMP4;BCAS3;ICE1;LCP1;TPR;RIPOR1;OAZ2;PCM1;NDEL1;VAMP2;CEP131;PCNT;PLK3
prerank,positive regulation of immune effector process (GO:0002699),-0.36878920042512864,-1.1421128677586228,0.2766726943942134,0.5335254539564334,1.0,5/27,10.99%,ANKRD17;PTPRJ;MYO18A;LBP;DDX60
prerank,covalent chromatin modification (GO:0016569),-0.4498533671967355,-1.1418333800985985,0.29744525547445255,0.5337822626589139,1.0,3/14,7.44%,CHD1;HDAC1;SETD5
prerank,spermatid development (GO:0007286),0.34971033020834763,1.1414186362044965,0.2534246575342466,0.6970935577515639,1.0,11/32,19.36%,DDX25;CCDC63;ZMYND15;BBS4;RNF8;IQCG;MKKS;YTHDC2;SYCP3;NME5;ACRBP
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4958155704967385,-1.1407393736114555,0.3,0.5358743257626085,1.0,3/10,15.79%,IL15;ROCK1;ROCK2
prerank,cardiac muscle cell development (GO:0055013),0.39360926570297317,1.1402250515323078,0.2585034013605442,0.6988362109337486,1.0,8/20,12.88%,FHOD3;CXADR;ALPK3;VEGFA;MYLK3;SLC8A1;PDGFRA;MYL2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.4545199653133919,-1.1389108253309193,0.3079710144927536,0.5396298337582975,1.0,3/11,8.24%,DNAJC13;LRRK2;MAPK1
prerank,positive regulation of DNA replication (GO:0045740),-0.42561508809640625,-1.1387041434927037,0.30111524163568776,0.5397004469982456,1.0,4/16,13.81%,STN1;EGFR;DNA2;CTC1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.3206253772625848,-1.1386892361643672,0.24820143884892087,0.5393159721170535,1.0,15/50,23.62%,CREBBP;FBXL17;TTC23;SMO;HERC4;WDR11;GLIS2;GLI3;MOSMO;FUZ;GPC3;ZIC1;KIF7;TUBD1;TULP3
prerank,protein processing (GO:0016485),0.27412569145515275,1.138569784373042,0.20334928229665072,0.702085930703742,1.0,21/102,13.28%,OMA1;MYRF;C1RL;MME;MMP16;CLN3;CPE;TYSND1;METAP2;ADAM19;KLK1;KLK6;BACE1;SPCS3;CPN1;PCSK2;AEBP1;CASP4;HTRA2;SPCS1;PCSK6
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3711790724486028,1.1384403545411708,0.2625570776255708,0.7008196824294955,1.0,6/25,19.06%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,regulation of wound healing (GO:0061041),-0.3346367563342791,-1.1383794870675226,0.2504854368932039,0.5396423889310493,1.0,9/42,12.91%,ITGB1;CAV1;PRKCE;CRK;PTK2;OCLN;MYLK;ARFGEF1;FGF2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.35918120469340376,1.1381754962175832,0.25,0.6999226211236158,1.0,5/25,9.62%,ANK3;ATP1B1;WNK2;WNK3;STAC
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.35826242841082184,1.1380425210361342,0.251131221719457,0.698639008534657,1.0,8/27,16.03%,HPCA;CALM2;CACNB3;CACNB4;ADRA2A;HRC;CACNB1;SELENON
prerank,regulation of cell division (GO:0051302),-0.29639727641697067,-1.1370519914648891,0.2184115523465704,0.5423607855618109,1.0,22/72,24.89%,MLLT3;SETD2;AHCTF1;ZFYVE26;FGF1;RAB11FIP3;PLK2;BIRC6;TAL1;TXNIP;KLHL13;RAB11A;PLK4;CETN2;CDK2AP2;KIF13A;PRC1;BLM;BECN1;KIF18B;TLE6;PLK3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.47567524293514263,-1.1364898508164525,0.31647940074906367,0.5432544771096013,1.0,2/10,9.36%,CBFB;SH3RF1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.3223919704408326,-1.1360779070739646,0.25636363636363635,0.5437603419072423,1.0,20/51,26.13%,NEK7;STN1;TENT4B;ATM;TCP1;XRN1;MAPK1;HMBOX1;CTC1;PNKP;PARN;HNRNPA1;TERF2;CTNNB1;CCT5;SMG6;NAF1;CCT2;PINX1;HNRNPU
prerank,brain development (GO:0007420),0.26513062700154943,1.1358629238873936,0.16262135922330098,0.7033702678661705,1.0,19/136,7.87%,CNTNAP2;ROBO2;CTNNA2;CNTN4;GRIN2B;DSCAML1;ADGRL3;GRIN2A;MDGA1;MEIS1;POMK;NDRG4;MEIS3;PITPNM1;SMG9;MAP1S;PAX2;PROX1;BBS4
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3706840341659031,-1.135276526087934,0.2970639032815199,0.5452045460718812,1.0,15/26,35.96%,RB1;NEK6;CUL3;CDC16;NSMCE2;CENPE;ANAPC7;DUSP1;ANAPC5;ANAPC11;PLK1;CDC6;ESPL1;FBXO5;UBE2C
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.47543398098955836,-1.1350480543132193,0.340036563071298,0.5453481366738655,1.0,5/10,31.24%,TNFRSF1B;NOTCH1;TNFRSF1A;EMILIN1;TGFB1
prerank,actin cytoskeleton reorganization (GO:0031532),-0.30778526578550347,-1.1348846988723762,0.23905109489051096,0.5453307642652852,1.0,27/63,26.42%,GAB1;PARVB;MYH9;PARVA;PTPN1;RICTOR;EZR;CDC42BPA;S1PR1;BCAR1;FLNA;PHACTR1;FGF7;NEDD9;RHOA;GRB2;CDC42BPB;TRPV4;ANXA1;MKLN1;RAP2A;NRK;PIP5K1A;SYDE1;SIPA1L1;DMTN;FGF10
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.48317272593738025,-1.134128874822873,0.3262786596119929,0.5466768187270089,1.0,4/10,14.78%,MLLT3;ACE;TP53;LMBR1L
prerank,C-terminal protein amino acid modification (GO:0018410),0.453508640417906,1.1339782888725582,0.3002309468822171,0.7071002167682007,1.0,3/11,11.98%,AGBL4;AGBL1;GPLD1
prerank,spindle assembly (GO:0051225),-0.3024761002201584,-1.1338747711585482,0.22719449225473323,0.5468992272336174,1.0,21/67,21.94%,NEK7;NEK6;CCDC61;STAG1;TOGARAM1;WRAP73;HAUS8;FLNA;RHOA;ARHGEF10;HAUS6;CSNK1D;KIF11;STAG2;TUBGCP5;TUBGCP4;RAB11A;RPS3;KIF3B;STARD9;MISP
prerank,regulation of plasminogen activation (GO:0010755),0.44836409986323433,1.1333198521362577,0.3068893528183716,0.7074051047219697,1.0,3/12,7.31%,MELTF;CLEC3B;PLGRKT
prerank,protein destabilization (GO:0031648),-0.35628019448318654,-1.1327170791599905,0.2608695652173913,0.5492186921868416,1.0,11/32,18.98%,CREBBP;RNF139;SOX17;FBXL3;CUL3;IRGM;CDC73;FBXW11;SENP2;CTSH;RAD23A
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.31880314909733803,-1.1320801409498178,0.23529411764705882,0.550381349260674,1.0,16/51,13.54%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;LIMCH1;SYNPO2;RHOA;WNT11;MYOC;ARHGEF10;SORBS3;RHOC;TPM1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3982838104196673,-1.131804735732951,0.29159212880143115,0.5505871255692601,1.0,7/20,15.43%,THBS1;PRKD2;DSTYK;FGF2;SPRY4;FGFBP3;SMOC2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2752500016256219,-1.1314793679007387,0.20272572402044292,0.5508916536898159,1.0,33/121,16.87%,PECAM1;GHR;LYN;PTPN1;PAK2;IL15;ACE;PTPRJ;IL6ST;BMP6;IL6R;HES1;GAS6;ABL1;PARP14;EPHA4;IL34;ARHGEF2;PLCG2;CSPG4;HAX1;TP53;FGF7;NEDD9;JAK2;STAP2;HGF;CD40;MIF;TNFRSF1A;ANGPT1;IGF1;NOX4
prerank,lipid biosynthetic process (GO:0008610),0.2912308698817222,1.131138647993237,0.2234762979683973,0.7121228738739633,1.0,19/77,17.43%,IDI2;FADS1;ACSS2;LSS;ELOVL4;CYP51A1;ACLY;ACACA;LIPC;OXSM;ACSL6;GNPAT;FDFT1;OLAH;SCD5;NDUFAB1;CLN8;ALOX5;SCD
prerank,regulation of protein secretion (GO:0050708),0.2687166114029752,1.1309205122818353,0.18561484918793503,0.711125464556883,1.0,23/119,12.29%,KCNC2;STXBP5L;SNAP25;GIP;GCK;KCNA5;EXOC1;CACNA1A;MTNR1B;CYP51A1;ANG;CACNA1D;ADRA2C;CACNA1E;GIPR;FRMD4A;EIPR1;ADRA2A;IL12A;ATP13A2;CCL5;LLGL1;PPID
prerank,positive regulation of macrophage activation (GO:0043032),-0.41254552972953695,-1.1296110285081953,0.2864864864864865,0.5549781566455902,1.0,9/17,44.30%,THBS1;LBP;CEBPA;TREM2;TLR6;TNIP2;STAP1;TLR4;TAFA3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.28307402540952376,1.1291434454369527,0.2311212814645309,0.7147063896995102,1.0,13/85,10.46%,COL2A1;PCDH15;COL1A1;SLC26A5;LHFPL3;EML2;COL11A2;ATP2B2;DCDC2;CACNA1D;SPTBN4;GRM7;MYO1A
prerank,positive regulation of macrophage migration (GO:1905523),-0.38980093931041754,-1.1286943115883041,0.2875,0.5567673749991002,1.0,4/19,8.63%,THBS1;PTK2;MAPK1;IL34
prerank,cellular response to cAMP (GO:0071320),-0.3564290340499342,-1.128651566671066,0.25618374558303886,0.5564516974960398,1.0,8/30,11.22%,RAPGEF2;PKD2;PDE2A;KCNQ1;EZR;RAP1A;RAP1B;RAPGEF1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3875639646435465,-1.128569716427931,0.30864197530864196,0.5562476026492705,1.0,6/22,12.31%,ADAM9;TNFRSF1B;SNX9;ROCK1;TIMP3;PTPN3
prerank,keratinocyte differentiation (GO:0030216),-0.3595762034022763,-1.128428216215509,0.30566037735849055,0.5561652782939567,1.0,9/29,19.36%,BCR;ADAM9;MED1;WNT16;TXNIP;ASAH1;JAG1;ANXA1;EPHA2
prerank,neuromuscular junction development (GO:0007528),-0.3762848205817243,-1.1281500998700027,0.2785714285714286,0.5564453029501147,1.0,7/24,11.59%,UNC13B;PPFIBP1;LRRK2;NEDD4;AGRN;PDZRN3;DCTN1
prerank,protein targeting to membrane (GO:0006612),-0.2919993792081094,-1.1280678566398379,0.23476702508960573,0.5562085070650762,1.0,36/83,36.70%,PARD3;ZDHHC6;ZDHHC3;AQP11;ABCD3;SRPRA;CHMP4B;CHMP4A;SGTA;RAB8B;PEX14;SIL1;SRP14;ZDHHC1;ZDHHC4;PEX3;ZDHHC12;RAB3IP;SEC61A1;VPS37B;PEX11B;ATG3;PEX19;GOLGA7B;RTP4;ZDHHC9;PEX26;ZDHHC22;SEC63;NCF1;ICMT;YIF1B;SRP19;VPS37C;RABGEF1;TAOK2
prerank,regulation of protein acetylation (GO:1901983),-0.46308106513156205,-1.1276456103047952,0.31386861313868614,0.5568384041747616,1.0,8/12,39.20%,GSK3B;DDX3X;KAT5;RAPGEF3;CEP295;FAM161A;PARK7;SIRT1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2905966285728266,-1.1273612275978537,0.22719449225473323,0.557075670634768,1.0,21/80,21.67%,VTI1A;ERC1;RAB7A;TMEM87B;HEATR5A;VPS54;TBC1D14;BET1L;SNX12;DCTN1;VPS26A;ANKFY1;VPS52;TBC1D23;SNX8;TBC1D17;VAMP3;WASHC1;CLN5;EVI5;SPAG9
prerank,cell cycle G2/M phase transition (GO:0044839),-0.27227076072093703,-1.1272909742993111,0.2195540308747856,0.5568275895399601,1.0,44/129,27.65%,FBXL7;MNAT1;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;HAUS6;PAFAH1B1;CSNK1D;FBXW11;CEP41;PLK4;CETN2;CEP152;ALMS1;PCM1;CNTRL;ODF2;HSP90AA1;CDC25A;CDK14;CEP131;PCNT;AJUBA;AKAP9;PLK3;FBXL22;DYNLL1;ARPP19;KHDRBS1;HAUS1
prerank,response to UV-B (GO:0010224),0.44097235277305113,1.1272344852837837,0.293598233995585,0.7187939431737902,1.0,3/12,10.01%,MME;STK11;IL12A
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3232137229976896,-1.1270258041429508,0.2568306010928962,0.5570361693874759,1.0,11/42,21.49%,SETD2;SHLD1;ARID2;MRNIP;SPIDR;FUS;CGAS;MAD2L2;RPA2;TIMELESS;CHEK1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.43708282144346755,-1.1269646907318216,0.3014705882352941,0.5567488391947444,1.0,4/14,10.01%,PPARA;IRS1;MFSD2A;AKT1
prerank,DNA replication (GO:0006260),-0.28177286629429515,-1.1265643055985033,0.2429078014184397,0.5572344964264044,1.0,49/105,34.12%,MCMBP;ATM;RBMS1;TOP3A;BAZ1A;MRE11;MCM9;RBBP8;CLSPN;MCM4;ORC5;KAT5;RPA3;DNA2;RPA1;REV1;TBRG1;PNKP;TOP1MT;PTMS;ORC2;POLE2;WRN;ORC4;RPA2;BRCA1;TIMELESS;BLM;RFC4;CHEK1;MCM3;TOP1;RFC1;POLA2;MCM7;MCM5;MCM10;POLL;EXO1;SET;ING5;RAD50;ORC3;MCM2;RMI1;PIF1;CDC6;TICRR;GRWD1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.44220630033424946,1.1262514968224144,0.3060747663551402,0.7200000594317548,1.0,5/12,20.59%,GMNN;WRNIP1;NUGGC;KAT7;WDR18
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.39490371056042006,-1.1260559444980254,0.31022530329289427,0.5580455694248685,1.0,12/19,31.80%,ADK;POLD3;AMPD2;HPRT1;AMPD3;TERT;ADA;POLL;PNP;APRT;GMPR2;DCK
prerank,negative regulation of inflammatory response (GO:0050728),-0.25605682197257207,-1.1259780225740292,0.20207253886010362,0.5577939217212892,1.0,27/182,9.75%,TEK;GNB1;RB1;KLF4;CALCRL;MYH9;MFHAS1;LYN;CD200;PRKACB;ADCY9;RAMP1;PLCG1;YES1;PPARA;TNFRSF1B;GGT5;OTULIN;PRKCD;CDH5;ADCY4;PLK2;RHBDF2;PLCG2;PPARD;RAMP2;FEM1A
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.37522841905603943,-1.1254183664169524,0.27526132404181186,0.5587097302488995,1.0,6/25,14.60%,HIP1;AFAP1L2;CBL;AKT1;ARAP1;HIP1R
prerank,regulation of platelet activation (GO:0010543),0.3869799845883577,1.1254172552065167,0.2828507795100223,0.7207977019176659,1.0,7/21,13.51%,BLK;C1QTNF1;PLEK;PDGFA;PDGFRA;APOE;TXK
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2929061642549007,-1.1253362362380632,0.23198594024604569,0.5584880591264076,1.0,26/72,29.26%,MNAT1;RBX1;POLR2G;ERCC2;POLD3;RPA3;TCEA1;RPA1;ERCC3;ERCC8;RPA2;USP7;RFC4;COPS7A;COPS8;RFC1;COPS4;POLR2C;ERCC6;POLR2H;POLR2L;LIG1;GTF2H3;PPIE;CCNH;COPS5
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2912279351470204,-1.1248748398553317,0.23508137432188064,0.5590993796608877,1.0,26/82,16.40%,ANKS1A;RAC1;LYN;ARHGEF28;CRK;YES1;AP2B1;MMP2;AP2A2;PSEN2;CHN1;AP2S1;PTK2;WASL;EPHA4;ROCK1;ITSN1;NCK2;PSEN1;ACTB;RASA1;RHOA;ROCK2;ARPC4;APH1A;FYN
prerank,cellular response to estrogen stimulus (GO:0071391),-0.4289712384607878,-1.1248461785773025,0.30666666666666664,0.5587678731322407,1.0,11/14,43.20%,NCOA4;BCAS3;RARA;WBP2;PELP1;TRIM24;AR;CRHBP;SERPINB9;SFR1;OCSTAMP
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.31197100018810886,1.1242048757841079,0.27927927927927926,0.7227134767644318,1.0,13/52,11.80%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;CELF6;DDX17;FXR2;ZC3H10;RBFOX3;RBM8A
prerank,electron transport chain (GO:0022900),-0.43070332435492004,-1.1240797951641621,0.30851063829787234,0.560195435776341,1.0,7/15,31.31%,ENOX2;PDIA5;UQCRFS1;ETFRF1;POR;SDHB;CYB561
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3976957150654038,-1.123891155866215,0.30514705882352944,0.5602058748820766,1.0,6/19,16.11%,STN1;TENT4B;XRN1;CTC1;HNRNPA1;TERF2
prerank,modulation by symbiont of host process (GO:0044003),0.4612538641788663,1.123302475385473,0.33771929824561403,0.7236852943384358,1.0,6/10,30.37%,HGS;UBB;MRC1;PGK1;RPS27A;UBC
prerank,membrane fusion (GO:0061025),-0.3460796835954195,-1.1228520053445035,0.28846153846153844,0.5622374546227007,1.0,12/33,22.32%,MYOF;DNM3;DYSF;DNM2;RABEP1;CHP1;VAPA;VAMP3;HUWE1;HACE1;VAMP2;RABIF
prerank,gliogenesis (GO:0042063),-0.426965140333183,-1.1225639301134764,0.3128390596745027,0.5624851342647742,1.0,6/15,18.48%,NFIB;METTL14;TGFB2;CDK6;NDUFS2;ANXA1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3230632973865706,-1.1223780244182835,0.2775800711743772,0.5625078950251468,1.0,10/42,14.00%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2;NOTCH1;ZIC3
prerank,platelet degranulation (GO:0002576),-0.27596409784178244,-1.1221161320044115,0.23255813953488372,0.5627325711478776,1.0,34/118,24.36%,ABCC4;VWF;PECAM1;PHACTR2;LYN;TMSB4X;THBS1;APP;SRGN;PROS1;GAS6;FAM3C;TGFB2;APOOL;FLNA;VEGFC;TIMP3;ACTN1;ACTN4;HGF;F5;IGF1;SOD1;LAMP2;NHLRC2;IGF2;VCL;ITGB3;FERMT3;SERPINE1;SYTL4;TLN1;LHFPL2;ITIH3
prerank,positive regulation of dendrite development (GO:1900006),-0.48029643096056174,-1.1220084069706688,0.32608695652173914,0.5625701325848342,1.0,2/10,3.28%,DAB2IP;BMP5
prerank,cellular response to oxygen levels (GO:0071453),0.45401556114766506,1.121985383792898,0.34265734265734266,0.7259221346880239,1.0,4/10,19.67%,CCDC115;ATP6V0A2;ATP6V0D1;ATP6V1A
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.4095107741283015,1.1218912378060741,0.3305084745762712,0.7245028906818766,1.0,2/15,7.99%,MAGI2;ACVR1B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.24090169653027363,-1.121855315788839,0.1636060100166945,0.5624938218606742,1.0,100/314,27.63%,FBXL7;WWP1;PELI1;RB1;ECPAS;NEDD4L;ZNRF1;SMURF2;FBXL12;TRIM25;UBE2K;PSMA2;FBXL17;SMURF1;FBXL3;RBX1;UBE4B;CUL3;NEDD4;LTN1;PSME2;CUL2;ANKZF1;PSMB4;UBE2J2;GSK3A;FEM1A;UBE2D3;SPSB1;UBR2;AREL1;TNFAIP1;RMND5A;ARMC8;SPOPL;CDC16;ATXN3;ANAPC16;KAT5;UBE4A;SGTA;MAN1B1;FEM1C;ERLIN2;FBXW11;PSMC2;PSMB2;FEM1B;DNAJC10;APPBP2;ERCC8;AGAP3;PSMB1;UBXN11;CTNNB1;TRIM13;PSMA8;KCTD10;DMAC2;DNAJB12;PSME1;UBR1;SPOP;TRIM3;DNAJB9;SIAH1;HUWE1;WWP2;RAD23A;RNF4;BUB1B;ECRG4;HERPUD1;UCHL1;TBL1X;BUB3;HACE1;PSMD4;RNF216;MDM2;NFE2L2;PSMD5;ARRB1;FZR1;ZFAND2A;FBXO17;FBXL22;NEMF;MAEA;ANAPC7;PSMA3;TMUB1;RNF34;RNF103;RNF122;KIF14;PSMB10;USP19;FBXO38;RNF103-CHMP3
prerank,epithelial cell migration (GO:0010631),-0.33920479767381406,-1.1213662251711758,0.26678765880217786,0.5632087098006794,1.0,11/37,14.82%,NOS3;ADGRA2;PLEKHG5;PXN;ABL1;ROCK1;PLXND1;STARD13;RHOA;PKN2;PKN3
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.3819254319022614,-1.1212583295906688,0.2824561403508772,0.563049076052786,1.0,5/22,7.62%,PDGFD;DDX3X;ACE;RASSF2;MRE11
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.24793683432753236,-1.1211787853841673,0.19686411149825783,0.5628160872837402,1.0,75/241,26.94%,SRSF11;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;PRPF6;SF3B6;FUS;SPEN;RBM19;HNRNPM;POLR2G;DDX39B;PHF5A;SF3B1;HNRNPA3;PRPF31;PUF60;CPSF7;SNIP1;EFTUD2;HNRNPUL1;DHX38;DBR1;HNRNPF;SFPQ;CTNNBL1;SLU7;SNRPE;HNRNPA1;SF3A1;SRSF12;CWC25;SYNCRIP;ZMAT5;CD2BP2;TFIP11;BUD13;RBM4B;SRRM1;FIP1L1;RNPS1;SRSF3;SRSF10;CWC22;NONO;TRA2B;LSM3;RBM6;PPIH;RBM15;PCBP1;PDCD7;USP39;GEMIN7;POLR2C;SF3B5;GCFC2;DHX9;RNPC3;POLR2H;PRPF40B;POLR2L;HNRNPU;HNRNPL;HNRNPD;PABPC1;TXNL4A
prerank,regulation of interleukin-12 production (GO:0032655),-0.3175496325408569,-1.1211697318304188,0.2665441176470588,0.5624224070441591,1.0,15/47,31.38%,FOXP1;THBS1;PLCB1;MAST2;PLCG2;CD40;IL16;CCL19;CMKLR1;HMGB1;MAPK11;LGALS9;MAPK14;LILRB1;IRF5
prerank,negative regulation of lipid storage (GO:0010888),-0.40035223290015964,-1.120963008771901,0.29014598540145986,0.5625111206792501,1.0,8/19,29.58%,PPARA;NFKBIA;PPARD;ITGB3;PPARG;PNPLA2;PTPN2;TREM2
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.44882407199352625,-1.1208289512686107,0.3314814814814815,0.5623980102889226,1.0,6/12,30.29%,JAM2;APP;RHOA;CXCL12;CXCL10;TNFRSF14
prerank,regulation of stem cell differentiation (GO:2000736),-0.2855750481769631,-1.120547727471661,0.24338624338624337,0.5626380036490438,1.0,30/89,26.89%,CBFB;TCF12;LMO2;PSMA2;HES1;ABL1;PSME2;LDB1;PSMB4;TAL1;YAP1;NOTCH1;PSMC2;PSMB2;TCF3;PSMB1;JAG1;NELFB;PSMA8;GATA2;PSME1;PRKDC;PSMD4;RBM24;PSMD5;PSMA3;PTN;HNRNPU;SP7;PSMB10
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3624603681287187,-1.1201072445765607,0.2768670309653916,0.5632720899706428,1.0,10/29,25.02%,RPS21;RPS14;NOL10;RPS16;UTP3;DCAF13;UTP4;RRS1;RPS8;WDR46
prerank,sensory perception of pain (GO:0019233),0.3776500822964795,1.120040125557197,0.3115124153498871,0.7282186693032405,1.0,3/21,4.69%,OPRM1;MME;KCNA2
prerank,glycolipid metabolic process (GO:0006664),-0.3201603160925261,-1.1199010101848812,0.26194690265486725,0.563356212750169,1.0,14/47,22.11%,ESYT2;ST3GAL6;ST3GAL4;ST6GALNAC3;ST3GAL2;ARSA;ASAH1;SMPD2;GBA2;GBGT1;GLTP;PIGW;GLA;CTSA
prerank,protein modification process (GO:0036211),-0.2944208820264877,-1.1198553174161596,0.26173285198555957,0.5630602460853831,1.0,22/76,21.28%,ST3GAL6;ST3GAL1;ST8SIA4;PLOD2;PARP4;CSNK1G3;YES1;ABL1;PHKA2;UBA7;UBE2D3;ERO1A;STK38;MSRA;UBE2M;UBE2L3;PLAT;BAP1;WWP2;PRKDC;UBL4A;LOX
prerank,sensory organ development (GO:0007423),-0.31997244265944974,-1.1197628740214112,0.2875,0.5628952877456623,1.0,13/51,16.55%,PBX1;SMOC1;SH3PXD2B;PBX3;RBP4;TGFB2;ECE1;SIPA1L3;SHROOM2;FOXC1;HIPK1;FREM2;SIX4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.4002061497379833,1.118886159735538,0.2955032119914347,0.7299832194007534,1.0,3/17,6.38%,ANK3;AKAP6;RNF207
prerank,glutamine family amino acid metabolic process (GO:0009064),0.33365205043920926,1.1188421160146236,0.26096491228070173,0.7284481316716082,1.0,16/33,25.77%,DDAH2;OAT;PYCR2;RIMKLA;GLS2;GLS;GLUD1;ART4;NIT2;RIMKLB;DDAH1;MTHFS;ALDH4A1;SIRT4;FPGS;GCLM
prerank,midbody abscission (GO:0061952),-0.40584306913415524,-1.1185235100254012,0.32620320855614976,0.5654243937328933,1.0,11/17,35.55%,CHMP4B;CHMP4A;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A;CHMP1B
prerank,macrophage chemotaxis (GO:0048246),0.4531227319996662,1.1183707790662467,0.32054176072234764,0.7281857391534061,1.0,4/10,18.48%,CCL5;CCL2;CXCL17;EDNRB
prerank,neuron projection fasciculation (GO:0106030),0.4650110256419736,1.1177294251525394,0.3333333333333333,0.7284272069466899,1.0,4/10,13.76%,CNTN4;NRCAM;RTN4;AMIGO1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.41549472626820694,1.1177004445402743,0.31403118040089084,0.7268484690209729,1.0,14/14,58.49%,POU4F1;IL23A;TYROBP;ATP6AP1;IFNG;POU4F2;CSF1;TRAF6;IL23R;IL12B;TNFSF11;TNF;OCSTAMP;CCR1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.36240652735986717,-1.117418010502875,0.2966417910447761,0.5677075337617787,1.0,11/29,26.43%,CBFB;ESR1;STRN3;YAP1;UFM1;WBP2;CARM1;BRCA1;SRARP;CNOT2;CNOT1
prerank,regulation of vacuole organization (GO:0044088),-0.390174920788232,-1.1170224206880235,0.3421985815602837,0.5682325830600182,1.0,4/20,8.66%,ANXA2;MTMR3;RAB5A;TBC1D14
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4053221926733599,1.1161613404169557,0.30217391304347824,0.7298726839593737,1.0,3/16,6.85%,CLDN18;CLDN14;CLDN11
prerank,cellular response to drug (GO:0035690),-0.364454582207308,-1.116107313514132,0.30335097001763667,0.569914776725865,1.0,7/25,9.82%,ACER2;TFRC;GAS6;KCNQ1;MEF2C;PPM1F;TP53
prerank,snRNA transcription (GO:0009301),-0.2952825005522863,-1.1160887708726215,0.25906735751295334,0.5695359769104756,1.0,22/70,25.42%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E2;GTF2E1;TAF11;SNAPC1;ICE1;INTS3;TAF8;INTS9;PHAX;TAF13;INTS7;CCNK;POLR2C;TAF9;SNAPC3;POLR2H;POLR2L
prerank,skeletal system development (GO:0001501),-0.2626251050186007,-1.1160548515809656,0.20418848167539266,0.5692075176680682,1.0,41/148,20.66%,TLL1;ZBTB16;AKAP13;EXT1;CDH11;TEAD4;PLS3;DYM;BMP5;ANKRD11;SH3PXD2B;BMP6;KIAA1217;RBP4;ALPL;TGFB2;TGM2;CREB3L2;SLC10A7;PCSK5;ADAMTS4;ETS2;RPL13;PKDCC;COMP;WWOX;NOTUM;WNT11;MYOC;RPS6KA3;EBP;TNFRSF11B;BMP7;IGF1;ANKH;HYAL2;SOX4;CMKLR1;HAPLN3;IGF2;HAPLN1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.40484173077939445,-1.1158130414890746,0.3236363636363636,0.5693494291269713,1.0,5/18,13.14%,RALBP1;KDR;MIEF1;BNIP3;MIEF2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3576878050555873,-1.1156930338468147,0.30905861456483125,0.5692489929240314,1.0,11/27,21.74%,UTRN;NEDD4L;SLMAP;DLG1;FXYD5;FXYD6;PTPN3;SCN3B;SCN4B;SNTA1;NOS1
prerank,negative regulation of autophagy (GO:0010507),-0.30834193593973264,-1.1156729506671244,0.2676518883415435,0.5688855761571924,1.0,10/54,10.01%,MCL1;TAB3;TLK2;ATG7;LRRK2;MTOR;RASIP1;TBC1D14;DAPL1;AKT1
prerank,tRNA metabolic process (GO:0006399),-0.4108817688404002,-1.1155953558306153,0.3333333333333333,0.5686633477757694,1.0,8/17,36.42%,FARS2;DARS2;TRPT1;RPP30;SSB;DTD2;SARS1;THG1L
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4123509676495314,1.1154424604037048,0.32727272727272727,0.7304066791380424,1.0,5/14,9.49%,PPP2R2B;PPP5C;PPP2R2C;PPP3CA;PPTC7
prerank,negative chemotaxis (GO:0050919),-0.3488729217798564,-1.1150930127789276,0.29608938547486036,0.569431787974136,1.0,13/33,20.69%,SEMA6A;SEMA3C;NTN1;SEMA7A;SLIT2;SEMA3G;SEMA6B;RHOA;SEMA4C;SEMA4A;SEMA3E;ITGB3;SEMA4G
prerank,sterol metabolic process (GO:0016125),0.29753999102186685,1.1145595824832575,0.2412280701754386,0.7314740680047688,1.0,15/60,13.32%,CYP46A1;INSIG1;PIP4P1;SULT2B1;CYP26B1;SC5D;CYP51A1;SQLE;NSDHL;CYP27A1;TSKU;OSBPL5;CYP11B1;ABCA5;APOE
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3732969872133248,-1.1144829387811441,0.30868761552680224,0.570427703161443,1.0,5/24,8.59%,WASF2;RAC1;PIK3R1;PLCE1;OCLN
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.35532830011315086,-1.1141917042679514,0.2992565055762082,0.570726818749261,1.0,14/30,34.89%,BIRC3;UBE2D3;CASP8;IKBKE;CD40;IKBKG;IKBKB;RIPK1;CD300LF;IRF7;TLR6;TICAM1;TBK1;CD14
prerank,macrophage migration (GO:1905517),0.4245531855052853,1.1141084615710801,0.31065759637188206,0.7312580796812449,1.0,4/13,18.48%,CCL5;CCL2;CXCL17;EDNRB
prerank,regulation of synapse maturation (GO:0090128),0.4619866699226145,1.1139007978424678,0.32036613272311215,0.7302572480542795,1.0,3/10,6.47%,NRXN1;ANAPC2;CAMK2B
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.29199506530073394,-1.1136346504167476,0.266553480475382,0.5716497717302131,1.0,20/70,21.35%,CBFB;TCF12;LMO2;PSMA2;ABL1;PSME2;LDB1;PSMB4;TAL1;YAP1;PSMC2;PSMB2;FOXC1;TCF3;PSMB1;PSMA8;GATA2;PSME1;PRKDC;PSMD4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.39896682630504776,-1.1132321781362178,0.3127147766323024,0.5722178019888536,1.0,6/18,16.27%,NCK1;PIK3R1;ERN1;USP13;ATXN3;BCL2L11
prerank,Golgi to plasma membrane transport (GO:0006893),-0.32027234306436847,-1.1121421472921873,0.2597402597402597,0.5744125437916372,1.0,14/47,21.36%,SPTBN1;EXOC6;STXBP6;EXOC4;GOLPH3L;MACF1;RABEP1;EXOC2;GOLGA4;EXOC8;GOLPH3;VPS35L;KIF13A;VAMP2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4164191108667472,1.111965905072708,0.3142857142857143,0.7343429970579277,1.0,4/14,9.62%,AK7;AK3;AK5;NME2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.37876096465839604,1.111727305890285,0.2984409799554566,0.7334234880595639,1.0,5/22,9.89%,RELL2;GADD45B;SPHK1;VEGFA;MINK1
prerank,icosanoid metabolic process (GO:0006690),-0.327746749726835,-1.1112360525207357,0.2898032200357782,0.57613944499624,1.0,17/40,32.70%,PLA2G4A;PON2;GGT5;MAPKAPK2;PTGS1;EPHX1;MGLL;GPX1;DAGLB;PTGR1;PNPLA8;PTGIS;GPX4;TBXAS1;ALOXE3;CYP1B1;ALOX5AP
prerank,metanephros development (GO:0001656),0.3610858197034987,1.1108154676756181,0.2964509394572025,0.7345273230885262,1.0,5/26,6.22%,ROBO2;WNT7B;OSR1;WT1;PAX2
prerank,neurogenesis (GO:0022008),-0.3242850183862637,-1.1102820776409046,0.2772808586762075,0.5779717142464492,1.0,15/43,19.66%,TRAK1;METTL14;THOC2;SIX1;TGFB2;BTBD3;BTBD1;CDK6;FAT4;SIX4;NDUFS2;ANXA1;DAGLB;RITA1;CLN5
prerank,response to interleukin-4 (GO:0070670),-0.46616098789002824,-1.1101852399516279,0.32578397212543553,0.5777681288556104,1.0,1/10,0.16%,LEF1
prerank,positive regulation of calcium ion import (GO:0090280),0.4281466564321707,1.1099983027324776,0.3054945054945055,0.7353239311287281,1.0,3/12,12.36%,STC1;SPHK2;CCL2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4537408111442419,1.1098933326291327,0.32339449541284404,0.7339879405610921,1.0,2/11,0.75%,BLK;ANK3
prerank,regulation of postsynapse organization (GO:0099175),0.35979361723614983,1.1098008398488226,0.29653679653679654,0.732632713403166,1.0,7/28,10.08%,IL1RAPL1;PPFIA2;CDK5;CDKL5;HOMER1;TANC2;ABI2
prerank,calcineurin-mediated signaling (GO:0097720),-0.4657994283897212,-1.1097006383077799,0.33747779751332146,0.5780522810508696,1.0,3/10,3.54%,NFAT5;NFATC1;NFATC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4657994283897212,-1.1097006383077799,0.33747779751332146,0.5780522810508696,1.0,3/10,3.54%,NFAT5;NFATC1;NFATC4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.4454838100527071,-1.109646871410935,0.3339449541284404,0.577777985759676,1.0,3/12,16.64%,GCNT2;FLOT1;BMP7
prerank,cellular response to leucine starvation (GO:1990253),-0.4730037153091002,-1.1091461547094998,0.3415061295971979,0.5785997397423703,1.0,4/10,16.70%,SESN1;MTOR;LARS1;GCN1
prerank,positive regulation of DNA binding (GO:0043388),-0.34787465998858585,-1.1091009673365522,0.2946593001841621,0.5782945013457376,1.0,14/31,31.24%,RB1;HES1;NGF;FOXC1;SKI;IGF1;CEBPG;TXN;PPARG;HMGB1;PINX1;TRIM6;PLAUR;TGFB1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.4633986184564259,-1.108578514611748,0.3352165725047081,0.5791483559208165,1.0,2/10,1.51%,ENG;CAV1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4406963557866609,-1.1084886862731496,0.3403041825095057,0.5789385869618081,1.0,6/12,24.59%,LIMA1;CFL2;PLEKHH2;MTPN;SEMA5A;PIK3CA
prerank,defense response to virus (GO:0051607),-0.2781875675495894,-1.1082316293054717,0.25136612021857924,0.579103280204249,1.0,41/100,29.16%,IRF2;IFIH1;ATG7;SETD2;TRIM56;ABCC9;SAMHD1;CLPB;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;PLSCR1;PDE12;CD40;CGAS;MAVS;NLRC5;MOV10;ZMYND11;SERINC5;ZDHHC1;EXOSC5;PTPRC;ABCE1;RELA;IFNAR2;AKAP1;MAP3K14;NCBP3;IFITM2;AGBL5;IRF7;CXCL10;BST2;RSAD2;OASL;IFNLR1
prerank,negative regulation of coagulation (GO:0050819),0.41520030840408567,1.1081968149235808,0.31130063965884863,0.7357755508989315,1.0,2/14,1.99%,VTN;HS3ST5
prerank,regulation of T cell activation (GO:0050863),0.32038688960373407,1.1081795603612634,0.27705627705627706,0.7342098573555619,1.0,8/42,15.75%,TNFSF18;PAG1;PRELID1;VTCN1;CCL5;CCL2;SIRPA;CD47
prerank,integrated stress response signaling (GO:0140467),0.4123971410297711,1.1079743771255222,0.3194444444444444,0.733231288264135,1.0,4/14,15.50%,OMA1;IMPACT;CCL2;EIF2AK1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.3621777093797093,-1.1075027421590835,0.31123388581952116,0.5804647424608662,1.0,10/25,27.76%,PRPF3;PRPF6;SF3B1;DBR1;SLU7;SRRM1;SRSF10;TRA2B;TXNL4A;SCAF11
prerank,zinc ion transmembrane transport (GO:0071577),-0.3789655475468735,-1.107233837346979,0.31053604436229204,0.5806897749118561,1.0,7/22,20.88%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,extracellular transport (GO:0006858),0.43736585336719186,1.1071583782550722,0.3404710920770878,0.7340084349278705,1.0,6/12,17.14%,ADCY10;TSG101;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.35085456430581824,-1.1069975528752989,0.30648330058939094,0.5808256768867096,1.0,10/28,19.73%,ESAM;NAA80;HAX1;FCHSD2;ARHGAP28;RASA1;GBA2;DBNL;ARHGAP35;FCHSD1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3826253060565366,-1.1066040428950914,0.3184257602862254,0.5813779444590195,1.0,10/22,37.86%,GSK3B;ROCK1;ROCK2;IKBKB;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B;MASTL
prerank,aminoglycan metabolic process (GO:0006022),0.4548888327030435,1.1063061506428475,0.32786885245901637,0.7348129373192679,1.0,4/10,18.06%,B4GALT7;CHST9;B3GAT1;GAL3ST3
prerank,negative regulation by host of viral process (GO:0044793),-0.47461773153805487,-1.1062870871451618,0.3389830508474576,0.5817466301464567,1.0,9/10,51.61%,VAPA;CCNK;EIF2AK4;CRP;CCL8;PTX3;PSMC3;ZC3H12A;LTF
prerank,heart process (GO:0003015),0.4009287438784342,1.1060555344823966,0.31473214285714285,0.7339214235770313,1.0,1/14,0.03%,SGCZ
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.31861822740404105,-1.1057128140775816,0.27175843694493784,0.5827098014205458,1.0,15/46,24.06%,FOXP1;ELN;THBS1;IL6R;BMP4;AKT1;EDN1;IGFBP5;TNFAIP3;IGF1;CTNNB1;PRKDC;PPARG;TCF7L2;PDGFRB
prerank,regulation of sensory perception of pain (GO:0051930),-0.45582271840227795,-1.1047274117035872,0.33620689655172414,0.5847541463963515,1.0,5/11,26.29%,MGLL;CCN3;ACP3;SPX;F2R
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.43989822148475655,-1.1046496422762713,0.3406193078324226,0.5845345055042768,1.0,5/12,31.08%,RAB27A;PLCG2;ADGRB1;SLC5A3;TLR6
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3594566005582439,-1.1044546681485898,0.32887189292543023,0.5845786611348919,1.0,10/27,21.14%,SLC47A1;SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC1A4;SLC3A2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3457813807130982,-1.1038724559292123,0.3233743409490334,0.5855767527979631,1.0,15/32,32.67%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;POLR2H;POLR2L;TAF1D;POLR1E;GTF2H3;CCNH;POLR1H;POLR2E
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.35039787175242654,-1.1033840398285601,0.32437275985663083,0.5863220301475109,1.0,10/29,16.85%,LYN;SHOC2;NGF;TGM2;NOTCH2;RAPGEF1;NOTCH1;JAK2;GRB2;IGF1
prerank,protein N-linked glycosylation (GO:0006487),-0.29526790149284876,-1.103341278359291,0.2907563025210084,0.5860226627737813,1.0,18/66,17.07%,ST3GAL1;ALG14;ST6GAL1;ALG10B;DAD1;MAN1C1;MGAT4B;GFPT2;FUT8;SLC39A8;ALG12;OST4;ALG8;ALG11;DOLPP1;ALG13;MGAT2;UGGT1
prerank,respiratory electron transport chain (GO:0022904),0.41705975590696365,1.1032904813777504,0.32142857142857145,0.7408747772642633,1.0,3/14,11.77%,SLC25A13;SDHA;NDUFA5
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.46585500493052034,-1.1030219153223177,0.33270676691729323,0.5859844683875205,1.0,7/10,41.81%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.46585500493052034,-1.1030219153223177,0.33270676691729323,0.5859844683875205,1.0,7/10,41.81%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2
prerank,sulfur amino acid metabolic process (GO:0000096),-0.36435375245463636,-1.1027365499852542,0.3292035398230089,0.5862250797362798,1.0,12/24,27.98%,MTHFD1;TXN2;MSRA;NOX4;CDO1;CTH;GCLC;ADO;MTRR;MPST;MTR;AHCY
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2929677160509895,-1.1026988643110254,0.28169014084507044,0.5859086717176878,1.0,23/73,25.15%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;FZD5;RIPK1;DHX9;ARFGEF2;HMGB1;DDT
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.33978766834810026,-1.1020144627712314,0.30824372759856633,0.587124288637588,1.0,16/33,35.79%,ACER2;LYN;ADAM9;TGFB2;PTK2;EPHA2;FERMT3;PTPN11;SERPINE1;ADA;FOXC2;SNAI2;CYP1B1;MUC1;SYK;LIF
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4787029498708861,-1.1017128455729344,0.35804701627486435,0.5874469670756713,1.0,4/10,16.81%,SP100;TP53;KAT5;TFAP4
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4473929601123262,-1.1014739492197783,0.32194244604316546,0.5876070197600698,1.0,3/12,8.23%,PRKD2;NIPBL;PRKD1
prerank,defense response to symbiont (GO:0140546),-0.2799797101009796,-1.1008886422502913,0.26773049645390073,0.5885341461538512,1.0,43/92,33.52%,IRF2;IFIH1;ATG7;SETD2;TRIM56;ABCC9;SAMHD1;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;PLSCR1;PDE12;CD40;CGAS;MAVS;NLRC5;MOV10;ZMYND11;SERINC5;EXOSC5;PTPRC;ABCE1;RELA;IFNAR2;MAP3K14;NCBP3;IFITM2;AGBL5;IRF7;BST2;RSAD2;OASL;IFNLR1;LILRB1;PMAIP1;RTP4;TRIM5;SHFL;IFIT2
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3376569629431654,-1.1006678133675558,0.30550621669627,0.5886565229766599,1.0,14/33,23.52%,NET1;MAP3K5;ABL1;PRKCD;ANKZF1;HDAC6;TNFAIP3;PPIF;ANXA1;RPS3;MAPK7;RELA;NFE2L2;RIPK1
prerank,embryonic axis specification (GO:0000578),-0.41283104740836973,-1.099919225771585,0.3006993006993007,0.5900563524815051,1.0,9/15,33.96%,SMAD2;TASOR;SMAD6;FZD5;TBX3;RIPPLY2;WNT7A;HOXD8;PTCH1
prerank,positive regulation of phosphatase activity (GO:0010922),0.36712053832768554,1.0998219634589923,0.31685393258426964,0.7495671536399184,1.0,3/21,5.51%,MAGI2;PLEK;CALM2
prerank,regulation of isotype switching (GO:0045191),-0.41501402288392797,-1.099806729261258,0.3235831809872029,0.5898915834782386,1.0,3/14,5.43%,SHLD1;TFRC;KMT5B
prerank,positive regulation of translational initiation (GO:0045948),-0.3954707595409104,-1.0994720288460313,0.338768115942029,0.5902895169871095,1.0,5/18,13.11%,DDX3X;MTOR;LARP1;POLR2G;CDC123
prerank,regulation of neurotransmitter secretion (GO:0046928),0.33143486333475825,1.0994532904318868,0.326226012793177,0.7490924358131008,1.0,6/32,10.44%,RIMS2;RIMS1;SYT11;SYN1;MCTP2;GPER1
prerank,response to amino acid (GO:0043200),0.3325476861344844,1.0988027692769278,0.32207207207207206,0.7493216079967312,1.0,4/31,5.98%,GLRA3;RRAGA;GLRA1;CPEB1
prerank,cellular response to amino acid starvation (GO:0034198),-0.295146946471484,-1.0986555172416588,0.285958904109589,0.5917521556451348,1.0,20/71,18.76%,SESN1;MAP3K5;MTOR;FAS;SEC13;PRKD1;MAPK1;DAPL1;MIOS;RPTOR;ATP6V1E1;LARS1;MAPK8;ATF4;KPTN;CASTOR1;GCN1;RNF152;DAP;ITFG2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.36253552910888076,1.0982272125939947,0.3267543859649123,0.7494239033950028,1.0,8/21,19.32%,TOX;PROX1;INSM1;VEGFA;FZD9;FZD3;CX3CL1;DISP3
prerank,negative regulation of bone remodeling (GO:0046851),0.4414152819774805,1.0980010211584126,0.34065934065934067,0.7485093676618775,1.0,2/11,3.58%,CARTPT;CALCA
prerank,sphingolipid metabolic process (GO:0006665),-0.2700777240405048,-1.0978923251558794,0.27256637168141595,0.5931726171928702,1.0,34/108,22.11%,SGMS1;ESYT2;CERT1;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ST6GALNAC3;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;ARSA;PDXDC1;AGK;SPTLC1;ORMDL1;ASAH1;CERS5;SMPD2;GBA2;SERINC1;VAPA;GLTP;PPP2CA;ELOVL7;DEGS1;ORMDL3;TEX2;GLA;CTSA
prerank,negative regulation of protein transport (GO:0051224),-0.3624438463341679,-1.0978214849594206,0.30303030303030304,0.5929268288324652,1.0,12/25,30.96%,RHBDF2;PPM1F;DPH3;SNX12;PKDCC;CSK;WWP2;NDFIP2;SERGEF;HMGCR;RSAD2;RHBDF1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.4019209647647145,-1.0975066649513028,0.335676625659051,0.5932191282897299,1.0,8/17,33.90%,RB1;CTCF;BUB3;TTK;MTBP;SPDL1;BOD1;MIS12
prerank,negative regulation of complement activation (GO:0045916),-0.4653706395870074,-1.0974053571762656,0.3548387096774194,0.593051054203773,1.0,2/10,6.56%,CR1L;CD55
prerank,neutrophil mediated immunity (GO:0002446),-0.22963730929003287,-1.09729311440289,0.18469217970049917,0.5928903282751462,1.0,103/432,22.22%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;ADGRE5;CTSC;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;KMT2E;ANXA3;RAB7A;DIAPH1;DDX3X;ACE;PTPRJ;LPCAT1;IDH1;AP2A2;PLD1;NFKB1;TNFRSF1B;RAB5B;MOSPD2;CD55;ENPP4;PRKCD;RAP1A;CD93;RAB27A;PDXK;HRNR;OSTF1;ROCK1;MAPK1;RAP1B;TSPAN14;RNASE3;NBEAL2;STOM;ADAM10;RAB4B;IGF2R;PGLYRP1;FRK;STK10;EEF2;ALDOC;ARMC8;PSEN1;ANO6;CAT;HMOX2;PA2G4;CEACAM1;RHOA;RHOG;PRCP;ARSA;LRG1;PSMC2;UBR4;RAB24;MIF;ASAH1;CTSZ;TOM1;PSMB1;SRP14;DSN1;ATP6V0A1;CTSH;VPS35L;DBNL;VAPA;PLEKHO2;LAMP2;NAPRT;FRMPD3;B4GALT1;HUWE1;NRAS;SCAMP1;RAP2C;PTPRC;CAP1;DEGS1;KCNAB2;GYG1;VCL;ORMDL3;NDUFC2;VAMP2;AMPD3;ITGAM;GLA;CTSA;CD53;HSP90AA1
prerank,organophosphate catabolic process (GO:0046434),0.44364971515996227,1.0972177528936968,0.3325635103926097,0.7491863395344455,1.0,1/11,1.50%,ENPP2
prerank,nucleoside catabolic process (GO:0009164),-0.44658052877297005,-1.0971098933590162,0.36971830985915494,0.5929084021691519,1.0,7/11,36.17%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DERA;DPYS
prerank,protein localization to chromosome (GO:0034502),-0.335513530823618,-1.09680798268763,0.322463768115942,0.5932158763170615,1.0,12/34,19.50%,RB1;ESR1;CTCF;MRNIP;XRCC4;MCM9;WAPL;RPA1;SLF2;TERF2;RPA2;ATRX
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3641125230381233,1.0966249887366109,0.3221476510067114,0.7493831371933702,1.0,4/21,6.35%,HS6ST3;HS3ST5;GPC1;HS6ST2
prerank,platelet aggregation (GO:0070527),-0.3412605210041198,-1.0965883831842274,0.2945326278659612,0.5933445955011256,1.0,14/33,27.58%,MYH9;FLNA;ILK;ACTB;ACTN1;PIK3CB;CLIC1;UBASH3B;VCL;ITGB3;FERMT3;TLN1;MYL9;RAP2B
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3593181923551459,-1.0960291662989698,0.336283185840708,0.594263952243076,1.0,18/26,45.68%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;TGFB1;CYP1B1;SARS1;IL1A;HIF1A;GATA4;ISL1;SULF1;NODAL;IL6;RORA
prerank,regulation of mRNA catabolic process (GO:0061013),-0.26672672927621516,-1.0958576890523035,0.26475849731663686,0.5942588670297382,1.0,41/121,26.89%,PSMA2;ZC3HAV1;PRKCD;XRN1;PSME2;MAPKAPK2;PUM1;SAMD4A;PSMB4;EXOSC1;EXOSC2;YWHAZ;AKT1;SERBP1;EXOSC3;RC3H1;PSMC2;PARN;PSMB2;ZC3H14;EXOSC8;PSMB1;MOV10;PSMA8;TNFSF13;NUP214;PSME1;EXOSC5;DCP1A;PSMD4;RBM24;PSMD5;CNOT8;FXR1;EXOSC7;PSMA3;CARHSP1;CNOT1;HNRNPD;PABPC1;PSMB10
prerank,sterol transport (GO:0015918),-0.39085500129341477,-1.095857595752765,0.32592592592592595,0.5938438817873991,1.0,5/19,21.12%,CAV1;LDLRAP1;STARD3;OSBPL2;LCAT
prerank,negative regulation of nuclear division (GO:0051784),-0.44624942625110553,-1.095419300871112,0.32922535211267606,0.5945238629420746,1.0,7/11,39.81%,BMP4;BMP7;TOM1L2;CHEK1;FBXO5;TOM1L1;AURKAIP1
prerank,cellular response to metal ion (GO:0071248),0.25941503298686874,1.0954070030784755,0.24242424242424243,0.7514107829208885,1.0,24/123,12.77%,NLGN1;SYT1;SYT5;DLG2;ANK3;RYR3;ADCY8;GLRA1;SYT12;SYT11;HPCA;HSF1;ADCY7;CPNE9;DPEP1;ACER1;SCN5A;CPNE1;CYP11B1;ATP13A2;SYT4;DLG4;GPLD1;SLC13A5
prerank,C4-dicarboxylate transport (GO:0015740),0.415455901240003,1.0950069028778653,0.34444444444444444,0.7509549975779769,1.0,4/14,12.77%,SLC25A13;LRRC8E;SLC1A2;SLC13A5
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3145579048287169,1.094870072645885,0.31235955056179776,0.7497599333496687,1.0,8/44,11.19%,AKR1D1;CYP46A1;INSIG1;SC5D;OSBPL6;SQLE;CYP27A1;ALOX12
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3143613494052999,-1.0948629129110277,0.31369150779896016,0.5954566306502177,1.0,23/48,38.04%,PRDM16;NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188;NOA1;NUP88;PRKAG2;NUP35;NOS2;NUP43;JMJD8;GCGR;HIF1A;NUP50;PGAM1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.272674927090375,-1.094856641538142,0.26465364120781526,0.5950566974155375,1.0,21/102,13.66%,TBC1D4;SORBS1;FOXO1;INSR;CAV1;PRKACB;KAT2B;ADCY9;SLC30A10;NFKB1;PIK3R1;IRS1;RHOQ;PRKCD;ADCY4;GSK3A;AKT1;CYSLTR2;CEACAM1;RAB8B;INSIG2
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.29461931859605756,-1.0947263083763297,0.2764811490125673,0.5949716202341367,1.0,28/68,31.61%,SLC2A1;PANK2;SLC25A32;SLC5A6;SLC19A2;MTHFD1;PDXK;RFK;AOX1;SLC52A1;SLC52A3;LMBRD1;CUBN;MTHFD1L;PCCA;GSTO2;PCCB;ALDH1L1;MTRR;PNPO;MTR;SLC19A3;SHMT1;SLC2A3;HLCS;VNN1;SLC23A1;SLC23A2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.37579033617838664,-1.094341697303033,0.3385518590998043,0.595429244044909,1.0,6/23,19.63%,CAV1;CBL;SH3BP5L;HYAL2;DUSP22;PTPRC
prerank,regulation of phagocytosis (GO:0050764),-0.3051755433627963,-1.094249843981303,0.3088512241054614,0.5952161891040916,1.0,14/53,19.63%,IL15;MERTK;DYSF;GAS6;TGM2;RAB27A;SCARB1;PLSCR1;ABCA7;LMAN2;PIP4P2;TULP1;GATA2;PTPRC
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3851111956632581,-1.0939230442516363,0.3211009174311927,0.5956025251745592,1.0,3/19,6.78%,PPARA;IRS1;PRKCD
prerank,regulation of cytoplasmic translation (GO:2000765),0.4043262402082166,1.0939099002479455,0.3522975929978118,0.7509727872794536,1.0,4/14,17.24%,CPEB1;PKM;CPEB3;DHX36
prerank,cell junction organization (GO:0034330),-0.2890575369569497,-1.0936156121739808,0.3041958041958042,0.5959346196519584,1.0,18/71,12.87%,TJP1;APBB2;FERMT2;LIMS2;PPFIBP1;LIMS1;APP;TGFB2;PPFIA1;TJP2;AGRN;OCLN;FLNA;ILK;PSEN1;ACTB;RHOA;RAB8B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.37898357321742465,-1.0931347361712833,0.3339587242026266,0.5966718405984464,1.0,7/22,19.74%,RNF139;MAN1C1;MAN1A2;MAN1B1;UGGT1;TRIM13;EDEM2
prerank,negative regulation of kinase activity (GO:0033673),-0.2965189516241846,-1.0924243965125175,0.30144404332129965,0.5979601697323754,1.0,18/62,21.92%,RB1;PPP2R5A;CEP85;PAK2;CDKN1B;RTRAF;LRP6;PPM1F;PRKRIP1;AKT1;CEACAM1;CHP1;TAF7;UBASH3B;PTPRC;AKT1S1;WARS1;NF1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3722133408619663,-1.0923342552851054,0.35700934579439253,0.5973339034447923,1.0,8/23,15.69%,PPP1R13B;YWHAE;YWHAZ;NMT1;TP53;CASP8;MAPK8;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3722133408619663,-1.0923342552851054,0.35700934579439253,0.5973339034447923,1.0,8/23,15.69%,PPP1R13B;YWHAE;YWHAZ;NMT1;TP53;CASP8;MAPK8;BBC3
prerank,positive regulation of cell cycle process (GO:0090068),-0.27932560611247415,-1.0918467982373108,0.26373626373626374,0.5980751341882364,1.0,21/91,20.15%,MAP3K20;INSR;LRP5;PRKCE;PKP4;SVIL;CUL3;CDC14A;EDN1;RGCC;KIF23;RHOA;EDN3;PKN2;PLSCR1;TPR;IGF1;PLK4;GIPC1;ATRX;IGF2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.38161112736293834,-1.0918390326885652,0.34476843910806176,0.5976834465180264,1.0,11/21,37.34%,RAB1A;RPL5;MAD2L2;PTEN;RPS7;FZR1;PLK1;CDC20;FBXO5;UBE2C;BAG2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.27555909540918255,-1.0916899328274388,0.30036630036630035,0.597592820025831,1.0,20/95,9.70%,ST3GAL6;ST3GAL4;ST3GAL1;EXT1;GCNT2;CSGALNACT1;B3GNT2;CHST15;NDST1;B4GALT4;GPC6;DSE;AGRN;HS3ST3B1;SLC10A7;CSPG4;ST3GAL2;HS3ST1;CHST11;HSPG2
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.4463438244325316,-1.0914545283870334,0.35368043087971274,0.5977098230963683,1.0,5/12,17.19%,RB1;CTCF;WAPL;AXIN2;CTNNB1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.43460227913467187,-1.0914147141376802,0.3621013133208255,0.5973830692303345,1.0,4/13,15.25%,SHANK3;APP;LGMN;ADCY1
prerank,regulation of adaptive immune response (GO:0002819),0.3869326666532378,1.0913571201412577,0.32798165137614677,0.7572957051911453,1.0,4/18,7.20%,SASH3;SAMSN1;TRIM27;ADCY7
prerank,muscle cell development (GO:0055001),-0.3461226760850784,-1.0912469207878255,0.30393996247654786,0.5973575384315429,1.0,8/30,9.59%,ENG;MYOF;DYSF;HES1;MYH11;NEBL;RAMP2;CHRNB1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.41038481310431585,-1.090758505947877,0.3464566929133858,0.5981751977884315,1.0,5/15,15.23%,EGFR;PTPN12;RHBDF2;CEACAM1;LGMN
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.39220368032325914,-1.0905773922716393,0.3272394881170018,0.5981823357037567,1.0,4/17,12.48%,KLF7;CAV1;APOLD1;CEACAM1
prerank,mismatch repair (GO:0006298),-0.3537012043467578,-1.0905689044784719,0.3303886925795053,0.5977968239212198,1.0,11/27,27.22%,SETD2;ABL1;MCM9;POLD3;RPA3;RPA1;XPC;RPA2;MSH3;LIG1;EXO1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.40141284685287854,1.0904185298264448,0.35129310344827586,0.7587100649904575,1.0,4/15,5.26%,KCNA5;KCNJ3;KCNN2;ATP1B1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.27440030833338547,-1.0903927253854893,0.2751798561151079,0.597800724516013,1.0,19/91,10.91%,HIP1;RUFY1;DNAJC13;STON1;PTPN1;RNF139;LRRK2;PLD1;RAB5B;ABL1;AP2S1;MAPK1;RAB5A;SCARB1;PICALM;SCFD1;RAB4B;BET1L;SNX12
prerank,regulation of multicellular organismal development (GO:2000026),-0.36131654562047555,-1.0897090911164147,0.3352059925093633,0.5990340715892786,1.0,5/25,11.17%,INSR;SOX17;NIPBL;TRIP12;EHMT1
prerank,regulation of chemokine production (GO:0032642),-0.3327083223540718,-1.0895876985628254,0.3121495327102804,0.598906506780744,1.0,17/36,39.67%,FOXP1;APP;IL6R;LPL;ACKR1;IL7;ADAM17;HMOX1;LGALS9;SNAI2;TREM2;CD74;TSLP;IL18;HIF1A;TLR2;SIGIRR
prerank,ether lipid metabolic process (GO:0046485),0.4006605786776233,1.0885083787354173,0.3611111111111111,0.7628711475310784,1.0,6/14,13.25%,FAR1;PLA2G7;PLA2G6;GNPAT;DHRS7B;PEDS1
prerank,striated muscle cell development (GO:0055002),-0.4146780261130949,-1.0883906552817864,0.38113207547169814,0.6013529841790884,1.0,3/14,12.36%,PGM5;TMOD3;LMOD1
prerank,negative regulation of receptor internalization (GO:0002091),0.43382300041192157,1.0881635552772526,0.3407079646017699,0.7622512566346411,1.0,4/12,11.94%,ANKRD13B;WDR54;MTMR2;DLG4
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3243082693752421,-1.0876596757420516,0.34545454545454546,0.602640485885175,1.0,13/40,20.30%,MCL1;ABL1;PRKCD;IER3;WDR76;FEM1B;UBE2V2;KMT5A;RFWD3;ARMT1;RPA2;NSMCE4A;USP1
prerank,protein targeting to peroxisome (GO:0006625),-0.3474576485026628,-1.087239191010114,0.3267148014440433,0.6032805966648103,1.0,13/29,32.89%,PEX1;ABCD3;PEX7;RAB8B;ZFAND6;PEX14;PEX3;PEX6;PEX11B;HACL1;LONP2;PEX19;PEX26
prerank,phosphatidic acid metabolic process (GO:0046473),-0.31407280110363794,-1.0872008743439714,0.3196428571428571,0.602945542247254,1.0,16/48,25.22%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;DGKZ;AGPAT4;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,polyamine metabolic process (GO:0006595),-0.43390112591790514,-1.086843072157429,0.3795620437956204,0.6033372576970752,1.0,5/13,23.37%,SMOX;HDAC6;HDAC10;OAZ2;SRM
prerank,response to peptide (GO:1901652),0.3269771465626159,1.086837440491969,0.31277533039647576,0.7644836341166441,1.0,5/33,4.47%,MMP12;CACNA1B;GNAI1;CACNA1A;INAVA
prerank,CENP-A containing chromatin organization (GO:0061641),0.33846589330348015,1.0864770074040537,0.3090909090909091,0.7623884264365107,1.0,10/29,20.47%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPW;CENPK;RBBP7;ITGB3BP;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.33846589330348015,1.0864770074040537,0.3090909090909091,0.7623884264365107,1.0,10/29,20.47%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPW;CENPK;RBBP7;ITGB3BP;CENPA
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.40582561081404267,-1.0861784136778025,0.36414048059149723,0.6045106172101469,1.0,7/15,29.58%,PPARA;LPL;PLIN2;PPARG;PNPLA2;PLIN3;TREM2
prerank,amino acid transmembrane transport (GO:0003333),-0.3101261667003422,-1.0861779581455728,0.3074141048824593,0.6041000175890653,1.0,7/45,7.06%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC38A11;SLC38A5;LRRC8D
prerank,defense response to bacterium (GO:0042742),-0.26820290663496227,-1.0859869317971682,0.2908777969018933,0.6041775240222578,1.0,38/105,32.94%,ANKRD17;NOD1;ANXA3;RAB1A;RNASE7;IL6R;IRGM;PRKCD;GBP6;LBP;RNASE3;PGLYRP1;STAB1;GBP4;MAVS;DEFA6;NOD2;DROSHA;RPL30;SERPINE1;ADGRB1;LYZL4;LCN2;ADAM17;RPL39;FCER1G;SELP;NLRC4;TREM2;TNFRSF14;MPEG1;TLR6;JCHAIN;CEBPB;LPO;NOS2;AQP1;FGR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4604117990545271,-1.085467131288541,0.36968576709796674,0.6046080895067232,1.0,5/10,19.26%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4604117990545271,-1.085467131288541,0.36968576709796674,0.6046080895067232,1.0,5/10,19.26%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,positive regulation of response to wounding (GO:1903036),-0.35878431694780777,-1.0854521508297597,0.33766233766233766,0.6042296544289277,1.0,7/24,11.99%,ITGB1;PRKCE;SCARF1;PTK2;OCLN;MYLK;ARFGEF1
prerank,protein autoubiquitination (GO:0051865),-0.2932868486518638,-1.0852142414557955,0.31305903398926654,0.604402722909419,1.0,20/61,23.69%,CNOT4;DTX3L;RNF213;CUL3;RNF115;UHRF2;SH3RF1;UBE2D3;RAD18;OBI1;ERCC8;TRIM13;RNF10;WWP2;RNF4;BRCA1;SH3RF2;MDM2;TRIM68;RNF146
prerank,mitochondrion organization (GO:0007005),-0.2507037101063746,-1.0851895677190375,0.2724252491694352,0.6040551488970036,1.0,54/165,29.19%,MEF2A;NOS3;DNM3;ALAS1;TRAK1;LRRK2;MIEF1;DNM2;CHCHD3;SIRT5;BNIP3;PYROXD2;HAX1;AFG3L2;AKT3;SAMM50;TOMM40;BCAP31;VPS13C;AGTPBP1;MTX1;MIEF2;GABPB1;SIRT3;AFG1L;HCFC1;TIMM17B;RAB32;TOMM5;VPS13D;FANCG;DNAJC19;NRF1;WASF1;HIGD2A;TERT;ATPAF1;BIK;GABPA;TMEM11;HIGD1B;IMMP2L;TIMM50;TIMM10;STOML2;TOMM20;RAB38;MTFR1;CAV2;SLC25A33;TOMM70;RHOT2;HIGD1A;YME1L1
prerank,actin crosslink formation (GO:0051764),-0.43551683234530303,-1.0849803258778368,0.36379928315412186,0.6041220201899389,1.0,4/12,13.18%,EPS8;BAIAP2L1;FLNA;LCP1
prerank,protein localization to vacuole (GO:0072665),0.40506012817237413,1.0849320924711603,0.3456221198156682,0.7654792638844317,1.0,5/13,12.43%,MFSD1;CD81;RTN4;ATP13A2;RNF128
prerank,nucleic acid-templated transcription (GO:0097659),-0.32142618783398097,-1.084911839959586,0.3304042179261863,0.6038742230373753,1.0,15/42,25.42%,MEF2A;THRB;POLR2G;PWP1;TAF1B;DRG1;CREBL2;RNPS1;PTMA;TERT;MED20;POLR2C;POLR2H;MLF1;POLR2L
prerank,polyol biosynthetic process (GO:0046173),0.4012146643750486,1.0839316597832296,0.33642691415313225,0.7669352458732734,1.0,5/16,10.85%,ITPKA;ISYNA1;CYP27A1;IP6K2;IPPK
prerank,organophosphate biosynthetic process (GO:0090407),0.32251402199400253,1.0837290748515167,0.3274336283185841,0.7659574590255023,1.0,8/37,11.32%,FADS1;ITPKA;TKT;TPI1;GK;IP6K2;IPPK;GNPAT
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.33536831526473154,-1.0835624324165516,0.32717190388170053,0.606685134947314,1.0,9/33,18.62%,PRKD2;PTPRJ;EZR;DGKZ;CEACAM1;DUSP3;RC3H1;IKBKG;RPS3
prerank,regulation of cell aging (GO:0090342),-0.44562715048157736,-1.08329853645321,0.3781362007168459,0.6068568096515674,1.0,4/11,17.39%,NEK6;LMNA;MIF;NUAK1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.42069146414091757,-1.082431315448468,0.3738656987295826,0.608511067470833,1.0,3/13,16.38%,PLA2G4A;MGLL;DGAT2
prerank,cardiac muscle cell differentiation (GO:0055007),0.3602044549319531,1.082408400474039,0.35152838427947597,0.7683767507792801,1.0,7/21,12.07%,NRG1;WT1;CXADR;ALPK3;IRX3;VEGFA;SLC8A1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.43971530775092726,-1.082240178412531,0.35208711433756806,0.6085807077526629,1.0,3/11,18.48%,SMAD7;RC3H1;ANXA1
prerank,positive regulation of protein secretion (GO:0050714),-0.29470462095587663,-1.082014960576759,0.3108348134991119,0.608696636251062,1.0,11/69,7.41%,UNC13B;MYRIP;CD2AP;GOLPH3L;BMP6;IER3IP1;ADAM9;RBP4;TGFB2;EZR;MYO18A
prerank,positive regulation of potassium ion transport (GO:0043268),0.31787899692416693,1.081829314328523,0.3255269320843091,0.7684879115670783,1.0,10/38,13.76%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;ADRA2A;GABBR1;KCNN3;AMIGO1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.3517898021395927,-1.0815552324303694,0.3534798534798535,0.6093746303793165,1.0,10/26,31.08%,SLC30A10;PPARA;RAB27A;PLCG2;ABCB7;COA8;ADGRB1;SLC5A3;SLC25A33;TLR6
prerank,homotypic cell-cell adhesion (GO:0034109),-0.32495470045173264,-1.081331091884656,0.3220640569395018,0.6094975848148466,1.0,17/39,27.58%,MYH9;TJP2;FLNA;ILK;ACTB;ACTN1;PIK3CB;CLIC1;UBASH3B;VCL;ITGB3;FERMT3;TLN1;PLPP3;MYL9;MEGF11;RAP2B
prerank,histone H4 acetylation (GO:0043967),-0.31116897927643783,-1.0808383853560204,0.32604735883424407,0.6102675547579363,1.0,16/47,24.24%,LEF1;KANSL3;EP400;TRRAP;PHF20;ZZZ3;HCFC1;TRIM16;TADA3;RUVBL2;JADE2;WDR5;OGT;BEND3;MORF4L1;APBB1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4347578399956027,-1.0807862293144188,0.36363636363636365,0.6099854173286627,1.0,2/12,1.51%,GJD3;CAV1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.36513142669887816,-1.0801766093329228,0.36252189141856395,0.6110253817506581,1.0,9/24,19.63%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2;CCL19;PTPRC
prerank,regulation of cellular respiration (GO:0043457),-0.3946980402757231,-1.0800627147148303,0.37407407407407406,0.6109210492313463,1.0,3/17,3.95%,CBFA2T3;PRDM16;IFNAR1
prerank,extracellular matrix disassembly (GO:0022617),-0.30226979335467563,-1.0799022591520409,0.3090909090909091,0.6108784089457936,1.0,12/53,14.80%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;ADAM10;ADAMTS4;CAPN2;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.33098872641373067,-1.0797935931382547,0.3368237347294939,0.6107051172657769,1.0,6/36,12.64%,SHANK3;ITGB1;HDAC1;EDN1;HFE;JAK2
prerank,phagosome acidification (GO:0090383),0.3457466564287832,1.079602014132841,0.3550420168067227,0.773757639497668,1.0,10/26,19.67%,ATP6V1B2;ATP6V0C;ATP6V0A2;ATP6V0D2;ATP6V1G2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2503097739882338,-1.079585638290267,0.26700680272108845,0.6108163513954444,1.0,52/159,26.35%,HIP1;FCHO2;STXBP6;EIF4H;EPS15;PXN;AHCTF1;NCK1;NUP98;AP2S1;PSMG2;TCP1;PIK3C2A;SMAD1;SNX9;SMAD2;PICALM;SMAD4;SAMM50;VBP1;POGZ;CHMP4B;CHMP4A;NCK2;RPL38;NUP153;PTGES3;HIP1R;TTC12;TPR;ANGPT1;CASQ2;DNAJB12;CENPE;VAMP3;AP2M1;ADRM1;PFDN6;HIGD2A;PSMD4;VAMP2;HSP90AA1;ARL2;HIGD1B;NDUFAF1;IMMP2L;TCF4;DHX9;DRC1;PSMG1;CCT2;GPX4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.27490496576421586,-1.0794865286406345,0.3126050420168067,0.6106305373621786,1.0,30/87,27.44%,RBFOX2;TBX1;SPRED2;CEP57;DSTYK;CBL;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;HNRNPA1;GRB2;FLRT2;HYAL2;FGFR4;DLL4;PTPN11;KIF16B;POLR2C;POLR2H;FRS2;FLRT3;POLR2L;FGF10;EGR3
prerank,regulation of muscle contraction (GO:0006937),0.34632159697597864,1.079414315035262,0.3333333333333333,0.7727378145985264,1.0,6/26,12.88%,CHRM2;ATP1A2;TNNC1;NMUR2;SRI;MYL2
prerank,axonal transport of mitochondrion (GO:0019896),0.4390973518341963,1.0793880456636755,0.35920177383592017,0.7712141329997662,1.0,7/11,25.64%,SYBU;MAPT;NEFL;TRAK2;HAP1;SPAST;ACTR10
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3922030545674601,-1.0789872790481243,0.3720073664825046,0.6106527188575687,1.0,9/20,26.79%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3922030545674601,-1.0789872790481243,0.3720073664825046,0.6106527188575687,1.0,9/20,26.79%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3922030545674601,-1.0789872790481243,0.3720073664825046,0.6106527188575687,1.0,9/20,26.79%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.35116770154451515,-1.0789317386891932,0.34137291280148424,0.610370514736448,1.0,12/26,33.23%,ADIPOR2;ELOVL5;ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3;PDK4;MID1IP1;PRKAG2;LPGAT1
prerank,positive regulation of insulin secretion (GO:0032024),0.31398905250361886,1.07872335869993,0.325635103926097,0.7717263235349283,1.0,10/36,15.72%,BLK;GCK;ADCY8;TRH;GPER1;PLA2G6;GPLD1;NLGN2;GLUD1;MCU
prerank,cranial nerve development (GO:0021545),0.4225325780641753,1.0787216287985746,0.3688888888888889,0.7701367963569253,1.0,2/11,8.71%,PAX2;POU4F1
prerank,cellular response to heat (GO:0034605),-0.3281272199884775,-1.0786245191144692,0.3374558303886926,0.61071365631777,1.0,11/35,17.98%,THBS1;YWHAE;ANO1;CLPB;FGF1;ATXN3;SLU7;TCIM;TPR;SUMO1;TRPV4
prerank,prostanoid biosynthetic process (GO:0046457),-0.409180853818692,-1.0785839447671157,0.3692870201096892,0.6103833552871284,1.0,10/15,31.19%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,regulation of phosphatase activity (GO:0010921),-0.3591714320951232,-1.0780597414655542,0.34674329501915707,0.6111922154707182,1.0,8/24,24.69%,PPP1R2;ZCCHC9;GPATCH2;PPP6R3;CHP1;CDK5RAP3;SH3RF2;BMP2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3465647204955735,1.0778084011185576,0.3616557734204793,0.7714531707479044,1.0,5/24,11.95%,AGBL4;TTLL8;TPGS1;TTLL10;TTLL5
prerank,negative regulation of phosphatase activity (GO:0010923),-0.3577396565887258,-1.0777226697729272,0.350844277673546,0.6116291598720209,1.0,12/25,37.86%,GSK3B;TGFB2;ZCCHC9;GPATCH2;CHP1;SH3RF2;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B;MASTL
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.40923773635709554,-1.0776628169740459,0.3736059479553903,0.6113675989295847,1.0,3/14,5.43%,SHLD1;TFRC;KMT5B
prerank,cellular component disassembly (GO:0022411),-0.3029982287389301,-1.0772131292037734,0.3109090909090909,0.6120072307995766,1.0,12/53,14.80%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;ADAM10;ADAMTS4;CAPN2;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,B cell differentiation (GO:0030183),-0.3120426354317164,-1.07712455751041,0.31499051233396586,0.6118126708606416,1.0,14/46,19.63%,ITGB1;PTPRJ;ZBTB7A;TPD52;PLCG2;HDAC4;ITGA4;NHEJ1;TCF3;VCAM1;CEBPG;CLCF1;DNAJB9;PTPRC
prerank,early endosome to Golgi transport (GO:0034498),0.4235872110721386,1.0766493207411822,0.3522012578616352,0.7733091027808017,1.0,4/11,15.08%,LMAN1;RAB6A;SURF4;TMED9
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.451973943082477,-1.076312383946373,0.38992537313432835,0.6133956471148351,1.0,3/10,5.42%,RAPGEF2;LYN;GAS6
prerank,organelle assembly (GO:0070925),-0.22701230497253497,-1.0762256253367084,0.22818791946308725,0.6132147984116884,1.0,86/384,19.45%,ABCC4;ABLIM1;PGM5;EXOC6;ASAP1;NEK7;CD34;PARVA;ATG7;FNBP1L;RAB7A;DDX3X;EXOC4;RAB1A;SH3PXD2B;NEK6;PTPDC1;MAP1LC3B;EHD2;LIMD1;SSX2IP;CCDC61;TMOD3;CEP250;HPS4;IRGM;E2F4;IFT140;AMBRA1;CDC14A;OGFOD1;RAB11FIP3;WDR11;EXOC2;HAUS8;FLNA;PDE6D;POGZ;GABARAP;CHMP4B;CHMP4A;PRRC2C;EHD1;NOTCH1;WIPI1;LMOD1;WDR35;GALNT11;CFAP44;ULK2;RAB8B;IFT52;VTA1;HAUS6;CHMP2B;CSNK1D;TRAF3IP1;RC3H1;VPS36;RAB23;ZFYVE1;EXOC8;ATG5;CEP41;EHD4;RAB32;FUZ;TUBGCP5;TUBGCP4;CHMP5;DZIP1L;NUDCD3;RAB11A;HDAC6;CFAP298;EDC3;PLK4;STX12;DBNL;TMEM17;CENPE;RPS3;PCM1;IFT43;KIF3B;EMC6
prerank,neutrophil degranulation (GO:0043312),-0.2253169922700999,-1.0758790510248797,0.24369747899159663,0.6136385043225779,1.0,101/425,22.22%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;ADGRE5;CTSC;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;ANXA3;RAB7A;DIAPH1;DDX3X;PTPRJ;LPCAT1;IDH1;AP2A2;PLD1;NFKB1;TNFRSF1B;RAB5B;MOSPD2;CD55;ENPP4;PRKCD;RAP1A;CD93;RAB27A;PDXK;HRNR;OSTF1;ROCK1;MAPK1;RAP1B;TSPAN14;RNASE3;NBEAL2;STOM;ADAM10;RAB4B;IGF2R;PGLYRP1;FRK;STK10;EEF2;ALDOC;ARMC8;PSEN1;ANO6;CAT;HMOX2;PA2G4;CEACAM1;RHOA;RHOG;PRCP;ARSA;LRG1;PSMC2;UBR4;RAB24;MIF;ASAH1;CTSZ;TOM1;PSMB1;SRP14;DSN1;ATP6V0A1;CTSH;VPS35L;DBNL;VAPA;PLEKHO2;LAMP2;NAPRT;FRMPD3;B4GALT1;HUWE1;NRAS;SCAMP1;RAP2C;PTPRC;CAP1;DEGS1;KCNAB2;GYG1;VCL;ORMDL3;NDUFC2;VAMP2;AMPD3;ITGAM;GLA;CTSA;CD53;HSP90AA1
prerank,mesonephros development (GO:0001823),-0.4503953599039638,-1.0757372208932083,0.37667304015296366,0.6135869632744306,1.0,3/11,6.64%,ZBTB16;BMP4;FGF1
prerank,regulation of programmed cell death (GO:0043067),-0.24902781367898824,-1.0755741098128708,0.27288135593220336,0.6135717857912416,1.0,30/161,13.82%,MECOM;HIP1;PPP1R13B;CREBBP;DAPK1;ACER2;ATM;LRRK2;BIRC3;RARG;FAS;ZBTB7A;ABL1;BNIP3;STEAP3;TGM2;RAF1;HAX1;BCAR1;CRADD;TP53;AKT1;PERP;ACER3;TM7SF3;ACTN1;JAK2;ACTN4;NDRG1;RTKN
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.37632359990834807,-1.075412313417555,0.3473491773308958,0.613558315517641,1.0,5/21,11.81%,MITF;MED1;JUN;MED13;MED17
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3772195987839462,-1.0741279631482874,0.36379613356766255,0.6162819082542669,1.0,8/19,26.61%,GFPT2;GNPDA2;GNPNAT1;UAP1;NANS;SLC35D1;UAP1L1;PMM2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.36965978963395446,-1.0738202514684727,0.3462246777163904,0.6165825497840242,1.0,6/22,14.16%,ESR1;MED1;TP53;MED13;MED17;PSMC2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4298847182370544,-1.0736543198705977,0.37168141592920356,0.6165923619556465,1.0,4/13,14.03%,GNAI3;LRRK2;RHOQ;RAB23
prerank,actin filament capping (GO:0051693),-0.3812989208169983,-1.073355609693046,0.3492647058823529,0.6164950885829303,1.0,3/18,3.17%,EPS8;ADD3;SVIL
prerank,barbed-end actin filament capping (GO:0051016),-0.3812989208169983,-1.073355609693046,0.3492647058823529,0.6164950885829303,1.0,3/18,3.17%,EPS8;ADD3;SVIL
prerank,epidermis development (GO:0008544),0.2947888907989056,1.0732437430308672,0.3234624145785877,0.7818873802770252,1.0,10/56,12.09%,OVOL3;ZNF750;POU2F3;SCEL;FGFR2;COL7A1;ACER1;LAMB3;CERS3;GATA6
prerank,negative regulation of cell projection organization (GO:0031345),0.29980899078247386,1.073122643055917,0.3442622950819672,0.7806418756945617,1.0,11/48,13.44%,DCC;GRIN2B;SPOCK1;ITM2C;TSKU;PTPRS;STMN2;MAG;DENND5A;APOE;PAQR3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.36836250853985136,-1.0729555512887923,0.35283363802559414,0.6170619604902452,1.0,7/23,24.89%,PLK2;NABP1;INTS3;CDK5RAP3;BUB1B;CHEK1;PLK3
prerank,neutrophil activation involved in immune response (GO:0002283),-0.22431741547298747,-1.072840919217151,0.24874791318864775,0.6169270186027435,1.0,101/428,22.22%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;ADGRE5;CTSC;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;ANXA3;RAB7A;DIAPH1;DDX3X;PTPRJ;LPCAT1;IDH1;AP2A2;PLD1;NFKB1;TNFRSF1B;RAB5B;MOSPD2;CD55;ENPP4;PRKCD;RAP1A;CD93;RAB27A;PDXK;HRNR;OSTF1;ROCK1;MAPK1;RAP1B;TSPAN14;RNASE3;NBEAL2;STOM;ADAM10;RAB4B;IGF2R;PGLYRP1;FRK;STK10;EEF2;ALDOC;ARMC8;PSEN1;ANO6;CAT;HMOX2;PA2G4;CEACAM1;RHOA;RHOG;PRCP;ARSA;LRG1;PSMC2;UBR4;RAB24;MIF;ASAH1;CTSZ;TOM1;PSMB1;SRP14;DSN1;ATP6V0A1;CTSH;VPS35L;DBNL;VAPA;PLEKHO2;LAMP2;NAPRT;FRMPD3;B4GALT1;HUWE1;NRAS;SCAMP1;RAP2C;PTPRC;CAP1;DEGS1;KCNAB2;GYG1;VCL;ORMDL3;NDUFC2;VAMP2;AMPD3;ITGAM;GLA;CTSA;CD53;HSP90AA1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.35007545505173443,-1.0726852831272788,0.3609022556390977,0.6168921011731918,1.0,10/25,18.74%,ACVRL1;CORO1C;THBS1;ACE;ROCK1;FAM107A;BCAS3;ROCK2;IKBKB;DUSP22
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3607408533768123,1.0725777508689995,0.3648068669527897,0.780811361443592,1.0,3/20,6.24%,GCK;CDA;BCKDK
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.44380576619919276,-1.0724483122493327,0.37823834196891193,0.6170777516948961,1.0,5/11,25.98%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2
prerank,negative regulation of translational initiation (GO:0045947),-0.4129764039266166,-1.0724343640413625,0.37455197132616486,0.6166983909057838,1.0,9/13,38.88%,EIF3E;LARP1;AGO2;TPR;EIF2AK4;PAIP2B;EIF4EBP3;EIF4EBP1;PAIP2
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.41443362278376233,1.0722779600637946,0.36255924170616116,0.7800973820962854,1.0,4/13,8.46%,KCNA5;KCNJ3;KCNN2;SCN5A
prerank,visual system development (GO:0150063),-0.32839644376471355,-1.0722229720603427,0.3690909090909091,0.6167532931366696,1.0,14/37,22.78%,PBX1;SMOC1;SH3PXD2B;PBX3;RBP4;TGFB2;SIPA1L3;FOXC1;HIPK1;FREM2;PBX2;ITGAM;CHRDL1;ATF6
prerank,regulation of protein transport (GO:0051223),-0.34500540400127605,-1.0720465197564941,0.3669724770642202,0.6167763235231196,1.0,12/27,24.65%,PTPN1;DNAJC1;RHBDF2;PPM1F;SCFD1;SNX12;CHP1;LCP1;WWP2;NDEL1;NDFIP2;DISP1
prerank,acute-phase response (GO:0006953),-0.42492483778723555,-1.071560938668689,0.39501779359430605,0.617540261787035,1.0,10/12,44.91%,IL6R;LBP;PLSCR1;IL22;AHSG;CEBPB;CRP;SIGIRR;ITIH4;IL6
prerank,negative regulation of lymphocyte activation (GO:0051250),0.36304265957445137,1.0712961640008345,0.3540772532188841,0.7815819660750094,1.0,5/21,16.60%,PAG1;SAMSN1;VTCN1;FOXJ1;FCGR2B
prerank,histone methylation (GO:0016571),-0.3484481794242743,-1.0712682335898942,0.34854014598540145,0.617805102471525,1.0,7/26,15.29%,CREBBP;NSD1;NSD3;SUV39H1;EHMT1;SMYD1;N6AMT1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.41140416870134394,-1.0712176306086452,0.391304347826087,0.6175284030110847,1.0,2/13,4.94%,OGDH;IDH1
prerank,regulation of filopodium assembly (GO:0051489),-0.31851954746464395,-1.0711843223853088,0.34766355140186916,0.6172019905602336,1.0,11/38,11.91%,MYO10;FNBP1L;PALM;PIK3R1;RHOQ;PRKCD;WASL;AGRN;RAB5A;ARAP1;BCAS3
prerank,intracellular protein transmembrane transport (GO:0065002),-0.3084470101201696,-1.0711028380810785,0.33992805755395683,0.61699611407001,1.0,20/42,36.99%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;SEC61A1;TOMM70;PEX26;SEC63;AIFM1;PAM16;AKT2;DNLZ;ZFAND2B;TIMM23
prerank,T cell activation (GO:0042110),-0.2835383568257726,-1.0710089936027303,0.3177737881508079,0.6168038446812603,1.0,35/69,40.52%,KIF13B;MSN;JAG2;NCK1;PIK3CD;CTPS1;CASP8;NCK2;LCP1;NHEJ1;ICOSLG;LMBR1L;CCL19;SOX4;PTPRC;DLL4;ADA;EIF2AK4;CD276;PTPN2;PPP3CB;LFNG;LAT;CD74;ZAP70;GPR89B;GPR89A;GATA3;CRTAM;LCK;TNFRSF4;IL4;MDK;CD44;CD28
prerank,positive regulation of myelination (GO:0031643),0.4281772320749402,1.0708339417460209,0.3770491803278688,0.7813535486736207,1.0,2/11,0.97%,TENM4;MYRF
prerank,glycosaminoglycan metabolic process (GO:0030203),0.29008765058571856,1.0707422667034383,0.3142857142857143,0.7800097508366373,1.0,10/54,8.71%,GPC5;HS3ST6;HS3ST5;HPSE2;GPC1;HS6ST2;GALNT5;B4GALT7;HS3ST2;CHST9
prerank,ethanol metabolic process (GO:0006067),0.41756599301319,1.0702270130203149,0.3728448275862069,0.7800440907170834,1.0,2/12,7.87%,ACSS2;ACSS1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2820380668820408,-1.0698407236294325,0.3146853146853147,0.619209049266359,1.0,27/68,35.77%,IFIH1;APP;IL6R;LBP;ARHGEF2;PLCG2;LPL;IL17RA;MAVS;IL16;HYAL2;NOD2;PTPN11;DHX9;HMGB1;F2R;LGALS9;TLR6;RAB7B;TLR1;NOS2;STAT3;IL1A;CD74;TSLP;TLR8;SYK
prerank,regulation of neuron projection arborization (GO:0150011),0.3979181502181952,1.0693214481351512,0.37844036697247707,0.7812693985709226,1.0,6/15,15.04%,GRIP1;NTNG2;NTNG1;DLG4;DVL2;MYO9A
prerank,negative regulation of ossification (GO:0030279),-0.3617475875588211,-1.0692874926176625,0.3767123287671233,0.6200969056113051,1.0,6/23,15.53%,SRGN;TRPM4;MEF2C;NOTCH1;BCOR;SMAD6
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.39396301833677877,1.0691221363174328,0.3474178403755869,0.7803283596733902,1.0,6/15,15.14%,APOM;LIPC;PLA2G3;ABCA5;APOE;APOC1
prerank,DNA methylation (GO:0006306),-0.3640320330289178,-1.0691211502553453,0.3606271777003484,0.6200818350276609,1.0,9/23,23.39%,KMT2E;METTL4;EHMT1;N6AMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3882750426456601,1.069001498124686,0.38329764453961457,0.7791514443587284,1.0,9/17,22.05%,ATP1A2;PKP2;ATP1B1;RYR2;SLC8A1;GJC3;GJA1;ATP1B2;ATP1A3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.3723562791734667,-1.068975878926384,0.34501845018450183,0.620018566601956,1.0,4/19,8.63%,THBS1;PTK2;MAPK1;IL34
prerank,regulation of chemotaxis (GO:0050920),-0.3372189856629165,-1.068966960489069,0.33094812164579607,0.6196396796561128,1.0,11/30,31.24%,ADGRA2;THBS1;STX3;PPM1F;DUSP3;CCL19;ZSWIM6;PDGFRB;PTPN2;TREM2;TGFB1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.40652102840356635,-1.0688801147867326,0.36915077989601386,0.619463039515037,1.0,6/14,16.28%,DYRK1A;PSEN2;ADAM10;PSEN1;ABCA7;APH1A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.29565387491170747,-1.0685374027216483,0.3396551724137931,0.6198856781943726,1.0,20/54,28.80%,UBE2K;TAX1BP1;BIRC3;GAS6;OTULIN;CASP8;CFLAR;HIPK1;TNFRSF1A;TNFAIP3;IKBKG;IKBKB;RIPK1;HSPA1B;GPS2;CASP1;ADAM17;PTPN2;RNF31;NLRP2B
prerank,cristae formation (GO:0042407),-0.34730196094471427,-1.0685140810625362,0.37749546279491836,0.6195358131105392,1.0,14/27,32.87%,CHCHD3;APOOL;AFG3L2;SAMM50;DMAC2L;ATP5F1E;ATP5F1C;UQCC3;ATP5MF;IMMT;ATP5PO;ATP5F1D;ATP5MC2;SPG7
prerank,metal ion transport (GO:0030001),0.27010310314881814,1.0683134957014278,0.3262411347517731,0.7796896647180821,1.0,21/86,12.21%,RYR3;CACNA1B;CACNA2D1;ATP2B2;TUSC3;CACNA1A;CACNB3;CACNG8;SLC8A2;CACNA1D;SELENOK;CACNG3;RYR2;CACNA1E;NIPA1;SLC39A2;NMUR2;CCL5;NIPAL1;SLC8A1;SLC8A3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.35561081257211247,-1.0677036319708937,0.3605072463768116,0.6211253791071086,1.0,11/24,28.36%,LYN;SLIT2;MOSPD2;ANO6;CCN3;LGMN;SERPINE1;CXCL12;HMGB1;CXCL10;DUSP1
prerank,regulation of histone acetylation (GO:0035065),-0.3381056280735659,-1.0675230751870537,0.379746835443038,0.6211734678251162,1.0,16/33,31.09%,RPS6KA5;IWS1;SETD5;RUVBL2;TAF7;BRCA1;CHEK1;NOS1;MYOCD;RAPGEF3;ARRB1;HDAC5;GLYR1;SET;SPI1;RPS6KA4
prerank,chromatin remodeling at centromere (GO:0031055),0.32330837130504636,1.0673318959889457,0.34285714285714286,0.7810738718135534,1.0,10/31,20.47%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPW;CENPK;RBBP7;ITGB3BP;CENPA
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3814643338700769,-1.0672233293790094,0.34946236559139787,0.6214813411688779,1.0,5/18,20.42%,COX16;COX18;SCO1;COX17;COA8
prerank,regulation of gluconeogenesis (GO:0006111),0.3263560718472646,1.0671265990128485,0.34,0.7800502673609242,1.0,6/27,14.03%,DGKQ;GCK;GNMT;DDB1;SIRT7;SELENOS
prerank,cell-cell junction maintenance (GO:0045217),-0.4432503499590667,-1.067004885591726,0.37842778793418647,0.6215961219239574,1.0,2/11,1.29%,TJP1;FERMT2
prerank,regulation of macrophage activation (GO:0043030),-0.3416694153953259,-1.0666075016009555,0.3768939393939394,0.6220967101187613,1.0,7/30,14.99%,MFHAS1;CD200;THBS1;MYO18A;LBP;GPR137B;MIF
prerank,cellular response to radiation (GO:0071478),-0.31811926990030237,-1.0658039290022163,0.35365853658536583,0.62359683782266,1.0,23/40,39.65%,NET1;SPIDR;TP53;NSMCE3;GRB2;LIG4;BLM;INTS7;GADD45A;INO80;RAD51AP1;GPR52;EEF1D;MAPK14;SWI5;KDM4D;RRH;OPN1MW3;OPN1MW;RAD1;GPR88;SIRT1;CDKN1A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.4382308323481457,-1.0657536542805215,0.38022813688212925,0.6233072295061638,1.0,6/11,35.25%,CBFB;VSIR;HMGB1;LGALS9;TWSG1;CD274
prerank,positive regulation of transmembrane transport (GO:0034764),0.4198853028234186,1.0657027477326442,0.37969094922737306,0.7827936391104441,1.0,5/13,12.08%,CA2;NR4A3;AZIN2;C2CD5;C3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.35367353265252505,-1.0654488446062473,0.3747779751332149,0.623620136673155,1.0,17/24,45.68%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;TGFB1;CYP1B1;IL1A;HIF1A;GATA4;ISL1;SULF1;NODAL;IL6;RORA
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3914542667037002,1.0653812314060214,0.37639198218262804,0.7822015020668243,1.0,4/16,10.88%,ATIC;PAICS;ADSS2;ADSS1
prerank,anion transmembrane transport (GO:0098656),-0.2809415832782506,-1.0643388181586915,0.3442028985507246,0.6258656465456905,1.0,15/67,14.37%,LRRC8C;SLC7A1;SLC7A5;SLC13A4;SLC5A6;SLC16A12;SLC38A5;LRRC8D;SLC39A8;SLC13A3;ARL6IP5;SLC35A3;SLC25A11;SLC36A4;SLC35B4
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.38436521625512654,-1.0641985168827115,0.38640429338103754,0.6258164947849733,1.0,3/19,3.92%,IFIH1;SETD2;DDX3X
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.2807842136995394,-1.0641685264819463,0.34615384615384615,0.6254850353322267,1.0,25/72,26.42%,RBFOX2;SPRED2;CEP57;CBL;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;HNRNPA1;GRB2;FLRT2;FGFR4;PTPN11;KIF16B;POLR2C;POLR2H;FRS2;FLRT3;POLR2L;FGF10
prerank,regulation of mitotic spindle organization (GO:0060236),-0.32395049122670627,-1.0638006829594406,0.3688811188811189,0.6259717762028771,1.0,22/35,39.94%,RAE1;CHMP4B;DCTN1;DRG1;CHMP2B;TPR;CHMP5;TACC3;PDCD6IP;HSPA1B;HNRNPU;CCSAP;CHMP3;BORA;CHMP1A;MAP9;PLK1;PSRC1;CHMP1B;PARP3;TPX2;CEP97
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.40517499803024637,-1.0637116712377983,0.3685185185185185,0.625773015784906,1.0,5/15,7.15%,TBX1;TGFBR2;SIX1;NIPBL;MTHFD1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.24815415052061446,1.0632508757624428,0.31376975169300225,0.7872037933105412,1.0,26/142,12.40%,ATP1A2;HCRTR1;C1QTNF1;ATP2B4;ATP2B2;ADCY8;CALCA;CLN3;CACNA1A;PTGER3;SLC8A2;RYR2;C3AR1;CCR6;GPER1;TMEM178A;CIB2;ADRA1D;ADRA1A;TACR1;NMUR2;DLG4;FZD9;SLC8A1;PDGFRA;HRC
prerank,cellular response to copper ion (GO:0071280),-0.39152142500837994,-1.0629456544962486,0.3807829181494662,0.6272112198788111,1.0,10/16,35.60%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;AQP1;MT3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3786697138541333,-1.0629005688158013,0.39201451905626133,0.6269150234475594,1.0,12/21,35.76%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13;PLK1;CDC20;FBXO5
prerank,macroautophagy (GO:0016236),-0.2600486368803806,-1.0628697647461098,0.32062391681109187,0.6265945931504082,1.0,48/118,34.77%,LIX1L;MTMR3;ATG7;ATG10;MAP1LC3B;PIP4K2A;AMBRA1;TECPR1;PIP4K2B;TOMM40;PRKAA1;GABARAP;CHMP4B;CHMP4A;FUNDC1;WIPI1;VTA1;CHMP2B;VPS36;ZFYVE1;ATG5;TOMM5;ILRUN;KLHL3;HDAC10;LAMP2;PRKAB1;PLEKHM1;BECN1;STAM2;VPS39;DYNLL1;TOMM20;CHMP3;VPS37B;TOMM70;ATG3;CHMP6;LIX1;VAMP8;ARL8B;YOD1;TCIRG1;PRKAG2;TOMM6;MTMR14;WIPI2;GABARAPL2
prerank,positive regulation of protein polymerization (GO:0032273),-0.28450983631864446,-1.0627445054567777,0.3357664233576642,0.6264656480100207,1.0,16/65,13.98%,BAIAP2L1;CLIP1;RAC1;PRKCE;NCK1;TOGARAM1;SNX9;OCLN;FCHSD2;NCK2;DCTN1;LMOD1;SLAIN2;CDC42EP3;DRG1;NCKAP1
prerank,regulation of cytokine production (GO:0001817),-0.2569472033821588,-1.06264073988446,0.3408695652173913,0.6263196597470128,1.0,21/126,15.18%,FOXP1;AFAP1L2;LYN;IFIH1;RPS6KA5;TRIM56;IL15;SRGN;TNFRSF1B;MAST2;MAPKAPK2;PIK3CD;CASP8;RGCC;ASB1;FLOT1;ICOSLG;N4BP1;MIF;C1QTNF3;AGPAT1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3009798945744453,-1.0626055767590454,0.36316695352839934,0.6259813983597919,1.0,17/46,29.09%,ZNF423;RB1;IL15;ID1;LAMA4;NOVA2;ADAMTS5;NOTCH1;ATF4;PCTP;ALDH1A1;ACVR2B;RHEB;ADAM17;ACOT11;FOXC2;DDIT3
prerank,brain morphogenesis (GO:0048854),0.415513208456191,1.062058802504366,0.3900226757369615,0.7891521216024303,1.0,6/12,16.89%,CTNNA2;PAX2;BBS4;SLC6A4;MKKS;BBS2
prerank,cellular response to nitrogen compound (GO:1901699),-0.3721701482403608,-1.0619934932720125,0.3775322283609576,0.6269179119024868,1.0,9/20,21.01%,DDI2;SPIDR;RTF2;NSMCE3;PDE12;ROCK2;ATRX;TIMELESS;BLM
prerank,insulin secretion (GO:0030073),0.37328807025801447,1.0619136832310376,0.37303370786516854,0.7880659829840563,1.0,2/19,1.47%,RIMS2;PTPRN2
prerank,positive regulation of growth (GO:0045927),-0.2868266210960049,-1.0617640967090691,0.3357664233576642,0.6270401952474173,1.0,16/64,15.29%,INSR;DDX3X;EGFR;PLCB1;TGFB2;PPM1F;EXOSC2;MFSD2A;ADAM10;AKT1;RPS6KA1;RPTOR;ZPR1;H3-3A;RPS6KA3;N6AMT1
prerank,mRNA catabolic process (GO:0006402),-0.3104646455077313,-1.06155993936484,0.3376865671641791,0.6271042853661752,1.0,15/44,29.69%,TUT7;ERN1;XRN1;TUT4;XRN2;RC3H1;PDE12;NUDT12;DIS3L2;METTL16;HSPA1B;THRAP3;DXO;LSM2;NBDY
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2925366840800889,-1.0613708216189226,0.3501742160278746,0.6271584903905335,1.0,17/56,15.79%,SPTBN1;STAMBP;SNX9;BIN3;ROCK1;CECR2;CUL7;CHMP4B;KIF23;RASA1;DCTN3;RHOA;SON;RHOC;RTKN;MITD1;ROCK2
prerank,maturation of LSU-rRNA (GO:0000470),-0.3431888137225241,-1.0612344794556472,0.3594306049822064,0.6270722135218245,1.0,9/26,26.62%,RPF1;RRP15;NOP2;RPL7A;RPL7L1;BOP1;PES1;ZNHIT3;WDR12
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.39070778965601394,-1.060905267463861,0.397887323943662,0.6274412774931025,1.0,6/17,11.13%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.40995515713067754,-1.0602909190652032,0.4031413612565445,0.6286227202573546,1.0,10/15,37.34%,DTX3L;ABL1;SMAD7;RPL5;MAD2L2;RPS7;BAG5;PARK7;FBXO5;BAG2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4193084679849166,-1.0600293713028313,0.4076086956521739,0.6288249139774997,1.0,5/12,21.30%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,muscle cell differentiation (GO:0042692),-0.3318341898167677,-1.0598469547470746,0.35647279549718575,0.6288778398408218,1.0,8/32,12.77%,MRTFB;TBX1;SYNE1;MEF2C;TMEM204;NEBL;CHRNB1;SEMA4C
prerank,dopaminergic neuron differentiation (GO:0071542),0.37139287261491544,1.0597688826695701,0.3424657534246575,0.7930256297312552,1.0,5/19,18.07%,PHOX2A;LMX1B;VEGFA;WNT2;RYK
prerank,iron ion homeostasis (GO:0055072),-0.29226413306186416,-1.0597534799856574,0.341421143847487,0.6286947162155201,1.0,13/58,17.65%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;BDH2;PICALM;SMAD4;HFE;HMOX2;ABCB7;FLVCR1;SOD1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.41824834004201067,1.059072831265663,0.3735763097949886,0.7935806694408392,1.0,3/11,8.66%,PTPRT;HGS;SOCS3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.325513445667062,-1.0587103230437784,0.35815602836879434,0.6308717557356909,1.0,5/33,9.94%,LEF1;ACIN1;IL34;HAX1;CASP8
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3739792877201674,1.0585945463749422,0.3930131004366812,0.7935100102553443,1.0,4/18,7.55%,TENM4;OPALIN;PTPRZ1;SOX1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3244311874496942,1.0585316966278695,0.34278959810874704,0.7921584604143157,1.0,6/30,11.58%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3
prerank,peptidyl-lysine methylation (GO:0018022),-0.34659623908620585,-1.0585229804756116,0.38666666666666666,0.6308964490947864,1.0,8/26,15.96%,SETD2;SUV39H1;SETD3;EHMT1;SMYD1;N6AMT1;KMT5A;ANTKMT
prerank,L-glutamate transmembrane transport (GO:0015813),0.4406815182323976,1.0585132142424851,0.38565022421524664,0.7906556515722899,1.0,3/10,11.03%,SLC25A13;SLC1A2;SLC1A3
prerank,cholesterol efflux (GO:0033344),0.3508636681158132,1.0584575874308704,0.3778801843317972,0.7892629111717224,1.0,8/20,21.40%,APOM;TSKU;ABCA5;APOE;APOC1;SOAT2;SOAT1;ABCG1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3540464963730658,-1.0582328769262679,0.3618181818181818,0.6312110539400092,1.0,14/24,38.15%,STN1;TENT4B;XRN1;CTC1;HNRNPA1;TERF2;PINX1;HNRNPU;TNKS2;PIF1;TNKS;SLX4;ERCC4;DCP2
prerank,regulation of inclusion body assembly (GO:0090083),-0.4358090577472136,-1.0582000560546192,0.390625,0.6308824325985626,1.0,5/11,29.66%,SNCAIP;DNAJB6;HSPA1B;BAG5;SACS
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3681652813207942,1.0580922477715666,0.39826839826839827,0.7888295576463891,1.0,4/18,5.68%,MELTF;PDPN;DDR2;FSCN1
prerank,innate immune response (GO:0045087),-0.2377199069223715,-1.0576281380028416,0.2983050847457627,0.6318617674727843,1.0,88/217,35.77%,SP100;ANKHD1;MFHAS1;LYN;ANKRD17;IFIH1;TRIM25;APP;SETD2;TRIM56;DDX3X;RNASE7;YES1;CLPB;OTULIN;GCH1;IRGM;PTK2;LBP;RNASE3;PLCG2;PIK3CD;SERINC3;ALPK1;PGLYRP1;FRK;TRIM14;IFITM3;IRAK1;NCF2;TRIM59;CD40;SRPK2;FYN;MAVS;NLRC5;TRIM13;NRROS;IKBKG;DEFA6;SERINC5;IKBKB;NOD2;TKFC;ZDHHC1;KYNU;TRIM28;PPARG;PTK2B;TRIM39;RELA;TRIM68;AKAP1;HMGB1;IFITM2;LCN2;RPL39;FCER1G;IRF7;CXCL10;BST2;TRIM6;RNF187;TIFA;IFNLR1;MASP2;TREM2;TRIM35;TRIM32;SRMS;VNN1;IRF5;CORO1A;JCHAIN;TRIM62;NOS2;FGR;TRIM5;SHFL;MFAP4;TBK1;CD300LB;NCF1;POLR3A;IFI27;CD74;TLR8;SYK
prerank,negative regulation of cell communication (GO:0010648),0.3564660044112339,1.057608470315322,0.36899563318777295,0.7888233462805003,1.0,3/21,3.53%,OPRM1;IGFBP3;GLRA1
prerank,response to steroid hormone (GO:0048545),-0.3257180175877892,-1.0572546211380773,0.34065934065934067,0.6323745611515381,1.0,10/31,18.54%,ABHD2;CAV1;THBS1;NR3C1;MED1;TGFB2;YAP1;UBE2L3;WBP2;TFPI
prerank,microtubule anchoring (GO:0034453),0.41687395961383256,1.057061504411577,0.35933806146572106,0.7889608567646745,1.0,4/12,17.60%,BICD1;BCCIP;CLASP2;CAMSAP3
prerank,mitotic spindle organization (GO:0007052),-0.24970862616329145,-1.0568945070943705,0.3415061295971979,0.6328308033073422,1.0,73/153,39.57%,CLIP1;MAD1L1;MAP4;NEK6;RANBP2;CCDC61;AHCTF1;STAG1;TOGARAM1;NUP98;PLK2;SEC13;WRAP73;FLNA;KIF23;RHOA;ARHGEF10;PAFAH1B1;MECP2;KIF11;STAG2;RPS27;RAB11A;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;PRC1;BUB3;TTK;MISP;CENPI;PCNT;CENPH;CENPN;DYNLL1;RAN;EML4;SPDL1;CDCA8;TUBG2;SPC25;STMN1;BIRC5;EFHC2;NUDC;WDR62;CEP192;MAP9;NUF2;AURKA;PLK1;CKAP5;MIS12;NUP43;TNKS;SPC24;CDC20;VCP;LSM14A;RMDN1;SPICE1;KIF2C;SMC3;CCNB1;DYNC1LI1;KIFC2;NSL1;CENPM;TPX2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3897470957148401,-1.0567736349859786,0.3683241252302026,0.6327286673313632,1.0,3/15,8.87%,ELOVL5;PPARA;PPARD
prerank,JNK cascade (GO:0007254),-0.3120706666565245,-1.056607983247481,0.3684210526315789,0.6327431657569185,1.0,15/40,24.29%,TAB3;NOD1;MAP3K5;MAP4K3;IRAK1;MAPK8;TNFRSF19;TAB2;IRAK2;MAP2K4;IKBKG;NOD2;SH2D3C;MAP3K7;GPS2
prerank,wound healing (GO:0042060),-0.2870714893157805,-1.0564313374732004,0.3618881118881119,0.6327633054687025,1.0,16/62,13.54%,MYOF;MYH9;DYSF;MACF1;AHNAK2;FGF1;TGFB2;SCARB1;RAF1;DST;FUT10;CFLAR;DCBLD2;FGF2;PRCP;TPM1
prerank,photoreceptor cell development (GO:0042461),0.39467267107297443,1.056280364725291,0.38660907127429806,0.7898523921077747,1.0,4/14,9.26%,AHI1;ARL3;DCX;VEGFA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4205239783077156,-1.0561697559080787,0.396584440227704,0.6329458324434669,1.0,5/12,18.41%,STARD3;FDX1;FDXR;STARD3NL;STAR
prerank,cellular response to interferon-gamma (GO:0071346),-0.26765784473662596,-1.0555994247604714,0.31616341030195383,0.6338831486441342,1.0,25/88,25.03%,SP100;DAPK1;IRF2;TRIM25;CCL25;JAK1;CAMK2G;ICAM1;MID1;PRKCD;GBP6;IRF1;JAK2;GBP4;PDE12;VCAM1;GBP5;SYNCRIP;CCL19;IFNGR2;RPL13A;FCGR1A;TRIM68;GBP3;CASP1
prerank,negative regulation of axon extension (GO:0030517),-0.33451528206417575,-1.0554892719584326,0.3824561403508772,0.633735476108816,1.0,11/30,20.69%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.40721923410826155,-1.0554699882123413,0.37842778793418647,0.6333742735840485,1.0,5/14,16.35%,PRKG1;SLIT2;MEF2C;TPM1;IGFBP5
prerank,phospholipid transport (GO:0015914),-0.2968211757440823,-1.055350746132453,0.36,0.6332480675291615,1.0,15/52,21.81%,ATP10A;PITPNC1;ATP8B1;PLTP;SCARB1;MFSD2A;ATP10B;ABCA7;TNFAIP8L3;PCTP;ATP9B;PRELID2;OSBPL2;ATP11C;PITPNA
prerank,acylglycerol catabolic process (GO:0046464),-0.328215430734736,-1.0548774031305392,0.3692022263450835,0.6339298959763471,1.0,12/30,41.73%,ABHD2;MGLL;LPL;LIPE;PNPLA2;FABP3;LIPH;ABHD12;FABP4;FABP12;LYPLA2;DAGLA
prerank,phagosome maturation (GO:0090382),0.3173502529863032,1.0547085584945353,0.3681917211328976,0.7931583635754424,1.0,11/35,17.01%,MREG;ATP6V1B2;ATP6V0C;ATP6V0A2;ATP6V0D2;ATP6V1G2;RAB34;RAB39A;ATP6V0D1;RAB20;ATP6V1C1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.43965101214274094,-1.0543966076142224,0.3996478873239437,0.6347291857250726,1.0,10/11,50.01%,TP53;ATF4;ATF6;DDIT3;CEBPB;ATF3;ATF6B;MBTPS2;CREB3L3;CREB3L1
prerank,regulation of heart contraction (GO:0008016),0.2579396016178133,1.054330619192322,0.33915211970074816,0.7927950215472757,1.0,17/90,13.30%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;CELF2;CALM2;NPPC;RNF207;SLC8A2;RYR2;SLC8A1;SLC8A3;SRI;HRC;CASQ1;FXYD4
prerank,early endosome to late endosome transport (GO:0045022),-0.3704685237479175,-1.054293811651541,0.4079696394686907,0.6345653561562166,1.0,7/20,22.92%,RAB7A;RAB5A;STX8;ANKRD27;AKTIP;KIF16B;BECN1
prerank,regulation of viral genome replication (GO:0045069),-0.288754211713816,-1.0541660479065929,0.3494983277591973,0.6344821269116445,1.0,24/56,29.55%,IFIH1;ZC3HAV1;DDX3X;LARP1;PPARA;IFITM3;PKN2;PLSCR1;PDE12;N4BP1;SRPK2;MAVS;ADARB1;RAD23A;STAU1;PPIH;IFITM2;PABPC1;BST2;TRIM6;RSAD2;PPIE;OASL;TNIP1
prerank,positive regulation of intracellular transport (GO:0032388),0.3100850363245775,1.0539056895148107,0.3477272727272727,0.7925538334781449,1.0,8/38,9.63%,ABCA12;TENM1;PGAP1;STK11;ZFAND1;SORL1;PLA2G4E;EIPR1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.3309345099880441,-1.0537961709809804,0.3786231884057971,0.6349983515253345,1.0,17/33,35.64%,IFIH1;TRIM56;DDX3X;IRF1;FLOT1;POLR3F;MAVS;PTPN11;HSP90AA1;DHX9;RIOK3;IRF7;TOMM70;IRF5;TBK1;POLR3A;TLR8
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4411892184719206,-1.0536276926591992,0.3951890034364261,0.6349807918728918,1.0,3/11,12.64%,JAK1;IL6ST;JAK2
prerank,cellular response to organic substance (GO:0071310),-0.2569595841168127,-1.0534596372960539,0.34275618374558303,0.6349680688422467,1.0,21/116,9.89%,LEF1;GHR;ACVRL1;NFAT5;PTPN14;KLF4;BMPR2;RAMP1;LDLRAP1;PTPN9;LRRK2;TIPARP;EMD;PTPN12;TGFBR2;SLIT2;ARL6IP5;HAX1;RAMP2;ACVR2A;SOCS2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3305461504327942,-1.053421942893179,0.3894736842105263,0.6346602658202986,1.0,8/30,19.50%,PPP1R13B;ACER2;FHIT;TP53;NDRG1;USP10;HINT1;ATRX
prerank,protein localization to cell surface (GO:0034394),-0.3441599761705009,-1.0533543580309102,0.3734290843806104,0.6344113530095975,1.0,10/26,20.45%,SMURF1;RIC3;PTPRK;FLNA;FBLN5;FGF7;WNT11;ANGPT1;CTNNB1;VCL
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.44972382626161184,-1.0529425300238793,0.4132841328413284,0.6350076814035386,1.0,10/10,55.06%,SMAD7;RC3H1;NFKBID;IL4;MALT1;FOXP3;TBX21;RC3H2;ZC3H12A;NFKBIZ
prerank,organophosphate ester transport (GO:0015748),-0.351340185890823,-1.0527593803231308,0.3854166666666667,0.635087016398581,1.0,8/24,21.81%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PCTP;PRELID2;OSBPL2;PITPNA
prerank,regulation of cilium assembly (GO:1902017),-0.28272495893735433,-1.0526329175072284,0.35489833641404805,0.6350246746791204,1.0,19/62,18.68%,LIMK2;TBC1D1;TBC1D2B;IFT140;CDK10;USP6NL;TBC1D30;TBC1D14;CROCC;YAP1;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;FUZ;TBC1D20;TBC1D8;ARHGAP35;TBC1D17
prerank,regulation of immune response (GO:0050776),-0.25260395955755816,-1.052535852372359,0.3381818181818182,0.6348425070485948,1.0,25/135,17.03%,FOXP1;ITGB1;XIAP;CD34;LYN;CD200;IL15;CLEC2D;ICAM1;BIRC3;SAMHD1;TGFB2;IRF1;PVR;CASP8;ITGA4;CSK;ICAM2;PLSCR1;N4BP1;CD40;VCAM1;GPR108;ERAP1;ZMPSTE24
prerank,negative regulation of microtubule polymerization (GO:0031115),0.41571084932074986,1.0523738471454913,0.3864168618266979,0.7956751835801191,1.0,6/12,18.55%,EML2;ARHGEF7;MAP2;STMN2;MAPRE1;TUBB4A
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4352417596531246,-1.0521766108938388,0.3939393939393939,0.6352469320953462,1.0,3/11,11.31%,P3H2;OGFOD1;P4HA1
prerank,negative regulation of defense response (GO:0031348),-0.2728118027760324,-1.0513001757618976,0.3507853403141361,0.6369034695349454,1.0,18/77,16.84%,TEK;RB1;KLF4;MFHAS1;PPARA;NMI;OTULIN;PRKCD;CDH5;PPARD;PPM1B;FEM1A;TRAF3IP1;CCN3;C1QTNF3;ILRUN;TNFRSF1A;TNFAIP3
prerank,response to interleukin-6 (GO:0070741),-0.44232390942749766,-1.0507203563974914,0.3953488372093023,0.6378980964414689,1.0,2/10,5.58%,ST3GAL6;NFKB1
prerank,camera-type eye development (GO:0043010),0.3396991977034935,1.050100743285371,0.3839479392624729,0.80111083109504,1.0,6/25,9.26%,TENM3;EFEMP1;WT1;PAX2;TSKU;VEGFA
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.36206288241412576,-1.0498115931268595,0.3953488372093023,0.6392676331989553,1.0,5/20,12.39%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.36206288241412576,-1.0498115931268595,0.3953488372093023,0.6392676331989553,1.0,5/20,12.39%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,eye morphogenesis (GO:0048592),-0.37419879281141544,-1.0493074401948725,0.3858695652173913,0.6401052050707788,1.0,8/19,15.88%,COL5A1;RARG;NIPBL;NKD1;COL5A2;SHROOM2;AGTPBP1;SKI
prerank,DNA strand elongation (GO:0022616),-0.3837898640508078,-1.0491230824150748,0.4010600706713781,0.640153832961998,1.0,12/18,33.14%,MRE11;MCM4;POLD3;GINS3;GINS1;DCLRE1B;RFC4;TERT;MCM3;MCM7;RAD50;GINS2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.26605894507713684,-1.0491158697252663,0.35110294117647056,0.6397681378412263,1.0,22/88,19.25%,CLINT1;VPS13A;EXOC6;STXBP6;EPS15;APP;EXOC4;SCAMP2;DNM2;RABEP1;PUM1;EXOC2;SCFD1;VPS13C;AP1G1;EXOC8;ACBD3;CORO7;VPS35L;AP4M1;SCAMP1;AP4B1
prerank,toll-like receptor signaling pathway (GO:0002224),-0.2651083788090206,-1.0487191759849561,0.36252189141856395,0.6403009815567097,1.0,32/84,35.64%,TAB3;BIRC3;NMI;MAPKAPK2;LBP;PLCG2;UBE2D3;CASP8;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;IKBKG;IKBKB;ITGAM;RIPK1;MAP3K7;HMGB1;LGALS9;TNIP1;TLR6;TICAM1;SCARA3;TLR1;TNIP2;PIK3AP1;TLR5;S100A9;CD14;TLR8
prerank,Fc receptor signaling pathway (GO:0038093),-0.26115941886397115,-1.0487081935638187,0.3579136690647482,0.6399244154693934,1.0,28/110,18.55%,TAB3;RAC1;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;JUN;PSME2;MAPK1;PLCG2;PSMB4;MAPK8;PIK3CB;FBXW11;PSMC2;PSMB2;GRB2;TAB2;PSMB1;GAB2;MAP2K4;PSMA8;IKBKG;PSME1;IKBKB
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.34515531236304786,1.0485460798175654,0.36323851203501095,0.8043416520436485,1.0,4/25,3.86%,B3GALT1;NDST4;FUT9;B3GALT5
prerank,prostaglandin biosynthetic process (GO:0001516),-0.37375090128174,-1.0480869263672088,0.4028268551236749,0.6410399793282963,1.0,11/18,31.19%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;HPGDS;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2726503872878859,1.0480018221140552,0.3516483516483517,0.8043988270169207,1.0,20/69,18.47%,BCL2;TYRO3;CLN3;PTPRZ1;NTRK2;VSTM2L;PLA2G3;GRN;POU4F1;FGF20;MAG;FZD9;CCL2;NRBP2;APOE;BDNF;ADAM8;RETREG1;MSH2;CX3CL1
prerank,regulation of protein modification process (GO:0031399),-0.2984876480924176,-1.0476638524973745,0.3864406779661017,0.641639255842471,1.0,11/50,10.88%,LYN;CORO1C;KAT2B;ATG7;ATG10;SPRED2;PTK2;CDH5;ASPSCR1;FNIP2;STAT2
prerank,cellular response to alcohol (GO:0097306),-0.3061333179707676,-1.0475069522759382,0.37410071942446044,0.6416153840681795,1.0,14/42,21.01%,CTNNA1;GNB1;SMO;LARP1;LRP6;SPIDR;CDH1;PTGFR;KLF9;ADCY1;CTNNB1;GOLPH3;BRCA1;BLM
prerank,regulation of TOR signaling (GO:0032006),-0.2806273214801023,-1.0472295049227773,0.3568965517241379,0.6418704560485746,1.0,18/67,19.88%,SH3BP4;GAS6;RICTOR;GNA12;DDIT4;SEC13;GSK3A;MIOS;UBR2;PRKAA1;TTI1;RPTOR;LARS1;GOLPH3;UBR1;ITFG2;TMEM127;AKT1S1
prerank,regulation of viral life cycle (GO:1903900),0.35743152011275997,1.0470885426541288,0.3978494623655914,0.8055473760477782,1.0,5/21,14.38%,HS3ST5;TYRO3;TRIM27;TSG101;PPIA
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.26888813186780763,-1.0464603501739123,0.3611111111111111,0.6432892643963893,1.0,26/80,22.39%,WASF2;EPS8;RAC1;FNBP1L;EPS8L2;PALM;PIK3R1;RHOQ;PLCE1;WASL;AGRN;OCLN;CROCC;ARAP1;BCAS3;CDC42EP3;NCKAP1;FAM98A;FUZ;ARHGAP35;CCL19;WASHC1;NDEL1;CDC42EP1;PLEKHM1;MIEN1
prerank,negative regulation of secretion by cell (GO:1903531),0.3039138561083619,1.0462123831451253,0.38478747203579416,0.8068718474250589,1.0,9/38,13.32%,IL1RAPL1;SYT11;CHGA;TRH;CYP51A1;GRM7;IL12A;SYT4;APOE
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2619713707881328,-1.0459878087271262,0.36813186813186816,0.6440209664962302,1.0,26/99,17.48%,CTNNA1;RAPGEF2;PKD2;SH3BP4;DIAPH1;MTOR;LARP1;PDE2A;SLIT2;PDE3A;KCNQ1;EZR;RAP1A;MEF2C;RAP1B;CDH1;CAPN2;RAPGEF1;ACTB;RPTOR;LARS1;P2RY6;HTR1B;IGFBP5;CTNNB1;GOLPH3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.36523298835333995,-1.0459315949343182,0.3960216998191682,0.6437623570876786,1.0,5/21,10.24%,PDZD8;MCUB;TGM2;AFG3L2;BCAP31
prerank,proteasome assembly (GO:0043248),-0.421415984506934,-1.0455365751733332,0.42985611510791366,0.6443229173800091,1.0,7/11,30.95%,PSMG2;ADRM1;PSMD4;PSMD5;PSMG1;OTUD6B;PSMD13
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.29547211009445573,-1.044766105875058,0.3881118881118881,0.6457453506505813,1.0,22/52,27.84%,PAN3;TUT7;CNOT4;SAMD4A;EXOSC1;EXOSC2;EXOSC3;TUT4;RC3H1;PDE12;PARN;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;CNOT2;CNOT8;EXOSC7;CNOT1;LSM2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.3296384778218797,-1.0441230426309644,0.366120218579235,0.6469599768271712,1.0,12/30,28.34%,HPS4;UBE2J2;GSK3A;UBE2D3;UBE2L3;BAP1;HUWE1;NPEPPS;FZD5;SAE1;ARIH2;RNF31
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.40820121563802264,1.0439209955001958,0.41150442477876104,0.8122672127205236,1.0,3/11,12.85%,ST18;GSN;HTRA2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.26021493052338635,-1.0437347028909432,0.3752244165170557,0.6475017224890921,1.0,28/109,18.55%,TAB3;RAC1;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;JUN;PSME2;MAPK1;PLCG2;PSMB4;MAPK8;PIK3CB;FBXW11;PSMC2;PSMB2;GRB2;TAB2;PSMB1;GAB2;MAP2K4;PSMA8;IKBKG;PSME1;IKBKB
prerank,stem cell development (GO:0048864),0.3828077960564761,1.0436717183740147,0.3804100227790433,0.8114309575427796,1.0,3/16,11.81%,NRG1;NOLC1;CDH2
prerank,regulation of viral transcription (GO:0046782),-0.31217997947851805,-1.0434372035411366,0.3791208791208791,0.6478023241207194,1.0,21/39,36.31%,UBP1;POLR2G;MDFIC;TRIM14;IFITM3;TRIM13;NELFB;SUPT4H1;POLR2C;DHX9;POLR2H;POLR2L;RSF1;LARP7;TRIM32;NELFA;TRIM62;POLR2E;NELFCD;TARBP2;POLR2A
prerank,neuron apoptotic process (GO:0051402),0.36711155347813784,1.043098833240886,0.3938679245283019,0.8115991064948845,1.0,4/19,6.05%,CDK5;BCL2;SCN2A;NAE1
prerank,positive regulation of RNA splicing (GO:0033120),-0.3344416083396017,-1.0430328677301928,0.39194139194139194,0.6483641471633068,1.0,8/29,21.37%,DYRK1A;PIK3R1;NUP98;ERN1;ZPR1;RBM20;TRA2B;RBM3
prerank,translational termination (GO:0006415),-0.26321108765862977,-1.0427412736512607,0.3856655290102389,0.6486606899191404,1.0,33/95,25.98%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;GSPT1;MRPL12;MRPS27;N6AMT1;MRPL58;MRPL24;MRPL57;MTRF1L;MRPS14;MRPS21;MRPL35;GFM2;ABCE1;MRPL54;MRPL34;MRPL13;MRPL9;MRPS28;MRPS35;MRPS2;MRPL43;MRPS31;MRPL11;TRMT112
prerank,positive regulation of ossification (GO:0045778),-0.3115839187436842,-1.0426130860936313,0.39186691312384475,0.6485444981502401,1.0,10/39,12.10%,ZBTB16;BMPR2;BMP6;BMP4;TGFB2;MEF2C;ACVR2A;ANO6;ADGRV1;PKDCC
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.40973801531598086,-1.04254062782679,0.4071550255536627,0.6483317146625185,1.0,6/13,29.82%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2;SPI1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.34046640822273555,1.0420916837821808,0.4072398190045249,0.8130469625681181,1.0,5/26,5.81%,ATP2B4;EFHB;AKAP6;CAMTA1;FHL2
prerank,transcription by RNA polymerase I (GO:0006360),-0.3228917747898512,-1.0420747773606256,0.40794223826714804,0.6490513708070108,1.0,15/34,32.67%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;POLR2H;POLR2L;TAF1D;POLR1E;GTF2H3;CCNH;POLR1H;POLR2E
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3875968891408103,-1.0418403507538474,0.383587786259542,0.6492092910497592,1.0,4/15,12.82%,CUL3;STXBP4;PLCG2;CDC73
prerank,amyloid-beta metabolic process (GO:0050435),-0.3823720655545399,-1.0416978230932827,0.4028520499108734,0.6491307278325799,1.0,6/16,16.28%,DYRK1A;ACE;PSEN2;PSEN1;ABCA7;APH1A
prerank,negative regulation of dephosphorylation (GO:0035305),-0.37069720885014357,-1.041633229268808,0.3946869070208729,0.6488537773160318,1.0,4/18,13.10%,MFHAS1;ZCCHC9;GPATCH2;CHP1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.32101340017686425,-1.041612286805923,0.3929889298892989,0.648508957984127,1.0,6/36,7.62%,ENG;PPP2R5A;PDGFD;DDX3X;RASSF2;MRE11
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.3346863351680499,-1.0412768208933836,0.3951473136915078,0.6489199110270282,1.0,10/27,34.89%,TAB3;IRAK1;TAB2;IRAK2;MAP3K7;TNIP1;TLR6;TLR1;TLR5;CD14
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.2994163441344421,1.040893687507477,0.3890160183066362,0.8152741988118818,1.0,8/41,13.72%,GRM5;DOCK3;NTRK2;ADRA2A;LILRA5;CSF1R;DLG4;BDNF
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3520126454779898,-1.040764886329147,0.4137323943661972,0.6497563465518318,1.0,11/24,23.25%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G;SEMA5A
prerank,protein insertion into ER membrane (GO:0045048),-0.31208877650889794,-1.040708235586752,0.3769911504424779,0.6494969105876564,1.0,12/37,21.36%,APP;EMD;UBE2J2;SGTA;TRAM2;EMC9;VAPA;EMC2;EMC6;WDR83OS;UBL4A;VAMP2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.395126173254586,-1.0402653209830763,0.40070921985815605,0.6501552026647646,1.0,2/14,6.05%,ENTPD1;ENTPD6
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.27187120501215306,-1.0399744464460294,0.37543859649122807,0.6504609532379778,1.0,30/78,26.08%,MNAT1;PKD2;CDKN1B;EGFR;CCND3;LATS2;AKT1;CCNY;RGCC;ACTB;TFAP4;CDK5RAP3;CCND1;CNPPD1;BLM;CDKN2C;PTEN;MYOCD;CCNYL1;CDC25A;GADD45A;CCNG1;CEBPA;NR2F2;CCNK;APC;CCNE2;CCNJ;CDKN3;ADAM17
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3318870649494207,-1.0397574482009913,0.4035714285714286,0.6505468266466854,1.0,7/29,13.54%,ENG;TGFBR3;S1PR1;ZFPM1;SMAD7;NOTCH1;TPM1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.38013129146825075,1.0388469923586603,0.3858093126385809,0.8200302141708911,1.0,5/15,13.64%,PSMD10;PRELID1;TRIAP1;GHITM;CLU
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.39362630365515655,-1.0387417641573102,0.3964285714285714,0.6526693341235005,1.0,6/16,21.16%,CHMP4B;CHMP4A;VTA1;VPS36;CHMP5;TMEM50B
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3529455898239348,-1.038680976887448,0.4158607350096712,0.6524065632797446,1.0,6/23,8.24%,GNB1;LRRK2;ABL1;KCNQ1;TGM2;MAPK1
prerank,autophagy of mitochondrion (GO:0000422),-0.3118426340582353,-1.0386503722578857,0.3982142857142857,0.6520723833422676,1.0,15/38,26.36%,ATG7;MAP1LC3B;AMBRA1;BNIP3;GABARAP;FUNDC1;WIPI1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B
prerank,rRNA catabolic process (GO:0016075),-0.39063633965556255,-1.0384427994895857,0.4186471663619744,0.6521492630023797,1.0,7/16,25.31%,XRN1;EXOSC2;EXOSC3;EXOSC8;PELO;EXOSC5;EXOSC7
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.29620944221735895,1.038373948063841,0.38826185101580135,0.8198776311475198,1.0,10/40,13.64%,MAGI2;VTN;BICD1;CD63;ATAD1;AHI1;VEGFA;SGIP1;C3;CLU
prerank,carbohydrate homeostasis (GO:0033500),-0.2801849567591866,-1.0383725487264173,0.3886861313868613,0.6519246754072333,1.0,9/67,10.57%,IGF1R;KLF7;INSR;ADIPOR2;TENT4B;RBP4;IRS1;HECTD4;PRKAA1
prerank,negative regulation of protein processing (GO:0010955),-0.4214405198630254,-1.0382021383783469,0.4203935599284436,0.6519369555186898,1.0,6/12,25.13%,THBS1;LRRK2;SNX12;CTSZ;SERPINE1;SERPINE2
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.34274160529171943,-1.0379013003294546,0.3981651376146789,0.6522618903723896,1.0,2/24,0.93%,ZBTB16;ACVRL1
prerank,cellular response to type I interferon (GO:0071357),-0.3076143145133563,-1.0377989160844103,0.4010327022375215,0.6517173508568644,1.0,9/41,11.91%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1
prerank,type I interferon signaling pathway (GO:0060337),-0.3076143145133563,-1.0377989160844103,0.4010327022375215,0.6517173508568644,1.0,9/41,11.91%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3984617079702889,1.0372550283836166,0.39514348785871967,0.8217329793778367,1.0,2/13,4.35%,BPNT2;SULT2B1
prerank,androgen receptor signaling pathway (GO:0030521),-0.4261332440727902,-1.037184293929926,0.41058394160583944,0.6528259435353722,1.0,5/11,29.81%,ZMIZ1;KDM3A;PMEPA1;PLPP1;RNF14
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3261792998422313,-1.037117200903154,0.3944636678200692,0.6525909041518058,1.0,10/33,18.56%,SH3BP4;SESN1;MTOR;UBR2;CAPN2;RPTOR;LARS1;CASTOR1;FYN;UBR1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.31799478154015093,-1.0370483441460643,0.4166666666666667,0.6523693341979955,1.0,16/33,34.27%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;MTURN;ARNT;PRKDC;HSPA1B;MAPK11;MAPK14;RAB7B;HOXA5;STAT3;SCIN
prerank,oligosaccharide biosynthetic process (GO:0009312),0.35502766327130697,1.0368525082404207,0.3978021978021978,0.8214129886035842,1.0,5/20,8.54%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,positive regulation of lipid storage (GO:0010884),-0.36318222730427274,-1.0367536574098386,0.4099616858237548,0.6526990125335895,1.0,6/21,16.97%,NFKB1;SCARB1;EHD1;IKBKE;LPL;PLIN2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.3072647047203571,-1.0367090208543932,0.38517179023508136,0.6524079458690236,1.0,15/38,28.34%,LRRK2;HPS4;UBE2J2;GSK3A;HAX1;UBE2D3;UBE2L3;BAP1;HUWE1;NPEPPS;FZD5;SAE1;ARIH2;BAG4;RNF31
prerank,response to tumor necrosis factor (GO:0034612),-0.2639138049451603,-1.0365830609111002,0.39896373056994816,0.6523223411225372,1.0,32/91,28.90%,DAB2IP;CCL25;MAP4K3;ADAM9;GGT5;GCH1;ARHGEF2;ADAM10;CASP8;AKT1;JAK2;ZFAND6;CD40;ASAH1;GSDME;IGBP1;HYAL2;CCL19;IKBKB;RPS3;BRCA1;RELA;NFE2L2;HAS2;RIPK1;DHX9;GBP3;ADAMTS7;ERBIN;BAG4;CACTIN;HYAL3
prerank,organic cation transport (GO:0015695),-0.36246097146324435,-1.0365255680682626,0.4110535405872193,0.6520620265233289,1.0,5/20,10.86%,SLC47A1;RALBP1;SLC22A5;SLC44A1;SEC14L1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2805177730364017,-1.0362616630867727,0.39361702127659576,0.6523021882029687,1.0,26/61,33.09%,MNAT1;RB1;CDKN1B;CRLF3;CUL3;MAX;CUL2;PLK2;LATS2;CDK6;GSPT1;CCND1;CACUL1;CDKN2C;CDC25A;PLK3;CCNE2;E2F3;CDKN3;KHDRBS1;CCNH;HINFP;CDC34;CDK4;CCNE1;CUL5
prerank,positive regulation of response to stimulus (GO:0048584),-0.3026938399718298,-1.0358872226788707,0.4099264705882353,0.6527800093326979,1.0,13/40,24.66%,IFIH1;IL15;TGFB2;PRKCD;YPEL3;ILK;ABI3;CGAS;MAVS;NSMCE4A;TAF9;DHX9;FXR1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.4142307118109816,-1.0357471180168467,0.4275092936802974,0.6527036517493012,1.0,3/11,6.91%,DAB2;MSN;EZR
prerank,oxoacid metabolic process (GO:0043436),0.32800422608333657,1.0354542405363616,0.3804100227790433,0.8242228955623375,1.0,8/27,19.68%,BPNT2;SULT2B1;GNMT;HAO1;THAP4;ENPP1;PPA1;DDO
prerank,inner dynein arm assembly (GO:0036159),0.42230579014771286,1.0350902951993304,0.4194260485651214,0.8237850234861847,1.0,2/10,8.48%,DNAAF5;DNAAF1
prerank,exit from mitosis (GO:0010458),-0.4118122190540114,-1.034739189611125,0.42123893805309737,0.6546459750680644,1.0,3/12,10.95%,EPS8;PPP2R2D;CHMP4B
prerank,catecholamine metabolic process (GO:0006584),-0.3949612777076848,-1.034218339184302,0.40734265734265734,0.6555109354700875,1.0,1/14,1.09%,SNCAIP
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4155344672859382,1.0337884259327146,0.38738738738738737,0.8262982085721022,1.0,2/11,5.03%,CD177;CAMK4
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3827802895000343,-1.033685914330103,0.4375,0.6563856339550969,1.0,3/15,6.05%,ENTPD1;CMPK1;ENTPD6
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.36330645493956937,1.0336680147943706,0.38979118329466356,0.8250861874382059,1.0,3/18,5.50%,CHRM2;OPRM1;CHRM3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.42064829964797834,-1.0336423853536598,0.4409171075837742,0.6560869870134084,1.0,6/12,24.66%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3211260246036932,-1.0334347862049118,0.4036363636363636,0.6561712721807716,1.0,12/35,19.42%,HIP1;RAC1;LDLRAP1;CBL;AAK1;PICALM;HFE;FLOT1;PIK3CB;HIP1R;CCL19;MKLN1
prerank,protein complex oligomerization (GO:0051259),0.2607102782971783,1.033393038583986,0.38177874186550975,0.8244240717780338,1.0,7/85,4.36%,KCNC2;MPP2;GLRA3;MS4A1;C9;ADCY8;ATL1
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.29306215330613306,-1.0333867057640689,0.3911504424778761,0.6554869101925445,1.0,13/51,19.19%,EMD;AHCTF1;NUP98;SEC13;REEP3;LMNA;CHMP4B;CHMP4A;CHMP2B;LBR;SUMO1;CC2D1B;PPP2CA
prerank,mitotic nuclear membrane organization (GO:0101024),-0.29306215330613306,-1.0333867057640689,0.3911504424778761,0.6554869101925445,1.0,13/51,19.19%,EMD;AHCTF1;NUP98;SEC13;REEP3;LMNA;CHMP4B;CHMP4A;CHMP2B;LBR;SUMO1;CC2D1B;PPP2CA
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3580573647318022,-1.0331217150419922,0.41207815275310833,0.6557512015439099,1.0,8/22,15.79%,LYN;RANBP9;SP1;EPHA4;GSK3A;PICALM;SLC2A13;ROCK2
prerank,ureteric bud morphogenesis (GO:0060675),-0.375681162053401,-1.0321364644703768,0.4216417910447761,0.6577068399204431,1.0,5/16,12.95%,PKD2;SIX1;BMP4;FGF2;WNT11
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.31734289128815363,-1.0319978438125514,0.3955094991364421,0.657642543332915,1.0,12/36,24.07%,EIF3H;TLK2;FHIT;RYBP;AQP11;HFE;N4BP1;GIPC1;USP7;TRIM39;OGT;TAF9
prerank,skin development (GO:0043588),-0.27754155655872503,-1.031980135520941,0.3860294117647059,0.6572845775518149,1.0,12/65,11.07%,ITGA6;BCR;ITGA3;LSR;ITGB4;COL5A1;ADAM9;MED1;HRNR;COL5A2;WNT16;TXNIP
prerank,prostaglandin metabolic process (GO:0006693),-0.3392063686577594,-1.0318041336243666,0.426497277676951,0.6572995634790211,1.0,11/26,24.12%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;ACOX1;HPGDS;DAGLB;PTGR1;PNPLA8;PTGIS
prerank,peptide hormone secretion (GO:0030072),-0.3379442148412075,-1.0314705695501554,0.39889705882352944,0.6576883571422798,1.0,6/26,13.13%,RAB1A;CAMK2G;EDN1;LTBP4;SNX19;EDN3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3521208621785678,1.0313515093166818,0.4314159292035398,0.8291304261711439,1.0,6/20,17.43%,FAR1;ACLY;ACACA;ACSL3;SCD5;SCD
prerank,regulation of proteolysis (GO:0030162),-0.29386432842084487,-1.030835775023409,0.4166666666666667,0.6588636913066801,1.0,14/48,19.84%,CAV1;RNF139;DNAJC1;ASPH;CASP8;AKT1;PERP;LTBP4;SPOPL;FBXW11;HDAC6;PLAT;SPOP;FGFR4
prerank,dephosphorylation (GO:0016311),-0.24274580754421154,-1.029981704299856,0.3982608695652174,0.6605150367069068,1.0,29/147,14.32%,PTPRG;PTPRB;PTPRM;PTPN14;PPP2R5A;PPM1H;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PPEF2;PPM1L;ALPL;PTPRK;ILKAP;PPM1F;MTMR6;PPM1B;UBLCP1;PPP1R12A;DUSP23;ACP6;PTPN3;DUSP3;CTTNBP2NL;PNKP;FBXW11;PTPN13
prerank,cGMP metabolic process (GO:0046068),-0.4085137513330277,-1.0298047470220797,0.43727598566308246,0.6605226855192021,1.0,5/12,23.13%,PDE2A;PDE9A;NPR1;GUCY1A1;GUCY2C
prerank,intermediate filament organization (GO:0045109),0.35751329720062197,1.0297095416305087,0.3947939262472885,0.8326709755407055,1.0,5/17,17.35%,PKP2;BFSP2;TCHH;NEFL;VIM
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3789137059814435,1.0289446639561428,0.42437923250564336,0.8334829148498433,1.0,3/14,12.84%,LPIN1;ETNK1;CHKA
prerank,amino acid transport (GO:0006865),0.287850941012209,1.0282079392615844,0.3876146788990826,0.8342537978234745,1.0,9/49,9.84%,SLC7A11;PDPN;SLC7A4;SLC6A15;SLC7A8;SLC36A2;SLC25A45;SLC7A14;SLC7A6
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2404379470316605,1.0280771761604366,0.37906976744186044,0.8331128087690131,1.0,25/140,12.91%,HTR2C;C1QTNF1;CACNA2D1;ADCY8;CALCA;CACNA1A;PTGER3;CACNB3;GRM1;RYR2;TRPM1;C3AR1;CCR6;GPR65;GPER1;CIB2;ADRA1D;ADRA1A;TACR1;NMUR2;DLG4;P2RX3;SLC8A1;PDGFRA;P2RX5
prerank,cell proliferation in forebrain (GO:0021846),-0.4355734547890162,-1.027552009932199,0.44082332761578047,0.6655976662529175,1.0,6/10,35.28%,NUMB;PCM1;AKNA;KIF14;WNT7A;NUMBL
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3426874411349631,-1.027307195182336,0.4111310592459605,0.6658145607508201,1.0,9/26,19.63%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2;CCL19;PTPRC
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.32071007874250473,-1.0271834565843065,0.41519434628975266,0.6657029882326435,1.0,8/31,14.68%,PARD3B;PARD3;MSN;DLG1;EZR;MTCL1;RHOA;MARK2
prerank,kidney development (GO:0001822),0.27094449277039157,1.0262855926645336,0.4051172707889126,0.8372852818487962,1.0,11/65,9.26%,ROBO2;MME;LHX1;OSR1;WT1;PAX2;HNF1B;VANGL2;PROX1;ARL3;VEGFA
prerank,positive regulation of viral process (GO:0048524),-0.28342680293511413,-1.0260677820063178,0.43133802816901406,0.6679585499723595,1.0,24/60,28.79%,RAB7A;DDX3X;LARP1;PPARA;POLR2G;MDFIC;PKN2;PDE12;TBC1D20;SRPK2;ADARB1;NELFB;RAD23A;STAU1;PPIH;SUPT4H1;POLR2C;DHX9;POLR2H;POLR2L;PABPC1;RSF1;PPIE;AXL
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.40285144925183947,-1.025753143102518,0.41155234657039713,0.668283412160003,1.0,7/13,28.91%,LSG1;RRS1;ABCE1;RPS15;RAN;NUP88;NMD3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.31769785797355843,-1.0257513884280562,0.40966010733452596,0.6678863708925603,1.0,11/34,18.74%,PTPRB;PTPN1;PTPN9;PTPRJ;PTPN12;DUSP3;PTPN13;UBASH3B;TNS2;DUSP16;DUSP22
prerank,regulation of cilium movement (GO:0003352),0.41770309314737425,1.0257477385452176,0.40582959641255606,0.8373661582713886,1.0,3/10,9.42%,ODAD2;DNAAF1;CFAP43
prerank,positive regulation of cellular component movement (GO:0051272),-0.34066729662327183,-1.0256938829348605,0.4076655052264808,0.6676131591429517,1.0,4/24,3.24%,ETS1;LYN;NTN1;SPOCK2
prerank,GTP metabolic process (GO:0046039),-0.3935024929600649,-1.024968750591357,0.4329159212880143,0.6689634429564721,1.0,4/15,14.03%,GNAI3;LRRK2;RHOQ;RAB23
prerank,glycogen catabolic process (GO:0005980),0.37360723222589004,1.024515205334931,0.41309255079006774,0.8396011548774962,1.0,8/15,22.80%,AGL;PHKG1;PYGM;PYGB;PYGL;PGM2;PGM2L1;GAA
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.22522700216712033,-1.0244575974513574,0.3960923623445826,0.6697546439741424,1.0,84/264,27.84%,SRSF11;CDK13;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;PRPF6;SF3B6;FUS;SPEN;RBM19;HNRNPM;POLR2G;DDX39B;PHF5A;SF3B1;HNRNPA3;PRPF31;PUF60;CPSF7;SNIP1;EFTUD2;HNRNPUL1;DHX38;DBR1;HNRNPF;SFPQ;CTNNBL1;SLU7;SNRPE;SCNM1;HNRNPA1;SF3A1;TGS1;SRPK2;SRSF12;CWC25;SYNCRIP;ZMAT5;CD2BP2;TFIP11;BUD13;RBM4B;SRRM1;FIP1L1;RNPS1;SRSF3;SRSF10;STRAP;CWC22;NONO;TRA2B;LSM3;RBM6;PPIH;RBM15;COIL;PCBP1;PDCD7;USP39;GEMIN7;POLR2C;SF3B5;GCFC2;DHX9;RNPC3;POLR2H;PRPF40B;POLR2L;HNRNPU;HNRNPL;HNRNPD;PABPC1;TXNL4A;CWC27;SCAF11;LSM2
prerank,apoptotic cell clearance (GO:0043277),-0.32460784152608424,-1.0237112007845208,0.41563055062166965,0.6711818318358721,1.0,12/30,24.41%,RAC1;RHOBTB1;THBS1;GAS6;TGM2;SCARB1;RHOG;RARA;ANXA1;ITGB3;ADGRB1;HMGB1
prerank,microtubule anchoring at centrosome (GO:0034454),0.4198527234620021,1.0236462915828959,0.40993788819875776,0.8407381331452123,1.0,6/10,19.05%,NINL;BBS4;KIF3A;CEP19;CCDC120;HOOK3
prerank,peptidyl-arginine modification (GO:0018195),0.3764805769323388,1.0234003175012902,0.42788461538461536,0.8399198856023551,1.0,4/15,16.29%,PADI1;PADI2;PRMT5;ART4
prerank,negative regulation of cell development (GO:0010721),-0.33415457886745914,-1.0233324286814598,0.43302752293577984,0.6717064109884892,1.0,10/25,32.80%,GSK3B;GSK3A;NOTCH1;IGF1;PCM1;RFLNB;FBN1;RFLNA;LILRB1;WNT7A
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.4222845620328716,-1.023197170611054,0.42857142857142855,0.6716344244413849,1.0,5/11,20.42%,SLC30A10;PPARA;ABCB7;FYN;COA8
prerank,negative regulation of reproductive process (GO:2000242),0.368587208083694,1.02305108642374,0.44567627494456763,0.8394936412730345,1.0,6/17,22.71%,SPINK13;NPPC;TIMP1;ACVR1C;GJA1;WDR77
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.36441330104192343,-1.0230346643383401,0.43144424131627057,0.6716239788909435,1.0,4/18,6.91%,CTSC;VGLL4;MSN;EZR
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3928784978881375,-1.0226613056480274,0.4136690647482014,0.6721306709167603,1.0,5/13,21.30%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4306959956154668,-1.0224055890720922,0.4672566371681416,0.6723450062568348,1.0,6/10,36.17%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DPYS
prerank,cardiac conduction system development (GO:0003161),-0.34939177517736286,-1.0223557850291496,0.43356643356643354,0.6720554530854403,1.0,11/24,29.92%,BMP4;SMAD1;MAML1;NOTCH2;SMAD4;HEY2;HEY1;MSX1;GJA5;MSC;HCN4
prerank,fatty acid transmembrane transport (GO:1902001),-0.3663852384236954,-1.021797632147612,0.4326750448833034,0.6729575902954736,1.0,4/19,11.05%,SLC2A1;ABCD3;ACACB;CPT1A
prerank,negative regulation of receptor binding (GO:1900121),-0.4201021442873414,-1.02179605666427,0.43485617597292725,0.6725606029165,1.0,5/10,38.31%,ATP2A3;HFE;ADAM15;ATP2A2;PTPRF
prerank,ganglioside biosynthetic process (GO:0001574),-0.3826160699572032,-1.0208352392313338,0.4262295081967213,0.674550740555152,1.0,4/15,9.19%,ST3GAL1;ST8SIA4;ST6GALNAC3;ST3GAL2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3538485256320012,-1.0204351060497696,0.41304347826086957,0.6750886312998126,1.0,8/20,25.07%,CDKN1B;LATS2;TFAP4;PTEN;MYOCD;CEBPA;NR2F2;APC
prerank,regulation of amyloid-beta formation (GO:1902003),0.30609680273934375,1.0204282943906706,0.4114942528735632,0.846248419716174,1.0,9/34,13.64%,LRRTM3;GGA3;NTRK2;ABCA2;SORL1;RTN4;GSAP;APOE;CLU
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.22228077436947494,-1.0203978745316982,0.3745704467353952,0.6747733884640754,1.0,52/291,13.58%,DAB2IP;RAPGEF2;GNB1;FOXO1;PKD2;ESR1;DAPK1;LYN;SH3BP4;NRIP1;ATM;TBX1;MTOR;FZD4;EGFR;ADAM9;NFKB1;TNFRSF1B;PXN;PDE2A;PDCD4;SLIT2;IRS1;PDE3A;KCNQ1;IRGM;PRKCD;PTPRK;EZR;RAP1A;MEF2C;JUN;TGM2;LBP;PRKD1;MAPK1;RAP1B;NFKBIL1;AKT1;CAPN2;RAPGEF1;ACTB;IRAK1;RPTOR;KAT5;RHOA;CDC73;WNT11;LPL;LARS1;TPM1;MAPK8
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3688318080575278,-1.019923536056754,0.42579505300353354,0.6754674708749857,1.0,5/18,15.81%,ESR1;NRIP1;EGFR;KAT5;RUVBL2
prerank,negative regulation of macroautophagy (GO:0016242),-0.33478465194494117,-1.019899690003129,0.4533106960950764,0.6751478526097191,1.0,6/26,10.96%,LRRK2;MTOR;SCFD1;AKT1;CHMP4B;CHMP4A
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4326021800185652,-1.0195051254531908,0.4658273381294964,0.6756946615424194,1.0,5/10,27.05%,RNF125;SEC14L1;GPATCH3;TKFC;RIOK3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.37777656314704194,-1.0194633394673747,0.43478260869565216,0.6754061730794636,1.0,6/16,20.02%,SHLD1;DTX3L;KMT5B;PNKP;MAD2L2;PRKDC
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.37601406625002415,-1.0191186937238799,0.43575418994413406,0.6758324768866141,1.0,5/16,12.91%,PKD2;SIX1;BMP4;FGF1;FGF2
prerank,regulation of protein dephosphorylation (GO:0035304),-0.3127092847620691,-1.0180158935975758,0.4394213381555154,0.6780692965277393,1.0,6/37,7.39%,PPP2R5A;MFHAS1;PPP1R2;PRKCD;CDH5;SPPL3
prerank,positive regulation of calcium ion transport (GO:0051928),0.30209896140394416,1.0177198965949186,0.43478260869565216,0.8532865436991168,1.0,9/36,12.91%,STC1;WNK3;CACNA1D;SPHK2;LILRA5;CCL5;P2RX3;CCL2;P2RX5
prerank,mesenchymal to epithelial transition (GO:0060231),0.420749167560857,1.0172640080742597,0.4345991561181435,0.8531637901503187,1.0,2/10,6.22%,WT1;PAX2
prerank,regulation of cell communication (GO:0010646),-0.3085656869975471,-1.0161315647938547,0.4237588652482269,0.6822089083070303,1.0,9/35,18.48%,GRK5;IGFBP7;PTPN1;CRK;SOCS2;MGLL;NCLN;CASQ2;ANXA1
prerank,cellular response to ketone (GO:1901655),-0.30581469837765907,-1.0152129557783127,0.43486238532110094,0.684023713585564,1.0,10/35,17.48%,GNB1;NR3C1;MSN;LARP1;PTGFR;NCOA4;KLF9;ADCY1;ROCK2;GOLPH3
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3725261595378897,-1.0151261433179881,0.4305799648506151,0.6838460576701361,1.0,4/17,11.03%,SLC9A2;SLC12A2;TRPM4;SLC9A5
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.42140424434546053,-1.015011230327997,0.4442508710801394,0.6837159009345505,1.0,3/11,10.01%,NOS3;GCH1;AKT1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4189865459911678,-1.0149427819449732,0.4543859649122807,0.6834696215850421,1.0,6/11,27.04%,SETD2;IWS1;NUP153;TPR;DHX9;KHDRBS1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.28150977653577336,-1.0145673728485858,0.4371584699453552,0.6840115979409954,1.0,13/56,18.60%,TAB3;NOD1;MAPKAPK2;LBP;PLCG2;ALPK1;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;NOD2
prerank,regulation of interleukin-4 production (GO:0032673),-0.3517712127858176,-1.0144477335672826,0.4543795620437956,0.6839257819682752,1.0,12/21,40.52%,LEF1;SLC7A5;ZFPM1;RARA;FCER1G;LGALS9;DDIT3;CEBPB;NLRP3;SYK;GATA3;CD28
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3579157671257886,-1.0141813718264068,0.44014084507042256,0.6841545812651542,1.0,6/20,11.13%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,carbohydrate biosynthetic process (GO:0016051),0.3416467945748492,1.0138229559602008,0.41163793103448276,0.8624798704033717,1.0,5/21,8.54%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,histone H4 deacetylation (GO:0070933),-0.4237830669353983,-1.0137646013370423,0.4506517690875233,0.684750575100401,1.0,4/10,18.51%,RCOR1;HDAC1;HDAC4;SMARCAD1
prerank,negative regulation of signaling (GO:0023057),0.32530693740459965,1.0137179072446534,0.4425531914893617,0.8612396805487611,1.0,3/25,3.53%,OPRM1;IGFBP3;GLRA1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4166896101987092,-1.0129927809476906,0.45688073394495415,0.6862045226419942,1.0,5/11,21.32%,STX18;ATL2;VCPIP1;MOSPD3;LPCAT3
prerank,regulation of cell differentiation (GO:0045595),-0.2373159056535292,-1.0128223603615387,0.4181494661921708,0.686193115385059,1.0,34/148,19.19%,SLC6A6;CREBBP;CBFB;KLF4;ZFHX3;SPOCK2;SMOC1;TBX1;SIK1;SIX1;NREP;SUZ12;PTK2;NGF;ROCK1;RAF1;NOTCH4;MOSMO;SMAD7;LTBP4;RPS6KA1;PA2G4;EDN3;TAF8;ATF4;CDK6;RPS6KA3;NR1D2;MCRIP1;HEY2;HEY1;CDK5RAP3;UQCC2;PPP2CA
prerank,regulation of protein metabolic process (GO:0051246),-0.2948455949977789,-1.0126790823088854,0.43278084714548803,0.6861264378369288,1.0,14/44,22.51%,KLF4;NEDD4L;KLF2;APP;ACE;LTBP4;SPOPL;MAPK8;ABCA7;ROCK2;SPOP;MAPK7;MDM2;MTPN
prerank,protein targeting (GO:0006605),-0.24826087369236918,-1.0122789389648454,0.40353982300884955,0.686619070333859,1.0,54/118,36.99%,PARD3;RASSF9;PEX1;KIF13B;ZDHHC6;TRAK1;ZDHHC3;HPS4;AQP11;SRPRA;TOMM40;FUT10;BCAP31;GABARAP;ZFAND6;TIMM17B;TOMM5;SRP14;DNAJC19;GIPC1;LAMP2;AP4M1;AP4B1;ZDHHC1;ZDHHC4;HOMER3;ZDHHC12;ZFAND2A;TIMM10;PEX6;RAB3IP;TOMM20;SEC61A1;VPS37B;TOMM70;ATG3;HACL1;LONP2;PEX19;GOLGA7B;RTP4;ZDHHC9;TIMM10B;ZDHHC22;SEC63;NCF1;TIMM13;ICMT;YIF1B;VPS37C;RABGEF1;ZFAND2B;TAOK2;TIMM23
prerank,positive regulation of TOR signaling (GO:0032008),0.2941394288898448,1.0120572772160261,0.4153498871331828,0.8649081176204745,1.0,7/40,8.74%,GPR137C;RRAGA;PIP4P1;HDAC3;FLCN;KLHL22;SEH1L
prerank,protein homotetramerization (GO:0051289),0.2779530471705366,1.0118760388319508,0.42596810933940776,0.8639157190519797,1.0,11/49,15.58%,HCN1;SYCP1;RYR3;AQP4;GNMT;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3369039015051448,-1.0116119928915361,0.4161849710982659,0.6878767221428425,1.0,7/24,20.34%,ABCG2;ALAS1;ABCB10;FLVCR1;SUCLA2;COX10;RSAD1
prerank,glucose import (GO:0046323),-0.3950570419768101,-1.011060991079056,0.45119705340699817,0.6888129636942922,1.0,3/13,11.89%,SLC2A1;RAB4B;SLC27A4
prerank,respiratory system development (GO:0060541),0.3078007082042793,1.010940691100022,0.42032332563510394,0.8653074358989141,1.0,7/32,9.26%,WNT7B;PDPN;WT1;PROX1;FGFR2;DNAAF1;VEGFA
prerank,ncRNA 3'-end processing (GO:0043628),-0.3861575016406168,-1.0107707026493231,0.4578096947935368,0.6891518478670409,1.0,8/14,29.73%,INTS8;INTS7;ELAC2;TRNT1;TOE1;INTS5;INTS12;SSB
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.43881533657225114,-1.010083539745,0.4701627486437613,0.6904705995834889,1.0,4/10,19.81%,MSN;EZR;RHOA;RAP2A
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.3469589581489829,1.009971562611801,0.4485776805251641,0.8669218865701149,1.0,4/19,6.35%,HS6ST3;HS3ST5;NDST4;HS6ST2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3420688943788658,-1.0098221990917204,0.45121951219512196,0.6906659233369489,1.0,15/23,53.23%,GAS6;CEACAM1;TNFAIP3;IGF1;NLRP2B;NLRP3;CARD16;CD33;GIT1;GSTP1;NLRP12;APOA1;FFAR4;ZC3H12A;IL10
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3757091714431853,1.008877054177329,0.46808510638297873,0.8687697752940042,1.0,6/14,20.90%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3078257497254538,1.008615301697438,0.42289719626168226,0.8679914175723522,1.0,8/31,12.88%,NRG1;PKP2;PROX1;FGFR2;RYR2;TNNC1;ZFPM2;MYL2
prerank,mitotic nuclear division (GO:0140014),-0.2670168559862913,-1.0083754862385286,0.45818815331010454,0.6939307970016051,1.0,23/71,27.79%,EPS8;CCDC61;STAG1;TOGARAM1;PPP2R2D;WRAP73;SMC4;FLNA;CHMP4B;RHOA;ARHGEF10;KIF11;STAG2;RAB11A;DSN1;NDEL1;KIF3B;MISP;KIF18B;RAN;INO80;CDCA8;TUBG2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4249957366066422,-1.008342883667329,0.4752650176678445,0.6935870030997976,1.0,5/10,29.17%,PODXL;FERMT3;PIEZO1;ADA;WNK1
prerank,ceramide biosynthetic process (GO:0046513),-0.30247462712483053,-1.0083338506046569,0.4384057971014493,0.6932064554240595,1.0,11/40,16.91%,SGMS1;ST8SIA4;DEGS2;SGMS2;ST6GALNAC3;CERS4;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4001850770974166,1.007991673839464,0.46099290780141844,0.8683270482342997,1.0,4/11,13.37%,DDX11;NOP53;IPPK;SIRT7
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4301097922841024,-1.0079503920340873,0.46808510638297873,0.6936893721200816,1.0,5/10,29.09%,ATF4;HERPUD1;NFE2L2;EIF2AK3;DDIT3
prerank,regulation of leukocyte migration (GO:0002685),0.36600337403885896,1.0078936236396718,0.44110854503464203,0.8670834667507529,1.0,4/16,9.26%,TNFSF18;HOXA7;CD81;VEGFA
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3718577641926734,-1.0076539789350165,0.45565217391304347,0.694003971198132,1.0,6/16,22.06%,SMAD4;BCOR;DNMT1;CTNNB1;BRCA1;WDR5
prerank,diol biosynthetic process (GO:0034312),0.3728776828203026,1.0074541684201237,0.45,0.8669432929712755,1.0,5/15,9.46%,QDPR;SPHK1;ABCA2;ACER1;SPHK2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.39448063814337875,-1.0072870686074928,0.44153577661431065,0.6945511372896026,1.0,2/14,5.54%,DYRK1A;NIPBL
prerank,negative regulation of transposition (GO:0010529),-0.37148050004596367,-1.006583684897783,0.4444444444444444,0.6958501823566527,1.0,9/16,39.66%,TUT7;UBR2;TUT4;MOV10;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,vesicle transport along microtubule (GO:0047496),0.3346920634322224,1.0056816416212928,0.4377880184331797,0.8708142649548518,1.0,11/23,19.50%,CLN3;KIFAP3;KIF5A;KIF3A;DYNC1I1;KIF1C;HTT;TRAK2;BICDL1;FYCO1;HAP1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.29001944347706465,-1.005482250522804,0.43884892086330934,0.6980894750356674,1.0,17/47,25.66%,THBS1;TGFBR2;PRKCD;RAB27A;PLCG2;DHRS4;TP53;AGTR1;GRB2;SOD1;ITGAM;GADD45A;RIPK1;ACE2;PDGFRB;ADGRB1;SLC5A3
prerank,neural tube closure (GO:0001843),-0.31208441305102835,-1.0054277408092014,0.43738977072310403,0.6978076029058798,1.0,9/34,15.88%,DVL3;LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.29002167860924044,-1.0053061314063574,0.45143884892086333,0.6977118248598216,1.0,12/47,16.40%,RAPGEF2;CAV1;CD34;SIK1;NFKB1;ACADL;CEACAM1;ERLIN2;ACADVL;C1QTNF3;ROCK2;FYN
prerank,regulation of neuron migration (GO:2001222),-0.3336471786948635,-1.0052639804011605,0.43462897526501765,0.6974060929325955,1.0,6/26,10.56%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2;PHACTR1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.3184495472015431,-1.0052334828560539,0.4630281690140845,0.6970822366326519,1.0,12/28,24.04%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;MECP2;RPS3;ARL2;AKAP9;HSPA1B
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3909070173629216,-1.0052063144294199,0.4462081128747795,0.6967402876459574,1.0,9/13,45.59%,TRIM13;TRIM28;CHMP3;TRIM35;TRIM32;TRIM5;PML;TRIM21;MID2
prerank,regulation of telomerase activity (GO:0051972),-0.2921981115432055,-1.0045889168206759,0.45359019264448336,0.6978230630716331,1.0,11/45,14.23%,KLF4;NEK7;ATM;PARP4;TCP1;MAPK1;TP53;HMBOX1;PNKP;PTGES3;PARN
prerank,negative regulation of catalytic activity (GO:0043086),-0.34060880828539786,-1.004297978526462,0.4482758620689655,0.6981437560877416,1.0,15/24,39.38%,NES;TP53;PPP1R12A;NOTCH1;APBA3;HDAC6;PLN;NOS1;PARP9;NOSIP;PHPT1;MT3;ATP5IF1;SIRT1;HP
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2656680373917549,-1.0042286943085037,0.4742647058823529,0.6979006135335842,1.0,18/79,18.67%,ST3GAL6;ST3GAL4;BMPR2;ST8SIA4;GCNT2;CSGALNACT1;ALG10B;DAD1;B3GNT2;ST3GAL2;CHST11;FUT10;GAL3ST2;B4GALT5;IGF1;GOLPH3;ST6GALNAC2;LARGE1
prerank,nitric oxide metabolic process (GO:0046209),-0.38449666690951834,-1.004170350186482,0.4375,0.697651119915709,1.0,6/14,21.74%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3342176889744287,-1.004157432874142,0.4696132596685083,0.6972700542372253,1.0,10/23,35.00%,COX18;SAMM50;AGK;BCL2L11;HSP90AA1;TIMM10;TOMM70;PMAIP1;TIMM10B;TIMM13
prerank,post-translational protein modification (GO:0043687),-0.21394861720307312,-1.0040831545796776,0.43386243386243384,0.6970455122069094,1.0,94/332,27.07%,FBXL7;ZBTB16;IGFBP7;KLHL5;DCAF10;DCUN1D3;PTP4A2;FBXL12;APP;PSMA2;RAB1A;IGFBP4;CUL9;FBXL3;RBX1;RAB2A;GAS6;LMO7;CUL3;DCAF5;BMP4;PSME2;CUL2;PDIA6;RAB5A;PSMB4;WSB2;ADAM10;FEM1A;SOCS2;SPSB1;CUL7;FBXW8;ITIH2;KLHL13;LRRC41;MSLN;ANO8;PRKCSH;NOTUM;CCDC8;ASB1;FEM1C;KLHL25;FBXW11;PSMC2;HIF3A;PSMB2;BTBD1;FEM1B;SERPINC1;ATG5;UBE2M;ERCC8;F5;DCAF13;PSMB1;IGFBP5;RAB11A;KLHL3;EPAS1;PSMA8;PSME1;GPC3;ELOC;MFGE8;PSMD4;CCN1;COPS7A;CHRDL1;ASB7;WDR5;FN3KRP;KEAP1;KTN1;COPS8;COPS4;PSMD5;PNPLA2;LAMB1;FBXO32;FBXO17;RBBP5;DTL;FBXL22;PSMA3;UBXN7;RABGGTB;TMEM132A;PSMB10;SCG3;RAB38;FBN1;RHBDD1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.32573225122410293,1.003961823422113,0.4474885844748858,0.8747056579007279,1.0,8/26,14.08%,ABCA12;NR1D1;ADCY8;EPHA5;ADRA2A;PLA2G6;GPLD1;BRSK2
prerank,regulation of interleukin-6 production (GO:0032675),-0.2490966047834352,-1.0039487791116741,0.44293015332197616,0.6969926731805535,1.0,36/96,35.77%,AFAP1L2;CD200;IFIH1;APP;IL6R;GAS6;MAPKAPK2;LBP;ARHGEF2;PLCG2;LPL;IL17RA;C1QTNF3;TNFAIP3;MAVS;IL16;HYAL2;NOD2;PTPN11;DHX9;HMGB1;ARRB1;F2R;LGALS9;TREM2;TLR6;RAB7B;TLR1;C5AR2;NOS2;STAT3;IL1A;CD74;TSLP;TLR8;SYK
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.34644431744161397,-1.0037915705727962,0.46441281138790036,0.6969450430937049,1.0,4/21,5.75%,PLTP;CAV1;RXRA;NFKBIA
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3316231229569086,1.0036948642157462,0.4588235294117647,0.8739944101139866,1.0,6/23,12.88%,PKP2;PROX1;FGFR2;IRX3;TNNC1;MYL2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.35525399125410256,-1.003654243104937,0.46181172291296624,0.696868070189042,1.0,11/20,36.65%,SP100;SYNE1;TAF8;SUN1;TAF3;ARL2;HNRNPU;TOPORS;PARK7;MORC3;ARL2BP
prerank,response to muscle stretch (GO:0035994),0.35954498913651833,1.003435411578371,0.45454545454545453,0.8732739420704275,1.0,4/15,12.07%,GSN;RYR2;CDH2;SLC8A1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.33105414686771256,-1.003324811718803,0.4542056074766355,0.6972385123330834,1.0,7/25,11.58%,LIMK2;SLIT2;PRKCD;CDK10;TBC1D30;YAP1;ABI3
prerank,apoptotic mitochondrial changes (GO:0008637),0.3042167143236865,1.0031529666751273,0.4502262443438914,0.8726216070732687,1.0,3/32,3.44%,ERBB4;BCL2;GGCT
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4021430038653213,1.002959917248286,0.4358974358974359,0.8716816028487667,1.0,2/10,9.76%,ATP1A2;ADRA2A
prerank,neural crest cell development (GO:0014032),-0.2887041233082273,-1.0026710585476097,0.46757679180887374,0.6984094284643002,1.0,14/44,20.69%,SEMA6A;SEMA3C;SEMA7A;CORO1C;TBX1;PHACTR4;KLHL12;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,transcription by RNA polymerase III (GO:0006383),-0.32884948590190616,-1.002529277020625,0.4718045112781955,0.6983251386722763,1.0,16/27,41.41%,IVNS1ABP;BRF1;SNAPC1;ICE1;GTF3C4;SNAPC3;POLR2L;POLR3GL;POLR3K;RO60;GTF3C3;ELL;GTF3C6;POLR3G;GTF3A;SNAPC5
prerank,myotube cell development (GO:0014904),-0.4249434560781139,-1.0024002024672674,0.4791288566243194,0.6982380133785138,1.0,6/10,35.94%,SIX1;SKI;IGF1;CAV2;MYORG;ACTA1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.37446644120117023,-1.002181574662834,0.4469964664310954,0.6983539818566259,1.0,5/15,19.60%,APP;VBP1;PSEN1;IAPP;PFDN6
prerank,leukotriene biosynthetic process (GO:0019370),-0.3834142524675664,-1.0020873893033482,0.45098039215686275,0.6981702632979424,1.0,2/14,5.76%,PLA2G4A;GGT5
prerank,nuclear membrane reassembly (GO:0031468),-0.2816219755784959,-1.0020695788429301,0.45357142857142857,0.6978096175629609,1.0,19/54,29.64%,EMD;AHCTF1;NUP98;SEC13;REEP3;LMNA;CHMP4B;CHMP4A;CHMP2B;LBR;SUMO1;CC2D1B;PPP2CA;NUP188;RAN;CHMP3;UBE2I;UBXN2A;CHMP6
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3982877142043972,1.0020593555535826,0.45588235294117646,0.8728457971766265,1.0,8/12,26.59%,ACLY;ACO1;IDH3A;GLUD1;ACO2;IDH2;SIRT4;IREB2
prerank,relaxation of muscle (GO:0090075),0.3843373383654415,1.0019643157799922,0.4668192219679634,0.8716453816911977,1.0,4/13,12.07%,ATP1A2;ATP1B1;GSN;SLC8A1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.37525578427691725,-1.0013460664134897,0.4634615384615385,0.6992248800159675,1.0,3/15,9.03%,SIK1;SCARB1;MFSD2A
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.24818155642290193,-1.0012977974029598,0.45501730103806226,0.6989335000101656,1.0,20/101,18.60%,DAB2IP;PRKCE;LYN;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;MEF2C;LBP;NFKBIL1;IRAK1;MTDH;RHOA;CDC73;MAPK8;CHMP5;TNFAIP3;DEFA6;NOD2
prerank,regulation of cellular localization (GO:0060341),0.28567525532463367,1.0010330915623242,0.45336225596529284,0.8730288722054064,1.0,7/46,8.02%,ABCA12;BLK;NR1D1;EPHA5;MAP2;GSN;STXBP2
prerank,response to cAMP (GO:0051591),-0.3026061706283606,-1.000962719745496,0.44563279857397503,0.6993388272827701,1.0,8/37,11.22%,RAPGEF2;PKD2;PDE2A;KCNQ1;EZR;RAP1A;RAP1B;RAPGEF1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.33389851168373064,-1.0003624965103703,0.4711033274956217,0.7004170187300739,1.0,5/22,21.50%,KLF4;GCNT2;FLOT1;BMP7;MAPK7
prerank,sister chromatid segregation (GO:0000819),-0.3134147934161438,-1.0001009704455668,0.4748201438848921,0.700667751769513,1.0,13/31,34.42%,RB1;WRAP73;SMC4;DSN1;KIF18B;RAN;INO80;CDCA8;TUBG2;PLK1;MIS12;ESPL1;TOP2A
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2598604889705253,-1.0000931752515136,0.4756756756756757,0.7002857599245105,1.0,26/80,25.44%,ARF3;STX18;ARCN1;RAB1A;GOLPH3L;COPG1;SCFD1;KIF23;KDELR3;COPA;COPE;USE1;KIF11;ERGIC2;KIF26A;KIF15;LMAN2;ATP9B;GOLPH3;CENPE;KIF3B;SEC22B;ARF5;COPZ1;PLPP3;RAB6B
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.40328941463172713,-0.9994034927179246,0.4681238615664845,0.7015066246363403,1.0,4/12,21.05%,PPARA;NFKBIA;ITGB3;PPARG
prerank,B cell activation (GO:0042113),-0.2638281379781824,-0.9992034540803412,0.44972577696526506,0.7015916321222572,1.0,20/68,20.69%,ITGB1;PTPRJ;ZBTB7A;MEF2C;TPD52;PLCG2;PIK3CD;CTPS1;CASP8;HDAC4;ITGA4;NHEJ1;CD40;TCF3;VCAM1;CEBPG;CLCF1;DNAJB9;PTPRC;CHRNA4
prerank,histone H2B ubiquitination (GO:0033523),-0.42353927804132196,-0.9986686294978585,0.47201492537313433,0.7025241629587297,1.0,3/10,12.82%,DTX3L;RNF40;CDC73
prerank,nitric oxide biosynthetic process (GO:0006809),-0.3931077337990627,-0.9986389004397627,0.4537037037037037,0.7021951104158737,1.0,6/13,21.74%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.29192326141726044,-0.9983416820165869,0.45640074211502785,0.7025203331368671,1.0,16/42,32.65%,RNASE7;IL6R;IRGM;LBP;RNASE3;DEFA6;DROSHA;RPL30;SERPINE1;ADGRB1;SELP;TREM2;TNFRSF14;MPEG1;NOS2;AQP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3910288783220424,0.9982778963112677,0.47757847533632286,0.8800768940173381,1.0,3/12,12.34%,LPIN1;VRK1;PRKCB
prerank,B cell proliferation (GO:0042100),0.3532720318841839,0.9981931275624883,0.4554865424430642,0.8787866945718775,1.0,2/17,3.16%,MS4A1;BCL2
prerank,aorta development (GO:0035904),-0.3893349677690693,-0.9980128113874169,0.4626334519572954,0.7028677181633411,1.0,6/14,9.56%,PKD2;TBX1;PDE2A;TBX2;HECTD1;ADAMTS9
prerank,cellular response to osmotic stress (GO:0071470),-0.34381053619843416,-0.9980122830628543,0.4774436090225564,0.7024663816950786,1.0,6/21,9.81%,PKD2;RCSD1;DDX3X;LRRC8D;ARHGEF2;MYLK
prerank,actin nucleation (GO:0045010),0.3387004202026631,0.9977320056736089,0.4595744680851064,0.8787227790869742,1.0,7/21,19.43%,SPIRE1;TRIM27;ARPC5L;SPIRE2;ARPC5;WHAMM;ARPC1A
prerank,cytoplasmic microtubule organization (GO:0031122),-0.27784825554325127,-0.9975734209705857,0.4434782608695652,0.7031161881587271,1.0,16/54,19.09%,CLIP1;LIMK2;DLG1;EZR;DST;DCTN1;SLAIN2;RHOA;CHP1;TUBGCP5;TUBGCP4;SLK;RAB11A;TRPV4;PCM1;CLIP2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.253909992322066,-0.9974064817345643,0.4750889679715303,0.7031266384272974,1.0,21/88,16.64%,DAB2IP;TRABD2B;MPP7;GSK3B;STX18;RAB7A;TFRC;SPIDR;CDH5;TAL1;FNIP2;RGCC;ICE1;SYNPO2;FLOT1;RHOC;SLF2;TPR;SUMO1;BCL2L11;BMP7
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.35247694084036785,-0.9972943458792161,0.45195729537366547,0.7029941964570309,1.0,10/20,28.16%,BMP5;SIK1;ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3;BMP2;PRMT3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3483475455894219,-0.9972272703336618,0.460573476702509,0.7027531760451137,1.0,11/19,40.23%,ZMIZ1;GAS6;PPP2R3C;PRKDC;IL7;AXL;SYK;ZAP70;GATA3;IL4;MDK
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3925277409478124,0.9971915961231645,0.4723404255319149,0.8788184737791803,1.0,4/12,14.59%,GINS4;CDC45;MUS81;CDC7
prerank,negative regulation of biosynthetic process (GO:0009890),-0.37197109803248957,-0.9963401454773138,0.4619666048237477,0.7045401714695044,1.0,5/16,20.42%,SLC30A10;PPARA;CEACAM1;ABCB7;COA8
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4268647421682444,-0.9958095531656047,0.49906890130353815,0.7054222504047392,1.0,6/10,39.41%,DNMT1;ATRX;BRCA1;DNMT3B;SIRT1;MYB
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.40747091639083033,0.9955282631677684,0.4724576271186441,0.882505366806596,1.0,3/10,6.07%,HECW1;OSR1;HECW2
prerank,melanosome organization (GO:0032438),-0.3261898796629049,-0.9954125241918536,0.46037735849056605,0.705990716518269,1.0,7/26,21.17%,HPS4;BLOC1S5;SHROOM2;AP1G1;RAB32;KIF13A;AP3B1
prerank,histone deubiquitination (GO:0016578),-0.3558930701816303,-0.9953778014085316,0.48014440433212996,0.7056754922950599,1.0,7/18,22.46%,UIMC1;TRRAP;USP15;BRCC3;USP7;ATXN7;USP16
prerank,glucose homeostasis (GO:0042593),-0.25822716310422894,-0.9947425151887168,0.45955882352941174,0.7067859883449317,1.0,10/83,8.45%,IGF1R;KLF7;FOXO1;INSR;ADIPOR2;PIK3R1;RBP4;IRS1;LRRC8D;HECTD4
prerank,iron ion transport (GO:0006826),-0.2853354550431447,-0.9946975487612728,0.4660714285714286,0.7064872851237962,1.0,11/47,14.48%,SLC40A1;TFRC;DNM2;SCARA5;STEAP3;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15;ABCB7
prerank,regulation of establishment of planar polarity (GO:0090175),-0.25443221634065966,-0.9944568751439253,0.46083788706739526,0.7066582067580837,1.0,21/88,19.26%,RAC1;FZD6;SMURF2;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1
prerank,positive regulation of T cell activation (GO:0050870),-0.2638510418245176,-0.9942754656117584,0.4729241877256318,0.7067257499700612,1.0,12/62,19.63%,ZMIZ1;SLC7A1;IL15;TFRC;IL6ST;NCK1;NCK2;VCAM1;ANXA1;CCL19;NOD2;PTPRC
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3872466515922877,-0.9937479066296401,0.4761061946902655,0.7076102849770699,1.0,6/14,26.83%,JAK1;JAK2;SUMO1;IFNGR2;PARP9;PTPN2
prerank,hyaluronan metabolic process (GO:0030212),-0.3357796171343638,-0.9936091821977066,0.44283121597096187,0.7075467552787401,1.0,10/23,31.24%,CEMIP2;FGF2;CHP1;HAS1;HYAL2;LYVE1;HAS2;HEXA;HYAL3;TGFB1
prerank,cellular respiration (GO:0045333),0.2892693176222772,0.9931576572755738,0.4461883408071749,0.8883410228098577,1.0,9/41,14.95%,SLC25A13;UQCR10;NR4A3;UQCRH;SDHA;NDUFS8;NDUFA5;NDUFS7;LYRM7
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3078691169792291,-0.9929960306997748,0.47684391080617494,0.708559479046398,1.0,6/33,14.60%,HIP1;AFAP1L2;CBL;AKT1;ARAP1;HIP1R
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.40421362444720477,0.9928534875237798,0.44655581947743467,0.8877715500204187,1.0,2/11,5.92%,GMNN;DONSON
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.23272028383462795,-0.9923816714509205,0.4831858407079646,0.7096452050720292,1.0,46/152,23.69%,XIAP;RSPO3;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;DDX3X;LRRK2;CSNK1G3;EGFR;TRPM4;NFKB1;MACF1;LRRK1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CSNK1G1;CDC73;DKK2;PLEKHA4;CSNK1D;PSMC2;PSMB2;DAAM2;USP34;SKI;PSMB1;TNFAIP3;LYPD6;PSMA8;PSME1;SOX4;GPC3;TBL1X;PSMD4;CAPRIN2;TERT;AMER1;RSPO2;SEMA5A;PSMD5;RNF146
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3122427074924852,-0.9922907304548942,0.46788990825688076,0.7094640667496025,1.0,8/30,19.11%,UBR5;SHLD1;RNF169;TRIP12;OGG1;CGAS;MAD2L2;TFIP11
prerank,negative regulation of platelet activation (GO:0010544),-0.36220079975982256,-0.9921848603985389,0.48534798534798534,0.7093162129652835,1.0,4/16,12.48%,PRKG1;NOS3;PRKCD;CEACAM1
prerank,protein O-linked glycosylation (GO:0006493),-0.24826842632813054,-0.9919611524946347,0.4737762237762238,0.7094509767449918,1.0,14/96,6.35%,EOGT;ST3GAL4;ST3GAL1;TMTC1;PLOD1;PLOD2;ST6GAL1;TRAK1;TMTC2;GALNT10;GXYLT2;B3GNT2;TET2;C1GALT1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.30836008774888524,-0.9916883440499471,0.45293072824156305,0.7096868674006918,1.0,9/31,19.63%,SHLD1;TFRC;KMT5B;RBP4;MAD2L2;CLCF1;DNAJB9;VAMP3;PTPRC
prerank,defense response to fungus (GO:0050832),-0.35900284066423926,-0.9912932980146227,0.4744525547445255,0.7102649235705262,1.0,12/17,52.70%,RNASE7;PLCG2;S100A9;GAPDH;CARD9;CLEC4D;BCL10;HRG;S100A8;CLEC6A;LTF;CLEC4E
prerank,peptidyl-proline modification (GO:0018208),-0.33232473887371394,-0.991175344773769,0.489010989010989,0.7101556952794363,1.0,7/25,17.53%,P3H2;PPIG;NKTR;OGFOD1;FKBP5;FKBP10;PPIF
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4131897393172229,-0.9910533495378903,0.48811700182815354,0.7096595409284513,1.0,3/11,18.63%,NOTCH4;AGO2;TNRC6A
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4131897393172229,-0.9910533495378903,0.48811700182815354,0.7096595409284513,1.0,3/11,18.63%,NOTCH4;AGO2;TNRC6A
prerank,monocyte chemotaxis (GO:0002548),-0.3083557330185108,-0.9909798448633731,0.4734982332155477,0.7094405348560264,1.0,3/32,5.39%,FLT1;CCL25;IL6R
prerank,catecholamine biosynthetic process (GO:0042423),-0.40630255179676855,-0.9903083398721066,0.49298245614035086,0.7106549306121505,1.0,2/11,6.73%,GCH1;TGFB2
prerank,neuron remodeling (GO:0016322),-0.42471537661535774,-0.9902182087924971,0.48598130841121495,0.7104713828628578,1.0,3/10,5.25%,ANKS1A;APP;SCARF1
prerank,regulation of centrosome cycle (GO:0046605),-0.34664304034911064,-0.9898471874016221,0.47079646017699117,0.7109365960269793,1.0,12/21,35.90%,CHMP4B;CHMP2B;CHMP5;PDCD6IP;CEP131;ATF5;CHMP3;CHMP1A;AURKA;PKHD1;CHMP1B;MARK4
prerank,snRNA 3'-end processing (GO:0034472),-0.3505293593625319,-0.9897643366889117,0.4732142857142857,0.7107338008627906,1.0,11/19,29.52%,INTS8;EXOSC2;EXOSC3;EXOSC8;USB1;EXOSC5;INTS7;EXOSC7;TOE1;INTS5;INTS12
prerank,inflammatory response (GO:0006954),-0.22547010346886404,-0.9897342470284773,0.4666666666666667,0.7104112405056632,1.0,91/195,41.77%,AFAP1L2;RAC1;MFHAS1;ADGRE5;NOD1;THBS1;F11R;NFATC4;CCL25;PARP4;LOXL3;HNRNPA0;NFKB1;GGT5;MAPKAPK2;PIK3CD;PXK;HSPG2;PTGFR;MGLL;AGTR1;HDAC4;ADM;CD40;ADCY1;TNFRSF1A;NOX4;AOC3;NRROS;IKBKG;LY75;IL10RB;ANXA1;CCL19;IKBKB;CMKLR1;CDO1;RELA;ACKR1;HMGB1;BMP2;PTGDR;F2R;CXCL10;HDAC5;LGALS9;IL2RA;IL22;HYAL3;NLRC4;TLR6;VNN1;TGFB1;CEBPB;TLR1;C5AR2;NOS2;TLR5;LAT;STAT3;NLRP3;PTGER1;S100A9;TBK1;IL1A;CCRL2;SIGLEC1;CD14;PROK2;IL18;CCL4;ITCH;TLR2;PTGER2;CRHBP;ABCF1;TNFRSF4;PTGER4;HPR;HP;CRP;IL4;PPBP;TUSC2;CD44;CCL8;CRH;FPR3;CCR1;CXCL5;TLR4
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.23747565104401736,-0.9895616717234137,0.4805414551607445,0.7104381140935011,1.0,50/125,35.01%,CLIP1;MAD1L1;SETD2;MAP4;NEK6;RANBP2;AHCTF1;NUP98;PLK2;SEC13;PAFAH1B1;MECP2;KIF11;RPS27;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;TACC3;BUB3;TTK;CENPI;PCNT;CENPH;CENPN;DYNLL1;RAN;EML4;SPDL1;CDCA8;TUBG2;SPC25;STMN1;BIRC5;EFHC2;NUDC;WDR62;NUF2;AURKA;PLK1;CKAP5;MIS12;ESPL1;NUP43;TNKS;SPC24;CDC20
prerank,negative regulation of neuron death (GO:1901215),0.2445150247894174,0.988889887079402,0.46770601336302897,0.8983758763567248,1.0,22/93,13.72%,CDK5;BCL2;TYRO3;CLN3;PTPRZ1;CHGA;NTRK2;VSTM2L;PLA2G3;GRN;SORL1;POU4F1;FGF20;KIR3DL2;MAG;ATP13A2;FZD9;CCL2;HTRA2;NRBP2;APOE;BDNF
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.33162064561913795,-0.9888857996518001,0.47217537942664417,0.7112290570840395,1.0,4/23,3.59%,CREBBP;DAB2;THBS1;RNF111
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.33162064561913795,-0.9888857996518001,0.47217537942664417,0.7112290570840395,1.0,4/23,3.59%,CREBBP;DAB2;THBS1;RNF111
prerank,fibrinolysis (GO:0042730),0.3789358230339602,0.9887560529144922,0.45905172413793105,0.8972391624208839,1.0,1/13,1.24%,CPB2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.30424807845587376,-0.9886963105917551,0.4691588785046729,0.7112746669882168,1.0,5/36,6.34%,SPTBN1;RAB7A;GOLPH3L;AFDN;MACF1
prerank,response to fatty acid (GO:0070542),-0.3612403569107857,-0.9876861642075115,0.4824399260628466,0.7132589480062526,1.0,4/17,13.17%,FOXO1;FOXO3;IRS1;LPL
prerank,vitamin transport (GO:0051180),0.3069137173412746,0.9876702244621302,0.4703196347031963,0.8991411776682493,1.0,8/29,12.52%,CBLIF;PDPN;SLC46A1;SLC2A10;SLC19A1;GC;SLC2A8;SLC35F3
prerank,T cell migration (GO:0072678),-0.3922622353313898,-0.9873477984172229,0.4626865671641791,0.7136635589737074,1.0,4/13,9.40%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.34886735575552746,0.9871472482800392,0.4780701754385965,0.8992040615131238,1.0,4/18,14.47%,CARTPT;TMEM178A;TCTA;LRRC17
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41802115491644554,-0.9870218896981023,0.46828358208955223,0.7140186263003131,1.0,5/10,20.15%,MECP2;KDM1B;PCGF3;PCGF5;IGF2
prerank,respiratory tube development (GO:0030323),-0.3157090975265878,-0.9868315420245616,0.4810344827586207,0.7140846116937598,1.0,9/28,14.00%,ITGA3;LOXL3;RBP4;BMP4;FGF1;PCSK5;FGF7;FGF2;ZIC3
prerank,negative regulation of bone mineralization (GO:0030502),-0.39402066410016395,-0.9868117286493693,0.48947368421052634,0.7137262681002277,1.0,7/13,30.05%,SRGN;TRPM4;BCOR;PTK2B;RFLNB;RFLNA;AHSG
prerank,fatty acid beta-oxidation (GO:0006635),-0.27890441346141626,-0.986330539272434,0.4642857142857143,0.7144748905130677,1.0,16/51,30.75%,HADHB;ABCD3;BDH2;PPARD;ACADL;ACAD11;CRAT;ACADVL;ACOX1;ACOX3;ECI2;ECHS1;EHHADH;IVD;ECI1;ACADS
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.2553921916071285,-0.9862190693430213,0.5027223230490018,0.7143467207928197,1.0,35/86,32.50%,CREBBP;KLF2;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;TP53;PSMC2;HIF3A;ATF4;PSMB2;PSMB1;GCN1;EPAS1;PSMA8;PSME1;ELOC;ARNT;PSMD4;CHEK1;MAPK7;NFE2L2;PSMD5;PSMA3;PSMB10;INO80;HMOX1;HIGD1A;DDIT3;STOX1;PSMD13;ATF3;PSMB6
prerank,regulation of lipid storage (GO:0010883),-0.3418312770233881,-0.9857364452336488,0.46309963099630996,0.7151133133492475,1.0,9/22,27.71%,NFKB1;NFKBIA;FTO;IKBKE;LPL;ITGB3;PTPN2;HILPDA;ALKBH7
prerank,ceramide metabolic process (GO:0006672),-0.2795327168188687,-0.9856050625333803,0.4727592267135325,0.7150430724541987,1.0,16/49,20.59%,SGMS1;ACER2;DEGS2;SGMS2;ST6GALNAC3;CERS4;ACER3;AGK;SPTLC1;ORMDL1;ASAH1;CERS5;SMPD2;PPP2CA;DEGS1;ORMDL3
prerank,negative regulation of protein polymerization (GO:0032272),-0.32063660096323826,-0.9849480019056204,0.4954627949183303,0.7162988106254141,1.0,8/27,14.60%,KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARFGEF1;HIP1R
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3826666831922035,-0.984466795618403,0.49575551782682514,0.717053112156804,1.0,4/15,9.84%,STOX2;RICTOR;TGFB2;CELF1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.28040225170997846,-0.9844653815882285,0.49295774647887325,0.7166569946978305,1.0,13/49,18.20%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1;CLCF1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2795874087282544,0.9844586741067106,0.46770601336302897,0.9058964992087855,1.0,7/44,7.40%,TENM1;PFN2;SPIRE1;BAIAP2L2;PFN1;GSN;CARMIL1
prerank,negative regulation of ATPase activity (GO:0032780),-0.37235345059148306,-0.9843793914189375,0.5009242144177449,0.7164495069899318,1.0,4/16,17.94%,PXK;TP53;PPIF;PLN
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2678798084659032,-0.9843773665394928,0.47302158273381295,0.716056289258595,1.0,17/61,21.35%,CAV1;PSMA2;PANK2;PPARA;SIRT5;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;FGFR4;NQO1;PSMD4
prerank,cellular response to amyloid-beta (GO:1904646),0.3002643705087193,0.9837374532863471,0.4942528735632184,0.906631048606419,1.0,5/35,4.16%,GRM5;CACNA2D1;CDK5;GRIN2A;CACNA1A
prerank,regulation of response to oxidative stress (GO:1902882),0.39279611839620066,0.9833038450953218,0.45806451612903226,0.9064787338409164,1.0,4/11,17.28%,SELENON;ALOX5;GGT7;ACOX2
prerank,actin filament network formation (GO:0051639),0.3885941359292625,0.9831563868640019,0.4891304347826087,0.9054112293590095,1.0,6/11,20.99%,SPIRE1;FHOD3;CARMIL1;SPIRE2;FHOD1;PLS1
prerank,SNARE complex assembly (GO:0035493),-0.41690364479624675,-0.982506078811119,0.483271375464684,0.7201785119309693,1.0,5/10,32.40%,STXBP6;VAMP3;VAMP2;VAMP8;VAMP4
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3381194781219123,0.9817560506565379,0.4953271028037383,0.9082687016882758,1.0,5/20,10.88%,ATIC;PAICS;AK3;ADSS2;ADSS1
prerank,anterior/posterior axis specification (GO:0009948),-0.36843658056792405,-0.9817474274599512,0.5025906735751295,0.7216298969052364,1.0,8/15,33.60%,TASOR;SKI;FZD5;TBX3;DDIT3;RIPPLY2;SHH;HOXD8
prerank,renal absorption (GO:0070293),-0.415284233974415,-0.9815416113440072,0.49162011173184356,0.7217546974803716,1.0,5/10,22.96%,KCNQ1;WNK4;KLHL3;HYAL2;HAS2
prerank,engulfment of apoptotic cell (GO:0043652),-0.3745956814774102,-0.9809881209556994,0.48250460405156537,0.722634953842117,1.0,3/15,2.66%,RAC1;RHOBTB1;THBS1
prerank,mitochondrial translational termination (GO:0070126),-0.2512986086517632,-0.9808498116627881,0.5067340067340067,0.7225630356055918,1.0,29/88,25.79%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPL12;MRPS27;MRPL58;MRPL24;MRPL57;MTRF1L;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS28;MRPS35;MRPS2;MRPL43;MRPS31;MRPL11
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.35033789324734294,0.9808162063787151,0.48847926267281105,0.9096312291072043,1.0,2/17,5.51%,MAGI2;CALM2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3074673998881401,-0.9808111651679444,0.48269581056466304,0.7222530021049416,1.0,9/32,17.19%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,DNA recombination (GO:0006310),-0.29725835136230805,-0.980757649838664,0.4606946983546618,0.7219806424735682,1.0,17/37,32.86%,DMC1;MRE11;RAD54B;RPA1;HDAC10;WRN;RAD54L;LIG4;BLM;MSH3;HMGB1;EXO1;XRCC2;RAD51D;TSN;RAD50;ENDOG
prerank,intestinal absorption (GO:0050892),-0.3872886303503702,-0.9802053207416463,0.5096660808435852,0.7228820482616352,1.0,3/13,6.94%,F11R;KCNQ1;TJP2
prerank,negative regulation of transferase activity (GO:0051348),-0.32046984199686046,-0.9798242827499766,0.4859154929577465,0.7233807286335133,1.0,7/28,11.42%,GSK3B;DTX3L;CDKN1B;ABL1;GSK3A;TP53;SMAD7
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.39092908462022385,-0.9796402619116136,0.49454545454545457,0.7234246169708193,1.0,5/13,22.22%,NOS3;GCH1;AKT1;MTHFD1L;HSP90AA1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2423396333508188,-0.9796381159916842,0.4734982332155477,0.7230278221405337,1.0,10/110,3.34%,ADGRL4;RAPGEF2;GNB1;ADGRG6;CALCRL;ADGRL2;ADGRE5;ADRA1B;ADCY9;RAMP1
prerank,phospholipid catabolic process (GO:0009395),-0.3220952026234984,-0.9794883106442107,0.4828828828828829,0.7229721198272089,1.0,4/24,14.15%,GPCPD1;PLA2G4A;GDPD1;GDPD3
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.24640459899814715,-0.9792737795963267,0.4848993288590604,0.7231032080363835,1.0,18/98,12.17%,INSR;KLF4;SLCO1C1;THBS1;ANXA2;IFNAR1;RAB1A;TGFBR2;PPARA;NFKBIA;ECE1;PPARD;DHRS4;ACACB;TP53;AKT1;AGTR1;STARD4
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3264566930593223,0.9789055964842797,0.489749430523918,0.914016552206151,1.0,4/23,10.66%,NRG1;AKAP6;PROX1;MYLK3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3156280039559297,-0.9786526824852566,0.48180242634315423,0.7241742946538845,1.0,9/27,22.88%,DYRK1A;ATM;SPRED2;YJU2;MIF;KMT5A;HIC1;MDM2;MSX1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.31399448373107325,-0.9783308593882382,0.5026086956521739,0.7245233509448078,1.0,11/28,21.18%,NOTCH3;EGFR;ZBTB7A;ARRDC1;AKT1;TCIM;HEY1;GATA2;WWP2;RITA1;DLL4
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3301663343770674,0.978312416609587,0.4748201438848921,0.9142177114820716,1.0,7/22,18.99%,CYP24A1;GC;ALDH1A2;CBR1;LRAT;CYP1A1;RBP1
prerank,positive regulation of heart contraction (GO:0045823),-0.3482861754822113,-0.9782399542841252,0.5018587360594795,0.7243323868847237,1.0,8/19,16.77%,TRPM4;KCNQ1;TGFB2;GSK3A;EDN1;ADM;EDN3;SCN3B
prerank,negative regulation of transport (GO:0051051),-0.27008668112744916,-0.9781283457657987,0.488245931283906,0.7242074748894151,1.0,15/51,21.82%,RAB7A;DYSF;PPM1F;PRKD1;ARL6IP5;PXK;SNX12;CTTNBP2NL;PLSCR1;ABCA7;PIP4P2;WWP2;ITGB3;PTEN;NDFIP2
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.3039507951641681,-0.9779574629176692,0.49909255898366606,0.7242234108891533,1.0,8/34,18.25%,FOXO1;FERMT2;ASXL1;YAP1;ANKRD26;ZFPM1;TRIO;GATA2
prerank,histone exchange (GO:0043486),0.2899011577473128,0.9777091666780277,0.4582392776523702,0.9146125928655726,1.0,12/37,20.47%,SMARCA5;CENPS;ACTR6;MIS18BP1;OIP5;RUVBL1;RNF8;CENPW;CENPK;RBBP7;ITGB3BP;CENPA
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.3667055983322286,-0.9772162314962339,0.486159169550173,0.7255665912317966,1.0,3/15,11.57%,TGFB2;SMAD7;HFE
prerank,negative regulation of endocytosis (GO:0045806),-0.3199596499572396,-0.9771876797547034,0.4833040421792619,0.7252384146364268,1.0,4/24,9.10%,CAV1;RAC1;PRKD1;PICALM
prerank,nerve growth factor signaling pathway (GO:0038180),0.3920728726672359,0.9770864791441707,0.4874141876430206,0.9150622310765995,1.0,2/10,4.85%,MAGI2;KIDINS220
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3278877386274422,0.9769556994096048,0.5103926096997691,0.9139346169779792,1.0,5/22,15.14%,PDE3B;BSCL2;ADRA2A;GPER1;APOC1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.39200911781434067,0.976823907219641,0.492600422832981,0.9127794944241169,1.0,3/11,6.16%,ENPP2;PDPN;ARHGEF7
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.32702120599055184,-0.9766472243583157,0.49029982363315694,0.726110597842859,1.0,13/25,34.26%,MTHFD1;ADK;AMPD2;HPRT1;AMPD3;PRPS2;ADA;PNP;APRT;GMPR2;SHMT1;DCK;GART
prerank,translational elongation (GO:0006414),-0.24461833222031193,-0.9764451551098,0.5160744500846024,0.7261415158343697,1.0,38/101,30.10%,DAP3;LTN1;PTCD3;MRPL32;MRPL47;EEF2;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPL12;MRPS27;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS28;MRPS35;MRPS2;MRPL43;EEF1B2;NEMF;TUFM;MRPS31;MRPL11;EEF1G;MRPL48;MRPS17;EEF1D;MRPL39
prerank,bone morphogenesis (GO:0060349),-0.36863794498019203,-0.9760160303300298,0.4972170686456401,0.7268062950365215,1.0,3/14,6.61%,LRP5;BMPR2;LRP6
prerank,histone H2A ubiquitination (GO:0033522),-0.3598790503285788,-0.9760061940679575,0.49907578558225507,0.7264328056280579,1.0,6/17,18.64%,DTX3L;RYBP;UBR2;RNF168;BCOR;RNF2
prerank,cellular response to peptide (GO:1901653),-0.27128338584544454,-0.9754874833504241,0.505338078291815,0.7273142678856819,1.0,16/56,16.85%,IGF1R;CAV1;NOD1;GSK3B;APP;ICAM1;EPHA4;ARHGEF2;TP53;PSEN1;ITGA4;LGMN;VCAM1;CHMP5;FYN;IGF1
prerank,glucan catabolic process (GO:0009251),0.35838748596522774,0.9751960495484219,0.4766355140186916,0.9161855420447687,1.0,8/15,22.80%,AGL;PHKG1;PYGM;PYGB;PYGL;PGM2;PGM2L1;GAA
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4090689584603439,-0.9750897013676115,0.48703703703703705,0.7278699724148618,1.0,6/10,27.38%,CSGALNACT1;DSE;XYLT2;PXYLP1;CSGALNACT2;XYLT1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2205491949706443,-0.9750561577278509,0.4863481228668942,0.7275480617369028,1.0,38/198,15.41%,PTPRB;PLCB4;LIMK2;PAK2;PLA2G4A;PANK2;LRRK2;MTOR;PLCG1;INPP1;LIMD1;INPP5A;PIP4K2A;GFPT2;ACYP2;PLCB3;PLCB1;ALPL;PLCE1;PIP4K2B;MINPP1;PLCG2;ITPKB;PIK3CD;AKT1;PFKFB3;INPP4A;ALDOC;DUSP23;ACP6;DUSP3;LPL;AGK;PIK3CB;PNKP;GK5;AGPAT1;TNFAIP8L3
prerank,chondrocyte differentiation (GO:0002062),-0.2987822657555075,-0.9750535211789954,0.48698884758364314,0.7271575802514862,1.0,7/32,14.59%,NFIB;BMPR2;BMP4;MEF2C;CREB3L2;SNX19;CCN3
prerank,regulation of myoblast differentiation (GO:0045661),-0.3057402348851737,-0.9747804650927641,0.5045372050816697,0.7273993351862006,1.0,16/32,31.55%,BOC;PLCB1;BMP4;MEF2C;NOTCH1;SMYD1;RBM24;TBX3;EID2B;KLHL41;LRRC8A;MAPK14;SOSTDC1;ZFP36L1;TGFB1;XKR8
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.2525787052804583,-0.974546229776676,0.5017361111111112,0.7275385949389677,1.0,17/77,17.58%,ITGA6;RB1;MCL1;THBS1;DDX3X;BMP4;BIRC6;CAAP1;SH3RF1;AKT1;CFLAR;MAZ;HGF;GPX1;IGF1;PPIF;ZMYND11
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2367302718405683,0.9734448161377371,0.5112107623318386,0.9201751901663479,1.0,16/107,12.21%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;CCL7;RYR2;TMCO1;CCL13;ATP13A2;CCL5;SLC8A1;SLC8A3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.37213788549381277,0.9733502003261717,0.5119305856832972,0.9189364370460746,1.0,4/14,10.88%,ATIC;PAICS;ADSS2;ADSS1
prerank,protein oxidation (GO:0018158),-0.40160429495720507,-0.9732734217339754,0.49250936329588013,0.7302257941304906,1.0,5/11,34.63%,LOXL3;LOXL1;LOX;SUMF1;LOXL4
prerank,regulation of calcium ion import (GO:0090279),0.3257093779169663,0.972941625258005,0.4943820224719101,0.9186358095790814,1.0,6/21,12.36%,STC1;WNK3;TRIM27;PLPP4;SPHK2;CCL2
prerank,oligodendrocyte development (GO:0014003),0.35592984117114124,0.9728339720208321,0.47912087912087914,0.9174259366068762,1.0,5/15,17.21%,MYRF;PLP1;TPPP;EIF2B1;B4GALT6
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.39767610171626877,-0.9722539966602138,0.5082266910420475,0.7319011619425136,1.0,6/11,30.42%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.39767610171626877,-0.9722539966602138,0.5082266910420475,0.7319011619425136,1.0,6/11,30.42%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,protein targeting to mitochondrion (GO:0006626),-0.2718413877857709,-0.9721344096077471,0.5100548446069469,0.7317580032790963,1.0,22/52,36.99%,SAMM50;TOMM40;BCAP31;AGK;IMMP1L;TIMM17B;TOMM5;DNAJC19;HSP90AA1;TOMM40L;IMMP2L;TIMM50;TIMM10;PMPCA;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;PAM16;DNLZ;TIMM23
prerank,maturation of 5.8S rRNA (GO:0000460),-0.35879268200774844,-0.9718550248268674,0.5009523809523809,0.7320297379689792,1.0,6/17,26.62%,RPF1;RRP15;NOL9;PRKDC;PES1;WDR12
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3486509686921705,-0.9717430899425177,0.5054347826086957,0.7319227098952144,1.0,3/18,11.36%,SLC2A1;OCLN;BRAF
prerank,positive regulation of viral transcription (GO:0050434),-0.3197140182422862,-0.971164923804351,0.477797513321492,0.7328944599087788,1.0,13/25,36.31%,POLR2G;MDFIC;NELFB;SUPT4H1;POLR2C;DHX9;POLR2H;POLR2L;RSF1;NELFA;POLR2E;NELFCD;POLR2A
prerank,regulation of calcium-mediated signaling (GO:0050848),0.31268441579540424,0.9709781889193051,0.48764044943820223,0.9217322601185299,1.0,8/25,17.63%,RIT2;PLEK;SLC8A2;MAPT;P2RX3;P2RX5;HTT;CDH13
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.30960145781913256,0.9708218842340264,0.5066371681415929,0.9207201645043771,1.0,9/25,25.02%,NPSR1;AKAP6;GPER1;CASQ1;CX3CL1;TRPC1;PDPK1;CAPN3;SNCA
prerank,amyloid fibril formation (GO:1990000),-0.2751097793609108,-0.9706077901306938,0.5336879432624113,0.7338180650531116,1.0,17/51,23.52%,SNCAIP;USP9X;APP;TSPAN14;ADAM10;HSPG2;TSPAN5;H3-3A;APH1A;IAPP;SIAH1;TGFBI;MFGE8;CALB1;MDM2;TSPAN33;RIPK1
prerank,detection of mechanical stimulus (GO:0050982),-0.34193696070443913,-0.9703793539316319,0.4972875226039783,0.7339358363611701,1.0,9/19,32.22%,PIEZO2;PKD2;PTK2;CTNNB1;PKD2L1;PIEZO1;TTN;JUP;LHFPL5
prerank,membrane raft organization (GO:0031579),-0.36455073397233007,-0.9701669355947932,0.5110294117647058,0.7340396462109262,1.0,10/15,38.25%,ANXA2;NAXE;FLOT1;ABCA7;PPT1;EMP2;MYADM;NPC1;S100A10;RFTN1
prerank,acylglycerol metabolic process (GO:0006639),0.28221606753285405,0.9697203777864821,0.5033259423503326,0.9226425882440218,1.0,9/37,16.59%,DGKK;DGKI;DGKQ;GK;PGS1;APOE;APOC1;ABHD6;SEL1L
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.29956839342007024,-0.9695937631066965,0.49644128113879005,0.7349694113795427,1.0,7/35,12.64%,GHR;CAV1;CRLF3;HES1;DOT1L;NOTCH1;JAK2
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3249351832723571,-0.969433418947079,0.4699248120300752,0.7349557837399067,1.0,3/23,6.15%,RAC1;SLIT2;MOSPD2
prerank,mitochondrial gene expression (GO:0140053),-0.2878309363927788,-0.9692017065578407,0.508833922261484,0.735144492635345,1.0,20/42,29.45%,FOXO3;PTCD3;MRPL47;MRPS18A;MRPL2;MRPS24;MRPL12;MRPL57;NDUFA7;MRPS14;MRPS21;FASTKD5;GFM2;IARS2;MRPS28;NOA1;MRPS2;SLC25A33;GATB;MRPS17
prerank,male meiosis I (GO:0007141),-0.3679495502158688,-0.9689826331420993,0.5065913370998116,0.7352577706191055,1.0,7/16,31.80%,ZSCAN21;FOXJ3;HSF2BP;TDRD9;DDX4;FOXJ2;MYBL1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.351017009994144,0.9689411459284641,0.5023041474654378,0.923555302848629,1.0,3/17,11.56%,VTN;NR4A3;CCL5
prerank,amide biosynthetic process (GO:0043604),-0.28145396017610463,-0.9688179273853315,0.5111940298507462,0.7352295232420947,1.0,11/47,16.91%,SGMS1;DEGS2;SGMS2;CERS4;PAM;PCSK5;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,ether lipid biosynthetic process (GO:0008611),0.405166954507145,0.9682236112928838,0.5201698513800425,0.9241912122604752,1.0,6/10,18.20%,FAR1;GNPAT;DHRS7B;PEDS1;CHPT1;LPCAT2
prerank,negative regulation of histone modification (GO:0031057),0.3580471422697501,0.9680606599833441,0.526431718061674,0.9231433238645883,1.0,4/14,15.14%,PRMT6;SPHK2;THAP7;TWIST1
prerank,mitotic chromosome condensation (GO:0007076),-0.3196293375166026,-0.968054399159054,0.48633879781420764,0.7366221419672053,1.0,15/26,39.10%,RB1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;TTN;SET;CHMP1A;PLK1;CSNK2A1;CSNK2A2;CCNB1
prerank,phospholipid biosynthetic process (GO:0008654),0.2895632912787975,0.9679909354138667,0.47685185185185186,0.9218457406819882,1.0,10/36,14.32%,IDI2;FADS1;CLN3;FAR1;HDHD5;SPHK2;CPNE1;GNPAT;NUS1;IDI1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.29952338039209747,0.9675148838026115,0.47413793103448276,0.9218215839154209,1.0,6/31,10.08%,NLGN1;PPFIA2;CDK5;CAMK2B;TANC2;ABI2
prerank,peptidyl-threonine modification (GO:0018210),-0.2599444126445618,-0.9672232487529457,0.5265017667844523,0.738115221431388,1.0,19/66,16.92%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;ROCK1;PRKD1;MAPK1;GSK3A;AKT1;GALNT11;MAPK8;MARK2;HIPK1;ROCK2;CDC42BPB
prerank,regulation of platelet aggregation (GO:0090330),0.34297468258888897,0.9671342741335299,0.5210970464135021,0.92145671019563,1.0,3/17,1.74%,BLK;C1QTNF1;PDPN
prerank,lytic vacuole organization (GO:0080171),0.2931019019922499,0.9665395237531027,0.49892008639308855,0.9218302145160272,1.0,14/32,23.99%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2;GAA;LAMTOR1;NAGPA
prerank,cellular response to hormone stimulus (GO:0032870),-0.25046307965390585,-0.96611526476856,0.5044883303411131,0.7403304419495134,1.0,19/69,18.54%,GHR;CAV1;LMO2;RAMP1;NR3C1;THRB;SLIT2;MED1;MEF2C;RAMP2;SOCS2;NCOA4;BCAS3;KLF9;RARA;UBE2L3;CTSH;WBP2;TFPI
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2231583805614305,-0.9659028433485644,0.5472370766488414,0.7404495445464987,1.0,46/171,21.88%,TTC28;AFAP1L2;RB1;NEK7;BTG3;IQGAP1;CDK13;APP;PSMA2;SIK1;CUL9;NEK6;CDKN1B;RNF40;PSME2;CDK10;PSMB4;USP2;ERCC2;TAL1;CUL7;CDC16;PTPN3;ANAPC16;DUSP3;CCDC8;XPC;PKN2;ERCC3;PSMC2;PSMB2;BTG2;FOXC1;LGMN;SMOC2;PSMB1;TFAP4;PSMA8;CDK5RAP3;PSME1;BUB1B;ANGEL2;CDK11B;BUB3;PSMD4;MDM2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.32997442842020297,-0.9658064679957852,0.5027223230490018,0.7402844172514488,1.0,3/22,5.59%,SLC7A5;TRPM4;TNFRSF1B
prerank,positive chemotaxis (GO:0050918),-0.3494889118826762,-0.9657741024504838,0.49566724436741766,0.7399627140428632,1.0,8/17,33.31%,PTPRJ;FGF7;ANGPT1;SEMA5A;FGF10;MET;CORO1A;TSC2
prerank,response to chemokine (GO:1990868),-0.3840497676536422,-0.9652002690708583,0.50187265917603,0.7409778650201014,1.0,7/13,29.17%,LRCH1;SLC12A2;RHOA;FOXC1;CXCL12;DUSP1;WNK1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3753582453148686,0.9647311363604618,0.5011337868480725,0.9259106572052099,1.0,4/12,15.61%,CDA;DPYSL5;DPYD;DPYSL2
prerank,cellular defense response (GO:0006968),-0.2832078947249404,-0.964693841381302,0.5113636363636364,0.7417611590539254,1.0,9/40,22.92%,ITGB1;ZNF148;LBP;CCR9;NCF2;RAB23;PTK2B;RELA;BECN1
prerank,embryonic organ morphogenesis (GO:0048562),0.27381071865526063,0.9646328890789152,0.5160599571734475,0.9246756838743633,1.0,11/42,15.26%,DSCAML1;EFEMP1;HOXD3;MEGF8;FGFR2;RYR2;MFAP2;HOXA4;PDGFRA;HOXA9;FBN2
prerank,L-serine metabolic process (GO:0006563),-0.4206941426721033,-0.9643491684361848,0.5296229802513465,0.7422024614917598,1.0,5/10,29.23%,SRR;SERINC3;SERINC5;PSAT1;SHMT1
prerank,regulation of chromosome segregation (GO:0051983),-0.3577517649352494,-0.9643044286543183,0.5106761565836299,0.7418941373843895,1.0,13/16,47.94%,SMC5;PUM1;RAD18;PUM2;CDC6;CSNK2A1;CSNK2A2;IHO1;KIF2C;SMC6;AURKB;RMI2;HORMAD1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.33983373254243554,0.9634845998930588,0.4898419864559819,0.9265765095496815,1.0,3/19,5.99%,BPNT2;SULT2B1;SLC35B2
prerank,glycoprotein catabolic process (GO:0006516),0.3411844466181938,0.9633389206349514,0.49443207126948774,0.9255340719621225,1.0,2/17,5.61%,MMP12;FBXO2
prerank,regulation of lymphocyte activation (GO:0051249),0.37497702205194566,0.9630549105317728,0.485838779956427,0.9248887404545587,1.0,2/12,11.56%,PAG1;CCL5
prerank,ruffle organization (GO:0031529),-0.34921828353937534,-0.9629288704634004,0.5037037037037037,0.744829331838426,1.0,2/16,1.94%,LIMA1;RAC1
prerank,regulation of mast cell degranulation (GO:0043304),0.3699351594710844,0.9628764462126829,0.5172413793103449,0.9238859130184809,1.0,3/14,9.46%,BLK;STXBP2;SPHK2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3833057874845516,0.9628255511740238,0.494199535962877,0.9225456585846855,1.0,2/11,6.48%,BCL2;TRIAP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.4115918221361831,-0.962291644517366,0.5359848484848485,0.7455430179134633,1.0,2/10,17.22%,CEP250;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.4115918221361831,-0.962291644517366,0.5359848484848485,0.7455430179134633,1.0,2/10,17.22%,CEP250;TULP1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.28774003716671,-0.9619054995330072,0.521891418563923,0.7460748705297781,1.0,19/41,38.04%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188;NUP88;PRKAG2;NUP35;NUP43;JMJD8;HIF1A;NUP50;PGAM1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3096620071981169,-0.9613016718865278,0.5224416517055656,0.7471610212618962,1.0,14/29,40.02%,LARP1;FUS;AXIN2;RBM24;TAF15;THRAP3;HNRNPU;PABPC1;TENT5C;TENT5B;TENT5D;NOCT;DND1;VIP
prerank,cellular response to inorganic substance (GO:0071241),0.3276495146438163,0.961092251357189,0.5011286681715575,0.9263569173871554,1.0,4/21,8.20%,KCNC2;DDX11;ADCY10;DPEP1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.33589917270305936,-0.9609023111711679,0.5072463768115942,0.7476729644646775,1.0,4/20,9.08%,MCL1;GSK3B;FAS;GSK3A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.29744071368855474,-0.9606127100661812,0.5357142857142857,0.7479690705240521,1.0,17/34,34.89%,DAB2IP;MFHAS1;LYN;NFKBIL1;OTUD4;GPR108;TNFAIP3;GPS2;CD300LF;CACTIN;NLRP2B;TREM2;TLR6;TICAM1;RAB7B;LRRC14;CD14
prerank,negative regulation of hormone secretion (GO:0046888),-0.40813588724701316,-0.9603561474549989,0.5212224108658744,0.7481849375191695,1.0,5/10,35.79%,RAB11FIP3;RAB11FIP1;RAB11FIP5;IL11;LIF
prerank,positive regulation of cyclase activity (GO:0031281),-0.3674413596089417,-0.9601506890731808,0.5131086142322098,0.7482701746145538,1.0,7/14,34.19%,NOS3;MAPK8;NOS1;NF1;MAPK14;NOS2;STIM1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3373213618910379,-0.9598102836483474,0.5169340463458111,0.7487053611522932,1.0,8/20,18.62%,DLG1;RHOQ;ROCK1;LCP1;NCKAP1;ROCK2;IKBKB;FMNL2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.25418984961881996,-0.9597690424150073,0.5294117647058824,0.7484028651037014,1.0,21/74,23.67%,CREBBP;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;NOTCH1;PSMC2;HIF3A;PSMB2;PSMB1;EPAS1;PSMA8;CITED2;PSME1;ELOC;ARNT;PSMD4;NFE2L2;PSMD5
prerank,heme biosynthetic process (GO:0006783),-0.3232464022009445,-0.9596350097232624,0.5057034220532319,0.7483283513274968,1.0,3/22,7.89%,ABCG2;ALAS1;ABCB10
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.41041289893957555,-0.9593692659828,0.5319548872180451,0.748558432602957,1.0,3/10,14.16%,ESR1;TP53;PSMC2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4097695431756914,-0.959124606304258,0.5439560439560439,0.748774649231262,1.0,3/10,8.31%,SHANK3;APP;RAB5A
prerank,heterochromatin assembly (GO:0031507),-0.33561607444073227,-0.9587687715769545,0.5008635578583766,0.749222007214598,1.0,4/20,14.40%,ZNFX1;HDAC1;SUV39H1;H3-3A
prerank,ceramide transport (GO:0035627),0.37854673736208183,0.9578270278329155,0.5086580086580087,0.9350131312444347,1.0,3/12,7.88%,ABCA12;SGPP1;ABCA2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3064482272345361,0.9573894906390658,0.49137931034482757,0.9348244040968355,1.0,5/26,5.80%,PFN2;SHANK1;PLEK;LIMK1;PFN1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3312160674279343,-0.9568999207851515,0.5161290322580645,0.7532600514872478,1.0,5/20,17.80%,LRRK2;ADGRV1;TCIM;MIF;IAPP
prerank,in utero embryonic development (GO:0001701),0.3076392352683675,0.9568079813131348,0.515695067264574,0.9351247324215202,1.0,7/25,11.68%,WNT7B;FLCN;FGFR2;LMX1B;VEGFA;ZNF568;ARNT2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.2589245915565791,-0.956721107206002,0.5485611510791367,0.7532810214739117,1.0,15/63,19.63%,SLC7A1;IL15;TFRC;CD38;IL6ST;NCK1;MEF2C;NCK2;CD40;MIF;VCAM1;CLCF1;ANXA1;CCL19;PTPRC
prerank,negative regulation of response to external stimulus (GO:0032102),-0.23468969956368113,-0.9564615552985034,0.5549645390070922,0.7535350087217082,1.0,24/105,16.84%,TEK;RB1;KLF4;MFHAS1;CRK;PPARA;NMI;OTULIN;PRKCD;CDH5;EPHA4;PPARD;PPM1B;FEM1A;NFKBIL1;DUSP3;FGF2;RTN4RL1;TRAF3IP1;CCN3;C1QTNF3;ILRUN;TNFRSF1A;TNFAIP3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.38818553837805564,0.9561129120800836,0.5133333333333333,0.9357288810842499,1.0,3/11,10.85%,ITPKA;IP6K2;IPPK
prerank,mesoderm development (GO:0007498),-0.3453399550348043,-0.9560621068244529,0.5017857142857143,0.7540718886708558,1.0,4/18,12.64%,TIE1;TBX1;BMX;JAK2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.29358721380659863,0.9559994416473189,0.5368171021377672,0.9345768383667052,1.0,4/32,5.51%,MAGI2;PPP1R7;CAMTA1;CALM2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.30398481831821506,0.9555984572858729,0.5165562913907285,0.9342812915721669,1.0,6/24,15.49%,SLC25A13;ADRB3;NR4A3;MRAP2;LYRM7;GFPT1
prerank,positive regulation of dendritic spine development (GO:0060999),0.32607018702031,0.955507897607318,0.5295404814004376,0.9330490537767285,1.0,5/20,13.32%,NLGN1;SHANK1;CAMK2B;CPEB3;APOE
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.2832648623107177,-0.9554633817894188,0.5346715328467153,0.7550907414795641,1.0,16/39,23.89%,UTRN;NEDD4L;YWHAE;TCAF1;NEDD4;FXYD5;TRPC6;FXYD6;PTPN3;SCN3B;SCN4B;PPIF;WWP2;FHL1;RIPK1;AHCYL1
prerank,negative regulation of developmental growth (GO:0048640),0.28909195898835444,0.9542752315266931,0.5440180586907449,0.9353272921145803,1.0,10/30,19.89%,DCC;MAP2;RTN4;PTPRS;MAG;TRIM46;SLC6A4;BBS2;FGFR3;RTN4R
prerank,melanocyte differentiation (GO:0030318),-0.38647546736399385,-0.9541173584091026,0.5210727969348659,0.7579203116666601,1.0,3/11,9.45%,MITF;MEF2C;USP13
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.290692067440636,0.9540643496329386,0.5173210161662818,0.9344166476404132,1.0,11/30,20.05%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1;DDOST
prerank,regulation of T cell proliferation (GO:0042129),-0.2582113209222868,-0.9540267618169314,0.5636042402826855,0.7577373785007463,1.0,12/61,21.44%,SLC7A1;IL15;TFRC;IL6ST;TNFRSF1B;NCK1;NCK2;VCAM1;ANXA1;CCL19;PTPRC;TNFSF8
prerank,secondary alcohol metabolic process (GO:1902652),0.27234084211042286,0.9534817085277275,0.53125,0.9346295376408933,1.0,16/42,21.52%,PIP4P1;SULT2B1;SQLE;NSDHL;CYP27A1;TSKU;OSBPL5;CYP11B1;IDH3A;ABCA5;APOE;CLN8;SOAT2;SOAT1;ABCG1;ANGPTL3
prerank,hyaluronan catabolic process (GO:0030214),-0.34344378617775617,-0.9534221620008555,0.5334538878842676,0.7588502130235092,1.0,8/18,31.24%,CEMIP2;FGF2;CHP1;HYAL2;LYVE1;HEXA;HYAL3;TGFB1
prerank,dicarboxylic acid transport (GO:0006835),0.2999284970563544,0.9533193299104197,0.5185995623632386,0.9336372460964539,1.0,8/28,14.94%,PDPN;SLC25A13;SLC46A1;SLC1A2;SLC19A1;SLC1A3;SLC13A5;SLC26A8
prerank,response to cholesterol (GO:0070723),-0.34989502711142473,-0.9531578700165277,0.5036231884057971,0.7590861892050607,1.0,4/17,8.50%,SMO;TGFBR2;LRP6;SMAD2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.23998711777977025,0.9528928604314448,0.5528089887640449,0.9334537067972236,1.0,20/84,16.23%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;QKI;CELF6;SRPK1;DDX17;FXR2;ZC3H10;RBFOX3;RBM8A;TIA1;NOVA1;HNRNPK;U2AF2;SF3B4
prerank,mRNA metabolic process (GO:0016071),-0.24267295189744825,-0.9527796205400297,0.5703971119133574,0.759577096019101,1.0,26/90,27.84%,SRSF11;PRPF3;HNRNPA0;HNRNPR;ERN1;TP53;CELF1;SFPQ;SON;LSM11;SNRPE;SF3A1;LSM10;NUDT12;NONO;LSM3;DIS3L2;SUPT4H1;METTL16;USP39;ALKBH5;HSPA1B;DXO;PRPF18;SCAF11;LSM2
prerank,intracellular cholesterol transport (GO:0032367),-0.36245759450561427,-0.9522617731285208,0.5449640287769785,0.7603353791582828,1.0,5/15,19.93%,LDLRAP1;LRP6;STARD4;STAR;OSBPL2
prerank,regulation of establishment of cell polarity (GO:2000114),-0.35859186702351226,-0.9521784610474066,0.5434380776340111,0.7601137811012081,1.0,6/16,15.79%,CDH5;ROCK1;RAP1B;BCAS3;ARFGEF1;ROCK2
prerank,glucose transmembrane transport (GO:1904659),-0.33515899602902444,-0.9521650405712075,0.5444444444444444,0.7597511782343753,1.0,4/18,12.94%,SLC2A1;PPARD;RAB4B;SLC2A9
prerank,negative regulation of immune system process (GO:0002683),0.3379085592737163,0.9513461272501333,0.5150862068965517,0.9368053235920507,1.0,6/16,17.70%,FCRLB;HOXA7;GPER1;COL3A1;FCGR2B;SOX9
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.33660932041689295,-0.9512959142158418,0.5232974910394266,0.7613774408466173,1.0,4/18,8.23%,CD200;RPS6KA5;PRKD2;PRKD1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.2800369438968387,0.9510698663578424,0.5286624203821656,0.9362047723951181,1.0,5/35,5.56%,HTR2C;RIMS2;DGKQ;AKAP6;EPHA5
prerank,response to alcohol (GO:0097305),0.30229824232623403,0.9504258230863288,0.5490196078431373,0.9366821578783738,1.0,5/27,10.41%,GRIN2B;GRIN2A;GLRA1;ABCA2;SLIT3
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.32736580626314776,-0.9500883976985126,0.5522388059701493,0.7638586415035535,1.0,9/22,22.88%,ATM;SPRED2;RPL37;EIF5A;HIC1;CDK5RAP3;RPS7;RPS15;MSX1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3915122149088504,-0.9500803474895372,0.5530035335689046,0.7634777566703204,1.0,4/11,14.99%,RIN3;SLIT2;CCN3;MIF
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.401956671193743,-0.9499985631634867,0.5647668393782384,0.7632442867858051,1.0,6/10,27.78%,SMAD4;BRCA1;CHEK1;RAPGEF3;SMARCB1;HDAC5
prerank,glycogen metabolic process (GO:0005977),-0.30994253654750314,-0.9498272444755049,0.5479930191972077,0.7632503344851742,1.0,6/27,13.59%,GBE1;GSK3B;PHKA2;PPP1R3C;GYS1;PHKB
prerank,positive regulation of cell aging (GO:0090343),-0.3859162945401181,-0.9492138685196939,0.543010752688172,0.7643422834741335,1.0,4/11,15.26%,YPEL3;LMNA;ABI3;CGAS
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.31579262341601083,0.9492001999806884,0.5352112676056338,0.9388660618906025,1.0,4/22,10.85%,RASL11A;DDX11;DHX33;IPPK
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3302197698191345,0.9488218808076078,0.5157657657657657,0.938511264947937,1.0,6/20,16.66%,SLC25A23;PHB2;PMPCB;SLC8A3;MCU;SLC8B1
prerank,phosphate ion transport (GO:0006817),0.35302408945000824,0.9486451688125032,0.5415676959619953,0.9375384410236699,1.0,2/16,4.70%,SLC34A1;SLC25A3
prerank,regulation of mRNA processing (GO:0050684),0.2924599791942319,0.948393255581736,0.5125858123569794,0.9367931809482971,1.0,8/32,15.59%,KHDRBS2;KHDRBS3;QKI;SRPK1;PTCD2;SAFB;TIA1;HNRNPK
prerank,positive regulation of telomerase activity (GO:0051973),-0.2964688463244458,-0.9482418568578745,0.527927927927928,0.7662443778065533,1.0,9/33,17.19%,KLF4;NEK7;TCP1;MAPK1;HMBOX1;PNKP;PTGES3;PARN;CTNNB1
prerank,regulation of interferon-alpha production (GO:0032647),-0.32225220723136183,-0.9481924904759844,0.5498281786941581,0.7659466801881096,1.0,3/23,3.92%,IFIH1;SETD2;DDX3X
prerank,transferrin transport (GO:0033572),-0.2899340214967646,-0.9479881241523179,0.5328596802841918,0.7660091222645308,1.0,9/33,17.50%,TFRC;DNM2;STEAP3;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15;ATP6V0A1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.40495641436946417,-0.9477606924063542,0.5513307984790875,0.7661474580020861,1.0,2/10,6.56%,TGFBR2;CD55
prerank,protein localization to lysosome (GO:0061462),0.29926179077919285,0.9475901785301215,0.5242494226327945,0.9377423493493622,1.0,8/28,12.43%,MFSD1;GGA3;CD81;HGS;SORL1;RTN4;ATP13A2;RNF128
prerank,actin polymerization or depolymerization (GO:0008154),-0.2649313168454382,-0.9475628514568839,0.5343915343915344,0.7662406328300025,1.0,15/50,19.76%,ABI1;RAC1;SVIL;MICAL2;DIAPH1;WASL;FAM107A;CFL2;JAK2;CORO7;PREX1;CFL1;WASF1;PSTPIP1;DSTN
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.34933197833871465,-0.9475551048483802,0.5327272727272727,0.7658562730121491,1.0,6/16,24.66%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,zymogen activation (GO:0031638),0.2765663561556264,0.9469823973949388,0.5405405405405406,0.9380618998430025,1.0,5/39,10.62%,OMA1;C1RL;GRIN2A;KLK1;RIPK2
prerank,positive regulation of reproductive process (GO:2000243),0.29240628995073176,0.9469377185532304,0.5134529147982063,0.9367300333459327,1.0,5/31,11.33%,CFAP69;GLRA1;ACVR1B;VEGFA;TACR1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.2792822684401436,-0.946910737105591,0.56,0.7669743398270011,1.0,11/39,20.79%,PTPRG;PODXL;AFDN;PTK2;CDH1;SMAD7;CEACAM1;JAG1;CITED2;MAGI1;FERMT3
prerank,regulation of ATP metabolic process (GO:1903578),-0.2660975330719361,-0.9460280780874228,0.5666666666666667,0.7686687725182108,1.0,24/54,38.04%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;UQCC2;OGT;BEND3;NUP188;NUP88;SLC25A33;PRKAG2;NUP35;NUP43;JMJD8;HIF1A;ATP5IF1;NUP50;COX7A1;PGAM1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.284792412753719,-0.9459038745999073,0.5669014084507042,0.7685773884743698,1.0,19/41,38.04%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188;NUP88;PRKAG2;NUP35;NUP43;JMJD8;HIF1A;NUP50;PGAM1
prerank,tRNA aminoacylation (GO:0043039),-0.2839146569384159,-0.9454228373841359,0.5368043087971275,0.7693270508755244,1.0,10/37,21.48%,WARS2;YARS1;FARS2;LARS1;AIMP2;DARS2;HARS2;FARSA;IARS2;WARS1
prerank,positive regulation of integrin activation (GO:0033625),-0.3926257442665898,-0.9452875656272093,0.524904214559387,0.7692635441120208,1.0,3/11,8.25%,FERMT2;RASIP1;RAP1B
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3098484034421112,-0.9449689083345056,0.5150943396226415,0.769609760058839,1.0,10/26,21.74%,NOS3;ACER2;GCH1;AKT1;ACER3;SPTLC1;ASAH1;CYB5B;NQO1;NOS1
prerank,negative regulation of viral genome replication (GO:0045071),-0.2773614360776499,-0.9448113355536281,0.5408695652173913,0.7695689177713839,1.0,15/40,29.55%,RESF1;IFIH1;ZC3HAV1;TASOR;IFITM3;PLSCR1;N4BP1;SRPK2;MAVS;IFITM2;BST2;TRIM6;RSAD2;OASL;TNIP1
prerank,cilium organization (GO:0044782),-0.2119466211044844,-0.9447154882462522,0.6371681415929203,0.7693883673960356,1.0,45/209,19.65%,ABCC4;ABLIM1;EXOC6;ASAP1;PKD2;PARVA;FNBP1L;EXOC4;RAB1A;PTPDC1;EHD2;SSX2IP;CEP250;IFT140;CDC14A;RAB11FIP3;WDR11;CEP78;EXOC2;FLNA;PDE6D;EHD1;NOTCH1;WDR35;GALNT11;CFAP44;RAB8B;IFT52;TRAF3IP1;RAB23;EXOC8;CEP41;EHD4;FUZ;DZIP1L;NUDCD3;RAB11A;HDAC6;CFAP298;PLK4;TMEM17;PCM1;IFT43;KIF3B;MNS1
prerank,cAMP-mediated signaling (GO:0019933),-0.31671086050788944,-0.9446236776138877,0.5224719101123596,0.7692039974938636,1.0,5/24,6.37%,RAPGEF2;ADGRG6;PDE7B;PDE2A;PDE3A
prerank,connective tissue development (GO:0061448),-0.290655331465617,-0.9444241691122724,0.5524475524475524,0.7692890102684069,1.0,5/35,9.00%,ZBTB16;LRP5;SH3PXD2B;CREB3L2;NAMPT
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.359743991681007,-0.9443902677468368,0.5052264808362369,0.768968026906415,1.0,7/14,36.17%,NT5E;NT5C1A;NT5C;UPB1;UPP1;CAD;DPYS
prerank,positive regulation of histone acetylation (GO:0035066),-0.32263617294929947,-0.9440653893322831,0.5572390572390572,0.7693646839541614,1.0,12/23,35.79%,RPS6KA5;SMAD4;RUVBL2;WBP2;BRCA1;NOS1;ARRB1;SMARCB1;GLYR1;RPS6KA4;MUC1;LIF
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.38346294155393856,0.9430599165731485,0.5218340611353712,0.9467763547099197,1.0,2/10,15.27%,RCC2;RACGAP1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.31626007288868596,-0.9427773078358793,0.542314335060449,0.7720477483600602,1.0,8/24,26.70%,POLD3;RPA3;RPA1;RPA2;LIG4;RFC4;RFC1;LIG1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2521496787660089,-0.9427539840687199,0.5726643598615917,0.771708490370522,1.0,24/66,35.64%,FOXP1;APP;CASP8;JAK2;LPL;PANX1;TRIM16;TNFAIP3;IGF1;GBP5;CCL19;NOD2;FZD5;CASP1;F2R;LGALS9;NLRP2B;NLRC4;TLR6;STAT3;NLRP3;CARD16;CD33;TLR8
prerank,dendritic spine organization (GO:0097061),-0.3119837409653776,-0.9425478103844465,0.5602968460111317,0.7717939623225845,1.0,5/26,7.31%,IGF1R;SHANK3;INSR;ITGA3;WASL
prerank,autonomic nervous system development (GO:0048483),0.33328707156630377,0.9424409187063834,0.5488888888888889,0.9471466240383906,1.0,1/17,0.40%,PHOX2A
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.306371407475534,-0.9415186902681107,0.5378927911275416,0.7737750375697595,1.0,13/26,33.69%,BIRC3;IRF1;NFKBIL1;OTUD4;FLOT1;GPR108;GPS2;IRF7;CACTIN;NLRP2B;TREM2;TLR5;LRRC14
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2245643013136785,-0.9414234921062548,0.6017699115044248,0.7735751635668364,1.0,32/129,18.77%,XIAP;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;DDX3X;LRRK2;CSNK1G3;EGFR;TRPM4;NFKB1;LRRK1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CSNK1G1;DKK2;PLEKHA4;CSNK1D;PSMC2;PSMB2;DAAM2;USP34;PSMB1;LYPD6;PSMA8;PSME1;SOX4;GPC3
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2971972890228318,-0.9413564998315362,0.5729166666666666,0.7733362549926509,1.0,10/31,24.04%,DAB2IP;PTPN1;ERN1;TM7SF3;ATXN3;HDAC6;DNAJB12;HSPA14;HSPA13;HSPA1B
prerank,negative regulation of cell cycle (GO:0045786),-0.24774165224433875,-0.9410623426583414,0.581651376146789,0.7736407458280614,1.0,31/73,31.24%,PPP1R13B;RB1;BTG3;CDKN1B;PDCD4;BMP4;PTPRK;LATS2;PTPN3;NUDT6;CDK6;RNF167;BTG2;FOXC1;BMP7;TFAP4;ANGEL2;PTEN;MYOCD;CEBPA;NR2F2;BMP2;APC;SIPA1;NUPR2;DUSP1;NLRP2B;TRIM35;LILRB1;CHMP1A;TGFB1
prerank,microtubule nucleation (GO:0007020),-0.3309447220239831,-0.9409910508108555,0.5628318584070796,0.7733920864032721,1.0,9/19,29.13%,RANBP9;SLAIN2;CSNK1D;TUBGCP5;TUBGCP4;NDEL1;AKAP9;TUBG2;TUBGCP3
prerank,negative regulation of metabolic process (GO:0009892),-0.25919612702818223,-0.9406878776103212,0.5989583333333334,0.7737267781558945,1.0,6/54,5.56%,ZNF423;RB1;IL15;ID1;LAMA4;NOVA2
prerank,cellular iron ion homeostasis (GO:0006879),-0.26318312606327887,-0.940526474705323,0.5834767641996558,0.7737146342874203,1.0,11/55,17.65%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;SMAD4;HFE;HMOX2;ABCB7;FLVCR1;SOD1
prerank,establishment of spindle orientation (GO:0051294),-0.30358316653330353,-0.940308447423189,0.566607460035524,0.7738172743269232,1.0,7/28,21.94%,ITGB1;MAP4;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,potassium ion import across plasma membrane (GO:1990573),0.2725107588053099,0.9401194887554919,0.573394495412844,0.9526269511208759,1.0,7/41,8.80%,ATP1A2;KCNJ3;ATP12A;ATP1B1;SLC12A5;KCNJ6;ATP4A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3591565293634742,-0.939988860029451,0.5574912891986062,0.7741923289190953,1.0,9/15,35.96%,NEK6;CDC16;TPR;CENPE;TACC3;ANAPC7;PLK1;CDC6;UBE2C
prerank,cognition (GO:0050890),-0.2782112906055884,-0.9396377781539872,0.5291828793774319,0.7746074175482214,1.0,8/42,9.03%,SHROOM4;ST3GAL4;SOBP;APP;NIPBL;SETD5;FAM107A;MFSD2A
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.313555081892521,-0.9386592473068025,0.5537037037037037,0.7764951999834973,1.0,7/24,23.55%,ACVRL1;BMPR2;DACH1;TERF2;RPS3;BLM;MSH3
prerank,fatty acid transport (GO:0015908),-0.33942367134384677,-0.938568795634544,0.5456238361266295,0.776295611290307,1.0,7/17,26.57%,PPARD;MFSD2A;SLC27A4;ACSL1;PPARG;SLC27A3;FABP3
prerank,Golgi ribbon formation (GO:0090161),-0.3712161905241653,-0.9384922734983319,0.5656742556917689,0.7760823355284381,1.0,7/13,32.40%,VTI1A;MYO18A;GOLPH3;TMED5;FHDC1;TRIP11;VAMP4
prerank,response to UV-A (GO:0070141),0.35412398471930817,0.9381961706425928,0.5555555555555556,0.9569861261693857,1.0,4/14,12.29%,MME;CERS1;TIMP1;PPID
prerank,regulation of bone mineralization (GO:0030500),-0.2649070656275867,-0.9381493157843083,0.5807622504537205,0.7764492782537006,1.0,16/55,18.20%,BMPR2;SGMS2;SRGN;BMP6;TRPM4;BMP4;MEF2C;S1PR1;ACVR2A;ANO6;ADGRV1;PKDCC;NOTUM;BCOR;BMP7;ANKH
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.3666358870111218,-0.9381157743449753,0.546617915904936,0.7761270804106711,1.0,4/13,15.91%,ATM;SPRED2;RPL26;HIC1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3598089087943718,-0.9380398156203442,0.5561403508771929,0.7759016735066636,1.0,3/15,7.93%,ADAM9;TNFRSF1B;SNX9
prerank,organonitrogen compound catabolic process (GO:1901565),-0.25911868507600955,-0.9379504764058569,0.5671378091872792,0.7756949900133023,1.0,18/57,21.41%,CPQ;PLA2G4A;MTOR;ACE;GNPDA2;TXN2;ENPEP;PDXDC1;GGACT;USE1;SMPD2;ERAP1;SIAH1;CLN5;NPEPPS;CTH;PNPLA8;ADO
prerank,fat cell differentiation (GO:0045444),-0.25813654914111633,-0.9366273715170573,0.5569395017793595,0.7784392199990996,1.0,29/57,39.59%,FOXO1;KLF4;PRDM16;TMEM120A;ZBTB7A;MED1;CTBP2;C1QTNF3;SMAD6;SENP2;ERAP1;PPARG;CEBPA;TCF7L2;ATF5;WNT5B;SDF4;TRIM32;ALOXE3;PID1;NR4A2;STEAP4;IL11;ADIG;AKT2;TFAP2B;BBS9;SIRT1;PER2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2837753210110975,-0.9364477465988649,0.5515370705244123,0.7784438291013505,1.0,16/36,40.23%,LEF1;ZMIZ1;GLI3;VSIR;SOX4;NKAP;BCL6;IL7;PNP;VNN1;SHH;ZAP70;GATA3;TESPA1;IL4;MDK
prerank,regulation of cholesterol transport (GO:0032374),0.3233478848791369,0.9359413529382068,0.5620915032679739,0.96231865642153,1.0,5/20,15.14%,OSBPL6;ABCA2;NUS1;ABCA5;APOC1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2702332672846597,0.9357268040123576,0.5468409586056645,0.9614619757596884,1.0,11/38,20.47%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;HIRA;CENPW;CENPK;RBBP7;ITGB3BP;CENPA
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.37965625734093944,0.9353360027108261,0.5330396475770925,0.9611815956262607,1.0,3/12,9.26%,LHX1;PAX2;VEGFA
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.28837949113635797,-0.9352421593445841,0.5567567567567567,0.7809405021438853,1.0,9/35,17.19%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,selective autophagy (GO:0061912),-0.2596549958031317,-0.9351265383626312,0.5893186003683242,0.7808034533034856,1.0,16/56,26.36%,ATM;RAB7A;MAP1LC3B;AMBRA1;WDFY3;ULK2;UFM1;ATG5;LGALS8;HDAC6;KLHL3;BECN1;PCNT;ATG2A;DYNLL1;ATG2B
prerank,regulation of smooth muscle contraction (GO:0006940),0.3187919241607455,0.9350867957815181,0.5412026726057907,0.9604596802904797,1.0,4/20,11.53%,CHRM2;CHRM3;SPHK1;NMUR2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.30269836684313,-0.9347669194416894,0.5706521739130435,0.7812434738633273,1.0,4/27,5.75%,PLTP;CAV1;RXRA;NFKBIA
prerank,cardiolipin metabolic process (GO:0032048),-0.36713429373315043,-0.9344460989085546,0.5500878734622144,0.7816047056831341,1.0,2/13,3.66%,HADHB;PLA2G4A
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.31950826680828065,-0.9342123101028211,0.5541284403669725,0.7817418735479238,1.0,8/22,25.07%,CDKN1B;LATS2;TFAP4;PTEN;MYOCD;CEBPA;NR2F2;APC
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.22005424612228922,-0.9341537012274127,0.6437177280550774,0.7814797555294464,1.0,46/145,26.89%,FBXL7;PSMA2;YWHAE;CEP57;RBX1;CEP250;PSME2;CEP78;PSMB4;HAUS8;DCTN1;DCTN3;HAUS6;PAFAH1B1;CSNK1D;MECP2;PSMC2;PSMB2;CEP41;PSMB1;RAB11A;PLK4;PSMA8;CETN2;CEP152;ALMS1;PSME1;CCND1;PCM1;CNTRL;FHL1;PSMD4;ODF2;HSP90AA1;CDC25A;CEP131;PCNT;PSMD5;AKAP9;DTL;PSMA3;DYNLL1;PINX1;BRD4;KIF14;PSMB10
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.33864027979757927,-0.9340906252684101,0.5598591549295775,0.7812100225549118,1.0,9/18,27.78%,HDAC1;GSK3A;HDAC4;NOTCH1;CCN3;FZD7;BMP2;FRS2;HDAC5
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3350923504516624,-0.93407865339748,0.5681818181818182,0.780834810405151,1.0,6/18,24.86%,CAV1;NEDD4L;SLC43A1;PPIF;KCNH2;CAB39
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3080043708513964,-0.9340077971525025,0.5621716287215411,0.7805919526413762,1.0,7/24,15.79%,PRKCH;CBFB;MED1;ROCK1;FOXC1;TRIM16;ROCK2
prerank,regulation of protein localization to membrane (GO:1905475),0.2978336417610213,0.9337730317402806,0.5607064017660044,0.9628381766530901,1.0,6/28,10.66%,GPC5;CDK5;CLN3;GPC1;GSN;VTI1B
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3440020302105668,-0.933770717609151,0.5677655677655677,0.7807056662902777,1.0,8/16,32.53%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,positive regulation of cellular protein localization (GO:1903829),-0.24571704396831795,-0.9335975152722319,0.6048,0.7806939917254643,1.0,16/69,16.40%,FERMT2;GSK3B;LIMK2;DTX3L;TFRC;RIC3;STX3;CEP250;AKT1;CROCC;YAP1;PRKAA1;GPR137B;TRAPPC12;ABCA7;FYN
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.22572115305747284,-0.9334392824623375,0.5964285714285714,0.7806626634033872,1.0,15/117,9.31%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;ADCY4;PLK2;RHBDF2;PLCG2;RAMP2
prerank,embryonic eye morphogenesis (GO:0048048),-0.3858685641252022,-0.9326811564794173,0.5418181818181819,0.7820321613314033,1.0,3/11,8.29%,RARG;LRP6;TBX2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2261773619075549,-0.9326462532407894,0.5905797101449275,0.7817074560069722,1.0,15/116,9.31%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;ADCY4;PLK2;RHBDF2;PLCG2;RAMP2
prerank,regulation of pH (GO:0006885),0.37609061533600924,0.9320331623659565,0.5294117647058824,0.9665324590185409,1.0,1/11,3.62%,SLC9A7
prerank,actin filament depolymerization (GO:0030042),-0.3750759685253655,-0.9316454947050867,0.5533088235294118,0.7837066049756879,1.0,4/11,19.76%,MICAL2;CFL2;CFL1;DSTN
prerank,skeletal system morphogenesis (GO:0048705),0.26505499308635555,0.931266860995563,0.5800865800865801,0.9673004155705069,1.0,14/42,20.67%,DSCAML1;HOXD3;CYP26B1;MEGF8;FGFR2;RAB33B;HOXA4;PDGFRA;HOXA9;FBN2;HOXD4;FGFR3;HHIP;DYNC2I1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3906738718808571,-0.9312364859448963,0.5613718411552346,0.7838718070789253,1.0,4/10,32.18%,KLF4;MAPK7;WNK1;MYADM
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3906738718808571,-0.9312364859448963,0.5613718411552346,0.7838718070789253,1.0,4/10,32.18%,KLF4;MAPK7;WNK1;MYADM
prerank,regulation of embryonic development (GO:0045995),-0.28857334024786474,-0.9311334610252903,0.5882352941176471,0.7836932070393442,1.0,7/34,11.17%,INSR;SOX17;NIPBL;PLCB1;RBM19;TRIP12;EHMT1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.385601613208151,-0.9307914504527517,0.5488454706927176,0.7840523446608485,1.0,3/11,6.50%,KCNJ2;YWHAE;KCNQ1
prerank,regulation of cell projection organization (GO:0031344),0.35298738289429815,0.9307560753283151,0.5510204081632653,0.9673111035785302,1.0,3/13,7.81%,NTNG2;NTNG1;ERMN
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3112039231696979,0.9306367676510305,0.5531914893617021,0.9661870573781279,1.0,8/24,21.52%,MAPT;STMN2;TPPP3;TPPP;STMN4;HDGFL3;STMN3;NCKAP5
prerank,regulation of microtubule polymerization (GO:0031113),-0.27612603953496156,-0.930031800672267,0.5686274509803921,0.7853831721963002,1.0,10/40,13.29%,DYRK1A;CLIP1;RAC1;TOGARAM1;ABL1;CDH5;OCLN;DCTN1;SLAIN2;DRG1
prerank,regulation of interferon-beta production (GO:0032648),-0.2704022324281716,-0.9298131363637913,0.5685920577617328,0.7854820313423202,1.0,22/46,35.64%,IFIH1;TRIM56;DDX3X;IRF1;PPM1B;FLOT1;POLR3F;MAVS;PTPN11;RNF216;HSP90AA1;YY1;DHX9;RIOK3;IRF7;TOMM70;CACTIN;LILRB1;IRF5;TBK1;POLR3A;TLR8
prerank,O-glycan processing (GO:0016266),0.2549721041859789,0.9298101411001725,0.5816091954022988,0.9670943979806899,1.0,8/54,11.17%,MUC20;GALNT15;GALNT13;GALNT12;GALNT5;GALNT14;C1GALT1C1;POFUT1
prerank,cellular response to unfolded protein (GO:0034620),-0.3007753588433409,-0.9297153531921789,0.5603448275862069,0.7852918838423538,1.0,5/26,12.33%,DAB2IP;PTPN1;ERN1;ABCB10;TM7SF3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2991109507010494,-0.929503689295698,0.5574912891986062,0.7853945991905318,1.0,13/29,28.77%,UBE2K;PTPN1;SAMHD1;STAT2;USP18;MAVS;NLRC5;PTPN11;ABCE1;IFNAR2;PTPN2;TRIM6;CACTIN
prerank,centromere complex assembly (GO:0034508),0.2731819478340942,0.929238523274624,0.5814977973568282,0.9673175847915487,1.0,11/36,20.47%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPW;CENPK;DLGAP5;RBBP7;ITGB3BP;CENPA
prerank,mitochondrial membrane organization (GO:0007006),0.2803508379719831,0.928582968260288,0.5736961451247166,0.9677854581992686,1.0,8/32,12.27%,BCL2;HSPA9;MFN1;MTX3;SLC25A4;CHCHD6;DNAJC11;GHITM
prerank,regulation of neurotransmitter transport (GO:0051588),0.33444646261046795,0.9285238504904594,0.5675675675675675,0.9665005014421515,1.0,3/16,10.25%,RIMS1;SYN1;MCTP2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3071071529323123,-0.9279001532606082,0.5709219858156028,0.7887969823527878,1.0,9/26,18.46%,LYN;PSME2;EPHA4;PICALM;VSIR;ROCK2;APH1A;FYN;PSME1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2413978403032513,-0.9278054932597969,0.6110091743119266,0.7886138902037629,1.0,12/75,11.55%,GRK5;RGS3;RGS5;GIT2;ZDHHC3;PLCB1;RGS12;PLCE1;ROCK1;NMT1;EDN1;MGLL
prerank,histone monoubiquitination (GO:0010390),-0.314116454267205,-0.927684817191505,0.5830188679245283,0.7884934644174005,1.0,7/24,18.64%,DTX3L;RYBP;RNF40;CDC73;RNF168;BCOR;RNF2
prerank,maturation of SSU-rRNA (GO:0030490),-0.28246228236961246,-0.9273101176881899,0.5992844364937389,0.7890106351234473,1.0,9/34,27.05%,RPS14;NOL10;RPS16;UTP3;DCAF13;UTP4;RPS8;WDR46;RIOK3
prerank,apoptotic DNA fragmentation (GO:0006309),-0.346114034495315,-0.9268088551574458,0.5810055865921788,0.7897710812677288,1.0,6/16,24.41%,CECR2;DICER1;KPNA1;EXOG;FOXL2;HMGB1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.30194351203127423,0.9268018560977267,0.5527426160337553,0.9701209767241057,1.0,6/24,11.39%,PDE3B;GNAI1;PEX5L;RNF157;PDE11A;PRKAR1B
prerank,cellular response to UV (GO:0034644),0.23518824909056882,0.9266044184555063,0.6355140186915887,0.9692340384103453,1.0,13/76,12.29%,MME;TMEM161A;CERS1;RHNO1;USP28;STK11;IMPACT;TRIAP1;TIMP1;DDB1;BMF;ATR;PPID
prerank,long-chain fatty acid import into cell (GO:0044539),-0.39164215079005876,-0.9265460630138286,0.5459363957597173,0.7899634587197983,1.0,4/10,23.05%,SLC2A1;SLC27A4;ACSL1;SPX
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.2703794137646289,-0.9265351500672904,0.5721925133689839,0.789580197259002,1.0,16/45,22.85%,BTG3;CDKN1B;BMP4;PLK2;NABP1;RGCC;PTPN3;BTG2;FOXC1;BMP7;CTNNB1;BUB1B;ANGEL2;TOM1L2;CHEK1;BCL6
prerank,peptidyl-asparagine modification (GO:0018196),0.2814136886795582,0.9265169274778516,0.5617715617715617,0.9680373852069354,1.0,11/31,20.05%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1;DDOST
prerank,glycolytic process (GO:0006096),0.29497801166393856,0.9263838273697067,0.5575620767494357,0.9670013311201215,1.0,6/28,19.06%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.34319019892304475,-0.9262700707908404,0.5659050966608085,0.7897607907375426,1.0,11/17,40.50%,DYRK1A;YJU2;MIF;MDM2;RNF34;SNAI2;ARMC10;CD74;SIRT1;PTTG1IP;CD44
prerank,regulation of ion transmembrane transport (GO:0034765),-0.29175602902277653,-0.9261807020525945,0.5592920353982301,0.7895486644345476,1.0,13/33,25.68%,NEDD4L;KCNJ2;YWHAE;KCNQ1;NEDD4;ANO6;KCNJ8;CASQ2;WWP2;KCNH2;AKAP9;AHCYL1;KCNJ13
prerank,negative regulation of cyclase activity (GO:0031280),0.3424694516857781,0.926101367442106,0.5575620767494357,0.9663331230999072,1.0,2/14,4.69%,GNAI2;GABBR2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.29859570611796604,-0.9256425433820092,0.5585412667946257,0.7903931391616786,1.0,4/27,12.70%,NFAT5;ETS1;IRAK1;RHOA
prerank,positive regulation of organelle assembly (GO:1902117),-0.2664453391609088,-0.925632457130745,0.6096654275092936,0.7900130344122788,1.0,15/44,26.43%,ASAP1;RAB3GAP1;STX18;PIP4K2A;PIP4K2B;CROCC;RAB3GAP2;LCP1;FUZ;PLK4;ARHGAP35;PDCD6IP;RALB;CNOT2;CNOT1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.25194411010715306,-0.9255319641894632,0.6282051282051282,0.7898561693916824,1.0,20/65,26.89%,FBXL7;PSMA2;RBX1;PSME2;NABP1;PSMB4;INTS3;PSMC2;PSMB2;PSMB1;PSMA8;CDK5RAP3;PSME1;FHL1;PSMD4;CHEK1;PSMD5;PSMA3;PINX1;PSMB10
prerank,cellular polysaccharide catabolic process (GO:0044247),0.33244972796838024,0.9254173212604454,0.528344671201814,0.966841676954667,1.0,8/16,22.80%,AGL;PHKG1;PYGM;PYGB;PYGL;PGM2;PGM2L1;GAA
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.38999295130832484,-0.925321503383788,0.5424354243542435,0.7899254395204338,1.0,3/10,13.06%,KDR;LRRK2;MYOC
prerank,activation of protein kinase activity (GO:0032147),-0.22901990432123426,-0.925118967216892,0.6312056737588653,0.7900211725747432,1.0,25/106,17.44%,GHR;INSR;PRKACB;ADCY9;PAK2;MTOR;TGFBR2;GAS6;RICTOR;STK3;ABL1;FGF1;TGFB2;PRKCD;ADCY4;CLSPN;AKT1;TAOK3;IRAK1;JAK2;MARK2;ADCY1;ANGPT1;IGF1;MAP4K4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3669308340151515,0.9250999622681987,0.55125284738041,0.966330986377378,1.0,5/12,24.26%,CDA;UCK2;UCK1;TK1;TK2
prerank,mitochondrial translational elongation (GO:0070125),-0.2375281144601883,-0.9248584582621553,0.62248322147651,0.7902384123393272,1.0,29/88,25.79%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPL12;MRPS27;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS28;MRPS35;MRPS2;MRPL43;TUFM;MRPS31;MRPL11
prerank,regulation of lipase activity (GO:0060191),-0.37686314851904157,-0.9248130379232109,0.5693430656934306,0.7899401684088424,1.0,4/13,13.49%,PCSK5;RHOA;LPL;RHOC
prerank,cellular response to glucagon stimulus (GO:0071377),-0.33023496485522236,-0.9245780737194226,0.5461393596986818,0.7900887337234989,1.0,5/17,15.25%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1
prerank,protein import into peroxisome matrix (GO:0016558),-0.3721672977884818,-0.924444683085201,0.5472370766488414,0.7899884979776233,1.0,3/12,15.33%,PEX1;PEX7;PEX14
prerank,L-amino acid transport (GO:0015807),-0.2961147791252276,-0.9240536712813422,0.5790441176470589,0.7905003120723292,1.0,9/28,21.14%,SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC1A4;SLC3A2
prerank,anterior/posterior pattern specification (GO:0009952),-0.25361670836458317,-0.9240100832176297,0.5836363636363636,0.7902012515998311,1.0,12/53,18.29%,LRP5;BMPR2;TBX1;HES1;HOXB6;SMAD2;PCSK5;HOXC6;SKI;HEY2;HEY1;HOXB9
prerank,nuclear pore organization (GO:0006999),-0.3608388738924787,-0.9238324385707881,0.584070796460177,0.7902023542575198,1.0,4/14,15.61%,AHCTF1;NUP98;NUP153;TPR
prerank,regulation of supramolecular fiber organization (GO:1902903),0.30925967619304007,0.9233852390044739,0.5516431924882629,0.9699475552365332,1.0,9/22,18.44%,MAP1S;MAP2;MAPT;MAP1B;AEBP1;MAPRE3;APOE;CAMSAP3;MAP1A
prerank,translesion synthesis (GO:0019985),-0.27338439628219025,-0.9232128136925742,0.6066433566433567,0.7912682193646211,1.0,13/42,25.42%,TRIM25;POLD3;RPA3;RPA1;REV1;USP10;MAD2L2;POLE2;RPA2;RFC4;RCHY1;RFC1;DTL
prerank,regulation of cell cycle process (GO:0010564),-0.2294782897702069,-0.9231812406868672,0.6413793103448275,0.7909305724301159,1.0,38/104,33.59%,DCUN1D3;CDK13;MAD1L1;SETD2;CEP85;CUL9;AHCTF1;ZFYVE26;CEP250;RAB11FIP3;PLK2;BIRC6;CUL7;KLHL13;CCDC8;KIF11;RAB11A;CTNNB1;PLK4;CETN2;KIF13A;PRC1;CHEK1;BECN1;ATF5;PLK3;APC;USP19;CAV2;CDKN2B;BORA;OBSL1;MAP9;SND1;AURKA;E4F1;KIF20A;PLK1
prerank,regulation of chromatin binding (GO:0035561),-0.4000395598957306,-0.9228990596537701,0.5734767025089605,0.791206881646902,1.0,4/10,10.06%,BTAF1;DTX3L;WAPL;HMBOX1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3799244447984559,-0.9228935987729724,0.5936329588014981,0.7908226295973908,1.0,5/12,15.47%,LAMA3;ACTB;LAMA5;TRAF3IP1;FUZ
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3398522405934033,0.9218155784639062,0.5625,0.973124817416408,1.0,3/14,11.56%,OXSR1;CCL7;CCL5
prerank,lung epithelium development (GO:0060428),0.3769691268622273,0.9217159149085168,0.5604395604395604,0.9719548430647741,1.0,3/10,14.80%,WNT7B;RCN3;FOXJ1
prerank,nuclear body organization (GO:0030575),-0.37705519800946774,-0.9216017048337889,0.5851063829787234,0.7934303928825529,1.0,4/12,16.37%,ETS1;SERBP1;ZPR1;SRPK2
prerank,protein localization to nucleus (GO:0034504),-0.23006679754732506,-0.9215945795410876,0.6440972222222222,0.7930370453543752,1.0,34/102,26.38%,YWHAE;CSE1L;SIX1;ZBTB7A;TOR1B;BMP4;SEC13;PPP1R10;AKT1;LMNA;NUP153;TBRG1;TAF8;ABCA7;TPR;SIX4;BMP7;TAF3;IPO8;WRN;NXT1;NUP214;RRS1;MDM2;MSX1;ARL2;NUP188;RANBP6;NOL8;E2F3;RAN;PINX1;HNRNPU;NUP88
prerank,positive regulation of viral genome replication (GO:0045070),-0.29640002479670075,-0.9215449740412497,0.5863874345549738,0.7927494780293198,1.0,10/29,22.47%,DDX3X;LARP1;PPARA;PKN2;PDE12;SRPK2;ADARB1;RAD23A;STAU1;PPIH
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3852803042311291,-0.9212104719540872,0.5526802218114603,0.7931224293424952,1.0,7/10,35.23%,DICER1;AGO2;DROSHA;TERT;TSN;MRPL44;TARBP2
prerank,protein-DNA complex assembly (GO:0065004),-0.2260469997494394,-0.9210944232824637,0.6171003717472119,0.7930077862712309,1.0,37/116,27.59%,MNAT1;KAT6B;PSMA2;DMC1;RBX1;BRD2;PSME2;PSMB4;ERCC2;SPTY2D1;MCM4;ORC5;RPA3;RPA1;XPC;ERCC3;PSMC2;PSMB2;H3-3A;PSMB1;ORC2;PSMA8;CETN2;PSME1;ORC4;RPA2;ATRX;PSMD4;MCM3;PSMD5;TCF4;PSMA3;MCM7;MCM5;PSMB10;GTF2H3;RSF1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21054900558543366,0.9210527521531607,0.6697247706422018,0.972393407080483,1.0,29/163,14.97%,PDE4B;BLK;MS4A1;BLNK;PSMC5;PAG1;BCL2;NFATC2;CD3G;PSMD10;GRAP2;VTCN1;PAK3;PAK1;PIK3R2;PSMD14;VAV3;MOG;RIPK2;CARD11;RBCK1;PSMB7;PRKCB;PSMA4;TXK;PSMB8;PSMF1;PSMD1;EIF2B1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.33579444514041684,-0.9208293774380352,0.5502742230347349,0.7932223971595963,1.0,7/16,42.36%,PDE12;PPIF;UQCC2;SLC25A33;VCP;COX7A1;ABCD1
prerank,response to retinoic acid (GO:0032526),-0.2506664458886566,-0.9207195439208815,0.5802469135802469,0.7930629306091941,1.0,9/59,6.27%,ACER2;LYN;ASXL1;RXRA;ATM;TBX1;FZD4;RARG;RBP4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3296888596499466,-0.9207130865861842,0.59245960502693,0.7926805762080545,1.0,10/18,42.06%,TCP1;PARN;RUVBL2;CCT5;NAF1;CCT2;CCT3;DCP2;CCT7;DKC1
prerank,cellular response to acid chemical (GO:0071229),-0.30419902157090806,-0.9205827674644591,0.5530035335689046,0.7925862474023888,1.0,6/27,13.29%,SH3BP4;KLF2;MTOR;CAPN2;RPTOR;LARS1
prerank,regulation of interleukin-2 production (GO:0032663),-0.2665401833657993,-0.9196305093130955,0.5974499089253188,0.7943111011887811,1.0,15/43,27.11%,SPTBN1;CD34;PRKD2;EZR;PLCG2;KAT5;TNFAIP3;ANXA1;RPS3;PTPRC;HDAC7;HOMER3;MAP3K7;STOML2;PNP
prerank,cellular response to light stimulus (GO:0071482),-0.24924344159786027,-0.9193761536823323,0.6234676007005254,0.7944944336703215,1.0,13/66,15.81%,GNB1;CREBBP;NEDD4;PRKCD;PTPRK;RPL26;TP53;NSMCE3;SAG;ATF4;COPS9;N4BP1;RUVBL2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.34915146195163416,0.9192543500524606,0.5668934240362812,0.9760717036350456,1.0,2/13,4.69%,GNAI2;GABBR2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.25465027311713484,0.9189978485806247,0.6280623608017817,0.9753919718406721,1.0,9/48,15.26%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;TXK;SLAMF6;IL23A
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2924547571612704,-0.9183902226076708,0.5912280701754385,0.7963637041703131,1.0,10/28,25.41%,SHLD1;DTX3L;KMT5B;MRNIP;PNKP;MAD2L2;TFIP11;PRKDC;ERCC6;PARP9
prerank,inorganic ion transmembrane transport (GO:0098660),-0.36777627889992326,-0.918291417008773,0.5854545454545454,0.7961922673997432,1.0,3/12,5.06%,PKD2;ABCC9;TRPM4
prerank,leukotriene metabolic process (GO:0006691),-0.32008935191649573,-0.9182203623647934,0.59245960502693,0.7959456005847564,1.0,3/19,7.60%,PLA2G4A;GGT5;MAPKAPK2
prerank,epithelium development (GO:0060429),-0.22654986472977925,-0.9176537622010434,0.6294326241134752,0.7968239072931456,1.0,18/107,13.89%,CD34;PKD2;TBX1;KDR;SOX17;SMO;LOXL3;MEOX2;SIX1;MTHFD1;TBX2;BDH2;ANXA4;MFSD2A;CPT1A;ALDOC;JAK2;ACADVL
prerank,bicarbonate transport (GO:0015701),-0.30238517079442956,-0.9176296328181923,0.5675675675675675,0.7964801395387343,1.0,4/25,7.12%,SLC26A7;SLC4A10;CA4;SLC39A8
prerank,inositol phosphate catabolic process (GO:0071545),-0.36880734374259877,-0.9175799513552031,0.5658627087198516,0.7961928655445126,1.0,6/12,30.42%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,regulation of extracellular matrix organization (GO:1903053),-0.346625324024989,-0.9175791122705316,0.5541740674955595,0.7957923661151644,1.0,2/15,1.33%,RB1;TIE1
prerank,cellular amide metabolic process (GO:0043603),0.2236406130602076,0.9175458091294912,0.6286407766990292,0.9782380492628393,1.0,25/102,17.86%,ABCA12;MME;SMPD3;PLPP2;SLC46A1;CPE;ABCA2;PLA2G4E;SLC19A1;ALDH1L2;OXSM;CPN1;AEBP1;ACSL6;MCCC2;NAAA;ACOT2;ACOT7;ACBD6;NSMAF;AASDHPPT;CLN8;MIPEP;ASAH2;SMPD1
prerank,regulation of interleukin-13 production (GO:0032656),-0.35561989289662116,-0.9173715586062753,0.5597014925373134,0.7958378126758338,1.0,1/13,0.16%,LEF1
prerank,acidic amino acid transport (GO:0015800),-0.3334106545432543,-0.9172871601782558,0.5761245674740484,0.795654501602971,1.0,6/17,19.03%,SLC6A6;LRRC8D;ARL6IP5;PRAF2;GIPC1;SLC1A1
prerank,lymphocyte mediated immunity (GO:0002449),-0.3668904928410977,-0.9172664801283518,0.5757575757575758,0.7953013595670824,1.0,7/12,45.25%,CD55;JAG1;GNL1;MYO1G;BTN3A3;KLRD1;SLA2
prerank,regulation of autophagosome maturation (GO:1901096),0.3468094813077842,0.9171121940866246,0.5504385964912281,0.9779975496286085,1.0,6/13,24.07%,CLN3;RUBCN;FYCO1;CLEC16A;SMCR8;UBQLN4
prerank,transepithelial transport (GO:0070633),-0.353314997400741,-0.9168927019608496,0.5934664246823956,0.7957383954039848,1.0,2/15,4.10%,ABCG2;SLC12A2
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2370727257348933,0.9167277402515532,0.6302325581395349,0.9776658568434798,1.0,14/70,16.75%,ENPP2;PCYT1B;LPIN1;PLA2G7;LIPC;PLA2G3;PLA2G4E;PLA2G6;MBOAT7;GPLD1;CHKA;CHPT1;SLC44A2;MBOAT2
prerank,RNA biosynthetic process (GO:0032774),0.28286663876783846,0.9166548526614261,0.6009501187648456,0.9764450565835535,1.0,5/31,10.06%,TBPL1;SMARCA5;TAF5;PRMT5;POLA1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.39704790665425793,-0.916629093988054,0.5798611111111112,0.7959294496987941,1.0,5/10,24.60%,DIP2B;SETD5;PRKAA1;MYOCD;DIP2A
prerank,substantia nigra development (GO:0021762),0.2742779857126842,0.9161815758986183,0.5960698689956332,0.976436885473381,1.0,8/37,14.30%,PLP1;CALM2;MAOB;CNP;PADI2;CCDC14;MBP;GLUD1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.31884491517200375,-0.9159442911025888,0.5805309734513274,0.7971083497125135,1.0,3/19,5.89%,PARD3B;PARD3;DLG1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.38508266296353766,-0.9159300634582993,0.5874769797421732,0.7967373934337185,1.0,5/10,32.94%,LYN;CD40;BTLA;LILRB1;FGR
prerank,modified amino acid transport (GO:0072337),-0.3423567560147084,-0.9158451512467534,0.5753176043557169,0.7965275057494985,1.0,3/15,5.02%,SLC25A32;SLC5A6;SLC16A12
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.27447719007353244,0.9153716452173536,0.5822510822510822,0.977274871670487,1.0,6/32,13.19%,NPSR1;AKAP6;GPER1;P2RX3;P2RX5;CASQ1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.23286023414848828,-0.9151179124587429,0.660482374768089,0.7977767078981617,1.0,28/88,26.43%,DAB2IP;DAPK1;RNF139;DDX3X;GIGYF2;LARP1;NFKB1;DNAJC1;SAMD4A;AKT1;EDN1;BTG2;IGFBP5;HDAC6;SYNCRIP;CDK5RAP3;PLAT;RPS3;TOB1;CAPRIN1;RPL13A;MRPL13;CNOT8;FXR1;EIF2AK3;SERPINE2;NANOS1;CNOT1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3495444914523189,-0.914858617193539,0.5809859154929577,0.7979231158769029,1.0,5/15,23.94%,KDR;VEGFC;IL16;F3;CXCL12
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.34815090296436646,-0.9148437983899518,0.5740072202166066,0.797161958686181,1.0,7/15,31.09%,TNRC6B;AGO2;TOB1;NANOS1;CNOT1;PABPC1;ZFP36L1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.34815090296436646,-0.9148437983899518,0.5740072202166066,0.797161958686181,1.0,7/15,31.09%,TNRC6B;AGO2;TOB1;NANOS1;CNOT1;PABPC1;ZFP36L1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.35913101390788804,-0.9147322823441353,0.5598526703499079,0.7970265119636355,1.0,3/12,2.78%,PODXL;PROM1;IQGAP1
prerank,primary alcohol metabolic process (GO:0034308),-0.30766773999232705,-0.9146948297350619,0.6,0.7967164202406963,1.0,11/25,34.27%,RBP4;NAPEPLD;RDH10;GDPD1;GDPD3;IGF1;RETSAT;GDE1;RDH12;CYP1B1;ADH1A
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.2912336319249359,0.9142987504505848,0.5667447306791569,0.9790092931529879,1.0,6/27,13.59%,DDR2;SPHK1;S100A6;PDGFA;PDGFRA;WNT2
prerank,response to organonitrogen compound (GO:0010243),0.2649358490308792,0.9141803710291223,0.6107226107226107,0.9778731799954002,1.0,7/38,17.43%,GLRA3;GLRA1;INAVA;RCN3;BRSK2;SEL1L;KAT7
prerank,digestive tract development (GO:0048565),-0.28739347237432744,-0.9139054991661139,0.5908289241622575,0.7980978694362756,1.0,8/32,14.00%,CLMP;SMO;NIPBL;TGFB2;PCSK5;GLI3;PKDCC;ZIC3
prerank,negative regulation of histone acetylation (GO:0035067),-0.3736453769442236,-0.9130837614299716,0.5811808118081181,0.7996145880203216,1.0,5/11,29.82%,SIN3A;TAF7;BRCA1;SET;SPI1
prerank,mesenchymal cell development (GO:0014031),0.32079279660544047,0.9121312577152405,0.5619469026548672,0.982307043215746,1.0,7/18,24.47%,NRG1;NOLC1;CDH2;TCOF1;HEYL;CYP26C1;TAPT1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.28331971295295755,0.9118538120444678,0.5748898678414097,0.9815929282093047,1.0,7/28,19.53%,IL12A;CCL2;XRCC6;SIRPA;IL23A;CD47;PRKCQ
prerank,positive regulation of immune system process (GO:0002684),-0.34183419623133876,-0.9117505247073782,0.6018181818181818,0.8021800680112731,1.0,5/16,18.48%,IL15;TGFB2;PIK3CD;PIK3CB;ANXA1
prerank,regulation of organelle organization (GO:0033043),-0.23701984172608312,-0.9112115530286166,0.6215277777777778,0.8029481122873077,1.0,12/80,8.24%,TJP1;F11R;PAK2;STX18;DIAPH1;MSN;PDE2A;EZR;PTK2;ARMH3;USP6NL;MAPK1
prerank,B cell homeostasis (GO:0001782),-0.38406069054734376,-0.9107705937317307,0.6076642335766423,0.8035858959028133,1.0,3/10,7.47%,LYN;MEF2C;PPP2R3C
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.300176523509262,0.9107018843173659,0.5981308411214953,0.983497335620249,1.0,3/24,6.48%,TMEM161A;BCL2;TRIAP1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.37417686177486076,-0.9104696533946591,0.5757009345794393,0.8038896810306915,1.0,6/11,29.14%,ITGB5;CCN3;VCL;KIFC3;THBS4;JUP
prerank,intestinal lipid absorption (GO:0098856),-0.3775247018649214,-0.909325893670967,0.5834896810506567,0.8061128346003055,1.0,1/11,0.90%,LIMA1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2625782058194304,-0.9076535353022265,0.6290909090909091,0.8095548917244396,1.0,21/47,33.26%,CHCHD3;APOOL;AFG3L2;SAMM50;MTX1;AGK;DMAC2L;ATP5F1E;ATP5F1C;UQCC3;ATP5MF;TMEM11;IMMT;TIMM10;ATP5PO;TOMM70;ATP5F1D;ATP5MC2;SPG7;MICOS10;TIMM10B
prerank,neurotrophin signaling pathway (GO:0038179),-0.30970485445582635,-0.9073343045988878,0.5930434782608696,0.809842016508121,1.0,6/21,11.22%,RAPGEF2;DDIT4;RAP1A;NGF;BCAR1;RAPGEF1
prerank,megakaryocyte differentiation (GO:0030219),-0.37264535359851686,-0.9072797649359818,0.5946428571428571,0.8095459998986819,1.0,3/11,11.33%,MED1;TAL1;ZFPM1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.26743243567994623,-0.9072359594896708,0.6190476190476191,0.8092345323553902,1.0,9/40,14.97%,SLC7A5;SLC38A11;SLC5A6;SLC38A5;SLC16A1;SLC13A3;SLC25A11;SLC36A4;SLC7A7
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2204985958806206,-0.9065055238573996,0.6736474694589878,0.8104876538804747,1.0,47/117,34.71%,BSG;DLD;PANK2;SLC5A6;PPARA;GGT5;SLC16A1;ACSF2;PPARD;SCPEP1;ABAT;THEM4;CPT1A;PDHB;SLC27A4;ACADSB;LPL;HOGA1;IGF1;GBA2;MTHFD1L;KYNU;GAMT;PCCA;PCCB;PTGR1;PPARG;PNPLA8;ACOT6;ACSF3;CKMT1A;ACOT11;ME2;GLO1;ALKBH7;SGPL1;HAGH;HACL1;LDHA;HLCS;VNN1;ME1;NPC1;ECHDC3;CYP4B1;ADH1A;ALDH8A1
prerank,regulation of feeding behavior (GO:0060259),0.35981682222777117,0.9061915643967463,0.5697940503432495,0.9948293291621153,1.0,4/11,23.57%,NR4A3;SGIP1;CFAP20;AGRP
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.36690657197871673,-0.9050844398242501,0.5796847635726795,0.8133231687069467,1.0,6/12,35.96%,RAB1A;PTEN;FZR1;PLK1;CDC20;UBE2C
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.30617463452164695,-0.9046121624659096,0.6097122302158273,0.8140076699149651,1.0,6/23,16.55%,SMO;SIX1;BMP4;PIK3CD;FGF2;SIX4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.34223830108860454,0.9043713552389161,0.5607064017660044,0.9985355497331136,1.0,3/13,15.26%,IL12A;IL12RB1;IL23A
prerank,carbohydrate transport (GO:0008643),-0.37056633938598027,-0.9040836914894989,0.5802919708029197,0.8147908036961873,1.0,6/11,32.65%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1
prerank,regulation of telomere capping (GO:1904353),-0.3115437889388019,-0.9040340902659684,0.5836431226765799,0.8144944713749117,1.0,13/23,37.98%,NEK7;ATM;MAPK1;PNKP;TERF2;USP7;SMG6;HNRNPD;TNKS2;RAD50;TNKS;MAPKAPK5;MAPK15
prerank,negative regulation of hemostasis (GO:1900047),0.35276310080701684,0.9040274423561326,0.5938864628820961,0.9980906447313617,1.0,1/12,0.25%,VTN
prerank,determination of bilateral symmetry (GO:0009855),-0.30103068005515565,-0.9036211313584459,0.6164383561643836,0.8150141135724476,1.0,8/24,21.20%,PKD2;TBX1;NOTCH1;GALNT11;ZIC3;CITED2;KIF3B;CFAP53
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.3418993004655769,-0.9034101689864089,0.5981132075471698,0.8150568783981829,1.0,3/15,6.58%,SMO;SIX1;BMP4
prerank,mRNA methylation (GO:0080009),-0.33887727884048474,-0.9031479548826149,0.6204379562043796,0.8152564280339106,1.0,3/15,10.07%,CBLL1;METTL14;WTAP
prerank,phosphate ion homeostasis (GO:0055062),0.3716929698000887,0.9029652457626133,0.5995575221238938,0.9995723947338679,1.0,1/10,1.59%,SLC34A1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3062891062974872,-0.9028895909004895,0.6124763705103969,0.8154388513376003,1.0,8/24,21.92%,MCL1;FOXO3;TGFB2;ATF4;SRPK2;CTNNB1;ITGAM;NF1
prerank,error-free translesion synthesis (GO:0070987),-0.315899326513574,-0.902831908644927,0.6118067978533095,0.8151817857619328,1.0,7/22,23.59%,RPA3;RPA1;REV1;RPA2;RFC4;RCHY1;RFC1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3136607849260914,-0.902672668435338,0.6223776223776224,0.815141701239608,1.0,4/20,6.64%,NEDD4L;PRKCE;YWHAE;NEDD4
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3399136556191347,0.9025914132223813,0.5634408602150538,0.9992281043871531,1.0,4/13,16.80%,TOX;CAMK4;FOXJ1;ADAM8
prerank,mitotic cytokinesis (GO:0000281),-0.2591470020594794,-0.9025573296925677,0.6197183098591549,0.8150127544530056,1.0,13/47,15.79%,SPTBN1;STAMBP;SNX9;ROCK1;CUL7;CHMP4B;KIF23;RASA1;SON;RHOC;RTKN;MITD1;ROCK2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.35302053366324687,-0.9021082451042755,0.6345454545454545,0.8156023078705003,1.0,5/13,12.91%,TGFBR3;MEF2C;TBX2;NOTCH1;FGF2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3858330881779376,-0.9020583177907097,0.5874769797421732,0.8153093927415321,1.0,7/10,47.22%,AKT1;TREM2;TLR6;TICAM1;TLR4;MIA3;MYD88
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.2992626652026031,-0.901826764385555,0.599271402550091,0.8154224844564574,1.0,9/25,27.11%,SPTBN1;PRKD2;PLCG2;ANXA1;RPS3;PTPRC;MAP3K7;STOML2;PNP
prerank,axon extension (GO:0048675),-0.3006175884616179,-0.9015080406659722,0.6236559139784946,0.8157454093069956,1.0,6/23,15.68%,NRP2;USP9X;SLIT2;ULK2;SPG11;SEMA5B
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.29569879387200715,-0.9013838056220886,0.6422182468694096,0.81563521855071,1.0,11/26,23.79%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;TRPV4;RPS3;ARL2;AKAP9
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.32137281005077545,-0.9012965577934532,0.6015625,0.8154315033252588,1.0,4/18,11.80%,SPTBN1;LDLRAP1;STX8;ACTB
prerank,transport along microtubule (GO:0010970),-0.3526506588424179,-0.9011648340612567,0.6074450084602369,0.8153228233310497,1.0,3/13,13.22%,APP;COPG1;SPG11
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.27900544758057505,-0.9010696664755097,0.6118881118881119,0.8151444064069138,1.0,11/35,26.99%,POLD3;OGG1;RPA3;RPA1;PNKP;RPA2;RFC4;NTHL1;RFC1;LIG1;POLL
prerank,replication fork processing (GO:0031297),-0.26875372226161465,-0.9010354083715194,0.6347197106690777,0.8148209362094672,1.0,11/38,21.01%,SAMHD1;MRE11;MMS22L;ZGRF1;DNA2;FANCM;THOC1;RFWD3;WRN;ATRX;BLM
prerank,negative regulation of cellular component organization (GO:0051129),0.22906323001855758,0.9009024576088417,0.6459770114942529,1.0,1.0,15/74,14.33%,TMEFF2;SYT11;APOM;IMPACT;MTMR2;HSF1;CARMIL1;SORL1;XRCC5;VEGFA;NOP53;PRKCZ;RUBCN;CLU;LRSAM1
prerank,positive regulation of peptidase activity (GO:0010952),-0.3239126143258234,-0.9008434032046991,0.6305970149253731,0.8148236091981172,1.0,6/20,18.46%,PSME2;MAPK12;VSIR;APH1A;CTSH;PSME1
prerank,positive regulation of endocytosis (GO:0045807),-0.2625594976225066,-0.9008184924774518,0.6263537906137184,0.814471970716567,1.0,10/45,13.25%,HIP1;DAB2;NEDD4L;CBLL1;LDLRAP1;CBL;HFE;ANO6;ANKFY1;FLOT1
prerank,primary neural tube formation (GO:0014020),-0.2852331516230613,-0.9007831975440853,0.6258620689655172,0.8141474398783324,1.0,8/30,15.88%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI
prerank,positive regulation of DNA repair (GO:0045739),-0.26064954920547484,-0.9006620288590187,0.648695652173913,0.814003629507824,1.0,19/46,24.41%,EYA4;UIMC1;EGFR;SPIDR;RNF168;BABAM2;SLF2;ERCC8;HDAC10;CEBPG;BRCC3;RPS3;BRCA1;TIMELESS;TRIM28;FAM168A;DHX9;ERCC6;HMGB1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.3758619785183097,-0.8999956526621307,0.5970425138632163,0.8150699260415291,1.0,5/10,40.33%,HDAC6;AOC3;MT3;HP;ETFBKMT
prerank,positive regulation of proteolysis (GO:0045862),-0.2538462731148581,-0.8997842925423485,0.6358885017421603,0.8151414531445085,1.0,25/55,40.16%,CTSC;ADAM9;TNFRSF1B;SNX9;ASPH;CASP8;PERP;FBXW11;MAPK12;CTSH;FGFR4;OGT;RHBDD1;NLRC4;TNIP1;TRIM32;PLK1;TBC1D10A;ATP5IF1;BAG2;HDAC2;CLN6;SH3D19;AURKAIP1;BAK1
prerank,multivesicular body organization (GO:0036257),-0.2836026937050465,-0.8992704320985889,0.5979020979020979,0.8159123379516646,1.0,14/31,30.64%,RAB27A;CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,negative regulation of protein depolymerization (GO:1901880),0.2903310822964554,0.8990370997186677,0.6423841059602649,1.0,1.0,6/24,17.60%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3
prerank,response to growth factor (GO:0070848),-0.2627293309649422,-0.8988638107029577,0.6323529411764706,0.8164235702526833,1.0,12/41,21.74%,ACVRL1;KLF4;BMPR2;EMD;TGFBR2;ACVR2A;AKT1;HDAC6;CTNNB1;EPHA2;MAPK7;NOS1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.31447348821599763,-0.8987782038547703,0.5963636363636363,0.8162057724322548,1.0,2/20,6.56%,IL1R1;CD55
prerank,acetyl-CoA metabolic process (GO:0006084),0.32513628089250973,0.8987685650849515,0.5927601809954751,1.0,1.0,7/15,20.44%,ACLY;ACACA;ACSS1;TDO2;HMGCS1;MVK;ACAT1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3377204497703278,-0.8985861306925742,0.6156583629893239,0.8162276041310821,1.0,4/16,15.73%,ESR1;RBFOX2;NCOA4;TADA3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3659807153910109,-0.89857218524462,0.5978062157221207,0.8154631884321366,1.0,3/11,17.46%,PKD2;GSTM2;CASQ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3659807153910109,-0.89857218524462,0.5978062157221207,0.8154631884321366,1.0,3/11,17.46%,PKD2;GSTM2;CASQ2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3526139761650674,0.8982856221576192,0.6088794926004228,1.0,1.0,2/12,6.88%,FADS1;FADS2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.28175746958199516,-0.8981669595135894,0.6144366197183099,0.8159610046010415,1.0,11/31,27.38%,EXT1;BMPR2;CSGALNACT1;HS3ST3B1;CHST11;EXTL3;IGF1;XYLT2;PXYLP1;CSGALNACT2;XYLT1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.3596831806052974,-0.8981427672518189,0.5893186003683242,0.8156195376691453,1.0,2/12,6.34%,PPARA;IRS1
prerank,protein K48-linked deubiquitination (GO:0071108),0.2976560374728452,0.8970563147160309,0.5929203539823009,1.0,1.0,11/23,24.88%,OTUD7A;USP25;OTUD7B;USP50;USP5;USP33;USP20;OTUB2;OTUB1;USP8;OTUD5
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2928616553946869,-0.8969300426309185,0.6105263157894737,0.8178702900798417,1.0,5/25,11.70%,RIN3;RAC1;APP;PICALM;PSEN1
prerank,zinc ion transport (GO:0006829),-0.3124023653286532,-0.8967970356241807,0.6091743119266055,0.8177514797465006,1.0,6/21,20.88%,SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,cilium-dependent cell motility (GO:0060285),0.3030822567384849,0.8967889104776807,0.5928411633109619,1.0,1.0,2/22,4.02%,TEKT1;CFAP54
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2806997979455438,-0.896674384559523,0.6268115942028986,0.8172157937969688,1.0,10/31,29.19%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2H;POLR2L;GTF2H3;CCNH
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2806997979455438,-0.896674384559523,0.6268115942028986,0.8172157937969688,1.0,10/31,29.19%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2H;POLR2L;GTF2H3;CCNH
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3046005352159892,-0.8963401032815631,0.5970695970695971,0.8175976757434995,1.0,9/23,26.29%,GHR;CRLF3;HES1;NOTCH1;JAK2;IL10RB;PTK2B;OCIAD2;F2R
prerank,negative regulation of RNA splicing (GO:0033119),-0.3149123757646094,-0.8961802806375622,0.6274165202108963,0.8175508281931623,1.0,8/19,30.32%,SRSF12;SFSWAP;RNPS1;SRSF10;PTBP3;RPS26;RPS13;SRSF6
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2651468670347969,-0.8961539989603505,0.6425992779783394,0.8172116015612656,1.0,10/41,16.85%,CD34;GAS6;LBP;NFKBIL1;DICER1;VSIR;ILRUN;RARA;TNFAIP3;IGF1
prerank,replicative senescence (GO:0090399),-0.35771465967889265,-0.8960709977430906,0.6137184115523465,0.8169843148796858,1.0,6/12,23.00%,ATM;WNT16;TP53;CHEK1;TERT;SERPINE1
prerank,negative regulation of T cell activation (GO:0050868),0.2663851061695193,0.8957832721368931,0.6623093681917211,1.0,1.0,6/35,16.60%,PAG1;VTCN1;SDC4;HAVCR2;CD86;FCGR2B
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.31045357410584973,-0.8957026104051307,0.625,0.8169973551881538,1.0,6/21,24.04%,EYA4;MCL1;AKT1;MAPK7;TERT;HSPA1B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.31045357410584973,-0.8957026104051307,0.625,0.8169973551881538,1.0,6/21,24.04%,EYA4;MCL1;AKT1;MAPK7;TERT;HSPA1B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3554828445970598,0.8956341811245022,0.6013824884792627,1.0,1.0,2/12,5.81%,ATP2B4;FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3554828445970598,0.8956341811245022,0.6013824884792627,1.0,1.0,2/12,5.81%,ATP2B4;FHL2
prerank,lipid droplet organization (GO:0034389),0.3026456001357184,0.8952358613493588,0.6357894736842106,1.0,1.0,6/22,17.81%,BSCL2;SQLE;PPID;PPIA;AUP1;CDS1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.29553500824004614,0.8952340248301545,0.616557734204793,1.0,1.0,8/23,16.62%,PIP4P1;MTMR2;MTMR11;MTMR10;MTMR7;OCRL;INPP5F;INPP5B
prerank,response to insulin (GO:0032868),-0.23233161572521063,-0.8950654948811183,0.6970802919708029,0.8180025818344566,1.0,13/80,13.66%,TBC1D4;SORBS1;FOXO1;INSR;KAT2B;PIK3R1;IRS1;RHOQ;GSK3A;AKT1;CEACAM1;RAB8B;INSIG2
prerank,negative regulation of JNK cascade (GO:0046329),-0.2825000187776606,-0.894838157645298,0.6561922365988909,0.8181076859531919,1.0,8/31,26.85%,MECOM;PDCD4;TAOK3;DUSP3;ZMYND11;SH3RF2;GPS2;AIDA
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.28308592402933785,-0.8948002023160628,0.6100746268656716,0.8177882458366915,1.0,10/29,28.58%,JAM2;GAS6;MOSPD2;ANO6;LGMN;SERPINE1;CXCL12;HMGB1;CXCL10;LGALS9
prerank,phagosome-lysosome fusion (GO:0090385),0.37419024435220716,0.8944391060219311,0.581140350877193,1.0,1.0,4/10,16.18%,CLN3;RAB34;RAB39A;RAB20
prerank,regulation of protein polymerization (GO:0032271),0.2670955733428417,0.8944040062806082,0.6390134529147982,1.0,1.0,8/35,12.48%,PFN2;PFN1;PAK3;MAP2;MAPT;TPPP3;TPPP;MAPRE3
prerank,nucleotide metabolic process (GO:0009117),0.29123560666577,0.8941120241788177,0.5887445887445888,1.0,1.0,7/23,17.51%,AK7;AK5;ENPP3;NME2;RNASEH2B;GUK1;AK1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.32509282455620536,0.8940988609026614,0.5933806146572104,1.0,1.0,3/16,10.69%,RASGRF1;ARHGAP24;AUTS2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.26584641885965876,0.8931296043966461,0.6455142231947484,1.0,1.0,12/35,21.46%,FAR1;ACLY;ACACA;HMGCLL1;ALOX12;HMGCL;SCD5;ALOX5;GGT7;SCD;ACAT1;HSD17B8
prerank,modulation by host of viral genome replication (GO:0044827),-0.35134509497489574,-0.8929421182882976,0.6169811320754717,0.8213966838668958,1.0,7/13,40.77%,TBC1D20;VAPA;CCNK;EIF2AK4;IFI27;FBXL2;CCL8
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.3759489688174943,-0.8929240946718799,0.6097087378640776,0.8210360142294797,1.0,3/10,12.48%,PRKG1;PRKCD;CEACAM1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.33786239945428764,-0.8917994230198225,0.6185383244206774,0.8231381806115975,1.0,3/15,23.37%,SMOX;DDC;SRM
prerank,cardiac cell development (GO:0055006),0.36387361223411735,0.8915046911956548,0.6073059360730594,1.0,1.0,4/11,12.07%,CXADR;ALPK3;VEGFA;SLC8A1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3247037122601057,-0.8914438156061993,0.6216216216216216,0.8235119056947937,1.0,7/16,16.85%,TGFBR3;MEF2C;TBX2;EDN1;NOTCH1;FGF2;IGF1
prerank,activation of protein kinase B activity (GO:0032148),0.27480492885602,0.8911594177271619,0.6426966292134831,1.0,1.0,5/29,9.76%,NRG1;CCDC88A;ANG;ADRA2C;ADRA2A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.24581830960146406,-0.8907910998373855,0.6818181818181818,0.8245148687383025,1.0,14/57,19.19%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1;CLCF1;PPP2CA
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2833211617692743,-0.8902621902625854,0.6326164874551972,0.8252721354370612,1.0,14/31,27.84%,POLR2G;EXOSC1;EXOSC2;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;DIS3L2;NT5C3B;CNOT8;EXOSC7;LSM2
prerank,diol metabolic process (GO:0034311),0.30857820990591345,0.8900405145540452,0.6143497757847534,1.0,1.0,6/19,11.74%,PLPP2;SPHK1;SGPP1;SPHK2;PRKG2;NAAA
prerank,membrane lipid catabolic process (GO:0046466),0.3631350457426106,0.8894251967864437,0.5870069605568445,1.0,1.0,2/10,6.50%,ENPP2;SMPDL3B
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2603117378715829,-0.8894047350815283,0.6333333333333333,0.8267814970237969,1.0,9/39,14.11%,MYO1D;FNBP1L;TRAK1;RAB1A;WASL;MYO1F;ACTN4;PAFAH1B1;FBXW11
prerank,response to glucagon (GO:0033762),-0.30814232827317056,-0.8893253041293675,0.6247689463955638,0.8265528513296342,1.0,8/19,26.59%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1;CREB1;ADCY6;ADCY5
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.31814084893652306,-0.8890768449527046,0.6132596685082873,0.8267188502673232,1.0,2/17,6.15%,RAC1;MOSPD2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.29119660330855784,-0.8888843392788939,0.6294964028776978,0.8267304237054629,1.0,6/26,17.90%,RNF111;RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,peptide metabolic process (GO:0006518),-0.23354942904700027,-0.8885544222758164,0.6737588652482269,0.8270265045982962,1.0,24/75,25.86%,CPQ;ACE;GSTT1;PSEN2;GSTT2;ABCB9;SPPL3;PCSK5;GSTM2;ENPEP;PSEN1;CPXM2;GPX1;ERAP1;SOD1;HPGDS;DNPEP;CLN5;NPEPPS;CPXM1;THOP1;GSTK1;CPZ;SEC11A
prerank,B cell activation involved in immune response (GO:0002312),0.3367574159797849,0.8884088578845835,0.6047516198704104,1.0,1.0,5/13,17.97%,BATF;RNF8;GPR183;FCGR2B;MSH2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2296632330220436,-0.8883661707211924,0.6863799283154122,0.8270550425002203,1.0,21/85,19.26%,RAC1;FZD6;SMURF2;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.32853490159164167,-0.8883214640294708,0.6298342541436464,0.8267497951074794,1.0,5/17,15.06%,KDR;SLIT2;AKT1;FGF2;PIK3R3
prerank,cAMP biosynthetic process (GO:0006171),0.36502032552763247,0.8880558381537608,0.6247422680412371,1.0,1.0,3/10,7.20%,ADCY8;ADCY10;ADCY7
prerank,negative regulation of innate immune response (GO:0045824),0.2729746288567171,0.8879828195557524,0.648590021691974,1.0,1.0,8/34,15.54%,TYRO3;TTLL12;SUSD4;GRN;SERPING1;CNOT7;OAS3;LYAR
prerank,fatty acid elongation (GO:0030497),0.33965622319757366,0.8879743890707105,0.6058700209643606,1.0,1.0,5/13,19.79%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,response to nitric oxide (GO:0071731),0.34325609793790446,0.8879576295645157,0.57847533632287,1.0,1.0,2/13,8.20%,KCNC2;DPEP1
prerank,cellular response to purine-containing compound (GO:0071415),0.3692701921499672,0.8872092827989312,0.5650224215246636,1.0,1.0,3/10,12.07%,RYR3;RYR2;SLC8A1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.24661390187976467,-0.8872030425351066,0.6515151515151515,0.8288148464770961,1.0,18/49,29.58%,GSK3B;DDX3X;LDLRAD4;RAF1;TRAF3IP1;SMAD6;HDAC6;IAPP;ANKRD27;TFIP11;PMEPA1;RPL13A;HMGB1;KIF14;AIDA;RIOK3;NLRP2B;TREM2
prerank,regulation of cellular protein localization (GO:1903827),-0.25617968105869754,-0.8871903359155062,0.6397306397306397,0.8284382055343498,1.0,17/45,23.64%,DVL3;PTPN1;SETD2;GPC6;SPIDR;PPM1F;PRKAA1;HFE;LCP1;VCPIP1;CTNNB1;GPC3;NDEL1;KCNAB2;HSP90AA1;RALB;RAB11FIP5
prerank,regulation of adenylate cyclase activity (GO:0045761),0.2968262740961906,0.8864983248238256,0.6244239631336406,1.0,1.0,3/22,6.63%,GNAI2;GABBR2;CACNA1D
prerank,positive regulation of B cell proliferation (GO:0030890),0.27983706503067385,0.8864439011710432,0.6331096196868009,1.0,1.0,5/29,9.16%,BCL2;NFATC2;SASH3;CD81;VAV3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.32799891147548155,0.8862126184905011,0.5548245614035088,1.0,1.0,9/15,22.30%,SCN1A;TMC1;TMC2;KIT;WHRN;MKKS;COL11A1;PDZD7;KCNK4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.2713619807933892,0.8860091292291354,0.667420814479638,1.0,1.0,11/32,23.52%,NPSR1;AKAP6;CALM2;GPER1;CASQ1;HTT;CX3CL1;HAP1;TRPC1;PDPK1;CAPN3
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.3570073851409584,-0.8857385871329924,0.6424682395644283,0.8312439166744731,1.0,5/12,25.15%,MTHFD1;AMPD2;HPRT1;PRPS2;ADA
prerank,histone H3-K36 demethylation (GO:0070544),-0.3815330884442585,-0.8856984605890004,0.6277372262773723,0.8309390713447564,1.0,3/10,15.09%,KDM2A;RIOX2;KDM7A
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.31421393010721066,0.885583297988311,0.6043010752688172,1.0,1.0,3/17,8.46%,SCN1B;CACNA2D1;SCN5A
prerank,chromosome organization (GO:0051276),-0.22309014468467478,-0.8855422572578165,0.7266187050359713,0.8308644168364319,1.0,33/99,28.24%,RAE1;RBX1;HDAC1;ZBTB7A;ABL1;SUV39H1;LDB1;HMG20A;DOT1L;AXIN2;EHMT1;HMGN3;XPC;H3-3A;TCF7L1;RFWD3;HDAC10;CETN2;HMGN2;LIG4;COPS7A;SUPT4H1;CENPH;COPS8;MSH3;COPS4;TCF7L2;PWWP3A;SETD7;CDCA8;HDAC5;PHF19;CDAN1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3644865679136331,0.885530368943929,0.6017505470459519,1.0,1.0,10/10,63.57%,CBARP;CALM3;CALM1;GNB5;DRD4;FMR1;DRD2;GPR35;CRHR1;DRD3
prerank,protein alkylation (GO:0008213),0.29279829041702254,0.8853598129653145,0.6383442265795207,0.9995714914174141,1.0,12/22,30.88%,METTL21A;EEF1AKMT2;SNRPD3;PCMT1;PRMT2;VCPKMT;PRMT8;EEF1AKMT1;FAM98B;EEF2KMT;METTL21C;LCMT1
prerank,triglyceride biosynthetic process (GO:0019432),0.3164970119518389,0.8853439895052464,0.5991379310344828,0.9982265264621314,1.0,3/18,12.95%,LPIN1;GK;MOGAT1
prerank,protein prenylation (GO:0018342),-0.37498823226381894,-0.8852314115340023,0.6057866184448463,0.831125067182164,1.0,8/10,50.32%,PTAR1;PGGT1B;RABGGTB;RCE1;RABGGTA;CHML;AIPL1;FNTA
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.31801763024598356,0.8847576679344837,0.6097560975609756,0.998452427023984,1.0,4/17,8.46%,PKP2;GPD1L;RYR2;SCN5A
prerank,sympathetic nervous system development (GO:0048485),-0.33393703700780597,-0.8840254042088519,0.6224299065420561,0.83334777037391,1.0,4/15,21.92%,NRP2;CTNNB1;SOX4;NF1
prerank,histone H4-K5 acetylation (GO:0043981),-0.334815631714752,-0.8834054235782052,0.6238361266294227,0.8338805431553372,1.0,6/15,22.69%,KANSL3;PHF20;HCFC1;JADE2;WDR5;OGT
prerank,histone H4-K8 acetylation (GO:0043982),-0.334815631714752,-0.8834054235782052,0.6238361266294227,0.8338805431553372,1.0,6/15,22.69%,KANSL3;PHF20;HCFC1;JADE2;WDR5;OGT
prerank,tube closure (GO:0060606),-0.2795951475071097,-0.8833768443246945,0.6619718309859155,0.8335406346709707,1.0,8/31,15.88%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI
prerank,regulation of fibroblast proliferation (GO:0048145),-0.25565384674130387,-0.883048198663785,0.6935483870967742,0.8338510609039244,1.0,12/45,21.92%,DAB2IP;EMD;GAS6;TP53;CDC73;CDK6;MIF;SKI;IGF1;CTNNB1;LIG4;NF1
prerank,mitochondrial translation (GO:0032543),-0.2211248511824907,-0.8828512374658108,0.747008547008547,0.8338378603820932,1.0,38/104,30.10%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPL12;MRPS27;MRPL58;MRPL24;MRPL57;MTRF1L;NDUFA7;MRPS14;MRPS21;MRPL35;GFM2;IARS2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS28;MRPS35;NOA1;MRPS2;MRPL43;TUFM;MRPS31;MRPL11;MRPL48;GATB;MRPS17;MTIF2;MRPL39
prerank,phosphatidylserine metabolic process (GO:0006658),-0.27508878755526106,-0.8826716596802304,0.6601423487544484,0.8338034110498898,1.0,10/32,28.33%,PLA2G4A;MBOAT1;PLSCR1;PTDSS1;SERINC1;SERINC5;PLA2G12A;LPCAT3;PLA2G4F;OSBPL10
prerank,peroxisomal membrane transport (GO:0015919),-0.2858391972630215,-0.8814795850182505,0.6515426497277677,0.8359718414660591,1.0,10/27,32.89%,PEX1;ABCD3;PEX7;RAB8B;PEX14;PEX3;PEX6;PEX11B;PEX19;PEX26
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24533181095423523,-0.8813758122571218,0.6619217081850534,0.835791357180616,1.0,25/55,36.51%,RAC1;THBS1;TGFBR2;SIRT5;AATF;DHRS4;TP53;AGTR1;GRB2;BRCA1;GADD45A;RIPK1;ACE2;PDGFRB;SLC25A33;MAPK14;PDK3;BST1;CYP1B1;TFAP2A;PID1;RAC2;MT3;PARL;FOXM1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3006372649487007,-0.8813580161411804,0.6247723132969034,0.8354211803281884,1.0,8/23,30.52%,GAS6;VSIR;RARA;HMGB1;LGALS9;AXL;DDIT3;LILRB1
prerank,lipoprotein catabolic process (GO:0042159),-0.3632395759273402,-0.8813351421467293,0.611214953271028,0.8350756098720343,1.0,6/11,29.87%,ABHD17A;NOTUM;ABHD17C;LYPLA1;PPT1;ABHD10
prerank,phasic smooth muscle contraction (GO:0014821),0.3594308808765352,0.8813264763658498,0.6222707423580786,1.0,1.0,4/10,22.90%,PTGER3;HTR1D;EDNRB;TIFAB
prerank,metanephric mesenchyme development (GO:0072075),0.3707816904919734,0.8812405310823105,0.6133333333333333,1.0,1.0,3/10,6.22%,OSR1;WT1;PAX2
prerank,mitotic cytokinetic process (GO:1902410),-0.3041636869179291,-0.8811086639745019,0.6415770609318996,0.8351776113788726,1.0,12/20,35.55%,CHMP4B;CHMP4A;RHOA;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A;CHMP1B
prerank,positive regulation of cation channel activity (GO:2001259),0.26171388045634564,0.8811023789147351,0.7099767981438515,1.0,1.0,8/40,15.41%,ANK3;STAC2;AKAP6;CALM2;STAC;CCL2;CASQ1;HTT
prerank,regulation of trophoblast cell migration (GO:1901163),0.3266602157799625,0.8802549445095386,0.6013667425968109,1.0,1.0,4/14,14.06%,TIMP1;ACVR1B;VEGFA;ACVR1C
prerank,sulfur amino acid catabolic process (GO:0000098),-0.36396685583003596,-0.8801011866259066,0.6190476190476191,0.8369010515985373,1.0,8/10,40.83%,TXN2;CTH;ADO;MTRR;MPST;BLMH;CBS;TST
prerank,diterpenoid metabolic process (GO:0016101),0.23455027674875592,0.8799323040509068,0.6724890829694323,1.0,1.0,8/55,13.82%,GPC5;AKR1C1;APOM;GPC1;SDC4;APOE;LRAT;AKR1B10
prerank,lung development (GO:0030324),-0.27154177859061285,-0.8795591197032304,0.6541218637992832,0.8376517206249523,1.0,9/33,14.00%,ITGA3;LOXL3;RBP4;BMP4;FGF1;FGF7;FGF2;WNT11;ZIC3
prerank,postreplication repair (GO:0006301),-0.25752465090270443,-0.879556217526887,0.6678507992895204,0.8372579383741652,1.0,13/45,25.42%,TRIM25;POLD3;RAD18;RPA3;RPA1;REV1;UBE2V2;USP10;RPA2;BRCA1;RFC4;RFC1;DTL
prerank,base-excision repair (GO:0006284),-0.25396143868601134,-0.8789131169370246,0.6830601092896175,0.8382466412896986,1.0,15/48,26.99%,POLD3;OGG1;RPA3;DNA2;RPA1;PNKP;WRN;RPA2;HUWE1;RFC4;NTHL1;RFC1;ERCC6;LIG1;POLL
prerank,positive regulation of ruffle assembly (GO:1900029),0.3442605138993224,0.8784962684438912,0.6244343891402715,1.0,1.0,2/13,5.80%,NLGN1;PFN1
prerank,tRNA methylation (GO:0030488),0.26866365645863116,0.8775473919432953,0.6616702355460385,1.0,1.0,13/34,26.45%,GTPBP3;TRMT13;TRMT10A;PRORP;FTSJ1;METTL2B;METTL2A;NSUN6;THUMPD3;TRMT5;THUMPD2;TRMT1L;TRMT61B
prerank,central nervous system neuron development (GO:0021954),-0.33509958296225,-0.8775105730018696,0.6399253731343284,0.840809919644443,1.0,7/15,22.22%,RAPGEF2;LHX6;B4GALT5;GBA2;ARHGAP35;PTEN;HSP90AA1
prerank,negative regulation of immune effector process (GO:0002698),0.341409158209183,0.8772429708451971,0.6310272536687631,1.0,1.0,4/13,15.75%,GRN;ENPP3;HAVCR2;CD47
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2980907697326187,-0.8772129143890933,0.6412078152753108,0.8410430475465149,1.0,6/23,21.94%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,regulation of mitochondrial fusion (GO:0010635),-0.36345465460830245,-0.8769824633275067,0.6596858638743456,0.8411382419112103,1.0,3/11,7.04%,ZDHHC6;TFRC;BNIP3
prerank,nucleoside salvage (GO:0043174),0.3561518792321049,0.8768713246755874,0.6094808126410836,1.0,1.0,5/10,24.26%,CDA;UCK2;UCK1;TK1;TK2
prerank,non-motile cilium assembly (GO:1905515),-0.27616401934306495,-0.8768612426879697,0.6804511278195489,0.8410154063866759,1.0,9/30,18.92%,TOGARAM1;CEP250;DCTN1;CSNK1D;FUZ;RPGRIP1;TBC1D32;TMEM17;PCM1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.3464686993255395,-0.8767845957426812,0.6415770609318996,0.840773813574231,1.0,6/13,39.38%,ABL1;HDAC6;NOD2;SZT2;MT3;HP
prerank,cellular response to zinc ion (GO:0071294),-0.3403637975754774,-0.8761619156278753,0.6212121212121212,0.8417037394965551,1.0,9/15,27.27%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;HVCN1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.3480917497523299,-0.8760674454404127,0.6054054054054054,0.8415096741704627,1.0,3/12,21.68%,ESR1;PPARG;TERT
prerank,termination of RNA polymerase II transcription (GO:0006369),0.26571441489300174,0.8757891872184438,0.6615384615384615,1.0,1.0,15/33,28.68%,MED18;CPSF1;CSTF2T;SNRPD3;CLP1;CPSF2;SCAF8;CSTF2;NCBP2;SETX;CSTF3;CPSF4;TTF2;PCF11;SNRPF
prerank,regulation of cholesterol esterification (GO:0010872),0.35944461623243956,0.8756333038775431,0.6084070796460177,1.0,1.0,5/10,22.91%,ABCA2;APOE;APOC1;ABCG1;LAMTOR1
prerank,cardiocyte differentiation (GO:0035051),-0.3724536067925166,-0.875444029104425,0.6404109589041096,0.842423302338269,1.0,4/10,10.23%,AKAP13;SIK1;TGFB2;KDM6B
prerank,regulation of double-strand break repair (GO:2000779),-0.2594044247707569,-0.8753854558788797,0.6547842401500938,0.8421483746073234,1.0,7/39,9.22%,UBR5;SETD2;DEK;RNF169;MRNIP;SPIDR;TRIP12
prerank,regulation of integrin activation (GO:0033623),-0.32457812900357064,-0.8752313327415355,0.62756052141527,0.8420398571516368,1.0,3/15,8.25%,FERMT2;RASIP1;RAP1B
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3707163355407899,-0.8736480828506383,0.6267857142857143,0.8449959216448992,1.0,6/10,42.90%,EMC9;EMC2;EMC6;EMC3;MMGT1;EMC8
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.31541550422708564,-0.873558553824118,0.6386404293381037,0.8447640683314274,1.0,7/17,27.39%,MOSPD2;ANO6;LGMN;SERPINE1;CXCL12;HMGB1;CXCL10
prerank,regulation of DNA recombination (GO:0000018),-0.27205565997070064,-0.8735490112535662,0.6854990583804144,0.8443815503832749,1.0,10/32,23.55%,SETD2;SPIDR;MRE11;KPNA1;THOC1;SMARCAD1;RPA2;BLM;CHEK1;MSH3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3359787593293458,0.8732142341568002,0.6298076923076923,1.0,1.0,4/14,15.41%,ATP2B4;PKIB;PRKAR1B;HTT
prerank,chordate embryonic development (GO:0043009),-0.24132870473738272,-0.8731797612860409,0.7155797101449275,0.8447522582932716,1.0,15/55,20.15%,MBNL1;PKD2;BMP5;TBX1;KIAA1217;FUT8;RBP4;ADAM10;PCSK5;WNT11;SIX4;BMP7;LIG4;IGF2;BRCA1
prerank,calcium-mediated signaling (GO:0019722),-0.2192594532273553,-0.8727863561961542,0.7590579710144928,0.845197685482995,1.0,16/93,11.57%,KDR;LRRK2;PLCG1;PTPRJ;EGFR;TRPM4;PLCE1;IRGM;STIMATE;PLCG2;CCR9;EDN1;BCAP31;PRKAA1;PTGFR;AGTR1
prerank,regulation of DNA replication (GO:0006275),-0.24898442978484825,-0.8727078054696129,0.6727272727272727,0.8449739793883724,1.0,10/49,13.81%,ACVRL1;ANKRD17;STN1;EGFR;WAPL;ORC5;OBI1;PDS5A;DNA2;CTC1
prerank,glycogen biosynthetic process (GO:0005978),-0.3530062245798742,-0.872567590794605,0.6433823529411765,0.8444654318219943,1.0,4/12,20.37%,GBE1;PPP1R3C;GYS1;GYG1
prerank,glucan biosynthetic process (GO:0009250),-0.3530062245798742,-0.872567590794605,0.6433823529411765,0.8444654318219943,1.0,4/12,20.37%,GBE1;PPP1R3C;GYS1;GYG1
prerank,regulation of catabolic process (GO:0009894),-0.3047767564353272,-0.8725160030738023,0.6585820895522388,0.84416686131418,1.0,2/18,2.00%,ITGB1;NEDD4L
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3477301570782117,0.872240275149311,0.6473214285714286,1.0,1.0,2/11,7.16%,MUC20;PAK1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.35911164069024165,0.8718398841596436,0.6021739130434782,1.0,1.0,1/10,0.25%,VTN
prerank,magnesium ion transport (GO:0015693),0.33433970512804706,0.8716410470495763,0.6057906458797327,1.0,1.0,4/12,15.05%,TUSC3;NIPA1;NIPAL1;NIPAL2
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.2181475613249061,-0.8715527176023494,0.726148409893993,0.8457978194565255,1.0,36/95,35.43%,DAB2IP;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;MEF2C;LBP;NFKBIL1;IRAK1;RHOA;CDC73;MAPK8;CHMP5;TNFAIP3;DEFA6;NOD2;RELA;SERPINE1;SHPK;FZD5;HMGB1;CASP1;CXCL10;CACTIN;AXL;MAPK14;LILRB1;TICAM1;TNIP2;NLRP3;IL1A;CARD16;CD14;CD274;CTR9
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3420458075390299,0.8715148326981326,0.6158940397350994,1.0,1.0,2/11,6.38%,AKAP6;RNF207
prerank,secretory granule organization (GO:0033363),-0.37456014217892103,-0.8712743316012846,0.6600361663652803,0.8459815842886185,1.0,7/10,47.00%,SRGN;F2R;BLOC1S2;BLOC1S1;F2RL3;BLOC1S3;DTNBP1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3127637520670593,-0.8710295307267651,0.6422018348623854,0.8461172892663817,1.0,9/18,36.81%,RNF139;MAN1B1;UGGT1;TRIM13;EDEM2;RNF103;RNF185;OS9;RNF5
prerank,polarized epithelial cell differentiation (GO:0030859),-0.34860557711249873,-0.8708225077922878,0.6575091575091575,0.8461744893038833,1.0,4/13,19.81%,MSN;EZR;RHOA;RAP2A
prerank,cardiac myofibril assembly (GO:0055003),0.32828069863832693,0.8703877430316527,0.6022988505747127,1.0,1.0,5/15,12.88%,FHOD3;PROX1;MYLK3;PDGFRA;MYL2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.3686888573729452,-0.8702674444801606,0.6504504504504505,0.8469283221521096,1.0,2/11,6.93%,TGFB2;MEF2C
prerank,protein maturation (GO:0051604),0.21284988446084036,0.870194994669615,0.7758620689655172,1.0,1.0,22/95,15.93%,MME;MMP16;DNAJB11;TSPAN15;CLN3;CPE;TYSND1;METAP2;ADAM19;SORL1;BACE1;CPN1;TESC;PCSK2;AEBP1;TSPAN32;PCSK6;NAA40;NDUFAB1;NFU1;ECE2;EEF1AKMT4-ECE2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3478073744875094,-0.8699703102536357,0.6278195488721805,0.8471596237453086,1.0,4/12,21.83%,DIAPH1;UBASH3B;CASQ2;PTK2B
prerank,regulation of B cell proliferation (GO:0030888),0.24988801193504417,0.8698997043965065,0.676605504587156,1.0,1.0,6/44,9.16%,BLK;BCL2;NFATC2;SASH3;CD81;VAV3
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3580947275806986,-0.8695610435545044,0.6303571428571428,0.8476028023565711,1.0,2/11,3.37%,LYN;ATM
prerank,regulation of lipid metabolic process (GO:0019216),-0.22481790275629465,-0.8691942904651672,0.7391304347826086,0.8479846521922682,1.0,26/88,21.89%,CREBBP;CAV1;RXRA;PANK2;SP1;PPARA;NFYC;MED1;GGPS1;PPARD;ACACB;SIN3A;HELZ2;C1QTNF2;SMARCD3;DHCR7;TGS1;ABCA7;TNFAIP8L3;NR1D2;NCOA6;CARM1;FGFR4;TBL1X;PPARG;PMVK
prerank,regulation of fibrinolysis (GO:0051917),-0.34170311180753116,-0.8689339195409985,0.6582278481012658,0.8481238058641982,1.0,9/13,51.93%,THBS1;SERPINE1;USF1;PLG;APOH;F11;HRG;F2;FAP
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2554242366472388,-0.8688784089368949,0.6943942133815552,0.8478428170254252,1.0,10/43,16.85%,CD34;GAS6;LBP;NFKBIL1;DICER1;VSIR;ILRUN;RARA;TNFAIP3;IGF1
prerank,regulation of protein kinase C signaling (GO:0090036),0.3227541815719804,0.8687103359741175,0.6607538802660754,1.0,1.0,4/14,11.25%,GPD1L;VEGFA;SPHK2;ADRA1A
prerank,regulation of myelination (GO:0031641),0.274355466494764,0.8685457511977538,0.6984478935698448,1.0,1.0,3/25,5.41%,TENM4;MYRF;PTPRZ1
prerank,regulation of primary metabolic process (GO:0080090),-0.2107733120319463,-0.8681859464833549,0.7752212389380531,0.8488835524461658,1.0,38/126,21.89%,CREBBP;RXRA;PSMA2;SP1;PPARA;NFYC;MED1;GGPS1;PSME2;PPARD;PSMB4;ACACB;SIN3A;HELZ2;AZIN1;C1QTNF2;PSMC2;PSMB2;SMARCD3;DHCR7;TGS1;ABCA7;TNFAIP8L3;NR1D2;ROCK2;PSMB1;PSMA8;OAZ2;NCOA6;PSME1;CARM1;PRKAB1;FGFR4;NQO1;TBL1X;PPARG;PSMD4;PMVK
prerank,regulation of metal ion transport (GO:0010959),0.31125131243231347,0.867811748823919,0.6470588235294118,1.0,1.0,4/16,12.39%,CACNA2D1;BCL2;CAMK2B;SRI
prerank,regulation of centrosome duplication (GO:0010824),-0.28150628641841186,-0.866822750989865,0.6567944250871081,0.8513645492739438,1.0,14/29,39.20%,PLK2;CHMP4B;CHMP2B;CHMP5;ALMS1;PDCD6IP;CEP131;CEP295;CHMP3;CHMP1A;PKHD1;CHMP1B;SPICE1;SIRT1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.35845311362787213,-0.8665741059930214,0.6549815498154982,0.8514571706145941,1.0,7/11,47.00%,H3-3A;ATRX;ASF1B;ASF1A;NASP;HAT1;CABIN1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.30860498210044096,0.8665303410186271,0.6496674057649667,1.0,1.0,4/17,17.70%,SULT2B1;AHI1;FOXJ1;SOX9
prerank,nucleus organization (GO:0006997),-0.25385494512239193,-0.8664108453371584,0.6781818181818182,0.8514145295356538,1.0,11/47,20.86%,SYNE1;NUP98;REEP3;CHMP4B;CHMP4A;CHMP2B;TPR;CHMP5;SUN1;ATXN7;PDCD6IP
prerank,histone H3 deacetylation (GO:0070932),-0.33151542523031613,-0.8663946107546385,0.6467289719626168,0.851053492847594,1.0,5/15,19.08%,HDAC1;SFPQ;HDAC4;SMARCAD1;ELK4
prerank,piRNA metabolic process (GO:0034587),0.3018903472963638,0.8663605676273145,0.681917211328976,1.0,1.0,19/19,69.85%,TDRKH;PIWIL2;EXD1;TEX15;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;MYBL1;DDX4;TDRD9
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.2801918648906815,0.8662733821163052,0.6652452025586354,1.0,1.0,4/25,7.56%,CTNNA3;PKP2;CXADR;RYR2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3427910487540172,0.8662336254561618,0.6333333333333333,1.0,1.0,3/12,7.56%,CTNNA3;PKP2;RYR2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.32459185038214267,-0.8661044602700863,0.6605504587155964,0.8512127616452757,1.0,5/15,20.41%,DDX3X;MKNK2;HNRNPA1;PPIF;GSTO2
prerank,cilium assembly (GO:0060271),0.18311594827031438,0.8656693947378672,0.8923766816143498,1.0,1.0,58/296,16.16%,DNAAF3;CFAP74;YWHAG;TEKT1;KIF17;RP2;BBOF1;CFAP54;EXOC7;EXOC1;B9D1;DYNC2H1;DCDC2;NINL;TTC8;VANGL2;BBS7;GSN;MAK;NPHP4;BBS4;PLA2G3;AHI1;DNAAF1;ARL3;RPGRIP1L;KIFAP3;DCX;CFAP43;SNX10;KIF3A;HAUS5;DYNC2I2;BBS5;CEP70;IQCB1;DYNLRB2;CEP19;CEP135;OCRL;ARL6;BBS1;RPGR;CEP72;CEP162;MKS1;CFAP410;FOXJ1;KIF3C;CFAP70;IFT172;MAPRE1;GAS8;TMEM138;IFT81;IFT22;WDR90;ATP6V0D1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.32174719808350694,-0.8654463660660916,0.6333333333333333,0.8521645474359264,1.0,4/15,15.42%,DDIT4;NGF;BCAR1;GRB2
prerank,lysosome organization (GO:0007040),0.2528541282807851,0.8649109372002994,0.668859649122807,1.0,1.0,15/36,24.87%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2;GAA;LAMTOR1;NAGPA;VPS33A
prerank,aminoglycan catabolic process (GO:0006026),0.26984595689785495,0.8647779299640916,0.6704288939051919,1.0,1.0,3/28,6.27%,GPC5;HPSE2;GPC1
prerank,protein catabolic process (GO:0030163),-0.2321813488923287,-0.8644942512844024,0.7235915492957746,0.8537282359256883,1.0,27/59,38.63%,DAB2IP;DDI2;MTOR;DENND3;ADAMTS9;CEACAM1;MAGEC2;USE1;PSMA8;LAMP2;SIAH1;CLN5;HSP90AA1;RIPK1;FBXO17;MANBA;ATE1;PPT1;PMAIP1;UBE2G2;CLPX;TRIM24;VCP;RNF5;DDI1;HSPA8;CLN6
prerank,arachidonic acid metabolic process (GO:0019369),-0.26331262788118004,-0.8644621155363096,0.6867256637168142,0.8533887731315823,1.0,14/35,32.37%,PLA2G4A;PTGS1;EPHX1;MGLL;PTGES3;GPX1;HPGDS;DAGLB;PNPLA8;PTGIS;GPX4;TBXAS1;ALOXE3;CYP1B1
prerank,negative regulation of insulin secretion (GO:0046676),-0.3124288235817373,-0.8642138867431393,0.6577946768060836,0.8534932065650919,1.0,2/17,6.34%,KLF7;IRS1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3062921407955478,0.864046567009606,0.6375266524520256,1.0,1.0,6/17,21.25%,CPEB1;HSF1;CPEB3;CCNT1;NCBP2;CDK9
prerank,camera-type eye morphogenesis (GO:0048593),-0.3671579642984305,-0.8634702744028516,0.6500920810313076,0.8546338541304209,1.0,5/10,21.92%,LRP6;TBX2;SHROOM2;SKI;NF1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.30372294331338523,-0.8629391238750078,0.6499068901303539,0.8553451025135145,1.0,2/19,6.15%,RAC1;MOSPD2
prerank,regulation of microtubule-based process (GO:0032886),0.2616695284867857,0.8629263747464396,0.6942528735632184,1.0,1.0,6/36,8.44%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.36722976101300797,-0.8625273452005474,0.6636363636363637,0.8557680904194239,1.0,5/10,28.28%,RUVBL2;ZNHIT3;TAF9;NAF1;NUFIP1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2941261577527271,0.8620309924404786,0.6774941995359629,1.0,1.0,3/20,7.53%,CHRM2;CHRM3;LY6G6D
prerank,morphogenesis of an epithelium (GO:0002009),-0.2875693508458284,-0.8618057380069809,0.6846846846846847,0.856797017422478,1.0,8/25,20.45%,LAMA3;LRP6;ACTB;LAMA5;TRAF3IP1;ARHGAP12;TIMELESS;VCL
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.22755069433669406,-0.8615832807369294,0.7562724014336918,0.8568332625616008,1.0,11/72,10.13%,SHANK3;LIMA1;KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARHGEF2;SMAD4;VBP1
prerank,import into nucleus (GO:0051170),0.22126457775598973,0.8613146138050123,0.7797356828193832,1.0,1.0,6/73,4.13%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;DDX20
prerank,ERAD pathway (GO:0036503),-0.21891466754508845,-0.8607703429946079,0.7463503649635036,0.8581005511412538,1.0,18/83,19.75%,ECPAS;TRIM25;RNF139;UBE4B;ANKZF1;UBE2J2;USP13;ATXN3;UBE4A;SGTA;MAN1B1;ERLIN2;DNAJC10;UGGT1;TRIM13;DNAJB12;DNAJB9;HERPUD1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.22904826703875888,-0.8607454240353966,0.7549549549549549,0.8577573555901565,1.0,20/71,22.42%,USP9X;CTSC;FBXL17;DDI2;CASP8;CAPN2;CHMP4B;ATXN3;ZER1;LGMN;CTSZ;HDAC6;TNFAIP3;ZYG11B;CTSH;PSMA8;PDCD6IP;CTSF;MDM2;CTSO
prerank,base conversion or substitution editing (GO:0016553),0.3458688909840335,0.860531515042616,0.6476190476190476,1.0,1.0,2/11,14.38%,ADARB2;NUDT16
prerank,cell cycle checkpoint signaling (GO:0000075),-0.349853031598198,-0.8604106510619077,0.6427289048473968,0.8580539957581522,1.0,3/12,19.56%,PLK2;NABP1;BUB1B
prerank,neuron maturation (GO:0042551),0.30336221270087804,0.859966004761802,0.6857798165137615,1.0,1.0,7/18,18.47%,ADGRB3;SRRM4;C3;ACTL6B;B4GALT6;LGI4;CX3CL1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3452961174942773,-0.859770332994836,0.6382978723404256,0.8589682888252922,1.0,7/12,38.41%,TIPARP;PARP11;PARP16;PARP6;TNKS2;TNKS;PARP3
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3254256890588104,0.8596989711578011,0.62877030162413,1.0,1.0,2/12,6.03%,MELTF;RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3254256890588104,0.8596989711578011,0.62877030162413,1.0,1.0,2/12,6.03%,MELTF;RCC2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.28645826293502874,-0.8596872588187766,0.6684782608695652,0.858726237343347,1.0,6/25,17.53%,TNFSF10;BNIP3;TP53;BBC3;BCL2L11;PPIF
prerank,retinoid metabolic process (GO:0001523),0.2213154257666375,0.8596009698785925,0.7450549450549451,1.0,1.0,10/71,13.82%,GPC5;AKR1C1;APOM;CYP26B1;GPC1;ALDH1A2;SDC4;APOE;LRAT;AKR1B10
prerank,neural crest cell differentiation (GO:0014033),-0.30990399114117756,-0.8586489049800258,0.6751824817518248,0.8604871187479471,1.0,4/18,8.16%,FBXL17;LRP6;MEF2C;KLHL12
prerank,positive regulation of hormone secretion (GO:0046887),-0.31157774933561094,-0.8584923875975686,0.6296992481203008,0.8604034281992188,1.0,4/17,15.07%,EDN1;HFE;EDN3;C1QTNF3
prerank,positive regulation of actin nucleation (GO:0051127),-0.3521866581039899,-0.8582332259960906,0.6514886164623468,0.8605352455284424,1.0,4/11,18.47%,WASF2;FCHSD2;NCKAP1;WASF1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.33958940013515526,-0.8580496839817534,0.6672566371681415,0.8604988060249088,1.0,3/13,12.64%,JAK1;IL6ST;JAK2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.33434656453619876,0.8580009884446222,0.6533957845433255,1.0,1.0,5/12,20.44%,ACSL3;APOC1;P4HB;SOAT2;SOAT1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.36784634001439265,-0.857970780285351,0.6357012750455373,0.8602725266752054,1.0,3/10,22.27%,TUT7;TUT4;DIS3L2
prerank,T cell receptor signaling pathway (GO:0050852),-0.20492344369358995,-0.8578070301797761,0.7927927927927928,0.8601867339378101,1.0,44/138,27.04%,PSMA2;PAK2;PRKD2;PLCG1;PTPRJ;NFKB1;NCK1;PIK3R1;SPPL3;PSME2;PLCG2;PSMB4;PIK3CD;THEMIS;EIF2B2;BCAR1;CSK;PIK3CB;RC3H1;FBXW11;ICOSLG;PSMC2;PSMB2;TAB2;PSMB1;FYN;PSMA8;IKBKG;PSME1;IKBKB;PTPRC;INPP5D;PSMD4;FYB2;RELA;CD247;PSMD5;MAP3K7;PIK3CA;PSMA3;CD276;STOML2;PSMB10;KHDRBS1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.29569678427480117,-0.8576049716205996,0.6648745519713262,0.8601793741581185,1.0,7/21,31.09%,KDR;MAPK1;IGF1;CTSH;FGF10;LGALS9;ZFP36L1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3522196540733203,0.857099132475001,0.6610978520286396,1.0,1.0,3/10,13.32%,APOM;ZDHHC8;APOE
prerank,isotype switching (GO:0045190),0.35242885129797685,0.8568369479011454,0.6175115207373272,1.0,1.0,4/10,17.97%,CCR6;BATF;RNF8;MSH2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.27127734035296563,-0.8567682219083701,0.702846975088968,0.8614975188772184,1.0,20/30,43.12%,DYRK1A;DDX39B;ACKR3;YJU2;MIF;THOC1;RPS3;MDM2;CXCL12;SNAI2;TRIM32;CD74;FBXO5;DDIAS;SIRT1;PTTG1IP;CD44;CDKN2D;BCL2L1;SFRP2
prerank,cellular response to alkaloid (GO:0071312),-0.3103103441510794,-0.8563722631410318,0.6755793226381461,0.8619033256119173,1.0,6/17,21.01%,SPIDR;TGM2;GSTM2;HTR1B;CASQ2;BLM
prerank,regulation of receptor recycling (GO:0001919),-0.31095097916325176,-0.8559459755867735,0.6843065693430657,0.8623887647816983,1.0,4/16,22.45%,ANXA2;ECE1;VAMP3;KIF16B
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2222880681971503,-0.8553978277185754,0.7531760435571688,0.8630995567725986,1.0,27/82,27.65%,YWHAE;CEP57;CEP250;CEP78;TP53;HAUS8;DCTN1;DCTN3;HAUS6;PAFAH1B1;CSNK1D;CEP41;PLK4;CETN2;CEP152;ALMS1;PCM1;CNTRL;ODF2;HSP90AA1;CEP131;PCNT;AKAP9;ATF5;DYNLL1;KIF14;HAUS1
prerank,histone ubiquitination (GO:0016574),-0.2963863880546041,-0.8551681431237161,0.6870229007633588,0.863182553644547,1.0,6/21,18.90%,DTX3L;RNF40;UBR2;CDC73;PHC1;HUWE1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.2882423079357793,0.8549407228863323,0.6820175438596491,1.0,1.0,4/21,7.20%,ADCY8;ADCY10;NPPC;ADCY7
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.2636632104565491,-0.8548429106661996,0.6901669758812616,0.8634710930045214,1.0,20/31,48.93%,PLCB1;PLCG2;CD40;IL16;CCL19;HMGB1;MAPK11;LGALS9;MAPK14;IRF5;SYK;TLR2;MDK;ISL1;TLR4;SCIMP;AGER;TLR3;IL12B;IL23R
prerank,ERBB2 signaling pathway (GO:0038128),0.26224907827620747,0.8546846327220486,0.721030042918455,1.0,1.0,2/31,0.53%,NRG1;ERBB4
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.2901924285381551,-0.8534879346139228,0.6932624113475178,0.8658087346549549,1.0,12/23,33.59%,UBE2K;APP;IRGM;MAPK1;RPTOR;BMP7;CAB39;TRIM6;STOX1;TGFB1;PRKAG2;PLK1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.23648902642602868,0.8528596116936606,0.74235807860262,1.0,1.0,11/48,20.31%,NPSR1;AKAP6;CALM2;GPER1;SRI;HRC;CASQ1;SELENON;CX3CL1;PDE4D;TRPC1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.30766479418694237,0.8527858922947434,0.6421052631578947,1.0,1.0,3/15,15.58%,QDPR;HAAO;TDO2
prerank,negative regulation of lyase activity (GO:0051350),0.30203427297134783,0.8527698799315875,0.6531531531531531,1.0,1.0,2/16,4.69%,GNAI2;GABBR2
prerank,negative regulation of protein catabolic process (GO:0042177),-0.2528310075980568,-0.8525242550891778,0.6963350785340314,0.8673119308219044,1.0,10/40,18.12%,DAB2IP;EGFR;ROCK1;FLNA;SNX12;TIMP3;PTPN3;AZIN1;MAD2L2;CDK5RAP3
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.3144845641645405,-0.8521059358006698,0.668488160291439,0.8677319191610051,1.0,8/16,45.80%,CEBPG;VAMP2;ARL8B;CORO1A;RAET1E;TUBB4B;SLAMF7;KLRK1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3070037647705566,0.8519794776542037,0.6622807017543859,1.0,1.0,7/17,24.41%,TERF1;UNG;ACD;TERF2IP;ERCC5;NEIL2;TDG
prerank,nuclear membrane disassembly (GO:0051081),0.32724622865798214,0.8519731337326512,0.6643835616438356,1.0,1.0,7/14,26.68%,LPIN1;VRK1;PRKCB;AKAP8L;CDK1;CTDNEP1;CCNB2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2635663199088155,-0.8519115104456243,0.6753246753246753,0.8677181715274563,1.0,13/33,28.09%,CDKN1B;PSME2;STXBP4;PLCG2;CDC73;TCIM;PSME1;PTEN;TRIM39;CRNN;KIF14;INO80;MN1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.22452725030135337,0.8517799483721067,0.7542168674698795,1.0,1.0,12/65,16.80%,KCND2;FMN2;SCN2A;CPEB1;VEGFA;NOP53;GATA6;SLC8A3;TWIST1;HIPK2;P4HB;ADAM8
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.35223544277560503,0.8516300579145014,0.6383928571428571,1.0,1.0,2/10,7.40%,PLEK;CARMIL1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2724100398752672,-0.8508767092196703,0.687037037037037,0.8693719650552673,1.0,6/31,13.88%,NEK7;ATM;MRE11;MAPK1;PPP1R10;PNKP
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.25685810385112545,0.8507984786377737,0.7086092715231788,1.0,1.0,6/33,10.44%,IGFBP3;TAFA5;NDRG4;ANG;IL12A;GPER1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2714287509439857,-0.8506548076992871,0.6903914590747331,0.869438906114885,1.0,7/28,16.40%,MIEF1;TCAF1;GDI1;MTCL1;CHP1;MIEF2;FYN
prerank,regulation of p38MAPK cascade (GO:1900744),0.25599478162966316,0.8506470403106772,0.7123287671232876,1.0,1.0,8/35,12.48%,RELL2;GADD45B;SPHK1;CYLD;VEGFA;MINK1;PHLPP1;RASGRP1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3487325179561023,-0.8506392781101305,0.6660649819494585,0.8690701104396655,1.0,2/11,14.55%,CAT;GPX1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.33459080799560426,-0.8505703180405341,0.6460980036297641,0.8688193034469899,1.0,5/13,26.43%,ZC3HAV1;RC3H1;MOV10;CNOT8;CNOT1
prerank,lipid oxidation (GO:0034440),0.32926023899009776,0.8503361312305476,0.6610526315789473,1.0,1.0,3/12,16.19%,PLA2G7;ALOX12;ALOX5
prerank,pinocytosis (GO:0006907),0.34701030085501317,0.850331911277674,0.6566125290023201,1.0,1.0,5/10,21.99%,CARMIL1;RAB34;SNX33;SNX5;MAPKAPK3
prerank,response to organic cyclic compound (GO:0014070),-0.2350447817955468,-0.8502182736094267,0.7292418772563177,0.8691093086632916,1.0,14/52,20.24%,ESR1;LRRK2;TIPARP;STRN3;GGT5;ALPL;ARL6IP5;SOCS2;IGFBP5;CTNNB1;ANXA1;SLC1A1;FGFR4;KYNU
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.30144480782030825,0.8502088036467091,0.6599099099099099,1.0,1.0,2/17,3.57%,GET1;CAMLG
prerank,cAMP metabolic process (GO:0046058),0.31698360115882596,0.8501900245139103,0.6517094017094017,1.0,1.0,3/13,7.20%,ADCY8;ADCY10;ADCY7
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.30214713870765747,-0.8499971359721823,0.6752767527675276,0.8691663062050446,1.0,3/18,9.56%,BPGM;SAMHD1;ADAMTS9
prerank,aerobic respiration (GO:0009060),0.2876430856011724,0.8498646771487192,0.697286012526096,1.0,1.0,9/20,26.13%,UQCR10;UQCRH;NDUFS8;NDUFS7;MDH2;UQCRB;ME3;OXA1L;MTFR1L
prerank,neuron projection extension (GO:1990138),0.25839968029359434,0.8496529027323717,0.6804597701149425,1.0,1.0,7/32,10.69%,SH3GL2;TMEM108;CDK5;IMPACT;CPNE1;MAP1B;AUTS2
prerank,regulation of cholesterol efflux (GO:0010874),-0.2686853710101107,-0.8493157966841969,0.7041742286751361,0.8701035151492549,1.0,4/30,5.75%,PLTP;CAV1;RXRA;NFKBIA
prerank,regulation of cellular amide metabolic process (GO:0034248),0.25431052303631185,0.8489250682328354,0.6894977168949772,1.0,1.0,2/32,1.42%,GRM5;DDX25
prerank,synaptic vesicle transport (GO:0048489),-0.35171300874254774,-0.8485147542338715,0.6871609403254972,0.8712834864114508,1.0,4/11,13.22%,DNM2;RAB27A;TMEM230;SPG11
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.34417442110620655,0.8473194084188512,0.625,1.0,1.0,3/11,19.53%,IL12RB1;IL23A;PRKCQ
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.2930591297112849,-0.8473190792437388,0.6757741347905283,0.8732022557618967,1.0,5/19,22.67%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,estrogen metabolic process (GO:0008210),0.3174971951105418,0.8471057667125046,0.6666666666666666,1.0,1.0,5/15,25.00%,HSD17B7;HSD17B14;CYP1A1;HSD17B8;HSD17B2
prerank,embryonic heart tube development (GO:0035050),-0.32099456552989813,-0.847038724814721,0.6890130353817505,0.8733132988620765,1.0,3/14,8.29%,SOX17;HES1;TBX2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.34591005922988677,0.8467561279108052,0.6837606837606838,1.0,1.0,3/10,8.84%,TERF1;MAPT;CORO2B
prerank,regulation of neuroblast proliferation (GO:1902692),0.30796371329814953,0.8467347403817409,0.6609442060085837,1.0,1.0,3/15,12.01%,TAFA1;VEGFA;FZD3
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.24773112335883082,0.8463306219716848,0.7482837528604119,1.0,1.0,7/39,15.72%,BLK;GCK;TRH;GPER1;NLGN2;GLUD1;MCU
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.23688237751995547,0.8459139215630646,0.7627118644067796,1.0,1.0,10/48,14.80%,ADCY8;ADCY10;AK5;SLC35B2;NPPC;ADCY7;ADSS2;ADSS1;ACOT7;ADCY3
prerank,interstrand cross-link repair (GO:0036297),-0.2344872747759398,-0.8456301307201959,0.7280701754385965,0.8757071961862204,1.0,17/53,24.76%,MCM9;RPA3;RPA1;RNF168;FANCM;RFWD3;FANCD2;FANCG;FANCC;RPA2;ERCC6L2;FANCL;USP1;RAD51AP2;DCLRE1B;FANCI;DCLRE1A
prerank,RNA catabolic process (GO:0006401),-0.24441618972561016,-0.8436528323770282,0.7373358348968105,0.8791695735493787,1.0,14/46,27.84%,ERN1;RNASE3;XRN2;DNA2;ZPR1;NUDT12;RNASEH2C;DIS3L2;METTL16;HSPA1B;EXOSC7;HNRNPD;DXO;LSM2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.329227764737393,-0.843524959226421,0.6923076923076923,0.8790142526204566,1.0,5/13,17.44%,TGFBR2;GSK3A;SMAD4;NOTCH1;HEY2
prerank,positive regulation of B cell activation (GO:0050871),-0.23985956045101056,-0.8432918299977367,0.7562277580071174,0.8790787238187736,1.0,12/50,19.63%,SHLD1;TFRC;CD38;KMT5B;MEF2C;PPP2R3C;CD40;MIF;MAD2L2;CLCF1;NOD2;PTPRC
prerank,fatty acid metabolic process (GO:0006631),0.2002563151636902,0.8431281348185288,0.8542600896860987,1.0,1.0,22/115,16.19%,NUDT19;LPIN1;ACSBG1;ELOVL4;ACLY;ACACA;LIPC;ACSL3;CPT1B;OXSM;CPT1C;ACSL6;ALOX12;GNPAT;NAAA;AASDH;ACOT2;ACOT7;NDUFAB1;MECR;CYP1A1;ALOX5
prerank,positive regulation of dephosphorylation (GO:0035306),-0.27300363569292985,-0.8427480812892632,0.7142857142857143,0.8797243277681898,1.0,4/27,7.39%,PPP2R5A;PRKCD;CDH5;SPPL3
prerank,positive regulation of double-strand break repair (GO:2000781),0.24470990690627514,0.8426756759141267,0.7268623024830699,1.0,1.0,6/39,5.97%,ZCWPW1;SPIRE1;DDX11;FMN2;SHLD3;SLF1
prerank,epithelial cell differentiation (GO:0030855),-0.21233931629370245,-0.8423565588641105,0.8059964726631393,0.8800870255599604,1.0,13/88,11.20%,DAB2;TBX1;KDR;SIX1;HDAC1;BMP4;E2F4;BDH2;ANXA4;AKT1;KDM6B;CPT1A;ALDOC
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.2266117368705413,-0.8415934983446312,0.778584392014519,0.8811243041734909,1.0,17/68,21.65%,GNAI3;NT5C2;LRRK2;RHOQ;ACSF2;TPST2;SULT1A1;PDE9A;THEM4;AMPD2;RAB23;HPRT1;HINT1;EPHA2;ACOT9;AMPD3;BPNT1
prerank,neutrophil migration (GO:1990266),0.22526556403963927,0.8414502406986846,0.7908045977011494,1.0,1.0,9/58,14.38%,PDE4B;CD177;CXADR;CCL7;PF4;CCL13;CCL5;CCL2;PPIA
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3116998919468933,-0.8404526955869267,0.6703910614525139,0.8829765532209476,1.0,9/16,33.84%,BOC;PLCB1;MEF2C;SMYD1;RBM24;LRRC8A;MAPK14;XKR8;HIF1AN
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3099564656626498,0.8401598455675463,0.6946902654867256,1.0,1.0,5/15,14.50%,SMPD3;SPHK1;SPHK2;PLA2G6;NSMAF
prerank,positive regulation of rRNA processing (GO:2000234),0.3437626255297941,0.8397213587425916,0.6666666666666666,1.0,1.0,3/10,13.37%,BUD23;DIMT1;SIRT7
prerank,ganglioside metabolic process (GO:0001573),0.2826995966897663,0.8396498974586251,0.7084233261339092,1.0,1.0,6/20,18.33%,B3GALT4;ABCA2;ST6GALNAC5;HEXB;ST8SIA3;ST8SIA2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3097513667024395,-0.8394572938674478,0.6863468634686347,0.8844992569438593,1.0,7/17,35.33%,PLA2G4A;PLA2G12A;LCLAT1;PLA2G4F;PLA2G5;LPGAT1;PLBD1
prerank,sphingosine biosynthetic process (GO:0046512),0.34225367431657083,0.8393691589729797,0.6696428571428571,1.0,1.0,4/11,9.46%,SPHK1;ABCA2;ACER1;SPHK2
prerank,sphingoid biosynthetic process (GO:0046520),0.34225367431657083,0.8393691589729797,0.6696428571428571,1.0,1.0,4/11,9.46%,SPHK1;ABCA2;ACER1;SPHK2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.3006723593433749,-0.839177018970871,0.6571969696969697,0.8846470284014931,1.0,7/18,22.38%,CD34;EZR;KAT5;TNFAIP3;PTPRC;HDAC7;HOMER3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.25937663675872535,0.8391628768669188,0.7130242825607064,1.0,1.0,6/32,11.11%,CDK5;CDC45;TYMS;NPAT;POLA1;TFDP2
prerank,protein localization to cilium (GO:0061512),-0.2664853001956184,-0.8388745010657188,0.720754716981132,0.8848126679137694,1.0,9/32,23.62%,ZNF423;IFT140;RABEP1;EHD1;WDR35;CSNK1D;TULP1;IFT20;TULP3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2686290441701703,0.8388680491094715,0.713953488372093,1.0,1.0,4/26,12.39%,ATP1A2;CALM2;ADRA2A;SRI
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3440516988275094,0.8385665868724981,0.6523702031602708,1.0,1.0,4/10,14.50%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3440516988275094,0.8385665868724981,0.6523702031602708,1.0,1.0,4/10,14.50%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.35161058025637354,-0.8384828906521045,0.6759776536312849,0.8852016444554281,1.0,5/11,35.00%,AGK;TIMM10;TOMM70;TIMM10B;TIMM13
prerank,neutrophil chemotaxis (GO:0030593),0.22669702640575748,0.8383560488682551,0.7764976958525346,1.0,1.0,8/53,14.38%,PDE4B;CXADR;CCL7;PF4;CCL13;CCL5;CCL2;PPIA
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.32083248764829053,-0.8382660165590425,0.6826241134751773,0.8852189212773898,1.0,4/15,12.09%,CSGALNACT1;DSE;CSPG4;BGN
prerank,response to hexose (GO:0009746),-0.27525608337980767,-0.8381541518153497,0.7065026362038664,0.885037256332247,1.0,10/25,33.29%,THBS1;EIF2B2;LPL;VAMP2;TCF7L2;PFKL;SELENOT;MAFA;EIF2B4;EIF2B5
prerank,peptide cross-linking (GO:0018149),-0.27532818395607506,-0.8381244000659646,0.6774193548387096,0.8846986604763908,1.0,19/25,49.78%,THBS1;TGM2;ABCA7;ANXA1;CD247;EVPL;FCGR3A;KRT10;TGM7;DSP;TGM4;TGM1;SPRR1A;LORICRIN;NDNF;TGM6;TGM5;EPB42;FN1
prerank,negative regulation of catabolic process (GO:0009895),0.23509717655553528,0.8376492277720027,0.7438202247191011,1.0,1.0,10/47,16.11%,PDE3B;FMN2;BSCL2;CYP51A1;SF3B3;AZIN2;ADRA2A;CST3;APOC1;ZDHHC7
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3060568289345612,-0.837520924190899,0.718336483931947,0.8854456445293615,1.0,3/17,10.00%,BMP6;CD55;NFKBIL1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3145007211500676,0.8374129173910279,0.7116704805491991,1.0,1.0,5/13,23.19%,ASPA;GLUD1;GAD1;DDO;MTHFS
prerank,phagolysosome assembly (GO:0001845),0.3283089493373583,0.8372482560252358,0.6409691629955947,1.0,1.0,4/12,16.18%,CLN3;RAB34;RAB39A;RAB20
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.25980273315311103,0.8370228183092038,0.7017167381974249,1.0,1.0,11/30,21.70%,ACSBG1;HACD1;ELOVL4;ACSL6;TECR;ACOT2;HACD2;ACOX2;HACD3;PEX2;ABCD4
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2797007709796626,-0.8358300060157938,0.7235188509874326,0.8882497166401842,1.0,13/25,38.19%,CHMP4B;CHMP4A;VTA1;CHMP2B;CHMP5;TMEM50B;CHMP3;CHMP6;CHMP1A;LEPROTL1;CHMP1B;VCP;RILP
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3205308840761687,-0.8356213954944158,0.6910420475319927,0.8882319860162077,1.0,2/14,6.56%,TGFBR2;CD55
prerank,positive regulation of lipid localization (GO:1905954),-0.3445566256484984,-0.8355165125308124,0.6855575868372943,0.8880192713918373,1.0,3/11,13.17%,NFKB1;IKBKE;LPL
prerank,mitochondrial fusion (GO:0008053),-0.30648143875040246,-0.8353873408656411,0.6886446886446886,0.8878588042931428,1.0,4/18,13.14%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2722317553143184,-0.8353554710927611,0.7117437722419929,0.8875296760460682,1.0,2/26,1.76%,EYA4;MCL1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3253225098714503,0.8353299515759931,0.6739606126914661,1.0,1.0,3/12,11.98%,ADCY8;PLA2G6;GPLD1
prerank,negative regulation of proteolysis (GO:0045861),-0.25522566028532023,-0.8348870688406105,0.7155797101449275,0.8880248538799874,1.0,10/34,18.40%,LRRK2;DNAJC1;EPHA4;ROCK1;AKT1;SNX12;TIMP3;PTPN3;HDAC6;PLAT
prerank,regulation of Golgi organization (GO:1903358),-0.3052387701637966,-0.8347995650060499,0.6799276672694394,0.8877704578353368,1.0,4/17,8.24%,STX18;ARMH3;USP6NL;MAPK1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.29081914111215246,0.8347442748516227,0.6997792494481236,1.0,1.0,4/18,15.54%,RASL11A;DHX33;SIRT7;LYAR
prerank,thyroid hormone generation (GO:0006590),-0.3519390718799778,-0.8345770727970913,0.6867030965391621,0.8877847463922762,1.0,1/10,0.45%,CPQ
prerank,membrane repolarization (GO:0086009),0.3057076747802441,0.8345552904944304,0.704954954954955,1.0,1.0,2/15,5.26%,ATP1A2;ATP1B1
prerank,activation of phospholipase C activity (GO:0007202),0.25491406161267854,0.8334479415020308,0.7274881516587678,1.0,1.0,8/29,16.25%,PHB2;ANG;NTRK2;ADRA1A;TXK;BDNF;CD86;ARHGAP6
prerank,glycosphingolipid metabolic process (GO:0006687),-0.24235703710051912,-0.8333684028244386,0.7345454545454545,0.8896969568662241,1.0,11/42,22.11%,ESYT2;A4GALT;ST6GALNAC3;ARSA;ASAH1;SMPD2;GBA2;GLTP;LARGE1;GLA;CTSA
prerank,TOR signaling (GO:0031929),0.26453333721946154,0.8332776778912238,0.7429805615550756,1.0,1.0,6/26,12.31%,CCDC88A;FLCN;RPS6KB1;RHEBL1;CARD11;PRR5L
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.23371196172217537,-0.8331233309833851,0.7779783393501805,0.8897553457801318,1.0,17/55,26.89%,FBXL7;PSMA2;RBX1;PSME2;PSMB4;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;FHL1;PSMD4;PSMD5;ATF5;PSMA3;PINX1;PSMB10
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.3386322350410521,-0.8330190654826626,0.7045045045045045,0.8895323347154817,1.0,3/11,14.19%,NEDD4L;PICALM;TAX1BP3
prerank,cellular response to lipid (GO:0071396),0.1874835602161505,0.8326244123865362,0.8914549653579676,1.0,1.0,32/191,15.09%,BRINP3;PDE4B;ATP1A2;WNT7B;NR1D1;INSIG1;GNAI1;ADCY8;BRINP1;PAX2;BRINP2;PF4;ADNP2;CCDC62;POU4F1;SPP1;SPHK2;NUGGC;TESC;GPER1;HMGB2;GPLD1;CCL2;WNT6;LCOR;HTRA2;WNT2;CD86;SELENOS;ADCY3;TRIM41;SIRPA
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2570773809382921,-0.8316316513337044,0.7396768402154399,0.891739074044171,1.0,12/33,26.09%,STN1;MRE11;PPP6R3;RPA1;CTC1;PTGES3;TERF2;DCLRE1B;TERT;HSP90AA1;RFC1;PINX1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.313711809212626,-0.8312421220277256,0.6901669758812616,0.892061994601419,1.0,6/15,21.38%,RTRAF;ERN1;TSEN15;RTCB;TSEN34;TRPT1
prerank,protein kinase B signaling (GO:0043491),-0.28174547842721964,-0.8312105851850993,0.7145454545454546,0.8917156061539634,1.0,13/23,35.60%,KDR;GAS6;AKT1;THEM4;PIK3R3;IGF1;EPHA2;PTEN;PLK3;ZFP36L1;TGFB1;TSC2;MT3
prerank,"wound healing, spreading of cells (GO:0044319)",-0.27842720294456896,-0.8311447491368195,0.7240143369175627,0.8914495244062505,1.0,7/24,13.49%,ACVRL1;COL5A1;FLNA;CEACAM1;RHOA;LCP1;RHOC
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.32108120275607877,0.8303824728278462,0.6433566433566433,1.0,1.0,2/12,6.48%,BCL2;TRIAP1
prerank,mitochondrial protein processing (GO:0034982),0.3241209022769039,0.829687585069524,0.6637362637362637,1.0,1.0,3/11,16.17%,OMA1;PMPCB;MIPEP
prerank,glucose metabolic process (GO:0006006),0.2228674751361559,0.8296447782428852,0.7846534653465347,1.0,1.0,4/58,5.24%,OMA1;SLC25A13;DCXR;TPI1
prerank,DNA alkylation (GO:0006305),-0.2936183296842212,-0.8294848940561591,0.7469879518072289,0.8936681266976778,1.0,7/19,23.39%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,DNA methylation or demethylation (GO:0044728),-0.2936183296842212,-0.8294848940561591,0.7469879518072289,0.8936681266976778,1.0,7/19,23.39%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,linoleic acid metabolic process (GO:0043651),0.3009807894781613,0.8290637306016361,0.6742738589211619,1.0,1.0,4/17,16.19%,FADS1;FADS2;ALOX12;ALOX5
prerank,protein K63-linked deubiquitination (GO:0070536),0.2562638921844149,0.8288789089466192,0.7437070938215103,1.0,1.0,6/31,10.54%,OTUD7A;USP25;CYLD;OTUD7B;PSMD14;USP50
prerank,regulation of water loss via skin (GO:0033561),0.30893925070537154,0.828446008072091,0.7099767981438515,1.0,1.0,1/15,0.50%,ABCA12
prerank,establishment of skin barrier (GO:0061436),0.30893925070537154,0.828446008072091,0.7099767981438515,1.0,1.0,1/15,0.50%,ABCA12
prerank,organelle fusion (GO:0048284),-0.2875270373801111,-0.8284000645152572,0.7384898710865562,0.8952894146650108,1.0,4/22,13.14%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,nuclear membrane organization (GO:0071763),-0.2926655428696281,-0.8283915889673562,0.7031539888682746,0.8948992655619046,1.0,4/19,11.59%,EMD;TOR1B;CHMP4B;DCTN1
prerank,response to acidic pH (GO:0010447),-0.32018332937374816,-0.8279232544867211,0.6839285714285714,0.8953471991900747,1.0,5/13,23.64%,CHP1;LGMN;PKD2L1;GPR4;RAB11FIP5
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3181999475533638,-0.8274569653439541,0.7033747779751333,0.8958452322744379,1.0,3/14,22.87%,LRRK2;HERPUD1;TXNDC12
prerank,regulation of ruffle assembly (GO:1900027),0.27938257304785696,0.8272327040491747,0.7070063694267515,1.0,1.0,4/23,10.27%,NLGN1;PFN2;PFN1;ARHGAP24
prerank,response to interferon-gamma (GO:0034341),-0.2209264127675538,-0.8270611494793736,0.7844202898550725,0.896194236484811,1.0,17/67,25.43%,SP100;DAPK1;CCL25;GCH1;GBP6;IFITM3;GBP4;PDE12;CD40;GBP5;SYNCRIP;CCL19;KYNU;RPL13A;GBP3;CASP1;IFITM2
prerank,glycolipid biosynthetic process (GO:0009247),0.24158139728874864,0.8269361903960023,0.748314606741573,1.0,1.0,11/38,19.07%,DPM1;ST8SIA5;PIGP;ST6GALNAC5;MPPE1;PIGB;PGAP3;ST8SIA3;B4GALT6;PIGQ;ST8SIA1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3297697045662814,0.8268774370041552,0.6783369803063457,1.0,1.0,3/11,15.81%,STK26;LANCL1;P4HB
prerank,ribosomal small subunit assembly (GO:0000028),0.2996835017741122,0.8268144323700896,0.679372197309417,1.0,1.0,5/16,17.33%,RRP7A;ERAL1;XRCC5;ABT1;PWP2
prerank,protein heterotetramerization (GO:0051290),0.31971343662113433,0.8261809669366049,0.6970387243735763,1.0,1.0,1/13,0.92%,GRIN2B
prerank,regulation of viral entry into host cell (GO:0046596),0.26339176293238453,0.8260104548178395,0.7377777777777778,1.0,1.0,4/30,7.21%,HS3ST5;LGALS1;TRIM27;GSN
prerank,gastrulation (GO:0007369),-0.3111122979221469,-0.8258305721962014,0.704331450094162,0.8980624387397022,1.0,5/15,18.77%,LRP5;SMAD2;TASOR;LMBRD1;GPC3
prerank,positive regulation of neutrophil migration (GO:1902624),-0.29317959843942415,-0.8258304539835243,0.7164179104477612,0.8976570162043418,1.0,2/18,6.15%,RAC1;MOSPD2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2747506557943257,-0.8255087132282813,0.7256317689530686,0.8978311449854766,1.0,13/24,38.56%,CTSC;PSME2;EPHA4;GPX1;PSME1;PTK2B;RHBDF1;UBE3A;ATP5IF1;DNAAF4;EFNA1;NUDT15;PSME3
prerank,response to metal ion (GO:0010038),0.2176420247596053,0.8252639111443963,0.8051643192488263,1.0,1.0,10/67,10.36%,KCNMA1;SLC34A1;SLC25A13;BCL2;PPP5C;CALM2;HOMER1;PPP3CA;MAPT;HAAO
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2795003881794692,-0.8247296560714424,0.7168784029038112,0.8988892486127312,1.0,5/22,9.82%,CDKN1B;BMP4;ROCK1;PRKRIP1;TP53
prerank,establishment of protein localization to organelle (GO:0072594),0.21241820121632757,0.8244794855687619,0.8070953436807096,1.0,1.0,13/72,17.98%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;RYR2;RANBP17;RPAIN;LRSAM1;HK1;HIKESHI;NUP107;POM121
prerank,negative regulation of immune response (GO:0050777),0.18971207468713913,0.8242961758018699,0.910913140311804,1.0,1.0,22/154,11.39%,NPSR1;GIP;ADCY8;CALCA;TYRO3;RNF26;CD3G;SAMSN1;FCRLB;TRIM27;ADCY7;DPEP1;HTR4;GIPR;ENPP3;ADRB3;GPR83;VIPR2;TSHR;COL3A1;GPR45;PRKAR1B
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.31862961272254603,0.8241600865923645,0.6978260869565217,1.0,1.0,3/12,13.20%,INSIG1;RER1;KDELR2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3030028613567812,-0.823652168520204,0.7093023255813954,0.9004517959529373,1.0,4/16,10.98%,CAV1;TRIM25;EXOC2;TRIM14
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2993155778046585,0.8233737827454293,0.6733780760626398,1.0,1.0,5/15,18.64%,ATL1;RTN4;ZFYVE27;REEP4;RTN3
prerank,proteolysis (GO:0006508),0.17742208629941633,0.8233668672040156,0.9429928741092637,1.0,1.0,44/252,16.97%,CPB2;TMPRSS11D;MMP12;MME;TRHDE;MMP16;CELA3A;PAPPA2;CTSK;CLN3;MMP24;MMP25;CPA2;FBXO2;CPE;TYSND1;METAP2;USP25;PRSS57;ADAM19;BACE1;SPCS3;TMPRSS7;CPNE1;CPN1;PCSK2;AEBP1;UFSP2;CASP4;HTRA2;SPCS1;PCSK6;CPA4;CPA3;CLPP;ATG4D;ECE2;EEF1AKMT4-ECE2;MIPEP;ATG4B;TPP1;LONP1;PSMB5;KLKB1
prerank,acyl-CoA metabolic process (GO:0006637),-0.25063696965248883,-0.8233496992099845,0.7495462794918331,0.900597538759048,1.0,6/35,10.81%,OGDH;ACSF2;ACACB;SUCLG2;HMGCS2;THEM4
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3005152315873538,-0.8231030697823671,0.7410714285714286,0.900659660048736,1.0,6/18,15.79%,SP1;EPHA4;GSK3A;PICALM;SLC2A13;ROCK2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.27063616249490496,-0.8229180279064601,0.7398058252427184,0.9005736830571214,1.0,8/25,21.57%,ITGB1;CD200;PARVA;ITGA4;VCAM1;DSG2;ITGB3;ITGA7
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.27219336152951856,-0.8227152945582891,0.7356746765249538,0.9005563436575271,1.0,8/23,21.83%,DIAPH1;PSEN2;NOS1AP;FYN;UBASH3B;CASQ2;NOS1;PTK2B
prerank,regulation of viral release from host cell (GO:1902186),-0.27665677557033147,-0.8221254890784455,0.7296819787985865,0.9012305938983157,1.0,10/21,32.96%,TRIM25;CHMP2B;TRIM13;TRIM28;CHMP3;VPS37B;TRIM35;TRIM32;TRIM62;TRIM5
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.2471428891066882,-0.8216403859711487,0.7307692307692307,0.9017438366481867,1.0,14/38,29.58%,DAB2IP;ESR1;PPM1B;CASP8;TRIM59;USP10;TNFAIP3;ZMYND11;TRIM39;RIPK1;RIOK3;CACTIN;TNIP1;TREM2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.29716568604051585,-0.8210640417208853,0.7245080500894454,0.9023792884335463,1.0,11/19,51.58%,TNFAIP3;IGF1;NLRP2B;NLRP3;CARD16;CD33;GIT1;GSTP1;APOA1;FFAR4;ZC3H12A
prerank,cytoplasmic translational initiation (GO:0002183),-0.298014715031078,-0.8207572993517633,0.702803738317757,0.9025140100381244,1.0,5/17,31.90%,EIF4H;EIF3A;EIF3I;EIF4A2;DHX29
prerank,detection of visible light (GO:0009584),-0.30369803506197257,-0.8204884232973296,0.7217068645640075,0.9026035765642431,1.0,11/16,54.01%,CEP250;TULP1;GNA11;PDE6B;RP1;GNAQ;RHO;GNAT1;REEP6;GNAT2;CACNA1F
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.24900406377377848,0.8200812453036603,0.744874715261959,1.0,1.0,10/37,15.91%,KIF17;DYNC2H1;KIFAP3;KIF3A;DYNC2I2;DYNLRB2;KIF3C;IFT172;IFT81;IFT22
prerank,retinoic acid metabolic process (GO:0042573),0.3097563762421961,0.8199113304856968,0.6470588235294118,1.0,1.0,4/14,22.55%,CYP26B1;ALDH1A2;BCO2;CYP26C1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.3122350571742769,-0.8198683876745708,0.7199248120300752,0.9033238239782042,1.0,10/15,40.90%,ATM;TERF2;SMG6;PINX1;TNKS2;RAD50;TNKS;SLX4;ERCC4;ERCC1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.28058172065701165,-0.8197735731538168,0.7272727272727273,0.9030860316961666,1.0,14/24,36.59%,KLF2;TP53;NOTCH1;ATF4;GCN1;MAPK7;ATF6;NFE2L2;DDIT3;CEBPB;ATF3;MUC1;MT3;HIF1A
prerank,protein localization to condensed chromosome (GO:1903083),-0.3325171783479182,-0.8195689465341625,0.7256317689530686,0.9030368852370028,1.0,8/12,46.15%,BUB3;TTK;MTBP;SPDL1;MIS12;AURKB;CHAMP1;KNL1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2575263186928692,0.8195358889155281,0.7422222222222222,1.0,1.0,6/29,14.19%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2575263186928692,0.8195358889155281,0.7422222222222222,1.0,1.0,6/29,14.19%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.35395843543349836,-0.818877536014561,0.7034358047016275,0.9038777399763311,1.0,1/10,0.53%,RAPGEF2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3037620469182206,-0.8179220302715325,0.7140319715808171,0.9051927640188808,1.0,8/16,40.03%,TGFB2;FOXC1;RBM24;PTN;SP7;TCF15;LTBP3;GATA4
prerank,regulation of macroautophagy (GO:0016241),-0.20380367058739174,-0.8178389321566678,0.8497409326424871,0.9049249973520508,1.0,24/105,20.27%,GNAI3;SESN1;KDR;EXOC4;LRRK2;MTOR;LARP1;NEDD4;ERN1;BNIP3;AKT1;PRKAA1;VPS26A;RPTOR;ATP6V1E1;MAPK8;EXOC8;HDAC6;TRIM13;ATP6V0A1;IKBKG;TBC1D25;PRKAB1;UCHL1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.30155782271439435,0.8177137789684348,0.7069767441860465,1.0,1.0,2/15,6.48%,BCL2;TRIAP1
prerank,intracellular lipid transport (GO:0032365),-0.28761868133047214,-0.8175077786940252,0.7429078014184397,0.9051325370098352,1.0,4/21,11.05%,CERT1;ABCD3;ACACB;CPT1A
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.276505055076932,0.8173674190848539,0.7423887587822015,1.0,1.0,3/21,12.04%,GRIN2B;USP50;PCID2
prerank,retinol metabolic process (GO:0042572),-0.3146985661221242,-0.8168491374283952,0.6918918918918919,0.9058800648878987,1.0,6/14,34.27%,RBP4;RDH10;RETSAT;RDH12;CYP1B1;ADH1A
prerank,regulation of glucose metabolic process (GO:0010906),0.24280158611577457,0.8167293337445308,0.7847222222222222,1.0,1.0,6/34,14.03%,DGKQ;GNMT;BCKDK;GPLD1;SIRT7;SELENOS
prerank,renal system development (GO:0072001),-0.22770397173171233,-0.8166851423485442,0.7800369685767098,0.9057537204509187,1.0,11/52,15.04%,SOX17;ACE;SIX1;RBP4;C1GALT1;BMP4;TGFB2;PCSK5;AGTR1;TRAF3IP1;FOXC1
prerank,regulation of peptidase activity (GO:0052547),0.2814689149880725,0.8164206572245798,0.720682302771855,1.0,1.0,6/19,14.56%,ECM1;A2ML1;ATP13A2;RCN3;PSMB8;CST3
prerank,tRNA processing (GO:0008033),0.21689821107427842,0.8164124723033446,0.8081264108352144,1.0,1.0,17/61,22.54%,QTRT2;CPSF1;TRMT10B;PTCD1;TRMT6;DDX1;TRMT10A;CLP1;ANKRD16;FTSJ1;AARS2;TRIT1;QTRT1;CSTF2;NSUN6;ADAT2;THUMPD1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.35036855974650993,-0.8160996745053432,0.7218181818181818,0.9064015563906977,1.0,6/10,45.48%,RC3H1;LGALS9;CD274;CRTAM;PDCD1LG2;FOXP3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2831325081996034,-0.815761955151515,0.7467889908256881,0.9061685847581991,1.0,6/21,18.57%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2831325081996034,-0.815761955151515,0.7467889908256881,0.9061685847581991,1.0,6/21,18.57%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,endosome organization (GO:0007032),0.2384086770119126,0.8156779622676016,0.7716186252771619,1.0,1.0,14/41,20.84%,TMEM9;RNF26;DNM1;LAPTM4B;SNX10;ANXA8;ANXA8L1;USP50;PHETA1;HOOK1;SNX33;HOOK3;VPS33B;SQSTM1
prerank,eye photoreceptor cell development (GO:0042462),0.3102602034940991,0.8153605961817245,0.7354260089686099,1.0,1.0,3/15,9.26%,BBS4;RPGRIP1L;VEGFA
prerank,regulation of neutrophil migration (GO:1902622),-0.3435025913120848,-0.8151350503298479,0.6962699822380106,0.9068760072933246,1.0,2/10,12.96%,RAC1;RHOG
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3073641611294649,0.8146788547331971,0.7240663900414938,1.0,1.0,5/13,19.79%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.21344794609973433,-0.813788931058047,0.8503649635036497,0.9089627519320902,1.0,15/69,19.75%,ECPAS;TRIM25;UBE4B;ANKZF1;UBE2J2;UBE4A;SGTA;MAN1B1;ERLIN2;DNAJC10;TRIM13;DNAJB12;DNAJB9;EDEM2;HERPUD1
prerank,DNA duplex unwinding (GO:0032508),-0.22992952559934401,-0.8137577476869841,0.7718360071301248,0.9086190691297465,1.0,19/50,33.23%,RBX1;MRE11;MCM9;ERCC2;MCM4;RPA1;XPC;ERCC3;WRN;CETN2;ANXA1;BLM;DHX9;MCM7;GTF2H3;CHD1L;RAD50;MCM2;PIF1
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.18630291039070226,-0.8132055652728145,0.9353049907578558,0.9091699382877994,1.0,41/170,23.35%,FOXP1;AFF1;PRDM5;MTMR3;APP;HMG20B;CTCF;NOVA2;KDM6A;CDH1;HNRNPAB;PRDM2;PRDM6;KDM6B;HMG20A;POGZ;TRIM14;PSEN1;RASA1;EDN3;FLOT1;MARF1;CDK6;ZNF462;PRDM9;ROCK2;IGF1;ZNF507;FUBP1;MKLN1;CAVIN4;PTPRC;TOB1;PRDM1;NKAP;TRIM39;KIF16B;MTMR4;RFXANK;TRIM68;PCBP1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3008998585097402,-0.8126989354362523,0.7209302325581395,0.9096750577893943,1.0,3/16,4.41%,ST8SIA4;A4GALT;ST6GALNAC3
prerank,histone H2A monoubiquitination (GO:0035518),-0.29524006447171675,-0.8126823865689589,0.7281553398058253,0.9092936304632041,1.0,6/17,19.46%,RYBP;RNF168;BCOR;RNF2;PCGF3;PCGF5
prerank,striated muscle cell differentiation (GO:0051146),-0.2968226042284879,-0.8126521223440845,0.7242647058823529,0.9089408042876076,1.0,4/16,10.23%,AKAP13;SIK1;MEF2C;KDM6B
prerank,metallo-sulfur cluster assembly (GO:0031163),0.2748462295439737,0.8125268889187994,0.7855579868708972,1.0,1.0,9/22,23.43%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;LYRM4;CIAPIN1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3162725102203919,-0.8124847340610176,0.7197106690777577,0.9088295343533191,1.0,8/14,42.36%,CRAT;ACOX1;ACOX3;ECI2;EHHADH;ACOXL;SCP2;ABCD1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.31705411619930896,-0.8120416227825916,0.7282809611829945,0.909185384820833,1.0,5/13,28.48%,RPS21;NOL9;RRS1;RCL1;UTP20
prerank,negative regulation of neuron differentiation (GO:0045665),-0.2786062590114372,-0.8119008164722348,0.7392086330935251,0.9090227386718428,1.0,7/22,25.32%,GSK3B;HES1;MED1;BMP7;HEY1;NEPRO;EIF2AK4
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3117803484176225,0.8115979073023888,0.7297297297297297,1.0,1.0,5/15,19.43%,TRIM27;ARPC5L;ARPC5;WHAMM;ARPC1A
prerank,negative regulation of wound healing (GO:0061045),-0.2579979030563661,-0.8113533011909729,0.7598499061913696,0.909586945876385,1.0,9/28,25.13%,CD34;CRK;SLC12A2;EDN1;FGF2;TFPI;PTEN;SERPINE1;SERPINE2
prerank,regulation of axon regeneration (GO:0048679),-0.33368075473478503,-0.8113236161110892,0.7467411545623837,0.9092336460506194,1.0,4/12,13.42%,SCARF1;STK24;EPHA4;RTN4RL1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3458449146449448,-0.8111638164778355,0.7269372693726938,0.9091117827361526,1.0,3/10,18.08%,NCK1;JUN;CITED2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.34376330645790454,-0.8108725102313981,0.7117117117117117,0.9091945646156092,1.0,2/10,4.98%,PTPRJ;PTPN12
prerank,negative regulation of interferon-beta production (GO:0032688),0.32760830153039266,0.8106156716355724,0.7297297297297297,1.0,1.0,3/10,15.09%,REL;PTPRS;SIRPA
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3232408973868975,-0.8103522661181303,0.7167530224525043,0.9097036245323105,1.0,9/13,40.50%,DYRK1A;YJU2;MIF;MDM2;SNAI2;CD74;SIRT1;PTTG1IP;CD44
prerank,ribosome assembly (GO:0042255),-0.23582690117196659,-0.8102964142225259,0.7955706984667802,0.9093891818451695,1.0,14/47,22.49%,DDX3X;RPS14;RPSA;NOP2;RPL3;RPL10;RPL5;NLE1;MPV17L2;RPS27;MDN1;BOP1;RRS1;RPS15
prerank,negative regulation of viral transcription (GO:0032897),-0.32385183299636755,-0.8093998365431716,0.7230769230769231,0.9105121851766954,1.0,7/13,32.51%,UBP1;TRIM14;IFITM3;TRIM13;LARP7;TRIM32;TRIM62
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.24286720621452743,-0.809170042127624,0.7881944444444444,0.9104980177618659,1.0,13/39,28.52%,RBX1;ERCC2;POLD3;OGG1;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1;GTF2H3;CHD1L
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.31109470150517043,-0.8091325520551372,0.7176684881602914,0.9101504705487824,1.0,7/14,31.24%,PTPN11;RFLNB;ADAMTS7;RFLNA;SNAI2;TGFBR1;WNT9A
prerank,protein targeting to lysosome (GO:0006622),-0.28220167138425256,-0.8083807508635413,0.730072463768116,0.911042923773309,1.0,7/20,19.54%,RAB7A;NEDD4;NCOA4;ZFYVE16;LAMP2;AP4M1;M6PR
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.29019004894693123,0.8082950289092923,0.7392241379310345,1.0,1.0,4/16,15.09%,ADCY7;CHID1;CUEDC2;SIRPA
prerank,DNA-dependent DNA replication (GO:0006261),0.19120234721592275,0.8078893704027998,0.9023809523809524,1.0,1.0,25/128,17.02%,GMNN;WRNIP1;GINS4;PSMC5;MCM8;PSMD10;CDC45;POLD4;PSMD14;POLA1;PSMB7;PSMA4;RPAIN;SIRT7;PURA;PSMB8;PSMF1;POLE4;PSMD1;CDC7;PSMD7;CDK2;ORC1;PSMB5;PSMD2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2984959187987182,-0.8070160575644321,0.7384615384615385,0.9130377942242014,1.0,2/17,4.87%,PLA2G4A;LPCAT1
prerank,negative regulation of response to wounding (GO:1903035),-0.28426848796919096,-0.8070029994807327,0.7574074074074074,0.9126553345413654,1.0,4/19,13.42%,CRK;EPHA4;FGF2;RTN4RL1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.29730336763016113,0.806607512086238,0.7516930022573364,1.0,1.0,6/15,22.40%,NYNRIN;ZC3H12B;ZC3H12C;NUDT16;RNASEH1;LACTB2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2382662938720417,-0.8065658935013107,0.8035087719298246,0.9129702457077621,1.0,10/40,17.53%,TNFSF10;BNIP3;TP53;AKT1;HGF;GPX1;BBC3;BCL2L11;IGF1;PPIF
prerank,dendritic cell migration (GO:0036336),-0.29397341411870587,-0.8062596384007235,0.7449908925318761,0.9130885389514872,1.0,2/16,5.06%,EPS8;TRPM4
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.23853161073619264,0.8061252214736089,0.8054298642533937,1.0,1.0,4/34,9.46%,PHB2;SASH3;INAVA;SPHK2
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2595616849982588,-0.8060835075162719,0.7852233676975945,0.9129790747698886,1.0,4/28,10.53%,MAP3K20;ATM;CLSPN;DOT1L
prerank,pseudouridine synthesis (GO:0001522),-0.3143690573550105,-0.8058861845412757,0.7212230215827338,0.912894928670465,1.0,5/13,28.77%,PUS10;TRUB1;PUSL1;RPUSD2;GAR1
prerank,positive regulation of metabolic process (GO:0009893),-0.20118350335105353,-0.8057889159557587,0.8678260869565217,0.9126551142223537,1.0,26/103,23.86%,IGF1R;INSR;CAV1;ADIPOR2;PRDM16;STAT6;UCP2;GRB10;ACADL;ACACB;KDM6B;IL4R;KDM3A;EHMT1;JAK2;AGPAT1;ACSL1;EPAS1;ALMS1;PRKAB1;CMKLR1;G0S2;DIO2;OGT;BEND3;ADRB1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.2939339283699748,-0.8057501753900931,0.7323420074349443,0.9123231152303686,1.0,6/17,31.24%,BMP4;RGCC;VSIR;F2R;LARP6;TGFB1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.24970069811943757,-0.805747614539236,0.7889273356401384,0.9119264806080808,1.0,9/33,20.04%,NEDD4L;RIC3;STX3;PICALM;HFE;TAX1BP3;ABCA7;CTNNB1;KCNAB2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.23111198157032112,0.8057303797022364,0.8057395143487859,1.0,1.0,7/42,13.24%,OXSR1;CCL7;PF4;CCL13;CCL5;CCL2;THPO
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.23082286878690916,-0.8056752562212051,0.8003533568904594,0.911635938518014,1.0,17/46,36.99%,TOMM40;AKT1;BCAP31;TIMM17B;TOMM5;DNAJC19;TOMM40L;TIMM50;TIMM10;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;PAM16;DNLZ;TIMM23
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.32560169780608944,-0.8056544243500516,0.7272727272727273,0.9112679187929853,1.0,9/12,45.09%,MAD1L1;CENPE;BOD1;NUF2;MIS12;RMDN1;KIF2C;CDT1;CHAMP1
prerank,response to iron ion (GO:0010039),0.31694597777393396,0.8053201661727416,0.7202643171806168,1.0,1.0,2/12,7.76%,BCL2;ACO1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.3218014390157695,-0.8052656525576202,0.7261029411764706,0.9115816330567047,1.0,8/12,52.44%,TREM2;IL18;STAP1;TAFA3;IL6;TNF;CCL3;IL1B
prerank,lymphocyte chemotaxis (GO:0048247),-0.24633651604144646,-0.8051960509305908,0.7943262411347518,0.9113005670010951,1.0,5/34,9.40%,CCL25;SLC12A2;GAS6;CYP7B1;PIK3CD
prerank,mononuclear cell differentiation (GO:1903131),-0.2707338814010715,-0.8050123157734647,0.7521968365553603,0.9112191323766192,1.0,4/24,6.58%,MYH9;LYN;GAS6;BMP4
prerank,axonal transport (GO:0098930),0.23766642893385062,0.8045582291035952,0.7843137254901961,1.0,1.0,8/36,16.23%,TMEM108;SYBU;AP3S2;MAPT;KIF3A;AP3M2;SNAPIN;NEFL
prerank,response to zinc ion (GO:0010043),-0.27021839616749765,-0.8040563507018421,0.7468581687612208,0.9124541279245364,1.0,12/25,30.39%,PAM;SLC30A5;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;HVCN1;SLC30A4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.23062642184464657,-0.8037998182472459,0.7974217311233885,0.9124687923620027,1.0,21/50,30.86%,MNAT1;CDKN1B;CCND3;ACTB;CDK5RAP3;CCND1;CNPPD1;BLM;CDKN2C;CDC25A;GADD45A;CCNG1;CCNK;CCNE2;CCNJ;CDKN3;CDKN2B;CCND2;CCNH;STOX1;CDK5R1
prerank,multivesicular body assembly (GO:0036258),-0.25529999650992163,-0.8036478732631511,0.764808362369338,0.9123189044312169,1.0,13/30,30.64%,CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,regulation of actin nucleation (GO:0051125),0.3141242937853107,0.8034874785388091,0.7311111111111112,1.0,1.0,12/12,68.61%,GSN;WHAMM;CORO1B;PICK1;ARFIP2;WASHC5;ARF1;ARFIP1;ARPIN;VIL1;SCIN;CORO1A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.29644363639322757,-0.8032893497988303,0.7495462794918331,0.9125125779506394,1.0,8/17,31.16%,AKT1;SFPQ;SOD1;MAPK7;NFE2L2;BAG5;TREM2;VNN1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3274322884103133,0.8032184701337556,0.7310344827586207,1.0,1.0,4/10,24.29%,ADRA2A;HBEGF;TGFA;EGF
prerank,positive regulation of cell development (GO:0010720),0.24429382807329542,0.8032041936714444,0.7571115973741794,1.0,1.0,2/31,2.02%,OPRM1;MME
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.28771152130667343,-0.8031206551227695,0.7565674255691769,0.9124018114822069,1.0,2/18,3.01%,ESR1;KAT2B
prerank,histone H2A acetylation (GO:0043968),0.2900971842335488,0.8029169987935493,0.7461368653421634,1.0,1.0,4/16,14.33%,MEAF6;SPHK2;RUVBL1;NAA40
prerank,actin filament polymerization (GO:0030041),-0.2545874379179938,-0.802472555903111,0.7900172117039587,0.9131071850175195,1.0,9/29,18.53%,RAC1;DIAPH1;WASL;FAM107A;JAK2;CORO7;PREX1;WASF1;PSTPIP1
prerank,activation of protein kinase A activity (GO:0034199),-0.2970188287664238,-0.8022993393263387,0.7366336633663366,0.9129940275801717,1.0,3/16,7.75%,PRKACB;ADCY9;ADCY4
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.2812952470101357,-0.8022121618440738,0.7444253859348199,0.9127323742013597,1.0,9/20,28.47%,SMAD1;SMAD4;NOTCH1;ATF4;SMAD9;RELA;NFE2L2;BMP2;CARF
prerank,antibacterial humoral response (GO:0019731),0.2934740386292729,0.8021299144934558,0.7345537757437071,1.0,1.0,3/16,10.56%,RNASE6;ANG;PLA2G6
prerank,endoderm development (GO:0007492),0.30492926297498585,0.8020075436778195,0.721627408993576,1.0,1.0,2/13,6.54%,LHX1;DUSP4
prerank,potassium ion export across plasma membrane (GO:0097623),-0.3171408923314418,-0.8018281576711537,0.730909090909091,0.9129688321979187,1.0,5/13,25.77%,KCNK5;KCNQ1;KCNE4;KCNH2;KCND3
prerank,oligosaccharide metabolic process (GO:0009311),-0.2308443859945179,-0.8018099932648146,0.8072072072072072,0.91260232622848,1.0,8/46,14.13%,ST3GAL6;ST3GAL4;ST8SIA4;ST6GALNAC3;FUT8;ST3GAL2;MAN1B1;MAN2B2
prerank,tRNA modification (GO:0006400),0.21347176614208166,0.8017649330450936,0.835990888382688,1.0,1.0,19/62,23.01%,QTRT2;TRMT6;GTPBP3;TRMT13;TRMT10A;PUS1;ANKRD16;FTSJ1;AARS2;TRIT1;QTRT1;TPRKB;METTL2B;METTL2A;NSUN6;ADAT2;THUMPD3;THUMPD1;TRMT5
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2927337422321258,0.8012408006786375,0.7299771167048055,1.0,1.0,2/14,6.80%,PELI3;TRAIP
prerank,positive regulation of leukocyte activation (GO:0002696),-0.28546969209983464,-0.8007097271688302,0.7574626865671642,0.914000821539684,1.0,2/18,8.14%,THBS1;LBP
prerank,positive regulation of T cell migration (GO:2000406),-0.2794057517049173,-0.8005726132292337,0.7464028776978417,0.9138330754430245,1.0,8/20,30.29%,APP;ADAM10;RHOA;CXCL12;ADAM17;CXCL10;WNK1;TNFRSF14
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.30066597123682054,-0.800520970464868,0.7361853832442068,0.913521093672393,1.0,5/15,26.01%,TCP1;RUVBL2;CCT5;NAF1;CCT2
prerank,mitochondrion morphogenesis (GO:0070584),0.3243198644855902,0.8002147151742116,0.7097505668934241,1.0,1.0,5/11,23.47%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,positive regulation of cilium assembly (GO:0045724),0.28068153871593415,0.7998980348762126,0.7417218543046358,1.0,1.0,6/18,21.01%,CCDC88A;BBS4;CEP135;HTT;HAP1;SEPTIN9
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.2862614592490267,0.7998623902217682,0.7251082251082251,1.0,1.0,16/16,71.40%,BCKDK;SCARB2;PDK1;PDK2;MLYCD;PRKN;ADIPOQ;FOXK2;RORA;ADIPOR1;SIRT1;GNB3;FOXK1;PDK3;PDK4;RORC
prerank,carnitine metabolic process (GO:0009437),-0.3276388963886834,-0.799849027379942,0.7413194444444444,0.9142307224644135,1.0,7/12,33.22%,ACADL;CPT1A;CRAT;TMLHE;BBOX1;SHMT1;CPT2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3003359474300348,0.7998039539467845,0.7300215982721382,1.0,1.0,4/14,13.89%,NR1D1;SYT11;GRN;LDLR
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.213403430825587,-0.7996652272748317,0.8354898336414048,0.9141185791640883,1.0,21/72,26.89%,PSMA2;BIRC3;PSME2;PSMB4;AKT1;DICER1;IRAK1;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;PSMD4;RELA;COPS8;PSMD5;MAP3K7;MAP3K14;PSMA3;PSMB10
prerank,chromosome condensation (GO:0030261),-0.24598617384820012,-0.7991927696761898,0.7926605504587156,0.9145184196515789,1.0,17/36,37.14%,RB1;ACIN1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;TTN;SET;CHMP1A;PLK1;AIFM1;TOP2A;CSNK2A1;CSNK2A2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.3051406669948309,-0.7990218949338165,0.7169459962756052,0.914416226862325,1.0,4/14,28.94%,DAGLB;NOS1;CHAT;SLC22A2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.33040165089655427,0.7981870444158725,0.714902807775378,1.0,1.0,2/10,8.60%,ATP5MC1;VPS9D1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.2966160516622607,0.7979414091723822,0.7388392857142857,1.0,1.0,2/14,6.27%,SHISA2;GPC1
prerank,lipid homeostasis (GO:0055088),-0.2212537561269735,-0.7977427298327588,0.8242530755711776,0.9161487625721346,1.0,17/57,26.57%,ZBTB20;DDX3X;PRKAA1;ORMDL1;NR1D2;ACOX1;DGAT2;TLCD1;ACOX3;ORMDL3;PPARG;PNPLA8;CEBPA;PNPLA2;TLCD3B;USF2;FABP3
prerank,skeletal muscle contraction (GO:0003009),0.2846101331977595,0.7967396847006881,0.7439824945295405,1.0,1.0,4/19,13.56%,STAC2;STAC;TNNC1;TNNI2
prerank,DNA replication checkpoint signaling (GO:0000076),0.29499974190020223,0.7966238793349933,0.7476851851851852,1.0,1.0,4/16,16.31%,CDC45;NAE1;RAD9B;ORC1
prerank,regulation of nuclear division (GO:0051783),-0.2786853308756716,-0.7955177658371488,0.7398230088495575,0.9193984745779286,1.0,4/20,12.90%,CDK13;CUL9;CUL7;CCDC8
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.338036856172208,-0.7954765749966815,0.7250922509225092,0.919061210484497,1.0,7/10,46.37%,TCP1;CCT5;CCT2;CCT3;CCT7;DKC1;CCT6A
prerank,cholesterol transport (GO:0030301),0.2252443830514207,0.7950650792586191,0.8325688073394495,1.0,1.0,11/45,15.14%,AKR1C1;APOM;SERAC1;LIPC;TSKU;OSBPL5;ABCA5;APOE;CLU;LDLR;APOC1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2570087667262262,-0.7950194723779566,0.763668430335097,0.9193882952148493,1.0,14/26,40.03%,LRRK2;AKT1;ATF4;FYN;TXN;MAPK7;NFE2L2;BAG5;PYCR1;VNN1;PARK7;PDE8A;SIRT1;GATA4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.24274518415697222,0.7949896016950205,0.8123569794050344,1.0,1.0,8/30,13.09%,CHSY3;DSEL;NCAN;CHST9;HEXB;CHST12;CHSY1;UGDH
prerank,chromatin assembly (GO:0031497),-0.23870404149683636,-0.7949408152707204,0.7992895204262878,0.9191177063265925,1.0,7/38,15.24%,KAT6B;CTCF;BRD2;SPTY2D1;TP53;H3-3A;PRDM9
prerank,steroid hormone biosynthetic process (GO:0120178),-0.25176610880224665,-0.7948563877284512,0.8068592057761733,0.9188468005553238,1.0,7/29,18.41%,MED1;STARD3;FDX1;FDXR;STARD3NL;DHCR7;STAR
prerank,inorganic anion transport (GO:0015698),0.2160522219003022,0.7926750715109195,0.869098712446352,1.0,1.0,11/53,16.28%,SLC34A1;CLCNKA;GLRA1;ANO4;CLCN2;ENPP3;SLC26A8;RACGAP1;ENPP1;SLC4A11;SLC13A1
prerank,granulocyte chemotaxis (GO:0071621),0.21417382909372634,0.7925751677430339,0.8424657534246576,1.0,1.0,8/55,14.38%,PDE4B;CXADR;CCL7;PF4;CCL13;CCL5;CCL2;PPIA
prerank,regulation of membrane depolarization (GO:0003254),-0.2835002334285624,-0.7925460202226605,0.7718978102189781,0.9222026529447981,1.0,9/18,30.54%,NEDD4L;LRRK2;SMAD7;PTPN3;SCN3B;FHL1;GJA5;HCN4;RANGRF
prerank,female gamete generation (GO:0007292),-0.2522341045434585,-0.7921125144227997,0.7914438502673797,0.9224963111648371,1.0,6/29,15.24%,USP9X;DMC1;MCM9;PARN;MARF1;PRDM9
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.31353576387468357,0.7920917909640258,0.7660550458715596,1.0,1.0,3/12,14.03%,TMEFF2;PF4;SELENOS
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.25548266494108884,-0.7918893447976837,0.7912713472485768,0.92245620074721,1.0,7/30,21.36%,SPTBN1;GOLPH3L;MACF1;GOLGA4;GOLPH3;KIF13A;VAMP2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.25610881435127025,0.7917444128284838,0.7802197802197802,1.0,1.0,6/24,19.65%,AKAP6;CALM2;SRI;HRC;SELENON;PDE4D
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3318675723242771,0.7916458117410118,0.7328918322295805,1.0,1.0,3/10,10.35%,PDE3B;RNF157;PDE11A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.21023068646399723,-0.7915633987695914,0.8591800356506238,0.9226010228702451,1.0,22/70,26.89%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;NCF2;PSMC2;PSMB2;PDIA3;PSMB1;PSMA8;IKBKG;PSME1;IKBKB;VAMP3;PSMD4;SEC22B;FCGR1A;PSMD5;PSMA3;FCER1G;PSMB10
prerank,negative regulation of cellular metabolic process (GO:0031324),0.235406960747614,0.7910293769922149,0.8207343412526998,1.0,1.0,7/37,13.32%,ANKRD13B;WDR54;PAX2;MTMR2;ABCA2;DLG4;APOE
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2764512219679189,-0.7910261144842065,0.7735507246376812,0.923048598410449,1.0,8/20,31.54%,PLOD2;PLSCR1;PTDSS1;GAMT;GCLC;HAGH;CNDP2;MGST2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3280353806734058,0.7910211871646012,0.7182795698924731,1.0,1.0,1/10,0.75%,ANK3
prerank,vasodilation (GO:0042311),-0.3116313100659076,-0.7908644479076151,0.7433628318584071,0.9228869804369447,1.0,2/13,2.50%,NOS3;KLF2
prerank,cholesterol homeostasis (GO:0042632),0.20860585261306552,0.7907809550889782,0.8447488584474886,1.0,1.0,22/64,24.61%,NR1D1;INSIG1;AKR1C1;APOM;LIPC;ABCA2;TSKU;ABCA5;APOE;LDLR;GRAMD1B;SOAT2;CD24;DISP3;SOAT1;ABCG1;ANGPTL3;CNBP;LAMTOR1;NR1H2;TMEM97;EPHX2
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.30616661869089434,-0.7907045694830387,0.7551789077212806,0.9227442442520122,1.0,4/14,18.55%,RPUSD4;MRPS27;MPV17L2;UQCC2
prerank,mitochondrial transport (GO:0006839),-0.21950758914897361,-0.7902556721427519,0.8372943327239488,0.9230369013679107,1.0,21/53,33.26%,COX18;BNIP3;ABCB10;STARD3;TOMM40;BCAP31;TMEM14C;TIMM17B;TOMM5;FLVCR1;PPIF;DNAJC19;HSP90AA1;SLC25A24;TIMM10;TOMM20;TOMM70;PMAIP1;SLC25A5;SPG7;TIMM10B
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.25518785659277754,-0.7902400541376136,0.7853107344632768,0.9226574082875514,1.0,6/27,14.23%,KHNYN;ERN1;XRN1;DICER1;PDE12;PARN
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.27540787682266415,-0.7899378990335301,0.7625,0.9227401102721549,1.0,7/19,19.63%,KDR;PTPRJ;STIMATE;BCAP31;PTGFR;VCAM1;PTPRC
prerank,ribosomal large subunit assembly (GO:0000027),-0.2653363038259614,-0.7897353912811572,0.7732656514382402,0.9226598646010926,1.0,8/24,20.96%,NOP2;RPL3;RPL10;RPL5;NLE1;MDN1;BOP1;RRS1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23535632229177272,-0.789702732054525,0.8243992606284658,0.9223178801892891,1.0,13/38,27.84%,PRPF3;PRPF6;PRPF31;SNRPE;TGS1;SRSF12;CD2BP2;SRSF10;STRAP;COIL;GEMIN7;AAR2;LSM2
prerank,monocyte differentiation (GO:0030224),-0.3353482964039962,-0.7893513611328378,0.7530647985989493,0.9224610975163161,1.0,5/10,24.96%,MYH9;BMP4;PIR;PPARG;MT1G
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2524028770083796,0.7892794171350554,0.7977777777777778,1.0,1.0,5/26,14.47%,CARTPT;HOXA7;TMEM178A;TCTA;LRRC17
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3203845690511279,0.7892093653664861,0.7710280373831776,1.0,1.0,2/10,4.31%,IQSEC1;EPB41L4B
prerank,positive regulation of lyase activity (GO:0051349),-0.30500141910645684,-0.7890579327859124,0.7504690431519699,0.9225113182967586,1.0,6/14,35.17%,NOS3;NOS1;NF1;NOS2;STIM1;PARK7
prerank,peptidyl-amino acid modification (GO:0018193),0.3274634583771711,0.7888370746195417,0.7584745762711864,1.0,1.0,3/10,19.29%,METAP2;METAP1;FKBP7
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3151976125393625,-0.7885640128429826,0.7700534759358288,0.9228850348208065,1.0,1/12,1.93%,ESR1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.21226535994919876,-0.7885247740362581,0.8670212765957447,0.9225468397163062,1.0,12/64,16.43%,PLA2G4A;ELOVL5;ACADL;EPHX1;GSTM2;ACAD9;CPT1A;MGLL;SLC27A4;GPX1;ACOX1;ACSL1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.2684520124911266,-0.7882065699211203,0.7552182163187856,0.9226578779614524,1.0,3/22,5.39%,GHR;CRLF3;HES1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2923911677793783,-0.7878111791057986,0.7781818181818182,0.9228867668711878,1.0,9/17,25.81%,HES1;TNFRSF1B;IL34;DICER1;NOTCH1;CLCF1;BMP2;SERPINE2;PTN
prerank,protein polymerization (GO:0051258),-0.21836308978560143,-0.7873638737563671,0.8442477876106195,0.9232097743761067,1.0,14/55,18.53%,RAC1;UBE2K;DIAPH1;WASL;FAM107A;CHMP4B;CHMP4A;JAK2;CORO7;CASQ2;PREX1;TRPV4;WASF1;PSTPIP1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.30916604201792525,-0.787006936722054,0.770949720670391,0.9233735491674249,1.0,8/14,47.30%,IRAK1;COPS8;MAP3K7;TLR6;ZFP91;CARD14;MALT1;TLR3
prerank,neuromuscular synaptic transmission (GO:0007274),-0.27975628784103124,-0.7868858740513793,0.7660377358490567,0.9231651730017775,1.0,6/18,23.76%,ERC1;CHRNB1;FCHSD2;STAC3;FCHSD1;CHAT
prerank,establishment of vesicle localization (GO:0051650),-0.28656531884663194,-0.7865636086906455,0.7800369685767098,0.9232751566831942,1.0,7/18,17.91%,LIMK2;DNM2;RAB27A;TMEM230;SPG11;RAB11A;IKBKG
prerank,negative regulation of gluconeogenesis (GO:0045721),0.30867152845917,0.7862040058662916,0.7763157894736842,1.0,1.0,1/11,1.96%,GCK
prerank,ncRNA transcription (GO:0098781),0.30162534015559966,0.7852058060189167,0.7546296296296297,1.0,1.0,6/13,24.41%,ANG;SIRT7;RPAP2;USPL1;NIFK;SPIN1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.17958728828484274,-0.785128522468833,0.9562043795620438,0.9250956867444533,1.0,52/184,27.04%,PSMA2;YWHAE;NEK6;CEP57;CUL3;CEP250;CDC14A;PSME2;CEP78;PSMB4;ERCC2;HAUS8;RGCC;DCTN1;CDC16;DCTN3;ANAPC16;XPC;HAUS6;PAFAH1B1;CSNK1D;ERCC3;PSMC2;PSMB2;CEP41;PSMB1;TFAP4;PLK4;PSMA8;CETN2;CEP152;CENPE;ALMS1;PSME1;PCM1;CNTRL;BUB1B;BUB3;PSMD4;ODF2;HSP90AA1;CEP131;PCNT;PSMD5;AKAP9;FZR1;ANAPC7;PSMA3;DYNLL1;KIF14;PSMB10;INO80
prerank,protein localization to microtubule organizing center (GO:1905508),0.2868787038558861,0.7842653089935637,0.7420814479638009,1.0,1.0,3/15,10.90%,BBS4;SNX10;CCDC14
prerank,pre-replicative complex assembly (GO:0036388),0.2076507498211941,0.7842252471254914,0.8833693304535637,1.0,1.0,14/64,17.02%,GMNN;PSMC5;MCM8;PSMD10;PSMD14;PSMB7;PSMA4;PSMB8;PSMF1;PSMD1;PSMD7;ORC1;PSMB5;PSMD2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.32303220921985004,0.784206148751079,0.7539863325740319,1.0,1.0,2/10,11.56%,OXSR1;CCL5
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.25975167355737716,-0.7841784954509946,0.7960644007155635,0.9261546276404153,1.0,12/25,38.18%,EPHA4;HFE;SGTA;RPL5;RPS7;TRIM39;PRKCG;OPHN1;GABARAPL2;CSNK2A1;CSNK2A2;EFNA1
prerank,lysosome localization (GO:0032418),0.23722783437998757,0.7833967407716879,0.8219780219780219,1.0,1.0,11/37,19.88%,PIP4P1;FLCN;CHGA;NR4A3;RAB3A;RAB34;KIT;BORCS5;SNAPIN;MAP6;VPS33B
prerank,protein import into nucleus (GO:0006606),0.20707105414596674,0.783135043101533,0.8758782201405152,1.0,1.0,5/66,3.39%,MMP12;SPRN;PHB2;NUP62CL;TNPO3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.21140499694668405,-0.782865941525297,0.8801431127012522,0.9277574000629962,1.0,19/67,23.67%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;NCF2;PSMC2;PSMB2;PDIA3;PSMB1;PSMA8;IKBKG;PSME1;IKBKB;VAMP3;PSMD4;SEC22B;FCGR1A;PSMD5
prerank,regulation of steroid biosynthetic process (GO:0050810),0.31573188125723106,0.7819768259350827,0.7374701670644391,1.0,1.0,2/11,5.11%,DGKQ;EGR1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3197371017012458,-0.7819196462505763,0.7791970802919708,0.928785851652238,1.0,4/12,14.59%,HDAC1;HDAC4;NOTCH1;CCN3
prerank,cyclooxygenase pathway (GO:0019371),0.32056995610304173,0.7817474394235889,0.7517084282460137,1.0,1.0,2/10,10.96%,PTGDS;CBR1
prerank,positive regulation of cell killing (GO:0031343),-0.3118145616712294,-0.7814456641022005,0.7564575645756457,0.9291505589280857,1.0,5/13,35.77%,RAC1;MAPK8;FZD7;NOS2;SYK
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.28573171575510536,-0.7814336191623876,0.7842778793418648,0.9287682610083602,1.0,5/17,26.88%,FERMT2;PTPRC;TERT;HNRNPU;N4BP2L2
prerank,retina homeostasis (GO:0001895),-0.263842247178682,-0.7812235745585403,0.7864963503649635,0.9286942311552056,1.0,10/23,32.81%,ACTB;POTEF;TULP1;SOD1;CCDC66;POC1B;JCHAIN;PRDX1;CRB2;ACTG1
prerank,digestive tract morphogenesis (GO:0048546),-0.30056155727010514,-0.7810992218507422,0.7626811594202898,0.9284789143086616,1.0,6/14,27.89%,SOX17;NIPBL;EPHB3;FOXF1;RBPMS2;STRA6
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3094618625085691,-0.7809907558101796,0.7508960573476703,0.9282468716133625,1.0,6/13,31.24%,BMP4;NOTCH1;TBX3;EID2B;SOSTDC1;TGFB1
prerank,regulation of immunoglobulin production (GO:0002637),0.2514274517134234,0.7803542553661433,0.7954545454545454,1.0,1.0,2/23,4.41%,PHB2;SASH3
prerank,DNA replication initiation (GO:0006270),0.23130114095835128,0.7803312038785667,0.8329571106094809,1.0,1.0,9/37,16.31%,GMNN;MCM8;CDC45;POLA1;PURA;POLE4;CDC7;CDK2;ORC1
prerank,nuclear envelope organization (GO:0006998),-0.2711687174410834,-0.7802411466808654,0.7896613190730838,0.9289878191880342,1.0,4/20,16.32%,EMD;TOR1B;REEP3;SUN1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.19576322659276843,0.7801969002105876,0.9142857142857143,1.0,1.0,11/90,10.19%,OMA1;ESRRG;KSR2;LPIN1;HDAC3;BSCL2;HSF1;ADRB3;VEGFA;MFAP2;TSHR
prerank,protein import (GO:0017038),0.1966374335607136,0.7792276085384563,0.8917050691244239,1.0,1.0,25/84,24.56%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;ATAD1;RANBP17;RPAIN;APOE;CLU;SNX33;HIKESHI;NUP107;POM121;GDAP1;FAM53B;FIS1;PRICKLE1;PEX2;FAM53C;ACBD5;NUP93;PEX12;FAM53A;ALDH3A2
prerank,positive regulation of bone mineralization (GO:0030501),-0.23969127236735138,-0.7790045208259871,0.8071833648393195,0.9304732154941006,1.0,8/35,12.10%,BMPR2;BMP6;BMP4;MEF2C;ACVR2A;ANO6;ADGRV1;PKDCC
prerank,mucosal immune response (GO:0002385),-0.29197614493096274,-0.7784255534000596,0.7462962962962963,0.9309526915095531,1.0,13/15,54.01%,RNASE3;DEFA6;RPL39;IFNLR1;NOS2;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.31593766605694495,-0.7782847356243016,0.7495621716287215,0.9307597394936908,1.0,4/12,17.22%,PROM1;NKD1;AGTPBP1;TULP1
prerank,regulation of T cell differentiation (GO:0045580),-0.24062303321432676,-0.7775808778436835,0.8318425760286225,0.9314139613538156,1.0,3/33,6.15%,CBFB;ZMIZ1;ABL1
prerank,glycerolipid metabolic process (GO:0046486),0.3112397085241508,0.7773257852994593,0.75,1.0,1.0,3/11,17.78%,DGKQ;GAL3ST1;PGP
prerank,glycerophospholipid catabolic process (GO:0046475),0.2504432137178918,0.777007079519848,0.7954022988505747,1.0,1.0,6/27,13.18%,ENPP2;PLA2G7;LIPC;PLA2G4E;PLA2G6;INPP5F
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2266373943193774,0.7767207118443111,0.8559139784946237,1.0,1.0,8/39,16.59%,RAB15;PDIA4;RAB3C;TANGO2;RAB3A;RCN3;COPG2;SEL1L
prerank,extracellular matrix assembly (GO:0085029),0.2568470989405425,0.7765331037025941,0.8064516129032258,1.0,1.0,4/23,8.62%,GPM6B;NTNG2;NTNG1;LAMB3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2898668994173807,-0.7763576502393831,0.7692307692307693,0.932886516386803,1.0,6/16,26.40%,NT5E;TET2;NT5C1A;CRMP1;NT5C;UPB1
prerank,sterol homeostasis (GO:0055092),0.20516536443659966,0.775795899473344,0.8894009216589862,1.0,1.0,22/65,24.61%,NR1D1;INSIG1;AKR1C1;APOM;LIPC;ABCA2;TSKU;ABCA5;APOE;LDLR;GRAMD1B;SOAT2;CD24;DISP3;SOAT1;ABCG1;ANGPTL3;CNBP;LAMTOR1;NR1H2;TMEM97;EPHX2
prerank,rRNA modification (GO:0000154),0.26355852204024344,0.7756915530522129,0.8009708737864077,1.0,1.0,7/21,22.89%,MTERF4;BUD23;DIMT1;TFB1M;TSR3;THUMPD1;NOP10
prerank,second-messenger-mediated signaling (GO:0019932),0.19609696828504738,0.7756400599837858,0.912472647702407,1.0,1.0,14/82,15.72%,PPP1R9A;KSR2;DDAH2;CHRM3;SPHK1;RYR2;CCR6;MCTP2;RCAN2;NMUR2;APOE;RCAN3;HRH1;MCU
prerank,regulation of mitochondrion organization (GO:0010821),0.2159403309907576,0.7755537719963536,0.8571428571428571,1.0,1.0,16/47,23.47%,OMA1;PRMT6;FLCN;MAPT;INF2;ATP13A2;HTRA2;SIRT7;RHOT1;MFF;VDAC1;FIS1;SQSTM1;PISD;USP36;DNM1L
prerank,serine family amino acid catabolic process (GO:0009071),-0.3320074072866077,-0.7752794659374121,0.7703435804701627,0.9340619357894377,1.0,6/10,38.80%,DLD;SHMT1;GLDC;GCSH;DAO;CBS
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27860355413770904,-0.774908820283481,0.8274647887323944,0.9342115678962416,1.0,10/18,39.20%,AKT1;NONO;MAPK7;NFE2L2;BAG5;VNN1;PARK7;HIF1A;TRAP1;SIRT1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.2553190742644298,-0.7744752783498695,0.786096256684492,0.9344838838409754,1.0,7/25,17.24%,FBXL17;CUL3;ATXN3;ZER1;HDAC6;UGGT1;ZYG11B
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.27287808378229217,0.7737722892414441,0.8008752735229759,1.0,1.0,2/18,5.84%,PAG1;VTCN1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.2705997788033034,0.7737431060007185,0.78,1.0,1.0,5/18,13.32%,CLN3;ADAM19;KLK6;BACE1;APOE
prerank,glutathione biosynthetic process (GO:0006750),0.3071963273334836,0.7736274294995743,0.7662337662337663,1.0,1.0,1/11,3.44%,GGCT
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.2566071757458125,-0.7735064546564475,0.7785977859778598,0.9355202257640243,1.0,10/25,39.98%,PPARA;CBL;HFE;PPARG;ACE2;CHMP6;RAMP3;SLC6A9;CRHBP;SNX6
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.23525901444688338,0.7723287306951483,0.8359550561797753,1.0,1.0,9/31,22.98%,PYCR2;LSS;CYP51A1;FDFT1;ALOX5;NOXRED1;NFS1;LIAS;PRLR
prerank,negative regulation of interleukin-6 production (GO:0032715),0.24624802596866013,0.7723065374854763,0.838495575221239,1.0,1.0,6/27,18.47%,PTPN6;SYT11;SELENOS;FOXJ1;SIRPA;CX3CL1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.26164176013882934,0.7720747017504449,0.7973856209150327,1.0,1.0,3/20,7.83%,BCL2;SELENOK;TMCO1
prerank,mRNA splice site selection (GO:0006376),0.24278280469125235,0.7719486309120359,0.8262806236080178,1.0,1.0,4/30,6.62%,CELF5;CELF4;CELF2;CELF6
prerank,positive regulation of biomineral tissue development (GO:0070169),0.22120416486591865,0.771656235961725,0.8498942917547568,1.0,1.0,11/40,16.19%,GPM6B;OSR1;NELL1;FZD9;SLC8A1;WNT6;ATRAID;WNT4;BMPR1B;FBN2;ALOX5
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.2917376587271958,-0.7715965003788038,0.7696428571428572,0.9379532358332346,1.0,7/15,35.77%,CD55;GLI3;NKAP;PNP;SHH;HSPH1;SYK
prerank,cartilage development (GO:0051216),-0.21512962654220447,-0.7708309338071064,0.8626760563380281,0.93867134311588,1.0,10/49,18.43%,ZBTB16;NFIB;BMP4;MEF2C;CREB3L2;SNX19;FGF2;CCN3;TRPV4;HYAL2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.19828866505209994,-0.770817596638867,0.9180327868852459,0.9382908435383296,1.0,29/83,30.13%,MNAT1;RB1;CDK17;CDKN1B;CRLF3;CUL3;MAX;CUL2;PLK2;LATS2;CDK6;GSPT1;CCND1;CACUL1;CDKN2C;CDC25A;CDK14;CDK18;PLK3;CCNE2;TFDP1;E2F3;CDKN3;BRD4;KHDRBS1;CDK16;CCNH;HINFP;CDC34
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2588637205612388,-0.7708087616775505,0.8003731343283582,0.9379063314179968,1.0,10/24,31.42%,SUZ12;TASOR;H3-3A;DNMT1;PPHLN1;PPM1D;AEBP2;PHF19;SPI1;DNMT3B
prerank,intraciliary retrograde transport (GO:0035721),-0.311361368819074,-0.7706429983599756,0.7797202797202797,0.9377487134672582,1.0,4/12,19.00%,IFT140;WDR35;DYNC2LI1;IFT43
prerank,negative regulation of viral process (GO:0048525),-0.21351224805101493,-0.7705519586162479,0.8707964601769912,0.9374752869968909,1.0,24/57,33.30%,IFIH1;ZC3HAV1;UBP1;TRIM14;IFITM3;PLSCR1;N4BP1;SRPK2;MAVS;TRIM13;TRIM28;IFITM2;BST2;CHMP3;TRIM6;RSAD2;LARP7;OASL;TNIP1;TRIM35;TRIM32;TRIM62;TRIM5;SHFL
prerank,regulation of mast cell activation (GO:0033003),-0.3294190905276406,-0.7704726520828741,0.7682481751824818,0.9371928876149714,1.0,4/10,28.08%,LYN;PLSCR1;CD300LF;MILR1
prerank,regulation of steroid metabolic process (GO:0019218),-0.2561568144138502,-0.7701161932237629,0.8236363636363636,0.9373221387863945,1.0,6/23,19.04%,PANK2;ACADL;ACADVL;ASAH1;STAR;FMO5
prerank,Golgi to lysosome transport (GO:0090160),-0.3137117661107061,-0.7696228078829008,0.7745098039215687,0.9376330882562581,1.0,6/11,32.19%,GAK;AP1G1;ANKFY1;AP4M1;RBSN;LAMP1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.19743758178745913,-0.7695854670208884,0.918625678119349,0.9372806703713311,1.0,24/88,27.51%,FBXL7;FBXL12;PSMA2;FBXL17;FBXL3;RBX1;PSME2;CUL2;PSMB4;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;DMAC2;PSME1;PSMD4;PSMD5;FBXO17;FBXL22;PSMA3;KIF14;PSMB10;FBXO38
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.24250272489676322,-0.7695011168398298,0.8241563055062167,0.9370161360260324,1.0,6/32,17.63%,PPP1R13B;FHIT;DDIT4;TP53;HIPK1;HINT1
prerank,epiboly involved in wound healing (GO:0090505),-0.2863608015339817,-0.769473688964399,0.7902350813743219,0.9366572562959251,1.0,7/16,21.55%,FLNA;CEACAM1;RHOA;LCP1;RHOC;ARHGAP35;CCN1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3019998395582423,-0.7692455966015798,0.7915129151291513,0.9365779528161954,1.0,7/13,32.41%,GREM2;NRROS;DAND5;CHRDL1;BMP2;FBN1;LTBP1
prerank,immunoglobulin mediated immune response (GO:0016064),0.3144234488253657,0.768621487165124,0.7676991150442478,1.0,1.0,2/10,16.60%,CD81;FCGR2B
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.3032675929719011,-0.7676236481071974,0.7818181818181819,0.9385019123031391,1.0,3/12,13.48%,NFIB;EPHA4;PAFAH1B1
prerank,peptidyl-methionine modification (GO:0018206),-0.3124827079516425,-0.767558519061443,0.7769911504424779,0.9382049256224188,1.0,2/12,10.14%,NAA16;NAA15
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.23461162416513706,-0.767371501097656,0.8514492753623188,0.9380635634710031,1.0,4/35,4.08%,PPP1R2;GSK3B;ITGA1;MTOR
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.28985557535504114,-0.7673573906759712,0.7791741472172352,0.9376877452783191,1.0,3/15,16.14%,GGT5;GGACT;HOGA1
prerank,response to axon injury (GO:0048678),-0.2780866795349376,-0.766952751828589,0.8087719298245614,0.937867444039142,1.0,6/18,29.58%,NREP;RTN4RL1;SOD1;FLRT3;MTR;TREM2
prerank,aerobic electron transport chain (GO:0019646),0.19909996969033666,0.7658889796659943,0.9022727272727272,1.0,1.0,15/68,17.91%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;NDUFAB1;COX6A1;NDUFB6;NDUFA11
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.2970473308784721,-0.76563900964327,0.7793103448275862,0.9393083150123955,1.0,8/13,36.29%,LRRK2;HGF;TXN;NFE2L2;MET;PYCR1;PARK7;PDE8A
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3011351483477584,-0.7655241503906635,0.78125,0.939070859125294,1.0,4/13,19.63%,HES1;DOT1L;JAK2;PTPRC
prerank,placenta development (GO:0001890),-0.30461455801617154,-0.7652263367828241,0.7700729927007299,0.9391070815809728,1.0,5/12,23.92%,PTK2;CUL7;SOD1;PPARG;E2F7
prerank,cellular macromolecule catabolic process (GO:0044265),-0.20941063160968607,-0.76518355784344,0.8789571694599627,0.9387671333998949,1.0,12/49,27.51%,DAB2IP;DENND3;RNASE3;ADAMTS9;XRN2;MAGEC2;RNASEH2C;RIPK1;FBXO17;EXOSC7;HNRNPD;MANBA
prerank,negative regulation of chemokine production (GO:0032682),-0.2982148615218403,-0.7649524886228403,0.79182156133829,0.9387200820964786,1.0,1/14,1.51%,KLF4
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2631601093191271,-0.7648304129093315,0.7857142857142857,0.938499945786419,1.0,8/20,30.47%,PSMG2;PTGES3;PFDN6;HSP90AA1;NDUFAF1;PSMG1;CCT2;PSMG3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2741044079810773,0.7647860314314446,0.8093126385809313,1.0,1.0,4/16,13.84%,IL12A;RASGRP1;CD226;SLAMF6
prerank,response to purine-containing compound (GO:0014074),0.2647823324572393,0.7644544977015665,0.7866666666666666,1.0,1.0,2/17,7.56%,DGKQ;RYR2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.31464694208883404,-0.7635610084016814,0.7729831144465291,0.9398680931842264,1.0,2/11,9.03%,SCARB1;MFSD2A
prerank,positive regulation of chemokine production (GO:0032722),-0.22122893239155444,-0.7629331559632598,0.8518518518518519,0.9403202306012042,1.0,17/44,38.23%,APP;DDX3X;IL6R;LPL;IL17RA;MAVS;HMGB1;IL7;ADAM17;HMOX1;LGALS9;CD74;TSLP;SYK;IL18;HIF1A;TLR2
prerank,defense response to protozoan (GO:0042832),-0.3114201553193694,-0.7627510057778498,0.778584392014519,0.9401737983794723,1.0,3/12,14.90%,GBP6;GBP4;CD40
prerank,regulation of protein processing (GO:0070613),0.2545969611437465,0.7623283075292209,0.8093126385809313,1.0,1.0,3/21,9.45%,TMEM59;CLN3;NKD2
prerank,snRNA processing (GO:0016180),-0.27562178370221413,-0.761766118947773,0.8035087719298246,0.9411256694065347,1.0,7/16,29.52%,INTS8;INTS3;INTS9;INTS7;TOE1;INTS5;INTS12
prerank,activation of adenylate cyclase activity (GO:0007190),0.2267020281035766,0.7616591059738781,0.8658008658008658,1.0,1.0,8/35,14.80%,ADCY8;ADCY7;GIPR;ADRB3;TSHR;LGR5;ACR;ADCY3
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.25263091882236244,-0.7616384762788142,0.82174688057041,0.9409087364938081,1.0,6/24,16.40%,MIEF1;TCAF1;MTCL1;CHP1;MIEF2;FYN
prerank,negative regulation of B cell activation (GO:0050869),0.2556569223205367,0.7614829188472398,0.8065217391304348,1.0,1.0,2/21,5.67%,BLK;SAMSN1
prerank,arachidonic acid secretion (GO:0050482),-0.3221067408712709,-0.76135349210975,0.7873873873873873,0.9405204503729527,1.0,5/10,36.44%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,arachidonate transport (GO:1903963),-0.3221067408712709,-0.76135349210975,0.7873873873873873,0.9405204503729527,1.0,5/10,36.44%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,ear morphogenesis (GO:0042471),-0.2667240970059821,-0.7611891610586266,0.8070796460176991,0.9403629903998948,1.0,3/20,5.54%,TBX1;SIX1;NIPBL
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.2938246020101952,-0.7611101847284167,0.7860869565217391,0.9400717607983199,1.0,5/13,29.27%,ITGB1;LPL;PPARG;FCER1G;CD9
prerank,regulation of aerobic respiration (GO:1903715),-0.2843765853082747,-0.7609228390321278,0.7885304659498208,0.9399312202153468,1.0,1/15,1.72%,CBFA2T3
prerank,acylglycerol biosynthetic process (GO:0046463),0.25103444837162125,0.7599852611965958,0.823404255319149,1.0,1.0,4/23,12.95%,LPIN1;ANG;GK;MOGAT1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2590349171781275,-0.7599843096594985,0.825925925925926,0.9408632559466101,1.0,8/22,26.89%,PSMA2;PSMB4;PSMB2;PSMB1;PSMA8;NFE2L2;PSMA3;PSMB10
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3187445017568395,-0.7594105770508037,0.7878228782287823,0.9412499436510998,1.0,4/10,24.76%,TERF2;TFIP11;DCLRE1B;DCLRE1A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2314302666656392,-0.7593969462622701,0.8500881834215167,0.9408684657858547,1.0,12/37,28.52%,RBX1;ERCC2;POLD3;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1;GTF2H3;CHD1L
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.21808175786776113,-0.7591995676790388,0.8532608695652174,0.9407433262916249,1.0,9/47,13.67%,KLF4;APP;NFKB1;NFKBIA;FOXO3;AKT1;EDN1;AGTR1;RPL10
prerank,regulation of phosphate metabolic process (GO:0019220),-0.2812194516361948,-0.75918949291684,0.8057553956834532,0.9403618491775672,1.0,10/16,42.70%,PSEN1;IGBP1;IKBKB;SMG6;MCM7;GNB3;PGAM1;IL4;SMG7;SRPX2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3051499435689704,-0.7589159866868861,0.7818853974121996,0.940322473533047,1.0,2/12,11.67%,LY6E;IFITM3
prerank,ganglion development (GO:0061548),0.3071392907467432,0.7586747857965801,0.7819383259911894,1.0,1.0,3/11,12.01%,UNC5C;INSM1;FZD3
prerank,basement membrane organization (GO:0071711),0.2864091855745557,0.7584278288172773,0.8013698630136986,1.0,1.0,3/14,8.62%,NTNG2;NTNG1;LAMB3
prerank,prostanoid metabolic process (GO:0006692),-0.3020406956798847,-0.7582133991649816,0.7947269303201506,0.940867115397157,1.0,4/13,21.01%,PTGS1;ACOX1;HPGDS;PTGR1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.24136980917132855,-0.75805514406938,0.8353982300884956,0.94067602299197,1.0,10/32,23.76%,LPCAT1;SLC44A1;STARD7;MFSD2A;PCTP;CEPT1;LPIN2;LCAT;LPCAT3;CHAT
prerank,natural killer cell activation (GO:0030101),-0.25633076301863805,-0.7578997244900152,0.8264014466546112,0.940488291515662,1.0,3/23,9.94%,PBX1;PIK3CD;CASP8
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.27149786985074836,-0.7577724787417199,0.8078994614003591,0.9402639317453652,1.0,5/19,15.90%,MTOR;ICE1;RPTOR;POLR3F;NAB2
prerank,positive regulation of histone modification (GO:0031058),-0.24162121936126085,-0.7576335484958874,0.8363970588235294,0.9400498858630338,1.0,10/33,31.09%,RPS6KA5;NIPBL;RUVBL2;SAP30BP;BRCA1;NOS1;ARRB1;GLYR1;APLNR;RPS6KA4
prerank,positive regulation of neuron death (GO:1901216),-0.21990089059847037,-0.7575637245953356,0.8484848484848485,0.9397625093082854,1.0,10/46,17.19%,GSK3B;MAP3K5;FOXO3;DDIT4;TGFB2;PICALM;ATF4;SRPK2;FYN;CTNNB1
prerank,cobalamin metabolic process (GO:0009235),0.2672957670143129,0.7570221953618207,0.7827050997782705,1.0,1.0,6/17,25.51%,CBLIF;MMAB;MMAA;ABCD4;CD320;MMADHC
prerank,cellular response to pH (GO:0071467),0.2625666858871254,0.7569848197890868,0.8137931034482758,1.0,1.0,4/17,14.93%,IMPACT;GPLD1;ASIC1;GPR68
prerank,regulation of interferon-gamma production (GO:0032649),0.1954496318336594,0.7569478744618523,0.9050772626931567,1.0,1.0,12/71,15.75%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;HAVCR2;TXK;SLAMF6;SIRPA;IL23A;CD47
prerank,negative regulation of cartilage development (GO:0061037),-0.2986038565928286,-0.7562993966604301,0.8039927404718693,0.9410897970196384,1.0,6/13,31.24%,WNT11;PTPN11;ADAMTS7;SNAI2;TGFBR1;WNT9A
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.18290092767278213,-0.756263929670029,0.9528130671506352,0.9407474046874454,1.0,37/132,24.26%,EIF4H;RBM5;RPS14;PRPF6;RPSA;NOP2;DDX39B;RPL3;SF3B1;CELF1;PUF60;CPSF7;DICER1;RPL38;CDC73;RPL10;SNRPE;PTGES3;RPL5;TGS1;NLE1;RPS27;SRPK2;MDN1;BOP1;PRKDC;SRSF10;STRAP;RRS1;HSP90AA1;RPS15;COIL;EIF3A;USP39;GEMIN7;GCFC2;DHX9
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.22458687196054022,0.7560315215792704,0.863849765258216,1.0,1.0,5/38,12.11%,MAGI2;FLCN;GPER1;NOP53;PHLPP1
prerank,tRNA wobble base modification (GO:0002097),-0.2926286317887382,-0.7552140665335305,0.7909604519774012,0.9417869413404883,1.0,8/14,39.68%,DPH3;TRMT9B;MOCS3;KTI12;CTU2;ALKBH1;ELP4;ELP3
prerank,chemical homeostasis (GO:0048878),-0.20566532373394258,-0.755123525794509,0.9147424511545293,0.9415142084876587,1.0,19/61,25.71%,ZBTB20;NEDD4L;SLC4A10;TENT4B;DDX3X;AQP11;WNK4;NR1D2;ACOX1;KLHL3;TLCD1;ACOX3;PPARG;PNPLA8;SLC66A1;CEBPA;PNPLA2;TLCD3B;USF2
prerank,regulation of defense response to virus (GO:0050688),-0.29254524647580243,-0.7541533368354109,0.8158379373848987,0.9423680976822348,1.0,7/14,24.26%,PPM1B;TRAF3IP1;ILRUN;TNFAIP3;ZMPSTE24;RNF216;DHX9
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.28897963197155796,0.75379361201367,0.8210023866348448,1.0,1.0,5/13,20.92%,PCID2;CDK5RAP2;ANAPC15;GEN1;MAD2L1
prerank,nucleocytoplasmic transport (GO:0006913),-0.2229485865025057,-0.7535580189785586,0.8646209386281588,0.9427871617991325,1.0,9/40,19.45%,RSRC1;NUP98;BACH2;SNRPE;HNRNPA1;LSG1;PHAX;NXT1;RITA1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.22252214995552078,0.7535192296581419,0.8622222222222222,1.0,1.0,10/38,17.91%,NDUFA1;NDUFA10;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;NDUFAB1;NDUFB6;NDUFA11
prerank,epithelial structure maintenance (GO:0010669),-0.3150151038553492,-0.7533429370786473,0.775047258979206,0.9426885610240187,1.0,6/11,37.29%,RBP4;NOD2;STRAP;MUC13;PIWIL4;MUC6
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.25725847761807863,-0.7529303708739619,0.8236331569664903,0.9427981558462263,1.0,14/21,41.66%,MECP2;RAB11A;CCND1;CDC25A;DTL;BRD4;STOX1;CDK4;FBXO5;DYRK3;ATAD5;CCNB1;CDC25C;RAD51C
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.30046915097575344,-0.7527041472187437,0.8089887640449438,0.942699633014814,1.0,4/13,17.65%,BMP5;NFKB1;ERLIN2;SOD1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.31959110156263415,-0.7523424826689349,0.8107142857142857,0.9427757127472483,1.0,4/10,27.04%,ATRX;E2F7;STOML2;INO80
prerank,regulation of rRNA processing (GO:2000232),-0.2798942224039731,-0.7518210438034789,0.8189655172413793,0.9430659435510583,1.0,2/16,5.87%,KAT2B;WDR75
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.27929976141748714,-0.7509988390535812,0.8086206896551724,0.9437651015379068,1.0,2/16,5.49%,TMSB4X;PPARA
prerank,regulation of lymphocyte proliferation (GO:0050670),0.26879344728483223,0.7496006817242802,0.8037383177570093,1.0,1.0,2/16,10.01%,TNFSF18;IL12A
prerank,regulation of protein sumoylation (GO:0033233),-0.2741653750620402,-0.7495867845495852,0.8058925476603119,0.9452467066941688,1.0,5/17,18.97%,ZMIZ1;UBA2;HDAC4;CTNNB1;PIAS4
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3078765637606743,0.7494862933422745,0.7713004484304933,1.0,1.0,2/10,6.65%,PHB2;MTMR2
prerank,glutamate metabolic process (GO:0006536),0.256597784459579,0.7494727270783452,0.8374164810690423,1.0,1.0,9/19,27.59%,OAT;GLS2;GLS;GLUD1;GAD1;MTHFS;FPGS;GCLM;ALDH5A1
prerank,regulation of osteoblast proliferation (GO:0033688),0.27022539425744807,0.7492306566151189,0.8213507625272332,1.0,1.0,4/17,15.49%,NELL1;FGFR2;ATRAID;EIF2AK2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.18829265920494462,0.7492245084548815,0.9376391982182628,1.0,1.0,23/84,21.39%,PATL2;GGA3;TYMS;ENC1;SPHK1;NTRK2;SORL1;RTN4;FXR2;CPEB3;EIF4A3;CNOT7;APOE;CLU;EIF4E2;EIF2AK2;DHX36;IGF2BP3;RTN3;HAP1;SAMD4B;RBM4;RTN1
prerank,fatty acid oxidation (GO:0019395),-0.20538628429834888,-0.7489608845561236,0.8981818181818182,0.9456245093949864,1.0,9/57,16.28%,HADHB;ADIPOR2;ABCD3;BDH2;PPARD;ACADL;ACAD11;ACADVL;ACOX1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2609632010421426,0.7488743285761993,0.8250539956803455,1.0,1.0,3/18,11.98%,BLK;C3AR1;GPLD1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.26311869769988394,0.7487976852702788,0.8337028824833703,1.0,1.0,4/17,13.84%,IL12A;RASGRP1;CD226;SLAMF6
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.28110848680814493,-0.7471455321080638,0.8043875685557587,0.9475360496027139,1.0,1/14,2.66%,THBS1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.2974350537664649,-0.7467785564745324,0.7845601436265709,0.9476310853977195,1.0,3/12,12.85%,CHMP4B;CHMP4A;SGTA
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.20802614053919477,0.7462143927526323,0.8776470588235294,1.0,1.0,8/48,13.47%,ROBO1;TTLL12;PELI3;TRAIP;PADI2;SLIT3;CNOT7;OAS3
prerank,protein lipidation (GO:0006497),0.19698786815728853,0.7459068280274315,0.9230769230769231,1.0,1.0,10/59,11.98%,DPM1;SELENOK;PIGP;ZDHHC8;MPPE1;ZDHHC13;ZDHHC20;PIGB;PGAP3;GPLD1
prerank,sulfur compound catabolic process (GO:0044273),0.21650297467376867,0.7458106120439008,0.8827751196172249,1.0,1.0,11/38,22.00%,GADL1;DPEP1;NCAN;PRELP;FMOD;HEXB;GGT7;OGN;VCAN;ACAT1;ACAN
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2110865963301787,-0.74571231011115,0.910873440285205,0.94858868951594,1.0,18/51,33.77%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;GBP5;IL16;CCL19;NOD2;FZD5;HMGB1;CASP1;LGALS9;NLRC4;TLR6;STAT3;NLRP3
prerank,negative regulation of locomotion (GO:0040013),-0.2961833788121111,-0.7455814558110504,0.8051948051948052,0.9483548926895825,1.0,3/12,12.78%,CRK;FRMD5;DUSP3
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2411474830811987,-0.7451169994074344,0.8445229681978799,0.9485393075751957,1.0,15/27,35.96%,UBE2D3;CDC16;UBE2E2;UBE2L3;RNF4;FZR1;ANAPC7;UBE2H;ANAPC10;ANAPC5;ANAPC13;ANAPC11;UBE2A;UBE2T;UBE2C
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.21455744211070177,0.744965736513312,0.8863109048723898,1.0,1.0,10/40,21.25%,DDX11;CENPS;DONSON;TRAIP;ATR;ETAA1;PCNA;GEN1;FBH1;CDK9
prerank,protein localization to centrosome (GO:0071539),0.2632187389590659,0.7449046228902659,0.8078602620087336,1.0,1.0,5/17,19.05%,BBS4;SNX10;CCDC14;GOLGB1;HOOK3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.27713102829167524,-0.7444486771387857,0.8076923076923077,0.9489713161796928,1.0,5/17,18.47%,WASF2;FCHSD2;NCKAP1;GMFB;WASF1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.20460348168059422,0.7444301538077766,0.9118329466357309,1.0,1.0,8/55,11.99%,GPC5;HPSE2;GPC1;NCAN;PRELP;FMOD;HEXB;SDC4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.27315015571567147,-0.7429716921212379,0.829443447037702,0.9504822501531837,1.0,8/18,26.70%,MCM4;POLD3;GINS3;GINS1;RFC4;MCM3;MCM7;LIG1
prerank,positive regulation of cellular senescence (GO:2000774),-0.3111195079556973,-0.7423390416044414,0.7880434782608695,0.9508882832729393,1.0,3/10,15.26%,YPEL3;ABI3;CGAS
prerank,apoptotic nuclear changes (GO:0030262),0.24247590075210074,0.7422279856863466,0.8429203539823009,1.0,1.0,6/24,15.68%,BLCAP;H1-0;GPER1;HMGB2;ACVR1C;DEDD2
prerank,tyrosine metabolic process (GO:0006570),0.2970309459544285,0.7420371548734452,0.8210290827740492,1.0,1.0,11/11,70.32%,THAP4;GSTZ1;FAH;IL4I1;TAT;PAH;TH;IYD;DCT;HGD;TYR
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.20232996474822867,-0.7413672382361406,0.924006908462867,0.951671730436778,1.0,19/62,31.67%,MCL1;DDX3X;LRRK2;ARHGEF2;AKT1;ACKR3;PPIF;HERPUD1;MAPK7;MDM2;TXNDC12;NFE2L2;CXCL12;BAG5;SNAI2;PLAUR;TRIM32;VNN1;ARMC10
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.29618864147105134,0.7408900067527224,0.7834821428571429,1.0,1.0,1/11,2.76%,CACNA2D1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3001675335295715,0.7403458726431733,0.7732426303854876,1.0,1.0,4/10,17.70%,EGR1;SORL1;CLU;HSP90AB1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2655337582748867,-0.739719075919674,0.8351063829787234,0.953237665966553,1.0,4/19,17.65%,CAT;GPX1;ACOX1;SOD1
prerank,negative regulation of defense response to virus (GO:0050687),0.3058023588982111,0.73936061646951,0.7570498915401301,1.0,1.0,3/10,14.04%,RNF26;TSPAN6;PCBP2
prerank,tRNA wobble uridine modification (GO:0002098),-0.2877635496490644,-0.7393306968151813,0.8025594149908593,0.9533004551055154,1.0,8/14,39.68%,DPH3;TRMT9B;MOCS3;KTI12;TRMU;CTU2;ELP4;ELP3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.19121527955738754,0.7392582119875053,0.9395973154362416,1.0,1.0,15/69,17.91%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;NDUFAB1;COX6A1;NDUFB6;NDUFA11
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.24927177131065748,-0.7388276352359898,0.8442028985507246,0.9535239053131025,1.0,11/23,36.16%,HERC4;GLIS2;GLI3;MOSMO;GPC3;KIF7;TULP3;SUFU;PTCH1;MGRN1;VCP
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2371073539984097,-0.7382589006704965,0.8766603415559773,0.9538245961963874,1.0,6/26,16.84%,NMI;PPM1B;NFKBIL1;TRAF3IP1;ILRUN;TNFAIP3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.24120357610522752,0.736894725307526,0.8696581196581197,1.0,1.0,2/23,6.59%,PPEF1;METAP2
prerank,hexose transmembrane transport (GO:0008645),-0.2559618672238111,-0.7363744338631154,0.8372943327239488,0.9556813449712811,1.0,3/21,12.94%,SLC2A1;PPARD;SLC2A9
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3067878999101532,-0.7361648785608583,0.8173258003766478,0.9555425056234587,1.0,1/11,3.01%,KAT2B
prerank,lymphocyte proliferation (GO:0046651),0.24400018289003933,0.736000580474914,0.8587699316628702,1.0,1.0,2/22,3.16%,MS4A1;BCL2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.20196540027093965,0.7358606670525495,0.9300225733634312,1.0,1.0,12/53,17.02%,PSMC5;PSMD10;BCKDK;PSMD14;PSMB7;PSMA4;PSMB8;PSMF1;PSMD1;PSMD7;PSMB5;PSMD2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.28727621797584524,-0.7357231427536421,0.8036036036036036,0.9557152055569911,1.0,4/12,21.90%,PTPRJ;CBL;F3;IFT20
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.23915004021957342,-0.7357091426300517,0.8563636363636363,0.9553377378063713,1.0,12/29,27.84%,EXOSC1;EXOSC2;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;CNOT8;EXOSC7;LSM2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2309311766486873,0.7351253703212657,0.8760869565217392,1.0,1.0,5/31,16.60%,BLK;VTCN1;SDC4;CD86;FCGR2B
prerank,response to muramyl dipeptide (GO:0032495),-0.29428312757695124,-0.7350083193541492,0.8050089445438283,0.9557963156056735,1.0,4/12,18.60%,NOD1;ARHGEF2;CHMP5;NOD2
prerank,cell part morphogenesis (GO:0032990),0.2861681590677108,0.7349123478860283,0.847926267281106,1.0,1.0,5/13,23.47%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,programmed necrotic cell death (GO:0097300),-0.261612084470176,-0.7341806517291624,0.8397887323943662,0.9564142349562674,1.0,13/18,49.33%,TRPM7;PPIF;RIPK1;ALKBH7;TICAM1;IPMK;CD14;MLKL;TLR4;TICAM2;ITPK1;TLR3;RIPK3
prerank,T cell differentiation in thymus (GO:0033077),-0.28377527695789817,-0.7341131826211129,0.8249097472924187,0.9560952419868655,1.0,6/14,33.04%,GLI3;PTPRC;LIG4;ADAM17;ZFP36L1;SHH
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2699488936583259,-0.7339362855988828,0.8303571428571429,0.9559324278046878,1.0,2/16,7.23%,CAV1;PARP14
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2890928108874141,-0.7335703737240413,0.8434163701067615,0.9559455388929695,1.0,7/13,33.44%,RNF168;NELFB;SUPT4H1;HNRNPU;LARP7;NELFA;NELFCD
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2046672822705921,-0.7335473003164765,0.9261363636363636,0.9555752072447243,1.0,9/53,18.98%,DAB2IP;GNA12;PSME2;FOXF2;ECSCR;PSMC2;GPX1;PSME1;RAD23A
prerank,sarcomere organization (GO:0045214),0.23641582079862486,0.7333359402429338,0.8519362186788155,1.0,1.0,4/27,13.19%,FHOD3;MYPN;MYLK3;CASQ1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.2658315997189614,-0.733075436051973,0.829136690647482,0.9557247767838976,1.0,8/17,32.53%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,nuclear transport (GO:0051169),-0.27539185474756683,-0.7320125790895082,0.8342342342342343,0.9565445426601141,1.0,2/16,6.74%,RSRC1;NUP98
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2512872046889032,-0.7318060710387818,0.8733705772811918,0.956374021003721,1.0,3/22,15.30%,CBFB;IRF1;VSIR
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.19161112794028543,-0.731144772847158,0.9343696027633851,0.9567430141269956,1.0,16/72,21.42%,RBX1;MRE11;ERCC2;DICER1;XRN2;POLD3;OGG1;RPA3;DNA2;RPA1;ERCC3;PDE12;EDC3;RPA2;DCP1A;RFC4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.24978221861063313,-0.7311068000081049,0.8616236162361623,0.9563893446130225,1.0,5/22,17.90%,RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,lipoxygenase pathway (GO:0019372),-0.27921228323859787,-0.7310718433386455,0.8304761904761905,0.9560432922704667,1.0,5/14,32.70%,PON2;GPX1;GPX4;ALOXE3;ALOX5AP
prerank,negative regulation of protein metabolic process (GO:0051248),-0.21165775867053005,-0.7309961312786039,0.8935018050541517,0.955755057197783,1.0,12/48,20.66%,EGFR;NFKB1;ROCK1;FLNA;EDN1;VBP1;SNX12;AZIN1;MAD2L2;IAPP;PFDN6;ITGB3
prerank,regulation of intracellular transport (GO:0032386),0.21347188239122966,0.7301716645604641,0.8865740740740741,1.0,1.0,12/38,21.56%,ATP9A;MAP2;PLA2G3;NEFH;ATP13A2;INPP5F;MLC1;NUMA1;AAAS;HAP1;RBM4;REEP5
prerank,icosanoid biosynthetic process (GO:0046456),0.3004346396726631,0.7293373612861863,0.8070588235294117,1.0,1.0,1/10,2.12%,FADS1
prerank,regulation of cell cycle phase transition (GO:1901987),0.180955251485985,0.729062548678416,0.9709821428571429,1.0,1.0,19/91,17.02%,ANAPC2;PSMC5;ATP2B4;PSMD10;DDB1;PSMD14;NEK10;NEK11;PSMB7;PSMA4;CDC26;PSMB8;PSMF1;TAF1;CDC27;PSMD1;PSMD7;PSMB5;PSMD2
prerank,myeloid dendritic cell activation (GO:0001773),0.2816893177902965,0.7265793487173783,0.8301886792452831,1.0,1.0,2/12,9.79%,CAMK4;BATF
prerank,ESCRT complex disassembly (GO:1904896),-0.31544049423445364,-0.7261238999751521,0.84375,0.9606147035552351,1.0,3/10,16.20%,VTA1;CHMP2B;CHMP5
prerank,ESCRT III complex disassembly (GO:1904903),-0.31544049423445364,-0.7261238999751521,0.84375,0.9606147035552351,1.0,3/10,16.20%,VTA1;CHMP2B;CHMP5
prerank,regulation of keratinocyte migration (GO:0051547),-0.2901877997111787,-0.7260681753643774,0.8163992869875223,0.9602685253088776,1.0,6/12,26.42%,MTOR;ADAM9;FGF7;MAP4K4;PTEN;FGF10
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.2514022059599838,-0.7259190567835765,0.8515769944341373,0.9600301959933872,1.0,7/21,32.27%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PLA2G4F;OSBPL10;PLA2G5
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.2782281690864306,0.7256209461320013,0.8032036613272311,1.0,1.0,4/12,19.20%,DOCK10;GPR183;FCGR2B;POU2AF1
prerank,tetrapyrrole metabolic process (GO:0033013),0.2541517943088342,0.7250211202448197,0.8449438202247191,1.0,1.0,3/18,14.24%,CBLIF;MMAB;MMAA
prerank,regulation of establishment of protein localization (GO:0070201),0.27595756240912406,0.7246899484332998,0.8363636363636363,1.0,1.0,3/13,12.80%,PTP4A3;CORO2B;CEP135
prerank,positive regulation of mRNA processing (GO:0050685),0.2484941796328421,0.7244529944662115,0.8561643835616438,1.0,1.0,8/21,21.45%,CELF4;SF3B4;DHX36;PRDX6;RBMX;DAZAP1;NCBP2;PAF1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.24696580750593722,-0.7240333545640099,0.8732876712328768,0.9617368086893344,1.0,5/21,12.09%,CSGALNACT1;CHST15;CSPG4;CHST11;BGN
prerank,fatty acid catabolic process (GO:0009062),-0.19401469852739886,-0.7239409342212784,0.9412811387900356,0.9614391164298928,1.0,13/67,20.57%,ABHD2;HADHB;ABCD3;BDH2;PPARD;ACADL;SLC27A4;ACAD11;ACADVL;ACOX1;PCCA;LPIN2;PCCB
prerank,determination of left/right symmetry (GO:0007368),-0.22007473571423197,-0.7239244219290333,0.8827708703374778,0.961059270522549,1.0,10/36,21.20%,PKD2;TBX1;SMO;NOTCH1;GALNT11;ZIC3;CITED2;KIF3B;DAND5;CFAP53
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2987510508866411,-0.7228014170158565,0.835820895522388,0.9618933127847746,1.0,4/11,18.10%,UQCR11;UQCRFS1;UQCRC1;UQCC3
prerank,neuron projection regeneration (GO:0031102),-0.3083093273487822,-0.7222239298647788,0.8147512864493996,0.9621649439216937,1.0,4/10,27.46%,NREP;RTN4RL1;PTN;MTR
prerank,defense response to Gram-positive bacterium (GO:0050830),0.21015977525650872,0.7221901019098642,0.9029345372460497,1.0,1.0,6/40,11.23%,RNASE6;CHGA;ANG;IL12A;HMGB2;MBL2
prerank,DNA geometric change (GO:0032392),-0.241195371846254,-0.7221021806988441,0.8758620689655172,0.9619165264950081,1.0,8/24,24.41%,MRE11;MCM9;DNA2;WRN;ANXA1;BLM;DHX9;HMGB1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2819288801952281,-0.7217911692568977,0.8296703296703297,0.9618869874479278,1.0,4/13,15.23%,ASPH;CASP8;PERP;LGMN
prerank,genitalia development (GO:0048806),-0.28731038820938654,-0.7215317144602433,0.8234234234234235,0.9617721205816318,1.0,6/12,33.04%,FOXF2;DNAJC19;PTPN11;TBX3;STRA6;SHH
prerank,lipoprotein transport (GO:0042953),0.29391196824918875,0.7214337188416197,0.8040089086859689,1.0,1.0,4/10,25.96%,PRKCB;VMP1;CD36;UNC119
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.22728321230073123,-0.7209593291209986,0.8992673992673993,0.9620085004680962,1.0,7/30,19.63%,CAV1;PRKCD;PARP14;SH3BP5L;HYAL2;PPP2CA;PTPRC
prerank,positive regulation of superoxide anion generation (GO:0032930),0.27809706347009794,0.7208741375292782,0.8561643835616438,1.0,1.0,2/13,8.44%,CD177;MAPT
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2507806634403258,-0.7207256856292874,0.8402154398563735,0.9618676773649597,1.0,7/20,28.73%,PPIG;NKTR;FKBP5;PPIF;PPIH;CWC27;PPIE
prerank,negative regulation of cell division (GO:0051782),-0.29068194741836956,-0.7204767945368755,0.8265682656826568,0.9617472419111004,1.0,3/11,23.92%,TXNIP;BLM;E2F7
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.30064906821033677,-0.7198359220117728,0.8218390804597702,0.9620680339263322,1.0,1/10,5.26%,ELOVL5
prerank,establishment of mitotic spindle localization (GO:0040001),-0.232107539355937,-0.7196149983068021,0.8841354723707665,0.9619268401330395,1.0,6/28,21.94%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,spliceosomal complex assembly (GO:0000245),0.20092283239889724,0.7194933638939395,0.9392624728850325,1.0,1.0,6/46,8.52%,CELF5;CELF4;CELF2;CELF6;SRPK1;DDX1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2717012360828809,-0.7192977563722769,0.825187969924812,0.9618786917497097,1.0,4/15,16.58%,RAB3GAP1;SRPRA;RAB3GAP2;SRP14
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.24778259124637173,0.7187194416347296,0.8300220750551877,1.0,1.0,4/18,16.74%,MPV17L;TMEM14A;FZD9;SLC35F6
prerank,mRNA modification (GO:0016556),-0.24030168327678292,-0.7180504486316233,0.8808664259927798,0.9627864854209718,1.0,3/22,10.07%,CBLL1;METTL14;WTAP
prerank,ncRNA metabolic process (GO:0034660),-0.21773086642839162,-0.7180462856469254,0.8833333333333333,0.9623951402766149,1.0,6/37,14.28%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2726808319169173,0.7179052252168452,0.8473451327433629,1.0,1.0,6/14,23.79%,XRCC5;ATR;ACD;TPP1;TERF2IP;BRCA2
prerank,meiosis I (GO:0007127),-0.24521046491472975,-0.7178495436061092,0.8533834586466166,0.9622073765535841,1.0,9/23,31.82%,ZSCAN21;FOXJ3;BCL2L11;HSF2BP;TDRD9;DDX4;FOXJ2;MYBL1;MEIOB
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3016413831575838,-0.7165061001295796,0.8377425044091711,0.963254384928772,1.0,5/10,44.13%,PDCD4;AIDA;DUSP19;GSTP1;HIPK3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.23083356344721073,-0.7163686794514331,0.8902654867256637,0.9630109868358505,1.0,11/27,27.38%,CSGALNACT1;CHST15;CSPG4;CHST11;BGN;CHST7;CHPF2;XYLT2;PXYLP1;CSGALNACT2;XYLT1
prerank,RNA polyadenylation (GO:0043631),-0.2352126337426208,-0.7163048693691464,0.8932874354561101,0.9622840672508874,1.0,8/26,26.65%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,mRNA polyadenylation (GO:0006378),-0.2352126337426208,-0.7163048693691464,0.8932874354561101,0.9622840672508874,1.0,8/26,26.65%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.26277065357073065,0.71621311289379,0.843400447427293,1.0,1.0,5/16,19.33%,CELF4;SF3B4;PRDX6;RBMX;DAZAP1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2195445660613885,0.7160617940313122,0.8877118644067796,1.0,1.0,6/29,15.26%,IL12A;IL12RB1;RASGRP1;CD226;SLAMF6;IL23A
prerank,cellular amino acid catabolic process (GO:0009063),0.17820122692841123,0.7155326786059828,0.9514348785871964,1.0,1.0,24/87,22.32%,OTC;QDPR;BCKDK;ASPA;SDSL;HMGCLL1;AMT;HAAO;MCCC2;HMGCL;GLS2;GLS;GLUD1;CARNS1;TDO2;SARDH;GAD1;DLST;BCAT2;DDO;ACAT1;SLC25A21;DDAH1;GSTZ1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.18803912380294438,-0.715269871735036,0.9436363636363636,0.9629350261965213,1.0,21/75,25.82%,GPCPD1;PLA2G4A;PLCG1;PLCB3;PLCB1;GDPD1;PIGV;ACP6;PAFAH1B1;AGK;GDPD3;PIGG;SERINC1;SERINC5;LCAT;PIGW;PIP5K1A;PDGFRB;DGKH;PLA2G4F;GDE1
prerank,positive regulation of chromosome organization (GO:2001252),0.2681838758383674,0.7151223447614657,0.8402777777777778,1.0,1.0,4/15,17.24%,DDX11;GNL3;RAD21;DHX36
prerank,regulation of lamellipodium organization (GO:1902743),0.27225155290784453,0.7148068600656746,0.8586497890295358,1.0,1.0,2/14,7.40%,PDPN;CARMIL1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.24241911014309891,-0.7144608448991187,0.8522522522522522,0.9633625173195826,1.0,2/22,3.48%,SLC7A5;IL15
prerank,renal water homeostasis (GO:0003091),0.23735156274939867,0.7141849230367593,0.8757637474541752,1.0,1.0,5/23,14.80%,ADCY8;AQP4;ADCY7;PRKAR1B;ADCY3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.28057585835187165,0.7141407853502914,0.827354260089686,1.0,1.0,1/11,5.58%,GNAT3
prerank,protein secretion (GO:0009306),-0.19510695283991963,-0.7138052215451295,0.9445438282647585,0.9636583307203832,1.0,9/56,12.87%,CAMK2G;TANGO6;MON1A;STEAP3;COPG1;PCSK5;TVP23A;SNX19;RAB8B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.25561828265615305,-0.7134006492523837,0.8747795414462081,0.9636706786368064,1.0,7/19,31.88%,DDIT4;TP53;HIPK1;PHLDA3;TMEM109;CDIP1;RPS27L
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.2885555354058817,0.7129962024371498,0.8325892857142857,1.0,1.0,2/11,7.88%,ITM2C;ABCA2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2904713698136272,-0.7123331081691939,0.8417391304347827,0.9639483859843445,1.0,5/11,35.77%,JAK1;PTK2B;IL2RA;IL2RG;SYK
prerank,cellular response to interleukin-2 (GO:0071352),-0.2904713698136272,-0.7123331081691939,0.8417391304347827,0.9639483859843445,1.0,5/11,35.77%,JAK1;PTK2B;IL2RA;IL2RG;SYK
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2740894519071519,-0.7121459456385179,0.8450184501845018,0.9637427637462302,1.0,5/14,30.37%,HNRNPA0;MAPKAPK2;ANGEL2;MAPK14;BOLL
prerank,carbohydrate catabolic process (GO:0016052),0.21122315586091062,0.7119930374290345,0.9211136890951276,1.0,1.0,4/38,10.76%,GCK;TPI1;PKM;ENO2
prerank,ceramide catabolic process (GO:0046514),-0.2771004687622223,-0.7114662885301667,0.8661844484629295,0.9640667159161944,1.0,5/14,27.42%,ACER2;ACER3;ASAH1;GLA;HEXA
prerank,negative regulation of neurogenesis (GO:0050768),-0.21929297842486956,-0.7114043908243866,0.8966165413533834,0.9637338148560565,1.0,8/34,21.92%,RAPGEF2;ARHGDIA;GDI1;NOTCH1;RHOA;PCM1;PTEN;NF1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.26433994734975924,-0.7113269360851713,0.8535262206148282,0.9634187139910743,1.0,4/16,16.85%,BMP5;IGFBP4;IGFBP5;IGF1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.3097875614380018,-0.710975530599428,0.8397085610200364,0.9633806187002216,1.0,2/10,9.08%,GRB10;GSK3A
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.25716764221967814,-0.7108645255301629,0.8738574040219378,0.963096311430818,1.0,16/18,48.25%,BNIP3;THEM4;PPIF;ALKBH7;PMAIP1;NAIF1;SLC25A5;SPG7;HEBP2;SLC25A31;BAK1;MUL1;BCL2L1;BAD;CAMK2A;TMEM102
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2558713968772259,-0.7100589945776216,0.8505535055350554,0.963503289090678,1.0,4/18,13.37%,SARNP;THOC2;IWS1;MCM3AP
prerank,tRNA 5'-end processing (GO:0099116),0.26037546305016623,0.7099428631063244,0.87117903930131,1.0,1.0,15/15,73.99%,RPP25L;PRORP;POP7;POP5;POP1;RPP21;HSD17B10;RPP38;RPP25;RPP14;TRMT10C;RPP40;SSB;POP4;RPP30
prerank,positive regulation of transporter activity (GO:0032411),0.27441782646616797,0.708350656194022,0.8256880733944955,1.0,1.0,6/13,23.49%,WNK3;KMT2A;SGK1;SGK2;STK39;PDZK1
prerank,regulation of T cell chemotaxis (GO:0010819),0.28327741140931834,0.7061792601415997,0.8490990990990991,1.0,1.0,2/11,11.56%,OXSR1;CCL5
prerank,DNA packaging (GO:0006323),0.25832835423757655,0.7061536206835912,0.8590021691973969,1.0,1.0,2/16,6.76%,M1AP;H1-0
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.2310980106351102,-0.7055515614811807,0.9061913696060038,0.9676299208923982,1.0,8/25,30.29%,SLC7A5;CD55;PLCG2;NOD2;FZD5;MAP3K7;TRIM6;TNFRSF14
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.23637159551546755,0.7054304600437832,0.8758620689655172,1.0,1.0,4/23,12.06%,OTC;SLC9A7;SLC12A5;SLC12A4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.2464860152056481,-0.7047564734955333,0.8721934369602763,0.9680264958683531,1.0,4/20,14.54%,ZBTB16;LDB1;CDC73;CDK6
prerank,regulation of coagulation (GO:0050818),-0.286023373801499,-0.7045352267543659,0.8375912408759124,0.9678374567410002,1.0,1/11,1.51%,CAV1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.28949479864319966,-0.7042882773829134,0.8661567877629063,0.9672820289581024,1.0,4/12,16.85%,SPPL3;STIMATE;LMCD1;IGF1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.28949479864319966,-0.7042882773829134,0.8661567877629063,0.9672820289581024,1.0,4/12,16.85%,SPPL3;STIMATE;LMCD1;IGF1
prerank,dendritic cell differentiation (GO:0097028),-0.24103940543095417,-0.7041713932771181,0.9059674502712477,0.9670180086222698,1.0,3/22,5.42%,LYN;TGFBR2;GAS6
prerank,myofibril assembly (GO:0030239),-0.2079815840445483,-0.7030221303768203,0.9226618705035972,0.9677400902888816,1.0,12/42,28.17%,PGM5;TMOD3;CSRP2;CFLAR;LMOD1;TPM1;SIX4;PDGFRB;ACTN2;TNNT3;KLHL41;TTN
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.24010378467932808,-0.7026801616678895,0.8898916967509025,0.9676500986844245,1.0,2/21,4.54%,TTC23;SMO
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2078702047321001,0.701622812891291,0.9232613908872902,1.0,1.0,4/36,5.92%,RHNO1;CDC45;USP28;DONSON
prerank,regulation of biosynthetic process (GO:0009889),0.2813382712949596,0.7013304138639114,0.7931818181818182,1.0,1.0,11/11,71.89%,SPHK2;ALOX5;SNCA;PCK1;UCP1;PIKFYVE;CCN6;GSTP1;THRSP;MID1IP1;SLC25A33
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2232650772976726,-0.7010118664025727,0.8948306595365418,0.9688720942711687,1.0,11/30,27.94%,DNAJC7;GAK;ERO1A;PTGES3;UGGT1;DNAJB12;HSPA14;HSPA13;HSPA1B;CCT2;SDF2L1
prerank,negative regulation of protein secretion (GO:0050709),-0.2104028081715159,-0.7006035236700024,0.926829268292683,0.9688663394852608,1.0,15/38,31.41%,CD200;IRS1;RAB11FIP3;RHBDF2;DPH3;CCN3;RAB11FIP1;RAB11FIP5;F2R;SERGEF;HMGCR;MIDN;RSAD2;RHBDF1;KCNB1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.19136933164967734,0.7004774926321736,0.9472477064220184,1.0,1.0,12/56,17.91%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;NDUFAB1;NDUFB6;NDUFA11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.19136933164967734,0.7004774926321736,0.9472477064220184,1.0,1.0,12/56,17.91%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;NDUFAB1;NDUFB6;NDUFA11
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.20070794843779047,0.6998024271522959,0.9478672985781991,1.0,1.0,5/42,10.06%,SYCP1;WRNIP1;POLD4;PCLAF;POLA1
prerank,positive regulation of type 2 immune response (GO:0002830),0.2642507106379425,0.6985395155026993,0.8488120950323974,1.0,1.0,3/14,13.75%,CD81;PRKCZ;CD86
prerank,histone H4-K16 acetylation (GO:0043984),-0.24806067007875038,-0.6980231909944044,0.8635514018691589,0.9709378587418459,1.0,6/19,22.69%,KANSL3;PHF20;HCFC1;JADE2;WDR5;OGT
prerank,positive regulation of establishment of protein localization (GO:1904951),0.2426167597077119,0.6978492463983055,0.8775055679287305,1.0,1.0,4/18,13.06%,PTP4A3;CORO2B;CEP135;WRAP53
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2651800140174835,-0.6974585505085947,0.8566308243727598,0.9710639970401943,1.0,4/15,17.25%,SAMHD1;STAT2;USP18;NLRC5
prerank,regulation of histone methylation (GO:0031060),-0.2736410189960618,-0.6969089441805425,0.8596802841918295,0.9712115474295941,1.0,1/13,1.17%,NSD1
prerank,response to unfolded protein (GO:0006986),0.19495849825897094,0.6966948153680745,0.9561200923787528,1.0,1.0,6/48,8.16%,PACRG;HSPA4L;DNAJB4;HSPA9;HSF1;HSPA1L
prerank,vitamin D metabolic process (GO:0042359),0.2676190917893124,0.6964027583728977,0.8511627906976744,1.0,1.0,3/13,15.55%,CYP24A1;GC;CYP1A1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.17755443225552642,-0.6959324985187514,0.9735915492957746,0.9717742363541462,1.0,27/87,28.13%,COX16;COX18;SAMM50;NDUFV3;ACAD9;SCO1;NDUFB11;UQCRFS1;NDUFB2;COX17;DMAC2;UQCC3;NDUFV1;NDUFS2;UQCC2;TMEM126B;NDUFA7;COA8;NDUFC2;NDUFV2;NDUFAF1;IMMP2L;NDUFB3;SDHAF4;NDUFB4;NDUFS5;SLC25A33
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.2675167243014483,-0.6958129594278811,0.872072072072072,0.9714883769243293,1.0,4/14,20.56%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,central nervous system neuron axonogenesis (GO:0021955),0.27147473669620353,0.6956313297369433,0.8736383442265795,1.0,1.0,6/12,24.93%,EPHB1;SPTBN4;B4GALT6;HSP90AB1;MYCBP2;EPHB2
prerank,glutathione metabolic process (GO:0006749),0.20293072967008452,0.6954071491043161,0.9446902654867256,1.0,1.0,4/38,8.20%,NAT8;GGCT;GLRX2;DPEP1
prerank,P-body assembly (GO:0033962),-0.2775953988343493,-0.6949945940794667,0.8791208791208791,0.971860689540882,1.0,4/12,21.35%,LIMD1;RC3H1;EDC3;LSM3
prerank,regulation of neuroinflammatory response (GO:0150077),-0.24333791009091044,-0.6941853356848229,0.8849056603773585,0.9721897431702905,1.0,2/19,5.59%,CD200;TNFRSF1B
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.1861073328990147,-0.6931445958559431,0.9637023593466425,0.9727388611577535,1.0,22/68,30.70%,MNAT1;ERCC2;CPSF7;TAF1B;MAZ;LSM11;TAF1C;ERCC3;SNRPE;CAVIN1;LSM10;FIP1L1;UBTF;POLR2H;POLR2L;TAF1D;POLR1E;GTF2H3;CCNH;MTERF2;POLR3K;POLR1H
prerank,iron-sulfur cluster assembly (GO:0016226),0.23061526573099028,0.6927475351142659,0.9099099099099099,1.0,1.0,9/24,23.43%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;LYRM4;CIAPIN1
prerank,regulation of histone deacetylation (GO:0031063),0.2648781943837546,0.6905552201082241,0.8640552995391705,1.0,1.0,2/13,9.46%,PRMT6;SPHK2
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2798011451460335,0.6903157704496599,0.847870182555781,1.0,1.0,2/10,10.84%,SPHK2;PRKCZ
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.1991420928886881,-0.6897304353171168,0.9391304347826087,0.9753979656918917,1.0,16/45,33.77%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;GBP5;CCL19;NOD2;FZD5;CASP1;LGALS9;NLRC4;TLR6;STAT3;NLRP3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.26759254648592035,0.6894677221822196,0.8711111111111111,1.0,1.0,2/13,9.46%,CD177;SPHK2
prerank,regulation of exit from mitosis (GO:0007096),0.20088463402892698,0.6883882560216524,0.9308855291576674,1.0,1.0,3/38,5.96%,ANAPC2;PHB2;ANLN
prerank,membrane lipid metabolic process (GO:0006643),-0.23133277828193127,-0.6883826940061928,0.9,0.9762170909716668,1.0,10/22,32.37%,ST3GAL6;B4GALT4;AGK;SPTLC1;SERINC1;TEX2;CERKL;MGST2;ALOXE3;CYP1B1
prerank,regulation of dephosphorylation (GO:0035303),-0.26015651037977994,-0.6879410919396564,0.9080675422138836,0.9762380176824379,1.0,5/15,25.21%,MTMR3;IGBP1;CDK5RAP3;MTMR4;SMG6
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.26262911421924473,0.6874020808503967,0.8348214285714286,1.0,1.0,2/13,11.67%,CHST2;EXTL2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.2685332773623474,0.6873730084974021,0.8537170263788969,1.0,1.0,3/12,11.28%,DSEL;NCAN;CHST12
prerank,DNA dealkylation (GO:0035510),-0.29015441296050715,-0.6868895149076369,0.8664192949907236,0.9764109361357869,1.0,2/10,7.63%,FTO;ASCC1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.29015441296050715,-0.6868895149076369,0.8664192949907236,0.9764109361357869,1.0,2/10,7.63%,FTO;ASCC1
prerank,protein methylation (GO:0006479),-0.20225579943491334,-0.6864711873068355,0.9435336976320583,0.9763720928882157,1.0,7/40,15.29%,NSD1;NSD3;SETD3;EHMT1;GSPT1;FAM98A;N6AMT1
prerank,homocysteine metabolic process (GO:0050667),-0.2822069557292453,-0.6856205876384264,0.8736842105263158,0.9767400749416169,1.0,7/11,40.83%,NOX4;CTH;MTRR;MPST;BLMH;CBS;TST
prerank,cellular response to misfolded protein (GO:0071218),-0.23834695598887243,-0.6854190063787019,0.8981818181818182,0.9765136117725738,1.0,12/20,46.11%,CUL3;ATXN3;UGGT1;DNAJB12;RNF185;KLHL15;VCP;RNF5;RNF126;POMT2;DNAJB14;DERL1
prerank,regulation of stem cell proliferation (GO:0072091),-0.25431037681354657,-0.6852618203710117,0.8745519713261649,0.9762582972039932,1.0,6/17,31.09%,ACE;YAP1;PTPRC;TERT;HNRNPU;ZFP36L1
prerank,response to sterol (GO:0036314),0.2760122147397541,0.6849543869221484,0.8830022075055187,1.0,1.0,2/11,7.88%,INSIG1;ABCA2
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.20374426412403304,-0.6847894490450566,0.9510357815442562,0.9762740570077629,1.0,4/37,11.79%,ENTPD1;ENTPD6;RNASE3;XRN2
prerank,ketone body metabolic process (GO:1902224),-0.2923587754621937,-0.6843539753785125,0.8780487804878049,0.9762521419748088,1.0,4/10,24.31%,BDH2;HMGCS2;OXCT1;ACSS3
prerank,cellular response to hypoxia (GO:0071456),-0.16639922856902586,-0.6842233780440501,0.9947183098591549,0.9759728199697993,1.0,41/126,31.09%,CREBBP;PSMA2;MTOR;LIMD1;RBX1;BNIP3;PSME2;CUL2;SUV39H1;PSMB4;TP53;LMNA;RGCC;NDRG1;PSMC2;HIF3A;PSMB2;PSMB1;BMP7;EPAS1;PSMA8;PSME1;ELOC;ARNT;NPEPPS;PSMD4;TERT;MDM2;PSMD5;PTGIS;PLK3;PSMA3;PSMB10;HILPDA;HMOX1;ANGPT4;HIGD1A;STOX1;PMAIP1;PSMD13;ZFP36L1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2770842002192804,-0.6838693250047545,0.8728971962616823,0.9758981551786242,1.0,3/12,16.81%,HDAC1;JUN;TFAP4
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.23163580646797927,-0.6811435638279175,0.9147826086956522,0.9778045364965494,1.0,6/23,25.30%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,natural killer cell mediated immunity (GO:0002228),-0.2552065888479688,-0.6808163651372275,0.8756756756756757,0.9777180184875621,1.0,7/15,45.80%,CEBPG;ARL8B;RAET1E;TUBB4B;SLAMF7;KLRD1;KLRK1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.18963758466514039,-0.6807473591399369,0.9574829931972789,0.9773750657117932,1.0,11/52,21.77%,DGLUCY;OGDH;SLC25A32;IDH1;MTHFD1;ALDH18A1;HOGA1;MTHFD1L;GCLC;ALDH1L1;MTRR
prerank,glial cell development (GO:0021782),-0.2256768759041253,-0.679999049973136,0.9185441941074524,0.9776015478905172,1.0,14/25,40.23%,APP;EIF2B2;CDK6;NRROS;SOX4;NF1;NSUN5;EIF2B4;PRDM8;EIF2B5;S100A9;MT3;TLR2;MDK
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.24378750879084207,0.6791649933419607,0.8733624454148472,1.0,1.0,5/16,23.51%,DCPS;PSIP1;SNRPC;NCBP2;WBP11
prerank,regulation of mitochondrial translation (GO:0070129),-0.23403928356651432,-0.6790855686236107,0.9016697588126159,0.9779740151397565,1.0,10/21,40.42%,RPUSD4;MRPS27;MPV17L2;UQCC2;MTG2;TSFM;ALKBH1;NSUN3;RCC1L;TRMT10C
prerank,regulation of tissue remodeling (GO:0034103),-0.24010285301727738,-0.678748825550696,0.8981132075471698,0.977849518861141,1.0,3/18,12.48%,IL15;FLT4;CEACAM1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.28898662351777576,-0.6787103488165689,0.8790035587188612,0.9774928629558108,1.0,2/10,6.46%,GSK3B;CEP250
prerank,hexose metabolic process (GO:0019318),-0.20187300541562297,-0.6769274032369607,0.9390862944162437,0.9785771402679924,1.0,12/39,26.61%,CHST15;HECTD4;PPARD;GALK2;ALDOC;GALK1;FPGT;BRAT1;FUOM;GALM;SLC37A4;PMM2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.25546039323261044,-0.6763811468520914,0.8938547486033519,0.9786471291709837,1.0,9/16,37.45%,ATM;TERF2;SMG6;NAF1;PINX1;TNKS2;TNKS;SLX4;ERCC4
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.19734660622393219,-0.67569169051926,0.9564459930313589,0.97882444193054,1.0,23/40,42.98%,LRRK2;ABL1;ARL6IP5;AKT1;SOD1;STOML2;RNF122;SLC25A33;STOX1;PYCR1;PMAIP1;PID1;PIP5KL1;HEBP2;PARK7;AKT2;VCP;ATP5IF1;BAK1;OPRD1;TUSC2;ABCD1;BCL2L1
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.1959460250090137,-0.6753744902926269,0.9611111111111111,0.9786968167827019,1.0,19/45,33.03%,GCNT2;APP;LARP1;FOXO3;PUM1;ZC3H7B;RPL10;RC3H1;RBM4B;RBM3;MTPN;METTL16;PARP9;NANOS1;TDRD7;ZC3H7A;METTL18;EIF2B4;PUM2
prerank,tRNA 5'-leader removal (GO:0001682),0.26034277104651904,0.6751211016426144,0.8647450110864745,1.0,1.0,13/13,73.99%,RPP25L;PRORP;POP7;POP5;POP1;RPP21;RPP38;RPP25;RPP14;RPP40;SSB;POP4;RPP30
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.28381529073669515,0.6750271778507813,0.8490566037735849,1.0,1.0,5/10,26.28%,TSKU;WHRN;PLS1;PDZD7;IFT88
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.22210101697164758,-0.6746035388010005,0.907942238267148,0.9789129381478903,1.0,2/24,4.87%,PLA2G4A;LPCAT1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.28917798548564,-0.6745063186788371,0.8966725043782837,0.9785901013529494,1.0,7/10,36.29%,LRRK2;TXN;NFE2L2;RIPK1;PYCR1;PARK7;PDE8A
prerank,negative regulation of inclusion body assembly (GO:0090084),0.2788242918274449,0.6744701127546585,0.8827433628318584,1.0,1.0,4/10,20.88%,SORL1;DNAJB1;DNAJB2;DNAJA4
prerank,positive regulation of macrophage differentiation (GO:0045651),0.27052300347971814,0.6742831722553763,0.8816964285714286,1.0,1.0,2/11,7.95%,HSF1;PF4
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.24852562573596948,-0.6742816830032088,0.8890977443609023,0.9783843388636756,1.0,4/16,24.12%,SCARB1;MFSD2A;DAGLB;PNPLA2
prerank,autophagosome maturation (GO:0097352),-0.21310636281976092,-0.6738671847230104,0.9372759856630825,0.9783399945170188,1.0,4/32,10.65%,LIX1L;MAP1LC3B;TECPR1;GABARAP
prerank,dermatan sulfate metabolic process (GO:0030205),0.2579363178281857,0.6733454478285037,0.8744075829383886,1.0,1.0,3/13,11.28%,DSEL;NCAN;CHST12
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2738488137687968,-0.6729445775372883,0.8726937269372693,0.9786792060473387,1.0,2/12,10.01%,PPARA;AKT1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.28195051702203244,-0.6728705415517376,0.8671586715867159,0.9783458647455388,1.0,8/10,51.27%,ANO6;TREM2;RAB31;APPL2;STAP1;F2RL1;NCKAP1L;CD300A
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.2843399102934007,-0.6727833703023945,0.8803571428571428,0.9780228868420087,1.0,4/10,33.06%,LRP6;CTNNB1;FZD1;WNT3
prerank,negative regulation of cholesterol transport (GO:0032375),0.27458716864673594,0.6724519034708959,0.8672768878718535,1.0,1.0,2/10,15.14%,ABCA2;APOC1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.2843798148161619,-0.6715994628463949,0.8869731800766284,0.9785364435132118,1.0,4/10,30.52%,CEACAM1;PTPRC;LGALS9;LILRB1
prerank,calcium import into the mitochondrion (GO:0036444),0.2769963335866338,0.6713431806443134,0.8388520971302428,1.0,1.0,6/10,27.09%,SLC25A23;MCU;SMDT1;MICU2;MCUR1;MAIP1
prerank,phospholipid homeostasis (GO:0055091),0.27001208882421157,0.6701481403475337,0.8816705336426914,1.0,1.0,4/11,21.52%,RCN3;TLCD2;ABCG1;ANGPTL3
prerank,sphingolipid catabolic process (GO:0030149),0.25286334624102697,0.6696602418145383,0.9028077753779697,1.0,1.0,3/15,8.39%,ENPP2;SPHK1;ACER1
prerank,glycerol metabolic process (GO:0006071),0.27896056502462746,0.6687607287007744,0.8577680525164114,1.0,1.0,4/10,21.52%,TPI1;GK;PGP;ANGPTL3
prerank,regulation of histone modification (GO:0031056),-0.2661905064746073,-0.6681854056528287,0.8886861313868614,0.9807815154055416,1.0,4/13,21.97%,SETD5;HPF1;IGF2;MYOCD
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.23645813393522752,-0.6665914726698929,0.9036363636363637,0.9815694140313781,1.0,12/18,41.66%,MECP2;RAB11A;CCND1;CDC25A;DTL;BRD4;STOX1;CDK4;FBXO5;CCNB1;CDC25C;RAD51C
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.16880552783287503,-0.6661656866898034,0.9872958257713249,0.9815012425522132,1.0,26/94,25.93%,YWHAE;CEP57;CEP250;CEP78;HAUS8;DCTN1;DCTN3;HAUS6;PAFAH1B1;CSNK1D;CEP41;RAB11A;PLK4;CETN2;CEP152;ALMS1;PCM1;CNTRL;ODF2;HSP90AA1;CEP131;PCNT;NPHP1;AKAP9;RAB3IP;DYNLL1
prerank,development of primary male sexual characteristics (GO:0046546),-0.20190275618523146,-0.6650203013894753,0.9386281588447654,0.9819551566550658,1.0,10/34,28.63%,KITLG;TGFB2;MAMLD1;NCOA4;SIX4;COL9A3;BIK;LHFPL2;WNT2B;LRP2
prerank,snRNA metabolic process (GO:0016073),-0.23576432962114666,-0.6645044405790016,0.9162303664921466,0.981948336405178,1.0,6/17,29.52%,INTS8;INTS3;INTS9;INTS7;INTS5;INTS12
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.2454038215209488,-0.6641729800193201,0.8819188191881919,0.9818206837148926,1.0,5/16,31.24%,BMP4;RGCC;F2R;LARP6;TGFB1
prerank,regulation of spindle organization (GO:0090224),-0.23955654343293217,-0.6640922676697047,0.9159049360146252,0.9815104376723573,1.0,10/18,39.57%,RAE1;DCTN1;RNF4;TACC3;SENP6;BORA;MAP9;PSRC1;PARP3;TPX2
prerank,gonad development (GO:0008406),0.1899024627134952,0.6640326416057917,0.9595505617977528,1.0,1.0,10/41,18.60%,ADAM29;WT1;GATA6;WNT4;KIT;MKKS;SOX9;NUP107;MSH2;ADAM21
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.23558671232716805,0.6627055109484108,0.8862660944206009,1.0,1.0,5/17,23.77%,LIPC;PCSK6;APOC1;ANGPTL3;NR1H2
prerank,cellular response to sterol (GO:0036315),0.25599694177196175,0.6625461253923235,0.8791208791208791,1.0,1.0,6/13,23.20%,INSIG1;GPLD1;GRAMD1B;MLC1;GRAMD1C;GRAMD1A
prerank,nucleosome assembly (GO:0006334),-0.20771240676157451,-0.6610914857908144,0.9387755102040817,0.9832706592855847,1.0,4/31,14.40%,KAT6B;BRD2;SPTY2D1;H3-3A
prerank,dendritic cell chemotaxis (GO:0002407),0.24978082779228705,0.6609333674110182,0.8948598130841121,1.0,1.0,4/14,17.31%,CCR6;CCL5;GPR183;CXCR4
prerank,positive regulation of telomere capping (GO:1904355),-0.24374352290703494,-0.6605451598564743,0.916058394160584,0.9832527673091574,1.0,3/17,13.88%,NEK7;MAPK1;PNKP
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2524335215600345,-0.6603548062210611,0.9056261343012704,0.9829925917292676,1.0,5/14,21.38%,RTRAF;TSEN15;RTCB;TSEN34;TRPT1
prerank,receptor recycling (GO:0001881),0.2690503862814014,0.6597892912417983,0.8793859649122807,1.0,1.0,3/10,19.02%,SORL1;PHETA1;NSG1
prerank,reticulophagy (GO:0061709),-0.26084457342634304,-0.6584539106541011,0.8878842676311031,0.9839994079284489,1.0,4/12,26.36%,ULK2;UFM1;ATG2A;ATG2B
prerank,RNA interference (GO:0016246),-0.23553955639768848,-0.6571097945046187,0.9243243243243243,0.9845613982740787,1.0,9/17,35.23%,CELF1;DICER1;AGO2;DROSHA;TERT;DHX9;TSN;MRPL44;TARBP2
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2454480371624594,-0.6568172937315049,0.9039145907473309,0.9843878760233697,1.0,7/16,32.09%,HDAC1;ROCK1;ABCA7;MYOCD;HMGCR;TREM2;LRP1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.237826998476131,-0.6567570687651799,0.9172794117647058,0.9840523785967727,1.0,9/17,40.52%,SLC7A5;RARA;FCER1G;LGALS9;CEBPB;NLRP3;SYK;GATA3;CD28
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23899754418639366,0.6563072026486345,0.9144144144144144,1.0,1.0,4/15,17.81%,NEK11;MUS81;RAD9B;CHEK2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.23838078432798035,-0.6562339309628503,0.9109461966604824,0.9840497723895373,1.0,3/16,15.92%,SHLD1;CGAS;MAD2L2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.22472202874545943,0.6558163456800241,0.9220489977728286,1.0,1.0,3/19,9.15%,SLC46A1;SLC19A1;ALDH1L2
prerank,triglyceride homeostasis (GO:0070328),-0.21216721088696,-0.6558079707629204,0.9190647482014388,0.9839378413715785,1.0,5/26,21.33%,SCARB1;LPL;C1QTNF3;DGAT2;PNPLA8
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2541234496996798,0.6553465215318539,0.8956521739130435,1.0,1.0,3/13,14.96%,ISCA2;CISD3;NFU1
prerank,folic acid metabolic process (GO:0046655),0.22708903652375484,0.654779987518443,0.9178082191780822,1.0,1.0,3/18,9.15%,SLC46A1;SLC19A1;ALDH1L2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.21716004465431965,-0.6543318006112538,0.9297297297297298,0.9845924882781226,1.0,8/25,24.04%,DNAJC7;GAK;ERO1A;PTGES3;DNAJB12;HSPA14;HSPA13;HSPA1B
prerank,pancreas development (GO:0031016),0.25322242837560177,0.6532966361981151,0.8824833702882483,1.0,1.0,2/12,8.48%,PROX1;DNAAF1
prerank,positive regulation of histone methylation (GO:0031062),-0.21650194511298432,-0.6532476063156546,0.9376146788990826,0.9849188963326574,1.0,11/24,39.41%,SMAD4;DNMT1;CTNNB1;BRCA1;WDR5;OGT;PHF19;DNMT3B;CTR9;SIRT1;MYB
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.2136862263358428,0.6529769466988365,0.9039301310043668,1.0,1.0,6/23,16.63%,LMAN1;SELENOS;SURF4;TMED9;SEL1L;AUP1
prerank,protein palmitoylation (GO:0018345),0.1997748665103052,0.6528937823064235,0.9402985074626866,1.0,1.0,6/30,16.11%,SELENOK;ZDHHC8;ZDHHC13;ZDHHC20;ZDHHC24;ZDHHC7
prerank,regulation of macrophage differentiation (GO:0045649),0.242273585715739,0.651615354601814,0.890625,1.0,1.0,2/15,7.95%,HSF1;PF4
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2573573559619753,-0.6514166209558737,0.9055258467023173,0.9857484559711862,1.0,3/13,15.31%,RIC3;STX3;ABCA7
prerank,positive regulation of cellular respiration (GO:1901857),-0.2715472401079384,-0.6512013860915566,0.9144385026737968,0.9855013406680436,1.0,6/11,39.78%,IFNAR1;IL10RB;IFNLR1;PARK7;VCP;IL4
prerank,response to light stimulus (GO:0009416),-0.1805526419737922,-0.6511855474289333,0.9750889679715302,0.9851167803735451,1.0,24/55,38.57%,MAP4K3;UBE4B;ERCC2;REV1;MAPK8;ERCC3;ERCC8;USP1;ERCC6;DTL;CRY2;GPR52;TYR;TRIM32;FECH;UBE2A;RRH;AANAT;USF1;OPN1MW3;OPN1MW;ERCC4;SLC24A1;GPR88
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.22168144500524967,-0.6508005640326893,0.9354838709677419,0.984594626371877,1.0,2/22,4.45%,ZDHHC6;ZDHHC3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.22168144500524967,-0.6508005640326893,0.9354838709677419,0.984594626371877,1.0,2/22,4.45%,ZDHHC6;ZDHHC3
prerank,microtubule depolymerization (GO:0007019),0.23240188383045532,0.6503023495548501,0.9150943396226415,1.0,1.0,17/17,76.78%,STMN2;STMN4;STMN3;NCKAP5;KIF18A;KIF2A;KIF24;STMND1;KATNB1;KIF2C;CKAP5;KIF19;NCKAP5L;STMN1;CCSAP;KIF14;KIF18B
prerank,pyruvate metabolic process (GO:0006090),-0.18348975881641527,-0.6499479292578371,0.9691780821917808,0.9847557885004056,1.0,6/52,11.82%,BSG;SRR;DLD;SLC16A1;ALDOC;PDHB
prerank,positive regulation of immune response (GO:0050778),-0.17494380457740635,-0.64987440594009,0.9857651245551602,0.9844141049095897,1.0,17/64,28.58%,IL15;IL6ST;NMI;TGFB2;AKIRIN2;PLSCR1;POLR3F;IFI35;GBP5;NOD2;PTPRC;ITGAM;DHX9;EIF2AK4;RIOK3;RSAD2;LGALS9
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.26270265479064414,0.6479631505792044,0.8896396396396397,1.0,1.0,3/10,18.47%,VEGFA;FZD3;CX3CL1
prerank,signal peptide processing (GO:0006465),-0.26624436427885406,-0.6475742549621499,0.9001751313485113,0.985513815733604,1.0,4/11,25.86%,SPPL3;PCSK5;CLN5;SEC11A
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.2142574963424837,-0.6474145836753759,0.9574861367837338,0.9852315226162563,1.0,6/23,23.60%,RBX1;XPC;CETN2;COPS7A;COPS8;COPS4
prerank,protein O-linked mannosylation (GO:0035269),-0.23392903182203142,-0.6471800101900433,0.9218472468916519,0.984976903933939,1.0,2/18,3.51%,TMTC1;TMTC2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2529685730300123,0.6470701529001572,0.8813186813186813,1.0,1.0,3/12,17.81%,NAE1;ORC1;CHEK2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.19928708791979602,-0.6467132473306298,0.9487632508833922,0.9849050953927592,1.0,6/33,19.21%,CBFB;ESR1;UFM1;H3-3A;HDAC6;CARM1
prerank,lymphocyte migration (GO:0072676),0.19839087231179828,0.6464248827704573,0.9524886877828054,1.0,1.0,7/32,18.47%,CCL7;CCR6;CCL13;CCL5;CCL2;ADAM8;CX3CL1
prerank,regulation of neurogenesis (GO:0050767),-0.17994102352861122,-0.6462598102548126,0.9751332149200711,0.9848318471369905,1.0,11/55,20.04%,HES1;SPEN;TGM2;YAP1;NOTCH1;NUMB;CTNNB1;HEY2;HEY1;PCM1;LIG4
prerank,regulation of ERAD pathway (GO:1904292),0.2615221225389574,0.6453893438736068,0.9104803493449781,1.0,1.0,2/11,6.83%,TMEM259;USP25
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2310339810966383,0.6453336000955282,0.9121338912133892,1.0,1.0,2/16,11.90%,CENPS;MUS81
prerank,microtubule bundle formation (GO:0001578),0.18928404599730975,0.6449698323839993,0.9678899082568807,1.0,1.0,10/42,18.92%,CFAP74;MAP1S;DCX;TPPP3;TPPP;FOXJ1;GAS8;NUMA1;AAAS;CDK5RAP2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.27573861501255725,-0.6446871768486375,0.9049360146252285,0.9854401624442909,1.0,5/11,27.02%,IWS1;SRPK2;CDK11B;DHX9;SLTM
prerank,retinal metabolic process (GO:0042574),0.25727558325630734,0.6434034417367233,0.918859649122807,1.0,1.0,1/12,2.79%,AKR1C1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.2465658688127549,0.6425423535559142,0.9205298013245033,1.0,1.0,5/14,17.60%,FSCN1;PATJ;FOXJ1;MYO9A;CAMSAP3
prerank,male gonad development (GO:0008584),-0.1952963617200409,-0.6421405638905031,0.9590017825311943,0.9866729245616176,1.0,4/34,11.26%,KITLG;TGFB2;MAMLD1;NCOA4
prerank,positive regulation of protein depolymerization (GO:1901881),-0.258490899756749,-0.6419900584495409,0.9169675090252708,0.9863714136916159,1.0,4/11,23.25%,NES;CFL2;TRPV4;SEMA5A
prerank,triglyceride metabolic process (GO:0006641),0.17940305440131518,0.6412712213675854,0.9685534591194969,1.0,1.0,7/48,16.59%,LPIN1;LIPC;GK;MOGAT1;APOE;APOC1;SEL1L
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.18219179613520453,-0.641211277182986,0.9852125693160814,0.9864660129894046,1.0,15/50,26.89%,PSMA2;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;NQO1;PSMD4;PSMD5;PSMA3;PSMB10
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.24807931084980978,0.6404465827442092,0.906392694063927,1.0,1.0,4/12,18.77%,APOE;CLU;LDLR;PFDN4
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.22762977022857744,-0.640100054426349,0.9462962962962963,0.98673475342748,1.0,6/19,31.24%,BMP4;RGCC;F2R;LARP6;EMILIN1;TGFB1
prerank,negative regulation of mRNA processing (GO:0050686),-0.24060044367048905,-0.6393705473116756,0.9237588652482269,0.9867908235225332,1.0,4/15,20.56%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,B cell mediated immunity (GO:0019724),0.265252322370073,0.6389768025185343,0.8928571428571429,1.0,1.0,10/10,73.49%,FCGR2B;MSH2;CD70;CD27;CD19;SLA2;CARD9;TLR8;CD74;FCER1G
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2379513478880325,-0.6367696842249615,0.9092495636998255,0.9879564771859256,1.0,5/14,30.31%,FOXO3;MRPL12;FASTKD5;SLC25A33;MTERF2
prerank,microtubule polymerization (GO:0046785),-0.2030661935427961,-0.6367529789261074,0.9561243144424132,0.9875799810738908,1.0,7/28,19.13%,RANBP9;SLAIN2;CSNK1D;TUBGCP5;TUBGCP4;TRPV4;NDEL1
prerank,regulation of transport (GO:0051049),-0.19239263324320632,-0.636385424142716,0.9739292364990689,0.9874239413294486,1.0,6/36,16.67%,LRRK2;ARL6IP5;SCFD1;ACTB;ICA1;RAB11A
prerank,protein depolymerization (GO:0051261),-0.20808814336429177,-0.6361623553510705,0.9518716577540107,0.9871592283698978,1.0,14/27,40.93%,MICAL2;CFL2;CFL1;DSTN;KIF18B;KIF14;MICAL1;STMN1;NCKAP5L;CKAP5;TWF2;KIF2C;VIL1;KATNB1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.20916201902031833,-0.6360880639849992,0.9445438282647585,0.9868192413274979,1.0,5/24,22.87%,LRRK2;AQP11;HERPUD1;LPCAT3;TXNDC12
prerank,activin receptor signaling pathway (GO:0032924),-0.23941780800709817,-0.6348275443561582,0.929368029739777,0.9871436958251542,1.0,2/15,9.46%,SMAD2;ACVR2A
prerank,RNA methylation (GO:0001510),0.16701903242129593,0.6339434024790643,0.9892008639308856,1.0,1.0,17/60,23.01%,MTERF4;TRMT6;GTPBP3;TRMT13;TRMT10A;BUD23;ZC3H13;DIMT1;TFB1M;FTSJ1;METTL8;METTL2B;METTL2A;NSUN6;CMTR1;THUMPD3;TRMT5
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2216771970416494,-0.6327678859796102,0.9384885764499121,0.9879020711831886,1.0,10/20,43.50%,RB1;FOXC1;IGF1;TRIM6;TGFB1;PARK7;PAX6;GATA3;NEUROD1;LAMTOR5
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.1891834131769985,-0.6327595076736696,0.9726775956284153,0.9875210240879482,1.0,10/39,27.05%,RPS14;RPSA;RPS16;RPS27;UTP4;RPS7;RPS15;RPS17;EMG1;RIOK3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.2301249651684708,-0.6323499644066839,0.946236559139785,0.9873812395222996,1.0,7/17,30.12%,FGF1;PRKAA1;ERLIN2;SOD1;LPCAT3;RAN;MBTPS1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.23696810675638266,0.6320807176057017,0.9331896551724138,1.0,1.0,1/14,5.26%,ATP1B1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.24646466558433158,-0.631905143786193,0.9296028880866426,0.987241068630853,1.0,8/14,39.20%,IRS1;AKT1;ARPP19;PTPN2;PMAIP1;AKT2;NNMT;SIRT1
prerank,regulation of cellular metabolic process (GO:0031323),-0.18436329834365567,-0.6308243809451535,0.9824253075571178,0.9874552355922519,1.0,19/45,37.40%,PANK2;PPARA;ACACB;FLOT1;AGPAT1;MKLN1;KIF16B;RNF34;VPS35;PDK4;PDK3;CYP1B1;PID1;PM20D2;TBC1D16;FASN;PARL;FOXM1;GNB3
prerank,cellular response to fatty acid (GO:0071398),-0.2551249421392401,-0.6307686924747606,0.9185840707964602,0.9870987295005488,1.0,6/12,33.13%,IRS1;LPL;DGAT2;PDK4;PDK3;PID1
prerank,stabilization of membrane potential (GO:0030322),0.22758782473108918,0.6301566959632031,0.9317180616740088,1.0,1.0,5/16,23.94%,KCNK12;KCNK9;KCNK10;KCNK4;KCNN4
prerank,stress granule assembly (GO:0034063),0.21607945062256081,0.6297740476324506,0.941320293398533,1.0,1.0,2/20,8.44%,BICD1;MAPT
prerank,t-circle formation (GO:0090656),-0.2671414592852185,-0.6294770205752012,0.9090909090909091,0.9867085522668139,1.0,4/10,27.22%,DNA2;WRN;BLM;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.2671414592852185,-0.6294770205752012,0.9090909090909091,0.9867085522668139,1.0,4/10,27.22%,DNA2;WRN;BLM;EXO1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.2671414592852185,-0.6294770205752012,0.9090909090909091,0.9867085522668139,1.0,4/10,27.22%,DNA2;WRN;BLM;EXO1
prerank,ovarian follicle development (GO:0001541),0.2388386259879648,0.6293405104275326,0.9287410926365796,1.0,1.0,3/13,14.65%,ANG;VEGFA;KIT
prerank,negative regulation of viral life cycle (GO:1903901),-0.23581339313838534,-0.6278969430164676,0.9484902309058615,0.987202372550108,1.0,2/15,11.67%,LY6E;IFITM3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.24180228426343975,0.625717612381783,0.9152173913043479,1.0,1.0,1/12,3.44%,GGCT
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.26859241991084365,-0.6256988607225497,0.9185441941074524,0.9880047236076904,1.0,1/10,5.68%,GFPT2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.25692734078184865,-0.6240019823546517,0.9294755877034359,0.9877549487114883,1.0,1/11,3.70%,PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.25692734078184865,-0.6240019823546517,0.9294755877034359,0.9877549487114883,1.0,1/11,3.70%,PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),-0.25692734078184865,-0.6240019823546517,0.9294755877034359,0.9877549487114883,1.0,1/11,3.70%,PANK2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.24534091665393246,-0.6235878155506707,0.9294532627865961,0.9875954927089919,1.0,1/13,1.27%,NOS3
prerank,UV-damage excision repair (GO:0070914),0.24527869573968403,0.6230836502241848,0.9168539325842696,1.0,1.0,2/12,10.06%,DDB1;POLA1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.1598254437906364,-0.6227508225263254,1.0,0.9876719599678966,1.0,32/84,35.96%,RB1;PSMA2;CUL3;PSME2;PSMB4;CDC16;ANAPC16;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;BUB1B;ECRG4;BUB3;PSMD4;PSMD5;FZR1;ANAPC7;PSMA3;PSMB10;FBXO31;ANAPC10;ANAPC5;PSMD13;ANAPC11;PSMB6;AURKA;PLK1;CDC20;FBXO5;UBE2C
prerank,regulation of nervous system development (GO:0051960),0.1860946814532804,0.6219271673981545,0.9591836734693877,1.0,1.0,2/37,5.41%,TENM4;PTPRZ1
prerank,lipid catabolic process (GO:0016042),-0.22698839162525825,-0.6206335365066153,0.9508196721311475,0.9883277741461012,1.0,3/18,14.21%,ACADL;LPL;LIPE
prerank,epithelial cell development (GO:0002064),0.21538531208479075,0.6206227191235872,0.9383561643835616,1.0,1.0,1/20,1.33%,WNT7B
prerank,triglyceride catabolic process (GO:0019433),-0.21713692108233107,-0.6205961477172326,0.9500959692898272,0.9879622408123967,1.0,6/19,39.84%,LPL;PNPLA2;FABP3;LIPH;FABP4;FABP12
prerank,mitotic DNA replication (GO:1902969),-0.2614960125229418,-0.6203838794482374,0.9288321167883211,0.9876984936871337,1.0,7/10,37.59%,MCM4;GINS3;GINS1;MCM3;LIG1;MCM2;MCMDC2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.25064749454049673,-0.6198612771241004,0.9357142857142857,0.9875807424783181,1.0,6/12,33.44%,RNF168;NELFB;HNRNPU;LARP7;NELFA;NELFCD
prerank,alpha-amino acid catabolic process (GO:1901606),0.189647149638002,0.6197415896469182,0.9631236442516269,1.0,1.0,8/29,23.91%,OTC;HAAO;TDO2;SARDH;DDO;ACAT1;GSTZ1;ALDH4A1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.20059773358952115,-0.6188050477814643,0.9537892791127541,0.9877200872521071,1.0,7/29,25.30%,PLA2G4A;LPCAT1;TMEM86B;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,protein trimerization (GO:0070206),-0.23510938891568722,-0.6186038830088915,0.9385964912280702,0.9870509302280357,1.0,7/14,33.37%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;ALOX5AP;STEAP4
prerank,protein homotrimerization (GO:0070207),-0.23510938891568722,-0.6186038830088915,0.9385964912280702,0.9870509302280357,1.0,7/14,33.37%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;ALOX5AP;STEAP4
prerank,regulation of DNA metabolic process (GO:0051052),0.1742058589594206,0.6181256912291925,0.9871794871794872,1.0,1.0,11/44,21.31%,WRNIP1;XRCC5;PDGFA;SMG5;SIRT7;UPF1;KAT7;WDR70;WDR18;CDK9;TERF2IP
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.25583760868588784,-0.6173327509413127,0.9355992844364938,0.9873171957670518,1.0,4/11,31.09%,CDC73;AHCYL1;LEO1;ZFP36L1
prerank,T cell proliferation (GO:0042098),0.23716143764229872,0.6172438587199338,0.9174107142857143,1.0,1.0,3/13,14.21%,TNFSF18;RASGRP1;DOCK8
prerank,regulation of B cell differentiation (GO:0045577),-0.22505494505494505,-0.6169322388022616,0.944043321299639,0.9871329655132159,1.0,17/17,77.52%,PPP2R3C;ZFP36L1;IKZF3;SYK;MMP14;NCKAP1L;SLAMF8;ID2;INHBA;INHA;ZFP36L2;XBP1;CD27;TLR9;IL4I1;SFRP1;BTK
prerank,nucleotide biosynthetic process (GO:0009165),-0.2201945537426642,-0.6163566944646487,0.9423423423423424,0.9870397855334833,1.0,7/18,34.26%,MTHFD1;HPRT1;PRPS2;PNP;ME1;NMNAT3;GART
prerank,regulation of microtubule-based movement (GO:0060632),0.241502149527515,0.6151208681653673,0.9310344827586207,1.0,1.0,2/11,8.27%,MAP2;NEFH
prerank,negative regulation of T cell proliferation (GO:0042130),0.19417177151457976,0.6146876076371712,0.9703389830508474,1.0,1.0,27/28,71.43%,VTCN1;SDC4;CD86;PRNP;TNFRSF21;IL4I1;SCRIB;PRKAR1A;VSIG4;PLA2G2F;DLG5;CD80;SPN;IL10;BTN2A2;PLA2G2D;GLMN;FOXP3;GPNMB;PDCD1LG2;CRTAM;ARG1;CD274;CEBPB;LILRB1;TNFRSF14;LGALS9
prerank,regulation of fatty acid oxidation (GO:0046320),-0.22477973601871656,-0.6124591108102472,0.9422382671480144,0.9885804132399483,1.0,7/16,32.30%,PPARA;ACADL;ACADVL;FABP3;LONP2;PDK4;PRKAG2
prerank,regulation of chromosome organization (GO:0033044),-0.2110083175563193,-0.611726482815489,0.9633911368015414,0.9885338819056069,1.0,9/22,33.26%,RB1;WAPL;TERF2;LIG4;SMG6;HNRNPD;SMG1;PIF1;HDAC8
prerank,long-chain fatty acid transport (GO:0015909),-0.19759622305185087,-0.6114834136450101,0.9548736462093863,0.9882571915730374,1.0,13/30,33.22%,ABCD3;MFSD2A;ACACB;CPT1A;SLC27A4;ACSL1;PPARG;SPX;FABP3;SLC27A6;MID1IP1;PRKAG2;CPT2
prerank,cellular response to chemokine (GO:1990869),-0.17755297958604904,-0.6104974767806087,0.9802513464991023,0.9883560481175739,1.0,13/46,30.22%,LRCH1;CCL25;SLC12A2;RHOA;ACKR3;FOXC1;CCL19;PTK2B;CXCL12;CXCL10;DUSP1;WNK1;GPR75
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2027121819398099,0.6089813137075967,0.9630484988452656,1.0,1.0,8/22,24.10%,VPS37D;TSG101;UBAP1;MVB12B;VPS4B;PTPN23;UBAP1L;VPS28
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.18432461228027594,0.6085103104456279,0.9796839729119639,1.0,1.0,4/32,10.50%,RNASE6;ANG;PF4;CCL13
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.21419077028873934,-0.6074709577757859,0.9569288389513109,0.9890192708188624,1.0,6/19,25.42%,POLR2G;TERF2;ATRX;POLR2C;POLR2H;POLR2L
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.21419077028873934,-0.6074709577757859,0.9569288389513109,0.9890192708188624,1.0,6/19,25.42%,POLR2G;TERF2;ATRX;POLR2C;POLR2H;POLR2L
prerank,neural tube development (GO:0021915),-0.22989450682831603,-0.6069744494852789,0.9356617647058824,0.9888628858788133,1.0,1/15,1.86%,PKD2
prerank,positive regulation of bone resorption (GO:0045780),0.2518101263061018,0.6065370793660002,0.9339407744874715,1.0,1.0,2/11,16.80%,SPP1;ADAM8
prerank,lipoprotein localization (GO:0044872),-0.2495448827875949,-0.6065324993771886,0.9387387387387387,0.9886747800677873,1.0,1/11,4.45%,ZDHHC3
prerank,T cell activation involved in immune response (GO:0002286),0.24666468987523268,0.6065118552163998,0.9395973154362416,1.0,1.0,1/12,2.07%,TNFSF18
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.19948442621730364,0.6052438991086888,0.9560185185185185,1.0,1.0,6/22,19.15%,PPP5C;DUSP4;DUSP8;PPM1G;DUSP7;DUSP18
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.22603917236771034,0.6030342011710527,0.9488372093023256,1.0,1.0,3/15,15.49%,DHX33;USP50;EIF2AK2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.1976127648574187,-0.6021537275577631,0.9652014652014652,0.9901630061109251,1.0,3/26,11.50%,APP;CBL;NCK2
prerank,inner ear morphogenesis (GO:0042472),-0.20656343536597324,-0.601790188705424,0.9580152671755725,0.989937342003248,1.0,2/22,5.48%,TBX1;SIX1
prerank,proteoglycan metabolic process (GO:0006029),-0.19862636313683038,-0.6012780904999507,0.9706390328151986,0.989781333465784,1.0,3/26,9.42%,BMPR2;CSGALNACT1;CHST11
prerank,epithelial cell morphogenesis (GO:0003382),0.215287695279225,0.6002160542439663,0.9253731343283582,1.0,1.0,1/17,2.86%,STC1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.1986866932857532,0.5996922542040124,0.9597457627118644,1.0,1.0,7/23,23.00%,H1-0;HMGB2;MUS81;REXO4;DNASE1L1;FBH1;DNASE1L2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.18810000869380356,0.5993279606074124,0.9651972157772621,1.0,1.0,12/29,24.66%,TERF1;ANKRD28;WRAP53;PPIA;CDK2;ACD;HSP90AB1;TERF2IP;TELO2;NOP10;SHQ1;RTEL1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.21600252290909402,-0.5990672194458097,0.9506172839506173,0.9903444468747996,1.0,5/17,28.95%,AFG1L;COX10;COX6C;COX5A;COX4I2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.22932552290478553,0.5987696248003282,0.9403669724770642,1.0,1.0,2/12,8.47%,TRH;SLC29A4
prerank,telomere maintenance via telomerase (GO:0007004),-0.19269306256685492,-0.5973439717966353,0.9714795008912656,0.9906963979459624,1.0,12/28,33.23%,MRE11;PPP6R3;RPA1;PTGES3;TERF2;TERT;HSP90AA1;RFC1;PINX1;GAR1;RAD50;PIF1
prerank,monosaccharide transmembrane transport (GO:0015749),0.21250088167578174,0.5971295724301902,0.9470198675496688,1.0,1.0,2/16,10.39%,SLC2A10;SLC2A8
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.21008447062730456,-0.5946813609890533,0.946983546617916,0.9913848192437706,1.0,4/19,20.69%,RIC3;CHRNB1;NQO1;CHRNA4
prerank,organelle disassembly (GO:1903008),0.17854643308634716,0.5944959643124248,0.9844789356984479,1.0,1.0,6/33,17.49%,ZFAND1;VRK1;UBA5;GOLGA2;UFL1;RETREG1
prerank,negative regulation of phagocytosis (GO:0050765),0.21016335900892608,0.5932033446899665,0.9563409563409564,1.0,1.0,4/17,16.60%,SYT11;SIRPA;CD47;FCGR2B
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.22678880324986875,-0.592551986402703,0.9605734767025089,0.9918670298854698,1.0,3/14,16.98%,SEMA7A;PLCG2;MAVS
prerank,cochlea morphogenesis (GO:0090103),-0.24791023721611796,-0.592063472959395,0.9489603024574669,0.9916817650744976,1.0,1/10,3.48%,TBX1
prerank,rRNA methylation (GO:0031167),0.19554486398618653,0.5920146579721014,0.967741935483871,1.0,1.0,4/22,13.00%,MTERF4;BUD23;DIMT1;TFB1M
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.21517319356515285,0.5919897217241705,0.958904109589041,1.0,1.0,6/17,25.30%,SELENOS;SEL1L;AUP1;HM13;DERL2;NPLOC4
prerank,endocrine system development (GO:0035270),-0.2036446205370278,-0.5918295096454227,0.9674329501915708,0.9913955907107518,1.0,3/21,12.95%,TBX1;SIX1;WNT11
prerank,carboxylic acid catabolic process (GO:0046395),0.2278449744575209,0.5909035460517067,0.924892703862661,1.0,1.0,3/12,20.49%,BCKDK;NPL;GNPDA1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.24437112675463865,-0.5907065445675742,0.9418181818181818,0.9914439078237951,1.0,4/10,28.77%,RPUSD4;NAF1;RPUSD2;GAR1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.21895748157091383,0.5905785327371408,0.9506726457399103,1.0,1.0,14/15,64.74%,SELENOS;SEL1L;AUP1;DERL2;NPLOC4;SYVN1;UFD1;TMEM129;FAF2;HSP90B1;DERL1;SEC61B;VCP;OS9
prerank,necroptotic process (GO:0070266),-0.21586187952364802,-0.5905099702202172,0.9616055846422339,0.9911404844208669,1.0,11/16,49.33%,TRPM7;RIPK1;TICAM1;IPMK;CD14;MLKL;TLR4;TICAM2;ITPK1;TLR3;RIPK3
prerank,coenzyme A metabolic process (GO:0015936),0.2223089435559372,0.5894102939345693,0.9606481481481481,1.0,1.0,6/14,25.13%,ACLY;ACOT7;ACAT1;CROT;DCAKD;COASY
prerank,positive regulation of protein sumoylation (GO:0033235),-0.249552770801364,-0.5891499700759212,0.9429590017825312,0.9912917485617292,1.0,4/10,25.76%,UBA2;HDAC4;PIAS4;SAE1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.245226195832974,-0.5889968361990153,0.9486238532110092,0.9909696074255012,1.0,4/11,33.21%,LRP6;CTNNB1;FZD1;NR4A2
prerank,protein mannosylation (GO:0035268),-0.20271523197615277,-0.5876177416531325,0.9583333333333334,0.9911037676772102,1.0,2/22,3.51%,TMTC1;TMTC2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.2205770584897842,0.5871753928782661,0.952914798206278,1.0,1.0,3/14,19.40%,RASGRP1;IL23A;CD84
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.2137994013640105,0.5869651749225823,0.9576837416481069,1.0,1.0,3/16,15.26%,IL12A;IL12RB1;IL23A
prerank,regulation of superoxide anion generation (GO:0032928),-0.2281624922149344,-0.586472435820362,0.9530685920577617,0.9911730472297231,1.0,4/14,21.64%,PRKCD;AATF;SOD1;ITGAM
prerank,regulation of telomere maintenance (GO:0032204),-0.19341401521147267,-0.5859422071289827,0.9730700179533214,0.9909925129968324,1.0,11/26,33.26%,MRE11;PPP1R10;TERF2;ATRX;USP7;SMG6;HNRNPD;SMG1;RAD50;PIF1;HDAC8
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.22879700848738135,0.5851335393852348,0.9570552147239264,1.0,1.0,1/13,2.15%,UBE2J1
prerank,glycine metabolic process (GO:0006544),0.2312459213895674,0.5849790015305449,0.9563218390804598,1.0,1.0,2/12,9.32%,SDSL;AMT
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.22095519753169218,0.5826735440042461,0.9776286353467561,1.0,1.0,3/14,12.74%,CD81;CARD11;CD226
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.20219406026191505,0.5825643016773768,0.9722863741339491,1.0,1.0,8/19,25.17%,ATP13A2;HTRA2;HTT;VDAC1;FBXO7;USP36;DNM1L;SREBF1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.24606355198952623,-0.5816202975304267,0.9566003616636528,0.9921480425078808,1.0,6/10,34.38%,ACER2;SERPINE1;SNAI2;WNK1;CYP1B1;MUC1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.23467545089957248,-0.5804317614300468,0.9514925373134329,0.9921701386361204,1.0,3/12,20.67%,RBP4;NOD2;STRAP
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.24186784353946567,-0.5798331823955809,0.9587813620071685,0.99198553926595,1.0,5/11,37.23%,SLC19A2;SLC19A3;DCK;SLC25A19;THTPA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.1909260695558213,0.5783976232147958,0.9562363238512035,1.0,1.0,6/23,19.91%,IL12A;RASGRP1;CD226;SLAMF6;ARRB2;CADM1
prerank,protein deneddylation (GO:0000338),-0.2411409216988819,-0.5750566233660277,0.9569471624266145,0.9932142206656777,1.0,4/10,29.26%,COPS7A;COPS8;COPS4;COPS5
prerank,maintenance of protein localization in organelle (GO:0072595),-0.20392912752502124,-0.5746372074347436,0.9664310954063604,0.9929710510594016,1.0,8/19,36.65%,AKT1;TAF8;TAF3;ARL2;HNRNPU;TOPORS;MORC3;ARL2BP
prerank,regulation of interleukin-17 production (GO:0032660),-0.1818655425799533,-0.5731188027540617,0.9798165137614679,0.9930812033110306,1.0,2/31,3.48%,SLC7A5;IL15
prerank,oogenesis (GO:0048477),0.2135655232899477,0.5718199962784452,0.9610983981693364,1.0,1.0,1/15,3.73%,FMN2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.2334174965544087,-0.5714861271592987,0.9477477477477477,0.9932344858008849,1.0,4/11,24.43%,ADM;SAG;GRK3;ARRB1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.22644063709004297,-0.5680430162072801,0.9715302491103203,0.9939390330184102,1.0,5/12,31.87%,SLC25A11;SLC20A2;SLC37A4;SLC20A1;SLC25A10
prerank,actin-myosin filament sliding (GO:0033275),-0.17141523167336276,-0.5679552497766645,0.9878682842287695,0.99320765940147,1.0,13/38,36.06%,TPM3;TPM1;MYL6;TNNI1;ACTN2;TNNT3;TTN;TPM2;TCAP;MYBPC2;MYL3;ACTA1;MYH6
prerank,muscle filament sliding (GO:0030049),-0.17141523167336276,-0.5679552497766645,0.9878682842287695,0.99320765940147,1.0,13/38,36.06%,TPM3;TPM1;MYL6;TNNI1;ACTN2;TNNT3;TTN;TPM2;TCAP;MYBPC2;MYL3;ACTA1;MYH6
prerank,mitochondrial transcription (GO:0006390),-0.23553524561274786,-0.5625143596104621,0.9550359712230215,0.9944010714803941,1.0,4/10,30.31%,FOXO3;MRPL12;SLC25A33;MTERF2
prerank,chromatin assembly or disassembly (GO:0006333),0.22346262131301223,0.5624120485820574,0.9530516431924883,1.0,1.0,1/11,5.69%,M1AP
prerank,positive regulation of leukocyte migration (GO:0002687),0.17589746857401944,0.5623742689302846,0.9764453961456103,1.0,1.0,4/27,16.80%,TNFSF18;VEGFA;JAM3;ADAM8
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.21950394025808098,0.5604838403556769,0.9681528662420382,1.0,1.0,2/11,13.06%,TERF1;WRAP53
prerank,regulation of small molecule metabolic process (GO:0062012),-0.179865858642296,-0.5592781835242128,0.9855072463768116,0.9949078205571716,1.0,4/28,13.89%,PANK2;PPARA;ACADL;ACADVL
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.20373539804064367,0.5590490888193556,0.9662162162162162,1.0,1.0,1/16,2.75%,TMEM161A
prerank,regulation of activated T cell proliferation (GO:0046006),-0.1759998001298134,-0.5589204001473858,0.9874551971326165,0.9946332582772199,1.0,19/30,49.33%,RC3H1;ICOSLG;IGF1;RPS3;IGF2;HMGB1;LGALS9;IL27RA;CD274;IL18;CRTAM;PDCD1LG2;TNFSF9;FOXP3;AGER;IL12B;IL23R;IL2;RIPK3
prerank,cGMP biosynthetic process (GO:0006182),-0.23461826122944257,-0.5588686345609322,0.9738805970149254,0.9942707705768897,1.0,3/10,23.13%,NPR1;GUCY1A1;GUCY2C
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.2123043452372835,-0.5575556572579684,0.9649446494464945,0.9942285327852384,1.0,7/14,39.41%,RARA;ANXA1;CCL19;NFKBID;NLRP3;IL18;MYB
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.22461809741454544,0.5562340297535273,0.977116704805492,1.0,1.0,3/11,17.63%,P2RX3;P2RX5;CDH13
prerank,protein localization to kinetochore (GO:0034501),0.20931692616775482,0.5546991919191195,0.9642058165548099,1.0,1.0,14/14,79.09%,RCC2;CDK1;IK;ZWILCH;ZW10;KNL1;CHAMP1;AURKB;CENPT;MIS12;SPDL1;MTBP;TTK;BUB3
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.21738288524128713,-0.5546315686437976,0.9529837251356239,0.9945942460951602,1.0,6/13,36.58%,GAS6;AP1G1;AXL;TICAM1;LAMP1;IL18
prerank,Golgi inheritance (GO:0048313),-0.22719254742663475,-0.5520808577151242,0.9716312056737588,0.9948527815599425,1.0,5/11,34.47%,YWHAZ;VCPIP1;PLK3;STX5;PDCD10
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.1956411165837119,0.5484534777677708,0.9655172413793104,1.0,1.0,3/15,15.97%,AP3S2;AP3M2;SNAPIN
prerank,anterograde synaptic vesicle transport (GO:0048490),0.1956411165837119,0.5484534777677708,0.9655172413793104,1.0,1.0,3/15,15.97%,AP3S2;AP3M2;SNAPIN
prerank,negative regulation of DNA recombination (GO:0045910),-0.15935802292839985,-0.5472644424799576,0.9942084942084942,0.9956840915092151,1.0,11/43,25.42%,SHLD1;POLR2G;CGAS;MAD2L2;TERF2;ATRX;BLM;MSH3;POLR2C;POLR2H;POLR2L
prerank,heterocycle biosynthetic process (GO:0018130),0.20705919651597954,0.5465738094447294,0.9760869565217392,1.0,1.0,5/14,22.66%,PYCR2;ALOX5;NOXRED1;NFS1;LIAS
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.22570083584991607,-0.5464358032497039,0.9757462686567164,0.995498311832527,1.0,2/11,12.24%,NOVA2;RASA1
prerank,carnitine shuttle (GO:0006853),0.21401098277498698,0.5455431789708551,0.9622641509433962,1.0,1.0,2/11,9.25%,ACACA;CPT1B
prerank,regulation of transposition (GO:0010528),-0.21355916460903135,-0.5431267606968114,0.974025974025974,0.9958852087292447,1.0,6/13,39.66%,UBR2;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.22374935959171002,0.5403533830788413,0.9702517162471396,1.0,1.0,1/10,5.25%,TYMS
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2198878627585007,0.5392284753200073,0.9647577092511013,1.0,1.0,3/10,20.34%,SOCS3;INPP5F;PPP2R1A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.21194648291975643,-0.5376810793139883,0.979047619047619,0.99673980666314,1.0,4/13,22.69%,SEC16B;BCAP31;EDEM2;SAR1A
prerank,regulation of cholesterol metabolic process (GO:0090181),0.17812578655608524,0.5356679363464112,0.984375,1.0,1.0,8/20,26.05%,DGKQ;ABCA2;APOE;SEC14L2;NR1H4;EPHX2;SREBF1;ARV1
prerank,protein polyglutamylation (GO:0018095),0.21018632203776622,0.535223131360205,0.9826839826839827,1.0,1.0,5/11,27.37%,TPGS1;TTLL5;CFAP20;TTLL11;TTLL2
prerank,kinetochore organization (GO:0051383),-0.2105404769689336,-0.5334295833262788,0.9886148007590133,0.9972895998654677,1.0,5/13,33.90%,POGZ;CENPE;CENPH;NUF2;MIS12
prerank,N-terminal protein amino acid modification (GO:0031365),-0.20904367611727898,-0.5330197391282472,0.9737827715355806,0.9969891156804044,1.0,2/14,10.14%,NAA16;NAA15
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.22042277915751257,-0.5321656625133051,0.9765342960288809,0.9967814841394453,1.0,6/11,42.98%,TP53;PTGIS;DLC1;DFFA;CIDEA;BCL2L1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.20814706331414623,0.5289837853579877,0.9690265486725663,1.0,1.0,2/12,15.26%,RASGRP1;IL23A
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.19364096765181307,0.5286650292262395,0.9864559819413092,1.0,1.0,7/16,28.70%,PIGP;PIGB;PIGQ;DPM2;PIGA;PIGM;PIGC
prerank,negative regulation of cation channel activity (GO:2001258),-0.17311888104107845,-0.5278170388662276,0.9853211009174312,0.9972853042089447,1.0,3/26,17.46%,PKD2;GSTM2;CASQ2
prerank,regulation of B cell activation (GO:0050864),0.1685619149337188,0.5270936063942724,0.9891540130151844,1.0,1.0,25/25,83.17%,SAMSN1;FOXJ1;FCGR2B;IL4I1;TLR9;MZB1;IGLL1;TNFSF4;SH3KBP1;ZFP36L2;LAPTM5;IL10;CD19;SLAMF8;IL6;CD22;IL4;AHR;THEMIS2;IKZF3;TNIP2;ZFP36L1;BANK1;NOD2;TNFAIP3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.20034015147226963,-0.5221439781045297,0.9867924528301887,0.9979290175871637,1.0,5/13,32.04%,AQP11;LPCAT3;EIF2AK3;USP19;MANF
prerank,female gonad development (GO:0008585),-0.18560656120401398,-0.5214682728520833,0.9895287958115183,0.9976634415878262,1.0,8/19,33.29%,EIF2B2;SOD1;FOXL2;COL9A3;NR2F2;CEBPB;EIF2B4;EIF2B5
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.2187310368609824,-0.5192641743820864,0.9754816112084063,0.9976822605582164,1.0,2/11,16.73%,JAK2;TAF7
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.21995056384089948,-0.5184206138615166,0.98,0.9974405735237988,1.0,3/10,28.56%,TAF7;BRCA1;SET
prerank,intracellular sterol transport (GO:0032366),-0.2034671115392493,-0.5169051676419649,0.9839857651245552,0.9973275817982648,1.0,3/13,19.93%,STARD4;STAR;OSBPL2
prerank,hexose biosynthetic process (GO:0019319),-0.15271170999460465,-0.514786359728788,0.9948542024013722,0.9972767422400416,1.0,5/42,14.31%,CHST15;RBP4;SLC25A11;ALDOC;ATF4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.2027705791838919,-0.5135375668776017,0.9849340866290018,0.9970999317266587,1.0,1/13,6.00%,CBL
prerank,establishment of spindle localization (GO:0051293),-0.19862423664915818,-0.5118183929006215,0.9818181818181818,0.9970083516052078,1.0,3/14,24.34%,MAP4;CFL1;TLE6
prerank,tryptophan catabolic process (GO:0006569),0.20243550310714958,0.5118122306511345,0.9767441860465116,1.0,1.0,11/11,79.77%,HAAO;TDO2;IL4I1;AFMID;ACMSD;IDO1;IDO2;AADAT;KYAT1;KMO;KYNU
prerank,tryptophan metabolic process (GO:0006568),0.20243550310714958,0.5102680493323599,0.9803921568627451,1.0,1.0,11/11,79.77%,HAAO;TDO2;IL4I1;ATP7A;ACMSD;IDO1;IDO2;AADAT;KYAT1;KMO;KYNU
prerank,ATP transport (GO:0015867),-0.21422592989391265,-0.505832382250449,0.9786856127886323,0.9975199785596048,1.0,1/10,6.69%,ABCC6
prerank,protein import into peroxisome membrane (GO:0045046),-0.17338225467897905,-0.5034516868048531,0.9944852941176471,0.9974835553246667,1.0,7/22,32.89%,ABCD3;RAB8B;PEX14;PEX3;PEX11B;PEX19;PEX26
prerank,indolalkylamine catabolic process (GO:0046218),0.20242279688676895,0.50148214919413,0.9851380042462845,1.0,1.0,10/10,79.77%,HAAO;TDO2;IL4I1;ACMSD;IDO1;IDO2;AADAT;KYAT1;KMO;KYNU
prerank,superoxide anion generation (GO:0042554),0.19260851560861036,0.49779570097555237,0.9812646370023419,1.0,1.0,2/13,11.77%,ALOX12;NOX3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.1978729414796208,-0.4949588486649181,0.9851576994434137,0.9982121560097846,1.0,4/13,32.84%,IRAK1;IRAK2;TNIP2;PIK3AP1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.18710028998417058,0.49226391710565787,0.9907192575406032,1.0,1.0,3/13,18.32%,BMF;VDAC2;RHOT1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.16411667022832688,0.492131944315618,0.9909297052154195,1.0,1.0,4/22,19.58%,IL12A;IL12RB1;IL23A;ZBTB1
prerank,DNA modification (GO:0006304),0.16285984687299,0.4883670957091363,0.9977272727272727,1.0,1.0,2/22,7.03%,TERF1;UNG
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.14326888033825452,0.48775792307232707,0.9977528089887641,1.0,1.0,6/37,16.19%,ADCY7;PLD3;CHID1;CUEDC2;SIRPA;ALOX5
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.17246440649065137,0.48650245445125945,0.9957356076759062,1.0,1.0,3/18,15.96%,CHGA;ADRA2A;BMP8A
prerank,gluconeogenesis (GO:0006094),0.14185717386925384,0.47994834551796545,1.0,1.0,1.0,2/39,5.24%,SLC25A13;TPI1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.18320598452540385,0.478153084174591,0.9977477477477478,1.0,1.0,2/12,13.06%,GNL3;WRAP53
prerank,microglial cell activation (GO:0001774),0.15718305185348241,0.47643306884049696,0.9956803455723542,1.0,1.0,4/21,18.47%,GRN;MAPT;CLU;CX3CL1
prerank,positive regulation of protein maturation (GO:1903319),0.18762161822861112,0.4757768463567357,0.9816933638443935,1.0,1.0,11/11,81.25%,NKD2;ADAM8;ASTL;CCBE1;TNP2;ANGPTL8;TFR2;BAG2;NLRC4;RHBDD1;SOX4
prerank,aggrephagy (GO:0035973),0.1514367252805158,0.47327419670305576,1.0,1.0,1.0,9/27,26.28%,DYNC1I1;DYNC1LI2;VIM;SQSTM1;UBB;ACBD5;DYNC1I2;ARL13B;IFT88
prerank,acylglycerol homeostasis (GO:0055090),-0.1637582142460342,-0.4675789654012581,0.9944444444444445,1.0,1.0,12/20,48.02%,SCARB1;LPL;PNPLA8;IL18;APOC4;PLA2G12B;RORA;NR1H3;HNF4A;ACSM2A;ANGPTL8;APOA1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.17928364854108594,-0.466668640783824,0.9929947460595446,1.0,1.0,2/13,12.09%,CSPG4;BGN
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.16590224521656763,-0.46630432866017923,0.9906716417910447,0.9999600611973046,1.0,5/18,24.41%,ICOSLG;IGF1;RPS3;IGF2;HMGB1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.1843693315288012,0.46361745314656644,0.9864559819413092,1.0,1.0,3/11,22.17%,UGGT2;AUP1;TOR1A
prerank,protein localization to phagophore assembly site (GO:0034497),-0.18898308562047395,-0.45938992078181606,0.9946808510638298,1.0,1.0,5/11,34.75%,WIPI1;WDR45B;ATG9A;PACS2;WIPI2
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.16456740658900584,-0.4579973733753545,0.9927007299270073,0.9998471896505803,1.0,3/18,20.80%,ABL1;PRKDC;PRDM1
prerank,rRNA transcription (GO:0009303),-0.17130810784148487,-0.45789959468961094,0.998211091234347,0.9994755472043003,1.0,5/17,25.90%,TAF1B;BRF1;CAVIN1;GTF3C4;POLR1E
prerank,RNA modification (GO:0009451),0.12438807454041004,0.45581764994201823,1.0,1.0,1.0,13/54,22.89%,QTRT2;TRMT6;TFB1M;ANKRD16;TSR3;FTSJ1;AARS2;TRIT1;QTRT1;NSUN6;ADAT2;THUMPD1;NOP10
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.17985230341975572,-0.44692312271509527,0.99644128113879,0.9998163897568779,1.0,6/11,38.25%,CASP8;RIPK1;TICAM1;SCARA3;TNIP2;RFTN1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.16263415041765633,-0.4416828199487293,0.9947916666666666,0.9997481028565126,1.0,10/16,49.32%,VSIR;LILRB1;CD274;TRIB2;PDCD1LG2;FOXP3;AGER;IL12B;IL23R;DLL1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.16277779148012744,0.4351799423105591,0.9957537154989384,1.0,1.0,2/15,11.67%,CHST2;EXTL2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.1377482058435024,-0.43327727312271663,1.0,0.9998133947140191,1.0,2/30,8.83%,CD34;PLCG2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.16088224253221886,-0.4271514982024289,0.9946428571428572,0.9996858374529155,1.0,7/16,39.96%,RC3H1;MOV10;RBM24;ZFP36L1;ZC3H12D;TRIM71;DND1
prerank,regulation of interleukin-10 production (GO:0032653),-0.12349734974728799,-0.42053635262872674,1.0,0.9995593328872351,1.0,24/44,49.32%,CD34;PLCG2;VSIR;NOD2;HMGB1;LGALS9;LILRB1;STAT3;CD274;TRIB2;TSLP;SYK;PDCD1LG2;IL4;CD28;TLR4;IL6;FOXP3;IRF4;AGER;F2RL1;IL12B;IL23R;DLL1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.1601417043537294,0.4148164765688483,1.0,1.0,1.0,1/13,7.03%,UNG
prerank,negative regulation of interleukin-17 production (GO:0032700),0.16757810927767203,0.41420667688466994,1.0,0.9999938572742885,1.0,1/10,10.01%,IL12A
prerank,smoothened signaling pathway (GO:0007224),-0.12372708164057791,-0.4018848007743299,1.0,0.9997379200872187,1.0,5/32,19.99%,SMO;GLI3;HIPK1;TMEM17;PKD2L1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.14421917748008667,-0.3986169300098416,0.996415770609319,0.9994260774905298,1.0,4/18,26.43%,TAF5L;CNOT2;PTN;CNOT1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.15808602666620047,0.3888394741233093,0.9977777777777778,0.9996415691121283,1.0,5/11,28.40%,NR4A3;FBXO7;RACK1;REST;PINK1
